<SEC-DOCUMENT>0000014272-22-000196.txt : 20221026
<SEC-HEADER>0000014272-22-000196.hdr.sgml : 20221026
<ACCEPTANCE-DATETIME>20221026113724
ACCESSION NUMBER:		0000014272-22-000196
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221026
DATE AS OF CHANGE:		20221026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		221332007

	BUSINESS ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmy-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737,d:42aefad24baa419bafa9083c3049e007--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:bmy="http://www.bms.com/20220930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmy-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF80LTEtMS0xLTExNzc1Ng_08dfb6f2-613e-44a6-8906-c95395618b89">0000014272</ix:nonNumeric><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF82LTEtMS0xLTExNzc1Ng_be868385-ec15-469b-b2cc-ae5e5e40c812">2022</ix:nonNumeric><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF83LTEtMS0xLTExNzc1Ng_55f5dcb5-2f6a-4ca7-97c4-3a4910ae2f15">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF84LTEtMS0xLTExNzc1Ng_556a1632-1f2a-4b82-8e43-8f808019a85f">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF85LTEtMS0xLTExNzc1Ng_c10ed4ef-3d4c-45e8-9121-5b48ea8a70ec">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF8xMC0xLTEtMS0xMTc3NTY_491f8fe4-dcd8-4a8c-b352-fe379efcb0cb">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmy-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68e3823dddb74db2958072c745a03097_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibffe096d269f4247ba0455fffac494c2_I20221014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c52b7c17b524a44903fa0bff0845939_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3909832868c44962a2e1a7cf39c79c87_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd8e6d78fde49408a97b0e2d733b6f0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0a72bb56bec4e89876d1ea244b49e22_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6d46fefd70244503bf70ff1057422f86_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae305004534c4cae8e7485e4dc74784a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if781377a20f34a65860112e032558c03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4db84d4e37a04e54af5c55bf28598232_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29266ae9af704e83ac646ebb6641fdb3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica0e3fbf1cf94fffa908248b335d98b8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02073132d0574931b33a0f63b07ca3c0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01cb0332a64c4a85999046b2d17073fe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044c0c7286a4460da3d4eeeba42cb69c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bc4b8be12534b2b9d7fa10bb00ae5c7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62bd0e6d660744a88a4153646993b3ad_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a5899d8d1b4d3e8ecbde0564615570_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23693b7b08249d3aa12050a006f0001_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e2e1abbc7064f37a17916a3c0555574_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6434d519a5ea436c9fdf8a130125e12f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04800f144c48480496199f7f1dcbef22_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af3648fd4884c20a605f122dfd20cc2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43278271a0ff474380032a771a7b1743_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec69e1d136440a8a76da2507fd0f758_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c166558cb7b467fb2cb4a39347b1703_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a53451866344aabc76f70abaf649a0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697262196a73456d97438e0a8c0db01c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4473234acb4698a92ec39a59dd736a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b29234dfee8455eae5c6cd393e05ad6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aebfbe0d44248bca085ae268561e653_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4003ca03f1e4e1983eef1fd2275159e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93af657bc36642fab0a352efe9e508d2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff59a735468f412282be47f01fe403fe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c3e2d54ddb4d6685984ee660b83ae5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9df57b8597af420d9c5ec3c15387bc01_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fe060f6be2495faa414c6e6ad65686_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62fda2db6b3941ccb2dc3fc8da4450e7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7599d4a3420d4aadbcf02d4eaba7532a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625e125bc434431ca1c8a772fea91d5e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80724b9311fc44598901283b8226c7c7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09afd557e9f3433cbf4edac16c1bd239_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4989d5918ce944d29e07c0809ff1d187_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7180b016692e484193376ecc09ef7603_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe4ffb2515d4f8b87bb7994bbe700c1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia300585bbecb4074986dc776703743c2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c1d84a792b475cbfa2c9a371ed8496_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f72bbf8c4304428b0ed80a8686b9248_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9d82f3486fe4d61884d139292c0a019_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93e43e0d5e449c9a5ac169c78f5729e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91564a174e264c93b41b7a67a1aba557_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52549b4b725c4beaa7e2e97bdb382deb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f173022564246479bb42891e0caadeb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7621f5141c74afea188b4fd300e0324_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b2771b60834bc88d400a6969621023_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33b8b166dcc47a19e7e82c8d64e0d0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375ecb41f5d34164b135dfb0419a036e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e88c910ffae4f9a9d5adc44c364d44c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c86bc8fc17947e8b991889d64c5e053_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3689d0fcaf24638a873a35863370488_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd8ef9dd4b34e74b6c7d422826a5a2a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib53644119d8a45f1863f5c215a118b2a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0cefbc0671402cb26abf2ad1c6e8e1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd31c065d2b4f2eac12a4313ca0b4e7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2977ed64024e9b82c97255c6614303_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i523864ecfe934c0a8c2a8ba3767f4efc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d028b025fa34a23934845203ff86eca_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib532e1cdc30944c5b30a57aeb3373c5a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ac2713db21647efa1e4c85b8371102c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3a202c6cd54c6b93f8c26bfb454aab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7edc171ac604a028ae6ba6d774d1184_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc68379ebba8498fbde398dcdfa0bbb9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief4fc5728521489486f5f10510221b0c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27953d1748346de8d241948e99fdfce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9253e2d1c9f14694a47e4b8ba936cd82_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2935cf5db0984e48a7311562d8957e88_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312e646a32594a92819e204cbcf9d30f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5077d69051d2407dac910cb1d4b5af89_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36674f96d1ba40588e290d02748a12d3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44bc11db15de490da4c09d2d876a005b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00488d76ec644f9f92320a9c1dcc6355_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d096e1112a84f968934e98a7d7e8897_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19f17c6b9684d4dae43eca5b8566729_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c063ffd131546f19b8bc98eaa3ea8c0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i992d193b56344cfaa5ba4098f9efd6f2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaae1d1308ff4f129502456c6536ad64_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b7e4ca6dec410ca3364c9088373428_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7db61f43aa43929a92deb8ac563b89_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b4ea4259ca469ca93f408a519be850_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24cc65b60058474db7537ab2b6b0a254_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a140f37738545fd8986a487a0effcd0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1539779a5914689aa5abc809e040af0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08528bb25e714575a7f5c80c04663b81_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ebc52b59af749918bb43f2480530ab9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4bb28437e7b4609b9fa0648528f45d4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7c15e9e75e4205a132cc94956026e4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c7cedbf6e5649418120798f7a9f2b6c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30592356ada44f519b3f806c7e67a991_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1276014500404e2e82de7171d6cb2c46_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c90420b4f6d468387df80ced89cde88_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639586984bcf4c9bb2800764224a0d97_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f8a8da7674641108fe5cccec2da9f32_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91a0cc6973147dbb665862c990ff09c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i515f50d74f9f403dbded026f016eecea_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c92b01540e8405eb5f3908c858d4523_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i957ae0dd10d742d585460837252b996f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0651d3b0cf44b9f9157cee57ba36939_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a88fbea78348eaa1d5f346ce2efeef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743233575df84038808b743f27ef5643_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1aaa93de272430e8ff046eb7df5c78e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfec8659679486082b93be2576c6ee7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c20938af5ea4f559a05d063bca23a37_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3d417b45d149649f2fab7b9c39c309_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b88401122a44aaae11d63f988564e3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia85644c821814dddb2f2fe08c06ecfea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd2c28076da74353b7a9b4be05493211_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b94424ed3440cdab12f30e34eef0e8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7cfc8d0143547ffb85e8991435779d0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718ffa0ce4264649a30d8e60f6d21e21_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5034bd9d5ac4d709b2d8bae0eda22ab_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c3c3b3adf74d829fdcffc4e2fd017b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b8d2d6534740bd9a6f4cd980bb5662_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib12e924a4a13410b84c6b424992cfa22_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f02d98cc4647e6a09a6e50ca3b081d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bf82dfff6346418613dbfd38767fc2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2360c71c4d7c4f60aff7afb5bd5adb43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2a2726ed8d946878e0409ab1bc8e479_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097fc6808da74bd2a448a5abc583ff06_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82055957ab0c488786f886e6b6babb70_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2b7e84f20fa4c0e8c203592f5fdc962_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5ca12fa8cf4f118404d35732aaa0e2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3fbc288f17842e0a75422793fa1f2d2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a091ee30a0546f2b3cf7109a52349aa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8a169883d84598b45391f2436b331d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i714ecd92180a4da09cfb9e1b711d8e13_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1682d31f29ab4c5c8e318685f109e06d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e11c81e870446bea062ed2f9a4dd75a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd51bc766ca44e85bd81070b4c92220b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68864aa7457c44f0a8c064e00afcf547_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b2fbe9642b4229bab1c013a4539695_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29f5777421440b5a7303c74ab686169_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:BridgeBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7d12df57f64215af002ee413e6d5dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e366068274246db8687bd2bf3a8caec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-17</xbrli:startDate><xbrli:endDate>2022-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54f1b4636db42e6988c8772120ddcb6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781907222fbe4667b1cd73c65ef72721_D20220817-20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-17</xbrli:startDate><xbrli:endDate>2022-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i793cb981ce5049e8b04829bfd1aebc05_D20220817-20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-17</xbrli:startDate><xbrli:endDate>2022-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b224fccd35141c6ab6c59ed52eab7c5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2142a064165c42acb01e69c102b6b950_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i094ac81d52ae4652a6b2c34240a43940_I20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i740d420ab04f43438529806760d35e0c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92913744fe924bd7afa2171de108004f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79552959d6b94618905e3c748636e2ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6dc427b52c490eaca902fe4c834622_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:LOTTECorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b18f99151344cda858f618b0c9b75e5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f79692d5f94137b6d2126460bcc45e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e0fb3f550cb46e7866c0f224cacb82b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb74491d80864f3eaa177e2b8be81ec4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic75f9bbfc5724ef3836a765059109689_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bac004294b34c42a5a7dbf2057b0487_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61db944e47a4581aaf245bb80e3db88_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e8f993a1cb4f79a93af4ee934de0b8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife53d46685aa4a87a864327520e67683_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93fcbb36dbf1444a8d0f08a84b035f69_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i992ba6626a224684911867fdc13bae74_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7f0dbcd1d24ef9a20304ac3ce6c2f5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9bad0f88cbc4be39604292bbbed7af6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id17ef668ac624a2f9ff552599af5c465_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ea20ff7bff341c7a20fcd4a22892b01_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadbb07e45d241d7a53c1917dfe4e639_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccec0e6e65dc4d6eb8d442778567cca1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0c115f0d654a1aad8188931e7d60e0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5689275b495b4b2f9cf12f272a88fefc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icda18d044f594a2ea664a02127e577a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82664611f3e4121968092cf4cd0861d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5d1dc816114f0ca32419717d7722db_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44f04ed35d04422a86bc2725b539aee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:AgenusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06dd7c1aa48f4cd691db5ffb92ff9be9_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15769c9092334b38abe2ab74542152e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i835e2f7f63d7466da1773c331a6cf84d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcab3a9d790d43a4aaa580b8ce49e8db_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>bmy:employee</xbrli:measure></xbrli:unit><xbrli:context id="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1410968e21274826afdf23dc9434f736_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead756ca21984013a7bd69516352fb13_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia870ef2304084b55ab48e0eae6731bb0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b86689f804f49e4ad0215f4c9f4f9c4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6962ac7520419e9e5528c42e86a43e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f20b9403da74f8ebf7c5eae9ba72e8c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1052bb4a0b64c1aac26a10e810aafe7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02826b699eda4a97ba070709457b65f1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4634dede34e4e588b48071be679100a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6947273e102141838832d4c25bb46991_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab45139100524f8f85cebfc6cbfa75ca_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e5de495c7546bfa0bb84d26e067aa1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f652f6a9e84b1091a70c260f8d4511_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4473abbbdf4a9eb56ed31379f62651_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcbea72907fd45ed8c844cd0e81ebc36_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib73eeb74828048d393d64170a29ce8f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b1ef508785f46e8951a4b5d8734fe0e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab4f089b9af40638285fff5aa6c4a64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7cf5a352a54110bd759e160ab71b37_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbcbcc18ebf94d8b84927842d8b4f534_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750af98d076240de881b7ff2bf09cd4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i664e35471e3b431f80b8059482063353_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032be76858324a3ea8ca82c8437b0d13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1750b8def3481db064bae547758030_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i599407fe2aa64479abc2cb9f8943ddf2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddf109f29964447db19dbc4a67325a91_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86460ffdc92343a1b34f3701d5ba3f73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023d3dd7e5e2466fa118f0a377f5a86e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023203ca7e2c44c6aef398e5ac1f362c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f21b31cd934d95bec8c47f5cca9d7d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751bb8a9c76a4066b66cc023f2f6e8ae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfb1a2171374f4680084a5e82d83fa3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6cfdd1ed78472f99fc8e5e7c606f21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6520e68dbf54cdc8ec17823e10b0646_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89986bb97ecb4e97aff1b91cce777c15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e9b662730384bb7b4ead3470de0d515_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9c861dc4c60414088ec212834a771e4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac1ef197e014b5dae4b0dcbf87a2891_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7100bf3c38b24a52bf40ec5e7f24933a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b888a0a457640ff861a14782a04bdbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib63b4fc1b0444bdfa216b46c39f99f6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaad04a4dfb54e4baa98287704d915e1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id32df06df7ee4312b8d69963af72d16c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001cf1d2900445718093f0ed5b320c01_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1b2dc24bcf49ce861f999cd524d75f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0bd321f5bb47f88e5f9bcc836bb474_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8881178a9a4ffd950fe4ca131ae180_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94029425ffb44b89b3a798ad9c779fa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia027865f0ea44b3a80cf5792949a8621_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6ee716584d44f0e92394dc97ec2e3e4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3291dcc3ae81483cb7fa13dfc3ad4b9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecb65891a224cfeac69f536b96a8bae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i951812de5a98402d9dea34b638a13c0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869c2864826e42ecb543c18a3ee8cad7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007f47041a3e4a0b8f534e32f84ef88f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ee3aac3606489e8746d195b398a934_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf0158c1228242f594f5547c1ecdf6af_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddfcd48ce404bf187e46620663765f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i886da8a6a90b461c9af99d1fdcba4377_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i668b51b58a0942a9aedf0c485aca6851_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i5eb686bfb0e04c65a42bb3210170dda7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f777b58fc44c61994b5a303994de56_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1fcfb5eba384919a6f3979d6d9e15be_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia29ecc9950894eb59b5cb3e5b2517a3c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ef79162dd034be895a4bcba78334e1c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339caa7c1e6a43eb90fd07efce417b64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac0fb0b0b75c45ee8d18d3d8d0b6d4c3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9113bb62f5fc4e84b6e97c82d3e2911b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfad7762f964e1ca74853b28c6b82a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387ddd833f71435ba85ff38a446a1ad4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5649feba80774237abf36efd972c7da1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ca08b52a6742409695aac6c23554f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de81def66b94b54849c6be2071f8a4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671a3558463349758ba20e3666722cc5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434b45cb2aa04afc908af8ac2c0b29e3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239d9003938740c39216c644b9c80fbb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa5e345526d4cb184e2c617cd44dde2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b5e6864bac4cc4a4d6c73ae31d6a8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356d70d9be5b40d3ae48415c984f8747_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae55e5eabed94fa8801cae43dc8309ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d2f488420464613bdeee86193ef4eee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide37ecb83af748fb901addbb7d586542_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed40edcdca04be1ac7f40fedd1fbf28_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341c5e7c579a49489d32d9cdb3032597_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52bc3e57749345ea918765039e97891b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbf70c949b4444abb6425eec36d8fdd7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d78e80b73040089346da240187c709_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8febe75ec14be68b29d9e554cbb15a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1cae60d9924382bb960c3201397998_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i623000336f474ce0a7c985a7099f9f33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a2f300fd224cf69ad83417e63b0645_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia507ce7f836d4c8f9300d3ffdffc8f80_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9681d173c7946ea819e81222ecfe950_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe3e81f2f1b4a57a73467c81f0b6af2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb1e679272541e9b87cbfb82b0c1cb7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2dd852e2564293b0c25120a2fea24e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id232f272e34d446b97e88ece5cdad405_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51db28aa096b432189a3788e6aa7123f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86fff4fcd97244e8a2031133dc96e519_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67fdac5f25c142198444d8440aeb1e36_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09ce9df741f740bb89856a5bf20958f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e98552285044c26ba232ed5924465b9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia35153af17cf4e51a7a041e312ab160e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf7a73a7127b44f3ae2722fff64309a6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f9f5be85464567b1c04db5316afee7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7982584c67704aeb87a3bc5199ecf7b8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac23d9ba09ef4f6f9bb57d9dc257b587_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib632c605afc443a9a1e66024aaf25726_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0daeb22196f04a9c979d9bea65d5029e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92872acbdf1845709dc97146229773d3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44851decbabe44c2aa827ce35420cd14_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f45381d84d492c9d4620e158db0048_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cb0c279ee9246b5a0b911c7c61e2557_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13e28e98ba32447bb7448a8051ebaf80_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c7d5843d7de40ddbe92cb7c600b33f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cacbe74c36b42af8f2449ab4f4558d6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cdf266395024196809286a2ed6e58ab_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic52749ea5b0c4ce2b65ccf38c233521a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a41df960fa54741b1d2968b3effa442_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i150c8a06bb804437a2510c0f68d2e14c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b217acaaa49469aad78b589be10377b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.600Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic78054c42bcb4ee9846b78e126b01988_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24f31e173564ef08923e7298471a389_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2000NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250BondsDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b5d7f1faad4e848093aeb065829a46_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3550BondsDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6404ab102144f6ba73c22e80f018486_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc346e3c2eca41249ffeaa6cda84f7db_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9789a0514bca4a1f9a657955e08feb99_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2052Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203a9a6396554765b8fa0659e4a3d831_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2062Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645d2dcb8c254458b2bba8716a3d4871_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18778c0e80e94ff1bbb25132a78a2670_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2550SeniorNotesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2250SeniorNotesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="creditfacility"><xbrli:measure>bmy:creditFacility</xbrli:measure></xbrli:unit><xbrli:context id="ib9a6a86876fc43d388aac8adf3fea7c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7a1031a2d014325bddb2d8b3e07d8d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5810116290c741c4ad8f11aed5bf0245_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2461c577cc2e466494498e4484b6c258_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a2ea2f6823b483bac68344cc193c509_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie48edd2512e6470bab3e50e5a0158fed_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>bmy:customer</xbrli:measure></xbrli:unit><xbrli:context id="i24c74d0c904c4e3c93154b14e664eeb0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27025e532fa946c5a66af008af75071f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i886174f12723459392de618ff498cab2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee682ed54c547b3b7f983bfdc4c3c2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6ada0a913014cb4a8b2d1fad754e062_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2f5ae04b7ca428da1a08620ad962073_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58caf9412c34780974fe127d4a49141_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba770528fa914f1e8e9ac8e274342513_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49772d239f2c4ae3ad2bb802c2f564a9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f0573b5eeb4100bf220e6512047183_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic605e8764c2d4fcfbfd94ae6c74b3e65_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc3701c2cc449cfb23ae43990a4a971_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id566a793fce34008bfef682147c19536_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d325d61d7f4391ae952172cc449249_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i653130003b5e4bc7b7676e60c391071f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e8639f3418a48268cee6497be9986b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219c2189e62b4365b40543aca350a443_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id243edc1992c42548f6d5cfeb9cb4676_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951972d8afae4eaabb5d09508787712e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccb38ad8451f4f6497c394f35b06eb08_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if704e1173f28402383a6c57f2e3df140_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fe41494b00144aeb5eef7881099386c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2168a62d5517410387e38e8ee41bdb64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20651cc5726a493da9cdd353ebddce96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d0354da6a042df94a411a0fc948ddd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide2fe15f76824880a795877832feb862_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0282842cd245059208dde198cff004_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08f80cfa602443b95ad13171165dfa8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6ea8a669ebd49d098c897a367c09915_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81843f4922a440dcba130d3844c32c51_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1959f27617924dd58c01a80cf6b58c30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a04a6cc493441c896b686ccf7d9db6c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10004cd63b014f3f8682ee02de56861b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id062426fbfc04f8c9b4ae0975bc9b322_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96fde31e46e241998655851bda819407_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i424fa464af494f00a96d5d2ecde941c1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70bb84b635a14384813aff1611be542e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie36c386d500b49e9b15964e0e07d8e99_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c5af4d6da0c46abafd596c61cea80e0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f675d87d624de7959d9b23d44a06ad_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90cad36c797440684daad86d7b7980c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a762be7d3142c79bcc98621c63a1b4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261fe8c2d46d4b2bbdcb71ceee0a2956_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708233e593ac416d8961d311b12dd0d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f6b897df93a45b0931e170cfe06cd39_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58393e2f2a5a48d6a80d43186ff0f68a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic389bf69a1b047ae8a8ca1032a58c315_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie839b830453247969319cb4087f8432e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f1af0105054a9d94aaf408f96a944e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i639f28b14fcb4c98a3e7676735c73daa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45849baa6e0c4606bd93975a061f7213_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie798c0b144ab4feaac7932ccbec3c84f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e7be709431d46ecab3d337838ec40ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1bb411461174751860a090a735e24e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69dbdf8184bb44cb9a23af5df39a7e17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab6129cd90e47629f61a8c46beb198c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbf10e85fa704140bd6819ab1c54a619_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16b6a9e7477b44bf812f52b13f664d43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb86ddecf754f1b9ed10ee592a8c467_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea49ce882bf4f63af2987bb1e15d6b6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89084d224e14efdb9d09b06d9c54c39_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id73e463a04364161a685d3c4430b5550_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7555f794ba413894219c16f451682c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d62d70afcd42918ea9a2bfec538e66_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28b2d4d8d91d4b278caf43bb6f13b862_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic367a2ecd9d0433e86bbfb9640e1163c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f58e8de911437f80231a5c3f56f8a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00793ef22204a91b9d9819706370521_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c911796bb404970a0c3702c1385d332_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63981ccb8d3246b7aa697743bf82119c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872f940e3394429d83f38b9f6d926087_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia128e4642cfa484ebf43540577cd5f09_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20e0a56327ff4170819c77cd3052bfc6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5304c82d5b4048f985873fbbdfca9327_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e16a4a57b3c403e9a92285a51739e1a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a7b2e0f79541e592a3eb7ca30e07b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a80b405b4bf48fba866761f2581c0ca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57dbfe3fc0b04540a9062b9da8ae1cfe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1451fd8e009248678887b28feb0d817a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6fd46ccee88439e82d67fa529a9ff35_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2133f6965b7a48aa889670197491b115_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1d2ccd1fdf457c81335d661d935b52_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe1775a56a28418cad0acff1223adbff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8be942a9fc84e4f9d8dd09313b7c6de_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6a2417ce314f85af97421da8e0d628_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a6b956076b456c914890389667aed8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02a3afd2d6d4dbab20a028d5348db71_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182f6377eff94cb4b6ac7e5d4a6b565f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a95cd7d7ed541189aceda668d7d654c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba0cfd360d4403caf7866291f6dead2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e212023ac5f4762aaca5b3d89139de6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d86b71f50834432b48b0b5ae6624d4c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i457c2ed3cca24d1090b72bce50a58a8f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2019ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ef053676a74ed99cf89ae337acf080_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i816eb507d5a445f2b307f4498312546d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a53e0c411d4dd6a1b3906051c59f59_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eac47f0f662452bab570a31fb550c4d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e87163d7174e1794368f54fd79d68d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id311a3410b814d8098ed2e0909160625_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7bcf421c5b3484f9aaf9c80235ca4cc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137caf5a65bd4e80a938b17ee3cb93f8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc4aed180144198bb9d2155f7e854fe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc5c8ecc7b1431b9d38a50d36e09fed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46a8d26897645bcbf98e6b68bcaa6ab_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b708b44785543eba9d88603d0d9fe17_D20150901-20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>bmy:patent</xbrli:measure></xbrli:unit><xbrli:context id="i239659e8afed4074998fed4287d1015c_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f40e9186eb64a12b2819fd50ddd4855_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d729505bb21466aa4b2151156e86b6c_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68e8486eb69e4b6e9cc08fa79cc5e099_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide99966f8de84c51b7647698c4934494_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i16e78aa141ae465bafe3f1d21cf16785_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e26862e568b4ada9e48b0f17370e14e_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6c532a43a946b58847610daa31145e_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cd813fc670a4450aabfafc92190f440_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bmy:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>bmy:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i975e062f55604508986037025ddd0a99_I20220330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342915fb33cf4e95b5ea927f1cf7228c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18f9080b9c994fa291b5e12c3b4813d0_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0 id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67 id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i42aefad24baa419bafa9083c3049e007_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU4_8d12313b-c2f8-445d-882c-27b338496af0">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY3_25418c5e-08cc-4191-8974-f81dc1f06822">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNjc_1c44a388-6429-478d-a7fe-59b3469c8616">September&#160;30, 2022</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU5_1ce52918-b767-46f8-bd7d-5f1dbeffe212">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYw_33a4e1b7-4735-4383-be6c-94aac08fe20f">001-01136</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYz_e32f53b7-15c2-40e0-a43a-2dddd8e743b4">BRISTOL-MYERS SQUIBB COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6MmM4ZDMxYWEzZDU2NDJkYjk0YzJlZmZhNWQxNTYzM2YvdGFibGVyYW5nZToyYzhkMzFhYTNkNTY0MmRiOTRjMmVmZmE1ZDE1NjMzZl8wLTAtMS0xLTExNzc1Ng_61549987-0237-4339-81b9-a5e268e3edae">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6MmM4ZDMxYWEzZDU2NDJkYjk0YzJlZmZhNWQxNTYzM2YvdGFibGVyYW5nZToyYzhkMzFhYTNkNTY0MmRiOTRjMmVmZmE1ZDE1NjMzZl8wLTItMS0xLTExNzc1Ng_34d9ffc6-57f6-4b93-bd32-89df15118d05">22-0790350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">I.R.S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"> Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY4_a331558a-ee3b-4ff8-b45a-ccf37e0419a4">430 E. 29th Street, 14FL</ix:nonNumeric>, <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcw_0eb5023c-7dde-48cd-bce1-a1fdb482c603">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYy_999553f1-271f-475c-bf35-babb298173cf">NY</ix:nonNumeric> <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY5_8f028af5-c91d-4878-a817-83bdd04a88b1">10016</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcx_2ee9bc84-2c4c-4be2-8574-754454be8cb7">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY0_c0dc3a34-caf6-49e5-94f5-6a554b3f92b2">546-4200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTAtMS0xLTExNzc1Ng_7e80b50b-5d9c-438f-990e-d6c247d1d725">Common Stock, $0.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTEtMS0xLTExNzc1Ng_74132e47-1ba8-40d9-9e3a-ccbd1b23b790">BMY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTItMS0xLTExNzc1Ng_c5816628-5e65-4033-a4d6-513d64545208">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTAtMS0xLTExNzc1Ng_b7b6c446-b1f0-463b-8e33-14778456fda6">1.000% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTEtMS0xLTExNzc1Ng_1300c661-5c02-4f66-b241-26168f98b92a">BMY25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTItMS0xLTExNzc1Ng_c3b66435-2093-40b1-8acb-7102034709a2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTAtMS0xLTExNzc1Ng_3bdd5b88-ca9d-4a03-8971-e8aa2769e07b">1.750% Notes due 2035</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTEtMS0xLTExNzc1Ng_40a3590c-7e52-408f-bd54-f5b984db7079">BMY35</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTItMS0xLTExNzc1Ng_605880e4-2e7c-4979-b73a-6a1634246879">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTAtMS0xLTExNzc1Ng_7eecdf4e-8655-42d3-81ba-c67d0a50b965">Celgene Contingent Value Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTEtMS0xLTExNzc1Ng_217078ee-5463-4e08-bfd8-d3497144d95b">CELG RT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTItMS0xLTExNzc1Ng_c6526179-224f-44c5-8340-5fc770efa1d8">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to the filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcy_08406a02-1b2b-4123-a75a-e2d23777b1ac">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcz_044f3eee-6d33-4610-b91e-e9ece7a6b2a2">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of &#8220;<ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY1_0422c029-1257-4215-84c4-f9e5ec0a9705">large accelerated filer</ix:nonNumeric>,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Smaller&#160;reporting&#160;company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU3_ef152d29-f155-447b-9775-365ea600c4b4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY2_41f553ec-fac7-46ad-9a93-28574248f529">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160; No &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICABLE ONLY TO CORPORATE ISSUERS:</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">At October&#160;14, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ibffe096d269f4247ba0455fffac494c2_I20221014" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yMzg1_13fa147c-1b44-400e-990b-f4ec90cadd43">2,126,160,347</ix:nonFraction> shares outstanding of the Registrant&#8217;s $0.10 par value common stock.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I&#8212;FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_13">Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_16">Consolidated Statements of Earnings and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_19">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_25">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_28">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_28">6</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_97">33</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_169">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_169">52</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_172">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_172">52</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#8212;OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_178">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_178">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_181">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_181">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_184">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_184">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_187">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_187">54</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_190">Summary of Abbreviated Terms</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_190">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_193">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42aefad24baa419bafa9083c3049e007_193">56</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. FINANCIAL STATEMENTS</span></div><div id="i42aefad24baa419bafa9083c3049e007_16"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions, Except Per Share Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi0xLTEtMS0xMTc3NTY_511f73f5-73b9-4867-92be-e7483e255b3b">10,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi0zLTEtMS0xMTc3NTY_2f04681e-f420-4c88-bc7a-1e8bea3dec06">11,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi01LTEtMS0xMTc3NTY_77b48c80-5ba8-4f2b-95b9-864d0a440423">33,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi03LTEtMS0xMTc3NTY_fc89a1cd-6452-4ea7-bdcd-c389e97e1c21">33,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance and other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c52b7c17b524a44903fa0bff0845939_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy0xLTEtMS0xMTc3NTY_983f59af-a27f-452d-b056-c0e31929a2c8">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3909832868c44962a2e1a7cf39c79c87_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy0zLTEtMS0xMTc3NTY_4eacf81d-5339-4f50-9a4f-d6c7812426e4">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd8e6d78fde49408a97b0e2d733b6f0_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy01LTEtMS0xMTc3NTY_cd21235f-1d8d-46be-919c-00ed37709e15">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a72bb56bec4e89876d1ea244b49e22_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy03LTEtMS0xMTc3NTY_7bc1a095-2fdd-4064-a5f8-b321f96a171c">954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC0xLTEtMS0xMTc3NTY_37482043-0afb-434a-b77f-2f15a9c00db9">11,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC0zLTEtMS0xMTc3NTY_db5b8744-8a88-4acc-beef-d937df09afd9">11,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC01LTEtMS0xMTc3NTY_c90d8ce5-507a-41b3-a97b-340953b940d1">34,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC03LTEtMS0xMTc3NTY_cd609d04-3d41-410a-8693-21bfa6dce735">34,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67">2,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b">2,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0">7,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc">7,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy0xLTEtMS0xMTc3NTY_a936db7b-9730-414b-8e60-56bcc38994dc">1,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy0zLTEtMS0xMTc3NTY_ea9bd535-91e6-4d6d-b11e-7c93be014b3d">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy01LTEtMS0xMTc3NTY_8238a064-d6da-4d8a-9ac6-393fd841825e">5,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy03LTEtMS0xMTc3NTY_d64b746e-6cfe-4aa7-ac4b-66ea8c80af4a">5,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC0xLTEtMS0xMTc3NTY_439e1685-2ada-4a16-a6ca-badf504dd898">2,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC0zLTEtMS0xMTc3NTY_182bf2f1-d857-473c-97ee-0dd17ef982b0">2,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC01LTEtMS0xMTc3NTY_595be055-bf12-4b4d-b18f-846ab243d0bc">6,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC03LTEtMS0xMTc3NTY_4cc58bb5-d75f-4ed1-8857-a9a8135db9c1">7,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS0xLTEtMS0xMTc3NTY_8ddc1c85-b5ef-43d3-b1d8-187ff7567b04">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS0zLTEtMS0xMTc3NTY_325ee1a3-758b-4fc9-9589-74cfe9311c09">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS01LTEtMS0xMTc3NTY_25133c44-46ce-4ca1-95cf-475b46327dbc">763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:AcquiredIPRD" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS03LTEtMS0xMTc3NTY_244990b6-4059-42b5-854d-8e65a26c48c8">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtMS0xLTEtMTE3NzU2_fc8f967f-b05a-4927-a8ae-0f4419d29cdb">2,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtMy0xLTEtMTE3NzU2_b935de85-3f12-48c2-a87a-3be9348d654e">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtNS0xLTEtMTE3NzU2_0910914a-1bc0-4aad-b421-b06b0210df9b">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtNy0xLTEtMTE3NzU2_0d1e43cb-4a8b-4a40-99fb-1311c4416eca">7,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtMS0xLTEtMTE3NzU2_b62f6884-1baf-4d12-b38c-d2c200023c6f">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtMy0xLTEtMTE3NzU2_52bf4823-6413-40ab-b131-36e984d5a593">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtNS0xLTEtMTE3NzU2_a5196b9f-1072-406d-9a46-883c9ab1470e">793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtNy0xLTEtMTE3NzU2_7316c7b0-f9e9-434e-aa87-8e1b66366a85">1,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItMS0xLTEtMTE3NzU2_5a037692-6756-4231-93b9-018b61a7d78c">9,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItMy0xLTEtMTE3NzU2_5f026a2d-a9f3-4b6c-a56d-09ac0fa49a88">9,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItNS0xLTEtMTE3NzU2_aeccf14a-f42c-478e-af1c-ef21e4250f21">28,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItNy0xLTEtMTE3NzU2_3247625e-c384-49b7-aa41-dfa4026d2e4f">28,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtMS0xLTEtMTE3NzU2_a2adcfe5-18a6-4237-87fd-364228f77ae4">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtMy0xLTEtMTE3NzU2_48b283a3-6af8-4ef4-9866-6ab952a3a7d7">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtNS0xLTEtMTE3NzU2_a31baa79-0071-40bb-9ade-a096b2f6469c">5,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtNy0xLTEtMTE3NzU2_142eb004-d081-4318-b914-ffd9111948dd">6,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtMS0xLTEtMTE3NzU2_30d210fc-9104-4189-9fea-a72101d537e8">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtMy0xLTEtMTE3NzU2_9144edee-ee25-48d5-a0d7-ce952e790831">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtNS0xLTEtMTE3NzU2_9e9219a7-a48b-4b7f-bc7a-33dcbfb0580b">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtNy0xLTEtMTE3NzU2_0728805e-4b52-4c59-a512-6d4c5eadd2d9">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtMS0xLTEtMTE3NzU2_bf5d1320-86f2-47b7-bc88-3fe004b214db">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtMy0xLTEtMTE3NzU2_a4eb7728-62d1-4eca-8d12-5e5ddfd9d157">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtNS0xLTEtMTE3NzU2_a57c105c-c78f-48be-998d-5b15ae66a59d">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtNy0xLTEtMTE3NzU2_1ab96859-98b0-4bd6-837f-d44234009610">4,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling Interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctMS0xLTEtMTE3NzU2_bb42b00c-504b-4506-9bf3-97a5cf3e698f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctMy0xLTEtMTE3NzU2_41737f4b-474b-4284-a72d-7c52ffa9f0f3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctNS0xLTEtMTE3NzU2_9396eb5f-76b5-4bc7-a65a-2973a756f51c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctNy0xLTEtMTE3NzU2_9a2dea80-1ab5-462a-9f07-6d704f2092ec">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtMS0xLTEtMTE3NzU2_e2f341f1-e7a2-4275-9694-917ab79788d9">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtMy0xLTEtMTE3NzU2_60cf0243-18f6-49a3-aa43-53538ceaa0bd">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtNS0xLTEtMTE3NzU2_3d314cd2-2e6a-4a27-9970-5aefdeec0349">4,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtNy0xLTEtMTE3NzU2_51a702b9-cbbc-43e5-915f-2f8135392479">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtMS0xLTEtMTE3NzU2_07821a8f-8da9-4757-a1fd-3c09287a779b">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtMy0xLTEtMTE3NzU2_5fa61ff7-3055-4fe8-ae7d-7edc577fca98">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtNS0xLTEtMTE3NzU2_474b2c88-be1e-4cc3-8ce9-6d7cb40e433f">2.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtNy0xLTEtMTE3NzU2_202b307e-332b-4588-9738-9b7f8b4f4d54">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItMS0xLTEtMTE3NzU2_b5d974d4-0ad6-4204-96f7-8cafa2a2ce1d">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItMy0xLTEtMTE3NzU2_eed7092b-bc64-478f-8f46-114d56d3a5c9">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItNS0xLTEtMTE3NzU2_522a0004-7fcd-49bb-811b-430979267bb0">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItNy0xLTEtMTE3NzU2_30122e23-d91c-462b-b8e2-3f8dd38e03a2">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3" footnoteRole="http://www.xbrl.org/2003/role/footnote">Excludes amortization of acquired intangible assets</ix:footnote>.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi0xLTEtMS0xMTc3NTY_2ea8ff28-8dce-4ed3-9402-65d00dc3155e">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi0zLTEtMS0xMTc3NTY_3514385c-8720-4044-a134-066692404331">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi01LTEtMS0xMTc3NTY_69956704-590c-4736-ad76-6192cc7f0a16">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi03LTEtMS0xMTc3NTY_883f9ba3-ccba-46f3-bdf4-10d3143ee6fd">4,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income, net of taxes and reclassifications to earnings:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC0xLTEtMS0xMTc3NTY_8a8efcf0-aa00-496e-ad84-29b3e92c95f8">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC0zLTEtMS0xMTc3NTY_97811a5a-63f0-4894-bb5a-c6dc77eebf6b">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC01LTEtMS0xMTc3NTY_4648852e-d2a7-49eb-9643-9b1d776bb9d0"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC01LTEtMS0xMTc3NTY_6b2fee47-7732-49bb-88b3-3572350d7157">618</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC03LTEtMS0xMTc3NTY_2f6cefe9-7680-4958-86d6-ffaa92002d81">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS0xLTEtMS0xMTc3NTY_b3d178d4-c55e-47a1-a5ef-97cf3e239fd8">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS0zLTEtMS0xMTc3NTY_44999901-f53e-4196-b564-8352f2bc96f8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS01LTEtMS0xMTc3NTY_bad60823-84fa-44c2-917a-b7a16d6e93c1"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS01LTEtMS0xMTc3NTY_f39a7c2f-8023-41ea-b94f-583480806dae">64</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS03LTEtMS0xMTc3NTY_9491cd64-0e31-4d02-a098-f0e57d66fe12">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi0xLTEtMS0xMTc3NTY_603f47ae-199a-4afd-b916-e4e2b622d45c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi0zLTEtMS0xMTc3NTY_05fd7662-6569-4b49-9c18-0573818c3cac">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi01LTEtMS0xMTc3NTY_ac6348f0-8681-4970-b70f-a2ee8f620895">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi03LTEtMS0xMTc3NTY_b2e9b68c-c8b9-4eb8-9493-b4f919895436">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy0xLTEtMS0xMTc3NTY_de2bcaec-c17a-4ed1-986a-0745e298aa25">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy0zLTEtMS0xMTc3NTY_d88e152f-7e8e-4935-a449-d2a953e5037c">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy01LTEtMS0xMTc3NTY_3620d4ec-a2b3-4043-9942-0d7acb32da34"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy01LTEtMS0xMTc3NTY_8ec9885c-d7d0-4f28-a30a-f4da743baa25">253</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy03LTEtMS0xMTc3NTY_3834cd16-8648-4348-aa4a-1b089180e46b">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC0xLTEtMS0xMTc3NTY_2cd18e53-b8c9-4841-9d82-2b5a7b7278ff">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC0zLTEtMS0xMTc3NTY_bea9892d-5dc5-4177-835b-47cb2b984abb">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC01LTEtMS0xMTc3NTY_03cf6446-0337-498f-96e9-9e08f356b918">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC03LTEtMS0xMTc3NTY_c3810eea-2b2d-4202-8b32-b9d1bdde870c">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtMS0xLTEtMTE3NzU2_8cc78c45-41a2-4d29-a903-6dc07c51409e">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtMy0xLTEtMTE3NzU2_28280a9b-0709-4333-b5f2-48f3adf69047">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtNS0xLTEtMTE3NzU2_173e9b61-aef8-4840-976b-deee690a3a59">4,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtNy0xLTEtMTE3NzU2_13fdfd99-52fc-45ca-a3e3-104f06170c98">5,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income Attributable to Noncontrolling Interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtMS0xLTEtMTE3NzU2_bb42b00c-504b-4506-9bf3-97a5cf3e698f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtMy0xLTEtMTE3NzU2_41737f4b-474b-4284-a72d-7c52ffa9f0f3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtNS0xLTEtMTE3NzU2_9396eb5f-76b5-4bc7-a65a-2973a756f51c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtNy0xLTEtMTE3NzU2_9a2dea80-1ab5-462a-9f07-6d704f2092ec">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income Attributable to BMS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItMS0xLTEtMTE3NzU2_67cecd26-bf1f-4ae6-98a0-21d8109b64df">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItMy0xLTEtMTE3NzU2_51f96c87-ed01-43c8-8d36-164530833549">1,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItNS0xLTEtMTE3NzU2_ff9f3ff1-a1d9-4604-b291-44692add9744">4,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItNy0xLTEtMTE3NzU2_2683433f-88cc-4ae5-a266-dde7dabd7bd6">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMi0xLTEtMS0xMTc3NTY_8f47ee27-6b84-4c4e-abb4-e081faad48d7">7,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMi0zLTEtMS0xMTc3NTY_fc4a41a3-4df9-4ac6-bbcb-1988ca15a5ee">13,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMy0xLTEtMS0xMTc3NTY_022250e2-e74d-4a27-ba51-591c4fbe5684">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMy0zLTEtMS0xMTc3NTY_e2b4d8d1-3af7-446e-9d0c-b73bd3b0e67d">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNC0xLTEtMS0xMTc3NTY_ec04a636-7426-4429-b898-498279bcc678">9,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNC0zLTEtMS0xMTc3NTY_53ed4554-1735-46e8-bdab-61822d00ffb5">9,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNS0xLTEtMS0xMTc3NTY_0fdc5c4d-3d07-4d3e-8497-2a30268fc3e1">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNS0zLTEtMS0xMTc3NTY_450b17b0-512f-4802-8253-38f5e2a23b8c">2,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNi0xLTEtMS0xMTc3NTY_fb3b5152-bec5-490d-8eb2-e2e317aecc81">6,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNi0zLTEtMS0xMTc3NTY_bfe7f9d0-9214-44ca-bb90-7277e12ff077">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNy0xLTEtMS0xMTc3NTY_5e0f4de8-3702-4dc0-b41f-019345144766">26,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNy0zLTEtMS0xMTc3NTY_1352d0e6-e704-4def-8b2d-bd9c7ef34f18">33,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOC0xLTEtMS0xMTc3NTY_8cd6b169-6d5c-44b0-b7e3-d1397b9aecc1">6,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOC0zLTEtMS0xMTc3NTY_709736e8-08b1-4b88-885e-6d2a5d7db7dd">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOS0xLTEtMS0xMTc3NTY_b9d35f14-fcce-482c-9079-955de159804a">21,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOS0zLTEtMS0xMTc3NTY_73ebfc34-4ad2-4eea-b04d-3cbbb19c732c">20,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTAtMS0xLTEtMTE3NzU2_dc026477-6d75-4855-95fd-f4912e3cf818">38,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTAtMy0xLTEtMTE3NzU2_991b688c-5023-46be-a83b-ecaa78fcca17">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTEtMS0xLTEtMTE3NzU2_2de19ce2-1213-4aef-bdf8-e042b55801b6">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTEtMy0xLTEtMTE3NzU2_862793c6-cb94-4db7-8a6d-bb339ec9d439">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTMtMS0xLTEtMTE3NzU2_c000ec0e-4ea1-4597-a2d5-2f146bb3eb59">4,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTMtMy0xLTEtMTE3NzU2_f1eef5e1-7040-4d94-b205-c57152e38be1">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTQtMS0xLTEtMTE3NzU2_44853d22-58f3-4364-a859-99cdb7b42b41">98,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTQtMy0xLTEtMTE3NzU2_8a68fcde-daa3-41a3-af59-457feefa3ae3">109,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTgtMS0xLTEtMTE3NzU2_16e8a356-9f45-462c-8220-992d372ffd67">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTgtMy0xLTEtMTE3NzU2_81f98954-c61f-41a1-a935-8049008d481a">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTktMS0xLTEtMTE3NzU2_dd93d10e-a1ed-49ed-9762-3b4bc22d3cf3">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTktMy0xLTEtMTE3NzU2_bb106c91-5075-4757-a6cf-d3494bd6355b">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjAtMS0xLTEtMTE3NzU2_20de9d00-f033-4a8e-88e6-4f2438ec6f0f">14,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjAtMy0xLTEtMTE3NzU2_d49f9ccf-69b7-47cb-8684-fe06f0bb9cd4">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjEtMS0xLTEtMTE3NzU2_09398544-bd92-48e1-8e74-88c2cee44a39">18,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjEtMy0xLTEtMTE3NzU2_cf3eb837-3992-4fbd-a91e-c8507cb57948">21,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjItMS0xLTEtMTE3NzU2_7e24b178-04e2-46a1-8cb8-4b4e89d0f139">2,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjItMy0xLTEtMTE3NzU2_af42afe2-ad92-4021-a036-1c2c35078643">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjMtMS0xLTEtMTE3NzU2_d2e3499a-6fd4-4fd4-943d-646d2a8e7e94">36,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjMtMy0xLTEtMTE3NzU2_7b15e0c1-21f7-40a9-96a0-3a4a493e2ded">39,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjQtMS0xLTEtMTE3NzU2_abdbae19-d929-47f7-835f-8eecee9a76ef">6,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjQtMy0xLTEtMTE3NzU2_a243fd73-efb3-4d3f-aa66-ab1d2d344c93">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjUtMS0xLTEtMTE3NzU2_9bb5697e-d786-4b04-a6d0-172beb8b4618">65,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjUtMy0xLTEtMTE3NzU2_0b13ced1-c0a2-4caf-90f5-0498b0a6897b">73,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjctMS0xLTEtMTMwNDYw_eb11afd6-08e4-4aec-96b2-124a042933f6"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjctMy0xLTEtMTMwNDYx_1e6fa3cd-4658-4bb2-942e-a4ea03e04cb4"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bristol-Myers Squibb Company Shareholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzEtMS0xLTEtMTE3NzU2_ce76107b-1d84-495c-be4b-304d906fc5f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzEtMy0xLTEtMTE3NzU2_95867fab-93a9-41de-8280-dd22159f8f85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzItMS0xLTEtMTE3NzU2_705be61f-0109-4ac6-994b-06cce03f1d24">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzItMy0xLTEtMTE3NzU2_bcf4333f-e0bb-4853-8660-fdacd58417e1">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value of stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzMtMS0xLTEtMTE3NzU2_37a452d2-2cce-435a-9f8c-5e3938458fe2">44,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzMtMy0xLTEtMTE3NzU2_386c9895-bc7f-4759-81cf-69fc9afc8633">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzQtMS0xLTEtMTE3NzU2_b31c9c7c-e8c5-4012-a94c-9a9b104b7c5f">841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzQtMy0xLTEtMTE3NzU2_7965820e-1f75-4b13-84e9-12d164e0b9e3">1,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzUtMS0xLTEtMTE3NzU2_8c9f1116-d5de-46e6-a5d2-6adf4a96bfe9">24,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzUtMy0xLTEtMTE3NzU2_f7f8d8b9-0e52-44a4-95d9-a74e5d20f7f0">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cost of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzYtMS0xLTEtMTE3NzU2_489acc98-8a25-471b-afeb-b69b9f0979fa">36,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzYtMy0xLTEtMTE3NzU2_e1a2d0b2-08cd-47e7-b22d-110060d33393">31,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzctMS0xLTEtMTE3NzU2_a879177b-d605-4665-af8d-08b8ee6266b8">32,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzctMy0xLTEtMTE3NzU2_77f85c34-ac33-4d23-bfe4-775610857acb">35,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzgtMS0xLTEtMTE3NzU2_6617ed0f-d02e-45a1-90db-98ffe2919cbf">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzgtMy0xLTEtMTE3NzU2_e7c05397-b22d-46cd-9afc-1de3d65d7787">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzktMS0xLTEtMTE3NzU2_c199cfd9-b266-467e-883a-43104ae9f1e1">32,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzktMy0xLTEtMTE3NzU2_a973ae15-a331-4103-b3db-8821e2190e66">36,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNDAtMS0xLTEtMTE3NzU2_58bc12ed-92e7-4e15-8795-58aadb00909d">98,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNDAtMy0xLTEtMTE3NzU2_5ac47c98-fcb8-46a5-b312-29c46e20952c">109,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMy0xLTEtMS0xMTc3NTY_c6547e7b-6a48-4648-bad1-1e39eb86f1c2">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMy0zLTEtMS0xMTc3NTY_d473a20c-9450-449f-a7f8-8c2bb1d9d754">4,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNS0xLTEtMS0xMTc3NTY_6fdde5d8-81c3-42b9-be70-03ce56df0823">7,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNS0zLTEtMS0xMTc3NTY_5da3b854-3793-403c-8e13-de55702ab57e">8,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNi0xLTEtMS0xMTc3NTY_d7e35267-1c6e-4918-b074-9a1de5c498fc">2,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNi0zLTEtMS0xMTc3NTY_11cf6787-77df-4e9d-b458-e56f5e31b8fa">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNy0xLTEtMS0xMTc3NTY_3a9b6f93-4c2a-497b-84b1-393435b26ba1">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNy0zLTEtMS0xMTc3NTY_314ed7c6-f764-47e9-814c-786b7b76c49a">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfOC0xLTEtMS0xMTc3NTY_da9455d0-2085-4b9f-9a49-36d091ddd2d0">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfOC0zLTEtMS0xMTc3NTY_c03a103d-7467-461d-98c3-5263c41e4702">1,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTAtMS0xLTEtMTE3NzU2_ed75c6e3-f48c-47b3-b832-8c7bee55474b">820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTAtMy0xLTEtMTE3NzU2_7d2ae9a0-f622-4e1f-acdb-446f3aae9185">462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTEtMS0xLTEtMTE3NzU2_0dc065bd-86e9-44d9-b584-f4f4285179f9">763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:AcquiredIPRD" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTEtMy0xLTEtMTE3NzU2_39a68296-1b68-4c9d-becb-4349c85215d8">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTItMS0xLTEtMTE3NzU2_1614e33e-947f-4801-9d48-42398b0df6ce">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTItMy0xLTEtMTE3NzU2_00e08e87-0617-4635-9a64-940fb4356dab">1,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTMtMS0xLTEtMTE3NzU2_4a3b7e63-b87b-43fa-b30d-cd809c8d9d9e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTMtMy0xLTEtMTE3NzU2_dc41df63-b1e4-4b60-803e-b70da86d80c3">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTQtMS0xLTEtMTE3NzU2_3da6de44-d4ec-4f71-b5f4-49297c5e533b">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTQtMy0xLTEtMTE3NzU2_acba2974-5b0b-4f09-827c-aad6f60ee8dc">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTYtMS0xLTEtMTE3NzU2_0638aed5-23e1-471e-9a6f-2c160cc3edd3">557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTYtMy0xLTEtMTE3NzU2_ed7a1bd3-b581-4021-88e4-0a566434ef8a">886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTctMS0xLTEtMTE3NzU2_36f45690-c733-4d49-8093-e656157315e8">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTctMy0xLTEtMTE3NzU2_3e72b17f-6d40-4c0b-a061-1ae340ce09f9">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTgtMS0xLTEtMTE3NzU2_cd446442-e003-4ec8-9361-3335b19d6381">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTgtMy0xLTEtMTE3NzU2_8249031e-f3c0-4fc2-b036-3b80c6c348f5">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTktMS0xLTEtMTE3NzU2_7f6ef0f9-ad7b-41e5-8e4b-24d55f1932c8">730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTktMy0xLTEtMTE3NzU2_4b450893-2c7b-4461-bff4-953257925f81">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjAtMS0xLTEtMTE3NzU2_514dc2cd-52c1-482f-a663-ae2ba441dbd2">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjAtMy0xLTEtMTE3NzU2_181a2684-089e-40ff-9aa9-706d8f14ad8c">841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjEtMS0xLTEtMTE3NzU2_f7478169-961f-42ec-8704-e333f00d6941">1,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjEtMy0xLTEtMTE3NzU2_c0d5d911-f716-4b3f-a9e9-c420862e2b4e">537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjItMS0xLTEtMTE3NzU2_a1681b97-a43a-4c98-b150-1951472e8aef">9,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjItMy0xLTEtMTE3NzU2_138ee17e-aa4a-44c8-be82-6ee37ff6ff9b">12,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale and maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjQtMS0xLTEtMTE3NzU2_7c538f68-0309-47f7-b1c1-47dd74b492f6">5,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjQtMy0xLTEtMTE3NzU2_121ece48-93d9-4f24-b5f0-5c2f1eaa447f">2,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjUtMS0xLTEtMTE3NzU2_389ced07-a278-427c-856b-e93237e12ec1">3,566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjUtMy0xLTEtMTE3NzU2_1bc19abf-60a3-4414-94fb-b17a55493274">3,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of equity investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjYtMS0xLTEtMTE3NzU2_3ffbc294-380d-4026-8071-8c4c1fb601ee">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjYtMy0xLTEtMTE3NzU2_b90090ed-8006-42ce-b6c8-db48ce956121">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjctMS0xLTEtMTE3NzU2_db3df891-e33e-4cdb-b0e6-36c64d616603">772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjctMy0xLTEtMTE3NzU2_49e696fb-7f6a-4ee2-bbcd-373a6b3b5e65">653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture and other proceeds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjgtMS0xLTEtMTE3NzU2_78a31e1c-1524-4df8-b40f-2a350c9ea444">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjgtMy0xLTEtMTE3NzU2_c72de2ca-81e0-4c97-b417-ab98e3165b50">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other payments, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjktMS0xLTEtMTE3NzU2_e363ee45-0be7-46e3-9010-ad7eb597c143">4,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjktMy0xLTEtMTE3NzU2_8b4cd82a-1085-4deb-8dc8-34a321116fef">1,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used in Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzAtMS0xLTEtMTE3NzU2_62f879bd-7c9b-4b14-8de2-cf8da6e33fb9">2,275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzAtMy0xLTEtMTE3NzU2_42fba857-4b79-45ac-8407-8abd819c0f26">939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzItMS0xLTEtMTE3NzU2_1ae48b32-7fcd-4f8d-b751-6d3bd03e907d">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzItMy0xLTEtMTE3NzU2_a32a3cd3-2836-4a8b-86b3-fe5d96930850">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzMtMS0xLTEtMTE3NzU2_acc7870d-7cef-4d10-97b2-4723fa703c39">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzMtMy0xLTEtMTE3NzU2_8d7be933-f84d-44e5-b08d-479af7af5d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzQtMS0xLTEtMTE3NzU2_6696a30f-fcfd-40fa-bd7d-0ddfcbb9ecf7">11,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzQtMy0xLTEtMTE3NzU2_f9dd4f0f-084e-49b8-a007-4b3ca66cdc6a">6,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzUtMS0xLTEtMTE3NzU2_426c9a81-0232-4f84-a6b3-60349357e69c">5,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzUtMy0xLTEtMTE3NzU2_93128c34-772e-4dc0-a02e-cf8100aedb87">3,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzYtMS0xLTEtMTE3NzU2_e83e69da-81fc-4f7d-a887-384aabccf98f">3,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzYtMy0xLTEtMTE3NzU2_af48cdf4-7738-410c-be19-34d9b286cec2">3,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzctMS0xLTEtMTE3NzU2_d2dde167-6786-4856-bb07-b8dfa6891857">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzctMy0xLTEtMTE3NzU2_b78542f1-8688-4667-b979-4af30c5141cb">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzgtMS0xLTEtMTE3NzU2_94ff8ac5-d59d-4e69-90e1-457b91112765">13,716</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzgtMy0xLTEtMTE3NzU2_45d78364-e205-4ee1-b97c-09db7b431cd7">12,257</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzktMS0xLTEtMTE3NzU2_8074ac8b-189d-425b-bc50-bdecac28f228">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzktMy0xLTEtMTE3NzU2_8f91e10b-5513-4425-ac72-cc61c45c71bf">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDAtMS0xLTEtMTE3NzU2_c519048e-22ab-413a-9736-5bbd80edfa1c">6,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDAtMy0xLTEtMTE3NzU2_f71da576-ba71-46a3-8c27-be5ebc6f984d">1,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDEtMS0xLTEtMTE3NzU2_88e221b3-5db9-4913-ad3d-ce8f522b2ae6">14,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if781377a20f34a65860112e032558c03_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDEtMy0xLTEtMTE3NzU2_733d402f-7914-4f2e-a9ca-f7b4b7b360ed">14,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDItMS0xLTEtMTE3NzU2_79f17507-6488-4395-bdea-ca0325f9ee18">7,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDItMy0xLTEtMTE3NzU2_706d38b5-92d2-426b-a553-572c896dcdd2">13,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yOC9mcmFnOmYwYjE0ZjM2ODcwNTRlY2Q4MGY2N2RkYmUzYjIyYzcyL3RleHRyZWdpb246ZjBiMTRmMzY4NzA1NGVjZDgwZjY3ZGRiZTNiMjJjNzJfNzY_fcc3abdb-df7d-4492-ad1d-55ade3c79482" continuedAt="i97015aa5bb97442681caa2209f73407d" escape="true">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ix:nonNumeric></span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_31"></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i97015aa5bb97442681caa2209f73407d" continuedAt="ibcd6f92bdeac40beb9d3d47dfaea5ef5"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY0NQ_2ea5e393-ef3d-4764-bb2f-1988e46221ce" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;, "we" or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position as of September&#160;30, 2022 and December&#160;31, 2021, the results of operations for the three and nine months ended September&#160;30, 2022 and 2021, and cash flows for the nine months ended September&#160;30, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTYzNw_17bb9cdd-9053-45e1-9c20-97a0c4780b5e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY1OQ_ad238467-3a49-4461-9ddf-a9232898cca0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTYzMw_187945ae-1c47-49a6-bfbb-968ec2630a0d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Upfront and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statements of earnings. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows are now presented separately in Rebates and discounts.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY1Mw_4784874a-4420-4a77-9630-a71b577ae706" continuedAt="i04487517b275444d8977931f6507c4f4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective basis. Early adoption is permitted.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ibcd6f92bdeac40beb9d3d47dfaea5ef5"><ix:continuation id="i04487517b275444d8977931f6507c4f4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTk1_859a378a-8626-4922-8be9-f4baacb530af" continuedAt="i02e2134d921e4f88938a39fafabd47ac" escape="true">REVENUE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i02e2134d921e4f88938a39fafabd47ac" continuedAt="i549500dfb4ff4516b81fb77ebc56aa43"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTg5_ce3b7486-f61a-4d01-b9bd-cb0be5f89113" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi0xLTEtMS0xMTc3NTY_511f73f5-73b9-4867-92be-e7483e255b3b">10,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi0zLTEtMS0xMTc3NTY_2f04681e-f420-4c88-bc7a-1e8bea3dec06">11,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi01LTEtMS0xMTc3NTY_77b48c80-5ba8-4f2b-95b9-864d0a440423">33,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi03LTEtMS0xMTc3NTY_fc89a1cd-6452-4ea7-bdcd-c389e97e1c21">33,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy0xLTEtMS0xMTc3NTY_128474f1-9515-4aa4-8d49-b612aefff71a">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy0zLTEtMS0xMTc3NTY_15d61c0c-4a23-4550-9686-918a27881263">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy01LTEtMS0xMTc3NTY_f64f0c2c-43e9-4425-874a-3addd2680d72">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy03LTEtMS0xMTc3NTY_dfbc80f1-62fd-4037-b70c-e23c647daa79">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29266ae9af704e83ac646ebb6641fdb3_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC0xLTEtMS0xMTc3NTY_1beb61ab-a6a4-4300-a980-f4faaee38afd">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica0e3fbf1cf94fffa908248b335d98b8_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC0zLTEtMS0xMTc3NTY_5ace8fd3-5d30-47ab-acab-74de67ea57a2">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02073132d0574931b33a0f63b07ca3c0_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC01LTEtMS0xMTc3NTY_1b1b9fb0-4274-4d52-ad54-9669f894629b">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01cb0332a64c4a85999046b2d17073fe_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC03LTEtMS0xMTc3NTY_ea7b5626-8294-48ef-985d-4918e3e9010f">459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS0xLTEtMS0xMTc3NTY_b98df12d-17cd-45b9-a554-e11f7a7a10ef">11,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS0zLTEtMS0xMTc3NTY_2414dc8e-7c55-4c9b-9459-70c663dfb337">11,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS01LTEtMS0xMTc3NTY_9c169704-5356-4cab-b8e0-3613b6121f74">34,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS03LTEtMS0xMTc3NTY_dc43ae96-aeca-48b7-ab02-5a59e40c4a95">34,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTk0_d165dac7-763c-427c-aa3c-6320dff0d5af" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044c0c7286a4460da3d4eeeba42cb69c_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi0xLTEtMS0xMTc3NTY_403e36ab-aea0-4b19-b4fc-d8db3ed182fb">17,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc4b8be12534b2b9d7fa10bb00ae5c7_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi0zLTEtMS0xMTc3NTY_d02e9d2b-c8cf-48c7-891f-09b92559b6d1">17,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62bd0e6d660744a88a4153646993b3ad_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi01LTEtMS0xMTc3NTY_13fb0800-ce67-4f34-b015-39dd3e2cf1b7">51,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a5899d8d1b4d3e8ecbde0564615570_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi03LTEtMS0xMTc3NTY_10250209-258d-4146-b250-0a5ffe433b37">49,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id23693b7b08249d3aa12050a006f0001_D20220701-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC0xLTEtMS0xMTc3NTY_1065e1d8-f2dd-4991-9b5d-c5ca27674784">1,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e2e1abbc7064f37a17916a3c0555574_D20210701-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC0zLTEtMS0xMTc3NTY_0477176f-7768-43c9-945e-7ae55bbb6dcc">1,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6434d519a5ea436c9fdf8a130125e12f_D20220101-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC01LTEtMS0xMTc3NTY_63c14e99-03e0-4bcf-8f59-1921e5d4a446">5,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04800f144c48480496199f7f1dcbef22_D20210101-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC03LTEtMS0xMTc3NTY_05b1ac3b-67f7-45ec-ae08-f54827384f72">5,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0af3648fd4884c20a605f122dfd20cc2_D20220701-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS0xLTEtMS0xMTc3NTY_6c18d9da-09af-44ea-87bc-23669e3c74f4">3,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43278271a0ff474380032a771a7b1743_D20210701-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS0zLTEtMS0xMTc3NTY_bf34f394-d134-4bea-84aa-31d6385f09ae">2,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec69e1d136440a8a76da2507fd0f758_D20220101-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS01LTEtMS0xMTc3NTY_dd54dbaf-e707-4fc2-b73e-a71d33966224">8,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c166558cb7b467fb2cb4a39347b1703_D20210101-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS03LTEtMS0xMTc3NTY_bcd4c3e0-3d1c-4954-b3a9-a73e9fdccd87">6,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a53451866344aabc76f70abaf649a0_D20220701-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi0xLTEtMS0xMTc3NTY_b98ccf3d-5430-4033-b9f2-5005afc260f8">1,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i697262196a73456d97438e0a8c0db01c_D20210701-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi0zLTEtMS0xMTc3NTY_3e1a9435-ae3c-4238-9546-45cdfd8403bb">1,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4473234acb4698a92ec39a59dd736a_D20220101-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi01LTEtMS0xMTc3NTY_872d448e-49dd-4e25-86a5-bfa2ffdafc72">4,526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b29234dfee8455eae5c6cd393e05ad6_D20210101-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi03LTEtMS0xMTc3NTY_8b191159-b32c-4258-9c4b-90e2d94d019e">4,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy0xLTEtMS0xMTc3NTY_2cf1a76f-22d8-4ead-b39d-ccfdd98d0ba3">6,793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy0zLTEtMS0xMTc3NTY_cc2ddff8-851c-4060-8248-1269102c52a3">6,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy01LTEtMS0xMTc3NTY_bf7fddb9-a1c1-43e8-81af-003144a12b44">17,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy03LTEtMS0xMTc3NTY_2e2856a3-9710-442a-a752-55bfefa61af4">16,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC0xLTEtMS0xMTc3NTY_27270e44-36f6-4fc3-ac16-f151423cc70e">10,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC0zLTEtMS0xMTc3NTY_0b698841-399d-469c-b3e6-0c320ca671b1">11,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC01LTEtMS0xMTc3NTY_905581ee-1a88-4a80-9105-65fbe14396a2">33,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC03LTEtMS0xMTc3NTY_3b883520-2a91-4b20-9d34-19a9bc142aa9">33,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjY3_f6db2427-49ee-410e-8f05-6790ccd475b5">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjc0_203d9e3f-d72a-4a90-a6c4-6456203fe273">207</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022, and $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjk2_b39f331e-0607-4b5a-b72e-96aee4dec720">10</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMzAz_00b72b50-279e-46e5-a7ce-d656983b01c4">282</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i549500dfb4ff4516b81fb77ebc56aa43"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMTAxMA_1168e518-5fd9-4819-81ed-071cfd7f4737" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In-Line Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aebfbe0d44248bca085ae268561e653_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy0xLTEtMS0xMTc3NTY_0d56e24f-682f-4e16-a9fc-0d160c2a2ff4">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4003ca03f1e4e1983eef1fd2275159e_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy0zLTEtMS0xMTc3NTY_2d41ab1b-c179-4535-9a1b-c58252068501">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93af657bc36642fab0a352efe9e508d2_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy01LTEtMS0xMTc3NTY_8985abfe-1cd9-485e-81fd-8de85da7bb06">9,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff59a735468f412282be47f01fe403fe_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy03LTEtMS0xMTc3NTY_3b064903-4d11-468f-89f9-70c43d942025">8,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48c3e2d54ddb4d6685984ee660b83ae5_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC0xLTEtMS0xMTc3NTY_2ff3eba0-8fe4-4975-b875-45d2c86b2164">2,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9df57b8597af420d9c5ec3c15387bc01_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC0zLTEtMS0xMTc3NTY_5968c44d-f19d-4d24-83c5-1f51998e3693">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fe060f6be2495faa414c6e6ad65686_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC01LTEtMS0xMTc3NTY_412106b4-b3b4-4020-9837-53ddd149f14f">6,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62fda2db6b3941ccb2dc3fc8da4450e7_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC03LTEtMS0xMTc3NTY_d30c8591-a573-4bd0-977c-c8849180a84e">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7599d4a3420d4aadbcf02d4eaba7532a_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS0xLTEtMS0xMTc3NTY_2b375c80-4bc5-43f6-a3a8-c954f5680987">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625e125bc434431ca1c8a772fea91d5e_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS0zLTEtMS0xMTc3NTY_406f2918-2e6a-4adc-b804-a19f911d3492">851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80724b9311fc44598901283b8226c7c7_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS01LTEtMS0xMTc3NTY_37927e9e-075d-4fe5-910e-78a108275116">2,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09afd557e9f3433cbf4edac16c1bd239_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS03LTEtMS0xMTc3NTY_a8e15bd9-af6f-450c-99bb-f43962fb33e6">2,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4989d5918ce944d29e07c0809ff1d187_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi0xLTEtMS0xMTc3NTY_7bb83cd6-bf70-4069-ae13-33d05f9f8271">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7180b016692e484193376ecc09ef7603_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi0zLTEtMS0xMTc3NTY_fc727148-72d8-4291-abb3-ae61458e36aa">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe4ffb2515d4f8b87bb7994bbe700c1_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi01LTEtMS0xMTc3NTY_b408ed23-ed76-4bd1-9a42-0bc9f768fe71">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia300585bbecb4074986dc776703743c2_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi03LTEtMS0xMTc3NTY_041c987b-7baa-4fa0-b4ea-c19bcbccaa85">2,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c1d84a792b475cbfa2c9a371ed8496_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy0xLTEtMS0xMTc3NTY_c9453257-671f-4444-b736-13d29b092fe3">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f72bbf8c4304428b0ed80a8686b9248_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy0zLTEtMS0xMTc3NTY_e2f6a9a7-155f-49ee-acee-0780c93fcce4">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d82f3486fe4d61884d139292c0a019_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy01LTEtMS0xMTc3NTY_47e86bc8-ce4f-4293-8cf1-a741d1063d7e">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93e43e0d5e449c9a5ac169c78f5729e_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy03LTEtMS0xMTc3NTY_4e0cd856-aa70-4911-a6a3-b59003a5b400">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91564a174e264c93b41b7a67a1aba557_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC0xLTEtMS0xMTc3NTY_ccca5b45-07f8-4915-aeae-0d604c062e3a">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52549b4b725c4beaa7e2e97bdb382deb_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC0zLTEtMS0xMTc3NTY_0c7aaaf4-f09b-471e-b9c8-e9574e11596b">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f173022564246479bb42891e0caadeb_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC01LTEtMS0xMTc3NTY_ce0fe7e6-ee2c-4478-993c-aa03aad6c7a4">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7621f5141c74afea188b4fd300e0324_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC03LTEtMS0xMTc3NTY_7c92d2c4-28e0-49d1-9907-0de97f15ded3">1,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b2771b60834bc88d400a6969621023_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS0xLTEtMS0xMTc3NTY_0002554b-5402-47b9-8b3f-a6df3935fa68">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33b8b166dcc47a19e7e82c8d64e0d0e_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS0zLTEtMS0xMTc3NTY_12f28295-7e40-44c4-a789-204298feb494">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375ecb41f5d34164b135dfb0419a036e_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS01LTEtMS0xMTc3NTY_5f36a80e-fceb-423e-83e6-b256bf08b692">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e88c910ffae4f9a9d5adc44c364d44c_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS03LTEtMS0xMTc3NTY_9d17a1fb-eb7f-4e2c-ba38-5b07546b650a">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c86bc8fc17947e8b991889d64c5e053_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtMS0xLTEtMTE3NzU2_854c4e18-73a1-445d-9004-4d32f7487e2d">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3689d0fcaf24638a873a35863370488_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtMy0xLTEtMTE3NzU2_4dbba166-daba-4b0e-b020-08edf14d1849">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd8ef9dd4b34e74b6c7d422826a5a2a_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtNS0xLTEtMTE3NzU2_d2be2c1e-1703-429b-800b-3dfb66964022">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53644119d8a45f1863f5c215a118b2a_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtNy0xLTEtMTE3NzU2_ba4d346a-cb26-4b30-9199-7ffd5af8a06d">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0cefbc0671402cb26abf2ad1c6e8e1_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtMS0xLTEtMTI4OTkz_73231367-6812-462a-8b3a-01d913f72bcf">8,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd31c065d2b4f2eac12a4313ca0b4e7_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtMy0xLTEtMTI4OTk1_5e47a4c6-fcd8-44db-b5f1-1863474ff297">7,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2977ed64024e9b82c97255c6614303_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtNS0xLTEtMTI4OTk2_8c875bf3-3c14-40c9-9174-f8635e597b23">25,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523864ecfe934c0a8c2a8ba3767f4efc_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtNy0xLTEtMTI4OTk4_f5d31b73-b696-4039-bc66-7b417c1f6e33">23,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d028b025fa34a23934845203ff86eca_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItMS0xLTEtMTE3NzU2_7000b1cf-5b54-4e83-a2e3-389bb6879867">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib532e1cdc30944c5b30a57aeb3373c5a_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItMy0xLTEtMTE3NzU2_7975faa6-3919-49b9-aad6-0988fc5764e4">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac2713db21647efa1e4c85b8371102c_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItNS0xLTEtMTE3NzU2_a0056f27-39f7-49a0-af91-601230c2e2bb">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3a202c6cd54c6b93f8c26bfb454aab_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItNy0xLTEtMTE3NzU2_0565e6dd-9c8d-438c-9302-1ff0dba95e1d">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7edc171ac604a028ae6ba6d774d1184_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtMS0xLTEtMTE3NzU2_ed989542-4f00-461f-9a6f-e2c0619999c9">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc68379ebba8498fbde398dcdfa0bbb9_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtMy0xLTEtMTE3NzU2_b18bfcde-4e49-488b-9192-7c3eaacabae7">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4fc5728521489486f5f10510221b0c_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtNS0xLTEtMTE3NzU2_a6d2ee20-1560-4b86-ba3a-d6aa00e416b4">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27953d1748346de8d241948e99fdfce_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtNy0xLTEtMTE3NzU2_b8edcc81-3691-4585-b702-8b650f69551e">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9253e2d1c9f14694a47e4b8ba936cd82_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtMS0xLTEtMTE3NzU2_cdf8dfa4-24b7-4688-b508-ec1826dfa5c2">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2935cf5db0984e48a7311562d8957e88_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtMy0xLTEtMTE3NzU2_1c0673e2-b40d-40a0-abe1-d2487e78d0c7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312e646a32594a92819e204cbcf9d30f_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtNS0xLTEtMTE3NzU2_5d1614a0-3ea4-47eb-80cc-eb212dc125f5">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5077d69051d2407dac910cb1d4b5af89_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtNy0xLTEtMTE3NzU2_90e7cfc3-d5d7-4471-9253-15c7fac613b4">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36674f96d1ba40588e290d02748a12d3_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtMS0xLTEtMTE3NzU2_e2b8d426-7f09-44ab-8b05-77719d27d2e8">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44bc11db15de490da4c09d2d876a005b_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtMy0xLTEtMTE3NzU2_d133e385-6db7-451a-a0b8-f68fec8d0e14">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00488d76ec644f9f92320a9c1dcc6355_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtNS0xLTEtMTE3NzU2_b921f2c3-243c-4773-8fbf-02f7ffbc7972">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d096e1112a84f968934e98a7d7e8897_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtNy0xLTEtMTE3NzU2_863b058e-2bd5-4ef9-87fa-bd2cc2209089">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19f17c6b9684d4dae43eca5b8566729_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtMS0xLTEtMTE3NzU2_b1185d7c-b30e-49ab-90f7-03eab991e80f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c063ffd131546f19b8bc98eaa3ea8c0_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtMy0xLTEtMTE3NzU2_c4aba662-0c5d-453c-be6b-7ed836ada947">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992d193b56344cfaa5ba4098f9efd6f2_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtNS0xLTEtMTE3NzU2_711253de-2a51-4bbb-bef9-7629c2f28969">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaae1d1308ff4f129502456c6536ad64_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtNy0xLTEtMTE3NzU2_2381215e-4814-428e-8c67-1705fbc4ae0b">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b7e4ca6dec410ca3364c9088373428_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctMS0xLTEtMTE3NzU2_a1d44c5e-5714-444b-8221-3feaaf550ae1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7db61f43aa43929a92deb8ac563b89_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctMy0xLTEtMTE3NzU2_3cdb81fe-3a00-4e4b-a2c3-780755439436">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b4ea4259ca469ca93f408a519be850_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctNS0xLTEtMTE3NzU2_0ec1c555-f2ea-4c82-809a-1ba583895d11">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cc65b60058474db7537ab2b6b0a254_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctNy0xLTEtMTE3NzU2_e7c700b4-f93c-44e6-aea8-d6ad1257c38c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a140f37738545fd8986a487a0effcd0_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtMS0xLTEtMTE3NzU2_7c9a2bc2-4ae7-4380-bfcc-057ffcd53932">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1539779a5914689aa5abc809e040af0_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtMy0xLTEtMTE3NzU2_21792eba-e0d9-4336-87cb-8a2919eeb773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08528bb25e714575a7f5c80c04663b81_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtNS0xLTEtMTE3NzU2_fb75be4b-074e-488e-91d7-3d2cf629d4bc">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ebc52b59af749918bb43f2480530ab9_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtNy0xLTEtMTE3NzU2_483b4217-c77c-44fa-86aa-2b69f31887ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4bb28437e7b4609b9fa0648528f45d4_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktMS0xLTEtMTE3NzU2_f0f37fef-86a0-4409-9cd3-75dc0e52b2de">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7c15e9e75e4205a132cc94956026e4_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktMy0xLTEtMTE3NzU2_a34c1eca-a291-44dc-9f5e-adb643bc1e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7cedbf6e5649418120798f7a9f2b6c_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktNS0xLTEtMTE3NzU2_a4acac1e-ac5a-407f-90ed-9cdcaecbb136">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30592356ada44f519b3f806c7e67a991_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktNy0xLTEtMTE3NzU2_125e86e9-5e2e-46cf-a29c-351adfdeb9b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1276014500404e2e82de7171d6cb2c46_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtMS0xLTEtMTI2NTM1_0af79f7b-b762-4876-95ec-5bea4d6b6c98">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c90420b4f6d468387df80ced89cde88_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtMy0xLTEtMTI2NTIx_5d86c9a9-4e49-4af0-961f-c14945e92753">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639586984bcf4c9bb2800764224a0d97_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtNS0xLTEtMTI2NTQy_063ec3eb-b113-4d15-b28f-6df72b584baf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8a8da7674641108fe5cccec2da9f32_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtNy0xLTEtMTI2NTI4_b34a6372-3928-48e7-9470-6f997462c874">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91a0cc6973147dbb665862c990ff09c_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMS0xLTEtMTI5MDE3_40ad69c6-cdf4-4270-a0df-0d35438ceb2c">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i515f50d74f9f403dbded026f016eecea_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMy0xLTEtMTI5MDE4_1b310a65-c35a-49bd-9309-bfb2b8165a1d">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c92b01540e8405eb5f3908c858d4523_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNS0xLTEtMTI5MDE5_c6e7e46e-6b28-44cf-897f-fc4e232a4fed">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957ae0dd10d742d585460837252b996f_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNy0xLTEtMTI5MDIx_3c53efd6-3b21-4904-a07d-e6a0fbc34ae3">730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0651d3b0cf44b9f9157cee57ba36939_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMS0xLTEtMTI5MDU2_71818265-f654-421d-9a5a-f7af13c6055b">8,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a88fbea78348eaa1d5f346ce2efeef_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMy0xLTEtMTI5MDU3_0cba1831-28f1-41c7-9264-48726cebe1ec">8,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i743233575df84038808b743f27ef5643_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNS0xLTEtMTI5MDU4_7a5bf226-b177-4f4a-9cf0-33fde238665e">26,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1aaa93de272430e8ff046eb7df5c78e_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNy0xLTEtMTI5MDYw_8d5d46b4-15ad-45a9-a078-b0fd4cdc0c3f">24,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfec8659679486082b93be2576c6ee7_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtMS0xLTEtMTE3NzU2_89ae7d6c-a6e1-4ebb-8c08-b3d19e9354d5">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c20938af5ea4f559a05d063bca23a37_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtMy0xLTEtMTE3NzU2_f9489711-5ba9-4acc-9905-0c6bc5bb125a">3,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3d417b45d149649f2fab7b9c39c309_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtNS0xLTEtMTE3NzU2_83cc46b8-b210-4e75-be46-d6623b80fbdb">7,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b88401122a44aaae11d63f988564e3_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtNy0xLTEtMTE3NzU2_b3d072fc-35ba-487e-a9bc-d94fce0c37c8">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85644c821814dddb2f2fe08c06ecfea_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMS0xLTEtMTE3NzU2_de369210-b94a-4ca8-8d57-265d2a9412e3">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd2c28076da74353b7a9b4be05493211_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMy0xLTEtMTE3NzU2_9b7fba27-6584-4650-af4f-99ef7b4feba2">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b94424ed3440cdab12f30e34eef0e8_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNS0xLTEtMTE3NzU2_622fa59b-c6b0-40a8-8ec9-1fcaa040b5b8">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cfc8d0143547ffb85e8991435779d0_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNy0xLTEtMTE3NzU2_c7a4c334-7d07-4eba-819e-2cd229a23c25">876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffa0ce4264649a30d8e60f6d21e21_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMS0xLTEtMTI5MDM3_70876b2b-cc7a-4bc4-9406-933291055128">2,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5034bd9d5ac4d709b2d8bae0eda22ab_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMy0xLTEtMTI5MDM4_cd79145d-14af-49dd-95e3-40cdc5f44504">3,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c3c3b3adf74d829fdcffc4e2fd017b_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNS0xLTEtMTI5MDM5_6e55d71a-ef22-4113-9f08-fc8a1caa108f">8,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b8d2d6534740bd9a6f4cd980bb5662_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNy0xLTEtMTI5MDQw_5ae0ea5c-7a20-4929-b597-90541db173ff">10,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMS0xLTEtMTE3NzU2_0dc61fd8-b2be-45e7-ab63-6800ad565660">11,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMy0xLTEtMTE3NzU2_7e999284-0512-4d95-bbe2-2495f087ceb3">11,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNS0xLTEtMTE3NzU2_58a80cee-c3be-433b-82f0-37305058e0ef">34,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNy0xLTEtMTE3NzU2_67765c79-392d-4ee8-8e40-3885712aeffd">34,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12e924a4a13410b84c6b424992cfa22_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtMS0xLTEtMTE3NzU2_4dccad67-6e5a-4544-8586-9069de492ed9">7,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f02d98cc4647e6a09a6e50ca3b081d_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtMy0xLTEtMTE3NzU2_9aa5ae23-a1e2-4423-8d3f-f5f4e3f3cad0">7,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69bf82dfff6346418613dbfd38767fc2_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtNS0xLTEtMTE3NzU2_bfae8d1d-49b7-4151-bfc9-2a9aeeda40c1">23,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2360c71c4d7c4f60aff7afb5bd5adb43_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtNy0xLTEtMTE3NzU2_263f68a3-7846-47dd-a39e-38410c15a261">21,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a2726ed8d946878e0409ab1bc8e479_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMS0xLTEtMTE3NzU2_a2aa46a6-ced7-48f0-bd69-4158f03583ea">3,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097fc6808da74bd2a448a5abc583ff06_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMy0xLTEtMTE3NzU2_47e2c940-0fd0-4752-9bb5-31dfebc09e10">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82055957ab0c488786f886e6b6babb70_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNS0xLTEtMTE3NzU2_0afe0cbe-29de-4b53-b64a-84164d6e5697">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2b7e84f20fa4c0e8c203592f5fdc962_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNy0xLTEtMTE3NzU2_e9147c56-4937-485b-a788-8685d536b423">12,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5ca12fa8cf4f118404d35732aaa0e2_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtMS0xLTEtMTE3NzU2_d29d89ba-90bb-4f1f-bbdb-02d4e0bfd499">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3fbc288f17842e0a75422793fa1f2d2_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtMy0xLTEtMTE3NzU2_b0f6baa9-da05-4e45-bf7b-9417c3c64908">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a091ee30a0546f2b3cf7109a52349aa_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtNS0xLTEtMTE3NzU2_9b615e9d-2661-4203-b443-336dc9e1ad6a">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8a169883d84598b45391f2436b331d_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtNy0xLTEtMTE3NzU2_8839e570-70a5-49cf-a0fd-e3046afe14dd">631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktMS0xLTEtMTE3NzU2_7d4472cd-ca6d-4f02-ba3b-019da8fb1c4f">11,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktMy0xLTEtMTE3NzU2_7d091443-dd05-444b-9711-19086b68ad14">11,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktNS0xLTEtMTE3NzU2_6e9fa6ea-5179-4355-a146-db43c5564217">34,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktNy0xLTEtMTE3NzU2_f26ce800-badf-49e0-89d1-e580165eb0b6">34,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfNzgz_15e4fbb0-78ba-4114-aac5-1f7ba83a8cc7">119</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfNzkw_9ec9fdf1-ff4c-4612-879d-012558ee3ba6">450</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfODEx_94e8baca-3bdb-48a2-869a-e24dc78e6e9d">73</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfODE4_c592a536-00f5-4310-8260-6e80681dd395">463</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk5Nw_cc4e28d5-fff3-49bc-a720-2f906c38880a" continuedAt="i39e9d2ab19d644f987d0b08497a72e86" escape="true">ALLIANCES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i39e9d2ab19d644f987d0b08497a72e86" continuedAt="i9a649e00262c468b8971e3d08233f4e7"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk5Mg_dd47336f-9f5d-4104-9f77-514a572adfd9" escape="true">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</ix:nonNumeric></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i9a649e00262c468b8971e3d08233f4e7" continuedAt="i74112ce78a5649eeb019d3d684a52bca"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk3OQ_e7d7bac9-53e0-4068-a6a6-a49f25058c36" continuedAt="ic0acb0d5b9514bd09e6cbf9d4eaf5bdd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714ecd92180a4da09cfb9e1b711d8e13_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy0xLTEtMS0xMTc3NTY_be8ed0f5-b4a6-48d3-8828-5f140453cebb">2,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1682d31f29ab4c5c8e318685f109e06d_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy0zLTEtMS0xMTc3NTY_e5848bee-2d30-4a98-a2e8-18f3339f6fc2">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e11c81e870446bea062ed2f9a4dd75a_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy01LTEtMS0xMTc3NTY_d8778f1a-7c59-4358-b139-cb6e1b30defa">9,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd51bc766ca44e85bd81070b4c92220b_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy03LTEtMS0xMTc3NTY_86e241b2-20ed-42b6-899c-49feb1f5c70b">8,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC0xLTEtMS0xMTc3NTY_128474f1-9515-4aa4-8d49-b612aefff71a">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC0zLTEtMS0xMTc3NTY_15d61c0c-4a23-4550-9686-918a27881263">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC01LTEtMS0xMTc3NTY_f64f0c2c-43e9-4425-874a-3addd2680d72">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC03LTEtMS0xMTc3NTY_dfbc80f1-62fd-4037-b70c-e23c647daa79">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS0xLTEtMS0xMTc3NTY_925b4a05-376b-4467-850a-538339992c55">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS0zLTEtMS0xMTc3NTY_65401f85-c0f4-4455-bfec-be95f7eecbdc">2,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS01LTEtMS0xMTc3NTY_b1cc98bb-6b08-40e3-9941-0aa9dd32d7e3">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS03LTEtMS0xMTc3NTY_b42141dc-6d03-4a32-ba89-40e9264972d7">8,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC0xLTEtMS0xMTc3NTY_fede7bdc-67cb-4be1-9d62-fe89c8388311">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC0zLTEtMS0xMTc3NTY_5f4dfaa3-499e-4872-b46f-133f31502bda">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC01LTEtMS0xMTc3NTY_b6a89288-b97d-4862-af6c-0aeb9dd96de9">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC03LTEtMS0xMTc3NTY_c03b56f2-143d-4b32-a806-83f4e8eff83e">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS0xLTEtMS0xMTc3NTY_e3bd790e-4899-4ca4-aab1-51087c6ba5c6">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS0zLTEtMS0xMTc3NTY_57f62a9e-bab7-4cb6-80ef-2c4340611ca9">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS01LTEtMS0xMTc3NTY_8a6fda36-84a6-46e6-a2e4-6ce1f80eedb7">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS03LTEtMS0xMTc3NTY_460f3919-be30-42e0-b5ce-2924d018b42e">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtMS0xLTEtMTE3NzU2_2717ea9b-6ce7-4329-8093-57fb590fc9f3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtMy0xLTEtMTE3NzU2_53ccb30f-2e95-4754-91ea-2191478c6339">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtNS0xLTEtMTE3NzU2_78b5f829-0e4b-40a0-b40d-a001320fe986">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtNy0xLTEtMTE3NzU2_befd76ae-ff08-4957-9b67-e9777111392e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" name="bmy:AcquiredIPRD" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtMS0xLTEtMTE3NzU2_075bb1c4-7723-4662-85c9-b01c9606eee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" name="bmy:AcquiredIPRD" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtMy0xLTEtMTE3NzU2_986de19a-b498-4fe8-aecc-139461645a15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtNS0xLTEtMTE3NzU2_1d8af823-b779-4bb7-996d-b0473c12673f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtNy0xLTEtMTE3NzU2_7402e00d-2872-45ad-a22c-47d14252caad">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItMS0xLTEtMTE3NzU2_54a3ac89-317a-4f16-bb0d-29dd4382324a">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItMy0xLTEtMTE3NzU2_bec65ca4-ca5e-4886-85df-f518b569f3da">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItNS0xLTEtMTE3NzU2_797e5ca1-8c8b-451e-8f97-8f1c0a1a4866">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItNy0xLTEtMTE3NzU2_ab9d95bf-38f1-4a17-9d1b-cba71055e352">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMi0xLTEtMS0xMTc3NTY_88ce3dc6-75eb-48b8-9476-53f607016632">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMi0zLTEtMS0xMTc3NTY_d08037c2-1136-44c8-a4b1-839a47a32800">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMy0xLTEtMS0xMTc3NTY_58207a28-e346-4b20-a3af-85bd714f881d">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMy0zLTEtMS0xMTc3NTY_5f4af321-8a3b-47cb-bcbb-4225cefa3e65">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfNC0xLTEtMS0xMTc3NTY_ed1e7dd5-15cb-4529-b77b-7d85dd938c6d">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfNC0zLTEtMS0xMTc3NTY_bd2fe215-9eba-43e0-b3ad-f3998f213d25">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ic0acb0d5b9514bd09e6cbf9d4eaf5bdd">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the nine months ended September&#160;30, 2022, and 2021 are set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BridgeBio</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, BMS and BridgeBio commenced an exclusive global collaboration to develop and commercialize BBP-398, a SHP2 inhibitor, in oncology. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ie29f5777421440b5a7303c74ab686169_D20220401-20220630" decimals="-6" name="bmy:UpfrontPaymentsMadeToCollaborativePartner" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMTk1MQ_c65e9adc-c3b1-43aa-a725-33eb74ff9afd">90</ix:nonFraction>&#160;million, which was expensed to Acquired IPRD during the second quarter of 2022. BridgeBio is eligible to receive contingent development, regulatory and sales-based milestones up to $<ix:nonFraction unitRef="usd" contextRef="ie29f5777421440b5a7303c74ab686169_D20220401-20220630" decimals="-6" name="bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMjEzNw_ef2af7be-89c0-4429-b751-7ffea0e491bd">815</ix:nonFraction> million, as well as royalties on global net sales, excluding certain markets. BridgeBio is responsible for funding and completing ongoing BBP-398 Phase I monotherapy and combination therapy trials. BMS will lead and fund all other development and commercial activities. BridgeBio has an option to co-develop BBP-398 and receive higher royalties in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nektar</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program are being discontinued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eisai</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Japan, China and certain other countries in the Asia-Pacific region (the &#8220;collaboration territory&#8221;). Eisai is responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS is responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i74112ce78a5649eeb019d3d684a52bca">A $<ix:nonFraction unitRef="usd" contextRef="icc7d12df57f64215af002ee413e6d5dd_D20210401-20210630" decimals="-6" name="bmy:UpfrontPaymentsMadeToCollaborativePartner" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzcyMw_d3a99f3d-95f5-49b0-aa1a-400d472402fc">650</ix:nonFraction>&#160;million up-front collaboration fee was expensed to Acquired IPRD during the second quarter of 2021. BMS is also obligated to pay up to $<ix:nonFraction unitRef="usd" contextRef="i8e366068274246db8687bd2bf3a8caec_D20210701-20210930" decimals="-8" name="bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzg4Nw_b75696c2-d32c-48c6-bafd-6c7bd3b7cdbf">2.5</ix:nonFraction>&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkyNw_d5b81aa8-1bee-457d-8a62-6b1b25bcb587" continuedAt="if5b7877689554761be6dc455907c90f5" escape="true">ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if5b7877689554761be6dc455907c90f5" continuedAt="ibd1c1f9f67cd4f9f99a155ba5f12a05f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Turning Point </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2022, BMS acquired Turning Point for $<ix:nonFraction unitRef="usd" contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817" decimals="-8" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzI5MDk_8307cc6f-3fb7-46a0-9f94-e7c485702925">4.1</ix:nonFraction>&#160;billion of cash (or $<ix:nonFraction unitRef="usd" contextRef="ie54f1b4636db42e6988c8772120ddcb6_D20220101-20220930" decimals="-8" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzI5NTg_eef202db-3973-4e8c-9e7b-ee69a1b55f79">3.3</ix:nonFraction>&#160;billion net of cash acquired). Turning Point is a clinical-stage precision oncology company with a pipeline of investigational medicines designed to target the common mutations and alterations that drive cancer growth. The acquisition provides BMS rights to Turning Point's lead asset, repotrectinib, and other clinical and pre-clinical stage assets. The transaction was accounted for as a business combination requiring all assets acquired and liabilities assumed to be recognized at their fair value as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNjU5NzA2OTc5ODc0NA_94725eb8-ffae-4f55-9f56-b1c245bb9451" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration for the acquisition consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for outstanding shares </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781907222fbe4667b1cd73c65ef72721_D20220817-20220817" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMS0xLTEtMS0xMjU2OTM_ce2063ae-6087-46a7-883b-817dea6d23fb">3,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for equity awards </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793cb981ce5049e8b04829bfd1aebc05_D20220817-20220817" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMi0xLTEtMS0xMjU2OTM_73b7a216-3a73-405d-9631-e80f200dc166">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Consideration paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMy0xLTEtMS0xMjU2OTM_c40b7a5d-b85b-4aa7-9240-c3889ade8b96">4,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unvested stock awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfNC0xLTEtMS0xMjU2OTM_689f096e-b3a0-4369-b904-76cc20f2ba95">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration to be allocated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfNS0xLTEtMS0xMjU2OTM_2c5c8e52-2efb-46d2-8732-36a06499488b">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unvested equity awards of $<ix:nonFraction unitRef="usd" contextRef="i3b224fccd35141c6ab6c59ed52eab7c5_D20220701-20220930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2MTA0OA_5b2f7885-00ec-4af7-9069-d39c08d97bba">73</ix:nonFraction>&#160;million expensed in Marketing, selling, and administrative and $<ix:nonFraction unitRef="usd" contextRef="i2142a064165c42acb01e69c102b6b950_D20220701-20220930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2MTA1Ng_5035c4e1-02b2-4941-bd8d-7bd930a78770">80</ix:nonFraction>&#160;million expensed in Research and development during the three months ended September 30, 2022.</span></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNjU5NzA2OTc5ODc0NQ_b1a9b4bf-0f89-4af3-8cd2-f1c512481fc5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed as of the acquisition date based upon their respective fair values summarized below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMS0xLTEtMS0xMjU2OTU_6df0c250-d9b9-463e-8de0-bc9cf0c73c22">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMi0xLTEtMS0xMjk4MTc_27e8f304-42e0-4933-9de5-770e66280ad5">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMi0xLTEtMS0xMjU2OTU_a07007c1-0650-4819-92fb-2e97271452f6">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMy0xLTEtMS0xMjU2OTU_16800f86-83da-464e-ac5d-281fad31fd36">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNC0xLTEtMS0xMjU2OTU_25fffec6-489a-477f-a5e9-3bd56d1e2ae5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNi0xLTEtMS0xMjU2OTU_c6c0f3f9-7b92-4fee-b905-12708e3d510c">643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNy0xLTEtMS0xMjk0ODA_c8ced5e5-65bf-401f-b9c0-f19ee543d75a">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable net assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNy0xLTEtMS0xMjU2OTU_fa1a17da-dc33-4c44-8ba6-59e27b38496f">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfOC0xLTEtMS0xMjU2OTU_495cc84b-55da-4314-8288-ffa50665af45">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration allocated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfOS0xLTEtMS0xMjU2OTU_6e867cc5-2a13-4e93-8ba1-25d148a75950">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Intangible assets primarily consist of IPRD allocated to repotrectinib ($<ix:nonFraction unitRef="usd" contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817" decimals="-8" name="bmy:AcquiredIPRD" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2NjU0OQ_4fe32242-dc21-41e3-a5b5-31c500b42cb6">2.8</ix:nonFraction>&#160;billion), a potential best-in-class tyrosine kinase inhibitor targeting the ROS1 and NTRK oncogenic drivers in NSCLC and other advanced solid tumors. Repotrectinib is currently in registrational Phase II study in adults and a Phase I/II study in pediatric patients. The estimated fair value of IPRD assets was determined using an income approach valuation method. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Goodwill resulted primarily from the recognition of deferred tax liabilities and is not deductible for tax purposes.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of Turning Point's operations were included in the consolidated financial statements commencing August 18, 2022, and were not material. Historical financial results of the acquired entity were not significant. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Divestitures</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkxOQ_9024193b-6bce-45bb-9315-0a59afcd9e15" continuedAt="i666c7caeea7a4ee8a3685c22cd73b59d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0xLTEtMS0xMTc3NTY_162016de-9923-4f68-ac20-8f1df6e8239f">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0zLTEtMS0xMTc3NTY_01f9ec7c-0048-4d4f-b2af-83b0a7094cae">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy01LTEtMS0xMTc3NTY_29a67fa5-757b-4bb4-853e-14977c963a26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy03LTEtMS0xMTc3NTY_d060fb60-5fb0-4211-b86d-ace138470396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy05LTEtMS0xMTc3NTY_421465c7-40f9-41a4-9f8f-aab4ddafe3c3">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0xMS0xLTEtMTE3NzU2_fcd52bae-aa77-4041-95e2-05de9eca90fe">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0xLTEtMS0xMTc3NTY_a508ecd5-f494-4e0a-843d-49b0fbbfe2e3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0zLTEtMS0xMTc3NTY_46d604bf-8f5b-44c5-ae35-2fb2fc8f4c86">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy01LTEtMS0xMTc3NTY_9dce1fd2-d565-49b9-9426-5628a667b792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy03LTEtMS0xMTc3NTY_23ba3fc4-fdd5-4e91-bcd8-cc6a45d2248f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy05LTEtMS0xMTc3NTY_704be661-ceed-4f70-9a4f-96128a19724f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0xMS0xLTEtMTE3NzU2_5234a704-2cb6-4626-8a28-42c31dfa5892">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0xLTEtMS0xMTc3NTY_08f269b0-2f89-4291-a32d-23901e7d9e2d">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0zLTEtMS0xMTc3NTY_abf3a9a1-f40a-4f7b-9cfa-b10e0cfaf8a6">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC01LTEtMS0xMTc3NTY_21a6a9cd-2d54-4cbb-ad97-7e1c6335a11d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC03LTEtMS0xMTc3NTY_31e96dc3-ea77-4625-86af-9f97f9908038">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC05LTEtMS0xMTc3NTY_060033d9-27aa-4c20-bad9-d591da3108ec">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0xMS0xLTEtMTE3NzU2_f2ed557e-0c48-4205-a311-2c73dc91dce8">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ibd1c1f9f67cd4f9f99a155ba5f12a05f" continuedAt="i8cdbe4bf55924eaaa73a7cfae9aa8fbb"><ix:continuation id="i666c7caeea7a4ee8a3685c22cd73b59d"><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0xLTEtMS0xMTc3NTY_728d662f-f9d7-4c2c-ba59-9ab4190c4e07">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0zLTEtMS0xMTc3NTY_7587bd82-9b8c-4dbd-babe-e63204c60221">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy01LTEtMS0xMTc3NTY_69d160e5-701d-4217-959d-3152c8eb52f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy03LTEtMS0xMTc3NTY_38d2b308-3f53-46ab-a089-299db49259b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy05LTEtMS0xMTc3NTY_5184813f-943c-4965-b9c5-de4572e0d8a7">595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0xMS0xLTEtMTE3NzU2_12b637dd-8515-4126-86eb-51cdbcd31483">445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0xLTEtMS0xMTc3NTY_981153bc-d821-4d6c-beb4-4e8653d8f971">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0zLTEtMS0xMTc3NTY_dfee708b-9bcc-4b2e-b584-43e4e54c7758">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy01LTEtMS0xMTc3NTY_41cfa599-058f-4664-86ce-be4d221631c8">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy03LTEtMS0xMTc3NTY_d539631a-60a1-4aa3-a60f-e46d7f279759">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy05LTEtMS0xMTc3NTY_e6851b39-5ae6-4953-b914-3a7e5bce8e49">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0xMS0xLTEtMTE3NzU2_3a31ffd3-1242-4623-b7eb-00b0e85286f0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0xLTEtMS0xMTc3NTY_3376266e-2295-4c3b-8677-bce92d9c0cbb">791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0zLTEtMS0xMTc3NTY_de078667-979d-452d-9ad6-6ffe3a996d57">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC01LTEtMS0xMTc3NTY_35e48dd5-1372-4b14-9cf1-ff74df718852">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC03LTEtMS0xMTc3NTY_e7f64b44-99fa-4e6a-8d8d-5c9c9dbfa1c7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC05LTEtMS0xMTc3NTY_4877e5f1-2db0-446f-b46c-ca174114064b">597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0xMS0xLTEtMTE3NzU2_54f935fe-c58e-4bf2-a8ee-bd24fe79901b">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mature Products and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, BMS agreed to sell its manufacturing facility in Syracuse, New York to LOTTE Corporation for approximately $<ix:nonFraction unitRef="usd" contextRef="i8a6dc427b52c490eaca902fe4c834622_I20220531" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjAzMQ_b472486c-96ee-4008-9dd9-03dc31e792f4">170</ix:nonFraction>&#160;million. The transaction is expected to close during the first quarter of 2023, subject to certain regulatory approvals and other closing conditions and will be accounted for as a sale of a business. The business was accounted for as held-for-sale and its assets were reduced to the estimated relative fair value resulting in a $<ix:nonFraction unitRef="usd" contextRef="i1b18f99151344cda858f618b0c9b75e5_D20220401-20220630" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjMzOA_7ac952af-197e-42aa-8d52-5fda3cd21547">43</ix:nonFraction>&#160;million impairment charge recorded to Cost of products sold during the second quarter of 2022. Assets and liabilities reclassified to held-for-sale and included within Other current assets and Other current liabilities were $<ix:nonFraction unitRef="usd" contextRef="i81f79692d5f94137b6d2126460bcc45e_I20220930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjQ2NA_cf669fb8-202d-4ac0-8853-9510bba6dda1">155</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i81f79692d5f94137b6d2126460bcc45e_I20220930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjQ3MQ_5ace8aab-2b35-46f7-9cd0-a42d3c72e94c">6</ix:nonFraction>&#160;million, respectively, as of September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i8e0fb3f550cb46e7866c0f224cacb82b_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjc1Nw_d7573f48-91f4-4444-8e66-96ada6a2c7f7">221</ix:nonFraction>&#160;million and a divestiture gain of $<ix:nonFraction unitRef="usd" contextRef="ibb74491d80864f3eaa177e2b8be81ec4_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjc4Ng_50469f2b-2644-4acd-b844-339cfbc8c6bb">211</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:LicensingAndOtherArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkyNg_fab721d0-1440-4cda-8243-c25845c283b4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic75f9bbfc5724ef3836a765059109689_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi0xLTEtMS0xMTc3NTY_dde17393-1a09-4416-b696-797794da1611">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bac004294b34c42a5a7dbf2057b0487_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi0zLTEtMS0xMTc3NTY_90515fc3-4fa7-4289-a4cb-9d1a0373997b">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61db944e47a4581aaf245bb80e3db88_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi01LTEtMS0xMTc3NTY_04d44572-6c86-4283-bc9d-745512802eac">732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2e8f993a1cb4f79a93af4ee934de0b8_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi03LTEtMS0xMTc3NTY_b4919b8e-3708-4563-afa3-001df029e0cf">611</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife53d46685aa4a87a864327520e67683_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy0xLTEtMS0xMTc3NTY_1fb48f64-d5e3-4cc6-ab34-3aa3209c6e23">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93fcbb36dbf1444a8d0f08a84b035f69_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy0zLTEtMS0xMTc3NTY_d233326e-e6aa-45a4-9ddb-69645e859736">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i992ba6626a224684911867fdc13bae74_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy01LTEtMS0xMTc3NTY_48ca23dd-cf41-402c-87b0-c1c69773f142">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7f0dbcd1d24ef9a20304ac3ce6c2f5_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy03LTEtMS0xMTc3NTY_f8bd31f0-1bd1-48f8-9f04-88a80e3a3295">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS0xLTEtMS0xMTc3NTY_af69e5b3-f420-4008-aca6-79d720c04a44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS0zLTEtMS0xMTc3NTY_25a11127-24f8-4e5f-ba1e-cf3980e466b7">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS01LTEtMS0xMTc3NTY_2c27206a-ebfd-4f33-bd49-16002ea694f3">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS03LTEtMS0xMTc3NTY_5a55b440-3562-4167-be00-8e65f805371a">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi0xLTEtMS0xMTc3NTY_8ec4affc-6331-4afb-97d2-55c95c0e1a8e">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi0zLTEtMS0xMTc3NTY_aac65284-5bd6-4b32-840e-8a7e6ed12a00">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi01LTEtMS0xMTc3NTY_4d2ff527-58e5-4da2-afed-8544471c3e7f">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi03LTEtMS0xMTc3NTY_bb2f9f4d-ee73-4f85-86e0-9d3ec2e6b9a9">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biohaven sublicense income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9bad0f88cbc4be39604292bbbed7af6_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0xLTEtMS0xMzY4Njg_86ba2f6b-5e66-4799-87cb-825c88e970a8">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17ef668ac624a2f9ff552599af5c465_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0zLTEtMS0xMzY4Njg_ca8bfc71-4f78-43f2-8353-c51ca59807fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ea20ff7bff341c7a20fcd4a22892b01_D20220101-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy01LTEtMS0xMzY4NzY_37154f60-0429-4a3d-865a-bfb7dd36d76b">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadbb07e45d241d7a53c1917dfe4e639_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy03LTEtMS0xMzY4NzY_8ebf5cd6-788b-4bf4-8c1a-4608eae27fa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccec0e6e65dc4d6eb8d442778567cca1_D20220701-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0xLTEtMS0xMTc3NTY_d3389f2c-c22a-460a-9fa8-3ec874cd706b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d0c115f0d654a1aad8188931e7d60e0_D20210701-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0zLTEtMS0xMTc3NTY_dec70854-887a-4b06-8bbc-f112b5ef8e0d">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5689275b495b4b2f9cf12f272a88fefc_D20220101-20220930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy01LTEtMS0xMTc3NTY_d900acc1-abe7-43e2-927e-69c17bff45ae">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icda18d044f594a2ea664a02127e577a6_D20210101-20210930" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy03LTEtMS0xMTc3NTY_376e501a-9d32-4fd8-a41a-7e0d57049caf">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC0xLTEtMS0xMTc3NTY_31492d21-4be7-4a40-b6b1-ecaee7e34f23">374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC0zLTEtMS0xMTc3NTY_9ba801d0-b64e-4dd8-9c34-067382246381">265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC01LTEtMS0xMTc3NTY_aeee88d7-d8ca-4403-ab06-06b808bc88f2">967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC03LTEtMS0xMTc3NTY_9bcc4175-cb50-4454-9990-cc9cc7709951">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-license Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS obtained a global exclusive license to Immatics&#8217; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ie82664611f3e4121968092cf4cd0861d_I20220930" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzgxMQ_0dbd55df-b600-4fbf-b6b7-5578456435d9">150</ix:nonFraction>&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $<ix:nonFraction unitRef="usd" contextRef="ie82664611f3e4121968092cf4cd0861d_I20220930" decimals="-6" name="bmy:ContingentAndRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzk4Mw_7b71c883-184b-4462-91e8-97eb4c02974f">770</ix:nonFraction>&#160;million as well as royalties on global net sales.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i8cdbe4bf55924eaaa73a7cfae9aa8fbb" continuedAt="ia35ca9801e0f480eb956db9f6f05d912"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, a Phase I development milestone for interlukin-12 (&#8220;IL-12&#8221;) was achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="ida5d1dc816114f0ca32419717d7722db_I20220930" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDE2Mg_bb2efb61-983f-42c2-ada2-97fd021f8b21">175</ix:nonFraction>&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Agenus</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, BMS obtained a global exclusive license to Agenus&#8217; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and a Phase I clinical trial was initiated in October 2021. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ib44f04ed35d04422a86bc2725b539aee_I20220930" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzg0ODI5MDcyNzg3Nw_b2b5b65c-1623-44f2-a91c-99c9dc412d59">200</ix:nonFraction>&#160;million expensed to Acquired IPRD for the third quarter of 2021. Agenus is eligible to receive contingent development, regulatory and sales-based milestones up to $<ix:nonFraction unitRef="usd" contextRef="ib44f04ed35d04422a86bc2725b539aee_I20220930" decimals="-8" name="bmy:ContingentAndRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzg0ODI5MDcyNzg5MQ_79119eeb-19ac-421c-8cb2-786b3f9c76b2">1.4</ix:nonFraction>&#160;billion as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Extinguishment</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia35ca9801e0f480eb956db9f6f05d912">In April 2022, BMS amended the terms of a license arrangement and paid a third party $<ix:nonFraction unitRef="usd" contextRef="i06dd7c1aa48f4cd691db5ffb92ff9be9_D20220401-20220430" decimals="-6" name="bmy:PaymentToExtinguishFutureRoyaltyObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDcxOQ_07b62979-4e9d-4b4c-a42e-f1d8d5e49097">295</ix:nonFraction>&#160;million to extinguish a future royalty obligation related to mavacamten, prior to its FDA approval in April 2022, resulting in an Acquired IPRD charge during the second quarter of 2022.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RleHRyZWdpb246MzIzMjExNTM4ZjdhNGYxNDlmODdmYWRjMWQyNTg0NjlfNDk_a8fa3036-85d2-47bc-9251-05eed527bb55" continuedAt="i01c4c959a5494aa1a1beb07c0cd928d0" escape="true">OTHER (INCOME)/EXPENSE, NET</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i01c4c959a5494aa1a1beb07c0cd928d0"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:ScheduleOfOtherIncomeExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RleHRyZWdpb246MzIzMjExNTM4ZjdhNGYxNDlmODdmYWRjMWQyNTg0NjlfNTU_936e9bb6-5a16-42d3-88bf-1f0364f190aa" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi0xLTEtMS0xMTc3NTY_1e27f141-8ed9-463c-8aca-e0578ae0321c">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi0zLTEtMS0xMTc3NTY_bc44154e-1e47-4605-ac15-dd013266b87e">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi01LTEtMS0xMTc3NTY_ab27d08d-bc55-4a2d-b087-49475b13d33c">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi03LTEtMS0xMTc3NTY_495fad33-746f-46fe-8c14-332aaadd42e4">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy0xLTEtMS0xMTc3NTY_bb3fee8e-002e-44ab-b939-e076b74eb96a">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy0zLTEtMS0xMTc3NTY_ff63ade3-674e-4fcc-9ef8-42c50e5ea475">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy01LTEtMS0xMTc3NTY_23ed518a-f96a-43ce-a93c-881425a8d90f">1,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy03LTEtMS0xMTc3NTY_b770f5c2-1570-4eed-bac9-6d033c18b640">1,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC0xLTEtMS0xMTc3NTY_9b5915e9-e5ea-495f-8685-fc0a080e5557">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC0zLTEtMS0xMTc3NTY_8caf944a-3c5a-4448-adcc-f7e1d942eb83">465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC01LTEtMS0xMTc3NTY_21f5414b-23b1-43a0-91d8-62e89cf55cfe">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC03LTEtMS0xMTc3NTY_3ee5df5a-e260-4cce-9ae7-fe4148d02722">1,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS0xLTEtMS0xMTc3NTY_24a2f4c2-befb-4b71-bd26-b9c9b8825d87">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS0zLTEtMS0xMTc3NTY_7a17759d-3223-43f4-b9d6-9a0541a20387">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS01LTEtMS0xMTc3NTY_cad6b0cd-ecb3-47f7-9e66-c79221490054">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS03LTEtMS0xMTc3NTY_6328d45c-e5a2-4560-8215-78e8d6b4f5be">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi0xLTEtMS0xMTc3NTY_bf142e86-6670-49c4-bdef-df3b3e158d47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi0zLTEtMS0xMTc3NTY_f82bfa50-f422-4b9b-9377-9ab9d045ecea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi01LTEtMS0xMTc3NTY_0225a6d1-bdd5-4f8a-a435-2bd01da7bdcd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi03LTEtMS0xMTc3NTY_253a662b-51d5-495c-a2af-a6e2aced3704">510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy0xLTEtMS0xMTc3NTY_adff0ca2-b098-434a-8bea-1090821c0b3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy0zLTEtMS0xMTc3NTY_096b1f5f-9ab3-4ba4-b55a-e7cf2e5bca31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy01LTEtMS0xMTc3NTY_aa2915c0-68bd-4f2a-93b6-c4d81ba5c9bd">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy03LTEtMS0xMTc3NTY_aa3f8208-c963-4c62-95aa-04489e2845ed">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC0xLTEtMS0xMTc3NTY_184d2cfc-9755-413f-8284-920be0f086f4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC0zLTEtMS0xMTc3NTY_d262382c-f5a2-43bd-b7c6-56ca1e8691b3">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC01LTEtMS0xMTc3NTY_d0e63a45-8599-43fe-93e1-a7507f321bfc">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC03LTEtMS0xMTc3NTY_544aee25-9eb8-4433-9d93-48ec86ed2708">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS0xLTEtMS0xMTc3NTY_68a3d3ac-12bc-4175-8877-e535b8bcbbcf">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS0zLTEtMS0xMTc3NTY_dd42f6cf-6e0f-4ebc-8e6e-956ff9b0c732">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS01LTEtMS0xMTc3NTY_26178a61-1191-4850-802f-02200ee310ab">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS03LTEtMS0xMTc3NTY_33f15d12-1cce-47e9-837f-aa404d6cb8d2">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtMS0xLTEtMTE3NzU2_c6dead9a-96c7-4c5c-b7ed-d56fd98f90ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtMy0xLTEtMTE3NzU2_1b01ba2f-e168-4b63-a840-35d6654dc620">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtNS0xLTEtMTE3NzU2_3895a123-95b6-4511-9f8c-31c01dc3e332">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtNy0xLTEtMTE3NzU2_20416f53-3dfe-45e9-bc2c-e7a843b57def">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtMS0xLTEtMTE3NzU2_b1e8a674-8432-44ef-b565-af173a0ae153">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtMy0xLTEtMTE3NzU2_0f6ad0d3-beb4-483e-a47f-712b787c35ff">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtNS0xLTEtMTE3NzU2_81e9d07a-1572-46e7-a831-1ae50156598e">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtNy0xLTEtMTE3NzU2_d25661fb-0f55-4fba-8105-96395de0a0dc">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktMS0xLTEtMTE3NzU2_368703fa-0826-433c-95e4-bb61b2ea63ec">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktMy0xLTEtMTE3NzU2_3d2a6c0d-aaa5-47e9-9443-325216398829">409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktNS0xLTEtMTE3NzU2_b7e20c97-bca5-4876-8fab-ed0f80b216d5">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktNy0xLTEtMTE3NzU2_a595ce23-ba33-406f-991f-d7098e6160fb">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkwNg_bb1a5b68-72aa-417d-9b37-5ac5ae2bf9e0" continuedAt="i8165e8b68de94406aa1b164402ba6d7f" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i8165e8b68de94406aa1b164402ba6d7f" continuedAt="i533f42e3c30c49768f3e9abc1256aab4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930" decimals="-8" name="bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMjk1_35b1c82e-1292-4c6c-a852-a49b90779266">3.0</ix:nonFraction>&#160;billion. The synergies are expected to be realized in Cost of products sold (<ix:nonFraction unitRef="number" contextRef="i15769c9092334b38abe2ab74542152e2_I20220930" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMzY3_6161df6f-efa9-4f8a-bf98-d4e636c1795e">5</ix:nonFraction>%), Marketing, selling and administrative expenses (<ix:nonFraction unitRef="number" contextRef="i835e2f7f63d7466da1773c331a6cf84d_I20220930" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDIw_416358bb-574d-477a-bd10-fbf7235982ce">65</ix:nonFraction>%) and Research and development expenses (<ix:nonFraction unitRef="number" contextRef="idcab3a9d790d43a4aaa580b8ce49e8db_I20220930" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDYz_4b6c8853-9f31-4afe-8af8-7f30a81ed478">30</ix:nonFraction>%). Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930" decimals="-8" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDkz_df53db17-cf11-4a93-80a7-4629c3f48ea9">3.5</ix:nonFraction>&#160;billion are expected to be incurred including cash outlays of approximately $<ix:nonFraction unitRef="usd" contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930" decimals="-8" name="bmy:Cashoutlays" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNTQ5NzU1ODI5NzUz_46946aa2-7b36-44c1-985f-506f167930d3">3.1</ix:nonFraction>&#160;billion. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNjMx_fabecbeb-b0c2-4541-9e0f-419011ff4498">3.0</ix:nonFraction>&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. Employee workforce reductions were approximately <ix:nonFraction unitRef="employee" contextRef="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTAwNw_a233d830-7e3e-4e47-a397-207ef8efb2f6">150</ix:nonFraction> and <ix:nonFraction unitRef="employee" contextRef="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTAxNA_84a46bb5-878e-4095-8d4a-040926196a8a">320</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i533f42e3c30c49768f3e9abc1256aab4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition on August 17, 2022, and the MyoKardia acquisition in 2020. Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i1410968e21274826afdf23dc9434f736_I20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTA5OTUxMTYzMzAzOA_efcc8239-8ccf-4d7e-95d5-3d8b88e3cc43">250</ix:nonFraction>&#160;million are expected to be incurred through the end of 2023, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of $<ix:nonFraction unitRef="usd" contextRef="i1410968e21274826afdf23dc9434f736_I20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTA5OTUxMTYzMzkxMQ_4d6f8399-6d5e-42bb-9ecf-cec1f09eaacf">151</ix:nonFraction> million have been recognized for these actions to date.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkxMg_0a839eaa-7d24-4ec1-84e1-2b144435cdb1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead756ca21984013a7bd69516352fb13_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi0xLTEtMS0xMTc3NTY_d752b5af-b743-46ed-b281-89991dbaa8c5">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia870ef2304084b55ab48e0eae6731bb0_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi0zLTEtMS0xMTc3NTY_a68d477c-600a-478a-ab6a-75b55268e6f1">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi01LTEtMS0xMTc3NTY_23e3599c-d28c-4458-9c5a-db7c51ae0171">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi03LTEtMS0xMTc3NTY_1c4f2d1a-655d-40f7-b4d3-6e48ae8f1cd0">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b86689f804f49e4ad0215f4c9f4f9c4_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy0xLTEtMS0xMTc3NTY_c8c3454e-e2d6-4a26-8b50-08892d54a2d4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6962ac7520419e9e5528c42e86a43e_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy0zLTEtMS0xMTc3NTY_f99e844d-8789-4780-be1d-60594f83f338">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f20b9403da74f8ebf7c5eae9ba72e8c_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy01LTEtMS0xMTc3NTY_31ca18d4-1ced-4c6d-a3db-27a9f594d895">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1052bb4a0b64c1aac26a10e810aafe7_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy03LTEtMS0xMTc3NTY_5290e8c0-7b69-4e27-a327-4b4a2492b15f">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS0xLTEtMS0xMTc3NTY_7cce985e-baf4-46cf-99a2-67a67988ef5d">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS0zLTEtMS0xMTc3NTY_bfd00d7a-097c-4a72-9e7f-2c547a391afc">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS01LTEtMS0xMTc3NTY_43e617f0-d2c3-462e-a7b1-64e69fb24b61">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS03LTEtMS0xMTc3NTY_633c786c-7cf3-45db-b3ff-7a0c48e8482f">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy0xLTEtMS0xMTc3NTY_a25d8f2a-827a-4078-8eac-5117631efbb7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy0zLTEtMS0xMTc3NTY_ad05ae8c-3594-48a8-8c75-0f6b6349ad6d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy01LTEtMS0xMTc3NTY_d3a9c86c-7366-4317-83ae-dd3fc53fd350">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy03LTEtMS0xMTc3NTY_9e990adc-c3bb-402f-b5cb-67c3ed16c82c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC0xLTEtMS0xMTc3NTY_fb38f64c-524c-4902-a58f-17181de105fa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC0zLTEtMS0xMTc3NTY_a0e73092-371c-402c-a8e2-c61fb558f917">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC01LTEtMS0xMTc3NTY_450748ea-bb7d-4762-a18c-b10706b34d64">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC03LTEtMS0xMTc3NTY_69f803d5-cfd0-4cc1-85f9-e0bea38a88eb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS0xLTEtMS0xMTc3NTY_054d7587-0e83-441f-9e79-a09bf55e0081">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS0zLTEtMS0xMTc3NTY_6bd2fdc4-0ce2-47d9-8ee6-dce8963b7fcd">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS01LTEtMS0xMTc3NTY_094d6b75-7b0d-4215-ae9a-c4f0dd424276">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS03LTEtMS0xMTc3NTY_2b128dd6-bfc3-4bb0-b290-68620c7ee634">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtMS0xLTEtMTE3NzU2_89abf384-7a2d-4789-a180-8f556e4b753c">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtMy0xLTEtMTE3NzU2_398955ba-6d2c-40de-b8d8-b6ab78a36c7c">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtNS0xLTEtMTE3NzU2_8986feef-bb26-4bc6-a7d6-195df03317eb">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtNy0xLTEtMTE3NzU2_603e1250-0c4b-4d52-97d7-d5bc80f7ad7a">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtMS0xLTEtMTE3NzU2_aca10127-d905-420d-b700-bbcab2fd7ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtMy0xLTEtMTE3NzU2_73fd9b99-da43-4b0b-978c-f94cfb462d20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtNS0xLTEtMTE3NzU2_b3f38ead-13a8-4951-bd6b-273bad898de7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtNy0xLTEtMTE3NzU2_6dcf5d0d-361c-4126-a2cc-dbb9852c5992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItMS0xLTEtMTE3NzU2_59ae5c73-3b48-44b1-b6a7-18ccc2e13dec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItMy0xLTEtMTE3NzU2_97e64d22-913f-4ec8-9e25-f1a57552bbed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItNS0xLTEtMTE3NzU2_8634d8e2-7445-4369-be90-de8112d3c7f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItNy0xLTEtMTE3NzU2_fe628396-d6ae-4cc0-bf5c-151b88b7476a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="bmy:OtherShutdownCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtMS0xLTEtMTE3NzU2_92583073-0517-4f18-a325-892ebc3e7ba4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtMy0xLTEtMTE3NzU2_1287d4a8-8cd9-4243-80a4-ebfcb5b0da77">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:OtherShutdownCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtNS0xLTEtMTE3NzU2_c359d200-3802-4d5f-8d9e-b08fc92fbdb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtNy0xLTEtMTE3NzU2_c22767a2-5929-4124-9558-fc4d19554d1d">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtMS0xLTEtMTE3NzU2_6d66cf72-ebc9-48c6-a10c-e2dc39036957">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtMy0xLTEtMTE3NzU2_889b0010-8b06-4c8a-9f52-537f8245cdfb">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtNS0xLTEtMTE3NzU2_db4cd73a-cf6b-4a0a-a6c3-6d5b5d3e7596">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtNy0xLTEtMTE3NzU2_fde6fb55-aa81-4a2d-b3f1-1b40ccb12e53">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtMS0xLTEtMTE3NzU2_5b14857c-2b7c-4f86-9ba1-978083fbf747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtMy0xLTEtMTE3NzU2_208f4c05-d2ba-4029-bacf-6288ede989e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtNS0xLTEtMTE3NzU2_0715e923-1996-4a71-99f9-8135738524a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtNy0xLTEtMTE3NzU2_6863beaa-0870-4d6b-9cb0-861005d21ea0">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctMS0xLTEtMTE3NzU2_cd63415f-5b41-4a07-983d-922aad490d5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02826b699eda4a97ba070709457b65f1_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctMy0xLTEtMTE3NzU2_a510122d-2b35-4fed-983f-3d6fe264d7a8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4634dede34e4e588b48071be679100a_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctNS0xLTEtMTE3NzU2_c17737db-3aab-4f79-8ec3-7c895b2ad3fa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6947273e102141838832d4c25bb46991_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctNy0xLTEtMTE3NzU2_d278dceb-0990-41bf-bc29-e327fd6f0624">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab45139100524f8f85cebfc6cbfa75ca_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktMS0xLTEtMTE3NzU2_7f6a3748-4bf8-430f-a35c-66d129716683">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e5de495c7546bfa0bb84d26e067aa1_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktMy0xLTEtMTE3NzU2_3353160a-1abe-495c-84d9-11c3651ba756">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f652f6a9e84b1091a70c260f8d4511_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktNS0xLTEtMTE3NzU2_20eee69a-de2f-4f1a-89ff-858239c9c01b">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4473abbbdf4a9eb56ed31379f62651_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktNy0xLTEtMTE3NzU2_3a7c0606-88c0-40df-9aa5-5c0aada1251d">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtMS0xLTEtMTE3NzU2_72462b6e-f0c9-49e8-907c-fb2e2b15bb49">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtMy0xLTEtMTE3NzU2_a6c8aa1a-e765-477d-a36d-147c762cf272">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtNS0xLTEtMTE3NzU2_37b73dbb-c782-4c3f-a93b-4e2942ec8a4b">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtNy0xLTEtMTE3NzU2_825bfc16-2e04-4454-ad5a-0f19e00d8f71">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkwNw_908d0a6a-5430-4e55-a2de-0ca383fe5f37" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMi0xLTEtMS0xMTc3NTY_a8a7fc89-1372-4739-ab8e-63b9ffadcf20">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if781377a20f34a65860112e032558c03_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMi0zLTEtMS0xMTc3NTY_cef082e0-5b7e-4b3e-ae19-e0cc30e0c721">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMy0xLTEtMS0xMTc3NTY_81308fa5-b725-492b-a5c9-00b1da29d5c8">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMy0zLTEtMS0xMTc3NTY_f2c8a030-9543-4614-b7e2-9d9120ca743b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNC0xLTEtMS0xMTc3NTY_cdbca460-683e-434e-ad84-fc3ad226c800">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNC0zLTEtMS0xMTc3NTY_f58a4176-9da2-4df8-aab8-c072602aa91d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNS0xLTEtMS0xMTc3NTY_fb314251-9ab4-46a5-bc6a-8e95731fb992">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNS0zLTEtMS0xMTc3NTY_97ce4bec-2177-41ca-8ee6-b676c0bd98df">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNi0xLTEtMS0xMTc3NTY_34582610-9523-43f2-bcd3-874e45e518f4">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNi0zLTEtMS0xMTc3NTY_aae36567-55cc-42ee-9bd4-fcb62b2d5f4f">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTc3NA_b9f9dbaf-df58-4e31-a34e-3c02845357bc">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNTQ5NzU1ODE1ODA2_9a490abe-a2cc-432c-8754-e9e2ac93e23a">17</ix:nonFraction> million for the nine months ended September 30, 2022 and 2021, respectively. Excludes $<ix:nonFraction unitRef="usd" contextRef="ibcbea72907fd45ed8c844cd0e81ebc36_D20210101-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTgxMA_dafef802-1d7a-4912-81db-05402d6371d7">12</ix:nonFraction> million for the nine months ended September 30, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfMTk3NA_82cac1af-b862-4b24-89d8-78c2c66cc2d9" continuedAt="idb5d3cbc1c6441f9b5fb5b6db45df278" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="idb5d3cbc1c6441f9b5fb5b6db45df278" continuedAt="i67cf149bcb2a462e930c29783fa7504a"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfMTk3Mg_14725ec6-f7c9-4520-adfa-b1d0633d6f1e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi0xLTEtMS0xMTc3NTY_a2adcfe5-18a6-4237-87fd-364228f77ae4">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi0zLTEtMS0xMTc3NTY_48b283a3-6af8-4ef4-9866-6ab952a3a7d7">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi01LTEtMS0xMTc3NTY_a31baa79-0071-40bb-9ade-a096b2f6469c">5,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi03LTEtMS0xMTc3NTY_142eb004-d081-4318-b914-ffd9111948dd">6,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy0xLTEtMS0xMTc3NTY_30d210fc-9104-4189-9fea-a72101d537e8">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy0zLTEtMS0xMTc3NTY_9144edee-ee25-48d5-a0d7-ce952e790831">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy01LTEtMS0xMTc3NTY_9e9219a7-a48b-4b7f-bc7a-33dcbfb0580b">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy03LTEtMS0xMTc3NTY_0728805e-4b52-4c59-a512-6d4c5eadd2d9">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC0xLTEtMS0xMTc3NTY_40ea24bb-b30d-4c42-a87f-37fdf766583e">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC0zLTEtMS0xMTc3NTY_9b92a532-56d3-456a-ba04-15588bb022d8">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC01LTEtMS0xMTc3NTY_fd815b89-4244-4852-ac5f-186557352391">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC03LTEtMS0xMTc3NTY_0becdcea-eb0b-424a-bdaa-324cb30dafe2">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments, intangible asset amortization, and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i67cf149bcb2a462e930c29783fa7504a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits as of September&#160;30, 2022 could decrease in the range of approximately $<ix:nonFraction unitRef="usd" contextRef="ib73eeb74828048d393d64170a29ce8f3_I20220930" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfODUx_1ab130b6-afe9-41d5-833e-f5fea31edb40">480</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i5b1ef508785f46e8951a4b5d8734fe0e_I20220930" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfODU3_9450bb25-9608-4e3a-8fd7-599b91fdd6b6">530</ix:nonFraction> million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RleHRyZWdpb246NDk5MTgzZGE1YmQ3NGIyMGJkZGE1MDY4ZmRmNTVmNjVfMjM2_8289e86a-051b-4cd9-83d8-9f7ec9d87459" continuedAt="i97f3a7c4c5104ec7992744af64ef58e5" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i97f3a7c4c5104ec7992744af64ef58e5"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RleHRyZWdpb246NDk5MTgzZGE1YmQ3NGIyMGJkZGE1MDY4ZmRmNTVmNjVfMjMw_dbe60351-3712-49f1-b326-3775023fd65f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi0xLTEtMS0xMTc3NTY_408c9e80-d4b6-4fb1-99bb-f456eced84a2">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi0zLTEtMS0xMTc3NTY_f8e2c187-97e8-4ae4-b887-bcccebcf7cfa">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi01LTEtMS0xMTc3NTY_8874f060-a82d-4549-bd28-60792b17c434">4,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi03LTEtMS0xMTc3NTY_692022a9-e354-4e9d-9a0f-1649a1087557">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC0xLTEtMS0xMTc3NTY_6497e19e-4882-48a0-9256-0017d77d61c3">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC0zLTEtMS0xMTc3NTY_97382047-12fd-4b0f-a45a-32412cf2a792">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC01LTEtMS0xMTc3NTY_931880c9-fdfe-440d-a897-e08a239cecf4">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC03LTEtMS0xMTc3NTY_53b529ae-db36-43df-9153-c1186b6ee635">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS0xLTEtMS0xMTc3NTY_ec6840b2-8ddb-4567-954e-ca9331258574">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS0zLTEtMS0xMTc3NTY_60ff42c5-2b7c-49fa-8053-b0b66a5c4f46">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS01LTEtMS0xMTc3NTY_ca30f2ff-c818-4fdf-947e-4b8ff8df06ea">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS03LTEtMS0xMTc3NTY_72c6c0e8-bffb-4faa-9ae5-cece8dfb6c41">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi0xLTEtMS0xMTc3NTY_8e760dd3-a05d-4006-8c54-08599d36e966">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi0zLTEtMS0xMTc3NTY_db15483e-7878-42fb-805d-fc06d999ad7d">2,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi01LTEtMS0xMTc3NTY_24f6b3ad-f189-4e65-a57d-315d9b948be3">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi03LTEtMS0xMTc3NTY_ee0ad695-27ae-4d69-9217-12b413885869">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS0xLTEtMS0xMTc3NTY_07821a8f-8da9-4757-a1fd-3c09287a779b">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS0zLTEtMS0xMTc3NTY_5fa61ff7-3055-4fe8-ae7d-7edc577fca98">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS01LTEtMS0xMTc3NTY_474b2c88-be1e-4cc3-8ce9-6d7cb40e433f">2.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS03LTEtMS0xMTc3NTY_202b307e-332b-4588-9738-9b7f8b4f4d54">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtMS0xLTEtMTE3NzU2_b5d974d4-0ad6-4204-96f7-8cafa2a2ce1d">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtMy0xLTEtMTE3NzU2_eed7092b-bc64-478f-8f46-114d56d3a5c9">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtNS0xLTEtMTE3NzU2_522a0004-7fcd-49bb-811b-430979267bb0">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtNy0xLTEtMTE3NzU2_30122e23-d91c-462b-b8e2-3f8dd38e03a2">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three and nine months ended September&#160;30, 2022 and 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMjc_b51e938f-f8c3-4299-ad21-86c80ca0853f" continuedAt="i60a120cf7a7940cc96fe9b1b71751640" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i60a120cf7a7940cc96fe9b1b71751640" continuedAt="i13aed5ff36734e94a81d7685d5f53fd8"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAxMDE_4a0427fe-5011-4196-97ef-bb1aeb3ab1a3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0xLTEtMS0xMTc3NTY_51b59b36-a502-4848-8371-19e3d56dd5b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0zLTEtMS0xMTc3NTY_308029a2-098b-45f2-94ac-4b90f1589c5c">4,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi01LTEtMS0xMTc3NTY_76619b9a-4c23-4641-9874-cfb9114a09ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi03LTEtMS0xMTc3NTY_b8aa07b3-e545-4fd9-9289-e9f5f4a5ddff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664e35471e3b431f80b8059482063353_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi05LTEtMS0xMTc3NTY_e1f01a7f-3fdc-46c4-81f2-5031f88266b3">12,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0xMS0xLTEtMTE3NzU2_f9924cf8-4769-4fa9-979e-8c4c8b378b9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1750b8def3481db064bae547758030_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0xLTEtMS0xMTc3NTY_c4acb7f4-ae22-4a14-a96c-7b84fdb5a524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599407fe2aa64479abc2cb9f8943ddf2_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0zLTEtMS0xMTc3NTY_5a9a7fcf-13d6-430b-865f-15b92679668f">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddf109f29964447db19dbc4a67325a91_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC01LTEtMS0xMTc3NTY_1bd772e4-2065-4f4c-ad85-ed78652525d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86460ffdc92343a1b34f3701d5ba3f73_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC03LTEtMS0xMTc3NTY_e96d51b7-18f8-4a6e-b165-525052c46f22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023d3dd7e5e2466fa118f0a377f5a86e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC05LTEtMS0xMTc3NTY_c4a56fb4-165d-45b2-8cf3-c6bf2c108b03">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023203ca7e2c44c6aef398e5ac1f362c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0xMS0xLTEtMTE3NzU2_d180e090-4ef6-4fa9-a4b9-7399dfe5e523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f21b31cd934d95bec8c47f5cca9d7d_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0xLTEtMS0xMTc3NTY_e480e1d9-ad16-416d-9c92-da1a7f00e96b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751bb8a9c76a4066b66cc023f2f6e8ae_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0zLTEtMS0xMTc3NTY_1249424d-70f9-44eb-9b43-3e4f7e957a4e">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfb1a2171374f4680084a5e82d83fa3_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS01LTEtMS0xMTc3NTY_3c790985-0cf8-4f34-9214-58b828738407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6cfdd1ed78472f99fc8e5e7c606f21_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS03LTEtMS0xMTc3NTY_55a072ee-498b-496d-9b64-2b555551bb21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6520e68dbf54cdc8ec17823e10b0646_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS05LTEtMS0xMTc3NTY_0b516224-61f6-497b-b9b5-2f5b809be326">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89986bb97ecb4e97aff1b91cce777c15_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0xMS0xLTEtMTE3NzU2_2863a682-3f38-4d67-8ece-08d71f7539ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9b662730384bb7b4ead3470de0d515_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0xLTEtMS0xMTc3NTY_e9a74820-8dc9-4131-9277-5b7dbda0e04d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c861dc4c60414088ec212834a771e4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0zLTEtMS0xMTc3NTY_88c0c609-8f1f-4554-a156-75169a4f8a67">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac1ef197e014b5dae4b0dcbf87a2891_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi01LTEtMS0xMTc3NTY_70a43859-971b-4b17-99b5-d584067e8a26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7100bf3c38b24a52bf40ec5e7f24933a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi03LTEtMS0xMTc3NTY_52863a86-a0ba-4282-8322-f2149817e18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b888a0a457640ff861a14782a04bdbd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi05LTEtMS0xMTc3NTY_3614c78e-caa2-4b65-9918-b01b34c850cd">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63b4fc1b0444bdfa216b46c39f99f6c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0xMS0xLTEtMTE3NzU2_e7228c50-72b7-4a87-8350-1f7dd5db2647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0xLTEtMS0xMTc3NTY_656b07ff-dbfe-4aa6-a750-34b42fec19a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0zLTEtMS0xMTc3NTY_db8a2098-d486-4197-8c33-f0708ca1aa6e">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy01LTEtMS0xMTc3NTY_91d62223-0a7e-477b-825e-d79a2e3c4a23">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy03LTEtMS0xMTc3NTY_a6e8b25c-827f-4916-a6f3-78f2e66dac4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664e35471e3b431f80b8059482063353_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy05LTEtMS0xMTc3NTY_4825fddd-68ae-44db-b2b3-4112db148f07">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0xMS0xLTEtMTE3NzU2_082d1eef-e491-4802-bc43-4b72dcfb4d14">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaad04a4dfb54e4baa98287704d915e1_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0xLTEtMS0xMTc3NTY_badc6f08-c7fa-4c82-bbf0-9120a08e1841">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id32df06df7ee4312b8d69963af72d16c_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0zLTEtMS0xMTc3NTY_2c293108-891b-4204-922e-6a75d0cd7bef">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i001cf1d2900445718093f0ed5b320c01_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC01LTEtMS0xMTc3NTY_d3e70862-ce72-47d3-b546-aa72446a7989">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1b2dc24bcf49ce861f999cd524d75f_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC03LTEtMS0xMTc3NTY_7ded1a20-dcb4-4087-8485-a67c23a8b4a4">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0bd321f5bb47f88e5f9bcc836bb474_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC05LTEtMS0xMTc3NTY_7b26f157-287e-489c-9d35-6a3b7f4fffd4">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8881178a9a4ffd950fe4ca131ae180_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0xMS0xLTEtMTE3NzU2_63d488dd-ddc4-4b67-946f-95bf78c81e7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0xLTEtMS0xMTc3NTY_cb196429-4853-46f1-9b89-e2997b39b68e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0zLTEtMS0xMTc3NTY_3732ed0b-05c0-46de-b320-3cbe5ece5c7c">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS01LTEtMS0xMTc3NTY_bca365b0-9f44-4db6-abae-438fab2f5a5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS03LTEtMS0xMTc3NTY_6e4e2102-90d3-4df6-9088-412fb790ac0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664e35471e3b431f80b8059482063353_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS05LTEtMS0xMTc3NTY_87efda02-739c-4591-9c1b-ce3b8e162582">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0xMS0xLTEtMTE3NzU2_80250347-d107-4f09-a04a-bcd07755c7e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94029425ffb44b89b3a798ad9c779fa_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMS0xLTEtMTE3NzU2_bf47dab0-f45c-4ab3-be64-4b68354729c0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia027865f0ea44b3a80cf5792949a8621_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMy0xLTEtMTE3NzU2_88deb6ee-1e62-4acf-9563-5b01d30a24de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6ee716584d44f0e92394dc97ec2e3e4_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtNS0xLTEtMTE3NzU2_2597cef1-6faa-458c-8fd6-3b2c6adc5c45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3291dcc3ae81483cb7fa13dfc3ad4b9b_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtNy0xLTEtMTE3NzU2_6e0363a1-a1ca-457c-a45e-ec204b6d134c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecb65891a224cfeac69f536b96a8bae_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtOS0xLTEtMTE3NzU2_5dc90456-f42d-4023-8aad-9fede6d8f9a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951812de5a98402d9dea34b638a13c0d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMTEtMS0xLTExNzc1Ng_d2c4b359-9b36-46e1-9de4-8c2c0d0be542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMS0xLTEtMTE3NzU2_63328f8d-52df-495c-bf59-4fb9d46d0142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMy0xLTEtMTE3NzU2_fd1b9b0a-a6a3-4644-b74f-4ddde9dd5d4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItNS0xLTEtMTE3NzU2_3d74cbef-7ec7-4262-b933-65faa1473274">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItNy0xLTEtMTE3NzU2_84365b05-7bdf-4185-beb5-465bec69515b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664e35471e3b431f80b8059482063353_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItOS0xLTEtMTE3NzU2_f33b5174-3c21-4e17-be47-324f387296be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMTEtMS0xLTExNzc1Ng_d123ac43-188a-413e-a3cf-aef4c5d50282">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2021 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of September&#160;30, 2022 and December 31, 2021. The restrictions will expire by April 2023.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i13aed5ff36734e94a81d7685d5f53fd8" continuedAt="ifd39b05a24b84914a48e8fbaac14b0fb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNTc_c23ff281-767e-4293-a694-f0b64c5d9918" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xLTEtMS0xMTc3NTY_bdec9dfa-5e4a-4368-abc9-1a7fd607f99e">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0zLTEtMS0xMTc3NTY_cc294e3e-fc8c-4360-9a2c-21bdf095b2a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy01LTEtMS0xMTc3NTY_9b194358-973b-41fd-be32-f18aa76f3feb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy03LTEtMS0xMTc3NTY_548ffa28-4dc1-48cc-ad4e-a7f601df1606">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy05LTEtMS0xMTc3NTY_3ff4bff1-3517-47a3-9ddd-0b64ac659d5f">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xMS0xLTEtMTE3NzU2_97831790-57ad-4575-b745-2bd903dc77ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xMy0xLTEtMTE3NzU2_7ed8e99a-1087-402a-9096-fda2ac02b46d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xNS0xLTEtMTE3NzU2_37222c0c-295b-4303-8f4d-c3e55bc06df4">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xLTEtMS0xMTc3NTY_3a9f0aaa-c4e8-4f62-8156-f72310ce3d2a">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0zLTEtMS0xMTc3NTY_ff551a09-403c-4fe1-9b43-0f964ba5cb25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC01LTEtMS0xMTc3NTY_4cec93ea-db40-459b-bbfe-28731945fa63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC03LTEtMS0xMTc3NTY_6888b89b-0f96-4228-824b-d997446fffa7">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC05LTEtMS0xMTc3NTY_587a877a-9644-4e90-b48c-67ddd14b2c02">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xMS0xLTEtMTE3NzU2_5b9cb2e2-6186-46c9-ac43-fc7aa78c2ba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xMy0xLTEtMTE3NzU2_994e9163-1dae-4dfb-9604-a21b39111171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xNS0xLTEtMTE3NzU2_f33c6c30-c504-4f7e-9705-1605406743e5">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xLTEtMS0xMTc3NTY_0c447082-20a5-4598-800a-3ff9cc24489a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0zLTEtMS0xMTc3NTY_2ba25d61-e7ec-4881-85d1-6767bf550a10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS01LTEtMS0xMTc3NTY_55a7ffb0-ec78-4c6b-84b6-4a5b30de8c1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS03LTEtMS0xMTc3NTY_20d359f7-739a-4345-bea4-198d5b332ab2">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS05LTEtMS0xMTc3NTY_d8852cc3-38e8-4712-81f8-d8b1e7791095">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xMS0xLTEtMTE3NzU2_a5cc42a2-25fd-47a6-9df6-27c459ddb4ac">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xMy0xLTEtMTE3NzU2_4379a3f4-d1e2-404d-a768-d5a43213c9c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xNS0xLTEtMTE3NzU2_1fc6a46f-0cf7-4027-83be-fb7f6566e9a0">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xLTEtMS0xMTc3NTY_fe594653-094c-4648-ac60-2004884b1466">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0zLTEtMS0xMTc3NTY_c332c992-80e6-4f67-b58f-6fe903a9de9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi01LTEtMS0xMTc3NTY_8f5893fc-7a22-4dd7-a2a3-f1893108ff25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi03LTEtMS0xMTc3NTY_bc791d2d-f64d-4cb0-a606-558b28ebeae8">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi05LTEtMS0xMTc3NTY_da5c60b9-d651-4d34-9eb6-78e484535e12">2,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xMS0xLTEtMTE3NzU2_0448f673-c1ba-48f8-a044-46ed35089fb1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xMy0xLTEtMTE3NzU2_672b9946-2397-4fdd-96bb-82bd2ae547b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xNS0xLTEtMTE3NzU2_f133c0e7-b133-489b-806e-d57d8dd2f99b">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of September&#160;30, 2022, and December&#160;31, 2021.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:ScheduleOfEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMzA_1d0fbeec-8611-41f9-b3f7-4146d4ddf4e5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMS0xLTEtMS0xMTc3NTY_84898160-96fd-4139-b86f-253a0d2d3e36">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMS0zLTEtMS0xMTc3NTY_d32130c1-6cd3-4d4f-830b-4102dfc72ec5">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMi0xLTEtMS0xMTc3NTY_56b0dc96-d17a-413e-ad8c-420f4accf0b7">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMi0zLTEtMS0xMTc3NTY_64f8bee6-82ee-41e3-9000-35a948196fce">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMy0xLTEtMS0xMTc3NTY_59d70c7b-2573-4a4f-9c89-4764c18daf20">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMy0zLTEtMS0xMTc3NTY_b8f29bec-fc0c-4cbe-bf82-47932817de64">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfNC0xLTEtMS0xMTc3NTY_7065d90f-500c-4d35-9bb2-016190712a61">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfNC0zLTEtMS0xMTc3NTY_71b9dd64-0f11-4149-8abb-8545341b33b5">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMzk_832adc6c-8f0b-4c74-936f-86c1159e4f5b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy0xLTEtMS0xMTc3NTY_34d8d1b7-a124-4da7-a569-5a50e6f0faaa">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy0zLTEtMS0xMTc3NTY_8220f9e7-6c4e-4b1c-baf3-9e851def7500">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy01LTEtMS0xMTc3NTY_52f165f7-428c-45a5-b409-7703e1f20e7a">927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy03LTEtMS0xMTc3NTY_736a137d-a076-4a09-991e-9f44e2b01655">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain)/loss recognized on investments sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC0xLTEtMS0xMTc3NTY_361d057b-98fb-41b2-9e29-aa9a1087a446">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC0zLTEtMS0xMTc3NTY_3172f2cb-3b6a-4145-8693-3bc5dfa2a885">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC01LTEtMS0xMTc3NTY_8c6495f0-f77c-4402-b207-2050066f6990">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC03LTEtMS0xMTc3NTY_46e21691-b13f-4649-8011-8dcb7c378a3f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS0xLTEtMS0xMTc3NTY_b67460c7-7dc8-48e8-b528-160d8a687a70">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS0zLTEtMS0xMTc3NTY_ca2377cf-10d3-447c-9df2-fbb72a0d9dc6">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS01LTEtMS0xMTc3NTY_93b7974f-1e04-4f0c-832d-5695f180ad46">944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS03LTEtMS0xMTc3NTY_84f36360-d2b0-4e09-8e00-fd9dc027ed30">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC0xLTEtMS0xMTc3NTY_6c63ada7-670d-4a71-8fd9-81722c28c76b">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC0zLTEtMS0xMTc3NTY_e656a515-c947-4e2a-8419-1cf265ef5c51">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC01LTEtMS0xMTc3NTY_c27c3ab8-a7f0-4e9b-ba18-5fb43c0a9f1b">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC03LTEtMS0xMTc3NTY_76482d3f-b01c-424d-9b51-327c61ad4ec3">908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS0xLTEtMS0xMTc3NTY_30ef889e-b49e-46d5-862b-0f30a4f67a9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS0zLTEtMS0xMTc3NTY_96de8905-33b4-4729-b676-05dd41e7240d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS01LTEtMS0xMTc3NTY_50aa4fdd-241e-43f6-a32a-f2c6ff2c4177">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS03LTEtMS0xMTc3NTY_156312e4-a9e2-4053-9564-072b4605b0e5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTAtNS0xLTEtMTE3NzU2_aa742f1c-9678-4f83-826b-a204539e2847">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTEtNS0xLTEtMTE3NzU2_f4682fb2-b66b-4cae-8fa7-51b56f09fa96">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss/(income) of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtMS0xLTEtMTE3NzU2_a9d04aa1-e037-45b7-bccb-f559a685e657">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtMy0xLTEtMTE3NzU2_c96eeeb9-d2e0-48fe-bcad-e1bfc5984a45">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtNS0xLTEtMTE3NzU2_8f768efe-c2f1-4c35-ac46-2c855476fe3d">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtNy0xLTEtMTE3NzU2_01979537-2040-4e83-b6ed-218570de25cb">214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $<ix:nonFraction unitRef="eur" contextRef="i886da8a6a90b461c9af99d1fdcba4377_I20220930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzQwMA_c545ccb0-703a-49b8-abbc-71b2d8e77301">5.1</ix:nonFraction> billion and Japanese yen of $<ix:nonFraction unitRef="jpy" contextRef="i668b51b58a0942a9aedf0c485aca6851_I20220930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzQyMw_42057a15-fefe-4660-a124-f19b13e69eb9">1.4</ix:nonFraction> billion as of September&#160;30, 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifd39b05a24b84914a48e8fbaac14b0fb" continuedAt="i2796db27a38845098c0874c4733d7cc1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, BMS entered into cross-currency interest rate swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in Accumulated other comprehensive loss and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency interest rate swap contracts was &#8364;<ix:nonFraction unitRef="eur" contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTMzNTc_f1a450ef-666f-449d-9d71-9560ebcce9c7">575</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTMzNjE_ed6b47c4-ea68-4621-a0e1-9af778abcb63">584</ix:nonFraction>&#160;million) as of September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. dollar borrowings of &#8364;<ix:nonFraction unitRef="eur" contextRef="i24f777b58fc44c61994b5a303994de56_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDI5OQ_237de885-2cca-4418-b251-ae8c51455589">375</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i24f777b58fc44c61994b5a303994de56_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDMwMw_91f1e6d4-9a95-404e-964d-3d94874e7694">368</ix:nonFraction> million) as of September&#160;30, 2022, are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $<ix:nonFraction unitRef="usd" contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDc0Nw_eb5a9d25-350f-492a-a571-fd9a88120fe2">1.4</ix:nonFraction> billion as of September&#160;30, 2022, are designated to hedge certain currency exposures of BMS&#8217;s net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other current and Other non-current assets or Other current and Other non-current liabilities. The notional amount of outstanding cross-currency interest rate swaps was primarily attributed to the Japanese yen of $<ix:nonFraction unitRef="usd" contextRef="ic1fcfb5eba384919a6f3979d6d9e15be_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNjA0NzMxMzk2NTY0NQ_93952c16-9058-4aac-a9fa-c76af68befb0">686</ix:nonFraction>&#160;million and euro of $<ix:nonFraction unitRef="usd" contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNjA0NzMxMzk2NTY1OQ_6b0221db-ea3f-4917-8267-ea2700f89601">584</ix:nonFraction>&#160;million as of September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (<ix:nonFraction unitRef="number" contextRef="ia29ecc9950894eb59b5cb3e5b2517a3c_I20220930" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ1NQ_987501b8-ee30-43da-a48c-b2af486112b7">3.14</ix:nonFraction>% as of September&#160;30, 2022) plus an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="3" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTUwMA_febebf35-6613-468e-85f1-d456cf5f3ae1">4.6</ix:nonFraction>%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNTM_8d31ff80-a807-4261-85ad-aeb60fd72ccd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef79162dd034be895a4bcba78334e1c_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xLTEtMS0xMTc3NTY_6f5f0f79-b344-4721-a71c-75a85a1fba09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339caa7c1e6a43eb90fd07efce417b64_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0zLTEtMS0xMTc3NTY_027dfb38-a1c1-4dff-92ae-a7e82670ccd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0fb0b0b75c45ee8d18d3d8d0b6d4c3_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC01LTEtMS0xMTc3NTY_d818dcc3-2927-4e13-b094-9adc78a61c48">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i339caa7c1e6a43eb90fd07efce417b64_I20220930" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC03LTEtMS0xMTc3NTY_842ad3d0-1973-4cdf-af66-1517f0f2c414">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9113bb62f5fc4e84b6e97c82d3e2911b_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC05LTEtMS0xMTc3NTY_103d6374-685f-4cb3-baba-42d35d0be4f8">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xMS0xLTEtMTE3NzU2_be9877ae-d9ea-4246-ad6a-34e3847bd525">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfad7762f964e1ca74853b28c6b82a0_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xMy0xLTEtMTE3NzU2_e0c3b69c-99d4-40b3-a78e-872759ce9b69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xNS0xLTEtMTE3NzU2_3ce638bd-31d6-4419-a1a3-b620c7482ee9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387ddd833f71435ba85ff38a446a1ad4_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xLTEtMS0xMTc3NTY_6f05adef-8abe-4957-aab2-3fbc2814a54e">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0zLTEtMS0xMTc3NTY_919f1100-cdd7-4268-8e42-1b9823c437c2">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5649feba80774237abf36efd972c7da1_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS01LTEtMS0xMTc3NTY_08ebf8bc-0e59-454f-ab93-9ed9b845b4e0">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS03LTEtMS0xMTc3NTY_7c9aefae-9fe8-4618-b7ad-2fa749417156">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64ca08b52a6742409695aac6c23554f3_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS05LTEtMS0xMTc3NTY_7ccf5c4c-80b3-40cc-bce5-cf7fa4e01c05">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de81def66b94b54849c6be2071f8a4e_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xMS0xLTEtMTE3NzU2_2b28e637-d138-4341-9b04-b33a70a53cf5">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671a3558463349758ba20e3666722cc5_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xMy0xLTEtMTE3NzU2_bd472847-e7dc-4447-b949-2e77f15865dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de81def66b94b54849c6be2071f8a4e_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xNS0xLTEtMTE3NzU2_2ee0a197-a797-4975-bd07-89b856827c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434b45cb2aa04afc908af8ac2c0b29e3_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xLTEtMS0xMTc3NTY_d5650fe4-ee09-4e1f-9012-ceb7eda02500">7,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i239d9003938740c39216c644b9c80fbb_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0zLTEtMS0xMTc3NTY_694b417d-8f16-401c-9183-d9efbf11165b">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa5e345526d4cb184e2c617cd44dde2_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi01LTEtMS0xMTc3NTY_91afefdc-45e9-4678-ad3d-cd447f9ed9f0">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i239d9003938740c39216c644b9c80fbb_I20220930" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi03LTEtMS0xMTc3NTY_193ecb33-456d-435f-bf4b-49f435d1093b">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b5e6864bac4cc4a4d6c73ae31d6a8b_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi05LTEtMS0xMTc3NTY_40767439-4a71-4b42-ac8d-f73878354cb7">3,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356d70d9be5b40d3ae48415c984f8747_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xMS0xLTEtMTE3NzU2_7a6a479b-29b3-4d30-bd04-0c5a600d1a36">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae55e5eabed94fa8801cae43dc8309ce_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xMy0xLTEtMTE3NzU2_ca677513-7225-4155-91e6-f4309e408a4e">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i356d70d9be5b40d3ae48415c984f8747_I20211231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xNS0xLTEtMTE3NzU2_d54ce1ae-0bee-4bd9-a5a3-7d511f835237">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f488420464613bdeee86193ef4eee_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xLTEtMS0xMTc3NTY_2f70e3c0-14e3-4e34-bdb4-fc03533543ca">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide37ecb83af748fb901addbb7d586542_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0zLTEtMS0xMTc3NTY_6ac90b29-7ba4-4fb1-b23b-3701c54b65e7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibed40edcdca04be1ac7f40fedd1fbf28_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS01LTEtMS0xMTc3NTY_9b064238-85ec-45e4-bc12-679b8aebcb7b">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide37ecb83af748fb901addbb7d586542_I20220930" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS03LTEtMS0xMTc3NTY_0d59118a-e826-4207-b1d8-8d43d9eff687">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341c5e7c579a49489d32d9cdb3032597_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS05LTEtMS0xMTc3NTY_f2e48b06-75a8-4a7e-8025-5b06409a667d">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xMS0xLTEtMTE3NzU2_ddf51bda-1946-49d0-84a8-c5d475f20759">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52bc3e57749345ea918765039e97891b_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xMy0xLTEtMTE3NzU2_a44f0ce4-09e1-4232-859a-e5bf89ac1012">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xNS0xLTEtMTE3NzU2_91d509ee-defa-419c-a4d3-dcf042cb3b01">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf70c949b4444abb6425eec36d8fdd7_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMS0xLTEtMTE3NzU2_4a78303a-4365-4efe-8e6e-0acaf925c64f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMy0xLTEtMTE3NzU2_c9829c79-934e-455e-b883-da7dd0e632a5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d78e80b73040089346da240187c709_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtNS0xLTEtMTE3NzU2_cd1f4589-298e-4544-9640-5b01d6be2451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtNy0xLTEtMTE3NzU2_85b18a68-21a2-4cc5-8f4e-6a17753b65fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8febe75ec14be68b29d9e554cbb15a_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtOS0xLTEtMTE3NzU2_58d45f09-ec7e-4679-976e-4583df1083a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1cae60d9924382bb960c3201397998_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTEtMS0xLTExNzc1Ng_bf65313c-a8f6-4046-9e22-204016ea8a4b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623000336f474ce0a7c985a7099f9f33_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTMtMS0xLTExNzc1Ng_fd60aa01-5063-4cc2-9f00-e04cc636068f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1cae60d9924382bb960c3201397998_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTUtMS0xLTExNzc1Ng_1e280dae-c769-4ad8-9866-bb1e1a7bb193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2796db27a38845098c0874c4733d7cc1" continuedAt="i0407a9b7424f46789de6021680f482e7"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNzg_b6e56f8b-5d58-4aa1-9835-ae118b12aca1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi0xLTEtMS0xMTc3NTY_312f423f-0cbd-44bf-9c7a-8697ae1fcd65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a2f300fd224cf69ad83417e63b0645_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi0zLTEtMS0xMTc3NTY_510ba274-2d21-46d5-a274-f5726dd644fe">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia507ce7f836d4c8f9300d3ffdffc8f80_D20220101-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi01LTEtMS0xMTc3NTY_12d8ffc3-6f6c-4740-93a5-af74a1970094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9681d173c7946ea819e81222ecfe950_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi03LTEtMS0xMTc3NTY_8779b113-4263-4cbd-ab3d-abcbb1fd21e5">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe3e81f2f1b4a57a73467c81f0b6af2_D20220701-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC0xLTEtMS0xMTc3NTY_ffedb77d-9cbf-418c-b266-eedc4521f2ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC0zLTEtMS0xMTc3NTY_5417ea38-d83b-4867-a647-9bc4a9f03133">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb1e679272541e9b87cbfb82b0c1cb7_D20220101-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC01LTEtMS0xMTc3NTY_b2dad089-2e4f-44d0-929d-42ecc4393edb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC03LTEtMS0xMTc3NTY_a1c09ccf-ec5b-43ef-816f-80bb0582bc76">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS0xLTEtMS0xMTc3NTY_9e8a77f5-4dd6-4794-a04a-d20fbc8d6458">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2dd852e2564293b0c25120a2fea24e_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS0zLTEtMS0xMTc3NTY_6cd795d3-4f50-44fc-a742-660527c65664">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS01LTEtMS0xMTc3NTY_836fd8f4-4b22-411f-8e9d-440fa69c23ac">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id232f272e34d446b97e88ece5cdad405_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS03LTEtMS0xMTc3NTY_55e4c85f-7c8c-4a43-baeb-35b97d45602a">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51db28aa096b432189a3788e6aa7123f_D20210701-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi0xLTEtMS0xMTc3NTY_8e9f8299-cb2f-4f28-bc70-fb257c393e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fff4fcd97244e8a2031133dc96e519_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi0zLTEtMS0xMTc3NTY_2cece273-bd12-43e9-8f1c-969f1fe57d5e">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67fdac5f25c142198444d8440aeb1e36_D20210101-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi01LTEtMS0xMTc3NTY_23dcf898-9d70-4745-a0c9-0b533e217b36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09ce9df741f740bb89856a5bf20958f7_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi03LTEtMS0xMTc3NTY_f6db9397-273f-4c2c-910e-987a432ac58a">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e98552285044c26ba232ed5924465b9_D20210701-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy0xLTEtMS0xMTc3NTY_ede5582c-5702-4887-bb7d-5f9bac30f304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy0zLTEtMS0xMTc3NTY_c5456c47-54a1-4eaa-9edd-98617762b22b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia35153af17cf4e51a7a041e312ab160e_D20210101-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy01LTEtMS0xMTc3NTY_22fab096-0922-44ae-a51a-147a2064ed96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy03LTEtMS0xMTc3NTY_9a5d9c7b-4bab-4711-b6df-242a618e8c82">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC0xLTEtMS0xMTc3NTY_5573fe1c-a3df-46dd-8303-c7ed68482ed5">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf7a73a7127b44f3ae2722fff64309a6_D20210701-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC0zLTEtMS0xMTc3NTY_bf1a2d9d-31a9-4bf9-ba28-73d811427865">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC01LTEtMS0xMTc3NTY_b4c2302e-aba3-41da-a7f5-50bcb0d167d7">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9f9f5be85464567b1c04db5316afee7_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC03LTEtMS0xMTc3NTY_79491a7e-4dec-47e3-bcc1-d0786be5c06b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7982584c67704aeb87a3bc5199ecf7b8_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC0xLTEtMS0xMTc3NTY_63447126-6fbb-48ec-8ca8-9f21101e006b">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac23d9ba09ef4f6f9bb57d9dc257b587_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC0zLTEtMS0xMTc3NTY_07ca2757-9316-46ca-ba51-cd8f959a0f1b">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib632c605afc443a9a1e66024aaf25726_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC01LTEtMS0xMTc3NTY_1db38627-3974-4bb4-bcb4-0cea8e4026f3">1,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0daeb22196f04a9c979d9bea65d5029e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC03LTEtMS0xMTc3NTY_f398f264-d0af-4b36-b874-c3ee377f887d">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS0xLTEtMS0xMTc3NTY_35b5559f-269f-44a1-be59-6c2ebad230c6">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS0zLTEtMS0xMTc3NTY_d3d9a4f5-b69f-4deb-a10d-3b353b5d7383">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS01LTEtMS0xMTc3NTY_f38ea4ec-b436-4980-a992-6a7910d1d0c2">408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS03LTEtMS0xMTc3NTY_ae5f69bc-4f46-4d33-a30a-59028b87588b">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0xLTEtMS0xMjU5NDE_3b1d00af-a274-4e6c-b525-222653da4042">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92872acbdf1845709dc97146229773d3_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0zLTEtMS0xMjU5NDE_05db3ca6-4754-4134-8bf9-8540e0615e80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy01LTEtMS0xMjU5NDE_60038867-8da2-4ce3-ab5c-e1bbff56695f">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy03LTEtMS0xMjU5NDE_f9119534-308f-4326-bcd7-450b0e0750da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC0xLTEtMS0xMjU5NDQ_197b12d2-632e-4c58-8f5c-67ab96c090c0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC0zLTEtMS0xMjU5NDQ_80a567c8-7b19-41c6-b40b-0ce92d336a79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC01LTEtMS0xMjU5NDQ_ff7b8c88-0208-4b59-912a-496bf6dc3ec1">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC03LTEtMS0xMjU5NDQ_63aab9bf-d07d-4cd6-a554-a8c96827770a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44851decbabe44c2aa827ce35420cd14_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0xLTEtMS0xMTc3NTY_e56b8368-f55b-44bd-b563-23449c2a6b32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f45381d84d492c9d4620e158db0048_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0zLTEtMS0xMTc3NTY_5944aaa2-1d40-47b4-8e78-7619680a0fa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cb0c279ee9246b5a0b911c7c61e2557_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy01LTEtMS0xMTc3NTY_99f7da14-9621-447a-891e-543934f2a050">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e28e98ba32447bb7448a8051ebaf80_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy03LTEtMS0xMTc3NTY_70531f77-e319-491f-a83e-93915d9f8b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtMS0xLTEtMTE3NzU2_47206694-8c74-4f37-b224-4e17d5bc8ccb">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92872acbdf1845709dc97146229773d3_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtMy0xLTEtMTE3NzU2_6461aa38-5938-496e-98ee-683578ba4884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtNS0xLTEtMTE3NzU2_fa1327c0-e043-48d0-8107-33ac006c4772">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtNy0xLTEtMTE3NzU2_cab31895-f783-4780-8ce3-a0fd3f1556fc">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c7d5843d7de40ddbe92cb7c600b33f3_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtMS0xLTEtMTE3NzU2_61151d5e-4e97-44b6-896a-6bc5bb1769bf">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cacbe74c36b42af8f2449ab4f4558d6_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtMy0xLTEtMTE3NzU2_ac4e9c14-055c-4ccf-b023-f67414d65855">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdf266395024196809286a2ed6e58ab_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtNS0xLTEtMTE3NzU2_1882623c-c243-4f15-8797-c64bc6092b6b">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52749ea5b0c4ce2b65ccf38c233521a_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtNy0xLTEtMTE3NzU2_312376da-f08a-4a15-bfea-cc8ed0722d4f">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 24 months.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTg_932a01fc-e031-4cec-aed4-588a59c5b438" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMS0xLTEtMS0xMTc3NTY_01fb854b-5d3a-4b02-b1f2-321f0b3a3cb1">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMS0zLTEtMS0xMTc3NTY_e5d1ed55-47a3-4723-8f3a-6f2398976979">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMi0xLTEtMS0xMTc3NTY_54b27970-7b65-4962-bbb0-44366d06934f">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMi0zLTEtMS0xMTc3NTY_528a8255-6c88-4375-b220-f6de7119b6e9">4,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMy0xLTEtMS0xMTc3NTY_a0653957-4d31-4bc9-b191-a25d5e6490c9">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMy0zLTEtMS0xMTc3NTY_f7c3e826-6298-4849-941a-81f6a1671507">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfNC0xLTEtMS0xMTc3NTY_6301b9c0-259d-40a7-8f83-99bfa5c1e211">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfNC0zLTEtMS0xMTc3NTY_23c22c92-2304-47b7-9c2c-7cfe38627df0">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i0407a9b7424f46789de6021680f482e7" continuedAt="i19fa8a7b505c418a899a9b427a09b066"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNjI_5ef1dad1-3481-4a9f-8649-240fc278d1ba" continuedAt="i336c3c6ffb674d74a02249f3ae26039c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMS0xLTEtMS0xMTc3NTY_b3eb7565-e4ff-49e6-92cc-2244ce5c21cf">38,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMS0zLTEtMS0xMTc3NTY_b15912ed-e993-4954-b553-c1cae2c11076">43,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a41df960fa54741b1d2968b3effa442_I20220930" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNC0xLTEtMS0xMTc3NTY_e5475cfd-51df-4277-ba7a-102cde057c4b">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150c8a06bb804437a2510c0f68d2e14c_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNC0zLTEtMS0xMTc3NTY_bd5d4130-eb49-4049-b6bc-cb7501f8c543">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNS0xLTEtMS0xMTc3NTY_841e7b06-c4cb-4c7f-ac4b-e8fdb17c71fd">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNS0zLTEtMS0xMTc3NTY_394cd614-0878-4cce-bf0b-d4dd1fa337ea">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNi0xLTEtMS0xMTc3NTY_99d46fb9-9845-4963-abe9-b78a7cd88d91">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNi0zLTEtMS0xMTc3NTY_4715c89c-dcec-44ad-a715-9a45e4682ab9">263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNy0xLTEtMS0xMTc3NTY_3a54f768-d244-4ab4-935a-387a27bf563e">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNy0zLTEtMS0xMTc3NTY_c1d923df-f7e4-4957-8e6d-1f760391ee47">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfOC0xLTEtMS0xMTc3NTY_5d96a980-bf60-46c4-82ed-ca32c03d162c">38,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfOC0zLTEtMS0xMTc3NTY_d5070d04-8876-4004-8fbb-dfe0c26834a2">44,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTAtMS0xLTEtMTE3NzU2_dc4ec536-6062-4c11-8fce-a75b36444489">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTAtMy0xLTEtMTE3NzU2_3139ca47-7389-4726-8014-4f121039e9b0">4,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTEtMS0xLTEtMTE3NzU2_763df134-d065-4221-bf23-813767c68e0d">36,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTEtMy0xLTEtMTE3NzU2_0b5a4a7f-e6e7-4694-864c-a14e37ff6020">39,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTItMS0xLTEtMTE3NzU2_5dbb3c77-aada-4417-b0ba-e9d0daa953e3">38,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTItMy0xLTEtMTE3NzU2_1bbfa608-40f7-4409-beb9-c141141d2d20">44,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzQxMQ_e43fa75b-4c39-4c61-a70c-dcd4e9d906cd">34.3</ix:nonFraction> billion as of September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzQyNA_25502e4e-7938-4058-b763-cc2e26747404">49.1</ix:nonFraction> billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30 2022, BMS purchased an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzc2Ng_ef828d51-6868-4403-8bcf-c752bb363926">6.0</ix:nonFraction>&#160;billion of certain of its debt securities for $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzgwNw_b2ff6cb1-d092-4e77-bb76-17986552df4a">6.6</ix:nonFraction>&#160;billion of cash in tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzkxMw_40c23fad-856d-4d43-81e5-f310eee5b7a1">266</ix:nonFraction>&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-7" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0NDg0NQ_04d9e23c-dadf-4b41-9bd1-c71e36864816">4.75</ix:nonFraction>&#160;billion of debt matured and was repaid including $<ix:nonFraction unitRef="usd" contextRef="i1b217acaaa49469aad78b589be10377b_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA1Mw_9a2366ac-b8e9-4f18-b9fd-df6b543b7d06">1.5</ix:nonFraction>&#160;billion <ix:nonFraction unitRef="number" contextRef="i1b217acaaa49469aad78b589be10377b_I20220930" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA1Ng_f778d659-30f3-4fb8-8546-4d31df100a7e">2.600</ix:nonFraction>% Notes, $<ix:nonFraction unitRef="usd" contextRef="ic78054c42bcb4ee9846b78e126b01988_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA2OQ_44bc16c5-b2d1-4dc1-8c76-caed03485bea">500</ix:nonFraction>&#160;million Floating Rate Notes, $<ix:nonFraction unitRef="usd" contextRef="ic24f31e173564ef08923e7298471a389_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDcz_244bdae7-16ae-4345-8a0e-256af4f142d0">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="ic24f31e173564ef08923e7298471a389_I20220930" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDg3_44e81e04-607e-45a3-8611-0d8f07357a38">2.000</ix:nonFraction>% Notes, $<ix:nonFraction unitRef="usd" contextRef="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDk0_0a2a2181-9ec6-4be6-892b-74dde47e1319">1.0</ix:nonFraction>&#160;billion <ix:nonFraction unitRef="number" contextRef="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTA4_98fa9cf6-638a-4b1c-8922-7286d30beb98">3.250</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="i58b5d7f1faad4e848093aeb065829a46_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTE2_1e9ff1a6-8b78-4c1c-b497-17e5aafdf1ee">1.0</ix:nonFraction>&#160;billion <ix:nonFraction unitRef="number" contextRef="i58b5d7f1faad4e848093aeb065829a46_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTMw_bba83e56-9bd3-4722-946e-5407d0df0492">3.550</ix:nonFraction>% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, we issued an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODE3Ng_d721797e-f8fd-4231-9c4a-eef4ea2f5bfe">6.0</ix:nonFraction>&#160;billion of debt with net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODIwOA_d515e473-1b4e-42dd-90af-a29f6a1912ca">5.9</ix:nonFraction>&#160;billion. <ix:continuation id="i336c3c6ffb674d74a02249f3ae26039c" continuedAt="i3a4d04c4b1c24f00bb7e3f2bbdfe1aef">The table below summarizes the issuances:</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i3a4d04c4b1c24f00bb7e3f2bbdfe1aef"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6404ab102144f6ba73c22e80f018486_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMi0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo3NDA1NDhlODM5N2I0YjZlYTkyOWFlYzY0NTg5ZTQ5NV80_f70f278c-b20a-4a8c-858a-3a15b73dfe3e">2.950</ix:nonFraction>% Notes due 2032</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6404ab102144f6ba73c22e80f018486_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMi0xLTEtMS0xMTc3NTY_6018ac39-8210-4f85-9953-b4eb05d1c06d">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc346e3c2eca41249ffeaa6cda84f7db_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMy0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjowNWY5ZTc0NTRiMWE0YWRhOGU2OTRjNjkwMDMwNzEwY180_25bdf5cf-f101-48e4-b2c0-e346cd472554">3.550</ix:nonFraction>% Notes due 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc346e3c2eca41249ffeaa6cda84f7db_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMy0xLTEtMS0xMTc3NTY_82169cba-21ca-4b27-a25e-22e94b20c38f">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9789a0514bca4a1f9a657955e08feb99_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNC0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2ZiYzY5YjNkMjM0YzkzOTZhYzU2MWJjNzZlMDEzMl80_3ac7967c-f3c1-4c51-95c9-d3585f241188">3.700</ix:nonFraction>% Notes due 2052</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9789a0514bca4a1f9a657955e08feb99_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNC0xLTEtMS0xMTc3NTY_0e41daf3-efd9-4f30-8fcc-d2e10f89cb64">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i203a9a6396554765b8fa0659e4a3d831_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNS0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjphZTg3OTg2OTlhZDg0OWI5YjBmYWJhY2RkZDY3MGFlMl80_1a91ab26-e60f-44f1-b0d2-2883b4b3bbdf">3.900</ix:nonFraction>% Notes due 2062</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203a9a6396554765b8fa0659e4a3d831_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNS0xLTEtMS0xMTc3NTY_24f27b1c-5835-48b0-a230-17ed8c7adff0">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNi0xLTEtMS0xMTc3NTY_90cacc5b-00ee-4e4d-904e-d9b5f9c04d70">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September 30, 2021, BMS purchased an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODU4Nw_ac0fe003-aadd-491a-9568-22777c3df79f">3.5</ix:nonFraction>&#160;billion of certain of its debt securities for approximately $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODY0Mg_1d56be8e-66e8-425a-889f-d84f34fa35b5">4.0</ix:nonFraction>&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODc1Mw_1056190a-35b2-4524-81c1-3730b1118f01">281</ix:nonFraction>&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0NDg2MA_b28435c1-5304-4e76-92d1-c47410a03f93">2.0</ix:nonFraction>&#160;billion of debt matured and was repaid including $<ix:nonFraction unitRef="usd" contextRef="i645d2dcb8c254458b2bba8716a3d4871_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODg5Nw_6dd97e02-7221-413c-a264-2e2e9aeadeb8">500</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i645d2dcb8c254458b2bba8716a3d4871_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkwMA_9abc059f-1a68-4a57-b91f-b3d5f56393d2">2.875</ix:nonFraction>% Notes, $<ix:nonFraction unitRef="usd" contextRef="i18778c0e80e94ff1bbb25132a78a2670_I20210930" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkxNA_9d14142a-9bc5-42d1-9e49-bf633e01555b">1.0</ix:nonFraction>&#160;billion <ix:nonFraction unitRef="number" contextRef="i18778c0e80e94ff1bbb25132a78a2670_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkxNw_41e362f8-709f-49a6-ba66-a86ef8800c69">2.550</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDk0NzgwMjM0MjEzMA_8fd7ff17-a00e-4bec-8b80-ed0bbdf34b77">500</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzg0ODI5MDcwOTA4Ng_22f5303e-e41c-4cd0-b7e8-8de0750f413a">2.250</ix:nonFraction>% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-8" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0MTk5NQ_799598f5-652f-4c6e-aac3-98ff73311bf2">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0MjAwNA_34fdab36-be60-4c82-805b-7832ed0f84ec">1.2</ix:nonFraction> billion for the nine months ended September 30, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, BMS had <ix:nonFraction unitRef="creditfacility" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="INF" name="bmy:NumberofRevolvingCreditFacilities" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTk_361696a5-abb9-4e33-b670-0e9cd448203e">four</ix:nonFraction> separate revolving credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTE1Ng_d8d5ad81-f91d-428d-abc3-4ca16911cfb6">6.0</ix:nonFraction>&#160;billion, which consisted of a 364-day $<ix:nonFraction unitRef="usd" contextRef="ib9a6a86876fc43d388aac8adf3fea7c7_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTE4OQ_cad2f374-925a-45bd-a275-7b78dc61ab30">2.0</ix:nonFraction>&#160;billion facility which expired in January 2022, a three-year $<ix:nonFraction unitRef="usd" contextRef="ic7a1031a2d014325bddb2d8b3e07d8d2_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTI0NQ_c61035a2-d1a2-4541-9aca-1198711c7a05">1.0</ix:nonFraction>&#160;billion facility which expired in January 2022 and two five-year $<ix:nonFraction unitRef="usd" contextRef="i5810116290c741c4ad8f11aed5bf0245_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTMwNQ_c2596852-e1d8-4765-8aa3-8fd9b1b5d3e6">1.5</ix:nonFraction>&#160;billion facilities that were extended to September 2025 and July 2026, respectively. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19fa8a7b505c418a899a9b427a09b066">In January 2022, BMS entered into a <ix:nonNumeric contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTI_195e9cfa-3c3b-45ed-b955-f917527d8336">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTQzMw_4bb6ed1a-13d1-412d-b02f-c1c0e3d28d0e">5.0</ix:nonFraction>&#160;billion facility expiring in January 2027, which is extendable annually by <ix:nonNumeric contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131" name="bmy:LongTermDebtRenewalPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNjk_64b92e66-de7c-4446-b8b2-a71a57eee10b">one year</ix:nonNumeric> with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing <ix:nonNumeric contextRef="i2461c577cc2e466494498e4484b6c258_I20220131" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwODI_2a60d216-5d0b-40c6-af9b-9e77196a37aa">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="i2461c577cc2e466494498e4484b6c258_I20220131" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTgwNQ_e2e36fff-b22d-431f-95fc-eaace1329d84">1.5</ix:nonFraction>&#160;billion facilities were terminated and the three-year $<ix:nonFraction unitRef="usd" contextRef="i7a2ea2f6823b483bac68344cc193c509_I20220131" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTg1NA_f13343ba-53ec-4bfa-b329-c647ad46c20f">1.0</ix:nonFraction>&#160;billion facility and 364-day $<ix:nonFraction unitRef="usd" contextRef="ie48edd2512e6470bab3e50e5a0158fed_I20220131" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTg3OA_e31228ef-8e26-4cf5-bf20-caaf0b96d8d9">2.0</ix:nonFraction>&#160;billion facility expired in accordance with their terms in January 2022. No borrowings were outstanding under any revolving credit facility as of September&#160;30, 2022 or December&#160;31, 2021.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjc2_d469b655-6f2a-42f6-b873-e1466827cbb7" continuedAt="ic822361fd15446b8a0b8aa48f491b71c" escape="true">RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="ic822361fd15446b8a0b8aa48f491b71c"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjc4_f2bd6437-4e69-426d-b4a8-14cc1b490926" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMS0xLTEtMS0xMTc3NTY_8a2b7cc0-a854-416f-9d5e-b05521835c94">8,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMS0zLTEtMS0xMTc3NTY_f9441005-1c42-41b1-aae8-6be200c63d48">8,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMi0xLTEtMS0xMTc3NTY_a00ef4ae-2525-484e-9eb6-d08e02022793">599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMi0zLTEtMS0xMTc3NTY_edc15ff5-a921-4f13-b393-059adebc1255">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMy0xLTEtMS0xMTc3NTY_c56a8b4e-9fc0-47ea-b288-7211498b640b">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMy0zLTEtMS0xMTc3NTY_df60e733-9cf6-4765-ad29-68e47313934f">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNC0xLTEtMS0xMTc3NTY_30dec437-90dc-43aa-804a-a4e5506f318f">8,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNC0zLTEtMS0xMTc3NTY_97635d82-58a2-425b-b714-741dbd11a938">7,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNS0xLTEtMS0xMTc3NTY_f7544a65-510b-4e45-9255-4f060ff88046">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNS0zLTEtMS0xMTc3NTY_c33e47b3-32df-4652-bca2-6c96092cb921">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNi0xLTEtMS0xMTc3NTY_35bcb290-6f01-4a50-8302-6a861c10eaf9">9,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNi0zLTEtMS0xMTc3NTY_3519a799-4e7e-4a57-bdbc-56f9468f1075">9,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfODM_cf28577d-be59-412f-87fd-f8fa45a81b22">809</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfOTA_c7ac4849-5c14-4ed0-836f-409fde92348a">1.1</ix:nonFraction> billion for the nine months ended September 30, 2022 and 2021, respectively. Receivables from the <ix:nonFraction unitRef="customer" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="INF" name="bmy:NumberOfLargestPharmaceuticalWholesalers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMTQ3_fc2a9e28-53d5-4bac-83e5-50afb87a9572">three</ix:nonFraction> largest customers in the U.S. represented approximately <ix:nonFraction unitRef="number" contextRef="i24c74d0c904c4e3c93154b14e664eeb0_I20220930" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjA2_24e29791-76c5-4224-8907-5aa664d1bc7d">67</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i27025e532fa946c5a66af008af75071f_I20211231" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjEz_4a14fec7-46df-422c-9344-1f6551af35ec">59</ix:nonFraction>% of total trade receivables as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfNjA3_c77bd051-174e-4088-b4cc-24c39a8707e7" continuedAt="id207df57381043beaf81d25484db8c85" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="id207df57381043beaf81d25484db8c85"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfNjE2_84293041-0034-4ef0-ac1e-a2a4cc9f7275" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMS0xLTEtMS0xMTc3NTY_080b54e5-bc8d-41b1-b9ae-ea0571adf901">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMS0zLTEtMS0xMTc3NTY_707fef4f-ad7c-46ea-ab8a-b7ac238dfea3">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMi0xLTEtMS0xMTc3NTY_ca2a91a5-2923-4ba3-a788-1862ac71a882">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMi0zLTEtMS0xMTc3NTY_c6f535ea-2afc-4b44-9552-863c53373215">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMy0xLTEtMS0xMTc3NTY_e69ffea4-812d-45e6-a86f-d2cdb1da8c7a">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMy0zLTEtMS0xMTc3NTY_6c30cf94-6562-4a35-ad33-59cd21b54752">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNC0xLTEtMS0xMTc3NTY_1e7617b0-1f2d-40f4-95da-48d16d229d08">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNC0zLTEtMS0xMTc3NTY_608eb07e-5c26-4f7d-8a1d-3fa1de1558e2">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNi0xLTEtMS0xMTc3NTY_0fdc5c4d-3d07-4d3e-8497-2a30268fc3e1">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNi0zLTEtMS0xMTc3NTY_450b17b0-512f-4802-8253-38f5e2a23b8c">2,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNy0xLTEtMS0xMTc3NTY_846ef203-6b8d-4869-8989-818b7c664440">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNy0zLTEtMS0xMTc3NTY_7d4c23f9-9d43-448b-8c03-6ab384b5b274">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value adjustments related to the Celgene acquisition were $<ix:nonFraction unitRef="usd" contextRef="i886174f12723459392de618ff498cab2_I20220930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfOTY_fb5fdc02-8e7e-45c0-bf18-628a484a1d2b">137</ix:nonFraction> million as of September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i0ee682ed54c547b3b7f983bfdc4c3c2a_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfMTA5_2081b55c-c6d4-4865-ba17-66a226c9ae88">508</ix:nonFraction> million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTQ0_af31534f-6f49-4bb2-bf7d-fbf2dfe071fe" continuedAt="i92d3c5c563664b8ba49d328c64f2c602" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i92d3c5c563664b8ba49d328c64f2c602"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTQy_03cbf4e6-9125-4a62-994c-974fc4fb1a39" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMS0xLTEtMS0xMTc3NTY_805b0346-1099-48e3-a4bc-7e8a025bc77d">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMS0zLTEtMS0xMTc3NTY_001be6b2-1a9d-43ae-9512-53f1068d24bf">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMi0xLTEtMS0xMTc3NTY_ff942afc-1d58-4946-ad9e-d2c61c2f538d">5,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMi0zLTEtMS0xMTc3NTY_1c7deed1-d9fd-40bc-88ca-46e83d8fc1dc">5,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMy0xLTEtMS0xMTc3NTY_9f856083-6583-4108-ac7e-0044f4abdbfd">3,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMy0zLTEtMS0xMTc3NTY_164df336-485a-4a2a-8f0b-f69025b3650a">3,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNC0xLTEtMS0xMTc3NTY_a6beedca-a792-4dfd-8dd7-c048bdaca002">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNC0zLTEtMS0xMTc3NTY_a2c22359-7dbb-4c9f-b378-ccd1ae8f1d4c">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNS0xLTEtMS0xMTc3NTY_7ca343ba-d278-46df-b038-ceaa193aa9ec">10,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNS0zLTEtMS0xMTc3NTY_c2cb86c4-0b06-4ec9-ac19-1f4066dd7fe2">10,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNi0xLTEtMS0xMTc3NTY_cf3ece56-1a10-4625-beb6-5a05f63638b2">4,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNi0zLTEtMS0xMTc3NTY_31ca32ef-e2b2-480e-914e-c174a4e87acc">4,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNy0xLTEtMS0xMTc3NTY_2670cfaa-a3c9-41b9-a143-8a1ef30ec53f">6,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNy0zLTEtMS0xMTc3NTY_bf9bd41a-0e3c-43e6-b674-20d7a66c8e7c">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfNzM_78a16e98-e30b-4145-9d4a-6a42ac4e8400">148</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfODA_e631109c-18fb-41cc-9c80-174106fb67cf">434</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTAx_5b657b89-8ffb-43cf-bc73-35f8453a78a9">144</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTA4_59387425-f7a7-439c-a3e2-37ce04edd6d5">422</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTY2Nw_f75d7bc0-df84-4f4f-bacf-b34fb8b6ac19" continuedAt="i53f0d3d2f12e4a5eaa91dfb9152f1d9c" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i53f0d3d2f12e4a5eaa91dfb9152f1d9c"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTY2OQ_d618b5d2-a1d1-40b8-8b98-fb70d51e7857" escape="true"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMS0zLTEtMS0xMTc3NTY_ca25590d-a232-488b-9262-979eed510d5d">21,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMS01LTEtMS0xMTc3NTY_f4dc906e-f099-4334-9534-88d7527a7e74">20,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic6ada0a913014cb4a8b2d1fad754e062_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo5MWJmNzc1MWI1YmU0ZWExOWJkZGUzYTI1YmNmYjZkYl80_9127a37b-88fc-46e8-a2b4-40cb88a7d389">5</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ib2f5ae04b7ca428da1a08620ad962073_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo5MWJmNzc1MWI1YmU0ZWExOWJkZGUzYTI1YmNmYjZkYl85_5b7f9f19-aef5-4b0a-94b8-e2ef1b9bc962">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58caf9412c34780974fe127d4a49141_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0zLTEtMS0xMTc3NTY_9596441e-281c-48c0-b93f-ae2cc8678421">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba770528fa914f1e8e9ac8e274342513_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC01LTEtMS0xMTc3NTY_11ad6150-729c-45c1-a705-e24f86cde096">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49772d239f2c4ae3ad2bb802c2f564a9_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjplYmIxZmVlMjQwNDk0YWFmOTk2ZjJmZTY1NzJhMjU1MF80_908ef851-eedf-4ebf-9e99-9115cc5f5cf8">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ib6f0573b5eeb4100bf220e6512047183_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjplYmIxZmVlMjQwNDk0YWFmOTk2ZjJmZTY1NzJhMjU1MF85_614dc565-8092-44b9-b5be-c8056a1dac04">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic605e8764c2d4fcfbfd94ae6c74b3e65_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0zLTEtMS0xMTc3NTY_cf6ddbe0-d65d-475c-beed-739295fcfc94">60,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc3701c2cc449cfb23ae43990a4a971_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS01LTEtMS0xMTc3NTY_9eae3091-3bd9-4da1-94eb-0b0c23493bdf">60,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id566a793fce34008bfef682147c19536_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2M1N2Q2OGUzNjU0MDlkYTIxZDMzYWUxYjYxY2JlYl80_0ba0d194-e458-4a77-be93-9732c3b4b284">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="i07d325d61d7f4391ae952172cc449249_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2M1N2Q2OGUzNjU0MDlkYTIxZDMzYWUxYjYxY2JlYl85_b65d8faa-013b-449a-b7bd-15569dbc4ca0">10</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i653130003b5e4bc7b7676e60c391071f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0zLTEtMS0xMTc3NTY_e2ed3e98-ed02-4a90-a148-1aa2019d024c">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8639f3418a48268cee6497be9986b4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi01LTEtMS0xMTc3NTY_ddf0e13c-140a-4a86-a472-d3dccdc15f8d">1,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219c2189e62b4365b40543aca350a443_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNy0zLTEtMS0xMTc3NTY_d5b41295-fb67-4c8f-9dbb-8e6ad5679d27">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id243edc1992c42548f6d5cfeb9cb4676_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNy01LTEtMS0xMTc3NTY_05738eca-c648-4598-ac20-f406e0f71fa0">3,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOC0zLTEtMS0xMTc3NTY_a4b6eb21-aa03-4424-90bc-b226cc8964ea">69,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOC01LTEtMS0xMTc3NTY_e86547ef-99d7-4917-9048-72866ca88acd">66,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOS0zLTEtMS0xMTc3NTY_8b13415b-3240-4074-8f0d-af5ef339c4ad">30,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOS01LTEtMS0xMTc3NTY_6192b867-2174-4a8c-a831-c450450fd989">23,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMTAtMy0xLTEtMTE3NzU2_5ae2380d-2f46-4131-afcc-4bd496c52193">38,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMTAtNS0xLTEtMTE3NzU2_1a5e2f85-1b80-421d-b76c-18e727313d5d">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes goodwill and other intangible assets recognized as part of the Turning Point acquisition in 2022. Refer to &#8220;&#8212;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#8221; for further information related to the Turning Point acquisition.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTA2_5bf76685-6d48-4b6f-90f4-494025012139">2.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTEz_7ebcc3b9-ca44-40ea-a6b5-3aeee5a5e674">7.4</ix:nonFraction> billion for the three and nine months ended September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTM0_3f27c116-8688-4c69-9f18-3108b4a4bc83">2.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTQx_d38bf339-cbb7-4eef-ba9c-5540cd7b985e">7.7</ix:nonFraction> billion for the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, a $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTA5OTUxMTYzMjY4OA_1b02bfe6-f6b9-420f-b5de-48e80d5fa93b">58</ix:nonFraction> million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Turning Point and was being studied as a potential treatment of advanced or metastatic solid tumors in adults. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, a $<ix:nonFraction unitRef="usd" contextRef="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMjA2_52f652ac-9398-4868-a422-88a9c1931980">40</ix:nonFraction>&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, a $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfNTQ5NzU1ODE2NjM1_2e6e5159-97a4-4c24-b65a-b040b82bfe48">610</ix:nonFraction>&#160;million IPRD impairment charge for an investigational compound was recorded in Research and development expense primarily resulting from changes in clinical timelines, expected launch dates and competitive landscape. The compound was being studied as a potential treatment for hematologic diseases and was acquired in the acquisition of Celgene. The charge represented a partial write-down of its carrying value based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, a $<ix:nonFraction unitRef="usd" contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfNjM3_23b5335f-a3df-4172-8fd4-db05e02074a5">230</ix:nonFraction>&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first of quarter of 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $<ix:nonFraction unitRef="usd" contextRef="iccb38ad8451f4f6497c394f35b06eb08_I20210331" decimals="-6" name="bmy:ContingentAndRegulatoryMilestoneNonCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTE5NQ_e77611b7-55d2-4337-b6bc-15669bd075f7">300</ix:nonFraction>&#160;million were achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTIyNw_03c42614-1b8e-4b3d-9028-df8943d99251">385</ix:nonFraction>&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTM3OQ_523d8934-d69c-4c57-b1d0-c5b8e088db17">315</ix:nonFraction>&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDYw_2d8d55fc-31fd-4e96-b6e7-d49320b1dfef" continuedAt="i48dedaf9618949e59034de017aa9670c" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i48dedaf9618949e59034de017aa9670c" continuedAt="i65d6980089e2443193ba14e0f154920a"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDcy_654aede5-3ca1-403f-bd74-d52f489fbbed" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMS0xLTEtMS0xMTc3NTY_ad8def6b-4325-4d8d-8e93-729695e7ff16">3,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMS0zLTEtMS0xMTc3NTY_61e07a36-f0e8-45ff-985a-4540147116ee">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMi0xLTEtMS0xMTc3NTY_029068f0-4765-40ac-9f2e-ef630903b768">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMi0zLTEtMS0xMTc3NTY_cf655a73-9dc0-46a4-abb2-428dc0b69b75">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMy0xLTEtMS0xMTc3NTY_331bc016-0069-4e74-a011-89892424e534">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMy0zLTEtMS0xMTc3NTY_b2eb0a1f-8acf-4d0c-9678-80c1b3d1c059">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:EquityInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNC0xLTEtMS0xMTc3NTY_f95bc77b-69a3-41af-b47b-c22fe7be11cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:EquityInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNC0zLTEtMS0xMTc3NTY_2469bd2a-eee3-4f41-8a7e-3ce095c00966">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNS0xLTEtMS0xMTc3NTY_ba3122c2-679c-4ca5-a258-28b47ca3928d">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNS0zLTEtMS0xMTc3NTY_0a00cfd4-ec9c-4feb-867d-82d3d0f25381">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNi0xLTEtMS0xMTc3NTY_be405ab5-0d45-44dc-a633-53119feb8223">1,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNi0zLTEtMS0xMTc3NTY_f270c4e8-d83d-46fa-95ee-d7372a8881fb">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNy0xLTEtMS0xMTc3NTY_3f02ee46-bf68-45a6-9b20-05158e5907c7">6,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNy0zLTEtMS0xMTc3NTY_1a6c4a59-8027-4d59-8ac2-52ff6e44803d">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i65d6980089e2443193ba14e0f154920a"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDcx_492416e9-6dc6-4046-91f9-871b920223e9" escape="true"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMS0xLTEtMS0xMTc3NTY_4805ed97-34c7-48fc-a009-9b6adc74d122">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMS0zLTEtMS0xMTc3NTY_b88df4d7-88f9-40f0-a2ef-460ce3103837">2,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMi0xLTEtMS0xMTc3NTY_bf0a8c63-5d65-4809-b4de-77120dd58a2b">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMi0zLTEtMS0xMTc3NTY_2a92aa21-ac5c-4e67-867d-bfa14d761e94">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMy0xLTEtMS0xMTc3NTY_d4f49be5-96e8-4591-8ea5-59499a8765c0">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMy0zLTEtMS0xMTc3NTY_958a79c8-f85e-46be-bd6a-1c8fb9cb479c">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNC0xLTEtMS0xMTc3NTY_e49e4d97-30d4-469d-93ee-bec1a41c6569">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNC0zLTEtMS0xMTc3NTY_0261cb6b-58d9-4075-8ecb-b807851b2a97">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNS0xLTEtMS0xMTc3NTY_8e8ce3d9-3668-42aa-8efa-fbf46a2c45d3">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNS0zLTEtMS0xMTc3NTY_08bb6684-a565-47fa-be86-493e16f1a9e4">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNi0xLTEtMS0xMTc3NTY_09d22889-e167-4905-b853-420879347637">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNi0zLTEtMS0xMTc3NTY_1eccc0a4-14fa-4bb3-9f99-9b81c5bf42bc">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNy0xLTEtMS0xMTc3NTY_1801fa96-b65e-4024-8b80-4cd81fe4de9e">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNy0zLTEtMS0xMTc3NTY_ae5ec749-29a8-4184-818b-3929335f70fd">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfOC0xLTEtMS0xMTc3NTY_eb0ae488-f9ce-4396-985a-007e5abcda03">4,745</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfOC0zLTEtMS0xMTc3NTY_c1e474f4-496a-45d6-a95c-9c73671ae02a">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. Restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfMzI5_bff842cb-e317-4672-9fa1-7fc060ac6b24">339</ix:nonFraction> million as of September 30, 2021, was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDY2_70aa16d8-5528-41d7-847b-cff969d7288d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMS0xLTEtMS0xMTc3NTY_33dd5102-2520-4305-9cfb-1646f95a963c">6,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMS0zLTEtMS0xMTc3NTY_90fdbd00-830f-4214-b2e9-1a29ca871ca8">6,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMi0xLTEtMS0xMTc3NTY_9937edc3-e5a5-4d0d-90da-37194cf01527">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMi0zLTEtMS0xMTc3NTY_a04115d2-e830-4c88-ad31-db7d8630b10b">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMy0xLTEtMS0xMTc3NTY_36794825-848d-483d-96a3-25b87a5c8986">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMy0zLTEtMS0xMTc3NTY_25ed40c9-f6cf-4e5e-8673-9358ccc081f1">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNC0xLTEtMS0xMTc3NTY_1df879b7-664a-4502-ac85-9e9d9ca2b9cb">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNC0zLTEtMS0xMTc3NTY_c720f082-7ed7-4ff1-aa61-85920e41d743">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNS0xLTEtMS0xMTc3NTY_e4551c1a-8e37-421c-b4c1-48ec23758a8f">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNS0zLTEtMS0xMTc3NTY_9121f2e3-085a-43d5-9d5b-a5155ec4c985">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNi0xLTEtMS0xMTc3NTY_0c516a2d-4766-41f4-b6fd-4b46a8b5448a">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNi0zLTEtMS0xMTc3NTY_bcf3df2c-a2af-4bd8-936a-af0bc71b0a5a">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNy0xLTEtMS0xMTc3NTY_3b83f2a8-88a4-4302-851c-5214caa52ee7">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNy0zLTEtMS0xMTc3NTY_1a4d6a43-9cc5-43c5-a8b8-9b65773f18e7">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfOC0xLTEtMS0xMTc3NTY_04d9df2b-6df3-43b2-9219-6c83d1eda0a4">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfOC0zLTEtMS0xMTc3NTY_3cc25810-5c19-44cc-981b-5d9875fd05c7">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTAtMS0xLTEtMTE3NzU2_87483185-be4b-4724-8193-ba0518a7bc1a">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTAtMy0xLTEtMTE3NzU2_1483b686-de96-47ab-8fd3-a86f7e62101d">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTEtMS0xLTEtMTE3NzU2_76962423-8af3-40d8-8d8b-afb4c5ccaed7">14,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTEtMy0xLTEtMTE3NzU2_9f131a2d-0d69-4f2d-8127-4f1fd1c17336">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDY3_8c872188-2793-4288-92b1-ba46c83d064a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMS0xLTEtMS0xMTc3NTY_e916953e-ed58-41af-adef-b3ef1a4dca4c">4,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMS0zLTEtMS0xMTc3NTY_c0238a33-b103-44de-87ab-8fa39b2eb7cf">4,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMi0xLTEtMS0xMTc3NTY_f356f3dd-5e9a-46a5-89ea-075a8a15f3d1">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMi0zLTEtMS0xMTc3NTY_e71fda5e-591f-4b68-821a-449aaa817b8e">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMy0xLTEtMS0xMTc3NTY_01b85f8d-cd9e-490a-a10f-4e10fc3c3b1b">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMy0zLTEtMS0xMTc3NTY_16c0706b-e395-428d-97ac-ea4345b4dc98">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNC0xLTEtMS0xMTc3NTY_f8cf845c-d2ad-4043-afd1-5a231a80a8fd">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNC0zLTEtMS0xMTc3NTY_87308870-8eb3-48fb-bb18-89031d6841f8">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNS0xLTEtMS0xMTc3NTY_0490b2b0-c03c-4853-b322-435899ad849a">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNS0zLTEtMS0xMTc3NTY_46725e09-9d0f-4a39-8a17-da9f026f36ba">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNi0xLTEtMS0xMTc3NTY_b385dd63-e48a-4160-bb92-2a704146f939">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNi0zLTEtMS0xMTc3NTY_be7c1355-7eba-436a-8ff3-94fad1e74070">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNy0xLTEtMS0xMTc3NTY_468b79a2-aaa3-4148-89a2-d9d6581fc592">6,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNy0zLTEtMS0xMTc3NTY_de2699ec-ea36-412d-9c30-eaa900fe42c9">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjMxNw_ceb5588b-2247-4e77-bb55-b2acd754080c" continuedAt="ie9fc1093339645c59d881375f9aca246" escape="true">EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie9fc1093339645c59d881375f9aca246" continuedAt="ib936c088fc8045f591d9d8e152cde5b4"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjM1MA_5e503b46-076e-4590-9f73-e06e08c83966" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2022: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if704e1173f28402383a6c57f2e3df140_I20211231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xLTEtMS0xMTc3NTY_09e44ab5-05ce-4db4-bf3f-019cd5ca73af">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if704e1173f28402383a6c57f2e3df140_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0zLTEtMS0xMTc3NTY_18594bb9-87a9-4143-8f9c-0dd6b76c2755">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe41494b00144aeb5eef7881099386c_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi01LTEtMS0xMTc3NTY_28c22004-2da1-4cbe-9da3-25876b348aa3">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2168a62d5517410387e38e8ee41bdb64_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi03LTEtMS0xMTc3NTY_7ad24096-3df8-4f68-ace0-1029bcd19b2a">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20651cc5726a493da9cdd353ebddce96_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi05LTEtMS0xMTc3NTY_5289cda6-6463-4d26-9fe6-73fa9641eb4d">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3d0354da6a042df94a411a0fc948ddd_I20211231" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xMS0xLTEtMTE3NzU2_95de805f-06be-4367-af5f-b82fae2fd50d">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3d0354da6a042df94a411a0fc948ddd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xMy0xLTEtMTE3NzU2_8716e660-6ae7-4e37-bc1c-5bd7239050a7">31,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2fe15f76824880a795877832feb862_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xNS0xLTEtMTE3NzU2_774b3bac-5ff7-414c-971a-ae6dd842adbc">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0282842cd245059208dde198cff004_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMy05LTEtMS0xMTc3NTY_87909b43-d04b-4170-a1c5-512c27950517">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08f80cfa602443b95ad13171165dfa8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMy0xNS0xLTEtMTE3NzU2_bc997721-630f-43a7-90d1-22b016d9aff2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6ea8a669ebd49d098c897a367c09915_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNC03LTEtMS0xMTc3NTY_5337e248-63dd-431a-afca-638af250e6c2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c0282842cd245059208dde198cff004_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNS05LTEtMS0xMTc3NTY_2f3664aa-aeb5-43fa-b716-45b4c8c324d7">1,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi01LTEtMS0xMTc3NTY_8141bf58-f5aa-4aec-8e19-c687f7e761bb">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi0xMS0xLTEtMTE3NzU2_7b1be789-92ec-48b9-8b28-1d848e0e666e">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi0xMy0xLTEtMTE3NzU2_df08ec62-e909-40f8-981a-efb461443f9a">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy01LTEtMS0xMTc3NTY_5fcea34f-c6da-45df-b95e-f70aae3c739f">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy0xMS0xLTEtMTE3NzU2_e565fbf4-ec7b-47d7-877b-7cba0e35b188">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy0xMy0xLTEtMTE3NzU2_477853c0-2a77-441c-afcf-937d5a26286b">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1959f27617924dd58c01a80cf6b58c30_I20220331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xLTEtMS0xMTc3NTY_5246cd8b-9f6d-419e-ad0c-446d793e68eb">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1959f27617924dd58c01a80cf6b58c30_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0zLTEtMS0xMTc3NTY_638c6fa6-0ef4-499e-afbc-a01434f1c8d6">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a04a6cc493441c896b686ccf7d9db6c_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS01LTEtMS0xMTc3NTY_e1e7f439-8a71-407e-817e-e4e4168a0036">43,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10004cd63b014f3f8682ee02de56861b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS03LTEtMS0xMTc3NTY_1c6f325c-3b32-4c37-bea1-5de0b1bff794">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id062426fbfc04f8c9b4ae0975bc9b322_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS05LTEtMS0xMTc3NTY_0dc72223-84d6-4b5d-beb4-399ba1e5217c">23,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96fde31e46e241998655851bda819407_I20220331" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xMS0xLTEtMTE3NzU2_e8189236-ee33-4150-b7a2-479060722541">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96fde31e46e241998655851bda819407_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xMy0xLTEtMTE3NzU2_5d62be37-b330-4a34-877c-29c13a756dcc">35,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i424fa464af494f00a96d5d2ecde941c1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xNS0xLTEtMTE3NzU2_427e987c-2c12-47eb-81ad-cf689bdb1bcc">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70bb84b635a14384813aff1611be542e_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTAtOS0xLTEtMTE3NzU2_56f9ce36-d61f-4e0d-b0f7-68b8b823801c">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36c386d500b49e9b15964e0e07d8e99_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTAtMTUtMS0xLTExNzc1Ng_b3aaee63-04a8-42b9-ba61-01241b811b31">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5af4d6da0c46abafd596c61cea80e0_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTEtNy0xLTEtMTE3NzU2_9c8a3e2c-f779-4e4f-95db-e8c9491799f7">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70bb84b635a14384813aff1611be542e_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTItOS0xLTEtMTE3NzU2_6062b1f1-3875-4571-985a-b561d9ab9d6a">1,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtNS0xLTEtMTE3NzU2_deef722d-98be-437a-b4e2-0831f0bca284">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtMTEtMS0xLTExNzc1Ng_70f890f6-ab25-41ab-8507-d1a677dfa771">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtMTMtMS0xLTExNzc1Ng_7e2488e1-a4b2-4e97-87cb-e615ed3f8726">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtNS0xLTEtMTE3NzU2_66574c52-7ebc-4a3d-8780-7ab84c2ef5f8">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtMTEtMS0xLTExNzc1Ng_a6db9c00-4844-44ad-95cd-9bc9d911438c">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtMTMtMS0xLTExNzc1Ng_8ed93805-4ad8-4b48-bc9d-e7c7bd8c546f">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTUtMTUtMS0xLTExNzc1Ng_e6ef80f9-633b-46a4-9180-e0c535765c40">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9f675d87d624de7959d9b23d44a06ad_I20220630" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMS0xLTEtMTE3NzU2_9281b169-1460-4517-a404-c19584dfe89f">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f675d87d624de7959d9b23d44a06ad_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMy0xLTEtMTE3NzU2_64439d46-c979-4812-a045-bd55534552fd">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90cad36c797440684daad86d7b7980c_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtNS0xLTEtMTE3NzU2_1b451d18-9cdf-4e49-ad68-4310f91c430b">44,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3a762be7d3142c79bcc98621c63a1b4_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtNy0xLTEtMTE3NzU2_820db78f-20eb-4ac3-a874-0d1e5b5d8dc8">992</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261fe8c2d46d4b2bbdcb71ceee0a2956_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtOS0xLTEtMTE3NzU2_c7abaac1-2abe-4d5e-a579-f354df89e3b7">24,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i708233e593ac416d8961d311b12dd0d9_I20220630" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTEtMS0xLTExNzc1Ng_77ea01c5-1585-439b-9c29-b71f8f10d772">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i708233e593ac416d8961d311b12dd0d9_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTMtMS0xLTExNzc1Ng_6634700f-aed7-49e6-a7a6-d03e1123f4e4">35,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6b897df93a45b0931e170cfe06cd39_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTUtMS0xLTExNzc1Ng_2bed277b-6fbc-450e-afc2-ae5edb2bdaf3">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTctOS0xLTEtMTE3NzU2_6ef9ae09-2940-47ce-8567-3e650e23df91">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58393e2f2a5a48d6a80d43186ff0f68a_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTctMTUtMS0xLTExNzc1Ng_051b7742-947d-4299-9db5-d0dc30263eda">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic389bf69a1b047ae8a8ca1032a58c315_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTgtNy0xLTEtMTE3NzU2_eac8a3a5-5ca4-4dbc-98cf-333d6318aca5">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTktOS0xLTEtMTE3NzU2_dbb397e8-22b1-482f-b7fe-99ca5d4fce60">1,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtNS0xLTEtMTE3NzU2_49345030-e367-43b2-ad0b-588b3f6e2647">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtMTEtMS0xLTExNzc1Ng_0a24d1f6-8588-4009-81c2-6d8650edd191">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtMTMtMS0xLTExNzc1Ng_1210139e-54ef-43dd-9989-0b5cf470f5ee">1,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtNS0xLTEtMTE3NzU2_936f4afb-ce0b-4cb2-8c45-fdf52885f2e0">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtMTEtMS0xLTExNzc1Ng_2c829c4a-0e18-4b6a-bc8a-5b8571a99264">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtMTMtMS0xLTExNzc1Ng_dec0d133-e4f3-46a2-9701-3e4a99165e2a">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie839b830453247969319cb4087f8432e_I20220930" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMS0xLTEtMTI1OTAw_81186cc6-5945-4113-b2e3-1506945a670d">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie839b830453247969319cb4087f8432e_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMy0xLTEtMTI1OTAy_5e4bec81-bad0-46ab-8b9d-b40fc7d61383">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f1af0105054a9d94aaf408f96a944e_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtNS0xLTEtMTI1OTA0_da4d2c5d-e525-4324-9bcd-e07c82ead947">44,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i639f28b14fcb4c98a3e7676735c73daa_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtNy0xLTEtMTI1OTA2_0a69df44-4a9b-4125-9df5-24788d737cd8">841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45849baa6e0c4606bd93975a061f7213_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtOS0xLTEtMTI1OTA4_05bea900-fd3f-46eb-9805-47bbeba612a1">24,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie798c0b144ab4feaac7932ccbec3c84f_I20220930" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTEtMS0xLTEyNTkxMA_5b05867d-2150-4866-a6fc-f7d0f6cfccb0">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie798c0b144ab4feaac7932ccbec3c84f_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTMtMS0xLTEyNTkxMg_b24811c7-4d18-4601-8618-3f43f8f1eae8">36,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7be709431d46ecab3d337838ec40ca_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTUtMS0xLTEyNTkxNA_299d3bff-c805-49b3-aa62-a4cc681a34ed">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_03eb350c-6da9-4615-a295-c8a7aa1a9336"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_be6ca4cb-6245-4e48-aa9b-5d5187d45a98"><ix:nonFraction unitRef="usdPerShare" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_fb44fb3f-f1ac-4e75-9b21-beb1d41036f8">0.54</ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three months ended March&#160;31, 2022, June&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1bb411461174751860a090a735e24e5_I20201231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xLTEtMS0xMTc3NTY_8a3a3ed1-7bf3-4b2c-af4b-bf7841833792">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bb411461174751860a090a735e24e5_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0zLTEtMS0xMTc3NTY_1f93914f-4c66-409c-8c84-3857f97d9b86">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dbdf8184bb44cb9a23af5df39a7e17_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi01LTEtMS0xMTc3NTY_67f70d0f-ff4a-476b-a3c3-2aa42e652bd9">44,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaab6129cd90e47629f61a8c46beb198c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi03LTEtMS0xMTc3NTY_c9822110-8ffb-43ef-9b3f-3cc7c29ce754">1,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf10e85fa704140bd6819ab1c54a619_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi05LTEtMS0xMTc3NTY_e2cbdf62-0b2c-415f-a3d7-13c1a866ca67">21,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16b6a9e7477b44bf812f52b13f664d43_I20201231" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xMS0xLTEtMTE3NzU2_04a42c16-1ae1-4e7a-a01a-01803fc87879">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b6a9e7477b44bf812f52b13f664d43_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xMy0xLTEtMTE3NzU2_6728c1da-924b-41aa-96ab-f891c20ec63c">26,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb86ddecf754f1b9ed10ee592a8c467_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xNS0xLTEtMTE3NzU2_1002fe0c-00ae-4c8c-8b8c-418f3f4122cb">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMy05LTEtMS0xMTc3NTY_019f174f-6461-4ec7-8589-6e0d481aad94">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea49ce882bf4f63af2987bb1e15d6b6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMy0xNS0xLTEtMTE3NzU2_0370195c-e52c-49f0-94af-f3ac06667b36">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89084d224e14efdb9d09b06d9c54c39_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNC03LTEtMS0xMTc3NTY_cd7ae8c4-22ac-48b5-95e7-942199e6381c">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNS05LTEtMS0xMTc3NTY_b69a16cb-a5e6-4f15-918f-502c46d709d9">1,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNi0xMS0xLTEtMTE3NzU2_835763e0-3f7e-49d1-b739-c9cdd4350586">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNi0xMy0xLTEtMTE3NzU2_a5321fa3-d610-42c5-8e38-12c3bcca5518">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id73e463a04364161a685d3c4430b5550_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy01LTEtMS0xMTc3NTY_4b0f9fa4-d79b-4851-93b1-19fd8e88d6f1">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy0xMS0xLTEtMTE3NzU2_3f3a6492-0db5-4175-93b2-16a68ef6adb1">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy0xMy0xLTEtMTE3NzU2_329e8d14-c655-4b2c-b87f-6bfde7557736">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a7555f794ba413894219c16f451682c_I20210331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xLTEtMS0xMTc3NTY_6ee6e5fd-c8c2-4dab-98ce-0e97925407fb">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7555f794ba413894219c16f451682c_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0zLTEtMS0xMTc3NTY_4bec8e88-50bd-41bd-b270-b40fc763c884">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d62d70afcd42918ea9a2bfec538e66_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS01LTEtMS0xMTc3NTY_f9eb5b5e-f8fc-40a1-abc5-9ad01b2d4d89">43,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28b2d4d8d91d4b278caf43bb6f13b862_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS03LTEtMS0xMTc3NTY_dbb1f936-4ba0-4814-9f9a-a53517aa709f">1,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic367a2ecd9d0433e86bbfb9640e1163c_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS05LTEtMS0xMTc3NTY_a23b40fc-0743-49ce-ad4c-b311141b3b2e">22,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xMS0xLTEtMTE3NzU2_423159b0-a5b8-4b7b-be38-d0b1b55b7e28">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xMy0xLTEtMTE3NzU2_b536fddb-ac71-4ac2-bfdf-94d0a04e0855">27,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f58e8de911437f80231a5c3f56f8a1_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xNS0xLTEtMTE3NzU2_7cae14e2-9a46-4863-91eb-a3d734c198b9">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00793ef22204a91b9d9819706370521_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTAtOS0xLTEtMTE3NzU2_c4825bca-a7f0-4085-abda-e28a37b1424d">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c911796bb404970a0c3702c1385d332_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTAtMTUtMS0xLTExNzc1Ng_4d65f605-976d-4c4c-bd16-590fbb5627f1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63981ccb8d3246b7aa697743bf82119c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTEtNy0xLTEtMTE3NzU2_1564d612-718a-4e4f-ac26-def03eab5fd0">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic00793ef22204a91b9d9819706370521_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTItOS0xLTEtMTE3NzU2_64afdf17-84d0-41a9-a49e-af5fc0a62925">1,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTMtMTEtMS0xLTExNzc1Ng_f0a30c2d-0a08-467e-9989-f9b31420ad90">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTMtMTMtMS0xLTExNzc1Ng_13e07e2a-a387-4208-81ad-4ce047b78826">1,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia128e4642cfa484ebf43540577cd5f09_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtNS0xLTEtMTE3NzU2_41ab571c-8f2d-4ab7-86d6-8c7b4404420d">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtMTEtMS0xLTExNzc1Ng_02747bc9-c554-466f-aec7-5ec6a0becae4">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtMTMtMS0xLTExNzc1Ng_e7b494d5-4ee5-4dac-8dc7-8d8ffdbaf8f2">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTUtMTUtMS0xLTExNzc1Ng_247ac4e7-0d87-4ea1-a1fb-6bdae86389ae">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20e0a56327ff4170819c77cd3052bfc6_I20210630" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMS0xLTEtMTE3NzU2_640180cc-00d8-4a26-8c06-22b2b0d8b5d1">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e0a56327ff4170819c77cd3052bfc6_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMy0xLTEtMTE3NzU2_fd2085df-7dcb-4fd2-93a7-40d8cf19a031">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5304c82d5b4048f985873fbbdfca9327_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtNS0xLTEtMTE3NzU2_218d88da-48b7-475d-bf9e-72928a651435">44,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e16a4a57b3c403e9a92285a51739e1a_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtNy0xLTEtMTE3NzU2_13f71e0a-2a78-4d89-ab70-fd9a8a1378ba">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7b2e0f79541e592a3eb7ca30e07b8_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtOS0xLTEtMTE3NzU2_8eb6f916-c4b2-40c7-ab9d-7c981b3a098d">22,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a80b405b4bf48fba866761f2581c0ca_I20210630" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTEtMS0xLTExNzc1Ng_2ee903b8-2c2c-4000-b51f-4bc29954c30e">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a80b405b4bf48fba866761f2581c0ca_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTMtMS0xLTExNzc1Ng_185511a1-e2e1-404d-b369-927ca72a8729">28,198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57dbfe3fc0b04540a9062b9da8ae1cfe_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTUtMS0xLTExNzc1Ng_393dd21a-97b8-4605-86b4-c3c541030535">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTctOS0xLTEtMTE3NzU2_1a3da7e1-3022-4adc-8914-71219213ecec">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1451fd8e009248678887b28feb0d817a_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTctMTUtMS0xLTExNzc1Ng_60d410b3-e4da-4d9d-b56d-344af85306fd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fd46ccee88439e82d67fa529a9ff35_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTgtNy0xLTEtMTE3NzU2_9f6959b9-e974-430e-995c-02f1c7dd085e">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTktOS0xLTEtMTE3NzU2_f21dea49-45fc-47e7-b817-80b1c30bbf8a">1,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjAtMTEtMS0xLTExNzc1Ng_b96a99ff-a59b-4639-95af-25caac41e4fa">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjAtMTMtMS0xLTExNzc1Ng_b21930d2-029b-4fee-8d0a-335d31a873e5">487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1d2ccd1fdf457c81335d661d935b52_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtNS0xLTEtMTE3NzU2_4991e027-6296-4433-bc92-2cf446eb6974">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtMTEtMS0xLTExNzc1Ng_e9090e55-e59d-4f86-a34b-e54bda19a471">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtMTMtMS0xLTExNzc1Ng_7d73b023-6518-452d-b265-bb3dc09df116">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe1775a56a28418cad0acff1223adbff_I20210930" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMS0xLTEtMTI1OTIx_41686410-f86c-45f5-9a34-7833ffa104eb">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1775a56a28418cad0acff1223adbff_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMy0xLTEtMTI1OTIx_63f38c01-afbf-4b13-95e6-79fb4c409278">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8be942a9fc84e4f9d8dd09313b7c6de_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtNS0xLTEtMTI1OTIx_c1d22686-1e0f-4ea2-bb5d-bf1c30166271">44,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e6a2417ce314f85af97421da8e0d628_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtNy0xLTEtMTI1OTIx_90a90cc4-f7dc-43cd-8378-1c65f9387820">1,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a6b956076b456c914890389667aed8_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtOS0xLTEtMTI1OTIx_86e8497d-2a99-4bb6-8455-4b8f380e77c3">22,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib02a3afd2d6d4dbab20a028d5348db71_I20210930" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTEtMS0xLTEyNTkyMQ_20e9c5aa-dfb5-4e45-a955-de554974b393">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib02a3afd2d6d4dbab20a028d5348db71_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTMtMS0xLTEyNTkyMQ_51d00873-283f-4e92-9d6c-c0086168a900">28,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182f6377eff94cb4b6ac7e5d4a6b565f_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTUtMS0xLTEyNTkyMQ_df7cd58f-08ce-4fe4-8265-3c9d0368b38f">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a95cd7d7ed541189aceda668d7d654c_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_9bce01ef-1d0c-4acf-8faa-b6b09745db6c"><ix:nonFraction unitRef="usdPerShare" contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_b1100fdd-88d0-4c6f-9409-4a8ea699774b"><ix:nonFraction unitRef="usdPerShare" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_f92922cb-06a2-428e-8c63-dcf1ccdcf0db">0.49</ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three months ended March&#160;31, 2021, June&#160;30, 2021 and September&#160;30, 2021, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ib936c088fc8045f591d9d8e152cde5b4" continuedAt="i238fc787a82e4c5cbe96a75c3e66dbea"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method. The outstanding share repurchase authorization under the program was approximately $<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNTkzMg_5374022d-65d9-4e3c-a8cd-f80f32c2b7de">15.2</ix:nonFraction> billion as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i1ba0cfd360d4403caf7866291f6dead2_I20220930" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTAzNQ_5e30f5d4-75b9-49c9-aaf8-9c50eba3ce88">5.0</ix:nonFraction>&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand. In the first quarter of 2022 approximately <ix:nonFraction unitRef="shares" contextRef="i7e212023ac5f4762aaca5b3d89139de6_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTIyMw_ea6bbed4-fea8-4874-a3eb-a3c9cd578b56">65</ix:nonFraction>&#160;million shares of common stock (85% of the $<ix:nonFraction unitRef="usd" contextRef="i6d86b71f50834432b48b0b5ae6624d4c_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTI2MQ_36d93e34-a109-4553-85e7-268a0cd9c346">5.0</ix:nonFraction>&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The remaining amounts in the ASR agreements were settled in two tranches during the second and third quarters and <ix:nonFraction unitRef="shares" contextRef="i457c2ed3cca24d1090b72bce50a58a8f_D20220101-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTQ0OQ_4d71e2a6-51fc-4265-9302-fef2c85c138e">4</ix:nonFraction>&#160;million shares of common stock were received by BMS and transferred to treasury stock. The total number of shares repurchased under the ASR agreements was based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. In addition, as part of its share repurchase program, BMS repurchased approximately <ix:nonFraction unitRef="shares" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNDk0NzgwMjMzMTg4NQ_defa140d-efda-4c02-aa48-c92a34eb2435">10</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzg0ODI5MDcwNDA5MQ_d4654f74-41d8-4b36-a9fa-b10f776cc860">701</ix:nonFraction>&#160;million during the three months ended September 30, 2022. The outstanding share repurchase authorization under the program was approximately $<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNTQ5NzU1ODE5NTIz_adc67ae7-3f94-45fb-acbe-45fb1eeda88f">9.5</ix:nonFraction>&#160;billion as of September 30, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i238fc787a82e4c5cbe96a75c3e66dbea"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjMzOA_5f2a4d85-ebc6-46e1-9047-ba3d373f5de3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0xLTEtMS0xMTc3NTY_92d8f8f2-6d1e-4072-a9c5-885c6da366e3">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0zLTEtMS0xMTc3NTY_96fc183b-9e16-4f78-b665-7ec806b5b447">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC01LTEtMS0xMTc3NTY_64f6c8f3-acad-4066-83ee-5504cf72ca83">439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC03LTEtMS0xMTc3NTY_a4e9b8c4-bd3a-48cc-be29-d7009a89cd02">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC05LTEtMS0xMTc3NTY_c016a9cf-919d-4330-9d6d-46d725d32edc">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0xMS0xLTEtMTE3NzU2_4db21f01-00d5-4e97-b785-949d1f6bdc52">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0xLTEtMS0xMTc3NTY_41daa82a-e7ef-4ab2-95f6-79535df9c1bd">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0zLTEtMS0xMTc3NTY_a236659c-9a36-4ed5-a668-2919eed7555d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS01LTEtMS0xMTc3NTY_1562cf6f-1a1c-471d-a998-a13468ee185f">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS03LTEtMS0xMTc3NTY_84bd78ac-c9e2-4057-9235-cfae1d108889">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS05LTEtMS0xMTc3NTY_c7471884-66d1-4215-9875-bf8b5b782177">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0xMS0xLTEtMTE3NzU2_549de4fe-1f50-4813-8834-dd183f16ac23">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0xLTEtMS0xMTc3NTY_2a44a95f-6fb6-4cf1-9735-79554bd81fc6">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0zLTEtMS0xMTc3NTY_c1ec56b4-e555-43b3-a516-74a1fba33457">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi01LTEtMS0xMTc3NTY_e5686083-4ef2-4602-8c6e-40e1daffc75c">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi03LTEtMS0xMTc3NTY_177a0535-815c-47a4-936b-9e8b2d9a83e7">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi05LTEtMS0xMTc3NTY_60508bb9-b92a-4f43-8252-237204d76627">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0xMS0xLTEtMTE3NzU2_30ff8105-4bd7-448c-81b5-44b7e8a03456">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0xLTEtMS0xMTc3NTY_9fa9928d-e597-4ed1-997a-8fa013bdd0f0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0zLTEtMS0xMTc3NTY_87e5b60d-2da0-4ce8-9705-34497f626558">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS01LTEtMS0xMTc3NTY_ab0ea94f-05c1-4327-9841-baaa9495bc83">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS03LTEtMS0xMTc3NTY_1e46faee-41c8-40ec-84a4-ebe2f84690a7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS05LTEtMS0xMTc3NTY_8dab5af7-c16a-47d7-84dc-a8a9166b9261">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0xMS0xLTEtMTE3NzU2_ba234b5b-9861-4a8d-ab7c-e696f8ee3531">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMS0xLTEtMTE3NzU2_a0ce9824-05b6-4c73-9241-918983e21e7e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMy0xLTEtMTE3NzU2_4cb2e716-5389-454f-847b-1bf63425fa32">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtNS0xLTEtMTE3NzU2_c5c6f2d4-d126-4787-85d0-f6906f6080aa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtNy0xLTEtMTE3NzU2_40a4e8c5-3cbd-414f-af3d-a95f3e5c3552">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtOS0xLTEtMTE3NzU2_e2321a20-6a45-46d5-ac68-2d979452d47a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMTEtMS0xLTExNzc1Ng_2512ef59-d364-4b64-9c01-3159e39c5602">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMS0xLTEtMTE3NzU2_4bd9f3d5-ca61-4db2-9e57-c4590dd33bd8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMy0xLTEtMTE3NzU2_7a811021-9518-4140-92bb-6521a9a6e3ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtNS0xLTEtMTE3NzU2_ada6e4b6-acbc-4396-b563-667889666235">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtNy0xLTEtMTE3NzU2_8d52f99c-a12f-4743-b098-9d1df5e10ed1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtOS0xLTEtMTE3NzU2_9952cd5d-cf8a-4570-85c3-495b8979c66d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMTEtMS0xLTExNzc1Ng_539c2365-e2c0-4d9e-bee6-73e5a16d0825">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMS0xLTEtMTE3NzU2_79761037-9844-4e9c-85ea-d7726c3fc58b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMy0xLTEtMTE3NzU2_381d0c18-00df-46a6-b706-cdf8f1164062">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItNS0xLTEtMTE3NzU2_8142e076-8c88-4a85-995b-cb73a0314905">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItNy0xLTEtMTE3NzU2_71dbf30d-393b-4aee-bd10-6bec41fb6e76">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItOS0xLTEtMTE3NzU2_314a7604-8363-4cff-8c8b-a8687181a6d9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMTEtMS0xLTExNzc1Ng_70ce9640-e02e-463e-a2fb-0ebdd949c506">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMS0xLTEtMTE3NzU2_804ed2b0-e688-4747-b3ff-47b69a7f1b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMy0xLTEtMTE3NzU2_183c3ae6-7c67-4aa0-a45c-e235e87a0a48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtNS0xLTEtMTE3NzU2_79bcc8ff-5801-4917-81b1-0fffce3dac6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtNy0xLTEtMTE3NzU2_77d6cd34-4e73-4013-8451-0d96ffea0fb7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtOS0xLTEtMTE3NzU2_c07e2008-582e-4b1b-83cc-5874ea63d475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMTEtMS0xLTExNzc1Ng_c60d0dd3-1490-4999-8bf9-a2c8a505bec8">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMS0xLTEtMTE3NzU2_7bb97903-c801-40e2-bd87-76bd19887819">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMy0xLTEtMTE3NzU2_018826ab-8f3b-443d-9bcf-bb20ffcb4570">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctNS0xLTEtMTE3NzU2_1add4ec9-3e4b-4ed1-b5c7-003dc3525943">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctNy0xLTEtMTE3NzU2_05d3d230-478b-425f-860a-d7b6b8ffed09">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctOS0xLTEtMTE3NzU2_2798543e-1879-45d1-9287-ba4a05d92559">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMTEtMS0xLTExNzc1Ng_e2fa8436-b71b-4dee-9f7a-6cfac07c4a86">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMS0xLTEtMTE3NzU2_f11565eb-2d2b-43bb-a6d2-14e44bba02d7">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMy0xLTEtMTE3NzU2_47facead-b936-4492-82eb-d84bc3d446b1">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktNS0xLTEtMTE3NzU2_6331e086-077c-4770-ac92-c372bac6c005">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktNy0xLTEtMTE3NzU2_227032a8-32f5-4b7f-8b23-eca1bd82f7d4">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktOS0xLTEtMTE3NzU2_f15671b6-2e2d-4e0f-a0a9-5867c1c6594a">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMTEtMS0xLTExNzc1Ng_62f2e215-c103-4de9-88bd-36f77ba9277d">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:-9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0xLTEtMS0xMzA0NzQ_aa90ace8-0634-4ab4-b905-206eb468aa89">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0zLTEtMS0xMzA0ODA_e5d7cff8-eb96-49ab-8634-3d302f17ddd4">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC01LTEtMS0xMzA0ODI_166ea8ef-2b70-401e-8ecf-81d7f2bd13c3">959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC03LTEtMS0xMzA0ODQ_77cac9e2-1418-484e-9c9f-beb5bbfc9e6f">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC05LTEtMS0xMzA0ODY_b74a8634-3594-4428-8f81-d6bf31f70a35">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0xMS0xLTEtMTMwNDg4_38e6ecbf-6303-4249-be40-7ef5d7e76495">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0xLTEtMS0xMzA0NzQ_1f6eb134-a2a4-4d9f-a39e-9921dd221950">391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0zLTEtMS0xMzA0ODA_4d2e3cd8-1b80-4d26-87ed-270d790e189c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS01LTEtMS0xMzA0ODI_73754d7e-a8ff-403f-9faa-64d3da65dddf">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS03LTEtMS0xMzA0ODQ_4abd009c-2827-4c63-9edc-d747df224e80">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS05LTEtMS0xMzA0ODY_3f906036-4fa2-4b93-a79c-2a5aadb35faa">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0xMS0xLTEtMTMwNDg4_1f26475f-c506-4479-8a58-d14af877d634">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0xLTEtMS0xMzA0NzQ_4f737e1b-6b48-4c77-94bf-0307cd73ec71">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0zLTEtMS0xMzA0ODA_2252b0ea-72fc-4096-ae27-7e48eeac6f72">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi01LTEtMS0xMzA0ODI_4648852e-d2a7-49eb-9643-9b1d776bb9d0"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi01LTEtMS0xMzA0ODI_6b2fee47-7732-49bb-88b3-3572350d7157">618</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi03LTEtMS0xMzA0ODQ_8a499f9a-3314-479e-87a3-fbe1508ddbc9">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi05LTEtMS0xMzA0ODY_6688559d-39e3-4f72-b888-18949ba90711">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0xMS0xLTEtMTMwNDg4_36397acc-0190-43a7-880f-3d44108c375b">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0xLTEtMS0xMzA0NzY_88871122-74b1-4c45-909b-346cd0d84b81">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0zLTEtMS0xMzA0ODA_04cc407a-1177-40eb-8a66-23493a82a0b2">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS01LTEtMS0xMzA0ODI_6129d172-31c3-4a17-bc78-f66525b36c54">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS03LTEtMS0xMzA0ODQ_d4fa22e6-78db-4cb8-932f-b79b76626996">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS05LTEtMS0xMzA0ODY_c7d89bef-d468-4a35-b00b-f476091a27ad">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0xMS0xLTEtMTMwNDg4_8492bd9c-6a6f-46a5-b9d4-92714c2f1334">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMS0xLTEtMTMwNDc2_d05c7d14-81ac-41c1-9d88-4b6a1661eb6c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMy0xLTEtMTMwNDgw_bc44747d-bee5-488a-916a-2e0fef0918b2">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtNS0xLTEtMTMwNDgy_55666333-de04-4dec-a463-951416f29db8">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtNy0xLTEtMTMwNDg0_2756f3cf-f12d-4a89-8adc-1c7c73859835">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtOS0xLTEtMTMwNDg2_e844fe0b-0248-4e7c-8109-70c2e11c8cb7">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMTEtMS0xLTEzMDQ4OA_7b82f81c-656c-437b-9424-4b544647eb05">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMS0xLTEtMTMwNDc2_f3a91e51-ddf4-4044-be31-55fdad1769a8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMy0xLTEtMTMwNDgw_68c352bb-d471-4d87-a00a-394c3884ca50">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtNS0xLTEtMTMwNDgy_87bcc4c4-f215-4104-8416-ea15956121a0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtNy0xLTEtMTMwNDg0_efbb8677-95e3-4f6f-88d2-bbf7d3795db5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtOS0xLTEtMTMwNDg2_a3175532-04ba-4339-9d7f-967817e294a1">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMTEtMS0xLTEzMDQ4OA_6c661a54-4ed6-4411-ac5e-03b1e96a90e3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMS0xLTEtMTMwNDc2_379967a1-e042-464e-a5be-2a6f8e2a4903">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMy0xLTEtMTMwNDgw_6307795d-4b5f-4fb1-becf-2126ac4dc4c5">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNS0xLTEtMTMwNDgy_bad60823-84fa-44c2-917a-b7a16d6e93c1"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNS0xLTEtMTMwNDgy_f39a7c2f-8023-41ea-b94f-583480806dae">64</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNy0xLTEtMTMwNDg0_27f58ab9-1fa0-41b0-94d0-29e175a1e6dd">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItOS0xLTEtMTMwNDg2_5728611e-ddfa-4b18-9a94-aafb81047e53">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMTEtMS0xLTEzMDQ4OA_cc7891ff-be58-464a-951c-7e17c62b4477">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMS0xLTEtMTMwNDc4_b232922f-6ef8-461f-9baa-aa7fd79005db">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMy0xLTEtMTMwNDgw_c3f7a999-3ac2-4327-97a5-2a84e1d9b839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtNS0xLTEtMTMwNDgy_96496fe4-a6ba-43dc-913a-5e0cb428f113">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtNy0xLTEtMTMwNDg0_3bea6211-a819-4a64-ab0b-80f836b53282">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtOS0xLTEtMTMwNDg2_c53cde37-022c-4e94-b06b-235bca6336d2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMTEtMS0xLTEzMDQ4OA_16fa128c-18fe-464b-8a7f-a745e73916bb">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMS0xLTEtMTMwNDc4_fea87bc1-f09b-4243-b96c-f875d4d0c42b">201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMy0xLTEtMTMwNDgw_87d610be-a73d-4507-8234-faa809e8685e">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNS0xLTEtMTMwNDgy_3620d4ec-a2b3-4043-9942-0d7acb32da34"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNS0xLTEtMTMwNDgy_8ec9885c-d7d0-4f28-a30a-f4da743baa25">253</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNy0xLTEtMTMwNDg0_2cafae57-dd13-45a7-8500-28d7d1bf0b26">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktOS0xLTEtMTMwNDg2_20af45a2-c27b-4ab8-91b5-6eba13a134c6">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMTEtMS0xLTEzMDQ4OA_c221bad4-8f39-44c3-b2c7-a15fd27a2033">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMS0xLTEtMTMwNDc4_2de7f4ab-f428-4ff9-848f-76ac78ac15df">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMy0xLTEtMTMwNDgw_b5bcddeb-79fb-4622-b9f4-4e2660489e30">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtNS0xLTEtMTMwNDgy_1041d1c0-ba83-4bb1-835c-d5429166f2d2">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtNy0xLTEtMTMwNDg0_cb2cff27-7d60-4e14-9629-f8d2619ffa9c">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtOS0xLTEtMTMwNDg2_eed4206d-eea6-492f-8fc3-6a3d2d4423f6">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMTEtMS0xLTEzMDQ4OA_e1c2cca1-644b-44f8-ac6e-75c43faffb71">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjM0NA_b95dcd86-98b3-4102-949e-645fb4c4b0b1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMS0xLTEtMS0xMTc3NTY_c1fdcd24-e0ea-42e7-8235-c36b431e2031">796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMS0zLTEtMS0xMTc3NTY_a1f06638-1c5d-4c2b-9c57-ac9cf90656e8">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMi0xLTEtMS0xMTc3NTY_e6ad3ef6-f92f-469c-bdce-9861e955a893">704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMi0zLTEtMS0xMTc3NTY_7c8f18b4-308c-4a4c-85c4-b0232b167066">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMy0xLTEtMS0xMTc3NTY_7f89ed34-5b0f-4d70-901c-6feb31fda8c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMy0zLTEtMS0xMTc3NTY_d328e903-984e-4ccd-b1a5-4212af038d3c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNC0xLTEtMS0xMTc3NTY_8fee7e9f-898d-4342-b5f7-6fc532eb3932">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNC0zLTEtMS0xMTc3NTY_d62653de-7ef3-4262-ad8c-661b8a141b87">680</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNS0xLTEtMS0xMTc3NTY_dd8d20c9-0d44-4153-8d16-add8ee68435b">841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNS0zLTEtMS0xMTc3NTY_4ccd6991-56a4-4c72-bb0b-2ca0b4e09bee">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDI1_5776505a-0e69-4bd5-a7e4-de5c2a377c5b" continuedAt="ib079e3f473b147ada66c28376a3e7e63" escape="true">EMPLOYEE STOCK BENEFIT PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib079e3f473b147ada66c28376a3e7e63"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMx_c1f0d871-404c-4995-910e-e68f78a84bfc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:50.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi0xLTEtMS0xMTc3NTY_eafecf93-5546-45f6-9809-4858cd6a7fa4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi0zLTEtMS0xMTc3NTY_52d99a77-7bcc-46ea-923d-94714c8c838e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi01LTEtMS0xMTc3NTY_1ff9eb84-68ef-4d48-9ddf-281680f6c9cb">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi03LTEtMS0xMTc3NTY_29b1587b-6858-4798-b7ec-d5227068f2f9">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy0xLTEtMS0xMTc3NTY_52ce4c43-f5be-42d4-aedf-3417e0e6f9c9">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02826b699eda4a97ba070709457b65f1_D20210701-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy0zLTEtMS0xMTc3NTY_63c6bad2-a80b-4f99-9e9c-d8927b1c00f4">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4634dede34e4e588b48071be679100a_D20220101-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy01LTEtMS0xMTc3NTY_08f46ba6-f996-4b34-8b6e-1767603c0bae">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6947273e102141838832d4c25bb46991_D20210101-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy03LTEtMS0xMTc3NTY_76b09898-40f1-403b-83ec-a1efd44cb4a6">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ef053676a74ed99cf89ae337acf080_D20220701-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC0xLTEtMS0xMTc3NTY_0df4286f-bf83-4f9b-ae38-874d055edc90">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816eb507d5a445f2b307f4498312546d_D20210701-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC0zLTEtMS0xMTc3NTY_d9798763-0b29-48a4-a09c-0d443b228bf2">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a53e0c411d4dd6a1b3906051c59f59_D20220101-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC01LTEtMS0xMTc3NTY_7c96e224-bb24-4589-b71d-29cddc9cb64a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eac47f0f662452bab570a31fb550c4d_D20210101-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC03LTEtMS0xMTc3NTY_97859f98-2453-4fc8-a1ec-13bb9409a5d4">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e87163d7174e1794368f54fd79d68d_D20220701-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS0xLTEtMS0xMTc3NTY_3a43a4cb-9664-4d93-88b4-58353e37096c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id311a3410b814d8098ed2e0909160625_D20210701-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS0zLTEtMS0xMTc3NTY_d4a0b906-03cc-48d9-8c78-8912739a2fe0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7bcf421c5b3484f9aaf9c80235ca4cc_D20220101-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS01LTEtMS0xMTc3NTY_b67ca243-c3b3-48f5-895a-ce99e1b77e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137caf5a65bd4e80a938b17ee3cb93f8_D20210101-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS03LTEtMS0xMTc3NTY_25b43284-4813-4db4-9929-219510778810">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi0xLTEtMS0xMTc3NTY_8bd12278-1d46-49b2-8713-d314d43add36">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi0zLTEtMS0xMTc3NTY_3f2cc81a-3464-45c7-a235-3022dcebfa8a">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi01LTEtMS0xMTc3NTY_3d770ce8-991c-4867-8d96-d7a5eef411f2">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi03LTEtMS0xMTc3NTY_2467ac39-ea74-429c-8c60-007c8f97ca3b">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC0xLTEtMS0xMTc3NTY_41f7d7f2-de46-4085-b7f5-266036e05a0a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC0zLTEtMS0xMTc3NTY_80284df2-2967-477f-98d0-26c5d182ea90">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC01LTEtMS0xMTc3NTY_152f0263-9411-426c-808d-e34bbe60a512">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC03LTEtMS0xMTc3NTY_69f44306-dd2a-4d85-9096-24726c237c02">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $<ix:nonFraction unitRef="usd" contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjE3_563a9670-535c-46ec-a431-f60e66263051">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjI0_93f14684-1f81-471c-8ad6-7d66ae37b641">63</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjQ1_07770261-e5d8-40a1-bc6e-d714bc4b8d1e">7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjUy_2600fbf0-1ed1-4a69-8357-cec24c58978c">36</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMw_ba89825d-8e6c-4e22-87b3-f8d65f74f0c5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the nine months ended September 30, 2022 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMi0xLTEtMS0xMTc3NTY_1e60d7bd-70fb-447f-a85d-99ce2e585ddb">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMi0zLTEtMS0xMTc3NTY_252e7dd6-3d6b-4a8f-a83c-9f3ab0a9212e">63.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMy0xLTEtMS0xMTc3NTY_2bdd152f-8ab6-440a-a0a6-21bff77b5fef">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMy0zLTEtMS0xMTc3NTY_f44f6976-568c-41e0-9be7-a6bcb8aac28a">60.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfNC0xLTEtMS0xMTc3NTY_f28c3f1e-3f9a-4020-8692-7d40f665a601">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfNC0zLTEtMS0xMTc3NTY_edf5604b-bf18-46eb-97a7-10b67b7d993a">66.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMz_71fe3197-39d9-4b7b-9b97-427c7176397f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc4aed180144198bb9d2155f7e854fe_I20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS0zLTEtMS0xMTc3NTY_72b94477-b06e-43d0-a82c-44a4de549180">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc5c8ecc7b1431b9d38a50d36e09fed_I20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS01LTEtMS0xMTc3NTY_8beccd06-c8cd-4f16-ba6d-3a8115fced8c">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46a8d26897645bcbf98e6b68bcaa6ab_I20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS03LTEtMS0xMTc3NTY_24daf54f-0a43-49a2-9083-528ccbdf241e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi0zLTEtMS0xMTc3NTY_c634daaf-89d6-46b0-90db-d006592e8b3f">2.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi01LTEtMS0xMTc3NTY_78ee305e-04c5-400b-bb07-a190bfc530a3">3.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi03LTEtMS0xMTc3NTY_9f8df021-fcef-409f-b596-e15326245668">1.8</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17. <ix:nonNumeric contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NzM_2dced8b2-2d32-4edf-b379-c8453b8dccda" continuedAt="i630cf74512c744fc9ac4125bc0942c5f" escape="true">LEGAL PROCEEDINGS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i630cf74512c744fc9ac4125bc0942c5f" continuedAt="i5cd68eec308b438a958676ecf6a00f29"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i5cd68eec308b438a958676ecf6a00f29" continuedAt="i50fd4526daea40a58a5b99fdf14cd786"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 Antibody Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to <ix:nonFraction unitRef="patent" contextRef="i6b708b44785543eba9d88603d0d9fe17_D20150901-20150930" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMjcxMg_6655294b-319e-4123-a4fe-df35c1e6b776">six</ix:nonFraction> related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#8217;s claims for damages before May 17, 2019&#8212;the date of the District Court&#8217;s ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. A trial has been scheduled for May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $<ix:nonFraction unitRef="usd" contextRef="i239659e8afed4074998fed4287d1015c_D20191201-20191231" decimals="-6" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDg4NQ_743495ce-8bcb-463a-884f-db445892a272">585</ix:nonFraction> million upfront payment and a <ix:nonFraction unitRef="number" contextRef="i2f40e9186eb64a12b2819fd50ddd4855_I20191231" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDkxMA_d111b7c8-0362-4fee-8ae6-2c2c5a1b6327">27.6</ix:nonFraction>% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $<ix:nonFraction unitRef="usd" contextRef="i3d729505bb21466aa4b2151156e86b6c_D20200401-20200430" decimals="-8" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNTQ0NA_034d07f0-1627-4f6a-a6c1-f887dfdc0402">1.2</ix:nonFraction> billion in royalties, interest and enhanced damages and a <ix:nonFraction unitRef="number" contextRef="i68e8486eb69e4b6e9cc08fa79cc5e099_I20200430" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNTQ5Nw_5ddbe7cb-6f01-47f9-9c6b-d0cf2cac0a0d">27.6</ix:nonFraction>% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#8217;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#8220;SPC&#8221;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. The Company is seeking permission to appeal from the Court of Appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and trials have been scheduled in certain of those cases. In May 2022, a Dutch court issued a decision denying a request by the Company for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In September 2022, a trial was held in Sweden regarding Teva&#8217;s challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision is expected on November 2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i50fd4526daea40a58a5b99fdf14cd786" continuedAt="iec0f324a817b48fdbd98d6a10ff10c76"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to <ix:nonFraction unitRef="aud" contextRef="ide99966f8de84c51b7647698c4934494_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTAxNTU_46c7009e-0bd8-40e9-b319-8a1b5354405a">449</ix:nonFraction> million AUD ($<ix:nonFraction unitRef="usd" contextRef="i16e78aa141ae465bafe3f1d21cf16785_D20220101-20220930" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTAxNjM_38464f33-716e-4cd1-b86d-e0eeded97296">292</ix:nonFraction> million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, Celgene received a Notice Letter from Qilu Pharmaceutical Co. Ltd. (&#8220;Qilu&#8221;) notifying Celgene that Qilu has filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against Qilu in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. In October 2022, Celgene entered into a confidential settlement agreement with Qilu, settling all outstanding claims in the litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. Subsequently, the Company also received paragraph IV certification letters from Accord, Biocon, and Nanocopoeia challenging the same patents, and the Company filed patent infringement actions against all three companies. In July and September 2022, BMS entered into settlement agreements with Accord and Biocon, respectively. No trial dates have been scheduled in the two remaining actions against Xspray and Nanocopoeia. Both Xspray and Nanocopoeia have filed motions for a judgment based on the pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#8220;Actelion&#8221;) filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#8220;&#8217;867 Patent&#8221;). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the &#8217;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="iec0f324a817b48fdbd98d6a10ff10c76" continuedAt="if805f79529e346c78d79db1b839d7bd9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $<ix:nonFraction unitRef="usd" contextRef="i3e26862e568b4ada9e48b0f17370e14e_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTQ3ODk_2dfd3d60-9ab6-418d-8857-31eabd1098a4">834</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="i9b6c532a43a946b58847610daa31145e_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTQ3OTg_6ba403b6-6a16-4aa2-8c3d-1b5ba8ce3262">417</ix:nonFraction>&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. An oral argument before the Hawaii Supreme Court is scheduled to occur in December 2022. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. In September 2022, the parties settled the New Mexico matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately <ix:nonFraction unitRef="lawsuit" contextRef="i8cd813fc670a4450aabfafc92190f440_I20220930" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTYyMTE_5e61d58d-5018-43b6-8b7b-9963ef59734c">2,700</ix:nonFraction> cases, comprising approximately <ix:nonFraction unitRef="plaintiff" contextRef="i8cd813fc670a4450aabfafc92190f440_I20220930" decimals="INF" name="bmy:LossContingencyNumberOfPlaintiffsDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTYyNDY_c1cad716-9d7b-4c02-82ff-b90d0e992582">3,900</ix:nonFraction> plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are <ix:nonFraction unitRef="lawsuit" contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTY1MzA_70d87689-ddde-4d4b-bd94-96efbcb9f704">eleven</ix:nonFraction> cases pending in Canada (<ix:nonFraction unitRef="lawsuit" contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NjU_2f99ef14-6efe-4aec-99e5-6d3f888c3dbf">four</ix:nonFraction> class actions, <ix:nonFraction unitRef="lawsuit" contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NjY_0ec151f0-9082-4465-8fcc-8293a5056ade">seven</ix:nonFraction> individual injury claims). Out of the <ix:nonFraction unitRef="lawsuit" contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTY2MjI_70d87689-ddde-4d4b-bd94-96efbcb9f704">eleven</ix:nonFraction> cases, only <ix:nonFraction unitRef="lawsuit" contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930" decimals="0" name="bmy:LossContingencyPendingClaimsNumberActive" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NzI_fd7831a6-819c-441c-8e7c-69c7f099b189">two</ix:nonFraction> are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases were pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The MDL decision is final as to Amylin and Lilly and all MDL claims have been dismissed. As of September 2022, all of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly have dismissed their claims with prejudice. In October 2022, all thyroid cancer claims that were pending in federal court were dismissed as well. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="if805f79529e346c78d79db1b839d7bd9" continuedAt="icf3a1a22e7ed4fdda1a035998ce00201"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#8220;JCCP&#8221;). On September 24, 2021, the JCCP court granted defendants&#8217; motion to exclude plaintiffs&#8217; only general causation expert and on January 5, 2022, the MDL court likewise granted defendants&#8217; motion to exclude plaintiffs&#8217; expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the <ix:nonFraction unitRef="lawsuit" contextRef="i975e062f55604508986037025ddd0a99_I20220330" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDk0NzgwMjYyMDQ0OQ_88c1ab02-07cc-40dd-a086-c44dd2ae8d93">18</ix:nonFraction> claims previously pending in California state court. Plaintiffs have filed an appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL have moved to alter or amend the MDL court&#8217;s order, and defendants have opposed. As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene</span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Securities Litigations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#8220;Schwab Action&#8221;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 (the &#8220;CalPERS Action&#8221;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#8220;DFA Action&#8221; and the &#8220;American Century Action&#8221;), and GIC Private Limited in September 2021 (the &#8220;GIC Action&#8221;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $<ix:nonFraction unitRef="usd" contextRef="i342915fb33cf4e95b5ea927f1cf7228c_I20210630" decimals="-8" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMjQ2MDk_1ddb4488-e00b-4551-bfc9-6ef5a1bc2ce7">6.4</ix:nonFraction>&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the court denied BMS&#8217;s motion to dismiss.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="icf3a1a22e7ed4fdda1a035998ce00201" continuedAt="i749f24ee01d44c7b9a14a75dcb97cf7b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 19, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#8217;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 22, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS was sued with three other manufacturers of HIV medications in related lawsuits in the Northern District of California. The initial lawsuits, filed on behalf of indirect purchasers, alleged that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remained. In October 2021, BMS entered a settlement agreement with the indirect purchasers. On May 6, 2022, the Court granted final approval of that settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. In March 2022, BMS entered into a settlement agreement with the direct purchasers (excluding the retailers discussed below). In June 2022, the Court granted preliminary approval of that settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. Those complaints made allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In January 2022, BMS entered into an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains, and those cases were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i749f24ee01d44c7b9a14a75dcb97cf7b" continuedAt="iac4a6ac63c7d4219a5c61930fc60cd49"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. Those complaints made allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and that case was dismissed. In April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In July 2022, BMS entered into a settlement agreement resolving these seven remaining indirect purchaser cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana Inc. (&#8220;Humana&#8221;), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint. In April 2022, the Court issued an order denying Celgene&#8217;s motion to dismiss. That order addressed only Celgene&#8217;s argument that certain of Humana&#8217;s claims were barred by the statute of limitations. The Court&#8217;s order did not address Celgene&#8217;s other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have served a renewed motion to dismiss. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United HealthCare Services, Inc. (&#8220;UHS&#8221;), Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;), BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation (&#8220;Cigna&#8221;), Molina Healthcare, Inc. (&#8220;Molina&#8221;) and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#8220;MSP&#8221;)) filed lawsuits making largely the same claims and allegations as were made in the class action litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> opt-out action. Certain of the matters have made additional claims related to copay assistance for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These cases are now pending in the U.S. District Court for the District of New Jersey and will proceed as described above with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opt-out action filed in March 2019. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#8217;s motion to remand to San Francisco Superior Court. In June 2022, the San Francisco Superior Court dismissed 63 of Molina&#8217;s claims and stayed the remaining 4 claims. No activity is expected in this case until disposition of the New Jersey actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. A trial has been scheduled for January 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="iac4a6ac63c7d4219a5c61930fc60cd49"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017,Celgene Logistics S&#224;rl (&#8220;Celgene Logistics&#8221;) and BeiGene, Ltd. (together with its assignees, &#8220;BeiGene&#8221;), entered into a License and Supply Agreement (the &#8220;LSA&#8221;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#8220;Plaintiffs&#8221;) filed a complaint against BMS, Celgene and Juno (collectively, &#8220;Defendants&#8221;). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least <ix:nonFraction unitRef="number" contextRef="i18f9080b9c994fa291b5e12c3b4813d0_I20220401" decimals="INF" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMzg2NDE_b285c33f-6732-4790-8b2d-55c8772719f8">1.5</ix:nonFraction>% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA and Other Remediation Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $<ix:nonFraction unitRef="usd" contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA0NDg_8ed96fb2-be61-4a39-9dcc-b2daff0b5850">87</ix:nonFraction> million as of September&#160;30, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of results of operations and financial condition is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q to enhance the understanding of our results of operations, financial condition and cash flows.</span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our principal strategy is to combine the resources, scale and capability of a pharmaceutical company with the speed and focus on innovation of the biotech industry. Our focus as a biopharmaceutical company is on discovering, developing and delivering transformational medicines for patients facing serious diseases in areas where we believe that we have an opportunity to make a meaningful difference: oncology (both solid tumors and hematology), immunology, cardiovascular and neurology. Our priorities are to continue to renew and diversify our portfolio through launching our new product portfolio, advancing our early, mid and late-stage pipeline, and executing disciplined business development. We remain committed to reducing our debt and returning capital to shareholders. For further information on our strategy, see &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Executive Summary&#8212;Strategy&#8221; in our 2021 Form 10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we have received 17 approvals for new medicines and additional indications and formulations of currently marketed medicines in major markets (the U.S., EU and Japan), including advancement in oncology through FDA and EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the first PD-1 inhibitor and LAG-3 blocking antibody combination. Additionally, in the U.S., EU and Japan, two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based regimens as first line treatments for unresectable advanced or metastatic ESCC were approved. We continue to advance and invest in our cell therapy portfolio through the approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Japan for the treatment of multiple myeloma, and approvals of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the second-line and third-line treatments of relapsed or refractory diffuse large B-cell lymphoma in the U.S. and EU, respectively. We continue the expansion of our cell therapy manufacturing capabilities at our existing facilities in Washington and New Jersey, as well as through the construction of new state-of-the-art manufacturing facilities in Massachusetts and in Leiden, Netherlands. In September 2022, we obtained approvals in the U.S. and Japan for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(deucravacitinib)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which expanded our portfolio in immunology for the treatment of plaque psoriasis. Within cardiovascular, we broadened our New Product Portfolio with the FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (mavacamten) for patients with symptomatic obstructive HCM. In addition, in August 2022, we acquired Turning Point, a precision oncology company, with the goal of expanding our solid tumor portfolio with the addition of repotrectinib and other pipeline assets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues increased by 1% for the nine months ended September&#160;30, 2022 due to In-Line Products (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Opdivo)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and New Product Portfolio (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), partially offset by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent LOE Products (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and the impact of foreign exchange. The $0.05 decrease in GAAP EPS primarily resulted from specified items, including equity investment and contingent consideration fair value adjustments, partially offset by lower impairment charges and higher divestiture gains in 2022. After adjusting for specified items, non-GAAP EPS increased $0.57 as a result of lower weighted-average common shares outstanding, higher royalties and licensing income and lower Acquired IPRD charges.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, including non-GAAP earnings and related EPS information, are adjusted to exclude specified items that represent certain costs, expenses, gains and losses and other items impacting the comparability of financial results. For a detailed listing of all specified items and further information, reconciliations and changes to our non-GAAP financial measures refer to &#8220;&#8212;Non-GAAP Financial Measures.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic and Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Actions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our products continue to be subject to increasing pressures across the portfolio from pharmaceutical market access and pricing controls and discounting, changes to tax and importation laws and other restrictions in the U.S., the EU and other regions around the world that result in lower prices, lower reimbursement rates and smaller populations for whom payers will reimburse, which can negatively impact our results of operations (including intangible asset impairment charges), operating cash flow, liquidity and financial flexibility. For example, on August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 ("IRA") which provides for (i) the government to negotiate prices for select high-cost Medicare Part D (beginning in 2026) and Part B drugs (beginning in 2028), (ii) manufacturers to pay a rebate for Medicare Part B and Part D drugs when prices increase faster than inflation beginning in 2022 for Part D and 2023 for Part B, and (iii) Medicare Part D redesign which replaces the current coverage gap provisions and establishes a $2,000 cap for out-of-pocket limits costs for Medicare beneficiaries beginning in 2025, with manufacturers being responsible for 10% of costs up to the $2,000 cap and 20% after that cap is reached. Implementation of this legislation is expected to be carried out through upcoming actions by regulatory authorities, the outcome of which is uncertain. Additionally, in connection with the IRA the following changes have been made to U.S. tax laws, including (i) a 15% minimum tax that generally applies to U.S. corporations on adjusted financial statement income beginning in 2023 and (ii) a non-deductible 1% excise tax provision on net stock repurchases, to be applied to repurchases beginning in 2023. We continue to evaluate the impact of the IRA legislation on our results of operations and it is possible that these changes may result in a material impact on our business and results of operations. Furthermore, countries are expected to make changes to their tax laws and updates to international tax treaties to implement the agreement by the Organization for Economic Co-operation and Development to establish a global minimum tax. See risk factors on these items included under &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;Product, Industry and Operational Risks&#8212;Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins&#8221; and &#8220;&#8212;Changes to tax regulations could negatively impact our earnings&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Russian Federation invaded Ukraine. As a result, the U.S. and many other countries have implemented extensive sanctions on the Russian Federation, with which BMS continues to fully comply. In June 2022, we transferred our commercial operations in the Russian Federation to a third-party distributor and incurred $38&#160;million of exit costs through September 30, 2022. Our remaining net assets in the Russian Federation are not material. The Russian Federation and Ukraine represent less than 1% of our total revenues, net assets, workforce and clinical trials, and while the situation continues to evolve, as of now, we do not anticipate any significant negative impacts on our business. For a more complete discussion of the risks we encounter in our business, please refer to &#8220;Part I&#8212;Item 1A. Risk Factors&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, international, federal, state and local public health and governmental authorities have taken, and continue to take, a number of actions to limit the spread of COVID-19 and address related disruptions in the U.S. and global economy. While we continue to experience impacts on revenues from COVID-19 primarily due to lower new patient starts and patient visits, the pandemic has not significantly impacted our results of operations. The situation remains dynamic and it is difficult to reasonably assess or predict the full extent of the negative impact that the COVID-19 pandemic may have on our business, financial condition, results of operations and cash flows. The future financial and operational impact of the COVID-19 pandemic on BMS will depend on future developments such as the ultimate duration and the severity of the spread of COVID-19 and any variant strains in the U.S. and globally, the effectiveness and outreach of vaccines, the effectiveness of federal, state, local and international government's mitigation actions, the pandemic's impact on the U.S. and global economies, changes in the behavior of patients and medical professionals and the timing for resumption to our normal operations, as well as developments affecting healthcare and the delivery of medicines to patients. See &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;General Risks&#8212;The COVID-19 pandemic is affecting our business and could have a material adverse effect on us&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic affected global healthcare systems as well as major economic and financial markets, we adopted several procedures focused on ensuring the continued supply of our medicines to our patients and protecting the health, wellbeing and safety of our workforce. Additional information on the procedures adopted are available at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.bms.com/about-us/responsibility/coronavirus-updates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Product and Pipeline Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the significant approvals received in 2022 as of October&#160;26, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approval</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for treatment of plaque psoriasis, generalized pustular psoriasis, or erythrodermic psoriasis, for patients who have had an inadequate response to conventional therapies.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdualag</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the first-line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumor cell PD-L1 expression &lt; 1%.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after one line of therapy who are not eligible for transplant or who relapsed within 12 months of first-line chemoimmunotherapy.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a first-line treatment for adult patients with unresectable advanced or metastatic ESCC regardless of PD-L1 status.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with fluoropyrimidine- and platinum-containing chemotherapy as a first-line treatment for adult patients with unresectable advanced or metastatic ESCC regardless of PD-L1 status.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a first-line treatment for adult patients with unresectable advanced or metastatic ESCC regardless of PD-L1 status.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with fluoropyrimidine- and platinum-containing chemotherapy as a first-line treatment for adult patients with unresectable advanced or metastatic ESCC regardless of PD-L1 status.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Camzyos</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adults with symptomatic obstructive HCM.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma and follicular lymphoma grade 3B after two or more lines of systemic therapy.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic ESCC with tumor cell PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1%. </span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the adjuvant treatment of adults with muscle-invasive urothelial carcinoma with tumor cell PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1% who are at risk of recurrence after undergoing radical resection.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic ESCC with PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1%.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdualag</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a fixed-dose combination of nivolumab and relatlimab, for the treatment of adult and pediatric patients 12 years of age and older with unresectable or metastatic melanoma.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with platinum-doublet chemotherapy for adult patients with resectable NSCLC in the neoadjuvant setting.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the adjuvant treatment of urothelial carcinoma.</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan&#8217;s Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least three prior therapies.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to &#8220;&#8212;Product and Pipeline Developments&#8221; for the developments in our marketed products and late-stage pipeline since the start of the third quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Divestitures, Licensing and Other Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Item 1. Financial Statements&#8212;Note 3. Alliances&#8221; and &#8220;&#8212;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#8221; for information on significant acquisitions, divestitures, licensing and other arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regional Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the changes in revenues was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues for the third quarter of 2022 and year-to-date increased primarily due to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis, Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and our New Product Portfolio, partially offset by our Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Average U.S. net selling prices increased 4% year-to-date compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues for the third quarter of 2022 and year-to-date decreased primarily due to lower demand for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a result of generic erosion and foreign exchange impacts. Average net selling prices decreased compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single country outside the U.S. contributed more than 10% of total revenues during the nine months ended September 30, 2022 and 2021. Our business is typically not seasonal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_121"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GTN Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of gross product sales to net product sales by each significant category of GTN adjustments was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,793)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,092)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,230)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments percentage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to provisions for product sales made in prior periods resulting from changes in estimates were $10 million and $207 million for the three and nine months ended September 30, 2022 and $10&#160;million and $282&#160;million for the three and nine months ended September 30, 2021, respectively. The reductions to provisions primarily related to Non-U.S. revisions in clawback amounts primarily driven by the VAT recoverable estimates in 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> coverage gap discounts in 2021. GTN adjustments are primarily a function of product sales volume, regional and payer channel mix, contractual or legislative discounts and rebates. U.S. GTN adjustments percentage increased primarily due to higher government channel mix, which has higher GTN adjustment percentages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In-Line Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Change in excess of 100%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from a prior reporting period as a result of a loss of exclusivity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_127"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (apixaban)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; an oral Factor Xa inhibitor, indicated for the reduction in risk of stroke/systemic embolism in NVAF and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 31% in the third quarter of 2022 and 22% year-to-date due to higher demand and higher average net selling prices, including favorable GTN adjustments. A majority of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patients enter the coverage gap during the third and fourth quarters which results in lower revenues during the second half of the year.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 16% in the third quarter of 2022 primarily due to foreign exchange impacts of 14% and lower average net selling prices. Excluding foreign exchange impacts, revenues decreased by 2%.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues decreased 3% year-to-date due to foreign exchange impacts of 11% and lower average net selling prices, partially offset by higher demand. Excluding foreign exchange impacts, revenues increased by 8%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.33pt">Following the May 2021 expiration of regulatory exclusivity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in Europe, and court decisions in (i) the United Kingdom finding the UK apixaban composition of matter patent and related SPC invalid and (ii) the Netherlands denying a BMS request for a preliminary injunction that would have prevented an at-risk generic launch, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> patents being filed in various countries in Europe. We believe in the innovative science behind </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the strength of our intellectual property, which we will defend against infringement. Refer to &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies&#8212;Intellectual Property&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab)&#160;&#8212;&#160;a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells that has been approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and various gastric and esophageal cancers. There are several ongoing potentially registrational studies for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> across other tumor types and disease areas, in monotherapy and in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and various anti-cancer agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 17% in the third quarter of 2022 and 15% year-to-date due to higher demand across multiple indications including the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combinations for NSCLC, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* combination for kidney cancer, bladder and various gastric and esophageal cancers, partially offset by declining second-line eligibility across tumor indications and increased competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 5% in the third quarter of 2022 due to foreign exchange impacts of 13%, partially offset by higher demand as a result of additional indication launches and core indications. Excluding foreign exchange impacts, revenues increased 8%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 1% year-to-date due to higher demand as a result of additional indication launches and core indications, partially offset by foreign exchange impacts of 10%. Excluding foreign exchange impacts, revenues increased 11%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pomalidomide) &#8212; a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 9% in both the third quarter of 2022 and year-to-date due to higher average net selling prices and higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 7% in the third quarter of 2022 and 1% year-to-date primarily due to foreign exchange impacts of 13% and 10%, respectively, partially offset by higher demand. Excluding foreign exchange impacts, revenues increased by 6% and 9%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(abatacept) &#8212; a fusion protein indicated for adult patients with moderate to severe active RA and PsA and is also indicated for reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular JIA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 6% in the third quarter of 2022 and 9% year-to-date due to higher demand and higher average selling net selling prices.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 11% in the third quarter of 2022 and 7% year-to-date due to foreign exchange impacts of 13% and 10%, respectively, partially offset by higher demand. Excluding foreign exchange impacts, revenues increased by 2% and 3%, respectively.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S. and EU, estimated LOE dates are based on method of use patents that expired in 2021. Formulation and additional patents expire in 2026 and beyond. There are no </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> biosimilars on the market in the U.S., EU or Japan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dasatinib)&#160;&#8212;&#160;an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromosome-positive CML in chronic phase and the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* (imatinib mesylate) and the treatment of children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome-positive CML.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 16% in the third quarter of 2022 and 14% year-to-date due to higher average net selling prices and higher demand.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 23% in the third quarter of 2022 and 18% year-to-date due to foreign exchange impacts of 13% and 11%, respectively and lower demand as a result of generic erosion. Excluding foreign exchange impacts, revenues decreased by 10% and 7%, respectively.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ipilimumab)&#160;&#8212;&#160;a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and esophageal cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 3% in both the third quarter of 2022 and year-to-date due to higher average net selling prices, partially offset by lower demand.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues remained constant in the third quarter of 2022 primarily due to higher demand as a result of additional indication launches and core indications, offset by foreign exchange impacts of 14%. Excluding foreign exchange impacts, revenues increased by 14%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 11% year-to-date due to higher demand as a result of additional indication launches and core indications, partially offset by foreign exchange impacts of 12% and lower average net selling prices. Excluding foreign exchange impacts, revenues increased by 23%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Empliciti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (elotuzumab) &#8212; a humanized monoclonal antibody for the treatment of multiple myeloma.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mature and other products &#8212; includes all other products, including those which have lost exclusivity in major markets, OTC products, royalty revenue and mature products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 9% in the third quarter of 2022 and 11% year-to-date primarily due to foreign exchange impacts of 5% and 4% and continued generic erosion. Excluding foreign exchange impacts, revenues decreased by 4% and 7%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(luspatercept-aamt) &#8212; an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions and for the treatment of anemia failing an ESA in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 6% in the third quarter of 2022 and 22% year-to-date primarily due to higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (idecabtagene vicleucel) &#8212; is a B-cell maturation antigen-directed genetically modified autologous CAR T cell therapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in May 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ozanimod) &#8212; an oral immunomodulatory drug used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and to treat moderately to severely active UC in adults. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (lisocabtagene maraleucel) &#8212; is a CD19-directed genetically modified autologous CAR T cell therapy indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after one or more lines of systemic therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (fedratinib) &#8212; an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in August 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (azacitidine) &#8212; an oral hypomethylating agent that incorporates into DNA and RNA, indicated for continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab and relatlimab-rmbw) &#8212; a combination of nivolumab, a PD-1 blocking antibody, and relatlimab, a LAG-3 blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in March 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mavacamten) &#8212; a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive HCM to improve functional capacity and symptoms. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (deucravacitinib) &#8212; an oral, selective, allosteric tyrosine kinase 2 inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(lenalidomide)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as a single agent is also indicated as a maintenance therapy in patients with multiple myeloma following autologous hematopoietic stem cell transplant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 6% in the third quarter of 2022 and 1% year-to-date due to lower demand from generic erosion, partially offset by higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 76% in the third quarter of 2022 and 55% year-to-date due to generic erosion across several European countries and Canada, lower average net selling prices and foreign exchange impacts of 3% and 4%, respectively. Excluding foreign exchange impacts, revenues decreased by 73% and 51%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S., certain third parties have been granted volume-limited licenses to sell generic lenalidomide beginning in March 2022 or thereafter. Pursuant to these licenses, several generics have entered or are expected to enter the U.S. market with volume-limited quantities of generic lenalidomide. In the EU, generic lenalidomide products have entered the market. In Japan, the composition of matter patent expired in July 2022, however BMS is not aware of any generic approvals. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline to approximately $9.0 billion to $9.5 billion in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(paclitaxel albumin-bound particles for injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a solvent-free protein-bound chemotherapy product that combines paclitaxel with albumin using our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform, and is used to treat breast cancer, NSCLC and pancreatic cancer, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 45% in the third quarter of 2022 and 31% year-to-date due to entry of authorized generics and lower demand. Year-to-date was also impacted by manufacturing delays in the first quarter of 2022. Revenues in the second and third quarter of 2022 include product supply sales and profit sharing fees resulting from authorized generic arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 13% in the third quarter of 2022 due to higher demand as the manufacturing delays experienced in the prior year were substantially resolved, partially offset by foreign exchange impacts of 7%. Excluding foreign exchange impacts, revenues increased by 20%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 18% year-to-date due to lower demand as a result of generic erosion and foreign exchange impacts of 4%. Excluding foreign exchange impacts, revenues decreased by 14%. During the first quarter of 2022, the manufacturing delays experienced in the U.S. and International were substantially resolved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S. and EU, generics have entered the market. In Japan, the estimated minimum market exclusivity date is 2023 based on a method of use patent. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline by approximately 25% to 30% in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_130"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated End-User Demand</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SEC Consent Order described in our 2021 Form 10-K, we monitor inventory levels on hand in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel. We are obligated to disclose products with levels of inventory in excess of one month on hand or expected demand, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception. Estimated levels of inventory in the distribution channel in excess of one month on hand for the following products were not material to our results of operations as of the dates indicated:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> had 2.3 months of inventory on hand as of September 30, 2022 in the U.S to support the product launch. The inventory is expected to be worked down as demand increases post launch.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> had 1.1 months of inventory on hand internationally in the distribution channel as of June 30, 2022 compared to 0.9 months of inventory on hand as of March 31, 2022 primarily to support the product launch in China and minimum stocking requirements in Greece.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we generally determine our months on hand estimates using inventory levels of product on hand and the amount of out-movement provided by our three largest wholesalers, which accounted for approximately 79% of total gross sales of U.S. products for the nine months ended September 30, 2022. Factors that may influence our estimates include generic competition, seasonality of products, wholesaler purchases in light of increases in wholesaler list prices, new product launches, new warehouse openings by wholesalers and new customer stockings by wholesalers. In addition, these estimates are calculated using third-party data, which may be impacted by their recordkeeping processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed in the U.S. primarily through contracted pharmacies under the Lenalidomide&#160;REMS (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> REMS&#160;programs, respectively. These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed under mandatory risk-management distribution programs tailored to meet local authorities&#8217; specifications to provide for the products&#8217; safe and appropriate distribution and use. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is only available through a restricted program called the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> REMS Program. Product distribution is limited to REMS certified pharmacies, and enrolled pharmacies must only dispense to patients who are authorized to receive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-U.S. businesses have significantly more direct customers. Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely. We limit our direct customer sales channel inventory reporting to where we can influence demand. When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and third-party market research data related to prescription trends and end-user demand. Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary. Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations. As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.S. business for the quarter ended September&#160;30, 2022 is not available prior to the filing of this Quarterly Report on Form 10-Q. We will disclose any product with levels of inventory in excess of one month on hand or expected demand for the current quarter, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception, in our next quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;In excess of +/- 100%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Excludes amortization of acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold increased by $62 million in the third quarter of 2022, primarily due to higher profit sharing due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue growth ($151 million) and higher costs resulting from expanding our cell therapy capabilities, partially offset by foreign exchange impacts and related hedging settlements ($214 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold decreased by $40 million year-to-date, primarily due to the impairment charges related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones in 2021 ($315 million) and foreign exchange impacts and related hedging settlements ($553 million), partially offset by higher profit sharing due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue growth ($529 million) and higher costs resulting from expanding our cell therapy capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing, Selling and Administrative</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, selling and administrative expenses increased $142 million in the third quarter of 2022 and $212 million year-to-date primarily due to higher costs to support new product launches and the cash settlement of Turning Point unvested stock awards ($73 million), partially offset by foreign exchange impacts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense decreased by $562 million in the third quarter of 2022, and $678 million year-to-date, primarily due to IPRD impairment charges in 2021 ($610 million in the third quarter and $840 million year-to-date), lower clinical development costs and foreign exchange impacts, partially offset by the cash settlement of Turning Point unvested stock awards ($80 million) and the unwinding of inventory purchase price adjustments for clinical use during 2022 ($22 million in the third quarter and $130 million year-to-date).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired IPRD</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPRD charges resulting from upfront or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights were as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai upfront collaboration fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus upfront license fee </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mavacamten royalty extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics upfront license fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BridgeBio upfront license fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prothena opt-in license fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GentiBio upfront license fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of acquired intangible assets decreased by $128 million in the third quarter of 2022 and $354 million year-to-date, due to a change in the expected expiration of the market exclusivity period for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to the first quarter of 2026.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income)/expense, net changed by $269&#160;million in the third quarter of 2022 and $1.9&#160;billion year-to-date, primarily due to equity investments, contingent value rights and other items discussed below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties and licensing income includes diabetes business royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties and milestones for products that have not obtained commercial approval. Refer to &#8220;Item 1. Financial Statements&#8212;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#8221; for further information. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investment losses/(income) includes fair value adjustments for investments that have readily determinable fair value and observable price changes for investments without readily determinable fair values resulting primarily from initial public offerings or third-party acquisitions of entities which we held an ownership interest. Our share of income or loss from equity method investments is primarily due to fair value adjustments attributed to limited partnerships. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for more information.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integration expenses primarily includes consulting fees to implement Celgene and other acquisition integration initiatives related to processes and systems.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration primarily includes fair value adjustments resulting from the change in the traded price of contingent value rights issued with the Celgene acquisition. The contractual obligation to pay the contingent value rights terminated in January 2021 because the FDA did not approve liso-cel (JCAR017) by December 31, 2020.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss on debt redemption resulted from the early redemption of long-term debt of $6.0 billion in 2022 and $3.5 billion in 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision for restructuring includes exit and other costs primarily related to the Celgene acquisition plan. We achieved the annualized pre-tax cost savings of at least $3.0 billion. Refer to &#8220;Item 1. Financial Statements&#8212;Note 6. Restructuring&#8221; for further information.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation and other settlements includes expenses for intellectual property and promotional practice matters, as further described in Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies&#8221;. In addition, year-to-date 2022 includes income of $40&#160;million resulting from a settlement resolving all legal claims and business interests pertaining to Nimbus&#8217; TYK2 inhibitor. The settlement also provides for contingent development, regulatory and sales-based milestones payable to BMS upon the occurrence of certain events.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Divestiture gains resulted from the divestiture of product rights for several mature products in 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other includes foreign exchange, interest income, transition service fees, as well as exit costs of $38&#160;million resulting from the transition of our commercial operations in the Russian Federation to a third-party distributor and acquisition costs of $32&#160;million related to the Turning Point acquisition in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_136"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Specified Items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate Excluding Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact attributed to specified items was primarily due to low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that were not taxable in 2021. The 2.3% increase in the effective tax rate excluding specified items was due to changes in previously estimated annual effective tax rates resulting from jurisdictional earnings mix in the third quarter of both periods. Refer to &#8220;Item 1. Financial Statements&#8212;Note 7. Income Taxes&#8221; for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i42aefad24baa419bafa9083c3049e007_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, such as non-GAAP earnings and related EPS information, are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. These items are excluded from non-GAAP earnings and related EPS information because the Company believes they neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business performance. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods including (i) amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, (ii) unwind of inventory purchase price adjustments, (iii) acquisition and integration expenses, (iv) restructuring costs, (v) accelerated depreciation and impairment of property, plant and equipment and intangible assets, (vi) divestiture gains or losses, (vii) stock compensation resulting from acquisition-related equity awards (viii) pension, legal and other contractual settlement charges, (ix) equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments) and (x) amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. We also provide international revenues for our priority products excluding the impact of foreign exchange. We calculate foreign exchange impacts by converting our current-period local currency financial results using the prior period average currency rates and comparing these adjusted amounts to our current-period results. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are included in Exhibit 99.2 to our Form 8-K filed on October&#160;26, 2022 and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the first quarter of 2022, significant R&amp;D charges or other income resulting from upfront or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights are no longer excluded from our non-GAAP financial measures. We made these changes to our presentation of non-GAAP financial measures following comments from and discussions with the SEC. For purposes of comparability, the non-GAAP financial measures for the three and nine months ended September 30, 2021 have been updated to reflect this change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP information is intended to portray the results of our baseline performance, supplement or enhance management, analysts and investors&#8217; overall understanding of our underlying financial performance and facilitate comparisons among current, past and future periods. This information is not intended to be considered in isolation or as a substitute for the related financial measures prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specified items were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to pretax income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on items above</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to net earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,355&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes amortization of purchase price adjustments to Celgene debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations from GAAP to Non-GAAP were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Diluted EPS Calculation &#8211; GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Diluted EPS Calculation &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share Attributable to BMS &#8211; GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to BMS &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net debt position was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,071)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,587)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_1099511629343"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly assess our anticipated working capital needs, debt and leverage levels, debt maturities, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions in order to maximize shareholder return, efficiently finance our ongoing operations and maintain flexibility for future strategic transactions. We also regularly evaluate our capital structure to ensure financial risks, adequate liquidity access and lower cost of capital are efficiently managed, which may lead to the issuance of additional debt securities, the repurchase of debt securities prior to maturity or the issuance or repurchase of common stock. Under the Tax Cuts and Jobs Act of 2017, research and development costs are required to be capitalized and amortized for U.S. tax purposes effective January 1, 2022. Absent a change in law, we estimate our U.S. income tax payments will increase by nearly $2.0 billion as compared to 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents and marketable debt securities together with cash generated from operations and, if required, from the issuance of commercial paper will be sufficient to satisfy our anticipated cash needs for at least the next few years, including dividends, capital expenditures, milestone payments, working capital, income taxes, restructuring initiatives, business development, business combinations, asset acquisitions, repurchase of common stock, debt maturities of approximately $10.6&#160;billion through 2026, as well as any debt repurchases through redemptions or tender offers. As of September 30, 2022, our net debt position increased by $2.5&#160;billion primarily due to common stock repurchases and dividends ($9.1&#160;billion), and the Turning Point acquisition ($3.3&#160;billion), partially offset by cash from operating activities ($9.8&#160;billion).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a share repurchase program authorized by our Board of Directors allowing for repurchases of our shares. The specific timing and number of shares repurchased will be determined by our management at its discretion and will vary based on market conditions, securities law limitations and other factors. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. The repurchases may be effected through a combination of one or more open market repurchases, privately negotiated transactions, transactions structured through investment banking institutions and other derivative transactions, relying on Rule 10b-18 and Rule 10b5-1 under the Exchange Act. The outstanding share repurchase authorization under the program was $15.2 billion as of December 31, 2021. During the first quarter of 2022, we executed ASR agreements to repurchase an aggregate $5.0 billion of common stock. In addition, as part of our share repurchase program, we repurchased 10 million shares of common stock for $701 million during the third quarter of 2022. The remaining share repurchase capacity under the share repurchase program was approximately $9.5&#160;billion as of September&#160;30, 2022. Refer to &#8220;Item 1. Financial Statements&#8212;Note 15. Equity&#8221; for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend payments were $3.5 billion during the nine months ended September 30, 2022. Dividend per common share of $0.54 was declared during each of the first, second, and third quarters of 2022. Dividend decisions are made on a quarterly basis by our Board of Directors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual capital expenditures were approximately $970 million in 2021 and are expected to be approximately $1.1 billion in 2022 and $1.2&#160;billion in 2023. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities, research and development and other facility-related activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we purchased an aggregate principal amount of $6.0&#160;billion of certain of our debt securities for $6.6&#160;billion of cash in tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a net $266&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we issued an aggregate principal amount of $6.0&#160;billion of debt with net proceeds of $5.9&#160;billion. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had four separate revolving credit facilities totaling $6.0 billion, which consisted of a 364-day $2.0 billion facility which expired in January 2022, a three-year $1.0 billion facility which expired in January 2022 and two five-year $1.5 billion facilities that were extended to September 2025 and July 2026, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into a five-year $5.0 billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5 billion facilities were terminated and the three-year $1.0 billion facility and 364-day $2.0 billion facility expired in accordance with their terms in January 2022. No borrowings were outstanding under revolving credit facilities as of September&#160;30, 2022 or December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our commercial paper program, we may issue a maximum of $5.0 billion unsecured notes that have maturities of not more than 366 days from the date of issuance. There were no commercial paper borrowings outstanding as of September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment portfolio includes marketable debt securities, which are subject to changes in fair value as a result of interest rate fluctuations and other market factors. Our investment policy establishes limits on the amount and time to maturity of investments with any institution. The policy also requires that investments are only entered into with corporate and financial institutions that meet high credit quality standards. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_154"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Ratings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current long-term and short-term credit ratings assigned by Moody&#8217;s Investors Service are A2 and Prime-1, respectively, with a stable long-term credit outlook, and our current long-term and short-term credit ratings assigned by Standard &amp; Poor&#8217;s are A+ and A-1, respectively with a stable long-term credit outlook. The long-term ratings reflect the agencies&#8217; opinion that we have a low default risk but are somewhat susceptible to adverse effects of changes in circumstances and economic conditions. The short-term ratings reflect the agencies&#8217; opinion that we have good to extremely strong capacity for timely repayment. Any credit rating downgrade may affect the interest rate of any debt we may incur, the fair market value of existing debt and our ability to access the capital markets generally.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of cash flow activities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow provided by/(used in):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from operating activities represents the cash receipts and disbursements from all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net earnings for noncontrolling interest, non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash and when the transactions are recognized in our results of operations. As a result, changes in cash from operating activities reflect the timing of cash collections from customers and alliance partners; payments to suppliers, alliance partners and employees; customer discounts and rebates; and tax payments in the ordinary course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.4 billion change in cash used in operating activities compared to 2021 was driven by higher tax payments ($1.4 billion) primarily resulting from research and development expenses that are capitalized and amortized for tax purposes, Turning Point related acquisition payments ($300 million) and cash collections and timing of payments in the ordinary course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from investing activities include cash used for acquisitions, manufacturing and facility-related capital expenditures and purchases of marketable securities with original maturities greater than 90 days at the time of purchase, proceeds from business divestitures (including royalties), the sale and maturity of marketable securities, sale of equity investments, as well as upfront and contingent milestones from licensing arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.3 billion change in cash used in investing activities compared to 2021 was primarily due to the acquisition of Turning Point ($3.2&#160;billion, net of cash acquired), lower proceeds from the sale of equity investments ($845 million) partially offset by lower Acquired IPRD payments ($594 million) and the changes in the amount of marketable debt securities held ($2.1 billion).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from financing activities include cash used to repay long-term debt, repurchase common stock, pay dividends and other borrowings offset by proceeds from issuance of long-term debt, other borrowings and exercise of stock options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.5 billion change in cash used in financing activities compared to 2021 was primarily due to higher repurchases of common stock ($2.0 billion), partially offset by changes in the amount of net debt borrowings ($621 million).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_160"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Pipeline Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D programs are managed on a portfolio basis from early discovery through late-stage development and include a balance of early-stage and late-stage programs to support future growth. Our late stage R&amp;D programs in Phase III development include both investigational compounds for initial indications and additional indications or formulations for marketed products. The following are the developments in our marketed products and our late-stage pipeline since the start of the third quarter of 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that results from the Phase III CheckMate -76K trial evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in the adjuvant setting in patients with completely resected stage IIB or IIC melanoma demonstrated a statistically significant and clinically meaningful benefit in recurrence-free survival and the risk of recurrence or death was reduced by 58% versus placebo. No new safety signals were observed. </span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo + Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that Part A of the Phase III CheckMate -914 trial, evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> as an adjuvant treatment for patients with localized RCC who have undergone full or partial removal of the kidney and who are at moderate or high risk of relapse, did not meet the primary endpoint of disease-free survival. The safety profile was consistent with previously reported studies of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> combination in solid tumors. </span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multiple Myeloma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced with our alliance partner, 2seventy bio, Inc., positive topline results from the Phase III KarMMa-3 trial evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory after two to four prior lines of therapy and refractory to the last regimen showing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> significantly improves progression-free survival. Treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> also showed an improvement in the key secondary endpoint of overall response rate compared to standard regimens.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:68pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Zeposia</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MS</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced retrospective analysis from the Phase III DAYBREAK open-label extension trial of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in MS showed that more than 92% of participants mounted a serologic response to COVID-19 exposure and vaccination, with only 10% of participants reporting COVID-19 adverse events &#8211; all were nonserious. Additional data from the Phase III DAYBREAK and RADIANCE trials demonstrated the effect of early </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> treatment on long-term cognitive function in patients with relapsing MS.</span></div></td></tr><tr style="height:68pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced post hoc analyses from the Phase III True North study evaluating the duration of response following continuous </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> treatment for up to one year and following treatment interruption in patients with moderately to severely active UC. After achieving a clinical response at the end of the induction period, 86.1% of patients who remained on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> showed no disease relapse at Week 52. Disease control was maintained for up to eight weeks in patients who switched to placebo after initial response.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdualag</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of the fixed-dose combination of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the first-line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumor cell PD-L1 expression &lt; 1%. The approval is based on results from the Phase II/III RELATIVITY -047 trial.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Camzyos</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that the FDA accepted the supplemental NDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for an expanded indication to reduce the need for septal reduction therapy. The FDA has set a target action date of June 16, 2023. The supplemental NDA is based on results from the Phase III VALOR-HCM trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:47pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">Sotyktu </span></div></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plaque Psoriasis</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced Japan&#8217;s Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for treatment of plaque psoriasis, generalized pustular psoriasis, or erythrodermic psoriasis, for patients who have had an inadequate response to conventional therapies. The approval is based on the results from the Phase III POETYK PSO-1 trial.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The approval is based on results from the Phase III POETYK PSO-1 and POETYK PSO-2 clinical trials.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced two-year results from the POETYK PSO long-term extension trial demonstrating that clinical efficacy was maintained with continuous </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> treatment in adult patients with moderate-to-severe plaque psoriasis. </span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses. Our critical accounting policies are those that significantly impact our financial condition and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates. For a discussion of our critical accounting policies, refer to &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our 2021 Form 10-K. There have been no material changes to our critical accounting policies during the nine months ended September 30, 2022. For information regarding the impact of recently adopted accounting standards, refer to &#8220;Item 1. Financial Statements&#8212;Note 1. Basis of Presentation and Recently Issued Accounting Standards.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (including documents incorporated by reference) and other written and oral statements we make from time to time contain certain &#8220;forward-looking&#8221; statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. You can identify these forward-looking statements by the fact they use words such as &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will&#8221; and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These statements are likely to relate to, among other things, our goals, plans and objectives regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance or results of current and anticipated products, our business development strategy, our ability to realize the projected benefits of our acquisitions of Celgene, MyoKardia, and Turning Point, the impact of the COVID-19 pandemic on our operations and the development and commercialization of our products, potential laws and regulations to lower drug costs, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about our ability to retain marketing exclusivity of certain products, and the outcome of contingencies such as legal proceedings and financial results. No forward-looking statement can be guaranteed. This Quarterly Report on Form 10-Q, our 2021 Form 10-K, particularly under the section &#8220;Item 1A. Risk Factors,&#8221; and our other filings with the SEC, include additional information on the factors that we believe could cause actual results to differ materially from any forward-looking statement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we have been prudent in our plans and assumptions, no assurance can be given that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Additional risks that we may currently deem immaterial or that are not presently known to us could also cause the forward-looking events discussed in this Quarterly Report on Form 10-Q not to occur. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise after the date of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risk, refer to &#8220;Item 7A. Quantitative and Qualitative Disclosures about Market Risk&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_172"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management carried out an evaluation, under the supervision and with the participation of its chief executive officer and chief financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of September&#160;30, 2022, such disclosure controls and procedures are effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting during the quarter ended September&#160;30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_175"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies,&#8221; to the interim consolidated financial statements, and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in the Company&#8217;s 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i42aefad24baa419bafa9083c3049e007_184"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the surrenders of our equity securities during the three months ended September 30, 2022:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares&#160;Purchased&#160;as Part of Publicly Announced Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares&#160;that May Yet Be Purchased Under the Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 to 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 to 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 to 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,995,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,898,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,333,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,178,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Includes shares repurchased as part of publicly announced programs and shares of common stock surrendered to the Company to satisfy tax-withholding obligations in connection with the vesting of awards under our long-term incentive program. Shares surrendered for tax withholding included 38,425 in July, 20,292 in August and 96,679 in September with average prices of $76.57, $73.50 and $70.36, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In May 2010, the Board of Directors authorized the repurchase of up to $3.0 billion of our common stock and in June 2012 increased its authorization for the repurchase of our common stock by an additional $3.0 billion. The Board of Directors approved a new share repurchase program authorizing the repurchase of an additional $3.0 billion of our common stock in October 2016 and further increased its authorization for the repurchase of our common stock by approximately $7.0 billion in November 2019 and $5.0 billion in February 2020. In January and December 2021, the Board of Directors approved an increase of $2.0 billion and $15.0 billion, respectively, to the share repurchase authorization for our common stock. The remaining share repurchase capacity under the program is approximately $9.5 billion as of September&#160;30, 2022. Refer to &#8220;Item 1. Financial Statements-Note 15. Equity&#8221; for information on the share repurchase program.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">During the first quarter of 2022, BMS entered into accelerated share repurchase (&#8220;ASR&#8221;) agreements to repurchase an aggregate $5.0 billion of common stock. Approximately 65 million shares of common stock (85% of the $5.0 billion aggregate purchase price calculated on the basis of a price of $65.89 per share, the closing share price of the Company's common stock on February 8, 2022) were received by BMS and included in treasury stock. During the second quarter of 2022, the first tranche of the ASR was settled and approximately 2&#160;million shares of common stock were received by BMS and transferred to treasury stock. During the third quarter of 2022, the final tranche of the ASR was settled and approximately 2&#160;million shares of common stock were received by BMS and transferred to treasury stock. The completed ASR had an average repurchase price of $72.71 per share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_187"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (listed by number corresponding to the Exhibit Table of Item&#160;601 in Regulation S-K).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31a_20220930.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31b_20220930.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32a_20220930.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32b_20220930.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates, in this Quarterly Report on Form 10-Q, brand names of products, which are registered trademarks not solely owned by the Company or its subsidiaries.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Otsuka Pharmaceutical Co., Ltd.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Gilead Sciences, LLC.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Amylin Pharmaceuticals, LLC; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Exelixis, Inc.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Novartis AG; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of AstraZeneca AB; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Merck Sharp &amp; Dohme Corp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Amgen Inc.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Genentech, Inc.; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Kite Pharma, Inc. Brand names of products that are in all italicized letters, without an asterisk, are registered trademarks of BMS and/or one of its subsidiaries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_190"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF ABBREVIATED TERMS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company and its consolidated subsidiaries may be referred to as Bristol Myers Squibb, BMS, the Company, we, our or us in this Quarterly Report on Form 10-Q, unless the context otherwise indicates. Throughout this Quarterly Report on Form 10-Q we have used terms which are defined below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Form 10-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the fiscal year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">acute myeloid leukemia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">loss of exclusivity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">marketing authorization application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">aNDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">abbreviated new drug application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">multi-district litigation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca PLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDS</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myelodysplastic syndromes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">biologics license application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPM</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">malignant pleural mesothelioma</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BridgeBio</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BridgeBio Pharma Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MS</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiple Sclerosis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAR T</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chimeric antigen receptor T-cell</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">new drug application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CERCLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Comprehensive Environmental Response, Compensation and Liability Act</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NKT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">natural killer T cells</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm Arzneimittel GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHMP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee for Medicinal Products for Human Use</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NVAF</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-valvular atrial fibrillation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CML</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chronic myeloid leukemia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over-the-counter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">colorectal carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed cell death protein 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-L1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed death-ligand 1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai Co., Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PsA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">psoriatic arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prothena</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prothena Corporation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">esophageal squamous cell carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rheumatoid arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">red blood cell</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. generally accepted accounting principles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">renal cell carcinoma</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gross-to-net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REMS</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">risk evaluation and mitigation strategy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hepatocellular carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hypertrophic cardiomyopathy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sBLA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental Biologics License Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIV</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">human immunodeficiency viruses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics Biotechnologies GmbH.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IO</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">immuno-oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ulcerative colitis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">value added tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LAG-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">lymphocyte activation gene-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i42aefad24baa419bafa9083c3049e007_193"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY<br/>(REGISTRANT)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Giovanni Caforio, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David V. Elkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.A
<SEQUENCE>2
<FILENAME>bmyex31a_20220930.htm
<DESCRIPTION>EXHIBIT 31.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icf7bc52cb47a4e69a608f97a23898fe9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Giovanni Caforio, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; October&#160;26, 2022 </font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.B
<SEQUENCE>3
<FILENAME>bmyex31b_20220930.htm
<DESCRIPTION>EXHIBIT 31.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2550715a0c974d058e5ed64415b9ede5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David V. Elkins, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; October&#160;26, 2022 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.A
<SEQUENCE>4
<FILENAME>bmyex32a_20220930.htm
<DESCRIPTION>EXHIBIT 32.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i587872ebcf064de88449fa20aa2f1912_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, Giovanni Caforio, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on October&#160;26, 2022, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.520%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;26, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.B
<SEQUENCE>5
<FILENAME>bmyex32b_20220930.htm
<DESCRIPTION>EXHIBIT 32.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib5e817eae99f4611a44deb136fce18e6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Financial Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, David V. Elkins, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on October&#160;26, 2022, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;26, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bmy-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmy="http://www.bms.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bms.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bms.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEARNINGS" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.bms.com/role/REVENUE">
        <link:definition>2103102 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCES" roleURI="http://www.bms.com/role/ALLIANCES">
        <link:definition>2108103 - Disclosure - ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS" roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS">
        <link:definition>2111104 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENET" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET">
        <link:definition>2119105 - Disclosure - OTHER (INCOME)/EXPENSE, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.bms.com/role/RESTRUCTURING">
        <link:definition>2122106 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.bms.com/role/INCOMETAXES">
        <link:definition>2127107 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.bms.com/role/EARNINGSPERSHARE">
        <link:definition>2131108 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>2134109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLES" roleURI="http://www.bms.com/role/RECEIVABLES">
        <link:definition>2147110 - Disclosure - RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.bms.com/role/INVENTORIES">
        <link:definition>2151111 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2154112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2157113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>2161114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITY" roleURI="http://www.bms.com/role/EQUITY">
        <link:definition>2167115 - Disclosure - EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANS" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS">
        <link:definition>2173116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIES" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES">
        <link:definition>2178117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.bms.com/role/REVENUETables">
        <link:definition>2304301 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESTables" roleURI="http://www.bms.com/role/ALLIANCESTables">
        <link:definition>2309302 - Disclosure - ALLIANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables">
        <link:definition>2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETTables" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables">
        <link:definition>2320304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.bms.com/role/RESTRUCTURINGTables">
        <link:definition>2323305 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.bms.com/role/INCOMETAXESTables">
        <link:definition>2328306 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.bms.com/role/EARNINGSPERSHARETables">
        <link:definition>2332307 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>2335308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESTables" roleURI="http://www.bms.com/role/RECEIVABLESTables">
        <link:definition>2348309 - Disclosure - RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.bms.com/role/INVENTORIESTables">
        <link:definition>2352310 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2355311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2358312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables">
        <link:definition>2362313 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYTables" roleURI="http://www.bms.com/role/EQUITYTables">
        <link:definition>2368314 - Disclosure - EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSTables" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables">
        <link:definition>2374315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregationofRevenueDetails" roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails">
        <link:definition>2405401 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails">
        <link:definition>2406402 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregationofRevenuebyProductandRegionDetails" roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails">
        <link:definition>2407403 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESDetails" roleURI="http://www.bms.com/role/ALLIANCESDetails">
        <link:definition>2410404 - Disclosure - ALLIANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails" roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails">
        <link:definition>2413405 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails" roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails">
        <link:definition>2414406 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails">
        <link:definition>2415407 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
        <link:definition>2416408 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
        <link:definition>2417409 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
        <link:definition>2418410 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails">
        <link:definition>2421411 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGAdditionalInformationDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails">
        <link:definition>2424412 - Disclosure - RESTRUCTURING - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
        <link:definition>2425413 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>2426414 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>2429415 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>2430416 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2433417 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
        <link:definition>2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails">
        <link:definition>2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails">
        <link:definition>2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
        <link:definition>2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
        <link:definition>2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
        <link:definition>2443425 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails">
        <link:definition>2444426 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails">
        <link:definition>2445427 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails">
        <link:definition>2446428 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESScheduleofReceivablesDetails" roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails">
        <link:definition>2449429 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESDetails" roleURI="http://www.bms.com/role/RECEIVABLESDetails">
        <link:definition>2450430 - Disclosure - RECEIVABLES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.bms.com/role/INVENTORIESDetails">
        <link:definition>2453431 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>2456432 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails">
        <link:definition>2459433 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
        <link:definition>2460434 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails">
        <link:definition>2463435 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails">
        <link:definition>2464436 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails">
        <link:definition>2465437 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails">
        <link:definition>2466438 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofStockholdersEquityDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails">
        <link:definition>2469439 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYAdditionalInformationDetails" roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails">
        <link:definition>2470440 - Disclosure - EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails">
        <link:definition>2471441 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2472442 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
        <link:definition>2475443 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
        <link:definition>2476444 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
        <link:definition>2477445 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIESDetails" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails">
        <link:definition>2479446 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bmy_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherrevenuesMember" abstract="true" name="OtherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Totalinventories" abstract="false" name="Totalinventories" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_BiohavenMember" abstract="true" name="BiohavenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcquiredIPRD" abstract="false" name="AcquiredIPRD" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ScheduleOfOtherIncomeExpenseTextBlock" abstract="false" name="ScheduleOfOtherIncomeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_MyoKardiaAcquisitionPlanMember" abstract="true" name="MyoKardiaAcquisitionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AmortizationOfDeferredIncome" abstract="false" name="AmortizationOfDeferredIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" abstract="false" name="RestructuringChargesExcludingAcceleratedStockbasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_DiabetesbusinessMember" abstract="true" name="DiabetesbusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberDismissed" abstract="false" name="LossContingencyPendingClaimsNumberDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_SprycelMember" abstract="true" name="SprycelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" abstract="true" name="OtherrebatesreturnsdiscountsandadjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UpfrontPaymentsMadeToCollaborativePartner" abstract="false" name="UpfrontPaymentsMadeToCollaborativePartner" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A2.600Notesdue2022Member" abstract="true" name="A2.600Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustments" abstract="false" name="GrosstoNetAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_InLineProductsMember" abstract="true" name="InLineProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.000Notesdue2025Member" abstract="true" name="A1.000Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.750Notesdue2035Member" abstract="true" name="A1.750Notesdue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InLineProductsAndNewProductPortfolioMember" abstract="true" name="InLineProductsAndNewProductPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcceleratedStockBasedCompensationMember" abstract="true" name="AcceleratedStockBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NoteDue2062Member" abstract="true" name="NoteDue2062Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsLineItems" abstract="true" name="GrosstoNetAdjustmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_EquityInvestmentsNonCurrent" abstract="false" name="EquityInvestmentsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityMember" abstract="true" name="AbilifyProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EmplicitiMember" abstract="true" name="EmplicitiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Cashoutlays" abstract="false" name="Cashoutlays" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsDomain" abstract="true" name="GrosstoNetAdjustmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EisaiMember" abstract="true" name="EisaiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_TurningPointMember" abstract="true" name="TurningPointMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" abstract="false" name="AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RestructuringRelatedCostsAssetImpairments" abstract="false" name="RestructuringRelatedCostsAssetImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_MatureBrandsAndOtherMember" abstract="true" name="MatureBrandsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_RoyaltyGuaranteesCommitmentsPercent" abstract="false" name="RoyaltyGuaranteesCommitmentsPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bmy_AmortizationofAcquiredIntangibleAssets" abstract="false" name="AmortizationofAcquiredIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A1BillionMaximumBorrowingCapacityMember" abstract="true" name="A1BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LOTTECorporationMember" abstract="true" name="LOTTECorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DragonflyMember" abstract="true" name="DragonflyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherRoyaltiesMember" abstract="true" name="OtherRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InrebicMember" abstract="true" name="InrebicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OnglyzaProductLiabilityLitigationMember" abstract="true" name="OnglyzaProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2250SeniorNotesDue2021Member" abstract="true" name="A2250SeniorNotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OrenciaMember" abstract="true" name="OrenciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BristolMyersSquibbMember" abstract="true" name="BristolMyersSquibbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ReblozylMember" abstract="true" name="ReblozylMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.5BillionMaximumBorrowingCapacityMember" abstract="true" name="A1.5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AlliancesAndCollaborationCompaniesAxis" abstract="true" name="AlliancesAndCollaborationCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A3550BondsDue2022Member" abstract="true" name="A3550BondsDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityLitigationMember" abstract="true" name="AbilifyProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_YervoyMember" abstract="true" name="YervoyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" abstract="false" name="ScheduleOfProvisionForIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ContingentValueRightsMember" abstract="true" name="ContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IntangibleAssetNameDomain" abstract="true" name="IntangibleAssetNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2022ASRMember" abstract="true" name="A2022ASRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2.875SeniorNotesdue2021Member" abstract="true" name="A2.875SeniorNotesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_CashDiscounts" abstract="false" name="CashDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_KeytrudaRoyaltiesMember" abstract="true" name="KeytrudaRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsIncome" abstract="false" name="LicensingAndOtherArrangementsIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" abstract="true" name="AcquisitionsDivestituresandOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LicensingArrangementsLineItems" abstract="true" name="LicensingArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LOEProductsMember" abstract="true" name="LOEProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CommonStock0.10ParValueMember" abstract="true" name="CommonStock0.10ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2000NotesDue2022Member" abstract="true" name="A2000NotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestonePayments" abstract="false" name="ContingentAndRegulatoryMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_CARTKiteLitigationMember" abstract="true" name="CARTKiteLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LongTermDebtRenewalPeriod" abstract="false" name="LongTermDebtRenewalPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bmy_NumberofRevolvingCreditFacilities" abstract="false" name="NumberofRevolvingCreditFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" abstract="false" name="ConsiderationForContingentDevelopmentAndRegulatoryApproval" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_NoteDue2042Member" abstract="true" name="NoteDue2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NoteDue2052Member" abstract="true" name="NoteDue2052Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AccruedRebatesAndReturns" abstract="false" name="AccruedRebatesAndReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ChargebacksandcashdiscountsMember" abstract="true" name="ChargebacksandcashdiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" abstract="false" name="LossContingencyPendingClaimsNumberIndividualInjuryClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" abstract="false" name="ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_NetproductsalesMember" abstract="true" name="NetproductsalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_TecentriqRoyaltiesMember" abstract="true" name="TecentriqRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2BillionMaximumBorrowingCapacityMember" abstract="true" name="A2BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicenseAndOtherArrangementsUpfrontPayments" abstract="false" name="LicenseAndOtherArrangementsUpfrontPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_IntangibleAssetNameAxis" abstract="true" name="IntangibleAssetNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ALLIANCESAbstract" abstract="true" name="ALLIANCESAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ExpectedSynergiesPercentage" abstract="false" name="ExpectedSynergiesPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bmy_EliquisMember" abstract="true" name="EliquisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UnamortizedBasisAdjustmentFromSwapTerminations" abstract="false" name="UnamortizedBasisAdjustmentFromSwapTerminations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OpdivoMember" abstract="true" name="OpdivoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ImmaticsMember" abstract="true" name="ImmaticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherShutdownCosts" abstract="false" name="OtherShutdownCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_SalesRevenueGrossMember" abstract="true" name="SalesRevenueGrossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AllianceandotherrevenuesMember" abstract="true" name="AllianceandotherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbecmaMember" abstract="true" name="AbecmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityLineItems" abstract="true" name="EquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OtherOtherIncomeExpense" abstract="false" name="OtherOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_NewProductPortfolioMember" abstract="true" name="NewProductPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherIncomeReceivedFromAlliancePartners" abstract="false" name="OtherIncomeReceivedFromAlliancePartners" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PercentageOfAggregateTotalTradeReceivablesDue" abstract="false" name="PercentageOfAggregateTotalTradeReceivablesDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_OnuregMember" abstract="true" name="OnuregMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsTableTextBlock" abstract="false" name="LicensingAndOtherArrangementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_RevlimidMember" abstract="true" name="RevlimidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SotyktuMember" abstract="true" name="SotyktuMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsDomain" abstract="true" name="LicensingAndOtherArrangementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Divestituregainsandroyalties" abstract="false" name="Divestituregainsandroyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PlavixAustraliaIntellectualPropertyMember" abstract="true" name="PlavixAustraliaIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CheplapharmMember" abstract="true" name="CheplapharmMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_EquityTable" abstract="true" name="EquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_MatureAndOtherBrandsMember" abstract="true" name="MatureAndOtherBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbraxaneMember" abstract="true" name="AbraxaneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyNumberOfPlaintiffsDismissed" abstract="false" name="LossContingencyNumberOfPlaintiffsDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_CamzyosMember" abstract="true" name="CamzyosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2019ASRMember" abstract="true" name="A2019ASRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PaymentToExtinguishFutureRoyaltyObligation" abstract="false" name="PaymentToExtinguishFutureRoyaltyObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ResearchandDevelopment" abstract="false" name="ResearchandDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquityInvestmentsCurrent" abstract="false" name="EquityInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_FloatingRateNotesdue2022Member" abstract="true" name="FloatingRateNotesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfEquityInvestmentsTableTextBlock" abstract="false" name="ScheduleOfEquityInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestoneNonCash" abstract="false" name="ContingentAndRegulatoryMilestoneNonCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A5BillionMaximumBorrowingCapacityMember" abstract="true" name="A5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InventoryPurchasePriceFairValueAdjustmentMember" abstract="true" name="InventoryPurchasePriceFairValueAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityInvestments" abstract="false" name="EquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ZeposiaMember" abstract="true" name="ZeposiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberClassAction" abstract="false" name="LossContingencyPendingClaimsNumberClassAction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_BridgeBioMember" abstract="true" name="BridgeBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberActive" abstract="false" name="LossContingencyPendingClaimsNumberActive" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_CelgeneContingentValueRightsMember" abstract="true" name="CelgeneContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PomalystImnovidMember" abstract="true" name="PomalystImnovidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneIntegrationMember" abstract="true" name="CelgeneIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" abstract="false" name="SellingGeneralandAdministrativeExpenseCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A2550SeniorNotesDue2021Member" abstract="true" name="A2550SeniorNotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NoteDue2032Member" abstract="true" name="NoteDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsAxis" abstract="true" name="GrosstoNetAdjustmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OtherRegionMember" abstract="true" name="OtherRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A3250BondsDue2022Member" abstract="true" name="A3250BondsDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MarketShareUnitsMember" abstract="true" name="MarketShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingArrangementsTable" abstract="true" name="LicensingArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Divestitureandotherproceeds" abstract="false" name="Divestitureandotherproceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LitigationTable" abstract="true" name="LitigationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ReceivablesSoldOnNonrecourseBasis" abstract="false" name="ReceivablesSoldOnNonrecourseBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AgenusMember" abstract="true" name="AgenusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BreyanziMember" abstract="true" name="BreyanziMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LegalProceedingsAndContingenciesLineItems" abstract="true" name="LegalProceedingsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OpdualagMember" abstract="true" name="OpdualagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentRegulatoryMilestoneIncome" abstract="false" name="ContingentRegulatoryMilestoneIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AntiPD1AntibodyLitigationMember" abstract="true" name="AntiPD1AntibodyLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ResearchAndDevelopmentNonCurrent" abstract="false" name="ResearchAndDevelopmentNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsAxis" abstract="true" name="LicensingAndOtherArrangementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" abstract="false" name="RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AlliancesAndCollaborationCompaniesDomain" abstract="true" name="AlliancesAndCollaborationCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NumberOfLargestPharmaceuticalWholesalers" abstract="false" name="NumberOfLargestPharmaceuticalWholesalers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_MedicaidandMedicarerebatesMember" abstract="true" name="MedicaidandMedicarerebatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bmy-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef5e017e-de04-41d3-a310-354f863f5ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e651f67c-bb4a-4edf-a89f-8d3e88257db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ef5e017e-de04-41d3-a310-354f863f5ddc" xlink:to="loc_us-gaap_ProfitLoss_e651f67c-bb4a-4edf-a89f-8d3e88257db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9061077b-c348-4752-95e0-5be2012c2cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ef5e017e-de04-41d3-a310-354f863f5ddc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9061077b-c348-4752-95e0-5be2012c2cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_013cb475-7145-4b6c-a047-730ec5ae0022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ed72faff-c8a6-46ec-a9f4-2c8af6866e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_013cb475-7145-4b6c-a047-730ec5ae0022" xlink:to="loc_us-gaap_Revenues_ed72faff-c8a6-46ec-a9f4-2c8af6866e10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b407feb8-8c5e-439b-ae57-2b409df97f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_013cb475-7145-4b6c-a047-730ec5ae0022" xlink:to="loc_us-gaap_CostsAndExpenses_b407feb8-8c5e-439b-ae57-2b409df97f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_359cc396-f6d0-424b-81c8-53ad5571469b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_359cc396-f6d0-424b-81c8-53ad5571469b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6b518f57-e682-4fb2-a60c-39b5a1c01230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6b518f57-e682-4fb2-a60c-39b5a1c01230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1706d6fc-f6c3-4fe8-89c1-c80db82ac942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1706d6fc-f6c3-4fe8-89c1-c80db82ac942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_a653e628-618d-40a6-a622-12230b6326e3" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_bmy_AcquiredIPRD_a653e628-618d-40a6-a622-12230b6326e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_45bc4e3d-4760-4d3a-90f8-c1d6f7da7d88" xlink:href="bmy-20220930.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_45bc4e3d-4760-4d3a-90f8-c1d6f7da7d88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7b056e1e-f6d0-4255-b4c1-fc0e6fafc548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df770cbb-fc30-44cc-8511-c8ed09d26999" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7b056e1e-f6d0-4255-b4c1-fc0e6fafc548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_471ea25e-5f11-466f-a40c-9598bc84a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d888608-85df-4b0d-92a6-16ea67640292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_471ea25e-5f11-466f-a40c-9598bc84a65f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d888608-85df-4b0d-92a6-16ea67640292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5418aeab-0734-4f14-8d99-1db10ad4bc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_471ea25e-5f11-466f-a40c-9598bc84a65f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5418aeab-0734-4f14-8d99-1db10ad4bc35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a9571aec-e2d2-40d3-9081-8b0f8a4a2f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c673433-3e4d-4ce5-94b8-eadb7aba51f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a9571aec-e2d2-40d3-9081-8b0f8a4a2f55" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c673433-3e4d-4ce5-94b8-eadb7aba51f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_aee5f56c-2897-448c-818d-0816cd236ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a9571aec-e2d2-40d3-9081-8b0f8a4a2f55" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_aee5f56c-2897-448c-818d-0816cd236ed2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_02687620-a098-4dd5-b15d-3f1dfbbdced2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7f83462-0ca7-4fc6-81df-915867ee702f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_02687620-a098-4dd5-b15d-3f1dfbbdced2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7f83462-0ca7-4fc6-81df-915867ee702f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45b8d8a3-dba0-4388-8bd7-c406f1f3e4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_02687620-a098-4dd5-b15d-3f1dfbbdced2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45b8d8a3-dba0-4388-8bd7-c406f1f3e4d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_751fdbe0-221b-4ddd-9b8a-c55dc9ad12fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_02687620-a098-4dd5-b15d-3f1dfbbdced2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_751fdbe0-221b-4ddd-9b8a-c55dc9ad12fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0c12ae33-758d-470b-b59c-803f2ebcfae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_02687620-a098-4dd5-b15d-3f1dfbbdced2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0c12ae33-758d-470b-b59c-803f2ebcfae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bba9312f-3ab0-4c19-8150-f7c2a9309d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9889e35d-8eec-427c-bb46-f96ca0cfcd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bba9312f-3ab0-4c19-8150-f7c2a9309d7a" xlink:to="loc_us-gaap_ProfitLoss_9889e35d-8eec-427c-bb46-f96ca0cfcd26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7979199a-e2ee-46af-aba9-60af152b689c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bba9312f-3ab0-4c19-8150-f7c2a9309d7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7979199a-e2ee-46af-aba9-60af152b689c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b87e9324-db13-4e3a-8e69-4192aba8ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_PreferredStockValue_b87e9324-db13-4e3a-8e69-4192aba8ff5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5d2b5e69-d704-454b-984d-c1bdb35fc85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_CommonStockValue_5d2b5e69-d704-454b-984d-c1bdb35fc85e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_872b31fb-e596-44ae-bb28-2ecb2f8f3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_872b31fb-e596-44ae-bb28-2ecb2f8f3dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b73fe2ba-5141-4451-884e-cd6ef1d6fbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b73fe2ba-5141-4451-884e-cd6ef1d6fbf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3839dc4d-d664-4340-8471-5daf7cc9c227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3839dc4d-d664-4340-8471-5daf7cc9c227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f4a263dc-70f7-4382-87f1-51d35afae9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a83cb6a1-c120-4b6d-b011-053e6da3b8d8" xlink:to="loc_us-gaap_TreasuryStockValue_f4a263dc-70f7-4382-87f1-51d35afae9f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_881c01be-cf77-4329-a2fd-f3ec850d76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f4f2c54a-734c-432a-a5e9-1ec48ad823a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_881c01be-cf77-4329-a2fd-f3ec850d76d0" xlink:to="loc_us-gaap_Liabilities_f4f2c54a-734c-432a-a5e9-1ec48ad823a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5f30a11-0a79-493b-9bc5-b0d75c1f06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_881c01be-cf77-4329-a2fd-f3ec850d76d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5f30a11-0a79-493b-9bc5-b0d75c1f06c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_47566361-1842-459e-b02a-b0a8152259dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_881c01be-cf77-4329-a2fd-f3ec850d76d0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_47566361-1842-459e-b02a-b0a8152259dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f6a2faa7-dc9b-440c-b244-a642b26abc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1559410d-c160-406b-aa1d-1831645ecdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f6a2faa7-dc9b-440c-b244-a642b26abc98" xlink:to="loc_us-gaap_LiabilitiesCurrent_1559410d-c160-406b-aa1d-1831645ecdb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_28cfd3da-6eeb-4ba2-a3f1-3074fb7eacb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f6a2faa7-dc9b-440c-b244-a642b26abc98" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_28cfd3da-6eeb-4ba2-a3f1-3074fb7eacb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a1161818-a90b-4902-9d4a-8f6acbec5411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f6a2faa7-dc9b-440c-b244-a642b26abc98" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a1161818-a90b-4902-9d4a-8f6acbec5411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_58989460-34ad-4420-82d1-b8ab0178eabe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f6a2faa7-dc9b-440c-b244-a642b26abc98" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_58989460-34ad-4420-82d1-b8ab0178eabe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_da67ffae-38e1-4dcd-b9a7-9e4f25c939be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_da67ffae-38e1-4dcd-b9a7-9e4f25c939be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c0435de8-8fd2-4d68-a83b-e8eee7d9a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c0435de8-8fd2-4d68-a83b-e8eee7d9a0ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f080a483-b2ca-4f04-9173-74c8233c9a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f080a483-b2ca-4f04-9173-74c8233c9a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26012c9a-6001-4a3e-83ff-11733ea70b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:to="loc_us-gaap_InventoryNet_26012c9a-6001-4a3e-83ff-11733ea70b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a98e59a2-2a83-43f4-b1d6-2ef87da75286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eb5b4049-28e9-4f52-8b63-095b6bf94230" xlink:to="loc_us-gaap_OtherAssetsCurrent_a98e59a2-2a83-43f4-b1d6-2ef87da75286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fb2409c8-786f-4126-99e0-6266abfb97fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_c23ecf31-00c4-4daa-8ba0-a3ae03ca3c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb2409c8-786f-4126-99e0-6266abfb97fd" xlink:to="loc_us-gaap_DebtCurrent_c23ecf31-00c4-4daa-8ba0-a3ae03ca3c9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_9494b3fc-5278-4ae8-91e9-322c902e1fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb2409c8-786f-4126-99e0-6266abfb97fd" xlink:to="loc_us-gaap_AccountsPayableCurrent_9494b3fc-5278-4ae8-91e9-322c902e1fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a3338131-c126-4dcc-b6da-30a7ed5e98de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb2409c8-786f-4126-99e0-6266abfb97fd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a3338131-c126-4dcc-b6da-30a7ed5e98de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42c1a811-1985-4f4e-9be7-aa1b75c9faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4d705fc9-d82b-4e7d-b54d-e2878c0a24aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42c1a811-1985-4f4e-9be7-aa1b75c9faf9" xlink:to="loc_us-gaap_StockholdersEquity_4d705fc9-d82b-4e7d-b54d-e2878c0a24aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1bc1230c-02e8-47e8-ace8-385d694155ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42c1a811-1985-4f4e-9be7-aa1b75c9faf9" xlink:to="loc_us-gaap_MinorityInterest_1bc1230c-02e8-47e8-ace8-385d694155ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bbb4646f-cbc0-4f83-b231-6590eac277d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_AssetsCurrent_bbb4646f-cbc0-4f83-b231-6590eac277d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8ee12756-a989-46cc-9b36-819978905c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8ee12756-a989-46cc-9b36-819978905c08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2595a24c-80d7-42bf-90dd-c7fbdb3b605e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_Goodwill_2595a24c-80d7-42bf-90dd-c7fbdb3b605e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0ad5faff-d2f3-4753-bbed-b293f7884655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0ad5faff-d2f3-4753-bbed-b293f7884655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_26dbe45e-960d-4e8f-9202-b57e7ec47de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_26dbe45e-960d-4e8f-9202-b57e7ec47de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_27a3d02c-a373-49ec-a479-f61c015724cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ecc486bb-a987-4d01-bc67-5aafd4722694" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_27a3d02c-a373-49ec-a479-f61c015724cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f2b8a4e0-3baa-45a1-890e-a7894352a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_ProfitLoss_f2b8a4e0-3baa-45a1-890e-a7894352a3c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_260c58ea-4176-4d3a-a809-5def7c94f4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_260c58ea-4176-4d3a-a809-5def7c94f4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c5c0fc83-69dc-43af-a751-25e756749aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c5c0fc83-69dc-43af-a751-25e756749aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d3d4802f-1902-41b3-9a9a-08cbd9ab5d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_ShareBasedCompensation_d3d4802f-1902-41b3-9a9a-08cbd9ab5d80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6afd30c1-e798-4424-88f0-1f429cce3997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6afd30c1-e798-4424-88f0-1f429cce3997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_b7cdd8f9-d030-4791-b19d-991493048862" xlink:href="bmy-20220930.xsd#bmy_Divestituregainsandroyalties"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_bmy_Divestituregainsandroyalties_b7cdd8f9-d030-4791-b19d-991493048862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_efe04755-03bc-43a3-bb2e-eb51e6fd833c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_GainLossOnInvestments_efe04755-03bc-43a3-bb2e-eb51e6fd833c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4eafbeb6-f894-4850-940e-e70d1576bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4eafbeb6-f894-4850-940e-e70d1576bdb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dee25744-d89d-40aa-a4ba-a375ee9d602b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dee25744-d89d-40aa-a4ba-a375ee9d602b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_602b7020-f2a4-48c4-878e-7a703ef2dd77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_602b7020-f2a4-48c4-878e-7a703ef2dd77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_30ca3f7b-e97b-4fbf-a46e-a4bb20224887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_30ca3f7b-e97b-4fbf-a46e-a4bb20224887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ba68f107-862d-43be-86e6-5983fbb48f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ba68f107-862d-43be-86e6-5983fbb48f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dd5a8c22-39a5-4233-bd06-adba5e7f7116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dd5a8c22-39a5-4233-bd06-adba5e7f7116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c21cdfac-efc8-459c-8c37-dcba840c4527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c21cdfac-efc8-459c-8c37-dcba840c4527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_23ec97cb-4795-4572-80a3-1fb3fca58f84" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_bmy_AcquiredIPRD_23ec97cb-4795-4572-80a3-1fb3fca58f84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_26ba5868-d543-4482-a858-bb95f9c0b10c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79ecc346-e0f9-45c8-ae2f-eb71e46230e6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_26ba5868-d543-4482-a858-bb95f9c0b10c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_6d94e939-14d0-4bab-805f-8c402ff7d87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_6d94e939-14d0-4bab-805f-8c402ff7d87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f7ac26cd-8522-4969-bd85-fbfca29a0069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f7ac26cd-8522-4969-bd85-fbfca29a0069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63ff76f4-8017-43af-8e1c-09c18a580191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63ff76f4-8017-43af-8e1c-09c18a580191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_532bd297-8e7d-447b-83d9-13c353a18014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_PaymentsOfDividends_532bd297-8e7d-447b-83d9-13c353a18014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_744094d8-d975-40ad-a5f3-a08956b1cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_744094d8-d975-40ad-a5f3-a08956b1cb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_fa8ffd5e-f8b6-4569-bb2e-776b4e9d4fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14ba9f19-7dbf-4531-9777-a2ff9670ab97" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_fa8ffd5e-f8b6-4569-bb2e-776b4e9d4fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f5407b0-d929-4cca-8cb4-af5606df2fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1ffe98eb-9cdb-4fc5-ad2c-e4af41070a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f5407b0-d929-4cca-8cb4-af5606df2fc1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1ffe98eb-9cdb-4fc5-ad2c-e4af41070a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8c1e88dd-79dc-4b99-bece-2e899a0c441e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f5407b0-d929-4cca-8cb4-af5606df2fc1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8c1e88dd-79dc-4b99-bece-2e899a0c441e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d2b0e089-9f49-45db-af68-87f3f4e00d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f5407b0-d929-4cca-8cb4-af5606df2fc1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d2b0e089-9f49-45db-af68-87f3f4e00d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3afed1df-0387-4e93-9319-a83016e9bdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f5407b0-d929-4cca-8cb4-af5606df2fc1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3afed1df-0387-4e93-9319-a83016e9bdc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_742d9454-42cf-44c5-a474-243a29361a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_742d9454-42cf-44c5-a474-243a29361a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_69049c38-31db-4c92-88ef-235367ea3442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_69049c38-31db-4c92-88ef-235367ea3442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98b18f8f-33c6-44d1-9f5a-5224abc02d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98b18f8f-33c6-44d1-9f5a-5224abc02d58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_107058f7-ebb4-4cda-b440-a226c4785b64" xlink:href="bmy-20220930.xsd#bmy_Divestitureandotherproceeds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_bmy_Divestitureandotherproceeds_107058f7-ebb4-4cda-b440-a226c4785b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f28945b1-0094-47e4-9fbb-b483b965ab94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f28945b1-0094-47e4-9fbb-b483b965ab94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_0b83a429-f7bf-48d2-adc2-0864027eb842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88946fd6-8a71-4cc9-a47d-bdb5854988f4" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_0b83a429-f7bf-48d2-adc2-0864027eb842" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_35fab896-e076-432b-b277-7fd7ff238b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_35fab896-e076-432b-b277-7fd7ff238b3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9abf99f7-99e5-4171-b146-c750047a7082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_9abf99f7-99e5-4171-b146-c750047a7082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b93198ef-b874-4920-9c57-70dc2cee6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b93198ef-b874-4920-9c57-70dc2cee6afe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9cd74b5d-cb42-4cd9-9517-771587f9f4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9cd74b5d-cb42-4cd9-9517-771587f9f4fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_30df5377-43b9-432d-8009-1d2b805c5e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_30df5377-43b9-432d-8009-1d2b805c5e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_54170968-d84a-4ed7-a7e1-4a0ba920bc42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_54170968-d84a-4ed7-a7e1-4a0ba920bc42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7789f7a7-5dce-4ba6-8021-10e1dfbe062b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8877835-4bd0-40f7-a0da-bb8a365df7db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7789f7a7-5dce-4ba6-8021-10e1dfbe062b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7f51470-01de-4444-a8d8-aeb9922b5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5df5d953-0ee9-410c-94a6-7610c7e45164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7f51470-01de-4444-a8d8-aeb9922b5f3a" xlink:to="loc_us-gaap_Goodwill_5df5d953-0ee9-410c-94a6-7610c7e45164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3dc1fa14-05b9-41e7-b40c-1e6078c9191d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7f51470-01de-4444-a8d8-aeb9922b5f3a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3dc1fa14-05b9-41e7-b40c-1e6078c9191d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_9e7e0560-fe1c-4c1d-8d80-bed4afe1209f" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_fc07bef0-cd17-4203-90a9-23c6e4562a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_9e7e0560-fe1c-4c1d-8d80-bed4afe1209f" xlink:to="loc_us-gaap_OtherNonoperatingIncome_fc07bef0-cd17-4203-90a9-23c6e4562a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_2ee4ab84-8acf-4606-96bb-8ee88a95fd85" xlink:href="bmy-20220930.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_9e7e0560-fe1c-4c1d-8d80-bed4afe1209f" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_2ee4ab84-8acf-4606-96bb-8ee88a95fd85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_fa7fe5e1-1c08-45e4-adc5-773ab7c85dd4" xlink:href="bmy-20220930.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_9e7e0560-fe1c-4c1d-8d80-bed4afe1209f" xlink:to="loc_bmy_AmortizationOfDeferredIncome_fa7fe5e1-1c08-45e4-adc5-773ab7c85dd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_f3ffc350-f58a-4fa4-9dd6-d39b696bfbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_9e7e0560-fe1c-4c1d-8d80-bed4afe1209f" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_f3ffc350-f58a-4fa4-9dd6-d39b696bfbe3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e0b6038d-2e56-41ac-b68e-1a1f3b466743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_InterestExpense_e0b6038d-2e56-41ac-b68e-1a1f3b466743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8c2601c4-153f-4c25-ac41-26909d91cc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8c2601c4-153f-4c25-ac41-26909d91cc23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_531d6945-7c6a-4525-8ad6-d558fdad98b2" xlink:href="bmy-20220930.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_531d6945-7c6a-4525-8ad6-d558fdad98b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_95862a63-803a-4b84-87a1-85f55a8f953a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_GainLossOnInvestments_95862a63-803a-4b84-87a1-85f55a8f953a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a25ac8e0-5b89-427e-93ca-3684492687a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a25ac8e0-5b89-427e-93ca-3684492687a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1eaf46e0-1775-4ede-b604-963e9f39e1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_RestructuringCharges_1eaf46e0-1775-4ede-b604-963e9f39e1cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_8f13e4bc-31ae-4bba-958a-e3e75ceffb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_8f13e4bc-31ae-4bba-958a-e3e75ceffb1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_cfad09e2-f192-4edc-b691-408b3b1deefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_cfad09e2-f192-4edc-b691-408b3b1deefe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5d7d198-061c-49c5-b8b6-896e50029ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5d7d198-061c-49c5-b8b6-896e50029ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_ad9db6cd-746c-40df-8a6e-c5bac5f888d0" xlink:href="bmy-20220930.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e118108b-1afc-4fcf-95ac-7717a6e23155" xlink:to="loc_bmy_OtherOtherIncomeExpense_ad9db6cd-746c-40df-8a6e-c5bac5f888d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_83717cf7-0566-4338-bc89-553774ff4326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2890574a-a880-4114-8760-12fa061c3769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_83717cf7-0566-4338-bc89-553774ff4326" xlink:to="loc_us-gaap_SeveranceCosts1_2890574a-a880-4114-8760-12fa061c3769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_ac9d7339-fd36-4b0a-ad94-1d01ab757324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_83717cf7-0566-4338-bc89-553774ff4326" xlink:to="loc_us-gaap_OtherRestructuringCosts_ac9d7339-fd36-4b0a-ad94-1d01ab757324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_77d1dd56-b6e1-4fc6-b5fd-db772e906a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_77d1dd56-b6e1-4fc6-b5fd-db772e906a05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_3f85ce26-22b7-49f7-a4a5-55541ca9a500" xlink:href="bmy-20220930.xsd#bmy_OtherShutdownCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:to="loc_bmy_OtherShutdownCosts_3f85ce26-22b7-49f7-a4a5-55541ca9a500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9b75daee-5d21-41ef-a1b7-8890628bae1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9b75daee-5d21-41ef-a1b7-8890628bae1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_450721d0-3820-4347-931d-9995eadab2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:to="loc_us-gaap_RestructuringCharges_450721d0-3820-4347-931d-9995eadab2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_88111db7-c197-4146-b349-8be63fd3698b" xlink:href="bmy-20220930.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_15ea79f1-19c3-4a2b-bdf4-1093bb6a4455" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_88111db7-c197-4146-b349-8be63fd3698b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_46cc2ec0-778f-459d-9c11-bf3293ed1e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b7dcc6f-c66b-4bb5-a558-ff9b8e241852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_46cc2ec0-778f-459d-9c11-bf3293ed1e73" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b7dcc6f-c66b-4bb5-a558-ff9b8e241852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fd3c848b-6dd5-4121-99a3-83d6bb4f2199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_46cc2ec0-778f-459d-9c11-bf3293ed1e73" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fd3c848b-6dd5-4121-99a3-83d6bb4f2199" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_57ccc6d3-a4d5-402f-b005-4bd792b01d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa12b257-8841-4f72-b53f-74a6a9f38ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_57ccc6d3-a4d5-402f-b005-4bd792b01d4d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa12b257-8841-4f72-b53f-74a6a9f38ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_21fe2395-ca60-4234-99b0-d0e2764f5eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_57ccc6d3-a4d5-402f-b005-4bd792b01d4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_21fe2395-ca60-4234-99b0-d0e2764f5eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_93b433e7-dea7-42b0-950a-155f7a9c9257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_57ccc6d3-a4d5-402f-b005-4bd792b01d4d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_93b433e7-dea7-42b0-950a-155f7a9c9257" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_3df50958-ad1e-403e-85da-57ddc45e28b6" xlink:href="bmy-20220930.xsd#bmy_EquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6c506ecf-f263-4701-8d50-fa2d2a288c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_3df50958-ad1e-403e-85da-57ddc45e28b6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6c506ecf-f263-4701-8d50-fa2d2a288c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_aae98815-ced0-45ea-bc20-64461d6ebf20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_3df50958-ad1e-403e-85da-57ddc45e28b6" xlink:to="loc_us-gaap_EquityMethodInvestments_aae98815-ced0-45ea-bc20-64461d6ebf20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_89ca376a-d32b-45b0-b8ff-ae6980e9d502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_3df50958-ad1e-403e-85da-57ddc45e28b6" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_89ca376a-d32b-45b0-b8ff-ae6980e9d502" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_087eed46-be13-4cb1-b203-90f0fc4b0c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_50b46280-7028-4a43-97b8-ae419aa69eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_087eed46-be13-4cb1-b203-90f0fc4b0c70" xlink:to="loc_us-gaap_LongTermDebtCurrent_50b46280-7028-4a43-97b8-ae419aa69eaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_323f0add-79f5-4d01-bc46-cda6e35b22ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_087eed46-be13-4cb1-b203-90f0fc4b0c70" xlink:to="loc_us-gaap_OtherShortTermBorrowings_323f0add-79f5-4d01-bc46-cda6e35b22ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_85506f6d-16fe-415d-a286-c5c5716acea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_087eed46-be13-4cb1-b203-90f0fc4b0c70" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_85506f6d-16fe-415d-a286-c5c5716acea2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cfff73a9-1564-457d-99c0-870be00e7cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_31a52244-d97c-4c15-a590-dc76a7306c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cfff73a9-1564-457d-99c0-870be00e7cb0" xlink:to="loc_us-gaap_LongTermDebtCurrent_31a52244-d97c-4c15-a590-dc76a7306c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_79451ea6-d7fe-47d1-bc9c-f40e154a0d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cfff73a9-1564-457d-99c0-870be00e7cb0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_79451ea6-d7fe-47d1-bc9c-f40e154a0d6f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_95243624-f6f1-453f-8c0a-16bdae6fd69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_64ae8fb6-b690-4c1c-bc8c-0f9863fdeb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_95243624-f6f1-453f-8c0a-16bdae6fd69c" xlink:to="loc_us-gaap_OtherReceivables_64ae8fb6-b690-4c1c-bc8c-0f9863fdeb7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_253cda17-bfa0-4605-9dc5-d38523c24816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_95243624-f6f1-453f-8c0a-16bdae6fd69c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_253cda17-bfa0-4605-9dc5-d38523c24816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_534b21ac-5f7b-4b03-8262-25e78be74f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_a6f46e3d-c6cf-405f-b9af-b1448ea13aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_534b21ac-5f7b-4b03-8262-25e78be74f16" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_a6f46e3d-c6cf-405f-b9af-b1448ea13aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_8406f822-7c6f-4755-84f4-d60a7688e4b9" xlink:href="bmy-20220930.xsd#bmy_CashDiscounts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_534b21ac-5f7b-4b03-8262-25e78be74f16" xlink:to="loc_bmy_CashDiscounts_8406f822-7c6f-4755-84f4-d60a7688e4b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cc6f71cc-5de6-4318-81ec-8b40fe3821b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_534b21ac-5f7b-4b03-8262-25e78be74f16" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cc6f71cc-5de6-4318-81ec-8b40fe3821b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_96df6994-2bb9-4e76-9a69-a94eeaec03c6" xlink:href="bmy-20220930.xsd#bmy_Totalinventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_edadc1de-8473-4f45-905e-2509c369a521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_96df6994-2bb9-4e76-9a69-a94eeaec03c6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_edadc1de-8473-4f45-905e-2509c369a521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8054679c-d676-42a5-8931-cc4d7a8a6014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_96df6994-2bb9-4e76-9a69-a94eeaec03c6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8054679c-d676-42a5-8931-cc4d7a8a6014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a62ff810-2175-41c9-b646-f25c33b6892b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_96df6994-2bb9-4e76-9a69-a94eeaec03c6" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a62ff810-2175-41c9-b646-f25c33b6892b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6076fa36-7f65-4923-88f0-0013b188e863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2a48d748-a4f1-4f68-b0ae-af06ffbeca1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6076fa36-7f65-4923-88f0-0013b188e863" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2a48d748-a4f1-4f68-b0ae-af06ffbeca1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8fb91e07-220c-4692-891d-72b7925b2623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6076fa36-7f65-4923-88f0-0013b188e863" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8fb91e07-220c-4692-891d-72b7925b2623" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6a30be91-dca7-4576-b2f7-ed862b989b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d870641-692a-4f07-b59a-caba3fc255b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6a30be91-dca7-4576-b2f7-ed862b989b8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d870641-692a-4f07-b59a-caba3fc255b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f731752c-07c5-4d5c-a1f6-5e2d5fe32e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6a30be91-dca7-4576-b2f7-ed862b989b8b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f731752c-07c5-4d5c-a1f6-5e2d5fe32e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ccc9f9d9-c16a-43af-97b9-4e77649a2e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_62960604-0ec9-45c7-a3b0-903da4dfc007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ccc9f9d9-c16a-43af-97b9-4e77649a2e64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_62960604-0ec9-45c7-a3b0-903da4dfc007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_630dd5fa-b359-445b-93c8-47f80c28a618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ccc9f9d9-c16a-43af-97b9-4e77649a2e64" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_630dd5fa-b359-445b-93c8-47f80c28a618" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_cf1bf2c7-6e22-44e3-ba3a-04d4f7f3fa0f" xlink:href="bmy-20220930.xsd#bmy_ResearchandDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_bmy_ResearchandDevelopment_cf1bf2c7-6e22-44e3-ba3a-04d4f7f3fa0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_d04b3af1-3ea9-4d84-9dd0-69b260f67406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_d04b3af1-3ea9-4d84-9dd0-69b260f67406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent_1eae7749-23bb-4801-93de-734bff9009f4" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_bmy_EquityInvestmentsCurrent_1eae7749-23bb-4801-93de-734bff9009f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e2ea6824-8839-493e-b921-5897291da122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e2ea6824-8839-493e-b921-5897291da122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_fb46495c-9e99-438f-9d60-cafe545915ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_us-gaap_PrepaidTaxes_fb46495c-9e99-438f-9d60-cafe545915ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_8766d9c6-d4c4-4aba-9293-5cca646b6ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_66ee76e6-b07e-4e27-ab93-6f7b5b023e66" xlink:to="loc_us-gaap_RestrictedCash_8766d9c6-d4c4-4aba-9293-5cca646b6ace" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_86f50696-8c8a-4634-9518-5ede85968985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_86f50696-8c8a-4634-9518-5ede85968985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_4ac3b4c1-e535-4a75-9733-33e3489cd97c" xlink:href="bmy-20220930.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_4ac3b4c1-e535-4a75-9733-33e3489cd97c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_9e112fec-9d3f-4114-9093-8c58f4f59033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_us-gaap_InventoryNoncurrent_9e112fec-9d3f-4114-9093-8c58f4f59033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_5ebbed26-4897-442b-b82b-56b796a6fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_5ebbed26-4897-442b-b82b-56b796a6fa9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7da31f64-c760-4614-9ad5-0fff3e375c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7da31f64-c760-4614-9ad5-0fff3e375c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_d9fd5b1b-fce2-490f-8c92-65f2219ec93c" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_d9fd5b1b-fce2-490f-8c92-65f2219ec93c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_94c067f1-dbd3-466e-b334-6add8b5add17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_5bb41cae-100a-486e-9f8d-20cc0a02a90d" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_94c067f1-dbd3-466e-b334-6add8b5add17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1c8cde41-3b0d-47be-a224-7fe727ca58df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1c8cde41-3b0d-47be-a224-7fe727ca58df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_9bbef1ce-2993-4f25-87eb-bade987af359" xlink:href="bmy-20220930.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_bmy_AccruedResearchAndDevelopment_9bbef1ce-2993-4f25-87eb-bade987af359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_b296109c-b98a-4a22-b338-91e8eeeb4dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_DividendsPayableCurrent_b296109c-b98a-4a22-b338-91e8eeeb4dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_04e53518-1135-42ea-8d7e-9ca51f41d16e" xlink:href="bmy-20220930.xsd#bmy_AccruedInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_bmy_AccruedInterest_04e53518-1135-42ea-8d7e-9ca51f41d16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7b502968-5bb5-4c03-b545-0860cee11b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7b502968-5bb5-4c03-b545-0860cee11b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_9e9329fb-f564-4d5d-bd1d-581f2ee11253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_9e9329fb-f564-4d5d-bd1d-581f2ee11253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_a38da26f-8d6d-4e43-b008-2fcb7a602bdf" xlink:href="bmy-20220930.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_bmy_AccruedRebatesAndReturns_a38da26f-8d6d-4e43-b008-2fcb7a602bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_78138284-cd64-44ee-85cc-b21758380b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_78138284-cd64-44ee-85cc-b21758380b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0605878f-9d0d-4b33-b3d1-50bcf58f0f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1e398e3b-aaf7-4782-b029-7232e2f4732b" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0605878f-9d0d-4b33-b3d1-50bcf58f0f47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_9c544c90-7edc-4724-8cf0-33ae1df7ec52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_9c544c90-7edc-4724-8cf0-33ae1df7ec52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c644b738-6689-47dd-8be7-35744698f33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c644b738-6689-47dd-8be7-35744698f33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4387ae8d-747a-478c-bd1b-fa4fbc4f098c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4387ae8d-747a-478c-bd1b-fa4fbc4f098c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_ae9dab86-a820-4abf-81b2-62f8ff274782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_ae9dab86-a820-4abf-81b2-62f8ff274782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_940a5089-5daa-4c39-9dc1-8ad248b25b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_940a5089-5daa-4c39-9dc1-8ad248b25b56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c14da085-faef-4ce3-9c65-daf81e1497e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6ae8f62c-c991-429a-8c93-aa0f1240fba3" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c14da085-faef-4ce3-9c65-daf81e1497e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ca518d1b-5191-4d9f-93f8-c4c14f9e7be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cfa2f82e-e005-4b0a-bdad-8386b7a51b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ca518d1b-5191-4d9f-93f8-c4c14f9e7be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cfa2f82e-e005-4b0a-bdad-8386b7a51b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_5fd1ecc0-2033-48d8-8ebb-c0bf9dd12b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ca518d1b-5191-4d9f-93f8-c4c14f9e7be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_5fd1ecc0-2033-48d8-8ebb-c0bf9dd12b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f1a1a543-8d95-4611-88f1-d8ba6e9b6f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6980b83a-9143-4136-a83c-5da2c8ff6e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f1a1a543-8d95-4611-88f1-d8ba6e9b6f32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6980b83a-9143-4136-a83c-5da2c8ff6e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b9d92d19-bd54-44f6-bcab-17f4ad9fc7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f1a1a543-8d95-4611-88f1-d8ba6e9b6f32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b9d92d19-bd54-44f6-bcab-17f4ad9fc7f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_62f4cefc-7409-405e-95a7-1f92c01e9377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f1a1a543-8d95-4611-88f1-d8ba6e9b6f32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_62f4cefc-7409-405e-95a7-1f92c01e9377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3a2a05dc-f76d-4c84-9b80-2e989ad08e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f1a1a543-8d95-4611-88f1-d8ba6e9b6f32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3a2a05dc-f76d-4c84-9b80-2e989ad08e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e109c2f4-18fb-4988-b0e6-9d0a2e6dc0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_80eee819-d082-4a40-a136-aafbb4886eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e109c2f4-18fb-4988-b0e6-9d0a2e6dc0b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_80eee819-d082-4a40-a136-aafbb4886eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3e17d3d3-d27d-44cb-a3c9-35de3b665721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e109c2f4-18fb-4988-b0e6-9d0a2e6dc0b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3e17d3d3-d27d-44cb-a3c9-35de3b665721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_7bcedeb1-33ac-4fd3-879b-def717965e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e109c2f4-18fb-4988-b0e6-9d0a2e6dc0b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_7bcedeb1-33ac-4fd3-879b-def717965e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4c988d7b-c365-4713-a93d-48dfa783ac85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_904a216e-d191-45e5-809b-faec790edf86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4c988d7b-c365-4713-a93d-48dfa783ac85" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_904a216e-d191-45e5-809b-faec790edf86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_cdc843e0-4508-4fe3-80d7-a229ce764058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4c988d7b-c365-4713-a93d-48dfa783ac85" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_cdc843e0-4508-4fe3-80d7-a229ce764058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_7e23e22f-3eab-46bf-a2be-02b414894057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_4c988d7b-c365-4713-a93d-48dfa783ac85" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_7e23e22f-3eab-46bf-a2be-02b414894057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b74a938a-a397-43ff-8725-8ecb2458719c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1a627310-f75a-4526-8f17-d7e1c77a2970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_b74a938a-a397-43ff-8725-8ecb2458719c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1a627310-f75a-4526-8f17-d7e1c77a2970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_207b4879-cef8-46f2-a31e-6a3adaf7ef62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_b74a938a-a397-43ff-8725-8ecb2458719c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_207b4879-cef8-46f2-a31e-6a3adaf7ef62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_292fd1c3-463f-4663-8a30-803724cfced1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_b74a938a-a397-43ff-8725-8ecb2458719c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_292fd1c3-463f-4663-8a30-803724cfced1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_04de9109-5bfc-4760-b468-4f8a5f62b69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_b74a938a-a397-43ff-8725-8ecb2458719c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_04de9109-5bfc-4760-b468-4f8a5f62b69c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ccad85ed-f526-4f3e-b9b1-0c47400b03eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7b9654c1-5755-4f3b-8df8-ec2d777ad566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ccad85ed-f526-4f3e-b9b1-0c47400b03eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7b9654c1-5755-4f3b-8df8-ec2d777ad566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_72d16e59-3ca5-4b41-a890-48bf43f03946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ccad85ed-f526-4f3e-b9b1-0c47400b03eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_72d16e59-3ca5-4b41-a890-48bf43f03946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6925e0ea-4add-49c7-ab59-d25ece62c578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_82f6bcc4-b176-42a4-ab88-1b18b4c3cfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6925e0ea-4add-49c7-ab59-d25ece62c578" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_82f6bcc4-b176-42a4-ab88-1b18b4c3cfc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_d75bd8ed-3010-47a7-9e20-012e2368dcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6925e0ea-4add-49c7-ab59-d25ece62c578" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_d75bd8ed-3010-47a7-9e20-012e2368dcd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4b56c2f1-0988-405c-8bee-99fa5edf9a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ccf03c57-9be7-48aa-9fee-fc72c58d8bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4b56c2f1-0988-405c-8bee-99fa5edf9a4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ccf03c57-9be7-48aa-9fee-fc72c58d8bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fe9e6699-a62b-48bd-996a-196b745330cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4b56c2f1-0988-405c-8bee-99fa5edf9a4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fe9e6699-a62b-48bd-996a-196b745330cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_ca849bad-441f-491d-848a-0e5333ace33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4b56c2f1-0988-405c-8bee-99fa5edf9a4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_ca849bad-441f-491d-848a-0e5333ace33b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_238aadc3-d5d9-4d3d-a651-8d00a78c3df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4d791b61-7da9-43e9-8bb3-6b2c8658519a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_238aadc3-d5d9-4d3d-a651-8d00a78c3df2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4d791b61-7da9-43e9-8bb3-6b2c8658519a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6bc9fca8-b735-4d00-b531-2e3692cbf814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_238aadc3-d5d9-4d3d-a651-8d00a78c3df2" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6bc9fca8-b735-4d00-b531-2e3692cbf814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_afd9c833-bb27-43a1-87fd-3c8358f8eca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_238aadc3-d5d9-4d3d-a651-8d00a78c3df2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_afd9c833-bb27-43a1-87fd-3c8358f8eca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dda26380-8278-41ff-94aa-ed3b33ca9cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_238aadc3-d5d9-4d3d-a651-8d00a78c3df2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dda26380-8278-41ff-94aa-ed3b33ca9cac" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bmy-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bms.com/role/CoverPage" xlink:type="simple" xlink:href="bmy-20220930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CoverPage" xlink:type="extended" id="i3d4559f8a5e3418db7efa23fdcf0a35e_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b7debb4f-3bd8-47fe-af6c-4ea5b36efe73" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentType_b7debb4f-3bd8-47fe-af6c-4ea5b36efe73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d8bf0952-2936-4624-a9a6-eccd74b36ed7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentQuarterlyReport_d8bf0952-2936-4624-a9a6-eccd74b36ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1eb846c9-aba0-4f1c-a0cd-5accb0fdea87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentPeriodEndDate_1eb846c9-aba0-4f1c-a0cd-5accb0fdea87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a607a6bc-802a-487f-ad6d-92b92f1f0b3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentTransitionReport_a607a6bc-802a-487f-ad6d-92b92f1f0b3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4e20d535-4d53-4a12-9820-3de8d8ba8a35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityFileNumber_4e20d535-4d53-4a12-9820-3de8d8ba8a35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a91e8fdd-67e0-4abb-a803-e8434407d2b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityRegistrantName_a91e8fdd-67e0-4abb-a803-e8434407d2b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8a0e0ff3-32f7-4292-a752-abfaf475052c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8a0e0ff3-32f7-4292-a752-abfaf475052c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4d0f64a6-1a57-45f7-b0d5-294b41eca905" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityTaxIdentificationNumber_4d0f64a6-1a57-45f7-b0d5-294b41eca905" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3a595705-db4b-4689-bf3c-2aa92c016c48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressAddressLine1_3a595705-db4b-4689-bf3c-2aa92c016c48" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9c34dd54-6e59-4491-9091-6fdc675e22e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressCityOrTown_9c34dd54-6e59-4491-9091-6fdc675e22e8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e59b3e07-fd8e-435f-87c1-8d29013554b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressStateOrProvince_e59b3e07-fd8e-435f-87c1-8d29013554b6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_625dc2ea-d593-4e34-8e3b-30b109216b21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressPostalZipCode_625dc2ea-d593-4e34-8e3b-30b109216b21" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6c123a1b-c53d-464f-a699-8994e1aeb234" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_CityAreaCode_6c123a1b-c53d-464f-a699-8994e1aeb234" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8a6e3310-a8e0-4155-b813-e2f027a351bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_LocalPhoneNumber_8a6e3310-a8e0-4155-b813-e2f027a351bf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4446d0b5-f87c-4797-98b4-04529ae7e6e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_Security12bTitle_4446d0b5-f87c-4797-98b4-04529ae7e6e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_479fabb9-7d50-483a-bf47-7550271cf51e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_TradingSymbol_479fabb9-7d50-483a-bf47-7550271cf51e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_551ba8c5-69b6-4ece-aa28-cd475d9fecee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_SecurityExchangeName_551ba8c5-69b6-4ece-aa28-cd475d9fecee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c0815664-bd35-4959-a392-c2bbc879d48e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCurrentReportingStatus_c0815664-bd35-4959-a392-c2bbc879d48e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b9e21899-df80-438b-a9d7-7572469640fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityInteractiveDataCurrent_b9e21899-df80-438b-a9d7-7572469640fc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5363de0e-6e1c-44f0-b10a-05597c5fb365" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityFilerCategory_5363de0e-6e1c-44f0-b10a-05597c5fb365" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2bbb15dc-7d93-45c9-bf71-f8e95a7ff9e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityEmergingGrowthCompany_2bbb15dc-7d93-45c9-bf71-f8e95a7ff9e8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_00a0c5df-d8a8-4ba6-9168-ed8fe660d68d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityShellCompany_00a0c5df-d8a8-4ba6-9168-ed8fe660d68d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f10ab91b-3440-4f05-a3bf-67833eb87e6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f10ab91b-3440-4f05-a3bf-67833eb87e6b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_64247400-d909-43a2-8cdb-8ace65d8c053" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCentralIndexKey_64247400-d909-43a2-8cdb-8ace65d8c053" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4a43a7d4-4fbe-45d8-a31e-d540183f57c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentFiscalYearFocus_4a43a7d4-4fbe-45d8-a31e-d540183f57c5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_98abc191-4be5-470b-93b5-4eec08cb44d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentFiscalPeriodFocus_98abc191-4be5-470b-93b5-4eec08cb44d9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9ed2845b-db57-4f45-8e3e-a26bd248922c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_CurrentFiscalYearEndDate_9ed2845b-db57-4f45-8e3e-a26bd248922c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0c71db44-512e-4a7e-aefd-cce8490c91ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_AmendmentFlag_0c71db44-512e-4a7e-aefd-cce8490c91ef" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_daa07f51-d3c9-4eba-b5de-8d05adae12d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntitySmallBusiness_daa07f51-d3c9-4eba-b5de-8d05adae12d1" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:to="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_087d58eb-1bb5-4731-8d29-eb0af92c9233_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:to="loc_us-gaap_ClassOfStockDomain_087d58eb-1bb5-4731-8d29-eb0af92c9233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:to="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_d93bdb70-0d90-4e35-9529-09775dd666ff" xlink:href="bmy-20220930.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_CommonStock0.10ParValueMember_d93bdb70-0d90-4e35-9529-09775dd666ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_0035f1c0-e31a-4e52-abe4-3cb2f591f802" xlink:href="bmy-20220930.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_A1.000Notesdue2025Member_0035f1c0-e31a-4e52-abe4-3cb2f591f802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_2d0a5b87-369a-4b48-99cf-7bc42d403b42" xlink:href="bmy-20220930.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_A1.750Notesdue2035Member_2d0a5b87-369a-4b48-99cf-7bc42d403b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_891a4d0d-641f-4db8-91bf-b9e968644f02" xlink:href="bmy-20220930.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_891a4d0d-641f-4db8-91bf-b9e968644f02" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended" id="i4a3eda981ff442e58291c279c0e92e40_CONSOLIDATEDSTATEMENTSOFEARNINGS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d936d535-42cd-458c-b4d7-6feb27c499eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_Revenues_d936d535-42cd-458c-b4d7-6feb27c499eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_74b8efbe-977f-48ce-b5fa-65b26874aa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_74b8efbe-977f-48ce-b5fa-65b26874aa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94fb96b0-123c-4681-9a55-47944a99645c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94fb96b0-123c-4681-9a55-47944a99645c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3da32ab1-9764-455a-8cb7-f98da7d71bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3da32ab1-9764-455a-8cb7-f98da7d71bc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_9dae8a9e-eab9-4461-94f9-9e8754f32fab" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_bmy_AcquiredIPRD_9dae8a9e-eab9-4461-94f9-9e8754f32fab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_68c9e820-eaf7-429f-b2ed-d0fd90305c47" xlink:href="bmy-20220930.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_68c9e820-eaf7-429f-b2ed-d0fd90305c47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_821e282c-b390-40b5-89c4-ff08f21c9905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_821e282c-b390-40b5-89c4-ff08f21c9905" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_66f45362-014b-4e74-b924-6864f36cd599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_CostsAndExpenses_66f45362-014b-4e74-b924-6864f36cd599" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97ed4884-0c51-4e70-9b49-e4f1a440b1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97ed4884-0c51-4e70-9b49-e4f1a440b1cb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9dfb0966-5729-477e-8c97-c855653f17aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9dfb0966-5729-477e-8c97-c855653f17aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fbd83eb7-94d7-470b-872c-a4c066ce64ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ProfitLoss_fbd83eb7-94d7-470b-872c-a4c066ce64ec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_81148844-7c8d-4960-8127-4c3695406a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_81148844-7c8d-4960-8127-4c3695406a99" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30c895a2-7328-408c-b3ba-a4b5dd7c4b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_NetIncomeLoss_30c895a2-7328-408c-b3ba-a4b5dd7c4b62" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bb43d0dd-fcf3-4dd4-b785-364371c8c601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_EarningsPerShareBasic_bb43d0dd-fcf3-4dd4-b785-364371c8c601" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1d47ee83-2da3-4617-a0c4-0d2604891246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1d47ee83-2da3-4617-a0c4-0d2604891246" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_4f42282a-38f5-49c8-9588-7f5e953e6971_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_4f42282a-38f5-49c8-9588-7f5e953e6971_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_42903061-9aee-493e-a583-6fae7e030179" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:to="loc_bmy_NetproductsalesMember_42903061-9aee-493e-a583-6fae7e030179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_64827901-992f-41d7-9aeb-42e53fa28a57" xlink:href="bmy-20220930.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:to="loc_bmy_AllianceandotherrevenuesMember_64827901-992f-41d7-9aeb-42e53fa28a57" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGTables"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended" id="ifc22008641bf428e99f96a1873010093_RESTRUCTURINGTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8a6b9f2a-b5ce-4edd-91a7-c9371c541125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8a6b9f2a-b5ce-4edd-91a7-c9371c541125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_3639fda9-a7ae-4ca1-b58e-4055f141f445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_3639fda9-a7ae-4ca1-b58e-4055f141f445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:to="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d71eeb90-c36a-44fc-a81c-a382e7e56c82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:to="loc_us-gaap_RestructuringPlanDomain_d71eeb90-c36a-44fc-a81c-a382e7e56c82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:to="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_fdb41525-dd8c-4cf9-9d85-10f1855b03a1" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:to="loc_bmy_CelgeneIntegrationMember_fdb41525-dd8c-4cf9-9d85-10f1855b03a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended" id="i4359951673c24c19bd59c3f4d85aeac1_REVENUEDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0adf6147-3047-40e1-903d-8ea0272290be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:to="loc_us-gaap_Revenues_0adf6147-3047-40e1-903d-8ea0272290be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ae69866a-8fad-467b-bfe5-05307147770c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ae69866a-8fad-467b-bfe5-05307147770c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_8cd1a703-7dd9-41e6-8577-af03dff4bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:to="loc_us-gaap_CollaborativeArrangementMember_8cd1a703-7dd9-41e6-8577-af03dff4bfb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_afc5310b-d268-4e80-b53d-14ba3d4c5715" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_bmy_NetproductsalesMember_afc5310b-d268-4e80-b53d-14ba3d4c5715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_b96d1a39-4d29-420f-b836-1c60bef7f953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_us-gaap_CollaborativeArrangementMember_b96d1a39-4d29-420f-b836-1c60bef7f953" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_d8e87e3f-cea5-4112-a646-cef6460fb48f" xlink:href="bmy-20220930.xsd#bmy_OtherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_bmy_OtherrevenuesMember_d8e87e3f-cea5-4112-a646-cef6460fb48f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended" id="i63f5f4d1028e40ee998ab327262edea1_REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8834c2d3-6f10-4670-91a2-aaa0d8be173c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_us-gaap_Revenues_8834c2d3-6f10-4670-91a2-aaa0d8be173c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_f3b1d9b6-6119-455d-8c42-ae16b88a2ca6" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_bmy_GrosstoNetAdjustments_f3b1d9b6-6119-455d-8c42-ae16b88a2ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_9f257292-3005-4d6a-8c43-320ae0976ed2" xlink:href="bmy-20220930.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_9f257292-3005-4d6a-8c43-320ae0976ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_cbdffc61-e8fe-4e8c-995c-a1bb55457601_default" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_cbdffc61-e8fe-4e8c-995c-a1bb55457601_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_2893bcc0-c6c0-4354-a7f7-e75f82b26836" xlink:href="bmy-20220930.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_2893bcc0-c6c0-4354-a7f7-e75f82b26836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_a316f22d-8d84-4716-ae91-ce872819ca94" xlink:href="bmy-20220930.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_a316f22d-8d84-4716-ae91-ce872819ca94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_a9b61c8e-32bd-4e4f-ba6c-0fd31c4445b8" xlink:href="bmy-20220930.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_a9b61c8e-32bd-4e4f-ba6c-0fd31c4445b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_38670587-b396-40f7-b0bd-9ba4d0917961_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_38670587-b396-40f7-b0bd-9ba4d0917961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_e7773d18-3226-44e3-b586-af0e9c888441" xlink:href="bmy-20220930.xsd#bmy_SalesRevenueGrossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:to="loc_bmy_SalesRevenueGrossMember_e7773d18-3226-44e3-b586-af0e9c888441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_ec7e1f11-0718-4eb3-97e3-71ae42070c56" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:to="loc_bmy_NetproductsalesMember_ec7e1f11-0718-4eb3-97e3-71ae42070c56" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended" id="i724f11ee16ab4fd39e26b47315f2b4a5_REVENUEDisaggregationofRevenuebyProductandRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cffcce7d-9434-4ad0-a73c-0f3b01ff6918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:to="loc_us-gaap_Revenues_cffcce7d-9434-4ad0-a73c-0f3b01ff6918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2e7e2903-dbfc-4343-8f13-539582ad1fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2e7e2903-dbfc-4343-8f13-539582ad1fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:to="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f40ed185-f44a-4b55-ba71-e3c85868e7a0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:to="loc_srt_ProductsAndServicesDomain_f40ed185-f44a-4b55-ba71-e3c85868e7a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:to="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:href="bmy-20220930.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:to="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:href="bmy-20220930.xsd#bmy_InLineProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:to="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_ed3b725b-7cbd-47d8-bd42-f4aca3991208" xlink:href="bmy-20220930.xsd#bmy_EliquisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_EliquisMember_ed3b725b-7cbd-47d8-bd42-f4aca3991208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_c16e8ee3-b402-4a16-836a-20ee24fffb45" xlink:href="bmy-20220930.xsd#bmy_OpdivoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_OpdivoMember_c16e8ee3-b402-4a16-836a-20ee24fffb45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_626774e0-5a07-47fb-ac95-211407363f97" xlink:href="bmy-20220930.xsd#bmy_PomalystImnovidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_PomalystImnovidMember_626774e0-5a07-47fb-ac95-211407363f97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_174439ed-8726-48eb-99b7-cd38cca9dc04" xlink:href="bmy-20220930.xsd#bmy_OrenciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_OrenciaMember_174439ed-8726-48eb-99b7-cd38cca9dc04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_2fa77f7b-9011-4b6b-bd03-ed403126e2df" xlink:href="bmy-20220930.xsd#bmy_SprycelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_SprycelMember_2fa77f7b-9011-4b6b-bd03-ed403126e2df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_70a6d648-683c-4b72-bdc0-c8e510374381" xlink:href="bmy-20220930.xsd#bmy_YervoyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_YervoyMember_70a6d648-683c-4b72-bdc0-c8e510374381" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_98d5ea36-51cf-45c4-9a42-cd53f35f5415" xlink:href="bmy-20220930.xsd#bmy_EmplicitiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_EmplicitiMember_98d5ea36-51cf-45c4-9a42-cd53f35f5415" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_acd7b843-a227-47a9-9956-6713a8487af7" xlink:href="bmy-20220930.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_MatureAndOtherBrandsMember_acd7b843-a227-47a9-9956-6713a8487af7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:href="bmy-20220930.xsd#bmy_NewProductPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:to="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_6eab88e7-7e95-4538-8405-5b73705f622b" xlink:href="bmy-20220930.xsd#bmy_ReblozylMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_ReblozylMember_6eab88e7-7e95-4538-8405-5b73705f622b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_7a37a845-b4e5-4434-8564-7ee7c5aa9786" xlink:href="bmy-20220930.xsd#bmy_AbecmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_AbecmaMember_7a37a845-b4e5-4434-8564-7ee7c5aa9786" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_d201863d-b01b-4533-99df-611092f924c1" xlink:href="bmy-20220930.xsd#bmy_ZeposiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_ZeposiaMember_d201863d-b01b-4533-99df-611092f924c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_12add1c2-314a-4b70-8d1e-a4df0e483f89" xlink:href="bmy-20220930.xsd#bmy_BreyanziMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_BreyanziMember_12add1c2-314a-4b70-8d1e-a4df0e483f89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_591e3ffe-f4e2-449a-a504-031904486976" xlink:href="bmy-20220930.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_InrebicMember_591e3ffe-f4e2-449a-a504-031904486976" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_8d4f9afe-09ce-467f-89b9-60e8dd5bd94c" xlink:href="bmy-20220930.xsd#bmy_OnuregMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_OnuregMember_8d4f9afe-09ce-467f-89b9-60e8dd5bd94c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_e7185aab-ca31-4667-940e-c9d62951a322" xlink:href="bmy-20220930.xsd#bmy_OpdualagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_OpdualagMember_e7185aab-ca31-4667-940e-c9d62951a322" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember_070b530f-8de2-4c20-9ba4-e2f1723bcb0b" xlink:href="bmy-20220930.xsd#bmy_CamzyosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_CamzyosMember_070b530f-8de2-4c20-9ba4-e2f1723bcb0b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember_4c3ea542-0f1b-4bc0-a1eb-7e0566447f4c" xlink:href="bmy-20220930.xsd#bmy_SotyktuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_SotyktuMember_4c3ea542-0f1b-4bc0-a1eb-7e0566447f4c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:href="bmy-20220930.xsd#bmy_LOEProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:to="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_69bac865-ac11-4836-835c-3abc8edcfa9b" xlink:href="bmy-20220930.xsd#bmy_RevlimidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:to="loc_bmy_RevlimidMember_69bac865-ac11-4836-835c-3abc8edcfa9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_ec03ce82-ef24-439f-ae68-e48e9990bf13" xlink:href="bmy-20220930.xsd#bmy_AbraxaneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:to="loc_bmy_AbraxaneMember_ec03ce82-ef24-439f-ae68-e48e9990bf13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:to="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ec7778e2-523b-4132-a831-eec31cb19fec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:to="loc_srt_SegmentGeographicalDomain_ec7778e2-523b-4132-a831-eec31cb19fec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:to="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_88a8c4b1-8474-45bc-a206-f76a644351bb" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_country_US_88a8c4b1-8474-45bc-a206-f76a644351bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember_c976f6d3-b310-45b7-b6cf-8d384851b78a" xlink:href="bmy-20220930.xsd#bmy_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_bmy_InternationalMember_c976f6d3-b310-45b7-b6cf-8d384851b78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_59e0ba10-55a0-406c-ae68-6698a1d15186" xlink:href="bmy-20220930.xsd#bmy_OtherRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_bmy_OtherRegionMember_59e0ba10-55a0-406c-ae68-6698a1d15186" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ALLIANCESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended" id="i021e2580b519415ba46ae91e513b56e5_ALLIANCESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8c93c10e-bffb-42af-b256-80e5db8bef5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_Revenues_8c93c10e-bffb-42af-b256-80e5db8bef5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9001a7a2-3cc0-49dc-b2df-6b60772d709a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9001a7a2-3cc0-49dc-b2df-6b60772d709a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_3c41b314-854c-4d40-bed7-de12e9c7aba6" xlink:href="bmy-20220930.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_3c41b314-854c-4d40-bed7-de12e9c7aba6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3fb2e07c-60d0-42d4-a4db-f668d9a5af49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3fb2e07c-60d0-42d4-a4db-f668d9a5af49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_94fef0d5-3a61-4cc1-b3af-d2dbde3e00df" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_AcquiredIPRD_94fef0d5-3a61-4cc1-b3af-d2dbde3e00df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6a1899b9-6943-4cff-9404-ef03825c6b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6a1899b9-6943-4cff-9404-ef03825c6b2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_ac68001a-ca2e-4b7c-9724-f7d0a2c35e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_ReceivablesNetCurrent_ac68001a-ca2e-4b7c-9724-f7d0a2c35e9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_67ead872-71dc-4952-8f4a-233c37e89184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_AccountsPayableCurrent_67ead872-71dc-4952-8f4a-233c37e89184" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_e5c69085-bfaf-4b5e-a894-de9f816c3cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_DeferredIncome_e5c69085-bfaf-4b5e-a894-de9f816c3cc8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_5cee5495-f328-4926-a715-32a06d1dd008" xlink:href="bmy-20220930.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_5cee5495-f328-4926-a715-32a06d1dd008" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_2afb9d02-2d64-4763-b300-c4fe15add96f" xlink:href="bmy-20220930.xsd#bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_2afb9d02-2d64-4763-b300-c4fe15add96f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_20aa6622-74cb-49c5-a95f-c1b496d568d7" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:to="loc_bmy_NetproductsalesMember_20aa6622-74cb-49c5-a95f-c1b496d568d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d6d1a55f-aaa4-43c4-b818-015573480525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d6d1a55f-aaa4-43c4-b818-015573480525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43e86e67-2695-4bc3-8b9b-98483002b588_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43e86e67-2695-4bc3-8b9b-98483002b588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_3d8529b0-2f7e-4eab-9e77-bdacee5ac608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:to="loc_us-gaap_CollaborativeArrangementMember_3d8529b0-2f7e-4eab-9e77-bdacee5ac608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_b59f6566-5f99-4f4b-bfcc-a300023f8c3a_default" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_b59f6566-5f99-4f4b-bfcc-a300023f8c3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BridgeBioMember_7994a72a-add3-4bee-8d61-2c6fc1d31694" xlink:href="bmy-20220930.xsd#bmy_BridgeBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:to="loc_bmy_BridgeBioMember_7994a72a-add3-4bee-8d61-2c6fc1d31694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember_8bb3b69e-2f2c-4f33-b8e5-5a7a1d48e49f" xlink:href="bmy-20220930.xsd#bmy_EisaiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:to="loc_bmy_EisaiMember_8bb3b69e-2f2c-4f33-b8e5-5a7a1d48e49f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails" xlink:type="extended" id="ie30d3d13a8df4c95be20edfdc78c9b83_ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff49022f-9c4c-4f27-adde-457af7c8316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff49022f-9c4c-4f27-adde-457af7c8316b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_98b41302-025d-4f44-9af8-6557db498483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_98b41302-025d-4f44-9af8-6557db498483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ce03fec-44cd-4a80-b528-5b335464db22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ce03fec-44cd-4a80-b528-5b335464db22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_3de4f073-a39a-4a88-a150-66f7594cf75a" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:to="loc_bmy_TurningPointMember_3de4f073-a39a-4a88-a150-66f7594cf75a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails" xlink:type="extended" id="icfe8a021327949dea2583af91f119f30_ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b653939-7341-420f-a9e1-6cede6c14929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b653939-7341-420f-a9e1-6cede6c14929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_50f68671-d2ad-43ef-8a9b-7b03159f7e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_50f68671-d2ad-43ef-8a9b-7b03159f7e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ba347698-f03a-41b0-906f-31dcf6f3fb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ba347698-f03a-41b0-906f-31dcf6f3fb68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be4de4a2-78c8-43ef-b80d-7b05d6eec327_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be4de4a2-78c8-43ef-b80d-7b05d6eec327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_72c35329-3911-4183-b909-a049f8d92b32" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:to="loc_bmy_TurningPointMember_72c35329-3911-4183-b909-a049f8d92b32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b4f30031-ac60-4ba4-a868-0902709dc1cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:to="loc_us-gaap_ClassOfStockDomain_b4f30031-ac60-4ba4-a868-0902709dc1cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:to="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5e4c785c-4a2a-4bcf-9936-e87cc9229a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:to="loc_us-gaap_CommonStockMember_5e4c785c-4a2a-4bcf-9936-e87cc9229a97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c7264ab-2d62-45c4-9a64-2f831bd93739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c7264ab-2d62-45c4-9a64-2f831bd93739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e623cd2a-e1b4-42d8-a90e-24d16e5d4193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:to="loc_us-gaap_StockCompensationPlanMember_e623cd2a-e1b4-42d8-a90e-24d16e5d4193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6455353a-c395-4ac5-a1a4-e51a3fe27f1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6455353a-c395-4ac5-a1a4-e51a3fe27f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_baba2cba-1aeb-4f88-89f7-7cfab6d13b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_baba2cba-1aeb-4f88-89f7-7cfab6d13b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6fc8b0d6-f87a-45f5-a44b-5f219c46aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6fc8b0d6-f87a-45f5-a44b-5f219c46aa2f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="extended" id="ied9971eddb09447d8835e090019b0978_ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_90fe051c-2b19-4c80-ba18-bf5d1d943233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_90fe051c-2b19-4c80-ba18-bf5d1d943233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_303cdaeb-3583-4d9f-a4ee-bdc55628879c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_303cdaeb-3583-4d9f-a4ee-bdc55628879c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4edcac7e-d964-43d1-a712-2f7dbff4ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4edcac7e-d964-43d1-a712-2f7dbff4ae58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_605095b9-4949-4ed2-ae93-782a3ebc61c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_605095b9-4949-4ed2-ae93-782a3ebc61c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_18b81b59-eb43-4ae4-a988-c326a2997958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_18b81b59-eb43-4ae4-a988-c326a2997958" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5397039d-d16a-4bc4-bb72-4bc5b45a5fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5397039d-d16a-4bc4-bb72-4bc5b45a5fd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2977021c-0cb4-43f9-b04c-f3c6e218ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2977021c-0cb4-43f9-b04c-f3c6e218ed93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d53f3e6a-45ed-4ab1-9ba1-61e3a5dde551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d53f3e6a-45ed-4ab1-9ba1-61e3a5dde551" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_afd7db89-0e9a-49c2-a019-57be5957697b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_Goodwill_afd7db89-0e9a-49c2-a019-57be5957697b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c11e30d8-2db9-4d87-a47d-0e356481b68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c11e30d8-2db9-4d87-a47d-0e356481b68e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_6cde92a5-c6fc-4fa0-8770-04a042c11bd5" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_bmy_AcquiredIPRD_6cde92a5-c6fc-4fa0-8770-04a042c11bd5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_f43ce905-9abb-4fc5-91e3-2853299b37e8" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:to="loc_bmy_TurningPointMember_f43ce905-9abb-4fc5-91e3-2853299b37e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended" id="i336abf40ed28448ca9f3f487ae98d28c_DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_bf3a0a85-f0ac-4549-bbf8-988c5c3595ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_bf3a0a85-f0ac-4549-bbf8-988c5c3595ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_28ba8f1a-2097-4174-8cfb-8912f5124b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_28ba8f1a-2097-4174-8cfb-8912f5124b9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_5ce9837d-799f-4288-8b8a-03d87e1e484d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_5ce9837d-799f-4288-8b8a-03d87e1e484d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14aad3e6-15bb-4a2d-b752-bc263118bf7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_14aad3e6-15bb-4a2d-b752-bc263118bf7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_e1ebe7d9-8a13-4d8a-afa3-5967deed2f02" xlink:href="bmy-20220930.xsd#bmy_DiabetesbusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:to="loc_bmy_DiabetesbusinessMember_e1ebe7d9-8a13-4d8a-afa3-5967deed2f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_eca51c70-d9a5-4865-abaa-2aedefaca56a" xlink:href="bmy-20220930.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:to="loc_bmy_MatureBrandsAndOtherMember_eca51c70-d9a5-4865-abaa-2aedefaca56a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended" id="i9f126c08459541798974f54a41200deb_DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_bbe4f92e-2a6f-4d42-a682-12fb6d708216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_bbe4f92e-2a6f-4d42-a682-12fb6d708216" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_b36c4551-5581-48ff-93ad-8d38dc27e260" xlink:href="bmy-20220930.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_b36c4551-5581-48ff-93ad-8d38dc27e260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_00611383-3dc1-4a8c-89f6-962b6cec34a6" xlink:href="bmy-20220930.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_AmortizationOfDeferredIncome_00611383-3dc1-4a8c-89f6-962b6cec34a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_e4f2fb97-ffb1-48ba-b441-093b1b7badf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_us-gaap_OtherNonoperatingIncome_e4f2fb97-ffb1-48ba-b441-093b1b7badf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_563cce37-2f13-4862-83e8-2142ed87e145" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_563cce37-2f13-4862-83e8-2142ed87e145" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_95a2191c-2050-42dd-8144-95bc13e97efc_default" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_95a2191c-2050-42dd-8144-95bc13e97efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_35bbf673-104d-43da-914a-5c13e8fd3a7d" xlink:href="bmy-20220930.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_35bbf673-104d-43da-914a-5c13e8fd3a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_70956df9-07df-4f13-a40d-8574779038a7" xlink:href="bmy-20220930.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_TecentriqRoyaltiesMember_70956df9-07df-4f13-a40d-8574779038a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BiohavenMember_3cd3894f-eae5-4c38-87a3-23584e3bf70c" xlink:href="bmy-20220930.xsd#bmy_BiohavenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_BiohavenMember_3cd3894f-eae5-4c38-87a3-23584e3bf70c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_757e6775-088e-4023-a6c5-e39f8ff92305" xlink:href="bmy-20220930.xsd#bmy_OtherRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_OtherRoyaltiesMember_757e6775-088e-4023-a6c5-e39f8ff92305" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="ic7d4b7074d574ae6af0713e4fb948e40_DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_85570025-3ecc-41a7-b568-0e31ff24c319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_85570025-3ecc-41a7-b568-0e31ff24c319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_d041d301-de2b-4e23-9240-0c28b6f61f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_AssetImpairmentCharges_d041d301-de2b-4e23-9240-0c28b6f61f34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_30a85742-85ad-4cca-8478-bb89799120e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_30a85742-85ad-4cca-8478-bb89799120e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_db9ac77b-5832-4036-8829-7bd4db182801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_db9ac77b-5832-4036-8829-7bd4db182801" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_a9aec06e-1526-4dd6-a311-926633a9c748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_a9aec06e-1526-4dd6-a311-926633a9c748" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5662a8bf-68f4-439c-bb22-bd5ef40d1d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5662a8bf-68f4-439c-bb22-bd5ef40d1d7b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_01966013-9798-418b-955e-03b587455a1f" xlink:href="bmy-20220930.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_01966013-9798-418b-955e-03b587455a1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_eb670dfc-fd53-464c-9bfe-5b428cdac232" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_eb670dfc-fd53-464c-9bfe-5b428cdac232" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_d4fc2fe7-8a33-4063-b335-cba94cf0aae6" xlink:href="bmy-20220930.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_d4fc2fe7-8a33-4063-b335-cba94cf0aae6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08c296e4-f7dc-4c8d-b28d-a0d80e961203_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08c296e4-f7dc-4c8d-b28d-a0d80e961203_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_f4044f37-1f54-484b-818d-482adc9e0e51" xlink:href="bmy-20220930.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:to="loc_bmy_MatureBrandsAndOtherMember_f4044f37-1f54-484b-818d-482adc9e0e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c309d91e-ccce-487d-8a8e-c47f19a824ec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c309d91e-ccce-487d-8a8e-c47f19a824ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOTTECorporationMember_07433a61-6e80-4cd2-be59-88215e7f5054" xlink:href="bmy-20220930.xsd#bmy_LOTTECorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_LOTTECorporationMember_07433a61-6e80-4cd2-be59-88215e7f5054" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_459bc23a-850a-438f-a578-0124703ef833" xlink:href="bmy-20220930.xsd#bmy_CheplapharmMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_CheplapharmMember_459bc23a-850a-438f-a578-0124703ef833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_4b032423-efb7-45ba-852d-8d15f4c77e2e" xlink:href="bmy-20220930.xsd#bmy_ImmaticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_ImmaticsMember_4b032423-efb7-45ba-852d-8d15f4c77e2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_a54ba2dd-9098-4d50-988b-2b904d77d865" xlink:href="bmy-20220930.xsd#bmy_DragonflyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_DragonflyMember_a54ba2dd-9098-4d50-988b-2b904d77d865" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember_78cdef93-96a2-4b4a-9c72-680c109fc19f" xlink:href="bmy-20220930.xsd#bmy_AgenusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_AgenusMember_78cdef93-96a2-4b4a-9c72-680c109fc19f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b2ac49cf-6416-4025-ab12-8dba85a1e2d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b2ac49cf-6416-4025-ab12-8dba85a1e2d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_17a7dacc-4e91-455b-a1ac-cd9a30c2ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:to="loc_us-gaap_CostOfSalesMember_17a7dacc-4e91-455b-a1ac-cd9a30c2ba54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_76249df3-ebbb-48dd-b79f-50e9a17cc7d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_76249df3-ebbb-48dd-b79f-50e9a17cc7d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_e95b655e-d133-43b4-a630-e022ac78220f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_e95b655e-d133-43b4-a630-e022ac78220f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended" id="i5636c3dec61c452fbcaa77259ac8a2a7_RESTRUCTURINGAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_863fb29f-ac5d-46a1-85a2-6ae7a2532e71" xlink:href="bmy-20220930.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_863fb29f-ac5d-46a1-85a2-6ae7a2532e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage_32e85b29-ef37-44a0-97df-e79ec09a26f7" xlink:href="bmy-20220930.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_ExpectedSynergiesPercentage_32e85b29-ef37-44a0-97df-e79ec09a26f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_75aba32e-2535-4d9d-b295-f99203acb5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_75aba32e-2535-4d9d-b295-f99203acb5f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_971fed1d-1c80-43a8-b26b-7b44dfa559c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_971fed1d-1c80-43a8-b26b-7b44dfa559c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_e7c07669-12c0-4d44-a260-35a321076676" xlink:href="bmy-20220930.xsd#bmy_Cashoutlays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_Cashoutlays_e7c07669-12c0-4d44-a260-35a321076676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5064475a-128f-4560-8194-2d39412a04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5064475a-128f-4560-8194-2d39412a04a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_b8bee88e-87b9-45ca-8311-5525607a59e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_b8bee88e-87b9-45ca-8311-5525607a59e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:to="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_372348df-5355-4223-99f8-75125da6fbf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:to="loc_us-gaap_RestructuringPlanDomain_372348df-5355-4223-99f8-75125da6fbf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:to="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_0c26a367-3f9a-43a3-a934-78b89f436d94" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:to="loc_bmy_CelgeneIntegrationMember_0c26a367-3f9a-43a3-a934-78b89f436d94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_e45e2d70-5687-411b-9b75-8d8f9385701b" xlink:href="bmy-20220930.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_e45e2d70-5687-411b-9b75-8d8f9385701b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_df4a3186-ad44-4f66-b1af-8155264208ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_CostOfSalesMember_df4a3186-ad44-4f66-b1af-8155264208ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_faaff991-284a-4f01-a182-b26377060203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_faaff991-284a-4f01-a182-b26377060203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_440d157a-c166-494b-a905-d244886d67fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_440d157a-c166-494b-a905-d244886d67fa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended" id="i4995e5644e7d48bea9891a8bb8fcbea5_RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_a586859e-ae92-4aad-8ade-18b7cdbe539d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_a586859e-ae92-4aad-8ade-18b7cdbe539d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e5686056-a583-49dd-9285-b5392ae6c7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_SeveranceCosts1_e5686056-a583-49dd-9285-b5392ae6c7e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_3b6b2480-d50e-47d1-85d5-34184d688dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_OtherRestructuringCosts_3b6b2480-d50e-47d1-85d5-34184d688dd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b7619458-7aca-494f-bd22-7492cca633c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringCharges_b7619458-7aca-494f-bd22-7492cca633c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_257843d5-4e59-4045-80fe-8f4603e42df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_257843d5-4e59-4045-80fe-8f4603e42df6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_0fb6661f-37f7-4a78-9d2b-f9dd4a7dd835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_0fb6661f-37f7-4a78-9d2b-f9dd4a7dd835" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_a9182293-b524-43fc-817d-155f462c6d8c" xlink:href="bmy-20220930.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_a9182293-b524-43fc-817d-155f462c6d8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_c94ee74e-d558-4b9f-9f3a-226f8325ddc6" xlink:href="bmy-20220930.xsd#bmy_OtherShutdownCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_bmy_OtherShutdownCosts_c94ee74e-d558-4b9f-9f3a-226f8325ddc6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:to="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_55559193-b3cc-4b62-ade5-921ff06d7c1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:to="loc_us-gaap_RestructuringPlanDomain_55559193-b3cc-4b62-ade5-921ff06d7c1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:to="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_3d0ea46e-1d42-4ec9-96fa-3687414eff54" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:to="loc_bmy_CelgeneIntegrationMember_3d0ea46e-1d42-4ec9-96fa-3687414eff54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_cb3e187c-fb53-4ed5-89a5-617aa7594649" xlink:href="bmy-20220930.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_cb3e187c-fb53-4ed5-89a5-617aa7594649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc345ebb-107d-4082-aaa5-7dd4d6beb694_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc345ebb-107d-4082-aaa5-7dd4d6beb694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_19d6c211-3fe6-4822-a2bc-9f0ff93b9d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_CostOfSalesMember_19d6c211-3fe6-4822-a2bc-9f0ff93b9d80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_678fcd71-3b6d-4926-903a-84bdb56741fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_678fcd71-3b6d-4926-903a-84bdb56741fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6c317599-accb-4865-9ff5-137f72ee62e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6c317599-accb-4865-9ff5-137f72ee62e6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="i2216ffce39d24825a96473de38f0f013_RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b48e563e-6754-46f2-9608-a6b5d5df5851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_RestructuringReserve_b48e563e-6754-46f2-9608-a6b5d5df5851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_33d7b257-5b0e-47c1-8733-d6d436638484" xlink:href="bmy-20220930.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_33d7b257-5b0e-47c1-8733-d6d436638484" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_7e4b100e-a1f7-45f3-b7fd-10b8f572e164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_7e4b100e-a1f7-45f3-b7fd-10b8f572e164" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8192ab26-ba16-494d-997c-af22032b65c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_PaymentsForRestructuring_8192ab26-ba16-494d-997c-af22032b65c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_bd181e68-809c-4b21-a63d-77b0b52a0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_13b7d6a9-3a78-4c74-af18-79a85e70a655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_13b7d6a9-3a78-4c74-af18-79a85e70a655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_acb5c207-fe8f-4ea4-93d4-b2b2aa90396e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringCharges_acb5c207-fe8f-4ea4-93d4-b2b2aa90396e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:to="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_314c86e2-c95c-4eea-837e-2ca7fbc76420_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:to="loc_us-gaap_RestructuringPlanDomain_314c86e2-c95c-4eea-837e-2ca7fbc76420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:to="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_4c883afd-ba07-4cc8-adee-9b0c9dc75e5d" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:to="loc_bmy_CelgeneIntegrationMember_4c883afd-ba07-4cc8-adee-9b0c9dc75e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_24aea9ef-739a-4dbd-aeac-29a7a30d9c94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_24aea9ef-739a-4dbd-aeac-29a7a30d9c94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_a59c6262-41bb-4ec0-a4b1-41bdff7d592c" xlink:href="bmy-20220930.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_a59c6262-41bb-4ec0-a4b1-41bdff7d592c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended" id="i6b236e999d544fb9b91ed9537ba1d287_INCOMETAXESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d7b8008f-ee9d-4fe8-826e-afa0867d0d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d7b8008f-ee9d-4fe8-826e-afa0867d0d63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:to="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:to="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1f21c051-ecf0-47df-a9f7-3358a5d7e838_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:to="loc_srt_RangeMember_1f21c051-ecf0-47df-a9f7-3358a5d7e838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:to="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da825759-0f8a-4a73-8f4c-bd3def4cf592" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:to="loc_srt_MinimumMember_da825759-0f8a-4a73-8f4c-bd3def4cf592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_92152204-66d8-4cf4-8bef-c198ffc04bad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:to="loc_srt_MaximumMember_92152204-66d8-4cf4-8bef-c198ffc04bad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="i38ab6fc225d0462fb773d2684aec11d9_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_acedf9c5-9ae5-4484-86f2-beeb390c4a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_acedf9c5-9ae5-4484-86f2-beeb390c4a9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70b7a537-842b-43c2-a99c-13fc7f8e9010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70b7a537-842b-43c2-a99c-13fc7f8e9010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e285594b-c33a-4585-aba8-a7a4ca79207f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_DerivativeAssets_e285594b-c33a-4585-aba8-a7a4ca79207f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1da814d2-e9c7-4332-b7d4-7a7e5b0df393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1da814d2-e9c7-4332-b7d4-7a7e5b0df393" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7fd28875-4431-4c11-8eee-b6d6df809aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_DerivativeLiabilities_7fd28875-4431-4c11-8eee-b6d6df809aea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_814dad63-0127-459e-b346-3d35b5c412cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_814dad63-0127-459e-b346-3d35b5c412cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_561c363f-ef5c-4266-822c-e17a265afc8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_561c363f-ef5c-4266-822c-e17a265afc8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8a95182d-e87d-4410-b705-7ed15e64a495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8a95182d-e87d-4410-b705-7ed15e64a495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_77d086a1-0077-4d48-91a6-a7b7b654be15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_77d086a1-0077-4d48-91a6-a7b7b654be15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_491146f4-a6b3-456f-aebb-86bcf73be9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_491146f4-a6b3-456f-aebb-86bcf73be9fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_116c395e-1e60-466b-beaf-0e0287ee199d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_116c395e-1e60-466b-beaf-0e0287ee199d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_21ee644f-dd41-4b85-ba4e-f00e37928dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CertificatesOfDepositMember_21ee644f-dd41-4b85-ba4e-f00e37928dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_576c3af3-9ad0-48f0-b5f7-c4df71f3f506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CommercialPaperMember_576c3af3-9ad0-48f0-b5f7-c4df71f3f506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b8fef6f0-40e3-458a-a893-69ab9257db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b8fef6f0-40e3-458a-a893-69ab9257db4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_1374aa1a-d92c-45b7-beca-d90a15b5598a" xlink:href="bmy-20220930.xsd#bmy_ContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:to="loc_bmy_ContingentValueRightsMember_1374aa1a-d92c-45b7-beca-d90a15b5598a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_3ab60455-d74d-4d32-b0c4-81d788a2fdca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:to="loc_us-gaap_OtherAssetsMember_3ab60455-d74d-4d32-b0c4-81d788a2fdca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended" id="ifeae56cf459b4b8999e65669d14a8a09_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a2032545-1572-47f3-a1d8-d46682d5924d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a2032545-1572-47f3-a1d8-d46682d5924d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e56ca3a5-0353-4249-bad4-f1a22ed9d23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e56ca3a5-0353-4249-bad4-f1a22ed9d23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_06201a90-2b5f-42b8-94c4-b7c12419f187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_06201a90-2b5f-42b8-94c4-b7c12419f187" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_198d244d-87e0-44a1-921f-da37eddfb1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_198d244d-87e0-44a1-921f-da37eddfb1e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cc3ce61-5742-44d5-9be5-b83a85c163ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cc3ce61-5742-44d5-9be5-b83a85c163ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_46d7cf42-a4d8-4357-a3b6-240fdff1afcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CertificatesOfDepositMember_46d7cf42-a4d8-4357-a3b6-240fdff1afcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d25c7d2b-8635-41e4-8c5f-0652a417e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CommercialPaperMember_d25c7d2b-8635-41e4-8c5f-0652a417e2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a8b176ee-13c0-4722-a189-6b288f189570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a8b176ee-13c0-4722-a189-6b288f189570" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="i17c22ad0af1c429aa1dc339e6158278a_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_43efab40-3a76-4ff9-8d45-5219b6a3dc85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_43efab40-3a76-4ff9-8d45-5219b6a3dc85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1008e637-7ef9-4153-a74a-e9cc64e1ac66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1008e637-7ef9-4153-a74a-e9cc64e1ac66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_bbbca5e7-dc8f-4d51-8641-39a7946d4477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_bbbca5e7-dc8f-4d51-8641-39a7946d4477" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_378fc537-f88d-429f-8200-912c2af29aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_378fc537-f88d-429f-8200-912c2af29aca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d5855f9f-e2b9-4810-b587-9f623ddb3d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d5855f9f-e2b9-4810-b587-9f623ddb3d62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_60c07306-4dcd-4887-9aa0-4bb71f8da87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_60c07306-4dcd-4887-9aa0-4bb71f8da87b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b2a4373-416c-4056-99c8-930ab978ec42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b2a4373-416c-4056-99c8-930ab978ec42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37673b93-d010-4155-a62a-a48b8331d98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37673b93-d010-4155-a62a-a48b8331d98b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_6240085b-45ee-4391-977b-c02223a093fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_RepaymentsOfDebt_6240085b-45ee-4391-977b-c02223a093fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251e00a8-ef28-4c7f-b382-65b9251288ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251e00a8-ef28-4c7f-b382-65b9251288ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7b9a44b4-2896-431b-b7c3-775c88fd3317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7b9a44b4-2896-431b-b7c3-775c88fd3317" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e7bdf030-879e-4aa7-826c-49a42099a219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_InterestPaidNet_e7bdf030-879e-4aa7-826c-49a42099a219" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_69404a63-1e72-425c-abbc-7bd7f329dba1" xlink:href="bmy-20220930.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_69404a63-1e72-425c-abbc-7bd7f329dba1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b08b9e56-e408-40ec-b2cc-50b24f54b671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b08b9e56-e408-40ec-b2cc-50b24f54b671" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_8e5c0033-6157-485b-9422-878121ac2102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_LongTermDebtTerm_8e5c0033-6157-485b-9422-878121ac2102" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_004d674a-5385-489f-bf87-33261148227d" xlink:href="bmy-20220930.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_004d674a-5385-489f-bf87-33261148227d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_f618d980-587b-4508-a306-d66fda953c1f_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:to="loc_currency_AllCurrenciesDomain_f618d980-587b-4508-a306-d66fda953c1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:to="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_4e146aec-8c10-4ab1-a43f-6ee20a0994a2" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:to="loc_currency_EUR_4e146aec-8c10-4ab1-a43f-6ee20a0994a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_c66ff7e3-36d0-4fab-a93f-17a4bd6028ad" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:to="loc_currency_JPY_c66ff7e3-36d0-4fab-a93f-17a4bd6028ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_626dbd81-2a96-4395-b47d-0e49acc79a11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:to="loc_us-gaap_HedgingDesignationDomain_626dbd81-2a96-4395-b47d-0e49acc79a11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:to="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_16dc674c-016f-4a9f-8087-7f8d0f06b605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_16dc674c-016f-4a9f-8087-7f8d0f06b605" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:to="loc_us-gaap_VariableRateDomain_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:to="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c754b084-9b54-46c6-b2eb-12489931a888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c754b084-9b54-46c6-b2eb-12489931a888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b6cf7f6-f2db-4587-87a4-b27012d6d37d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b6cf7f6-f2db-4587-87a4-b27012d6d37d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.600Notesdue2022Member_eb117e08-f3b0-4ca7-9ba7-2487778ddd6a" xlink:href="bmy-20220930.xsd#bmy_A2.600Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2.600Notesdue2022Member_eb117e08-f3b0-4ca7-9ba7-2487778ddd6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FloatingRateNotesdue2022Member_5fcde9f2-bda8-40e4-8ebf-bc02fcfb1a1c" xlink:href="bmy-20220930.xsd#bmy_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_FloatingRateNotesdue2022Member_5fcde9f2-bda8-40e4-8ebf-bc02fcfb1a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_6941c4e4-f954-4c77-b825-1c0b78374b99" xlink:href="bmy-20220930.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_6941c4e4-f954-4c77-b825-1c0b78374b99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_e93ceb64-3dbe-4557-abaf-46eec1a03380" xlink:href="bmy-20220930.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_e93ceb64-3dbe-4557-abaf-46eec1a03380" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2000NotesDue2022Member_7d002269-950c-4df2-88e7-324ae132437e" xlink:href="bmy-20220930.xsd#bmy_A2000NotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2000NotesDue2022Member_7d002269-950c-4df2-88e7-324ae132437e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250BondsDue2022Member_f31d348f-2e64-4a78-8a64-3e6d90741230" xlink:href="bmy-20220930.xsd#bmy_A3250BondsDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A3250BondsDue2022Member_f31d348f-2e64-4a78-8a64-3e6d90741230" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3550BondsDue2022Member_ed4b8374-dc44-4561-b302-a160532c89b9" xlink:href="bmy-20220930.xsd#bmy_A3550BondsDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A3550BondsDue2022Member_ed4b8374-dc44-4561-b302-a160532c89b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5be6cb44-ca8e-4beb-8c2c-fad112e207a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:to="loc_us-gaap_CreditFacilityDomain_5be6cb44-ca8e-4beb-8c2c-fad112e207a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:to="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_09f1dcc5-b2bf-4d35-a1f9-9e4abb001d23" xlink:href="bmy-20220930.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_09f1dcc5-b2bf-4d35-a1f9-9e4abb001d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_639c4b1b-c41b-4516-bb8e-716d57f4615e" xlink:href="bmy-20220930.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_639c4b1b-c41b-4516-bb8e-716d57f4615e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_cd8ed1e7-85dc-4afe-be0b-b622f59463b7" xlink:href="bmy-20220930.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_cd8ed1e7-85dc-4afe-be0b-b622f59463b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_ef381441-7da9-418f-96d2-45b39356628c" xlink:href="bmy-20220930.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_ef381441-7da9-418f-96d2-45b39356628c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da211356-812f-46ef-a19d-9aafb5d6505f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da211356-812f-46ef-a19d-9aafb5d6505f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b333b752-c6e9-48ba-b77d-de228aeff7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b333b752-c6e9-48ba-b77d-de228aeff7b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ceaf8a5f-6315-4dcc-9a75-cc3969df90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ceaf8a5f-6315-4dcc-9a75-cc3969df90ce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended" id="ia6784f1f6a604c478dadb28b0bb6ffe4_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_73e17a20-13ec-4739-9eda-653bb8eabbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeNotionalAmount_73e17a20-13ec-4739-9eda-653bb8eabbbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_31ab31ca-ea07-4b1d-b6b5-c589faedfd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeAssets_31ab31ca-ea07-4b1d-b6b5-c589faedfd0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f18ca417-2986-4fcd-a4f7-e18b13dc9f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeLiabilities_f18ca417-2986-4fcd-a4f7-e18b13dc9f39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_03e06f4a-eb74-45c0-9515-f9416584ee3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:to="loc_us-gaap_HedgingDesignationDomain_03e06f4a-eb74-45c0-9515-f9416584ee3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:to="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4a9ffb86-1a14-42db-bd1f-f42230100ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4a9ffb86-1a14-42db-bd1f-f42230100ccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_24bce09e-fde0-4ca1-a373-2113aa516a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:to="loc_us-gaap_NondesignatedMember_24bce09e-fde0-4ca1-a373-2113aa516a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55375e90-dc31-47bd-85d2-beda8dc61a8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55375e90-dc31-47bd-85d2-beda8dc61a8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_863fb49d-8ac8-4b6a-bb0e-688c6fd09c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_InterestRateSwapMember_863fb49d-8ac8-4b6a-bb0e-688c6fd09c9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_bb297de1-17b2-4c9f-b5b3-215628b182ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_bb297de1-17b2-4c9f-b5b3-215628b182ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d9ea14b0-0b04-4921-be37-432a6670623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d9ea14b0-0b04-4921-be37-432a6670623e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_7f8b2d20-0bc0-4ff8-86cb-4befa131766f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_OtherContractMember_7f8b2d20-0bc0-4ff8-86cb-4befa131766f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_dc4c7e5f-ac08-4dcf-b765-2a394069bd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:to="loc_us-gaap_AssetsMember_dc4c7e5f-ac08-4dcf-b765-2a394069bd5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_a218b12b-1c33-4de8-86d0-c074705d0ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:to="loc_us-gaap_LiabilityMember_a218b12b-1c33-4de8-86d0-c074705d0ce5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="ia27a050ccc9944e894bb410eb13e0489_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b56a9ff5-8da1-47d8-bb3d-36f101381aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b56a9ff5-8da1-47d8-bb3d-36f101381aad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f02d86fe-94a6-42d0-a3fd-150e8a6c5bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_InterestRateSwapMember_f02d86fe-94a6-42d0-a3fd-150e8a6c5bee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ab8c95d7-6f30-4371-a122-62169d8a33c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ab8c95d7-6f30-4371-a122-62169d8a33c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b837731b-4d45-4b55-9790-129da5574777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b837731b-4d45-4b55-9790-129da5574777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1919e7d7-ab21-4957-92fd-e88f92da329c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1919e7d7-ab21-4957-92fd-e88f92da329c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9c68fa8d-e166-4fd5-b147-f989873127a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:to="loc_us-gaap_CostOfSalesMember_9c68fa8d-e166-4fd5-b147-f989873127a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_87c11f0e-31c9-4ca6-a7c8-5314556e6480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:to="loc_us-gaap_OtherIncomeMember_87c11f0e-31c9-4ca6-a7c8-5314556e6480" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended" id="if0fbd474701a41c3824b47451425e296_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6ba844d3-a252-4f42-ab39-404022c0bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6ba844d3-a252-4f42-ab39-404022c0bdae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_94b7f4b2-62f3-4f5f-893a-f3d1195f1e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_94b7f4b2-62f3-4f5f-893a-f3d1195f1e59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_39d6079b-64b3-4f55-9100-008cefc4b80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_39d6079b-64b3-4f55-9100-008cefc4b80b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_fc18a3b5-431f-490b-9980-10c77fb72d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_fc18a3b5-431f-490b-9980-10c77fb72d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_67befe9b-34c9-469d-80fe-307fdef61d6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_67befe9b-34c9-469d-80fe-307fdef61d6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3e69b7b2-d16e-4e10-afc8-f8f19d69289f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3e69b7b2-d16e-4e10-afc8-f8f19d69289f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_818b5b3e-0548-453d-a5cc-21a4669d406c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_InterestRateSwapMember_818b5b3e-0548-453d-a5cc-21a4669d406c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_683bd32f-3e90-4a61-816f-f59b73138064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_683bd32f-3e90-4a61-816f-f59b73138064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_178ac7d7-9504-4f19-8d3e-d6f64aaababf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_178ac7d7-9504-4f19-8d3e-d6f64aaababf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bea4aaa9-f89f-467f-bd6b-8fcdaf5859bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_CostOfSalesMember_bea4aaa9-f89f-467f-bd6b-8fcdaf5859bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_5a505bd6-794e-41d3-8280-2547dc726bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_5a505bd6-794e-41d3-8280-2547dc726bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_4bb52610-b21f-4930-b173-33d6f5e1ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_OtherIncomeMember_4bb52610-b21f-4930-b173-33d6f5e1ccc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_12b95b8e-8102-408e-b39a-57c930fddffc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:to="loc_us-gaap_HedgingDesignationDomain_12b95b8e-8102-408e-b39a-57c930fddffc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:to="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc97219d-e069-4ebd-9f36-5a14cdcee750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc97219d-e069-4ebd-9f36-5a14cdcee750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_7c1726cd-6725-4298-b840-9a6f81e518e4_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:to="loc_currency_AllCurrenciesDomain_7c1726cd-6725-4298-b840-9a6f81e518e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:to="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_91098b33-e4f8-435d-bff7-ec526fcc0321" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:to="loc_currency_EUR_91098b33-e4f8-435d-bff7-ec526fcc0321" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended" id="ic2a97ede9aec49f9abf17f27aee0b7f8_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d848e9c-dee2-4924-a40a-74cc15fb12fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d848e9c-dee2-4924-a40a-74cc15fb12fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e256d73e-5a68-4f7e-99dc-238ac339e299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DerivativeLiabilities_e256d73e-5a68-4f7e-99dc-238ac339e299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_693688cc-a6b9-429b-88c9-f9671bccee60" xlink:href="bmy-20220930.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_693688cc-a6b9-429b-88c9-f9671bccee60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_df6f5aa0-136e-46e0-86a4-cf0a25870fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_df6f5aa0-136e-46e0-86a4-cf0a25870fce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_13fef5d5-83f2-480a-838f-bd2f1630ef46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_13fef5d5-83f2-480a-838f-bd2f1630ef46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5762de1c-ec6b-4933-a699-5da01bb6a9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebt_5762de1c-ec6b-4933-a699-5da01bb6a9da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_92604bb7-7d74-4048-9974-dc941c67fb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebtCurrent_92604bb7-7d74-4048-9974-dc941c67fb1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_73ff0f9a-4cd9-4bb9-96a7-9bfa8389a62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_73ff0f9a-4cd9-4bb9-96a7-9bfa8389a62b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f268db7-4076-48f1-92e6-ed1d7b1364e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f268db7-4076-48f1-92e6-ed1d7b1364e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_15282ba9-726e-4aa1-809d-03a61a0a6b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:to="loc_us-gaap_InterestRateSwapMember_15282ba9-726e-4aa1-809d-03a61a0a6b7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails" xlink:type="extended" id="ifac8d93646dc449b9c570cb423ec665a_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_70e8469d-22de-4354-8cf3-5caba888c683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_70e8469d-22de-4354-8cf3-5caba888c683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_94ffbc76-e9af-4884-9bd2-6fc2baa892ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_94ffbc76-e9af-4884-9bd2-6fc2baa892ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e18db6de-82ee-4829-ba81-e1e863ffce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e18db6de-82ee-4829-ba81-e1e863ffce8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a37f65b-94e4-4031-9943-efcb76b57430_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a37f65b-94e4-4031-9943-efcb76b57430_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2032Member_aa38f43f-bd48-4e75-b62e-1cc13bf6b2a5" xlink:href="bmy-20220930.xsd#bmy_NoteDue2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2032Member_aa38f43f-bd48-4e75-b62e-1cc13bf6b2a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2042Member_28ad2427-fe55-4808-82ef-46be9bc3b762" xlink:href="bmy-20220930.xsd#bmy_NoteDue2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2042Member_28ad2427-fe55-4808-82ef-46be9bc3b762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2052Member_6e4f6db4-ef0b-4d0c-af54-59158759825e" xlink:href="bmy-20220930.xsd#bmy_NoteDue2052Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2052Member_6e4f6db4-ef0b-4d0c-af54-59158759825e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2062Member_aeab961f-c13c-4c29-8898-7d9e6efaf710" xlink:href="bmy-20220930.xsd#bmy_NoteDue2062Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2062Member_aeab961f-c13c-4c29-8898-7d9e6efaf710" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_4ecbf247-3ec7-4e3d-9c29-28b719ab5e66" xlink:href="bmy-20220930.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_4ecbf247-3ec7-4e3d-9c29-28b719ab5e66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_093c9353-ade4-4e49-b0df-ab9e1f26fd6a" xlink:href="bmy-20220930.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_093c9353-ade4-4e49-b0df-ab9e1f26fd6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2250SeniorNotesDue2021Member_ad510812-ce9e-4786-a888-2e14faa781b5" xlink:href="bmy-20220930.xsd#bmy_A2250SeniorNotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2250SeniorNotesDue2021Member_ad510812-ce9e-4786-a888-2e14faa781b5" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended" id="ie58ddef88e8a47e9ad1ac76f733e3d29_RECEIVABLESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_5df11382-1589-48d2-9d42-8b72201b0844" xlink:href="bmy-20220930.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_5df11382-1589-48d2-9d42-8b72201b0844" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_266b4feb-2afd-4655-a169-ea934f4c3443" xlink:href="bmy-20220930.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_266b4feb-2afd-4655-a169-ea934f4c3443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_72c0b382-dbac-4187-b5c6-687dca547d98" xlink:href="bmy-20220930.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_72c0b382-dbac-4187-b5c6-687dca547d98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e89cef00-c341-488c-b05e-dbba10262ce5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e89cef00-c341-488c-b05e-dbba10262ce5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8d509a43-b386-4c76-ac4b-db192d8b0be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8d509a43-b386-4c76-ac4b-db192d8b0be2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INVENTORIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended" id="ia787c01eefc442ea81b2a35dd5af3ca7_INVENTORIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bde15c46-7c06-45b0-94ab-3b91cd871a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bde15c46-7c06-45b0-94ab-3b91cd871a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_33642e68-b74e-4212-89bf-74d7302ebd28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_33642e68-b74e-4212-89bf-74d7302ebd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_38d3cc3b-c48d-4790-8d8a-0b7c9b578647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_38d3cc3b-c48d-4790-8d8a-0b7c9b578647" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_1e11f8e9-58d8-43ab-bf43-18eb6e76fcde" xlink:href="bmy-20220930.xsd#bmy_Totalinventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_bmy_Totalinventories_1e11f8e9-58d8-43ab-bf43-18eb6e76fcde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_75ed4737-db01-4860-a427-5feccb6945da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryNet_75ed4737-db01-4860-a427-5feccb6945da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_3b399eb1-5a5b-46a8-b904-a9ebe0456fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryNoncurrent_3b399eb1-5a5b-46a8-b904-a9ebe0456fba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3a46dbca-0f85-4916-b9de-5933d405e4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3a46dbca-0f85-4916-b9de-5933d405e4e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dc80f3d9-9684-454f-9488-d48517db610c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dc80f3d9-9684-454f-9488-d48517db610c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a41b78e8-0c75-4474-b27c-3e3e39440ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a41b78e8-0c75-4474-b27c-3e3e39440ee6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d8e8b1b7-ad4e-4216-9b0e-625b616c709c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d8e8b1b7-ad4e-4216-9b0e-625b616c709c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_9b2ffd8d-8ec9-4383-837c-1c0a3eb86785" xlink:href="bmy-20220930.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_9b2ffd8d-8ec9-4383-837c-1c0a3eb86785" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended" id="i4d0cd0a2e2d045358b75c1f246c58fad_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d2486729-948b-4a78-83e1-cdb2a80d9927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_Goodwill_d2486729-948b-4a78-83e1-cdb2a80d9927" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_93d04f86-442c-4e49-94e7-06c97c77880c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_93d04f86-442c-4e49-94e7-06c97c77880c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18ca6acb-1b95-4811-b0c1-fdf45ecce610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18ca6acb-1b95-4811-b0c1-fdf45ecce610" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ec077b-a3c8-4eb8-a568-657d06d62acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ec077b-a3c8-4eb8-a568-657d06d62acf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1fead4bf-b875-43ee-8b38-5245a4b24e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1fead4bf-b875-43ee-8b38-5245a4b24e96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1079d3d-6e65-4cbf-9f51-4e68ebaea005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1079d3d-6e65-4cbf-9f51-4e68ebaea005" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d572a891-627d-4bc1-9db4-f096d2f321ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d572a891-627d-4bc1-9db4-f096d2f321ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd5774e1-3e65-479b-a800-e3cfda5c35f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:to="loc_srt_RangeMember_bd5774e1-3e65-479b-a800-e3cfda5c35f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:to="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fc51d866-7520-489b-a698-3552df5f91d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:to="loc_srt_MinimumMember_fc51d866-7520-489b-a698-3552df5f91d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_223ef572-2eaa-44fc-ac05-ac458b5243aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:to="loc_srt_MaximumMember_223ef572-2eaa-44fc-ac05-ac458b5243aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3bff5582-ea29-41e7-8fb1-891f75bac1eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3bff5582-ea29-41e7-8fb1-891f75bac1eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9cca5e0f-3d1c-42d7-beb2-cbb5d1218abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_LicensingAgreementsMember_9cca5e0f-3d1c-42d7-beb2-cbb5d1218abb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ec6ce2c6-ab1c-4a4a-b1a7-0e85a993bf37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ec6ce2c6-ab1c-4a4a-b1a7-0e85a993bf37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_52188cf3-e341-4918-b984-00c4d44725e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_52188cf3-e341-4918-b984-00c4d44725e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_05441606-beab-4471-bb10-182cdbab49de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_05441606-beab-4471-bb10-182cdbab49de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6769b974-dc3f-444b-8214-0eb6105c4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6769b974-dc3f-444b-8214-0eb6105c4f8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended" id="idf740b6f755749f189f7c8695ed1590f_GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3128f1ec-18da-4c50-b436-6b59220679d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3128f1ec-18da-4c50-b436-6b59220679d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ad3ee2b5-0fe5-403a-996a-e875589b291b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ad3ee2b5-0fe5-403a-996a-e875589b291b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_9e826d03-3ea0-4197-8598-f782df3a2732" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_9e826d03-3ea0-4197-8598-f782df3a2732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5da9c37d-a657-4500-8705-85501ba70489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5da9c37d-a657-4500-8705-85501ba70489" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:to="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_2e7894a3-9f00-414e-b337-b0d6a5343d07_default" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:to="loc_bmy_IntangibleAssetNameDomain_2e7894a3-9f00-414e-b337-b0d6a5343d07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:to="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_e3dec3a2-62b7-4aee-84bd-15cf83d79dc9" xlink:href="bmy-20220930.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:to="loc_bmy_InrebicMember_e3dec3a2-62b7-4aee-84bd-15cf83d79dc9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended" id="i8380e17f7c1f46859b58e49eb45ddc3f_EQUITYScheduleofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:href="bmy-20220930.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7fb066d-2518-4c13-b619-572e1584e083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7fb066d-2518-4c13-b619-572e1584e083" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2fe8b624-b4d0-4f2f-bc95-520c7f106a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_SharesIssued_2fe8b624-b4d0-4f2f-bc95-520c7f106a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c00cacd-87ca-4f8a-9610-84787243b267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_StockholdersEquity_1c00cacd-87ca-4f8a-9610-84787243b267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_436aeca8-98b6-4dbd-bdb6-6b4c30908d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_ProfitLoss_436aeca8-98b6-4dbd-bdb6-6b4c30908d35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b35b567c-e199-44da-8d84-466a40d01c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b35b567c-e199-44da-8d84-466a40d01c69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7d22c1dc-92a9-4bed-baf2-0361d4706156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_DividendsCommonStockCash_7d22c1dc-92a9-4bed-baf2-0361d4706156" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0ec19e55-8e57-49b0-bf0a-cc4f4ca1bcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0ec19e55-8e57-49b0-bf0a-cc4f4ca1bcf5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c6920e29-c756-451c-9cd2-a416e1d4e5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c6920e29-c756-451c-9cd2-a416e1d4e5e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b76ee1ce-18e2-4269-9065-e63cabf2d928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b76ee1ce-18e2-4269-9065-e63cabf2d928" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a817a6bf-42f0-4901-8757-71a1529f754d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a817a6bf-42f0-4901-8757-71a1529f754d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_6c7d64b7-cc36-4bfb-982f-ca7b706106b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_Dividends_6c7d64b7-cc36-4bfb-982f-ca7b706106b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_135d2401-6386-4b50-926f-aa02cc717ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d661f78e-419e-46f4-a558-6f384f79e1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:href="bmy-20220930.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:to="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cacb8292-0ff2-47c0-b790-363f742c4b29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:to="loc_us-gaap_EquityComponentDomain_cacb8292-0ff2-47c0-b790-363f742c4b29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:to="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7971dd02-4f73-4774-934c-9701b52796bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_CommonStockMember_7971dd02-4f73-4774-934c-9701b52796bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_44de0086-502a-4c5c-99bf-5e15ee80d093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_44de0086-502a-4c5c-99bf-5e15ee80d093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a693dc5b-0a0a-45fe-9546-0b7d0ed4a54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a693dc5b-0a0a-45fe-9546-0b7d0ed4a54b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4d94e7ae-91b5-4559-8476-f3ad7139a3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_RetainedEarningsMember_4d94e7ae-91b5-4559-8476-f3ad7139a3eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_07491aa9-31b4-4926-9154-462e9c4077f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_TreasuryStockMember_07491aa9-31b4-4926-9154-462e9c4077f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_35fe1be2-22a9-472d-8d5b-81b3652d3236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_NoncontrollingInterestMember_35fe1be2-22a9-472d-8d5b-81b3652d3236" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended" id="i55f2cec77a2241be9a3ad028cf0bd6e5_EQUITYAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:href="bmy-20220930.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4ca8e092-4af4-4f9a-b33e-bceea11d3534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4ca8e092-4af4-4f9a-b33e-bceea11d3534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2770bab-1651-4859-94cd-c010c19fee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2770bab-1651-4859-94cd-c010c19fee4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_72fb2dd4-303b-42ff-8856-94d298ed67be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_72fb2dd4-303b-42ff-8856-94d298ed67be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7599506d-8b8e-419a-ae6e-98e86c60b04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7599506d-8b8e-419a-ae6e-98e86c60b04d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:href="bmy-20220930.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_eb088818-5c53-4af0-8f57-68b7a76d5cb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_eb088818-5c53-4af0-8f57-68b7a76d5cb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_c625c8b6-4a91-4a5b-b849-ded00039814c" xlink:href="bmy-20220930.xsd#bmy_A2022ASRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:to="loc_bmy_A2022ASRMember_c625c8b6-4a91-4a5b-b849-ded00039814c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2019ASRMember_eed000da-d93d-4537-a798-f95f95803f70" xlink:href="bmy-20220930.xsd#bmy_A2019ASRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:to="loc_bmy_A2019ASRMember_eed000da-d93d-4537-a798-f95f95803f70" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended" id="i386842a09f03439fb641363c968d8289_EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_44600e11-db46-4e91-b660-92dd9b1a44ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_44600e11-db46-4e91-b660-92dd9b1a44ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e3fff710-5b9f-4d53-9437-fef5bfed044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e3fff710-5b9f-4d53-9437-fef5bfed044b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_317ac7d9-d1e4-49cf-bc54-84e5b4e21dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_317ac7d9-d1e4-49cf-bc54-84e5b4e21dc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c30cf6b2-bc03-4d05-9fcc-e35b5150c261_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c30cf6b2-bc03-4d05-9fcc-e35b5150c261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_205a28c3-ca92-4b9c-b2b4-cb2b81635785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_CostOfSalesMember_205a28c3-ca92-4b9c-b2b4-cb2b81635785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5621cddc-8cea-41c1-8814-5f3a647aa576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5621cddc-8cea-41c1-8814-5f3a647aa576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1d41ff21-540b-4840-b49a-7973907f4647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1d41ff21-540b-4840-b49a-7973907f4647" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_8e9c88d0-f587-45c1-aa6d-d9fc8bd8f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_OtherIncomeMember_8e9c88d0-f587-45c1-aa6d-d9fc8bd8f82f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended" id="ie3440f442a4f40b0a5dfba4fb4c3877c_EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_96ec0195-db64-4b91-9714-d8287085ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_96ec0195-db64-4b91-9714-d8287085ce66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02ba549f-9353-47d4-bb68-43e091c626cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02ba549f-9353-47d4-bb68-43e091c626cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:to="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:to="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ca663d6-382f-4738-8a28-97e85408a0aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ca663d6-382f-4738-8a28-97e85408a0aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d785ff57-85ab-4947-b82c-7884672257b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d785ff57-85ab-4947-b82c-7884672257b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_7eb9f451-6e37-4d89-9714-8b485fa49ef9" xlink:href="bmy-20220930.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_bmy_MarketShareUnitsMember_7eb9f451-6e37-4d89-9714-8b485fa49ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6d22420d-6d1b-4b69-9cf6-f49551897823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_us-gaap_PerformanceSharesMember_6d22420d-6d1b-4b69-9cf6-f49551897823" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended" id="ief8f3cf1691d4b12bb84171e6b1d609f_EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b9f5e91e-a679-4a98-8932-2d11615c40f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b9f5e91e-a679-4a98-8932-2d11615c40f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_571fa65e-8e03-45af-aa32-fa2aac19c069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_571fa65e-8e03-45af-aa32-fa2aac19c069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:to="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:to="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f8b3316b-5c8b-4b1c-991d-f1183da97d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f8b3316b-5c8b-4b1c-991d-f1183da97d5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_7dbec63d-7b0a-4068-92ca-85a3945eae10" xlink:href="bmy-20220930.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_bmy_MarketShareUnitsMember_7dbec63d-7b0a-4068-92ca-85a3945eae10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d20cb7c8-c947-42a2-b1b0-a648873ae12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_us-gaap_PerformanceSharesMember_d20cb7c8-c947-42a2-b1b0-a648873ae12a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended" id="i3dd9bb5892b347a0b2081ae48e45325c_LEGALPROCEEDINGSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:href="bmy-20220930.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c655af57-1845-47bd-9d63-40058464ae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c655af57-1845-47bd-9d63-40058464ae3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_c58129d5-4664-45be-8aef-3cd3845a28d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_PaymentsForRoyalties_c58129d5-4664-45be-8aef-3cd3845a28d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_690cc03f-ed98-4bcf-b40a-ef491b526f2d" xlink:href="bmy-20220930.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_690cc03f-ed98-4bcf-b40a-ef491b526f2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_2cd9f1a4-d510-4cf7-ab13-b557239dab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_2cd9f1a4-d510-4cf7-ab13-b557239dab25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_81ac4260-12e8-41d5-9c57-f390d756e003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_81ac4260-12e8-41d5-9c57-f390d756e003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0a54e38e-b96e-4aea-be03-61a79047ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0a54e38e-b96e-4aea-be03-61a79047ea83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_7ab8e1ed-f3e3-4278-b876-b1643477095e" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_7ab8e1ed-f3e3-4278-b876-b1643477095e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_70112130-7064-49da-99ab-ce0d51508b45" xlink:href="bmy-20220930.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_70112130-7064-49da-99ab-ce0d51508b45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_53e18226-9be3-4f12-97e7-016351f48bc2" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_53e18226-9be3-4f12-97e7-016351f48bc2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_9ce275e0-3660-45fb-a01a-54f91aae3caa" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_9ce275e0-3660-45fb-a01a-54f91aae3caa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_1ad5daf2-fedd-4d20-9763-58a7cfde9072" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_1ad5daf2-fedd-4d20-9763-58a7cfde9072" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_6eca77a4-ce6c-4d98-9a64-f60e71424d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_ContractualObligation_6eca77a4-ce6c-4d98-9a64-f60e71424d7f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_239f42b0-8770-4692-80e2-902950842b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_239f42b0-8770-4692-80e2-902950842b98" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:href="bmy-20220930.xsd#bmy_LitigationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cec806b2-37cf-46d3-9b66-26cdb20d4a2b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:to="loc_srt_LitigationCaseTypeDomain_cec806b2-37cf-46d3-9b66-26cdb20d4a2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:to="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_0de7394c-d0c4-43ad-8905-047ce1123c70" xlink:href="bmy-20220930.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_0de7394c-d0c4-43ad-8905-047ce1123c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_a92aadda-fd0d-4937-9356-32ced5e3645b" xlink:href="bmy-20220930.xsd#bmy_CARTKiteLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_CARTKiteLitigationMember_a92aadda-fd0d-4937-9356-32ced5e3645b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_a3617627-bfd6-4524-a093-bb2096e7e7ff" xlink:href="bmy-20220930.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_a3617627-bfd6-4524-a093-bb2096e7e7ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_d6b62b49-df3a-4a3f-8136-41e80b7e9e41" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AbilifyProductLiabilityMember_d6b62b49-df3a-4a3f-8136-41e80b7e9e41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_9d2572a2-dac3-43c4-ac37-0c5668abcd64" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_9d2572a2-dac3-43c4-ac37-0c5668abcd64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_52432d16-9d5b-4795-861b-67829198ed59" xlink:href="bmy-20220930.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_52432d16-9d5b-4795-861b-67829198ed59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_9f918b49-9f2b-4eba-ab67-097352fa3826_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:to="loc_currency_AllCurrenciesDomain_9f918b49-9f2b-4eba-ab67-097352fa3826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:to="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_aa1fb59c-5c77-4895-84e3-b45a4633b2d9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:to="loc_currency_AUD_aa1fb59c-5c77-4895-84e3-b45a4633b2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_1679102c-8489-4790-8991-5a4f3a47ee90" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:to="loc_currency_USD_1679102c-8489-4790-8991-5a4f3a47ee90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7dde6182-8d89-4b50-b0cb-b3caad7dde89_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:to="loc_dei_EntityDomain_7dde6182-8d89-4b50-b0cb-b3caad7dde89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:to="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_f3a3f2bf-5256-40b6-857e-7ac6cb74d97a" xlink:href="bmy-20220930.xsd#bmy_BristolMyersSquibbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:to="loc_bmy_BristolMyersSquibbMember_f3a3f2bf-5256-40b6-857e-7ac6cb74d97a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1303b958-3422-481a-ae0d-61bf023a251c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:to="loc_srt_SegmentGeographicalDomain_1303b958-3422-481a-ae0d-61bf023a251c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:to="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_da4bedcc-b371-4755-9c35-cece1c9b8063" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:to="loc_country_CA_da4bedcc-b371-4755-9c35-cece1c9b8063" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmy-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c0005352-31a8-423c-9ae7-49edde5823f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityLineItems_42a0c098-9bc0-4d75-bc4e-87821410db63_verboseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_2870fe0d-3de6-46cd-ad96-35dc76919dc4_terseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_label_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_documentation_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems" xlink:href="bmy-20220930.xsd#bmy_EquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityLineItems" xlink:to="lab_bmy_EquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_29adbcda-bdaa-440b-9430-c88040260950_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_df0dd9c0-4228-47b6-9423-a7e8fe397f6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_c6fc421f-d5f4-4f4d-9f46-24c4a26382d0_terseLabel_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_label_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_documentation_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:href="bmy-20220930.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:to="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8a4c3a75-77e7-4691-a9c9-3f46cd661742_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_bf93104c-79c7-45a2-9f1b-f68fc9c288c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_7232fa65-2188-405a-a913-30e6374b23d7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_970a091e-f24e-4850-a0b4-7a1f25c5ed76_terseLabel_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total In-Line Products and New Product Portfolio</link:label>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_label_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products and new product portfolio [Member]</link:label>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_documentation_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products and new product portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember" xlink:href="bmy-20220930.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember" xlink:to="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_06c62049-3876-4c08-8747-7de6512b3227_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5e9de449-f16b-4310-899b-29717a35db2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_5bf70f58-e4ea-436b-98d9-de0398fb13f5_terseLabel_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_label_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Aggregate Total Trade Receivables Due</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_documentation_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:href="bmy-20220930.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:to="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2c36085f-2d9a-44fc-8342-0065505038c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_ce9b30ab-a05e-476f-9998-aa2d39ef73cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_1ba8f07d-457a-42e3-ad1b-915c431d48b9_terseLabel_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_label_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_documentation_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:href="bmy-20220930.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:to="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_054db92e-fab2-4a2c-9c37-74013ccd67ee_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimates</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_9e58436d-c536-4f91-a1c6-8385edf64133_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_eb19c8e4-190b-4d11-95f8-081ebbb50279_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_605432fd-3c3e-430a-9990-1f2e4a0fb6da_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual injury claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentValueRightsMember_b52b993e-ce96-4589-a4d8-ebfec41db024_terseLabel_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent value rights</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMY Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember" xlink:href="bmy-20220930.xsd#bmy_ContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentValueRightsMember" xlink:to="lab_bmy_ContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_f3eb3732-fa25-4624-b42a-3f7f5b3bbcfb_terseLabel_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_label_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:to="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_e28ccfb1-b250-46c0-ae68-5bca36b8f461_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment losses/(income)</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRoyaltiesMember_7373383c-6956-4073-83ef-6a025539297a_terseLabel_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_label_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties [Member]</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember" xlink:href="bmy-20220930.xsd#bmy_OtherRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRoyaltiesMember" xlink:to="lab_bmy_OtherRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1cc77a00-0895-47f6-909d-007e4f790049_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_a7d5ccaa-92e0-4402-92b5-f55528380bc2_terseLabel_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_label_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_documentation_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember" xlink:href="bmy-20220930.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MedicaidandMedicarerebatesMember" xlink:to="lab_bmy_MedicaidandMedicarerebatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_9b5fa889-5470-4d71-a96f-7587b0ab3620_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_29c8e97e-3d73-468a-a4f0-912014a1da1c_terseLabel_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to extinguish future royalty obligation</link:label>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_label_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment To Extinguish Future Royalty Obligation</link:label>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_documentation_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment To Extinguish Future Royalty Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:href="bmy-20220930.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:to="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ada5dbc3-0b16-4bd2-822c-1e47c695a8b4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5402e483-445b-44ea-9949-88dddd7ebdb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_5279f8c8-cddf-4c22-9d4f-04f13a22d2aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquiredIPRD_5f86d792-be44-4fcb-8d20-a3ffc3512f78_terseLabel_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_label_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_documentation_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquiredIPRD" xlink:to="lab_bmy_AcquiredIPRD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_af9e50ab-5ebe-40d7-a210-aff389936af8_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_21e66106-8cd2-4314-89c7-0a30ff0693cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_f2c30086-f416-4eb2-84cd-166c33cdaad1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ad2e0ce6-020b-4d7c-8592-ebb17a4ed28f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9e45ecbe-ae91-4fca-a251-165f02cca8e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityTable_c28f663b-fa1f-4fb0-84fd-f15ebce936c8_terseLabel_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_label_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_documentation_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable" xlink:href="bmy-20220930.xsd#bmy_EquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityTable" xlink:to="lab_bmy_EquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_d4cbac92-6e1b-4580-9e51-9f26e6bb8c97_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_c5bedfcc-c6db-4120-a1fa-79e8d8e990b5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value of stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_0712e3aa-9be1-4203-9a74-3bd19938dd7c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation satisfied in previous period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5b10c10d-9e2f-4063-a772-1ff92c65ba97_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ee6cd5a0-9d99-4bc6-b3e4-f774d6104d33_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6bf6dc85-dd8f-44a6-836d-3840022de68c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_88a5af4d-db87-498a-bcd2-c78435dddc31_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_5774eaaa-2fa6-441c-ba7f-2f585b96aa6c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_4931c3b1-bd06-4030-b7b0-180116c8d6ee_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:to="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_50ab8e50-80f3-43c1-9385-c440798a52f2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_9457cd41-ce59-4f19-9465-2e85add12de5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_807cbac3-6c01-48bb-b9a0-def2f5468018_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_fede4085-c77e-4e4f-984f-5a9f1dd50015_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_efd97a2c-af09-48fd-bff2-2bca0352d638_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings and Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_77ac2f3c-f4eb-4988-8543-da2e0a59f9cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_9453f861-b615-48a9-b93b-300510304b4d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3450c9fe-25f6-446b-9cbb-4cf6c296f95c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_b297e3e4-2086-4186-95a8-2f81a933aae8_terseLabel_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_label_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_documentation_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:href="bmy-20220930.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:to="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_9e1b9726-1263-4c19-abb0-212d57851452_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_823aabf9-d05f-4744-8629-17c407bafc55_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense</link:label>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:to="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_17e41f8a-d821-4728-a1df-3d6572fc774e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_018505f2-3053-44ba-9c7b-7afc5be625b0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_e3b61937-bb94-4ab0-b8c8-19762f489a70_terseLabel_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_label_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates and returns</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_documentation_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns" xlink:href="bmy-20220930.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedRebatesAndReturns" xlink:to="lab_bmy_AccruedRebatesAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_289930ba-6202-4ce9-a8ec-7f084f4230b2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrevenuesMember_654e56c1-2651-48a7-a891-14a614839ba5_terseLabel_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_label_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember" xlink:href="bmy-20220930.xsd#bmy_OtherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrevenuesMember" xlink:to="lab_bmy_OtherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NetproductsalesMember_0676cbe2-1076-4236-9a87-2d30f4e55575_terseLabel_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_label_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_documentation_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NetproductsalesMember" xlink:to="lab_bmy_NetproductsalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_b5e14e6e-1e1c-4365-8755-0b49a7ba8dd0_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:to="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_3f899627-7315-4a6c-9e2c-8ded28b4bcf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_c6388b82-ea32-4550-8ca5-f7aa0790977a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_5cb50bb7-b8ed-4e7f-930d-8157e52ef9ed_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs, dismissed cases</link:label>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_label_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs, Dismissed</link:label>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_documentation_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:href="bmy-20220930.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:to="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_dc319903-4544-4eb5-9224-72a17939a733_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6da90edd-8dfb-4c40-ae47-6aa679b562ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_f4539a17-8f26-4f65-a884-ec3fda99e743_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_a6663d1f-5c60-4656-acaf-1696f5eeffea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CamzyosMember_19bb072d-9b98-41aa-a137-c7fc11ef4768_terseLabel_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos</link:label>
    <link:label id="lab_bmy_CamzyosMember_label_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos [Member]</link:label>
    <link:label id="lab_bmy_CamzyosMember_documentation_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember" xlink:href="bmy-20220930.xsd#bmy_CamzyosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CamzyosMember" xlink:to="lab_bmy_CamzyosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4ba9634e-ad84-4782-99ce-283688671774_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_959ce328-43ec-4d9c-a135-33b5f5fcb1d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7a73577e-28c5-4cc5-b68a-794eba002e46_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7c54e46e-cddf-401e-ae57-31d692567129_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities, fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5cf45328-b699-46e7-912d-ae9f90f8b18d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_081f566e-2d9b-43d9-9509-e4188dc7740e_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_label_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Other Income Expense</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_documentation_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense" xlink:href="bmy-20220930.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherOtherIncomeExpense" xlink:to="lab_bmy_OtherOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d451e9e2-2cd8-4dcd-bd37-cbfaeace1609_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_b4f3a468-b157-4f6a-a2f0-dbdea2285c45_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LOEProductsMember_2b9374a8-9e91-480c-81f8-9ffe351c1cca_terseLabel_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Recent LOE Products</link:label>
    <link:label id="lab_bmy_LOEProductsMember_label_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOE products [Member]</link:label>
    <link:label id="lab_bmy_LOEProductsMember_documentation_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOE products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember" xlink:href="bmy-20220930.xsd#bmy_LOEProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LOEProductsMember" xlink:to="lab_bmy_LOEProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_030346a6-e09c-4557-a72f-24450a21c5d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b70b6750-7e96-48cb-9bfb-1f3b6722cc45_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b2fcd685-2a24-4774-a145-1495af0e3eda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91119c21-554e-409c-932c-ea39f5b38687_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, net of taxes and reclassifications to earnings:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_9cb2ebde-5f2b-4c44-b139-d74c16d7720d_terseLabel_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_label_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember" xlink:href="bmy-20220930.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceandotherrevenuesMember" xlink:to="lab_bmy_AllianceandotherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e9da8207-7e3d-4dc9-a607-46058582af0a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_b89593e8-dc1c-436b-810d-c5f8603924dc_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_76458853-5dc9-473a-950c-e5ce69e0f6e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_3e0fd2ba-7cfc-40ec-bb4a-d73b1bf21621_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_15f0b29b-2da2-4529-bb78-7d1796e36c77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_ca8c3991-2993-401c-90ce-4df9adb41e5d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account Receivables [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_75ac0f62-0c86-4740-8e4d-bbb4b12b0b8c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_cbab4f23-53b1-4989-bb5e-5504e29692fb_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_efb758e3-b41d-461c-851a-0c5cde6675c8_terseLabel_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_label_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:to="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_3d9685ff-7c7c-4cd1-84a6-1cb48a9bdc95_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_164da11c-be52-4944-914b-1d9dd2b436be_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_ecd01721-315c-4c3f-9c61-4b4b5a78d7a8_verboseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_76aee7ad-b1d1-47fe-8ba1-1139a41b9212_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsCurrent" xlink:to="lab_bmy_EquityInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_b7b61061-8ae8-46d6-a89d-573089ea5d65_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_539b11f2-e07b-47fc-8975-2f4c7daaa5ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_8541f798-25fd-4916-9491-11f17760324a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsTable_93520c6b-3157-4562-875a-f218ed3ec0c6_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_label_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsTable" xlink:to="lab_bmy_LicensingArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5f5529ae-beaf-4718-a7b9-66863ebe4821_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_441700c5-cb42-4d87-a7ca-f9f64e3fef22_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_c9af2643-2e1a-4718-bf3e-23ae318cd7f8_terseLabel_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revolving credit facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_label_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_documentation_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities" xlink:href="bmy-20220930.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberofRevolvingCreditFacilities" xlink:to="lab_bmy_NumberofRevolvingCreditFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_3347fa8c-fa27-44b1-9876-137a12ec444c_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_69b168e1-ae41-4feb-9113-7fb5dbdccc52_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_e6ebc562-f258-478e-b891-18031d4c5520_terseLabel_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal period</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_label_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_documentation_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod" xlink:href="bmy-20220930.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LongTermDebtRenewalPeriod" xlink:to="lab_bmy_LongTermDebtRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0809709e-f6da-4043-b024-cf824d940003_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_cd0bd621-64ee-4132-b3d4-2da54d77bc59_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_11eb4346-9805-4050-a2d0-d3de829d87b8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d350d890-9197-4ab2-9d1e-ba2be6f80ac8_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_264a13e6-4aa0-4733-80e5-fd5f6abdf4e9_terseLabel_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_label_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Largest Pharmaceutical Wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_documentation_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of the largest pharmaceutical wholesalers used by the company in the territory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:href="bmy-20220930.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:to="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7162d44b-9f66-418f-92c2-0228fb184261_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a3687c10-7aa8-42ee-8db8-fa8a428a785c_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired marketed product rights</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fe96419c-4b11-406b-9441-7bb131d39caa_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_387f9297-c47f-4ab9-ba1a-cf36837342d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_fc65df15-9fa7-4197-bf65-174e12df1cbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_5e47b3d3-a603-4aab-a46f-8f413b283b1a_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_671745b0-d6ff-4b2c-a3a9-aafadc59bea9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RevlimidMember_7a1907e7-e187-4b45-b538-656f7202c7fe_terseLabel_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid</link:label>
    <link:label id="lab_bmy_RevlimidMember_label_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:label id="lab_bmy_RevlimidMember_documentation_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember" xlink:href="bmy-20220930.xsd#bmy_RevlimidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RevlimidMember" xlink:to="lab_bmy_RevlimidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_75ee33f5-ce7a-4ab4-97b6-c0f4ebbd0769_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_690c225c-f6a1-4acc-b825-8bb2fc1f9047_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reduction of manufacturing, selling, administrative, and research and development personnel</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_68202fe2-4df4-4639-9c47-a3036b20803c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4ed9aadf-7685-4d2a-a202-e9187d6db1cc_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustments_91b3458b-42de-4e44-956c-95be4631d145_negatedTerseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustments" xlink:to="lab_bmy_GrosstoNetAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7d628bc4-229a-414b-826e-6770f22450ea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_4d752f74-7bc3-43d9-983c-141b8cd65940_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_3b2cebc5-994d-4097-8728-dbb37e6819b7_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_1a71487c-8330-437d-a95f-29095a111174_terseLabel_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments made to collaborative partner</link:label>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_label_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments Made To Collaborative Partner</link:label>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_documentation_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments made to partner as part of collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:href="bmy-20220930.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:to="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fac398df-7092-4787-89cd-52ddf6d13575_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_27eb07bf-7903-45eb-a9d6-8c93b06f74b1_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a0dab8cd-5a4a-41ef-9bf9-23028cb36bb6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_167e9fea-5276-4cd7-9886-8ad1cd856215_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_1de4993b-0d03-4e67-9077-7ad1dfaa7b6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other termination costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_1912380c-6952-4937-a612-182a681d6c38_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1dd26b63-81d2-4564-8c45-cd18bb86f621_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f6781c20-f55d-45b5-8c6c-5b42dd18623e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6b1c62d1-4a13-4141-bfad-731f33ccc93b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_3b45cb79-1b5f-4b29-a5e3-25e8d25964af_terseLabel_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_label_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_documentation_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:href="bmy-20220930.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:to="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_79ede4ae-07ec-49eb-81b0-cff05cbdc916_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SalesRevenueGrossMember_b6a5550e-85a8-40e6-b14f-5258e384c587_terseLabel_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross product sales</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_label_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_documentation_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember" xlink:href="bmy-20220930.xsd#bmy_SalesRevenueGrossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SalesRevenueGrossMember" xlink:to="lab_bmy_SalesRevenueGrossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e8daf78e-f9ed-4e20-a35c-8e261c827412_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_b6841a42-8465-4467-9be9-c1dac6055e96_terseLabel_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_label_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_documentation_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:href="bmy-20220930.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:to="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BreyanziMember_9299f033-c2dc-49c8-8fbe-168156c27c9c_terseLabel_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:label id="lab_bmy_BreyanziMember_label_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi [Member]</link:label>
    <link:label id="lab_bmy_BreyanziMember_documentation_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember" xlink:href="bmy-20220930.xsd#bmy_BreyanziMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BreyanziMember" xlink:to="lab_bmy_BreyanziMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_67fe8ec1-a9f8-404f-b55c-b0d3ab9a5e32_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5822999c-8fbc-4d5f-b9b5-de776799efd7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_003481b1-924b-455d-996a-261b63b2e093_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e141d690-90b1-4359-b73a-a9f96993ff5c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_5871687d-59fc-4b7f-a735-60ddb74ceede_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized purchase price adjustments of Celgene debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_058e83db-c3bf-4a99-a902-f8b3343e2c8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_4aca1159-cdde-4f0f-8d93-273b40730714_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_7cc88dd7-7b3a-4e33-b193-62c827b3fea0_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_148e3333-e6c5-4b4b-81ff-d0d453133b05_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_ace04cc0-d47c-40d6-8ea2-97cb052545ee_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_2021be6c-d726-446d-b6d7-5f9a0ad5d1a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_36a3e345-b560-4516-a8c1-ea11c9048ca2_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_0c0ed404-8cef-4344-bf1f-7a9ff1eca842_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ecce1af4-1eb3-4dc7-8edc-61760d0e90df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_8d3d8373-b732-4234-b863-78d6a7e2edf8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1887e5c5-feba-4072-870b-90b86b647a19_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_82683c1e-181c-4626-9e5b-8b7b83fb5a5a_terseLabel_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and other products</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_label_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands [Member]</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_documentation_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember" xlink:href="bmy-20220930.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureAndOtherBrandsMember" xlink:to="lab_bmy_MatureAndOtherBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_aa3c5739-daa1-40ee-b459-ce8038d715eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NoteDue2062Member_62b28087-bd1a-4737-9177-a8d066439397_terseLabel_en-US" xlink:label="lab_bmy_NoteDue2062Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2062</link:label>
    <link:label id="lab_bmy_NoteDue2062Member_label_en-US" xlink:label="lab_bmy_NoteDue2062Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2062 [Member]</link:label>
    <link:label id="lab_bmy_NoteDue2062Member_documentation_en-US" xlink:label="lab_bmy_NoteDue2062Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2062</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2062Member" xlink:href="bmy-20220930.xsd#bmy_NoteDue2062Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NoteDue2062Member" xlink:to="lab_bmy_NoteDue2062Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e124254c-d47d-4f2d-a406-ba417726d71a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_71ae8302-05e1-4085-a33f-df0936f43c24_terseLabel_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember" xlink:href="bmy-20220930.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneContingentValueRightsMember" xlink:to="lab_bmy_CelgeneContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestituregainsandroyalties_adedc04a-dc05-47b7-a58f-7b86987d0e29_negatedTerseLabel_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_label_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_documentation_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the amount of gains and royalties as a result of business divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties" xlink:href="bmy-20220930.xsd#bmy_Divestituregainsandroyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestituregainsandroyalties" xlink:to="lab_bmy_Divestituregainsandroyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_27a3bd53-2c2d-432c-b217-784848249461_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb Company Shareholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_def858dc-7421-4ab6-b57e-d6d3858ce06e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b9b7c03a-8606-45e1-a26e-d5c36a178118_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6daa261b-1546-4c58-9f1d-39d6ce8b119c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_39f0de2f-b0d7-45b3-bb26-d9e5fa7ee33c_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_YervoyMember_91c04fd2-f89e-428d-938b-1ad885cf902a_terseLabel_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy</link:label>
    <link:label id="lab_bmy_YervoyMember_label_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember" xlink:href="bmy-20220930.xsd#bmy_YervoyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_YervoyMember" xlink:to="lab_bmy_YervoyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_54a5b0a3-6685-48f5-9fd8-36cae6a4e563_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_f10dd7ec-5b5b-4308-a153-f20973323997_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_TurningPointMember_1287611b-ab52-4575-84bc-33bc571a2fc6_terseLabel_en-US" xlink:label="lab_bmy_TurningPointMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turning Point</link:label>
    <link:label id="lab_bmy_TurningPointMember_label_en-US" xlink:label="lab_bmy_TurningPointMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turning Point [Member]</link:label>
    <link:label id="lab_bmy_TurningPointMember_documentation_en-US" xlink:label="lab_bmy_TurningPointMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turning Point</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_TurningPointMember" xlink:to="lab_bmy_TurningPointMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_254e2ebc-927b-4ba3-8bac-8b0d87f9ba83_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_36735ae2-3724-4f0f-841b-2160ee008083_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d4012290-1046-4db3-81f8-b0f737d6ff94_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives and Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_941036ee-3070-406f-9904-65fd7dbc17a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_3a13f03f-ea00-4496-bd9d-74541fa34b2e_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b6f99a7f-92ac-45f7-9ee3-cf3744bdcaf8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_cc1a50ed-ef5f-46e7-a6a6-f1ffe1dcade4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt redemption</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_38204bb6-792d-4a8f-9e02-6fe139f583bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_cb4ede94-2638-4c71-8a9a-74638b452999_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ad84823e-266e-48b3-aef0-f114e86f4d93_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b6361e99-f414-413d-8ba5-62218ba555bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_d60e5b6e-3ca3-48f5-a93d-746c8ba05683_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:to="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchandDevelopment_3619487a-90a9-4994-ba87-fd152c77a2fd_terseLabel_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_label_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_documentation_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment" xlink:href="bmy-20220930.xsd#bmy_ResearchandDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchandDevelopment" xlink:to="lab_bmy_ResearchandDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SotyktuMember_2e87c366-f3e4-47ae-96b8-cb0999088c30_terseLabel_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu</link:label>
    <link:label id="lab_bmy_SotyktuMember_label_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu [Member]</link:label>
    <link:label id="lab_bmy_SotyktuMember_documentation_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember" xlink:href="bmy-20220930.xsd#bmy_SotyktuMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SotyktuMember" xlink:to="lab_bmy_SotyktuMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_3ecbd3bf-c53a-4c35-85dd-c35aa2481d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bc79bafa-4e0c-415f-8c7c-8dfb2da6081a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_9b07ed08-aed8-4822-858f-3fd2a154f5e1_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_210e92f3-7d04-4fab-a5b7-60c302d11a52_terseLabel_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Running royalty</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_label_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_documentation_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:href="bmy-20220930.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:to="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CARTKiteLitigationMember_734528c2-85e8-4a71-ae1d-630a921cbbbe_terseLabel_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_label_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_documentation_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember" xlink:href="bmy-20220930.xsd#bmy_CARTKiteLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CARTKiteLitigationMember" xlink:to="lab_bmy_CARTKiteLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_b7162e31-3648-4ab3-8055-710d194dde44_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5689b57-7bf2-42ab-bbe3-cd1151985c66_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, fair value adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_7a99cd2e-ce86-4191-a60e-2a040fed589b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_07d36917-b9bc-44a8-8f1f-95b2784adf7f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_a860f60a-42b1-417e-abc1-fbc5f35e6be3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, term (in years)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e29587c-c2a1-429c-a94f-b0d89664f359_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A3550BondsDue2022Member_d859338b-708e-47e5-a50c-cd500478b7ab_terseLabel_en-US" xlink:label="lab_bmy_A3550BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.550% Bonds due 2022</link:label>
    <link:label id="lab_bmy_A3550BondsDue2022Member_label_en-US" xlink:label="lab_bmy_A3550BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.550% Bonds due 2022 [Member]</link:label>
    <link:label id="lab_bmy_A3550BondsDue2022Member_documentation_en-US" xlink:label="lab_bmy_A3550BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.550% Bonds due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3550BondsDue2022Member" xlink:href="bmy-20220930.xsd#bmy_A3550BondsDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A3550BondsDue2022Member" xlink:to="lab_bmy_A3550BondsDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f726b98d-fc80-4aa8-a590-0a93cec77d07_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_4fe7e8cc-ef22-4d71-86b0-12c0366b46e8_terseLabel_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_label_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_documentation_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:href="bmy-20220930.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:to="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ALLIANCESAbstract_c63cc955-1ccf-45b2-a2ce-eab2941b6741_terseLabel_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_label_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_documentation_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract" xlink:href="bmy-20220930.xsd#bmy_ALLIANCESAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ALLIANCESAbstract" xlink:to="lab_bmy_ALLIANCESAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a2ec6f20-8006-4f61-b6a3-655d05d1a4dc_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NewProductPortfolioMember_65baced3-4e82-4d45-8160-53f0238dbd12_terseLabel_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total New Product Portfolio</link:label>
    <link:label id="lab_bmy_NewProductPortfolioMember_label_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New product portfolio [Member]</link:label>
    <link:label id="lab_bmy_NewProductPortfolioMember_documentation_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New product portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember" xlink:href="bmy-20220930.xsd#bmy_NewProductPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NewProductPortfolioMember" xlink:to="lab_bmy_NewProductPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_18592c37-5947-49ad-9f5d-501127607832_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c9edca91-2eb9-40f2-bfef-ea51d9eba393_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_118a4ab5-575f-4a78-a161-52b7e74773c2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c7f380e6-92b1-44a0-852a-5e0d19da716c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2dd8e5f7-dcd1-402a-a8bf-76520faed86e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_0ee93c48-8bf9-4e27-b122-6e58e3f95853_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsNonCurrent" xlink:to="lab_bmy_EquityInvestmentsNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0d1db05c-688d-4143-8cf3-80ab3d2cbc90_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4322fea0-d5d2-44ba-95e3-994a77834005_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_63e8eeb3-4067-4546-9f3d-a41b52627abe_terseLabel_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition Gross-To-Net Adjustments</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_label_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:href="bmy-20220930.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:to="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_df22c9b3-5f32-46ff-bfce-397ad217f585_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_8c50109d-a86d-465d-b2a6-49c9c8b9bb30_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_5cbe5594-63b9-4ff9-ab09-cd8e9cd8da03_terseLabel_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract" xlink:to="lab_bmy_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_FloatingRateNotesdue2022Member_7e009966-53d9-45c9-a654-58e7a2a8fb5e_terseLabel_en-US" xlink:label="lab_bmy_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022</link:label>
    <link:label id="lab_bmy_FloatingRateNotesdue2022Member_label_en-US" xlink:label="lab_bmy_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_bmy_FloatingRateNotesdue2022Member_documentation_en-US" xlink:label="lab_bmy_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FloatingRateNotesdue2022Member" xlink:href="bmy-20220930.xsd#bmy_FloatingRateNotesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_FloatingRateNotesdue2022Member" xlink:to="lab_bmy_FloatingRateNotesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7cd7dbb2-6359-4795-b64f-13ce148bf380_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f7c6ff23-74dc-40f8-be27-be695a7648d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_33d6dfb8-99ee-456e-8860-0e2414bccc69_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated depreciation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:to="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_6dd1c122-8607-40d2-a89f-1ae29982c27f_terseLabel_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment" xlink:href="bmy-20220930.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedResearchAndDevelopment" xlink:to="lab_bmy_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_c3398025-bb8b-4ccd-a59e-72845dfb7b72_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6042ac1c-d11f-4f05-ace4-570f262bf90e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_7b9bf64f-a20b-47d6-b513-bc6259e17fc1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1d552083-d97d-45ee-a597-f5c9246afd95_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_87af72ae-5f92-4a2c-ae6a-49a0cd9816fd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates and Judgements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2145616f-3b93-413f-a95e-c541423753de_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - money market and other securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_246e1344-637a-4058-8e57-1c3a5da84b84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_c2dd8e3c-a9c7-4ea7-a194-024b86707d57_terseLabel_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share</link:label>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="bmy-20220930.xsd#bmy_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_15784017-5dc1-4caf-842e-1ae124525bd0_terseLabel_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_label_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_documentation_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:href="bmy-20220930.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:to="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f71a37a3-ee3b-4930-9e2e-5baec79d2547_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_7322afad-6716-4605-b58a-4e95ca0758fb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_d7a9e143-3a5f-4a6f-bc89-42ecea831e0d_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_49a35e83-7dd7-449b-9e98-f08c67de5a01_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration allocated</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_5ec3d58e-ffab-47ac-b2d3-b3bbb022184f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_43fca9e8-6ddd-4fb2-8977-4ad39f3bad69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_998ff840-5628-4431-8ea3-e7eddd226a1e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_79e84183-fd7e-414a-830f-a56be288cb26_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related charges incurred to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InternationalMember_eebf0bc9-4c00-4d97-9093-f52caf7ff148_terseLabel_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_bmy_InternationalMember_label_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_bmy_InternationalMember_documentation_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember" xlink:href="bmy-20220930.xsd#bmy_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InternationalMember" xlink:to="lab_bmy_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_7cfd2348-8eb9-401e-8d0e-9e2b661ceebc_terseLabel_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_label_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment [Member]</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_documentation_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:href="bmy-20220930.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:to="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_fb83d32d-ac1c-4d21-8cc4-6dd48a939fd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_ad85a906-e9ff-4dae-bd8e-3b9ed3d1731f_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_label_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsLineItems" xlink:to="lab_bmy_LicensingArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_8d99f1fd-380b-45d8-b3c2-a9f681b1db69_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for debt extinguishment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Cashoutlays_a4cf3a88-0b57-4096-8884-0a9cd143c609_terseLabel_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_label_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_documentation_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays" xlink:href="bmy-20220930.xsd#bmy_Cashoutlays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Cashoutlays" xlink:to="lab_bmy_Cashoutlays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_57d87aa9-9f09-4aad-a382-6f105e9ba702_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_db25f09d-b8b2-47c3-bd42-5c72f3eda116_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_aec7b634-855b-4cfc-8fbe-f7c554c95e6e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_108fda5f-c688-4e6f-8785-e1385a805ebe_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6bd723ff-f968-4970-80f0-41fac22d77f7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_585b160a-d5b8-4836-a660-c65e4fe68c9a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_e2d6fd77-2279-4628-94a9-6e8290f01be6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_b13482f8-b061-4398-ba4c-7aff76256994_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_d2a4df35-d1b7-4f09-9413-8ada57592923_terseLabel_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_label_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_documentation_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:href="bmy-20220930.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:to="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_46da9343-a7ec-4fd1-bddb-bc3c435c1ee3_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NoteDue2042Member_1d9a66ab-60a6-4a3a-aa94-fe70ea571acc_terseLabel_en-US" xlink:label="lab_bmy_NoteDue2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2042</link:label>
    <link:label id="lab_bmy_NoteDue2042Member_label_en-US" xlink:label="lab_bmy_NoteDue2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2042 [Member]</link:label>
    <link:label id="lab_bmy_NoteDue2042Member_documentation_en-US" xlink:label="lab_bmy_NoteDue2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2042Member" xlink:href="bmy-20220930.xsd#bmy_NoteDue2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NoteDue2042Member" xlink:to="lab_bmy_NoteDue2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_9f75120b-abee-43c9-92cb-828fa62a21b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedInterest_8ee696d5-79fc-414b-ba04-894a470c26f1_terseLabel_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_label_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_documentation_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest" xlink:href="bmy-20220930.xsd#bmy_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedInterest" xlink:to="lab_bmy_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_2436485b-f613-4be9-a994-6951477693a9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_89faee6d-7ce1-4cf4-95c7-78086995e4b0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_d0497d7b-e2be-48b5-97da-ae1f6a634c97_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Table Text Block]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:to="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_ad67a525-485f-457a-ac0f-aa3941b2e9ba_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_a76a0773-e88c-48a4-9274-1ca7acff4fb6_terseLabel_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_label_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan [Member]</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_documentation_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:href="bmy-20220930.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:to="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_70b36c4d-0789-4e1a-94e7-f32f8c308f41_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a7f18f47-2c45-4ee8-a855-aa6359e5588e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_93a79a96-b26e-4092-9d67-6e93b86840ff_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_91ee2111-926d-4a02-82c0-67948a1e1416_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c454e944-2b6f-421b-b6b1-a88254325f0b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4eaf673c-dd61-4bbd-b28d-e0c6d8d57639_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_80d9171d-e536-4988-ac4b-7e323d36e920_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_64c8b407-05c1-452b-99ef-a55826913c3e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2000NotesDue2022Member_11db9443-1552-4f96-bfc2-4036d3055f6d_terseLabel_en-US" xlink:label="lab_bmy_A2000NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% Notes due 2022</link:label>
    <link:label id="lab_bmy_A2000NotesDue2022Member_label_en-US" xlink:label="lab_bmy_A2000NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% Notes due 2022 [Member]</link:label>
    <link:label id="lab_bmy_A2000NotesDue2022Member_documentation_en-US" xlink:label="lab_bmy_A2000NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2000NotesDue2022Member" xlink:href="bmy-20220930.xsd#bmy_A2000NotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2000NotesDue2022Member" xlink:to="lab_bmy_A2000NotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_7eb84604-9ba6-49d6-93a0-120939614514_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_abbce90a-7a96-433f-9938-2773751d0072_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_2ae1e406-86ee-48f8-80a5-19539f268cd0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_d664d93e-2f01-45dc-8077-dd418e370286_terseLabel_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_label_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties [Member]</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember" xlink:href="bmy-20220930.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_TecentriqRoyaltiesMember" xlink:to="lab_bmy_TecentriqRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd42312d-b2ef-422b-acdd-182b2deb0b5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_424d2bb3-e79f-4f62-9f85-212bcecaf3a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3fe86c06-9eb9-45c5-8b71-6174f49594d1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_b0ebccd5-9d81-4523-876b-d83ada4f2e7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_26dae876-71d6-4018-a40b-203d09bed20a_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_34d927e5-41f1-4eec-8f85-fd3ad79081c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_5e9ea515-8deb-4a1b-92d3-a3a4504c247e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and other settlements</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_ed22137c-75a1-4439-b6c0-aa1b621690e8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c67cb14a-6d35-4117-8aab-339cc091148d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_4831195f-f154-4fe6-9a9d-ea4a59bcad36_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_52cfaf38-8903-454a-989c-d161c31e48e7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, value</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_56801831-3e25-4fe4-ab4f-5f550cc3d4e5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9437d1fa-ffcc-4999-8933-96028f8cb0dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d3a3c976-54c9-45eb-a2f1-2cab915a0898_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_6f27c159-5b7a-4aa3-8c90-2f0da4d64b65_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameAxis" xlink:to="lab_bmy_IntangibleAssetNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_87bd636b-142d-45ea-a2ef-1d0ca1133b5c_terseLabel_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_label_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value [Member]</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_documentation_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommonStock010ParValueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember" xlink:href="bmy-20220930.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CommonStock0.10ParValueMember" xlink:to="lab_bmy_CommonStock0.10ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_a2e01aa6-730d-483a-aa35-ce0f820b70eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_f61ac49b-655e-4efa-90b3-f92dec2ee2ec_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_0db8c0f1-9e16-48a4-b210-b3af91d08ed7_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables &#8211; from alliance partners</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_4d5496b6-3c9f-4868-aa3f-c605500183da_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_77455828-4d7d-4c35-b3fb-2b2748fdd746_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_48e2e589-5e6b-4bb0-b4f8-c7bb0f7a47d8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cfbe05dc-36c1-455d-a598-a5f21f6abd94_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ba22a768-57dd-4b3c-9f52-317b5b292be3_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_108a0996-f05a-4074-9683-e7768ccc6cdb_terseLabel_en-US" xlink:label="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for contingent development and regulatory approval</link:label>
    <link:label id="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_label_en-US" xlink:label="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for Contingent Development and Regulatory Approval</link:label>
    <link:label id="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_documentation_en-US" xlink:label="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:href="bmy-20220930.xsd#bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:to="lab_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_e760ff23-e557-484a-b7ea-edf91a7276ec_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_a2ce6e58-5e17-4114-9b74-e4620250eeee_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_9e25d265-c5ea-4d3d-b18c-f7c6737b2a83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss recognized on investments sold</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_d650ef80-e565-4d8a-8b30-190d8950b713_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_651a78dc-e368-418d-89eb-e07b1693f575_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NoteDue2052Member_c0b9e082-297a-4af8-a581-4e9bed195c24_terseLabel_en-US" xlink:label="lab_bmy_NoteDue2052Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2052</link:label>
    <link:label id="lab_bmy_NoteDue2052Member_label_en-US" xlink:label="lab_bmy_NoteDue2052Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2052 [Member]</link:label>
    <link:label id="lab_bmy_NoteDue2052Member_documentation_en-US" xlink:label="lab_bmy_NoteDue2052Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2052</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2052Member" xlink:href="bmy-20220930.xsd#bmy_NoteDue2052Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NoteDue2052Member" xlink:to="lab_bmy_NoteDue2052Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f3dc6d4b-7862-422d-9383-f6c1d3690991_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1d27409-7bae-4023-8a96-ac56d7d75ee2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d002c196-4604-4754-8588-0c5d0eb0e557_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_53f18b44-ec77-44df-8bb3-0a1bcda021a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_ec73f543-49e5-43b7-8952-ed416a0a56be_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_9dbb0622-229e-420c-9722-5ce9d5d09f22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b5a2f541-db1f-447b-bc82-f596fa73e501_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_3ca055cb-9c11-430f-8ba2-ac0c6481cff2_terseLabel_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_label_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_documentation_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:href="bmy-20220930.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:to="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_fbd9f9af-f3b0-414f-b99a-5382f4e6a17d_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_5e916bf2-dcd6-4f47-8166-3efb78a3192a_terseLabel_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220930.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c90a114-5fed-4d24-a353-4d4d97e882fa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_86a5b326-aad7-4bda-8a79-f998d089cc5a_negatedTotalLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:to="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_536394ec-cdaa-4a09-b964-494dd4a5db70_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_611bc61d-8bee-4d40-b544-3944e0cb93c9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2f391ddb-ed20-4c76-9e74-f710bfbab882_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_c952d20c-7c68-457b-a182-68f7a6de1729_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:to="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d5df24cd-f06b-4d57-b881-e939a2ff5289_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_bd8e68e3-cd23-44fd-9be0-53ec4a93269d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_53d45771-2252-44b3-bfdd-f93377be8370_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EisaiMember_7914bb76-0a06-4b09-9792-96696b6d7796_terseLabel_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai</link:label>
    <link:label id="lab_bmy_EisaiMember_label_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai [Member]</link:label>
    <link:label id="lab_bmy_EisaiMember_documentation_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember" xlink:href="bmy-20220930.xsd#bmy_EisaiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EisaiMember" xlink:to="lab_bmy_EisaiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2e1bc1db-d208-4781-96e9-f12d1272790e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BridgeBioMember_1c3e883a-3874-49e7-bc16-8727805cc6e0_terseLabel_en-US" xlink:label="lab_bmy_BridgeBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BridgeBio</link:label>
    <link:label id="lab_bmy_BridgeBioMember_label_en-US" xlink:label="lab_bmy_BridgeBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BridgeBio [Member]</link:label>
    <link:label id="lab_bmy_BridgeBioMember_documentation_en-US" xlink:label="lab_bmy_BridgeBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BridgeBio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BridgeBioMember" xlink:href="bmy-20220930.xsd#bmy_BridgeBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BridgeBioMember" xlink:to="lab_bmy_BridgeBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb6544da-a638-42d6-9d26-387e3b2d3ed2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_11641fce-2dea-44c2-b9a7-0faa98e98fcc_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_b1ee7e5d-f3c8-4ec9-b25f-931e44cafd8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e03213ec-9a7a-49cf-b639-8741eb9897e5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2961de98-d097-4e91-bb88-478eb8ea3344_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dd50847f-6af4-4e26-8856-135e783dc767_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_585c056b-1c1c-4084-ab6b-637c5c4142c2_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as net investment hedges</link:label>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:to="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_3215553b-da2e-42e1-ac75-842e80da4f6a_terseLabel_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_label_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties [Member]</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember" xlink:href="bmy-20220930.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_KeytrudaRoyaltiesMember" xlink:to="lab_bmy_KeytrudaRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MarketShareUnitsMember_3e74a77a-7d50-4ff1-bfc9-6d5161f128f7_terseLabel_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units</link:label>
    <link:label id="lab_bmy_MarketShareUnitsMember_label_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember" xlink:href="bmy-20220930.xsd#bmy_MarketShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MarketShareUnitsMember" xlink:to="lab_bmy_MarketShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_a2bfc91e-e080-4efc-83c2-dbc7fce8e04b_negatedTerseLabel_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_label_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_documentation_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome" xlink:href="bmy-20220930.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationOfDeferredIncome" xlink:to="lab_bmy_AmortizationOfDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_820c5fad-f8d0-4e04-ada6-ae3b768ca3a5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_726d2fdd-4d0c-49f2-9e57-6ac9d4f941e3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cea360f0-5b8d-44a5-a3a6-4aeb765e5be6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_05fd6544-a6c2-459e-9f34-a094285b5071_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_86962ff6-9e5a-4391-8491-be60a970b581_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_79bff04b-1726-46ce-acfa-90d5ce6bc09c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_e0c4b765-c656-4130-8d0d-5052893f4b16_terseLabel_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_label_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:href="bmy-20220930.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:to="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_94c9cd45-f225-46f4-8845-c2b15d974ac9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InrebicMember_62f65118-829b-4c93-8d50-355936a6c746_terseLabel_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic</link:label>
    <link:label id="lab_bmy_InrebicMember_label_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:label id="lab_bmy_InrebicMember_documentation_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember" xlink:href="bmy-20220930.xsd#bmy_InrebicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InrebicMember" xlink:to="lab_bmy_InrebicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d84ca012-aaa0-48aa-9f39-30a2165ffda4_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_a7a17ab8-22cb-4482-8cda-f72b6e4e37d1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_f3921f88-70aa-4857-939e-6d0a7faf5c54_terseLabel_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies [Domain]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_label_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies [Domain]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_documentation_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:to="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_2824aafd-e590-4e98-a4a6-5048e5e49c73_terseLabel_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:href="bmy-20220930.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:to="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c3395474-4119-44db-b426-ba2600ecad59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_c18731d2-0126-48d4-a91c-41633316bcbf_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_12a3231f-031c-4331-bbe5-e973cf873b51_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6c8dea13-2bc9-45a7-b518-b6feb8dda181_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_481eef9b-d858-4f0b-b3b6-4f0a8f083e4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_58a8210d-053d-4a4d-8293-a7cf737ef012_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5bf466b1-c9d6-477a-848e-6b89a759e72e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_be0f5339-4f77-446d-b759-03a6c37ae12a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0fd403c3-ade5-4c77-9723-e1e57bbc2994_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e7128dee-bac6-4530-a976-b89147d454e7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;in Excess of Par Value of&#160;Stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_cd704d0e-f2c8-4fde-9e2b-23862ac1e81e_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_48804d30-45c1-41c7-a906-06d9d61787be_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e4eabc4d-d523-4618-9c3c-eebc04264214_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_9505f61c-a7eb-4387-8c38-34b246c84b1f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_3bbea1ef-d040-4bf7-80bd-00bb83ca0408_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_ed293a70-1b46-4fba-a201-68c8f06d9e02_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_494616b3-8f80-493d-b29c-b22cdb9acc8e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Common Shares Outstanding - Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5d31f731-97fa-49ec-80e6-0af02f47fb55_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_984d9378-2b9b-429d-befe-dd4a63452758_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_3f42b2bb-12d7-40b8-a1f0-31724d629110_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LitigationTable_42366131-cd69-4d3b-99a5-9a758fff0de3_terseLabel_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:label id="lab_bmy_LitigationTable_label_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable" xlink:href="bmy-20220930.xsd#bmy_LitigationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LitigationTable" xlink:to="lab_bmy_LitigationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_4d9b1bfd-c54f-4712-a4d0-fb5dabea2841_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_c93df759-d463-4ee7-a872-6a8dbebd98bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_label_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Bank Loans and Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_afe5e42a-6eaf-49cf-827d-4335f034b99a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8bcf300b-186d-4749-9646-40f627e56aaf_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_0ca7ca23-45df-4b27-9daa-db0bb69d5163_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and downward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_4ce7b45c-fc10-4280-b8f0-e13e03da5884_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance revenues</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d5bf294d-fa8c-470b-a91a-23bfc855ba5a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_34049b93-14ac-4951-90b7-dc867de14e19_terseLabel_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies [Axis]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_label_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies [Axis]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_documentation_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:to="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_3592dc28-3bac-45e1-8e80-0281745ce506_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_01592da5-dd59-42f3-bc68-6bc2be9b6b58_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_b193aa1b-39af-4461-b102-2b8e11461c8f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_6bfc90db-3c5e-4e38-8e84-62d15b9f7e22_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_27da0c06-15a9-4a16-adb3-a63534f7d920_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b7aac065-3fd2-470f-9fd8-ced83b95ec4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_d299baf5-417c-480d-9c76-80ef768c292e_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:to="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_c4ac66e4-2253-4833-bb3b-59d3fbf03971_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Gross to Net Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:to="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c15c970c-6f8b-4a9a-8a4c-537720541f25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e0bc13fe-58b9-4912-8531-57319ad1d76d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_577a6074-860a-4112-84b1-821af53f16b4_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reasonably possible decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c678c93b-a4d2-41af-991e-df180747e8f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_faedbccd-89d2-44c0-a8a6-a6d6a9d4ef3f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at End of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d4cb2ba6-6c6e-4b21-bfe6-815ffdaf05cd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_37c29c96-479a-4e32-ad6b-1aad2eba86d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_615c8633-a8d5-47de-bff3-0c3012fe2042_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_0c71cfb0-8034-4ff9-9794-1a8216e9097f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_acb68f34-4f5f-4688-be4d-85fd5a45bf00_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_8379d25e-a2c5-40b5-aa71-110b39d5af1e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partnerships and other equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_b251d125-2172-4ed7-9884-37b2147af84c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9f2252a3-78b9-4f50-b38c-d7064a61db8c_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8f6f5044-f4f3-421e-bd7a-89aa62c8e0db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_92957df1-b1c1-4f2e-8987-30788befcdd2_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed cases</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_297b21dc-2113-4812-8eeb-23740ab06d37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_963706a6-7ef9-4259-8a76-60a8a89a2be8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for CERCLA matters</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_64fed8a6-b0cf-4a1e-9ba6-d5244dc7a40a_terseLabel_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized basis adjustment from swap terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_label_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Basis Adjustment From Swap Terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_documentation_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:href="bmy-20220930.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:to="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f839f8a5-4585-462a-bd7f-9ca804b07183_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0f05faab-bb6c-415f-876b-ca6c15060f05_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_0241a15c-ba3f-4014-923f-52e136c2085c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate debt, lower range of basis point spread</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8612c5b-8703-4cab-a6d9-938c32cfa5a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_0c22b276-31f1-40b3-901d-ab57750b84dc_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_34af2821-c8bf-411f-a0fb-ae24083cfd8c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3ee845d-9dfa-4c4c-bc54-ce1bb69a74c8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f2d3f823-b65e-4470-a13c-6c4f0bbb1abd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bfcfd954-ecce-49a9-af9b-44aaebd0c538_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e851ea86-32b3-4be4-8b2b-40f958951a7d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_2e21142d-5863-4061-b4cf-97d0f1645973_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4ae280e6-f23e-4acf-ab00-c65eb43d83ec_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_ee62533f-1219-4eb7-9ca9-68e2bd3a9976_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00fe9ada-bdb1-4078-9f88-903148f1ecc0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3eda034d-c124-40c5-b097-f275a78bde3a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_515a45a9-af60-4e84-86e6-39abe9284613_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A3250BondsDue2022Member_e6c103c9-2279-433b-b74f-dcbf9f54ed96_terseLabel_en-US" xlink:label="lab_bmy_A3250BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Bonds due 2022</link:label>
    <link:label id="lab_bmy_A3250BondsDue2022Member_label_en-US" xlink:label="lab_bmy_A3250BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Bonds due 2022 [Member]</link:label>
    <link:label id="lab_bmy_A3250BondsDue2022Member_documentation_en-US" xlink:label="lab_bmy_A3250BondsDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Bonds due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250BondsDue2022Member" xlink:href="bmy-20220930.xsd#bmy_A3250BondsDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A3250BondsDue2022Member" xlink:to="lab_bmy_A3250BondsDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_ce2d6aa0-a14a-4531-9dff-faa40f6eb420_terseLabel_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.550% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_label_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.550% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_documentation_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.550% Senior Notes due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member" xlink:href="bmy-20220930.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2550SeniorNotesDue2021Member" xlink:to="lab_bmy_A2550SeniorNotesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_e8d56806-b2a0-4337-bb90-5782ab32a293_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:to="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94c077ae-cd72-4580-8353-83cdaea77576_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_aadf3c16-214b-4e79-b8e2-e1dde758cadb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_c403f1e3-24f7-4f24-9dc9-ca5a7fc0259a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_68742326-64df-4eb4-b1a2-aa1950888f1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9f6fbf88-8aa4-48e2-80fb-a568e1464151_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_97e45859-926c-404d-9a55-a3df1b5911aa_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Totalinventories_57a34c74-05e9-429c-bc4c-5d75aa58dbed_totalLabel_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_label_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_documentation_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the total inventory, current and non-current, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories" xlink:href="bmy-20220930.xsd#bmy_Totalinventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Totalinventories" xlink:to="lab_bmy_Totalinventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_f3372a0e-9a34-4d84-82b8-27baea48102f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_4407b361-de5b-4881-93d9-29b372d56699_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameDomain" xlink:to="lab_bmy_IntangibleAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_7556c300-1bed-41e2-85b6-e6a795a7c2b0_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b0c42b46-d55d-4f19-8dac-46128d2e5de8_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization, net</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_2a231b69-1123-4fe2-9ee8-05b90645d022_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_07d08261-f766-48c1-9bcd-6830767a5b59_negatedLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_0c08deea-c73d-4a01-bfc4-140b00fc25ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty income, nonoperating</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:to="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_2f75f682-fc2e-4d5a-a46d-f458dd63de2d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AgenusMember_8d3b92db-f3c1-419f-b93c-80eb6062e847_terseLabel_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus</link:label>
    <link:label id="lab_bmy_AgenusMember_label_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus [Member]</link:label>
    <link:label id="lab_bmy_AgenusMember_documentation_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember" xlink:href="bmy-20220930.xsd#bmy_AgenusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AgenusMember" xlink:to="lab_bmy_AgenusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_ae5016ce-192b-48ea-bd17-f77634e25714_terseLabel_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_label_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_documentation_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:href="bmy-20220930.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:to="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PomalystImnovidMember_510a7cb9-b61e-401c-9b25-1fc689a7bdbf_terseLabel_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_label_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_documentation_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember" xlink:href="bmy-20220930.xsd#bmy_PomalystImnovidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PomalystImnovidMember" xlink:to="lab_bmy_PomalystImnovidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3d92a3e9-d65a-44e0-8796-0ca73a2fabe4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_994b99e0-634e-47a1-a1a6-13dda58ba367_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_adfb5e80-c143-4e54-9edf-8ace163ee963_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f4ed7fee-3d2e-484f-bb7c-cc86862318cb_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_1f1c538d-bd74-4fd3-9cb2-35c6777eb513_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and regulatory milestone</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:to="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DragonflyMember_53d4d5d5-300f-40ce-af44-393f1c56dfe6_terseLabel_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:label id="lab_bmy_DragonflyMember_label_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly [Member]</link:label>
    <link:label id="lab_bmy_DragonflyMember_documentation_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember" xlink:href="bmy-20220930.xsd#bmy_DragonflyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DragonflyMember" xlink:to="lab_bmy_DragonflyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30d8cc86-0f2a-4ed8-a701-a7ae4a926ae2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_b4072c13-0586-4c69-977b-37a25b1d2979_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8d085ced-9743-4b1e-98d0-1ba9b6a7af82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a567f195-f0a0-4dc0-a836-08b2b1023f28_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_b2fd51f6-f63c-4890-9e4c-47447de3a3ca_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_9ec0c289-beab-48b3-9cab-d22a22fe1837_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency interest rate swap contracts gain:</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:to="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_e183bc4a-4ffc-4118-829f-5511fb8db96b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_c175e730-850c-4336-9eec-e3ee56231989_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2019ASRMember_07d2b621-e392-45ff-9d32-2ea0f38e0784_terseLabel_en-US" xlink:label="lab_bmy_A2019ASRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 ASR</link:label>
    <link:label id="lab_bmy_A2019ASRMember_label_en-US" xlink:label="lab_bmy_A2019ASRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 ASR [Member]</link:label>
    <link:label id="lab_bmy_A2019ASRMember_documentation_en-US" xlink:label="lab_bmy_A2019ASRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 ASR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2019ASRMember" xlink:href="bmy-20220930.xsd#bmy_A2019ASRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2019ASRMember" xlink:to="lab_bmy_A2019ASRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_10220b71-f50b-48db-b378-30301736ad0f_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cost of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9ad9cca3-815c-4691-b135-4269aaf68a22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_759656f2-8946-4f72-8ade-9de3a38df879_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_4b29e038-9ae8-439b-8971-f7ea89e9e9a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/Expense, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2022ASRMember_512a6e3f-7968-4d98-9171-da4cf4c38883_terseLabel_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:label id="lab_bmy_A2022ASRMember_label_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR [Member]</link:label>
    <link:label id="lab_bmy_A2022ASRMember_documentation_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember" xlink:href="bmy-20220930.xsd#bmy_A2022ASRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2022ASRMember" xlink:to="lab_bmy_A2022ASRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_137172f2-4d67-4916-af44-46aca007f677_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_368f7927-d9f7-4ed0-beda-85d0d4d36a0f_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture (Gains)/Losses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_bbe77d37-0818-43ab-89cc-e528255686e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gain</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3d5c6540-7b85-4746-937c-41636e664cc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture losses/(gains)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_67cbec42-8f79-4566-8cc5-c81f3127430d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Allowance for expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1d55c3ef-420a-46d2-b0c5-de0ed55d2b68_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2075c2e6-33b8-4694-9509-fe4ceab4db37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_445658eb-14b9-41d7-83b9-36f3633a969d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_594dbe12-5ebf-4b79-af60-7b5a94a1d428_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_75135f61-1cea-4634-992c-ba9d7242cac4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3122e77f-a4d9-40ee-a905-fccb27ad7b2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0bd24075-5024-411e-b682-4681b93d2e01_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3aefc4d3-dea6-47f9-ad9a-6a72543936db_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_2eaf65e6-6991-45a0-a911-5d06f1b176f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d83fcffc-c1f3-4e23-a101-119f8588716c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4a8d4c22-05a7-4905-8646-d427e3c8ccaf_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_8e78bfcb-7fcf-41d9-b648-256c34f86443_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_422240bd-6125-4446-ba4f-f5aeffa419b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1267dc0c-dfae-449f-8a6b-f31a96c28fc5_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTable_85494729-edf7-42d7-a88e-5de7df10fa67_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneIntegrationMember_bd62466e-f184-4794-b94b-69500a046576_terseLabel_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Acquisition Plan</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_label_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_documentation_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneIntegrationMember" xlink:to="lab_bmy_CelgeneIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af605c34-5a51-4eb9-ad2b-823333aa787e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_d829c375-00d3-4802-a2a0-c89b41aae3ef_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash for contributions and settlements</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_7088e305-236c-45a9-9dbe-51ad1fff2e7e_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3995b89c-37bd-4b28-9a2e-949e66428541_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherShutdownCosts_7bf3fc38-e087-47b0-8244-f1794b86a07a_terseLabel_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs, net</link:label>
    <link:label id="lab_bmy_OtherShutdownCosts_label_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs</link:label>
    <link:label id="lab_bmy_OtherShutdownCosts_documentation_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts" xlink:href="bmy-20220930.xsd#bmy_OtherShutdownCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherShutdownCosts" xlink:to="lab_bmy_OtherShutdownCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4fbe9778-f758-4a32-8164-d600787cd169_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_9c65eca4-8804-4ecd-bbfc-1d717a470a75_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_b028ecab-0c11-41b7-aff4-9edc37483ecd_terseLabel_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_label_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035 [Member]</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_documentation_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One750NotesDue2035Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member" xlink:href="bmy-20220930.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.750Notesdue2035Member" xlink:to="lab_bmy_A1.750Notesdue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_c0b65587-5e4e-47f7-b2d7-ff59d19f7652_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_9cc740f2-6198-4cf4-b0b3-096062976a10_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:to="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_0049cb78-abb2-4c2d-907c-7a5a2b09d105_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4f50dd96-f568-4636-8621-00e492021bde_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_954cd425-04be-4322-8cc5-d2fdec366499_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_bff4c0fd-262c-490a-9929-5e91dfcef1f4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_834859f6-28f2-49cb-962b-a77e1c927d87_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NoteDue2032Member_b601624f-e2bb-4ddd-adc7-4dc36b8fe986_terseLabel_en-US" xlink:label="lab_bmy_NoteDue2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2032</link:label>
    <link:label id="lab_bmy_NoteDue2032Member_label_en-US" xlink:label="lab_bmy_NoteDue2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2032 [Member]</link:label>
    <link:label id="lab_bmy_NoteDue2032Member_documentation_en-US" xlink:label="lab_bmy_NoteDue2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2032Member" xlink:href="bmy-20220930.xsd#bmy_NoteDue2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NoteDue2032Member" xlink:to="lab_bmy_NoteDue2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_9eaa79be-b67d-4b3b-a4d3-51e35272face_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_25721f8b-2803-4ab1-9de8-bd2eb58821ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_11867885-4e57-472a-98cd-9ead8b0225c7_terseLabel_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_label_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:href="bmy-20220930.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:to="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_99851e79-add0-46c6-a3a6-bb416db1a968_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_de638074-2721-40f5-9ce7-b57c5e25707d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_293fcde3-39c4-4900-906c-dbf41716ec9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_e0b7bc2d-c960-4ade-a24a-9401d7e8b224_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_fcbdc3bc-6b97-495a-a131-83fdb7eb86a5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts gain/(loss):</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivatives [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:to="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d6838d4b-43cb-4c11-8b3f-81bad0cbf24a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bc89f06b-5d86-4053-9e89-9d3d116dbd42_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnuregMember_44480313-ae2e-49be-bb62-48275ac1930d_terseLabel_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:label id="lab_bmy_OnuregMember_label_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg [Member]</link:label>
    <link:label id="lab_bmy_OnuregMember_documentation_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember" xlink:href="bmy-20220930.xsd#bmy_OnuregMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnuregMember" xlink:to="lab_bmy_OnuregMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_c26b62c3-ef70-45f2-9c71-24c7dc75b3b6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_080af226-56bf-41ca-b07a-064aea807b9f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_a5ea4c68-91ab-4224-bfcb-e91a889ebcc8_totalLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, total</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_727f6d45-83fd-4f93-845a-0e876fc356d0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CashDiscounts_22d1e06e-9117-4740-8a70-ad136b464d3e_negatedTerseLabel_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_label_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_documentation_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts" xlink:href="bmy-20220930.xsd#bmy_CashDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CashDiscounts" xlink:to="lab_bmy_CashDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_bd7a1b50-f6ad-44b4-be07-95e6e4fd55d1_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties and licensing income</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_label_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Received From Alliance Partners</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_documentation_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:href="bmy-20220930.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:to="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_3675a7fb-1194-4774-9a3d-d7ee80d4056e_terseLabel_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost savings and avoidance</link:label>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_label_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</link:label>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_documentation_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:href="bmy-20220930.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:to="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_3ff1fbe2-8ee9-4aa4-8aaa-7608fc42b67e_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7f82e7b6-e843-4e97-9167-e09a33c2c1ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_c627d88b-6dc5-4817-a7af-b5f2927f5241_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_833f66b2-4b3a-41c3-93c3-01bb040655eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biohaven sublicense income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncome" xlink:to="lab_us-gaap_OtherNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_55148204-166e-4234-a96a-9cdc09ae9baa_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_12d9d7e8-a567-44f4-8cdb-7b01d4ad5326_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance, Royalties, VAT and other</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4db2a369-43b5-4706-8dbd-e4fbe4e2551a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2a9434cd-0598-4afa-8168-3385d9ed99a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_5f67eb6b-5e90-4847-8370-9a5cafa0dbe9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdivoMember_1bffda35-0e3e-4943-b844-25a552939136_terseLabel_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo</link:label>
    <link:label id="lab_bmy_OpdivoMember_label_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo [Member]</link:label>
    <link:label id="lab_bmy_OpdivoMember_documentation_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember" xlink:href="bmy-20220930.xsd#bmy_OpdivoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdivoMember" xlink:to="lab_bmy_OpdivoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f023dc5e-fc8f-4dda-b56a-012d7f494540_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c2e6cde-a70a-422d-bf66-7818d895887c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_61737825-cf9a-46bc-b2cd-f225afb6d26c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d25b4e76-5c5e-4c55-8df2-84561b0ce855_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdualagMember_ded2c225-db95-464a-84fa-eee43125ac0a_terseLabel_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:label id="lab_bmy_OpdualagMember_label_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag [Member]</link:label>
    <link:label id="lab_bmy_OpdualagMember_documentation_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember" xlink:href="bmy-20220930.xsd#bmy_OpdualagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdualagMember" xlink:to="lab_bmy_OpdualagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_f0b6d013-6c49-47fd-a46d-cf15fc703464_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_986b8464-37bf-4f7d-ad10-4405a0b56cfa_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &#8211; to alliance partners</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_abdae58d-b5f0-4bbd-a917-fe5f1610fd0e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_f88e55e5-c266-4381-b383-a67e28f7f85f_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_4c5435bb-27ab-404c-92f1-3db120819c75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_962fd5ac-c844-4ba7-ab82-b7cb97da3884_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized bond discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_2ce15538-1dd4-47f5-bb8e-7d9da096b4c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determined fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_fab95725-3865-4ba9-b2cb-92243ea21190_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestitureandotherproceeds_8a963a50-bf3a-4499-8ee3-c17116bdf08a_terseLabel_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_label_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_documentation_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds" xlink:href="bmy-20220930.xsd#bmy_Divestitureandotherproceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestitureandotherproceeds" xlink:to="lab_bmy_Divestitureandotherproceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_17fd1c48-be1b-47a1-90c8-5eb51808924e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_fc47b338-c48d-4dc3-9a3a-4b2c51c3d854_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d522d229-362f-4a56-a1b6-8c2e8ba886f5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13032ebc-413b-4c5c-8d93-1fe6eb0a4aea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Common Shares Outstanding - Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_465d2378-b399-4669-a25e-375fe7ed04c2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_70d67d03-b01c-455c-bfa0-bcd253694603_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_64b2f261-0716-4c3c-9359-23e38f5b8714_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BiohavenMember_c4a2e915-09e7-466e-801f-88c0328a453b_terseLabel_en-US" xlink:label="lab_bmy_BiohavenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biohaven</link:label>
    <link:label id="lab_bmy_BiohavenMember_label_en-US" xlink:label="lab_bmy_BiohavenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biohaven [Member]</link:label>
    <link:label id="lab_bmy_BiohavenMember_documentation_en-US" xlink:label="lab_bmy_BiohavenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biohaven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BiohavenMember" xlink:href="bmy-20220930.xsd#bmy_BiohavenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BiohavenMember" xlink:to="lab_bmy_BiohavenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2.600Notesdue2022Member_f9c2ce5e-1217-4e84-8d7c-8d82f7587cd7_terseLabel_en-US" xlink:label="lab_bmy_A2.600Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.600% Notes due 2022</link:label>
    <link:label id="lab_bmy_A2.600Notesdue2022Member_label_en-US" xlink:label="lab_bmy_A2.600Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.600% Notes due 2022 [Member]</link:label>
    <link:label id="lab_bmy_A2.600Notesdue2022Member_documentation_en-US" xlink:label="lab_bmy_A2.600Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.600% Notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.600Notesdue2022Member" xlink:href="bmy-20220930.xsd#bmy_A2.600Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2.600Notesdue2022Member" xlink:to="lab_bmy_A2.600Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_a721d82d-a3d6-435a-bfb9-56a3f6a9b3d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a459d211-0abf-480b-99a1-1539056d359f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_627df8d4-bf54-4353-996c-542d37d685d9_terseLabel_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Products and Other</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_label_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other [Member]</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_documentation_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember" xlink:href="bmy-20220930.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureBrandsAndOtherMember" xlink:to="lab_bmy_MatureBrandsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SprycelMember_840e794c-77fb-448e-9ffa-797083e89a42_terseLabel_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel</link:label>
    <link:label id="lab_bmy_SprycelMember_label_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember" xlink:href="bmy-20220930.xsd#bmy_SprycelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SprycelMember" xlink:to="lab_bmy_SprycelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e18a145f-34d5-4853-8607-d3d93e77ce11_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_eb8ad24f-c775-4cb9-a51a-6099684b33f6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BristolMyersSquibbMember_6eab173e-6016-48a9-9522-1f2d63342506_terseLabel_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_label_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb [Member]</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_documentation_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember" xlink:href="bmy-20220930.xsd#bmy_BristolMyersSquibbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BristolMyersSquibbMember" xlink:to="lab_bmy_BristolMyersSquibbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_32b85916-87b3-427d-ad5e-d0099f512152_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ca7dbf7b-d3a2-40d2-8d84-b71b59bc6dda_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bad2bb02-18bb-43db-ab69-086232d28163_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cf174ee3-70e6-4984-b15a-3ef507b537c2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LOTTECorporationMember_47f5f6d0-0508-40de-86b7-aa4102f978ac_terseLabel_en-US" xlink:label="lab_bmy_LOTTECorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOTTE Corporation</link:label>
    <link:label id="lab_bmy_LOTTECorporationMember_label_en-US" xlink:label="lab_bmy_LOTTECorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOTTE Corporation [Member]</link:label>
    <link:label id="lab_bmy_LOTTECorporationMember_documentation_en-US" xlink:label="lab_bmy_LOTTECorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOTTE Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOTTECorporationMember" xlink:href="bmy-20220930.xsd#bmy_LOTTECorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LOTTECorporationMember" xlink:to="lab_bmy_LOTTECorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_0e624411-8d40-470e-a1d9-d1161fc703fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b28cab1e-035c-47e5-b3bd-d6d44ccc9592_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested Stock Awards</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_dedc6848-8ccd-4493-b38e-9c73e42cd3ea_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages paid</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_af50d2b0-d472-4f1a-82f2-42930281edc4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_7f475ae5-b657-48f2-83a3-2206721eb77f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c4ef5de2-0014-4d4c-a123-2089f3fbe9d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f359079-ea20-4eee-9f5d-fd1cad6c17a9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLineItems_5f862547-48f5-42bf-bb59-10a7fdb90ee8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_faf0d73d-78e0-41dd-bf29-4dbc665db596_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Benefit Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_98b0bdca-0803-4d14-b1e1-d898a1cb0c88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_704c31c0-b616-4311-8d51-0c491fb01db9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3d252c96-946a-4f26-b616-fffb733f976f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0b63cb30-2744-41e6-8134-2f3829eed31e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_93e54a42-d964-4654-864b-023139bcd005_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d836f074-89b2-45fb-b755-ce22e42209b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_5ff01981-41ea-470a-8c3f-2f26edbaa57d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_faf050f7-4b72-4c84-bee5-bfd261a85a9f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_005d6478-8bd8-4760-b7d7-3966cffe725e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation to holders of the contingent value rights</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_683d6417-fabe-429b-9135-b43925f77504_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_4f0edfcb-6f95-4d6c-99d7-d89762d90d35_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_7e9dffb6-f242-48bd-99c6-654429a06a58_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw and packaging materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_c513220f-2958-4466-92f7-6d38a04415b4_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f5e5c847-6468-4325-95a2-3cca983b7d93_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_5c8e7844-b8b3-4376-be63-c1a259ecb3b5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-derivatives qualifying as net investment hedges</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_c9c63720-1052-49d5-8d19-c3c5d866a4e7_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityMember" xlink:to="lab_bmy_AbilifyProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_93596725-9e60-4591-b668-a4599cfdeb89_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Shares Attributable to Share-Based Compensation Plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_bb46526c-5314-41b9-8c2c-15ce6f2466cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_f931487e-27c3-4d21-ade4-5952c53f0a42_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims, active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f4c0d449-b4e8-4c73-8b4c-38e5d45f62a7_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestments_a87420aa-8b33-4f7c-afb8-59e4439af0a2_totalLabel_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_label_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_documentation_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments" xlink:href="bmy-20220930.xsd#bmy_EquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestments" xlink:to="lab_bmy_EquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_edf1c050-c888-4215-b684-a2e5c2225419_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6b98c72b-65d1-4c90-a9de-eae775453c35_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other payments, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8755c152-e37e-4c0c-a10a-1bd1cb05a9b5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4c49a040-ae59-4390-b00b-b201a9256665_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3f830e5e-76c7-45e4-9aed-d84d3b152e0e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_80a6d069-4ff8-48e3-a578-37a38d7aa65a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_aac51027-fa7f-4383-93d6-f8f6a38f91a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_55c2dfa7-fc2c-4d2a-8352-7e4e4c797c44_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d0cf9f4e-662f-4345-be51-2567f1fd9415_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0effd467-7567-451e-8494-3c7c97ac8433_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_24abc10d-eb90-4ec6-b949-7c5add7fe7e7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock_dde7d69d-b3b8-4a47-87ee-ac913bae18a7_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-Term Commitment</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-Term Commitment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" xlink:to="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OrenciaMember_cb666592-49c5-4ef0-ba52-3ecb9fdc45bd_terseLabel_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia</link:label>
    <link:label id="lab_bmy_OrenciaMember_label_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember" xlink:href="bmy-20220930.xsd#bmy_OrenciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OrenciaMember" xlink:to="lab_bmy_OrenciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DiabetesbusinessMember_ce8cd872-5eac-4736-8a85-cc394f7593b6_terseLabel_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Business</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_label_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_documentation_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember" xlink:href="bmy-20220930.xsd#bmy_DiabetesbusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DiabetesbusinessMember" xlink:to="lab_bmy_DiabetesbusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_1bfedb8a-a5f5-497a-8176-5ad04a859d2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_b4ab5343-618c-4102-909d-3b1ca37573eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3e3f12b9-3e3c-4215-8d83-8624fe7082d8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2809fa9d-dba9-4eba-bc1c-eb547508e174_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_84d617b8-1ce9-4bea-9f9e-277250477439_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_8a9d0148-fba4-4997-981b-35cb4ea96aed_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_c51e5b4e-a9d4-4e42-8830-5bf6bdd9c755_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_f6a43498-f5b0-418b-becb-9e28b94eb2ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_dc017902-a5ef-4b23-aaa7-637e426c9339_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncome_942b7eed-69ff-4246-be35-dbfacb99122d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income from alliances</link:label>
    <link:label id="lab_us-gaap_DeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncome" xlink:to="lab_us-gaap_DeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_ffeca629-b894-4a63-ba3d-abc82640aace_terseLabel_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected synergies, percentage</link:label>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_label_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Synergies, Percentage</link:label>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_documentation_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Synergies, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage" xlink:href="bmy-20220930.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ExpectedSynergiesPercentage" xlink:to="lab_bmy_ExpectedSynergiesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b0419bb7-4ea4-4975-b296-78457f8cfff6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_17fc6af3-1c86-4c70-8940-7b234ab3ec2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_08178469-a5ca-4aa8-a8d2-7e8543d2bb44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_9982ab3b-0f0a-4393-bc0b-c799b01fb57f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EliquisMember_32fc1c28-f4bd-42f5-bb1e-1f807ebdc752_terseLabel_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis</link:label>
    <link:label id="lab_bmy_EliquisMember_label_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember" xlink:href="bmy-20220930.xsd#bmy_EliquisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EliquisMember" xlink:to="lab_bmy_EliquisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_37cdfac5-29e5-4a33-8c93-bea9426f17d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss/(gain) recognized</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1ee66003-cd00-4993-9aae-b882449f58a9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_b9e0979b-c4b6-42e1-b7eb-9d2815440be3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ba67dd68-6957-431e-8907-061bda7613d0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_0f68ccee-d4e9-43cd-908c-2fdf222c77cb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. dollar borrowings gain:</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EmplicitiMember_d456fa07-e06d-4023-a117-ee045e4ea77a_terseLabel_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti</link:label>
    <link:label id="lab_bmy_EmplicitiMember_label_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:label id="lab_bmy_EmplicitiMember_documentation_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember" xlink:href="bmy-20220930.xsd#bmy_EmplicitiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EmplicitiMember" xlink:to="lab_bmy_EmplicitiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_a33ce4db-a17a-4276-a372-5b7e216367b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss/(gain) recognized on investments still held</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_892edc20-4f68-44e4-9f1b-5ed1088fb362_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e9b5503e-67d3-4700-9a42-e377d454eef8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_103566c0-a2c1-475b-ae5f-0f7e451718ea_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_006dc742-fe1a-41ea-bce3-a049eae23112_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_1ad178b9-172c-4a50-95b7-2c007bfe171e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative impairments and downward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_84135dbb-8665-4e58-9bd8-867f15e26038_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation and other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_36ca9699-a435-4ccd-8e40-9614dee722a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a8dfcb89-6b62-435e-9a7a-f1cacef9f0b1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_f4e8e561-555d-42f0-8857-d9ea0a1e9679_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_902cb299-8f7b-4bf6-84c7-e4dc60c2d741_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_601508c9-55d7-4b5e-bf04-0bcd5c8270e3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_e1ed92d4-ab1e-46ca-ae89-a4bbd8997dbf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_9f93acf2-3bd6-4860-b41b-61fb8d49a0ac_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b700764f-c5e9-4581-820f-25178d66ed98_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_316cb880-4a66-4f0e-9c20-5786bfa186fb_terseLabel_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220930.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c8e3c4b5-333d-44c8-b10b-2aad0e5c8a15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_05ab3313-e123-4703-acb4-09156a0175c7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_ed27416e-fd1d-4960-82f2-00a08ce617e7_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_03a05469-f029-4dfe-965c-8574c55fdfd1_terseLabel_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220930.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5931f6f8-d625-4cca-bf64-0d824843e135_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value and Other Adjustments to Long Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_f0f75884-e5d5-47e0-bf71-f8cab2721051_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReblozylMember_92de9551-c6b4-4105-a476-dee41bb10d7e_terseLabel_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl</link:label>
    <link:label id="lab_bmy_ReblozylMember_label_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:label id="lab_bmy_ReblozylMember_documentation_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember" xlink:href="bmy-20220930.xsd#bmy_ReblozylMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReblozylMember" xlink:to="lab_bmy_ReblozylMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_61bdb0fe-7632-4752-a0aa-87ed0af23d95_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_a4b94b54-9ef5-4c31-88cf-ce2b281349e6_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_label_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Cash Flow Hedge Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:to="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_6636bf68-457e-4776-805d-29554f300934_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_7682f109-1b0d-4b4a-9556-7fb959b697b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of equity investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_6fc40c83-0c26-4acb-b1f1-7a2d55826a8d_terseLabel_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. receivables sold on a nonrecourse basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_label_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold On Nonrecourse Basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_documentation_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of receivables sold on a nonrecourse basis during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:href="bmy-20220930.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:to="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_a1d7ccd2-38ed-4a2f-9f33-0097b7318dfc_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:to="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2250SeniorNotesDue2021Member_391610df-668e-48ed-aeeb-334ca93fecf8_terseLabel_en-US" xlink:label="lab_bmy_A2250SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2250SeniorNotesDue2021Member_label_en-US" xlink:label="lab_bmy_A2250SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2250SeniorNotesDue2021Member_documentation_en-US" xlink:label="lab_bmy_A2250SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2250SeniorNotesDue2021Member" xlink:href="bmy-20220930.xsd#bmy_A2250SeniorNotesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2250SeniorNotesDue2021Member" xlink:to="lab_bmy_A2250SeniorNotesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3415709c-dce9-47b6-9750-aedd56561909_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9ec8bd89-73f7-4b5a-a50b-3a4704d23dc5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbraxaneMember_28ad6ae6-8b1f-4b4b-9852-66f468240bae_terseLabel_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane</link:label>
    <link:label id="lab_bmy_AbraxaneMember_label_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:label id="lab_bmy_AbraxaneMember_documentation_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember" xlink:href="bmy-20220930.xsd#bmy_AbraxaneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbraxaneMember" xlink:to="lab_bmy_AbraxaneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_ade3e478-d6dc-42c9-ba0b-fb49adbc3c58_terseLabel_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for provisions for product sales made in prior periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_label_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_documentation_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:href="bmy-20220930.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:to="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d9288d07-7528-40da-8c12-96dcd8ac3f34_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_c385e7c1-5c94-4906-ba5f-a19b97902187_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_e56bf7d2-5a65-4e5d-b4e2-a419400eac60_terseLabel_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_label_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_documentation_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember" xlink:href="bmy-20220930.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ChargebacksandcashdiscountsMember" xlink:to="lab_bmy_ChargebacksandcashdiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5f3e897f-9326-4c7d-a8fa-384a932b98b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ZeposiaMember_11fe2a47-d5c9-4104-aa09-206ba48c0364_terseLabel_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:label id="lab_bmy_ZeposiaMember_label_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia [Member]</link:label>
    <link:label id="lab_bmy_ZeposiaMember_documentation_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember" xlink:href="bmy-20220930.xsd#bmy_ZeposiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ZeposiaMember" xlink:to="lab_bmy_ZeposiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_3cee2d27-6942-4e9d-86f2-625f3e98ca87_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f9e153e2-e4ca-4ff6-82c9-1ee2b39081ce_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_935de037-8770-423d-8abe-983ab189dce3_terseLabel_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_label_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025 [Member]</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_documentation_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One000NotesDue2025Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member" xlink:href="bmy-20220930.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.000Notesdue2025Member" xlink:to="lab_bmy_A1.000Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_7a23c268-37ce-4fef-b644-998d11c60c51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6bb17983-46fb-490b-96d8-7b00ae1ed917_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_b4eae35f-37cd-413c-94a8-a5c24977d824_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_785425e1-5745-4f49-ba18-3b35ebcbc976_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_54c0d1e0-9be9-4334-9173-4d98175dec34_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_095440e9-7ae8-406e-9b02-b15d79c33735_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_bc69456c-9450-414e-adf8-558643a80534_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1bca82af-4c17-4133-8b9e-675fd7d0a030_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration to be allocated</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_3ca415f9-a95a-46bd-ac1d-bcb5e2ab3999_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f24c353d-d838-45bd-bbab-aead56e760be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7ab0cf3f-d15e-4e6a-9697-21d61f551450_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbecmaMember_f653141b-e101-4e31-bed8-6617ea8d70bd_terseLabel_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:label id="lab_bmy_AbecmaMember_label_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma [Member]</link:label>
    <link:label id="lab_bmy_AbecmaMember_documentation_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember" xlink:href="bmy-20220930.xsd#bmy_AbecmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbecmaMember" xlink:to="lab_bmy_AbecmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InLineProductsMember_67f75aab-df05-4cc2-a990-ed7aeeacbfaf_terseLabel_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total In-Line Products</link:label>
    <link:label id="lab_bmy_InLineProductsMember_label_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products [Member]</link:label>
    <link:label id="lab_bmy_InLineProductsMember_documentation_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember" xlink:href="bmy-20220930.xsd#bmy_InLineProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InLineProductsMember" xlink:to="lab_bmy_InLineProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_99cee078-a650-4326-9086-f2dc64829ea6_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_a4ab67ae-923a-4b63-94c1-d33dfd56ad2d_terseLabel_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_label_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain" xlink:to="lab_us-gaap_NameOfReportingCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_68c032da-3685-4827-90da-cb8dd826e80f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_02f008ae-3374-4a35-ac80-b1eec349dcc5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_4da58177-bfa7-4eb9-aeea-890ac391554c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of other intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c6da69a4-7684-4ebb-9109-10642a33fa07_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_82e976b4-5e0c-4ac8-93c6-870cf298682d_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_f83b807d-ea62-4778-b38a-ff39485b9afa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CheplapharmMember_d60a3d86-b763-4cfc-a4c7-2887c3c46ef0_terseLabel_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:label id="lab_bmy_CheplapharmMember_label_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm [Member]</link:label>
    <link:label id="lab_bmy_CheplapharmMember_documentation_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember" xlink:href="bmy-20220930.xsd#bmy_CheplapharmMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CheplapharmMember" xlink:to="lab_bmy_CheplapharmMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_64c1b30f-14c5-4fc0-bdec-72629c170113_terseLabel_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220930.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c880b441-8566-4ae4-a807-b86b96128d34_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_110f7256-ef50-4cc7-8e8f-8253931b3b6d_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and regulatory milestone payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:to="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2667cfcc-a383-4c1c-aabb-dfac297c94b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_8e29b973-e91e-4bc9-913b-ba36b2a69d0d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_9d94c51c-54b9-4dcb-84e0-801a71f1235b_negatedTerseLabel_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent milestone income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_label_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_documentation_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:href="bmy-20220930.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:to="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4ca8a698-ea71-408b-95dc-689982df5e42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_bad3c9e8-bef5-409e-b0a9-1497c494d667_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e946c102-2505-41e6-ae46-936ecabfa32a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net loss/(income) of affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0428b589-8677-4675-853d-696579f4c2e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ImmaticsMember_72b77b1a-63de-4c11-92c2-aa95ae665e9d_terseLabel_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:label id="lab_bmy_ImmaticsMember_label_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics [Member]</link:label>
    <link:label id="lab_bmy_ImmaticsMember_documentation_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember" xlink:href="bmy-20220930.xsd#bmy_ImmaticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ImmaticsMember" xlink:to="lab_bmy_ImmaticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_c91b8b68-07e5-4f40-a48b-2e9216e0785f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ac0eeefd-013b-45a9-bbbf-c8e7ede95972_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_de958e18-b357-46f9-b676-a1ba811c3a9f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_3d0b1e0b-b067-49e5-958e-734b3dd6b1dd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRegionMember_992aaecd-4772-4c17-8525-1bb930f0c76b_terseLabel_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region</link:label>
    <link:label id="lab_bmy_OtherRegionMember_label_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember" xlink:href="bmy-20220930.xsd#bmy_OtherRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRegionMember" xlink:to="lab_bmy_OtherRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_29745811-fe2e-4c1e-bf43-70f3bf7089e7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0b2016cd-7488-462f-8cbb-ee67205d010e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4fd1d211-20da-4ab5-92f8-b0ed0d8d7361_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses, net of cash divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0fb1f729-cc43-4fc0-99e0-2d5b31d58956_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6339c840-83f3-401f-9b86-559b3f9f4f07_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_4e06aad7-a6fc-4456-b998-f14f5fc672ad_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmy-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9703ce78-1d61-4ed1-8e00-e60024251c1b,g:7cc5b05a-1f92-4d79-827b-c52cd76a0737-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CoverPage" xlink:type="simple" xlink:href="bmy-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c09ff1e6-879c-4952-9f1a-0987e47b2cc2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c09ff1e6-879c-4952-9f1a-0987e47b2cc2" xlink:to="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:to="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_087d58eb-1bb5-4731-8d29-eb0af92c9233" xlink:to="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_d93bdb70-0d90-4e35-9529-09775dd666ff" xlink:href="bmy-20220930.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_CommonStock0.10ParValueMember_d93bdb70-0d90-4e35-9529-09775dd666ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_0035f1c0-e31a-4e52-abe4-3cb2f591f802" xlink:href="bmy-20220930.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_A1.000Notesdue2025Member_0035f1c0-e31a-4e52-abe4-3cb2f591f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_2d0a5b87-369a-4b48-99cf-7bc42d403b42" xlink:href="bmy-20220930.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_A1.750Notesdue2035Member_2d0a5b87-369a-4b48-99cf-7bc42d403b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_891a4d0d-641f-4db8-91bf-b9e968644f02" xlink:href="bmy-20220930.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f91a1d16-3bca-4a33-b819-21df1f5fddc1" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_891a4d0d-641f-4db8-91bf-b9e968644f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e32a487e-c81e-41dd-9da6-9abbd2b5c597" xlink:to="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b7debb4f-3bd8-47fe-af6c-4ea5b36efe73" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentType_b7debb4f-3bd8-47fe-af6c-4ea5b36efe73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d8bf0952-2936-4624-a9a6-eccd74b36ed7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentQuarterlyReport_d8bf0952-2936-4624-a9a6-eccd74b36ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1eb846c9-aba0-4f1c-a0cd-5accb0fdea87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentPeriodEndDate_1eb846c9-aba0-4f1c-a0cd-5accb0fdea87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a607a6bc-802a-487f-ad6d-92b92f1f0b3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentTransitionReport_a607a6bc-802a-487f-ad6d-92b92f1f0b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4e20d535-4d53-4a12-9820-3de8d8ba8a35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityFileNumber_4e20d535-4d53-4a12-9820-3de8d8ba8a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a91e8fdd-67e0-4abb-a803-e8434407d2b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityRegistrantName_a91e8fdd-67e0-4abb-a803-e8434407d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8a0e0ff3-32f7-4292-a752-abfaf475052c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8a0e0ff3-32f7-4292-a752-abfaf475052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4d0f64a6-1a57-45f7-b0d5-294b41eca905" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityTaxIdentificationNumber_4d0f64a6-1a57-45f7-b0d5-294b41eca905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3a595705-db4b-4689-bf3c-2aa92c016c48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressAddressLine1_3a595705-db4b-4689-bf3c-2aa92c016c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9c34dd54-6e59-4491-9091-6fdc675e22e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressCityOrTown_9c34dd54-6e59-4491-9091-6fdc675e22e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e59b3e07-fd8e-435f-87c1-8d29013554b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressStateOrProvince_e59b3e07-fd8e-435f-87c1-8d29013554b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_625dc2ea-d593-4e34-8e3b-30b109216b21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityAddressPostalZipCode_625dc2ea-d593-4e34-8e3b-30b109216b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6c123a1b-c53d-464f-a699-8994e1aeb234" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_CityAreaCode_6c123a1b-c53d-464f-a699-8994e1aeb234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8a6e3310-a8e0-4155-b813-e2f027a351bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_LocalPhoneNumber_8a6e3310-a8e0-4155-b813-e2f027a351bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4446d0b5-f87c-4797-98b4-04529ae7e6e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_Security12bTitle_4446d0b5-f87c-4797-98b4-04529ae7e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_479fabb9-7d50-483a-bf47-7550271cf51e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_TradingSymbol_479fabb9-7d50-483a-bf47-7550271cf51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_551ba8c5-69b6-4ece-aa28-cd475d9fecee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_SecurityExchangeName_551ba8c5-69b6-4ece-aa28-cd475d9fecee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c0815664-bd35-4959-a392-c2bbc879d48e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCurrentReportingStatus_c0815664-bd35-4959-a392-c2bbc879d48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b9e21899-df80-438b-a9d7-7572469640fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityInteractiveDataCurrent_b9e21899-df80-438b-a9d7-7572469640fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5363de0e-6e1c-44f0-b10a-05597c5fb365" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityFilerCategory_5363de0e-6e1c-44f0-b10a-05597c5fb365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2bbb15dc-7d93-45c9-bf71-f8e95a7ff9e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityEmergingGrowthCompany_2bbb15dc-7d93-45c9-bf71-f8e95a7ff9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_00a0c5df-d8a8-4ba6-9168-ed8fe660d68d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityShellCompany_00a0c5df-d8a8-4ba6-9168-ed8fe660d68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f10ab91b-3440-4f05-a3bf-67833eb87e6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f10ab91b-3440-4f05-a3bf-67833eb87e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_64247400-d909-43a2-8cdb-8ace65d8c053" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntityCentralIndexKey_64247400-d909-43a2-8cdb-8ace65d8c053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4a43a7d4-4fbe-45d8-a31e-d540183f57c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentFiscalYearFocus_4a43a7d4-4fbe-45d8-a31e-d540183f57c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_98abc191-4be5-470b-93b5-4eec08cb44d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_DocumentFiscalPeriodFocus_98abc191-4be5-470b-93b5-4eec08cb44d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9ed2845b-db57-4f45-8e3e-a26bd248922c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_CurrentFiscalYearEndDate_9ed2845b-db57-4f45-8e3e-a26bd248922c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0c71db44-512e-4a7e-aefd-cce8490c91ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_AmendmentFlag_0c71db44-512e-4a7e-aefd-cce8490c91ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_daa07f51-d3c9-4eba-b5de-8d05adae12d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4669e818-3b90-4e8b-9663-9de883cf2b08" xlink:to="loc_dei_EntitySmallBusiness_daa07f51-d3c9-4eba-b5de-8d05adae12d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e36e40c3-ec33-4c32-bba9-7f3e8c5ac83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e36e40c3-ec33-4c32-bba9-7f3e8c5ac83d" xlink:to="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_4f42282a-38f5-49c8-9588-7f5e953e6971" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_42903061-9aee-493e-a583-6fae7e030179" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:to="loc_bmy_NetproductsalesMember_42903061-9aee-493e-a583-6fae7e030179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_64827901-992f-41d7-9aeb-42e53fa28a57" xlink:href="bmy-20220930.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c4b96948-7f58-4380-b78b-79d45d588efe" xlink:to="loc_bmy_AllianceandotherrevenuesMember_64827901-992f-41d7-9aeb-42e53fa28a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10cde47a-45de-46c9-9184-948cf34bb8ed" xlink:to="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d936d535-42cd-458c-b4d7-6feb27c499eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_Revenues_d936d535-42cd-458c-b4d7-6feb27c499eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_74b8efbe-977f-48ce-b5fa-65b26874aa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_74b8efbe-977f-48ce-b5fa-65b26874aa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94fb96b0-123c-4681-9a55-47944a99645c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94fb96b0-123c-4681-9a55-47944a99645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3da32ab1-9764-455a-8cb7-f98da7d71bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3da32ab1-9764-455a-8cb7-f98da7d71bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_9dae8a9e-eab9-4461-94f9-9e8754f32fab" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_bmy_AcquiredIPRD_9dae8a9e-eab9-4461-94f9-9e8754f32fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_68c9e820-eaf7-429f-b2ed-d0fd90305c47" xlink:href="bmy-20220930.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_68c9e820-eaf7-429f-b2ed-d0fd90305c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_821e282c-b390-40b5-89c4-ff08f21c9905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_821e282c-b390-40b5-89c4-ff08f21c9905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_66f45362-014b-4e74-b924-6864f36cd599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_CostsAndExpenses_66f45362-014b-4e74-b924-6864f36cd599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97ed4884-0c51-4e70-9b49-e4f1a440b1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97ed4884-0c51-4e70-9b49-e4f1a440b1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9dfb0966-5729-477e-8c97-c855653f17aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9dfb0966-5729-477e-8c97-c855653f17aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fbd83eb7-94d7-470b-872c-a4c066ce64ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ProfitLoss_fbd83eb7-94d7-470b-872c-a4c066ce64ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_81148844-7c8d-4960-8127-4c3695406a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_81148844-7c8d-4960-8127-4c3695406a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30c895a2-7328-408c-b3ba-a4b5dd7c4b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_NetIncomeLoss_30c895a2-7328-408c-b3ba-a4b5dd7c4b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bb43d0dd-fcf3-4dd4-b785-364371c8c601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_EarningsPerShareBasic_bb43d0dd-fcf3-4dd4-b785-364371c8c601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1d47ee83-2da3-4617-a0c4-0d2604891246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f6e179b5-97e1-4024-af46-2b07adc4d402" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1d47ee83-2da3-4617-a0c4-0d2604891246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d6cef860-7632-4a11-ad03-3d1983fb9a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:to="loc_us-gaap_ProfitLoss_d6cef860-7632-4a11-ad03-3d1983fb9a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a70b76aa-f64d-45e2-b4a6-e975e6549a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a70b76aa-f64d-45e2-b4a6-e975e6549a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2a60f853-9005-429b-8039-4b1faa5d5a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2a60f853-9005-429b-8039-4b1faa5d5a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c0516874-f5e1-47e7-b9ff-b6fbeade7d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c0516874-f5e1-47e7-b9ff-b6fbeade7d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_526ba89a-e09a-4def-a222-8f2abbab3ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_526ba89a-e09a-4def-a222-8f2abbab3ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d60be63c-bc98-4fcd-b6ba-b9c59c789773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1781cca8-8085-4fe7-92c5-49bb5abcfb8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d60be63c-bc98-4fcd-b6ba-b9c59c789773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_724b68df-9ba3-45a0-92cc-8e2b1aa008e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_724b68df-9ba3-45a0-92cc-8e2b1aa008e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_22cf781c-966b-46ec-a0ef-08d4c4cbb00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_22cf781c-966b-46ec-a0ef-08d4c4cbb00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_eb6b6fe1-19c9-499e-9e80-9dfedde63684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56427a1e-7587-47da-9df9-4bdddfb5d864" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_eb6b6fe1-19c9-499e-9e80-9dfedde63684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8f9392ff-927f-4f3e-a0a0-7ce0c1bc745b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f9392ff-927f-4f3e-a0a0-7ce0c1bc745b" xlink:to="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe2c9124-2031-4f33-b8d1-0c2826800b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe2c9124-2031-4f33-b8d1-0c2826800b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_9db9d77b-148d-4931-909f-3bb0c73470c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_9db9d77b-148d-4931-909f-3bb0c73470c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1924482d-1ae8-4a05-bae9-f82cc8b6dab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_ReceivablesNetCurrent_1924482d-1ae8-4a05-bae9-f82cc8b6dab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3a029976-fbb7-4d9e-914b-0f53cec11b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_InventoryNet_3a029976-fbb7-4d9e-914b-0f53cec11b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_03a2f623-8a6d-43d6-b810-b5770217b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_OtherAssetsCurrent_03a2f623-8a6d-43d6-b810-b5770217b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7faf182e-48a9-4ed6-982d-76af8192187c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fbd8355a-576c-4e75-820c-73abf47b0bdd" xlink:to="loc_us-gaap_AssetsCurrent_7faf182e-48a9-4ed6-982d-76af8192187c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9f6f99c-ecd7-4b42-960e-a84d88803782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9f6f99c-ecd7-4b42-960e-a84d88803782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0d6d4b17-27fc-497a-bca7-d5a8a02b427d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_Goodwill_0d6d4b17-27fc-497a-bca7-d5a8a02b427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_60508e55-0abb-4cfb-bd87-7b2ee4d33ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_60508e55-0abb-4cfb-bd87-7b2ee4d33ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7138ee3a-0481-45f4-9378-da7679bed724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7138ee3a-0481-45f4-9378-da7679bed724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_059818da-3a89-4b8d-aae9-d93233aa9464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_059818da-3a89-4b8d-aae9-d93233aa9464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_24cc8268-22d0-4912-a202-ead9c4000224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68fcc195-e538-4811-a6e6-abfd2503ab1b" xlink:to="loc_us-gaap_Assets_24cc8268-22d0-4912-a202-ead9c4000224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f9392ff-927f-4f3e-a0a0-7ce0c1bc745b" xlink:to="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_25e2b1d0-26d6-4fe0-993f-c9dcfb45ced7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:to="loc_us-gaap_DebtCurrent_25e2b1d0-26d6-4fe0-993f-c9dcfb45ced7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d07e1b0f-4d20-45d1-b06c-8a0d38d19e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:to="loc_us-gaap_AccountsPayableCurrent_d07e1b0f-4d20-45d1-b06c-8a0d38d19e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bd654809-03e4-437b-9a46-68fbbedc4b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bd654809-03e4-437b-9a46-68fbbedc4b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_01a55ca3-dfaf-44d1-b69d-29be82e5b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_acb8936c-d102-407b-a911-3eb4bae0a0bd" xlink:to="loc_us-gaap_LiabilitiesCurrent_01a55ca3-dfaf-44d1-b69d-29be82e5b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8865b653-ea9a-40e0-b234-a66599623a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8865b653-ea9a-40e0-b234-a66599623a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_56c01833-20af-4286-ad77-5eed7bee43b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_56c01833-20af-4286-ad77-5eed7bee43b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_86774029-dc17-46ee-a3c1-eb6e3c875a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_86774029-dc17-46ee-a3c1-eb6e3c875a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f8c4a4db-b965-4aef-b1ce-c70982c85274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_Liabilities_f8c4a4db-b965-4aef-b1ce-c70982c85274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_85fd8836-014f-4c77-9508-3c233149d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_351d19bb-cf67-4fa5-83d1-1e1ef442a95e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_85fd8836-014f-4c77-9508-3c233149d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_537cb544-e5fd-46f5-91e5-c16cfdabcd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f9392ff-927f-4f3e-a0a0-7ce0c1bc745b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_537cb544-e5fd-46f5-91e5-c16cfdabcd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_537cb544-e5fd-46f5-91e5-c16cfdabcd89" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4c27ca09-f507-436e-bdd1-f5eda1f3ed1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_PreferredStockValue_4c27ca09-f507-436e-bdd1-f5eda1f3ed1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_73659b19-7d03-48fb-a7a9-0013ea8eba99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_CommonStockValue_73659b19-7d03-48fb-a7a9-0013ea8eba99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_87cd6149-cbdb-420f-81e4-939a3c932030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_87cd6149-cbdb-420f-81e4-939a3c932030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0c114cec-ef01-4aee-9d75-abe5a1f15699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0c114cec-ef01-4aee-9d75-abe5a1f15699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4f71711-7cbd-49e3-a80a-a34909ae7e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4f71711-7cbd-49e3-a80a-a34909ae7e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_287870c4-b18a-4e5b-ab7d-3c8a95c7d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_TreasuryStockValue_287870c4-b18a-4e5b-ab7d-3c8a95c7d8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_097c270e-812e-4763-bd59-08107a6f7af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e192e4b9-9ac5-44ed-ac6d-a8cdf4b001c3" xlink:to="loc_us-gaap_StockholdersEquity_097c270e-812e-4763-bd59-08107a6f7af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_261376b1-635e-433a-a8e2-2f58973b3318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_537cb544-e5fd-46f5-91e5-c16cfdabcd89" xlink:to="loc_us-gaap_MinorityInterest_261376b1-635e-433a-a8e2-2f58973b3318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab8d6521-61fc-407c-897d-faa6f62024c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_537cb544-e5fd-46f5-91e5-c16cfdabcd89" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab8d6521-61fc-407c-897d-faa6f62024c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a4b16b5-fb49-48b9-9481-0d05effe368c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f9392ff-927f-4f3e-a0a0-7ce0c1bc745b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a4b16b5-fb49-48b9-9481-0d05effe368c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmy-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c4023dc-e981-447a-bbac-68a0237512d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:to="loc_us-gaap_ProfitLoss_9c4023dc-e981-447a-bbac-68a0237512d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7a692a80-be11-4312-88cb-aaf4337bbf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7a692a80-be11-4312-88cb-aaf4337bbf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fd54620e-344f-4d9b-853b-034973112f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fd54620e-344f-4d9b-853b-034973112f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f13ec980-2801-48c9-abdb-44f489813a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_ShareBasedCompensation_f13ec980-2801-48c9-abdb-44f489813a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_f3e6b2c2-2b27-42bd-ab2f-0724d7a4782a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_f3e6b2c2-2b27-42bd-ab2f-0724d7a4782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_1adb5ebf-245b-43e2-9665-0487e70fffa2" xlink:href="bmy-20220930.xsd#bmy_Divestituregainsandroyalties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_bmy_Divestituregainsandroyalties_1adb5ebf-245b-43e2-9665-0487e70fffa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_d774b9d8-b537-466d-ac5a-b01ea3de6641" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_bmy_AcquiredIPRD_d774b9d8-b537-466d-ac5a-b01ea3de6641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b6d47dbd-beb8-47b4-adf2-2346a04b42f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_GainLossOnInvestments_b6d47dbd-beb8-47b4-adf2-2346a04b42f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_76850038-1fce-485e-92a0-231e8f4677a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_76850038-1fce-485e-92a0-231e8f4677a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b8876a89-edd9-46c2-9348-be99902a0b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b8876a89-edd9-46c2-9348-be99902a0b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20473c0f-a219-41b3-8608-ae3b1d3860d8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_e90421c0-7787-4722-951c-89c294933d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_e90421c0-7787-4722-951c-89c294933d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_91a64bf3-25c0-4b34-827d-7eec20cfc621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_91a64bf3-25c0-4b34-827d-7eec20cfc621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_aadc99e4-f3b6-4bbc-872f-468db3c88dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_aadc99e4-f3b6-4bbc-872f-468db3c88dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_a1e4ccd8-a974-43fd-910e-21d876de7604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_a1e4ccd8-a974-43fd-910e-21d876de7604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4ff9a4ad-cf9f-43c5-ac0b-2fa62a32ca78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4ff9a4ad-cf9f-43c5-ac0b-2fa62a32ca78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b28323e5-0323-4e12-a9da-0a8efe1f5806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b28323e5-0323-4e12-a9da-0a8efe1f5806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40c17a35-c4ca-45bf-8682-23c6490dc498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6fe66412-b477-42f4-b73f-5c63166882be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40c17a35-c4ca-45bf-8682-23c6490dc498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_17ecb621-8a3d-4844-aac7-a00fd4544c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_17ecb621-8a3d-4844-aac7-a00fd4544c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9ef92ef9-8b6f-4a9a-8ade-560b5ce4d80c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9ef92ef9-8b6f-4a9a-8ade-560b5ce4d80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_50bc9589-7b5d-4e1d-b6e2-bb95542f0860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_50bc9589-7b5d-4e1d-b6e2-bb95542f0860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7a0534ac-4f13-4358-a85d-ed4217b5106c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7a0534ac-4f13-4358-a85d-ed4217b5106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_ab1f0cd0-c3b1-45c5-8b86-7cf7a96a1af4" xlink:href="bmy-20220930.xsd#bmy_Divestitureandotherproceeds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_bmy_Divestitureandotherproceeds_ab1f0cd0-c3b1-45c5-8b86-7cf7a96a1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9602b7ee-78f5-4ca8-9f68-2f6f1e0cc6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9602b7ee-78f5-4ca8-9f68-2f6f1e0cc6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3cf93e44-cc99-43f9-a1a1-82ea637f33d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1922fa9b-eed1-49c8-8cea-ac30c3854ac1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3cf93e44-cc99-43f9-a1a1-82ea637f33d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2be5e5a3-954d-44a5-8828-4077d88a50c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b6c0a77c-a818-4a9b-be6b-93bd36035824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b6c0a77c-a818-4a9b-be6b-93bd36035824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_b03fbfc3-0a19-4d26-8bc6-42adb6480244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_b03fbfc3-0a19-4d26-8bc6-42adb6480244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_49f20ea1-9a4c-4d6d-9472-03e29ade1ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_49f20ea1-9a4c-4d6d-9472-03e29ade1ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c0c4f3a2-9e59-4b83-91b2-b0a890aae18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c0c4f3a2-9e59-4b83-91b2-b0a890aae18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_aadbb7c9-587d-43eb-9b6c-a65ca1495fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_PaymentsOfDividends_aadbb7c9-587d-43eb-9b6c-a65ca1495fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c16f34e-4154-4eb0-a97c-6d99da490228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c16f34e-4154-4eb0-a97c-6d99da490228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed0cbe7b-97ea-4799-a9a0-1a4a1ea6e3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf84fd9c-2e33-4a55-a205-e174c4a1db14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed0cbe7b-97ea-4799-a9a0-1a4a1ea6e3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4123b4fd-9177-442f-91a7-c073fc8689d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4123b4fd-9177-442f-91a7-c073fc8689d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c69f6688-d68b-4762-a0ec-358ff09e3077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c69f6688-d68b-4762-a0ec-358ff09e3077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4caebd7-3a8e-4fe8-a065-90beb7fab895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4caebd7-3a8e-4fe8-a065-90beb7fab895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21fe12fa-2896-4782-a8ae-67ca2448462e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a803c8f-86b3-49e8-a00f-d481ad36e884" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21fe12fa-2896-4782-a8ae-67ca2448462e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="bmy-20220930.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c26a8f02-ec83-41eb-a99b-824acc03f08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_768878e5-0a7f-42de-9e96-1bac97a5130c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26a8f02-ec83-41eb-a99b-824acc03f08b" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_768878e5-0a7f-42de-9e96-1bac97a5130c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUE" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_324c6f66-40da-4c2a-9fc3-ea8c04b706e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_aef14454-5d00-464e-9338-ba08ebab7dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_324c6f66-40da-4c2a-9fc3-ea8c04b706e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_aef14454-5d00-464e-9338-ba08ebab7dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCES" xlink:type="simple" xlink:href="bmy-20220930.xsd#ALLIANCES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_973ce4e8-dfe5-47ab-b95d-a32bb2f4b0b7" xlink:href="bmy-20220930.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_676bb3b9-3788-4344-9066-17c6246f2828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_973ce4e8-dfe5-47ab-b95d-a32bb2f4b0b7" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_676bb3b9-3788-4344-9066-17c6246f2828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_67b94552-dfdc-4027-b831-649a9f04f93f" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_10e73327-7b5e-4533-8ed6-c6774d94e7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_67b94552-dfdc-4027-b831-649a9f04f93f" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_10e73327-7b5e-4533-8ed6-c6774d94e7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="simple" xlink:href="bmy-20220930.xsd#OTHERINCOMEEXPENSENET"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_9657c80b-85d0-460c-abc7-6933127914f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_65cb0adc-5ead-4be3-94e0-361a972cfe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_9657c80b-85d0-460c-abc7-6933127914f9" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_65cb0adc-5ead-4be3-94e0-361a972cfe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_f154216d-8818-48d5-a989-d6630ee8fcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e7627a80-1d4e-4ed9-8dc2-16a43a644d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_f154216d-8818-48d5-a989-d6630ee8fcba" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e7627a80-1d4e-4ed9-8dc2-16a43a644d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bmy-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f11cf539-64a5-4026-8c0c-8d818119e491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9014c453-ea0f-4b09-a97b-773779df3736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f11cf539-64a5-4026-8c0c-8d818119e491" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9014c453-ea0f-4b09-a97b-773779df3736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bmy-20220930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9980f1a3-40f8-4222-b723-9505fe66a479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ca7cfb14-6c1e-4224-b6f9-7044419c3188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9980f1a3-40f8-4222-b723-9505fe66a479" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ca7cfb14-6c1e-4224-b6f9-7044419c3188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05b5e738-ecf9-402f-827d-1cb308be4e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f7332d49-8803-47bc-acb0-fcdbbd4c1f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05b5e738-ecf9-402f-827d-1cb308be4e11" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f7332d49-8803-47bc-acb0-fcdbbd4c1f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLES" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_283f16db-9634-414a-b11f-9fc23fd927c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_624c6b0d-a3d3-4c03-b92e-faf9081b8f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_283f16db-9634-414a-b11f-9fc23fd927c8" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_624c6b0d-a3d3-4c03-b92e-faf9081b8f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIES" xlink:type="simple" xlink:href="bmy-20220930.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_aaaa0c5e-a287-4a22-ae91-fb3d6b20f1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_563a8ba1-e6cd-43f0-81eb-c08e3aa5680c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_aaaa0c5e-a287-4a22-ae91-fb3d6b20f1a2" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_563a8ba1-e6cd-43f0-81eb-c08e3aa5680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="bmy-20220930.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f2973a0c-4404-4a90-817c-8f384f01b96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_30890036-951e-4ab5-993e-c3703a33e2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f2973a0c-4404-4a90-817c-8f384f01b96f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_30890036-951e-4ab5-993e-c3703a33e2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f674643e-299e-4a68-a273-401c7793d103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c9ade224-2eb1-4e64-b46c-86262e6c7b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f674643e-299e-4a68-a273-401c7793d103" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c9ade224-2eb1-4e64-b46c-86262e6c7b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_aae18a7d-a959-47d3-b2f6-4afabb3cc5a6" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_847d62db-a5fd-4938-bcfe-4e1956199cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_aae18a7d-a959-47d3-b2f6-4afabb3cc5a6" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_847d62db-a5fd-4938-bcfe-4e1956199cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITY" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITY"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_22e26913-df8c-455c-aef8-2364d68e8007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2f5c5894-31ec-4074-add0-accaa3fb7bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_22e26913-df8c-455c-aef8-2364d68e8007" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2f5c5894-31ec-4074-add0-accaa3fb7bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_406c8a2a-ea30-4edb-a47f-4f34f64cf11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4f8792ce-66c1-40f9-b2e1-735e82545d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_406c8a2a-ea30-4edb-a47f-4f34f64cf11d" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4f8792ce-66c1-40f9-b2e1-735e82545d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="simple" xlink:href="bmy-20220930.xsd#LEGALPROCEEDINGSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a113322-56aa-4350-8029-24c7abf3b075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_937b7c90-6c3c-4513-9dfc-706e1a239b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a113322-56aa-4350-8029-24c7abf3b075" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_937b7c90-6c3c-4513-9dfc-706e1a239b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="simple" xlink:href="bmy-20220930.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3a943cf9-c094-445d-a0dd-a9e98ee1f998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3a943cf9-c094-445d-a0dd-a9e98ee1f998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_068f3d39-9b2b-4740-bff4-b82de144a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_068f3d39-9b2b-4740-bff4-b82de144a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f6f57d86-77b4-4d22-9382-29679de1882e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_UseOfEstimates_f6f57d86-77b4-4d22-9382-29679de1882e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1022c9b5-9952-49be-9cb3-9599b8aab3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1022c9b5-9952-49be-9cb3-9599b8aab3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ff095cd2-9b70-461c-968f-9c9ec7a0e0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ff095cd2-9b70-461c-968f-9c9ec7a0e0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_0ee6134b-ab55-4505-bbe5-3770627756b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9172d9f-5411-4270-b78b-f2f237ed534a" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_0ee6134b-ab55-4505-bbe5-3770627756b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUETables" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e28b8dd-4eb1-470a-bb41-90d993c294f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d3b18e74-245f-44c6-b5af-d2dac6da5277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e28b8dd-4eb1-470a-bb41-90d993c294f2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d3b18e74-245f-44c6-b5af-d2dac6da5277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_11619c8f-923a-4309-8012-a7a90c6f1da3" xlink:href="bmy-20220930.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e28b8dd-4eb1-470a-bb41-90d993c294f2" xlink:to="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_11619c8f-923a-4309-8012-a7a90c6f1da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_dfa4f33c-d867-468b-ad9a-2ae3d336f6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e28b8dd-4eb1-470a-bb41-90d993c294f2" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_dfa4f33c-d867-468b-ad9a-2ae3d336f6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#ALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_188ee1cc-a187-4662-9810-e9c409cea632" xlink:href="bmy-20220930.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_856a071f-18ce-44ac-92cd-edb74ed3b94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_188ee1cc-a187-4662-9810-e9c409cea632" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_856a071f-18ce-44ac-92cd-edb74ed3b94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_980254ee-1b93-4c48-a68f-01a726eee6bc" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_35c6413e-1ac9-4156-ab81-5e9fd2c7af66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_980254ee-1b93-4c48-a68f-01a726eee6bc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_35c6413e-1ac9-4156-ab81-5e9fd2c7af66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock_75e51bcb-0df6-415d-b2e9-119ff6f138e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_980254ee-1b93-4c48-a68f-01a726eee6bc" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock_75e51bcb-0df6-415d-b2e9-119ff6f138e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0d175200-a5ef-457f-966d-f00c921de923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_980254ee-1b93-4c48-a68f-01a726eee6bc" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0d175200-a5ef-457f-966d-f00c921de923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_c5c8cce6-e4e4-4694-89ec-7899e498c66e" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_980254ee-1b93-4c48-a68f-01a726eee6bc" xlink:to="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_c5c8cce6-e4e4-4694-89ec-7899e498c66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#OTHERINCOMEEXPENSENETTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_71a4cbcc-0f7f-431a-8db8-538904819c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_8276f541-3891-421f-90b4-73bb605a6102" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_71a4cbcc-0f7f-431a-8db8-538904819c45" xlink:to="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_8276f541-3891-421f-90b4-73bb605a6102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_b4d787ac-e570-47d4-985c-de68d101d0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_b4d787ac-e570-47d4-985c-de68d101d0df" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:to="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_d71eeb90-c36a-44fc-a81c-a382e7e56c82" xlink:to="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_fdb41525-dd8c-4cf9-9d85-10f1855b03a1" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_771642bc-330f-4055-b2ce-e4bf98fa6faa" xlink:to="loc_bmy_CelgeneIntegrationMember_fdb41525-dd8c-4cf9-9d85-10f1855b03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cadb2a7c-c939-4126-a87e-3860da936483" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8a6b9f2a-b5ce-4edd-91a7-c9371c541125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8a6b9f2a-b5ce-4edd-91a7-c9371c541125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_3639fda9-a7ae-4ca1-b58e-4055f141f445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0e845717-5680-49e7-be1e-1d9a7510fd77" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_3639fda9-a7ae-4ca1-b58e-4055f141f445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_68fd84d2-81b5-4f38-8b0e-42ccb02ab765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_466b1b24-9fe4-4a44-a28d-f57366282aa4" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_68fd84d2-81b5-4f38-8b0e-42ccb02ab765" xlink:to="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_466b1b24-9fe4-4a44-a28d-f57366282aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bmy-20220930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7a17aff2-2b32-47eb-bb25-58123da31dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_01e51d75-2563-4a7c-b510-366b51bb7044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a17aff2-2b32-47eb-bb25-58123da31dae" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_01e51d75-2563-4a7c-b510-366b51bb7044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_694acf20-4a59-42f7-8cab-cc64988076be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_694acf20-4a59-42f7-8cab-cc64988076be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_4aab098c-918c-4fff-badf-580324bae741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_4aab098c-918c-4fff-badf-580324bae741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_b0895453-6d47-4a3b-ae1c-ea2ce6f4c74e" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_b0895453-6d47-4a3b-ae1c-ea2ce6f4c74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_3c9b2cea-56cf-4039-946b-a883eca7cd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_3c9b2cea-56cf-4039-946b-a883eca7cd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d1e3ad56-3ae5-4ab5-b327-190f996d59c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d1e3ad56-3ae5-4ab5-b327-190f996d59c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_55f28027-89d6-4470-85e4-3834dc69b839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_55f28027-89d6-4470-85e4-3834dc69b839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_37f23e51-9fc5-435c-910f-715e77db1ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_37f23e51-9fc5-435c-910f-715e77db1ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d65303b0-dce2-45d8-bb89-5b55041f4d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27a99866-c002-4574-9f3b-58bc41fc5356" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d65303b0-dce2-45d8-bb89-5b55041f4d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_f4173d50-813d-470a-9224-bc0ef4ebc75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7cf4ca09-bd55-446b-9791-c513f8f06317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_f4173d50-813d-470a-9224-bc0ef4ebc75a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7cf4ca09-bd55-446b-9791-c513f8f06317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_d865fbb9-d5d1-45f6-8213-e7f6463c0c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0d771fcf-1daf-46ff-9d13-405b7413fe0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d865fbb9-d5d1-45f6-8213-e7f6463c0c2b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0d771fcf-1daf-46ff-9d13-405b7413fe0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2fb18057-8791-48b0-a024-b3d0964135f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c9cf0a7e-807c-43a3-b22c-152dabcf7bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2fb18057-8791-48b0-a024-b3d0964135f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c9cf0a7e-807c-43a3-b22c-152dabcf7bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_620a9db2-93ec-49f3-9f47-868889ec8945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_83e6cc37-b603-42fa-b8b0-a2a16f1fcab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_620a9db2-93ec-49f3-9f47-868889ec8945" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_83e6cc37-b603-42fa-b8b0-a2a16f1fcab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_bcf29d96-e628-4b53-9583-71697cb4e483" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_3cdb4ec2-11b1-42c9-af9c-67ead188a787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_bcf29d96-e628-4b53-9583-71697cb4e483" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_3cdb4ec2-11b1-42c9-af9c-67ead188a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_548e405f-a3c3-428c-ac1a-2c4e5e1abbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_bcf29d96-e628-4b53-9583-71697cb4e483" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_548e405f-a3c3-428c-ac1a-2c4e5e1abbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7c5b2d9e-6c52-4a6b-804c-a8e6030f821f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_bcf29d96-e628-4b53-9583-71697cb4e483" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7c5b2d9e-6c52-4a6b-804c-a8e6030f821f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f6594c98-839e-47dd-b19f-e304cb31f104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_bcf29d96-e628-4b53-9583-71697cb4e483" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f6594c98-839e-47dd-b19f-e304cb31f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fddd6c7d-d832-44f4-a9f4-a69dd2cd95b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_8dd73e95-61e3-4fdd-83fc-309b415c0844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fddd6c7d-d832-44f4-a9f4-a69dd2cd95b9" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_8dd73e95-61e3-4fdd-83fc-309b415c0844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_718bf011-4d79-4eae-b309-a2a650e9f4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fddd6c7d-d832-44f4-a9f4-a69dd2cd95b9" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_718bf011-4d79-4eae-b309-a2a650e9f4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_308deb36-2f53-4692-8dfd-55cb2601fc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fddd6c7d-d832-44f4-a9f4-a69dd2cd95b9" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_308deb36-2f53-4692-8dfd-55cb2601fc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5be64586-f467-45f5-b01d-dc1f458ae2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_3773990b-4ea6-4ebd-b1a5-de76f5439fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5be64586-f467-45f5-b01d-dc1f458ae2be" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_3773990b-4ea6-4ebd-b1a5-de76f5439fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_5c9fe69f-065b-4d7d-b5f5-e51e4f925982" xlink:href="bmy-20220930.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5be64586-f467-45f5-b01d-dc1f458ae2be" xlink:to="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_5c9fe69f-065b-4d7d-b5f5-e51e4f925982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_93ef9e4d-1645-4f56-a074-57ed67bf42a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5be64586-f467-45f5-b01d-dc1f458ae2be" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_93ef9e4d-1645-4f56-a074-57ed67bf42a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_08421ae1-23ce-4043-bcd2-2cbbe9760610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_08421ae1-23ce-4043-bcd2-2cbbe9760610" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ae69866a-8fad-467b-bfe5-05307147770c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_8cd1a703-7dd9-41e6-8577-af03dff4bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f9008b3e-edc0-4fd4-a321-c44565ba6930" xlink:to="loc_us-gaap_CollaborativeArrangementMember_8cd1a703-7dd9-41e6-8577-af03dff4bfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_fbe0bac1-7908-47c5-b5bf-ae8e792ccbbf" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_afc5310b-d268-4e80-b53d-14ba3d4c5715" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_bmy_NetproductsalesMember_afc5310b-d268-4e80-b53d-14ba3d4c5715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_b96d1a39-4d29-420f-b836-1c60bef7f953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_us-gaap_CollaborativeArrangementMember_b96d1a39-4d29-420f-b836-1c60bef7f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_d8e87e3f-cea5-4112-a646-cef6460fb48f" xlink:href="bmy-20220930.xsd#bmy_OtherrevenuesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_87cecd1b-75b6-4395-bb86-a90190c3ac47" xlink:to="loc_bmy_OtherrevenuesMember_d8e87e3f-cea5-4112-a646-cef6460fb48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17e34117-f857-4db2-a67c-e01c46d18a35" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0adf6147-3047-40e1-903d-8ea0272290be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_80741715-c649-4725-aed6-aad581a055e8" xlink:to="loc_us-gaap_Revenues_0adf6147-3047-40e1-903d-8ea0272290be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b003052-27f0-4207-830f-786c8bb8d2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b003052-27f0-4207-830f-786c8bb8d2d6" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_cbdffc61-e8fe-4e8c-995c-a1bb55457601" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_2893bcc0-c6c0-4354-a7f7-e75f82b26836" xlink:href="bmy-20220930.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_2893bcc0-c6c0-4354-a7f7-e75f82b26836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_a316f22d-8d84-4716-ae91-ce872819ca94" xlink:href="bmy-20220930.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_a316f22d-8d84-4716-ae91-ce872819ca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_a9b61c8e-32bd-4e4f-ba6c-0fd31c4445b8" xlink:href="bmy-20220930.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_473ab666-3d30-4f7a-9cff-725281a756f8" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_a9b61c8e-32bd-4e4f-ba6c-0fd31c4445b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_38670587-b396-40f7-b0bd-9ba4d0917961" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_e7773d18-3226-44e3-b586-af0e9c888441" xlink:href="bmy-20220930.xsd#bmy_SalesRevenueGrossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:to="loc_bmy_SalesRevenueGrossMember_e7773d18-3226-44e3-b586-af0e9c888441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_ec7e1f11-0718-4eb3-97e3-71ae42070c56" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_84ff3fa0-b568-4b87-a150-0e3c3fc9b40b" xlink:to="loc_bmy_NetproductsalesMember_ec7e1f11-0718-4eb3-97e3-71ae42070c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6f5e1574-1668-4f76-b694-51e4e7a580de" xlink:to="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8834c2d3-6f10-4670-91a2-aaa0d8be173c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_us-gaap_Revenues_8834c2d3-6f10-4670-91a2-aaa0d8be173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_f3b1d9b6-6119-455d-8c42-ae16b88a2ca6" xlink:href="bmy-20220930.xsd#bmy_GrosstoNetAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_bmy_GrosstoNetAdjustments_f3b1d9b6-6119-455d-8c42-ae16b88a2ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_9f257292-3005-4d6a-8c43-320ae0976ed2" xlink:href="bmy-20220930.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_8d958c68-8ae3-4a5b-b696-5ed54359d958" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_9f257292-3005-4d6a-8c43-320ae0976ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#REVENUEDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cbb45658-802a-4932-9be1-fbfe8d03325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cbb45658-802a-4932-9be1-fbfe8d03325e" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:to="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f40ed185-f44a-4b55-ba71-e3c85868e7a0" xlink:to="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:href="bmy-20220930.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:to="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:href="bmy-20220930.xsd#bmy_InLineProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:to="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_ed3b725b-7cbd-47d8-bd42-f4aca3991208" xlink:href="bmy-20220930.xsd#bmy_EliquisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_EliquisMember_ed3b725b-7cbd-47d8-bd42-f4aca3991208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_c16e8ee3-b402-4a16-836a-20ee24fffb45" xlink:href="bmy-20220930.xsd#bmy_OpdivoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_OpdivoMember_c16e8ee3-b402-4a16-836a-20ee24fffb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_626774e0-5a07-47fb-ac95-211407363f97" xlink:href="bmy-20220930.xsd#bmy_PomalystImnovidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_PomalystImnovidMember_626774e0-5a07-47fb-ac95-211407363f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_174439ed-8726-48eb-99b7-cd38cca9dc04" xlink:href="bmy-20220930.xsd#bmy_OrenciaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_OrenciaMember_174439ed-8726-48eb-99b7-cd38cca9dc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_2fa77f7b-9011-4b6b-bd03-ed403126e2df" xlink:href="bmy-20220930.xsd#bmy_SprycelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_SprycelMember_2fa77f7b-9011-4b6b-bd03-ed403126e2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_70a6d648-683c-4b72-bdc0-c8e510374381" xlink:href="bmy-20220930.xsd#bmy_YervoyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_YervoyMember_70a6d648-683c-4b72-bdc0-c8e510374381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_98d5ea36-51cf-45c4-9a42-cd53f35f5415" xlink:href="bmy-20220930.xsd#bmy_EmplicitiMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_EmplicitiMember_98d5ea36-51cf-45c4-9a42-cd53f35f5415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_acd7b843-a227-47a9-9956-6713a8487af7" xlink:href="bmy-20220930.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_4fba086b-cfd1-4a3d-bfb9-dbed3b8583a2" xlink:to="loc_bmy_MatureAndOtherBrandsMember_acd7b843-a227-47a9-9956-6713a8487af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:href="bmy-20220930.xsd#bmy_NewProductPortfolioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember_33c609ef-ee63-48d4-a043-f6c7dfc0e190" xlink:to="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_6eab88e7-7e95-4538-8405-5b73705f622b" xlink:href="bmy-20220930.xsd#bmy_ReblozylMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_ReblozylMember_6eab88e7-7e95-4538-8405-5b73705f622b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_7a37a845-b4e5-4434-8564-7ee7c5aa9786" xlink:href="bmy-20220930.xsd#bmy_AbecmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_AbecmaMember_7a37a845-b4e5-4434-8564-7ee7c5aa9786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_d201863d-b01b-4533-99df-611092f924c1" xlink:href="bmy-20220930.xsd#bmy_ZeposiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_ZeposiaMember_d201863d-b01b-4533-99df-611092f924c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_12add1c2-314a-4b70-8d1e-a4df0e483f89" xlink:href="bmy-20220930.xsd#bmy_BreyanziMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_BreyanziMember_12add1c2-314a-4b70-8d1e-a4df0e483f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_591e3ffe-f4e2-449a-a504-031904486976" xlink:href="bmy-20220930.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_InrebicMember_591e3ffe-f4e2-449a-a504-031904486976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_8d4f9afe-09ce-467f-89b9-60e8dd5bd94c" xlink:href="bmy-20220930.xsd#bmy_OnuregMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_OnuregMember_8d4f9afe-09ce-467f-89b9-60e8dd5bd94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_e7185aab-ca31-4667-940e-c9d62951a322" xlink:href="bmy-20220930.xsd#bmy_OpdualagMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_OpdualagMember_e7185aab-ca31-4667-940e-c9d62951a322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember_070b530f-8de2-4c20-9ba4-e2f1723bcb0b" xlink:href="bmy-20220930.xsd#bmy_CamzyosMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_CamzyosMember_070b530f-8de2-4c20-9ba4-e2f1723bcb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember_4c3ea542-0f1b-4bc0-a1eb-7e0566447f4c" xlink:href="bmy-20220930.xsd#bmy_SotyktuMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_79bc19af-7ae3-46a7-8098-1e92a0545b6e" xlink:to="loc_bmy_SotyktuMember_4c3ea542-0f1b-4bc0-a1eb-7e0566447f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:href="bmy-20220930.xsd#bmy_LOEProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a8037bb7-d77c-4f67-acd4-65312cf101fb" xlink:to="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_69bac865-ac11-4836-835c-3abc8edcfa9b" xlink:href="bmy-20220930.xsd#bmy_RevlimidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:to="loc_bmy_RevlimidMember_69bac865-ac11-4836-835c-3abc8edcfa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_ec03ce82-ef24-439f-ae68-e48e9990bf13" xlink:href="bmy-20220930.xsd#bmy_AbraxaneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LOEProductsMember_e4edb8a1-0050-4732-8515-a388e99137d6" xlink:to="loc_bmy_AbraxaneMember_ec03ce82-ef24-439f-ae68-e48e9990bf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:to="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ec7778e2-523b-4132-a831-eec31cb19fec" xlink:to="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_88a8c4b1-8474-45bc-a206-f76a644351bb" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_country_US_88a8c4b1-8474-45bc-a206-f76a644351bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember_c976f6d3-b310-45b7-b6cf-8d384851b78a" xlink:href="bmy-20220930.xsd#bmy_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_bmy_InternationalMember_c976f6d3-b310-45b7-b6cf-8d384851b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_59e0ba10-55a0-406c-ae68-6698a1d15186" xlink:href="bmy-20220930.xsd#bmy_OtherRegionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a81acd3-2b79-404b-a7a1-321fa7dfe46a" xlink:to="loc_bmy_OtherRegionMember_59e0ba10-55a0-406c-ae68-6698a1d15186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ae839b14-0af5-4f0b-8a24-9e1045ef4154" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cffcce7d-9434-4ad0-a73c-0f3b01ff6918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:to="loc_us-gaap_Revenues_cffcce7d-9434-4ad0-a73c-0f3b01ff6918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2e7e2903-dbfc-4343-8f13-539582ad1fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3d596b0a-10ac-4ec5-8c2a-cb6a2f3d4107" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2e7e2903-dbfc-4343-8f13-539582ad1fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ALLIANCESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_860774df-e0e5-4a6f-88b3-d2e6a003ef42" xlink:href="bmy-20220930.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_860774df-e0e5-4a6f-88b3-d2e6a003ef42" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_7cb4dc2e-eff2-4d3a-9c03-1acf1cedcd86" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_20aa6622-74cb-49c5-a95f-c1b496d568d7" xlink:href="bmy-20220930.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:to="loc_bmy_NetproductsalesMember_20aa6622-74cb-49c5-a95f-c1b496d568d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d6d1a55f-aaa4-43c4-b818-015573480525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bab2d3ed-103e-4475-8838-b760ffb3d40d" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d6d1a55f-aaa4-43c4-b818-015573480525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_43e86e67-2695-4bc3-8b9b-98483002b588" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_3d8529b0-2f7e-4eab-9e77-bdacee5ac608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2a76723d-24e1-4635-bc1e-fca10f2013ad" xlink:to="loc_us-gaap_CollaborativeArrangementMember_3d8529b0-2f7e-4eab-9e77-bdacee5ac608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:href="bmy-20220930.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_b59f6566-5f99-4f4b-bfcc-a300023f8c3a" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BridgeBioMember_7994a72a-add3-4bee-8d61-2c6fc1d31694" xlink:href="bmy-20220930.xsd#bmy_BridgeBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:to="loc_bmy_BridgeBioMember_7994a72a-add3-4bee-8d61-2c6fc1d31694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember_8bb3b69e-2f2c-4f33-b8e5-5a7a1d48e49f" xlink:href="bmy-20220930.xsd#bmy_EisaiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_93f78205-06f1-4fc4-95a2-d849a3e36596" xlink:to="loc_bmy_EisaiMember_8bb3b69e-2f2c-4f33-b8e5-5a7a1d48e49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_685fa89b-58c6-43fd-bd69-cae43dfc6d4d" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8c93c10e-bffb-42af-b256-80e5db8bef5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_Revenues_8c93c10e-bffb-42af-b256-80e5db8bef5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9001a7a2-3cc0-49dc-b2df-6b60772d709a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9001a7a2-3cc0-49dc-b2df-6b60772d709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_3c41b314-854c-4d40-bed7-de12e9c7aba6" xlink:href="bmy-20220930.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_3c41b314-854c-4d40-bed7-de12e9c7aba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3fb2e07c-60d0-42d4-a4db-f668d9a5af49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3fb2e07c-60d0-42d4-a4db-f668d9a5af49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_94fef0d5-3a61-4cc1-b3af-d2dbde3e00df" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_AcquiredIPRD_94fef0d5-3a61-4cc1-b3af-d2dbde3e00df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6a1899b9-6943-4cff-9404-ef03825c6b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6a1899b9-6943-4cff-9404-ef03825c6b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_ac68001a-ca2e-4b7c-9724-f7d0a2c35e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_ReceivablesNetCurrent_ac68001a-ca2e-4b7c-9724-f7d0a2c35e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_67ead872-71dc-4952-8f4a-233c37e89184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_AccountsPayableCurrent_67ead872-71dc-4952-8f4a-233c37e89184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_e5c69085-bfaf-4b5e-a894-de9f816c3cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_us-gaap_DeferredIncome_e5c69085-bfaf-4b5e-a894-de9f816c3cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_5cee5495-f328-4926-a715-32a06d1dd008" xlink:href="bmy-20220930.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_5cee5495-f328-4926-a715-32a06d1dd008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_2afb9d02-2d64-4763-b300-c4fe15add96f" xlink:href="bmy-20220930.xsd#bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cd9e8d3b-eb16-447a-ab53-152a62ec33ba" xlink:to="loc_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval_2afb9d02-2d64-4763-b300-c4fe15add96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ecff3152-89c5-41b7-99a6-73325e00046d" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ecff3152-89c5-41b7-99a6-73325e00046d" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ce03fec-44cd-4a80-b528-5b335464db22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_3de4f073-a39a-4a88-a150-66f7594cf75a" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0ea5f8-5491-4e59-a700-34cd9da88ea3" xlink:to="loc_bmy_TurningPointMember_3de4f073-a39a-4a88-a150-66f7594cf75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTable_0dff868d-02ee-4265-ad9d-cc7173d89d9d" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff49022f-9c4c-4f27-adde-457af7c8316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff49022f-9c4c-4f27-adde-457af7c8316b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_98b41302-025d-4f44-9af8-6557db498483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLineItems_24564e9d-e6c2-4482-9dde-3bae742098dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_98b41302-025d-4f44-9af8-6557db498483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fb83875c-f157-4f57-b864-f9f5b1cece55" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fb83875c-f157-4f57-b864-f9f5b1cece55" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be4de4a2-78c8-43ef-b80d-7b05d6eec327" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_72c35329-3911-4183-b909-a049f8d92b32" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69586414-3025-485d-93db-5ac212b6df2e" xlink:to="loc_bmy_TurningPointMember_72c35329-3911-4183-b909-a049f8d92b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b4f30031-ac60-4ba4-a868-0902709dc1cd" xlink:to="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5e4c785c-4a2a-4bcf-9936-e87cc9229a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_74815015-71da-4c09-98cd-e25a42d64096" xlink:to="loc_us-gaap_CommonStockMember_5e4c785c-4a2a-4bcf-9936-e87cc9229a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5c7264ab-2d62-45c4-9a64-2f831bd93739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e623cd2a-e1b4-42d8-a90e-24d16e5d4193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69dde599-aed8-418c-b8d5-8f03b64cea71" xlink:to="loc_us-gaap_StockCompensationPlanMember_e623cd2a-e1b4-42d8-a90e-24d16e5d4193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6455353a-c395-4ac5-a1a4-e51a3fe27f1a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_baba2cba-1aeb-4f88-89f7-7cfab6d13b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_baba2cba-1aeb-4f88-89f7-7cfab6d13b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6fc8b0d6-f87a-45f5-a44b-5f219c46aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_636572b4-2e56-41cf-8de9-aca41b3c8f63" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6fc8b0d6-f87a-45f5-a44b-5f219c46aa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_31853932-2657-462f-b48f-1c2942d3fb9a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b653939-7341-420f-a9e1-6cede6c14929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b653939-7341-420f-a9e1-6cede6c14929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_50f68671-d2ad-43ef-8a9b-7b03159f7e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_50f68671-d2ad-43ef-8a9b-7b03159f7e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ba347698-f03a-41b0-906f-31dcf6f3fb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5a70ce2-e7d2-46a6-8e91-cf7a24c0d7e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ba347698-f03a-41b0-906f-31dcf6f3fb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_be7c8c85-489c-45d9-8d29-f5e73821c07a" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_be7c8c85-489c-45d9-8d29-f5e73821c07a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5cd4590a-3d06-4f04-b3e7-01c2e9a3a993" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TurningPointMember_f43ce905-9abb-4fc5-91e3-2853299b37e8" xlink:href="bmy-20220930.xsd#bmy_TurningPointMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53483983-fef2-4a01-999a-a2d9de13ab79" xlink:to="loc_bmy_TurningPointMember_f43ce905-9abb-4fc5-91e3-2853299b37e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e8d8896-7c44-4823-8c60-8e8bf554f90c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_90fe051c-2b19-4c80-ba18-bf5d1d943233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_90fe051c-2b19-4c80-ba18-bf5d1d943233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_303cdaeb-3583-4d9f-a4ee-bdc55628879c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_303cdaeb-3583-4d9f-a4ee-bdc55628879c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4edcac7e-d964-43d1-a712-2f7dbff4ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4edcac7e-d964-43d1-a712-2f7dbff4ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_605095b9-4949-4ed2-ae93-782a3ebc61c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_605095b9-4949-4ed2-ae93-782a3ebc61c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_18b81b59-eb43-4ae4-a988-c326a2997958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_18b81b59-eb43-4ae4-a988-c326a2997958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5397039d-d16a-4bc4-bb72-4bc5b45a5fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5397039d-d16a-4bc4-bb72-4bc5b45a5fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2977021c-0cb4-43f9-b04c-f3c6e218ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2977021c-0cb4-43f9-b04c-f3c6e218ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d53f3e6a-45ed-4ab1-9ba1-61e3a5dde551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d53f3e6a-45ed-4ab1-9ba1-61e3a5dde551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_afd7db89-0e9a-49c2-a019-57be5957697b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_Goodwill_afd7db89-0e9a-49c2-a019-57be5957697b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c11e30d8-2db9-4d87-a47d-0e356481b68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c11e30d8-2db9-4d87-a47d-0e356481b68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_6cde92a5-c6fc-4fa0-8770-04a042c11bd5" xlink:href="bmy-20220930.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd2edc87-7535-49c7-b9ac-b9ad4dfab62c" xlink:to="loc_bmy_AcquiredIPRD_6cde92a5-c6fc-4fa0-8770-04a042c11bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fed6289a-451f-424d-ad4f-54a991a0aa1d" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fed6289a-451f-424d-ad4f-54a991a0aa1d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_14aad3e6-15bb-4a2d-b752-bc263118bf7e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_e1ebe7d9-8a13-4d8a-afa3-5967deed2f02" xlink:href="bmy-20220930.xsd#bmy_DiabetesbusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:to="loc_bmy_DiabetesbusinessMember_e1ebe7d9-8a13-4d8a-afa3-5967deed2f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_eca51c70-d9a5-4865-abaa-2aedefaca56a" xlink:href="bmy-20220930.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d86e119b-5bd5-4d55-ad85-c60cd9e90bb1" xlink:to="loc_bmy_MatureBrandsAndOtherMember_eca51c70-d9a5-4865-abaa-2aedefaca56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c74c956-209b-48ac-aad9-7617288b5546" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_bf3a0a85-f0ac-4549-bbf8-988c5c3595ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_bf3a0a85-f0ac-4549-bbf8-988c5c3595ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_28ba8f1a-2097-4174-8cfb-8912f5124b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_28ba8f1a-2097-4174-8cfb-8912f5124b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_5ce9837d-799f-4288-8b8a-03d87e1e484d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2622b0c1-02c3-48b1-bd07-56d85ba96d3f" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_5ce9837d-799f-4288-8b8a-03d87e1e484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_60f46d61-c50e-4b39-ba23-04b5ca533c21" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_60f46d61-c50e-4b39-ba23-04b5ca533c21" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_95a2191c-2050-42dd-8144-95bc13e97efc" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_35bbf673-104d-43da-914a-5c13e8fd3a7d" xlink:href="bmy-20220930.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_35bbf673-104d-43da-914a-5c13e8fd3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_70956df9-07df-4f13-a40d-8574779038a7" xlink:href="bmy-20220930.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_TecentriqRoyaltiesMember_70956df9-07df-4f13-a40d-8574779038a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BiohavenMember_3cd3894f-eae5-4c38-87a3-23584e3bf70c" xlink:href="bmy-20220930.xsd#bmy_BiohavenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_BiohavenMember_3cd3894f-eae5-4c38-87a3-23584e3bf70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_757e6775-088e-4023-a6c5-e39f8ff92305" xlink:href="bmy-20220930.xsd#bmy_OtherRoyaltiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_b6d04bc1-819d-4684-8964-a512e35cfc0a" xlink:to="loc_bmy_OtherRoyaltiesMember_757e6775-088e-4023-a6c5-e39f8ff92305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef7fdd81-2b39-4104-8e75-673399aa8c7f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_bbe4f92e-2a6f-4d42-a682-12fb6d708216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_bbe4f92e-2a6f-4d42-a682-12fb6d708216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_b36c4551-5581-48ff-93ad-8d38dc27e260" xlink:href="bmy-20220930.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_b36c4551-5581-48ff-93ad-8d38dc27e260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_00611383-3dc1-4a8c-89f6-962b6cec34a6" xlink:href="bmy-20220930.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_AmortizationOfDeferredIncome_00611383-3dc1-4a8c-89f6-962b6cec34a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_e4f2fb97-ffb1-48ba-b441-093b1b7badf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_us-gaap_OtherNonoperatingIncome_e4f2fb97-ffb1-48ba-b441-093b1b7badf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_563cce37-2f13-4862-83e8-2142ed87e145" xlink:href="bmy-20220930.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15e8ebad-5040-45be-a314-ba5f9d0d3127" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_563cce37-2f13-4862-83e8-2142ed87e145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fabace91-1dad-43bc-8bdf-58e321162242" xlink:href="bmy-20220930.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_fabace91-1dad-43bc-8bdf-58e321162242" xlink:to="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08c296e4-f7dc-4c8d-b28d-a0d80e961203" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_f4044f37-1f54-484b-818d-482adc9e0e51" xlink:href="bmy-20220930.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7e3cb75a-6522-46e9-beeb-bc5a101982bf" xlink:to="loc_bmy_MatureBrandsAndOtherMember_f4044f37-1f54-484b-818d-482adc9e0e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c309d91e-ccce-487d-8a8e-c47f19a824ec" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOTTECorporationMember_07433a61-6e80-4cd2-be59-88215e7f5054" xlink:href="bmy-20220930.xsd#bmy_LOTTECorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_LOTTECorporationMember_07433a61-6e80-4cd2-be59-88215e7f5054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_459bc23a-850a-438f-a578-0124703ef833" xlink:href="bmy-20220930.xsd#bmy_CheplapharmMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_CheplapharmMember_459bc23a-850a-438f-a578-0124703ef833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_4b032423-efb7-45ba-852d-8d15f4c77e2e" xlink:href="bmy-20220930.xsd#bmy_ImmaticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_ImmaticsMember_4b032423-efb7-45ba-852d-8d15f4c77e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_a54ba2dd-9098-4d50-988b-2b904d77d865" xlink:href="bmy-20220930.xsd#bmy_DragonflyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_DragonflyMember_a54ba2dd-9098-4d50-988b-2b904d77d865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember_78cdef93-96a2-4b4a-9c72-680c109fc19f" xlink:href="bmy-20220930.xsd#bmy_AgenusMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c57bc16-28e4-4665-8290-610760ed324e" xlink:to="loc_bmy_AgenusMember_78cdef93-96a2-4b4a-9c72-680c109fc19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b2ac49cf-6416-4025-ab12-8dba85a1e2d0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_17a7dacc-4e91-455b-a1ac-cd9a30c2ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c46c2980-484d-4489-b83e-ab95f3c421b7" xlink:to="loc_us-gaap_CostOfSalesMember_17a7dacc-4e91-455b-a1ac-cd9a30c2ba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_76249df3-ebbb-48dd-b79f-50e9a17cc7d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_e95b655e-d133-43b4-a630-e022ac78220f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b65bbd6-ce61-4ec1-ab91-b79c593401c3" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_e95b655e-d133-43b4-a630-e022ac78220f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:href="bmy-20220930.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_71e86ad4-4a13-4630-b741-1da2736b61a1" xlink:to="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_85570025-3ecc-41a7-b568-0e31ff24c319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_85570025-3ecc-41a7-b568-0e31ff24c319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_d041d301-de2b-4e23-9240-0c28b6f61f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_AssetImpairmentCharges_d041d301-de2b-4e23-9240-0c28b6f61f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_30a85742-85ad-4cca-8478-bb89799120e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_30a85742-85ad-4cca-8478-bb89799120e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_db9ac77b-5832-4036-8829-7bd4db182801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_db9ac77b-5832-4036-8829-7bd4db182801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_a9aec06e-1526-4dd6-a311-926633a9c748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_a9aec06e-1526-4dd6-a311-926633a9c748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5662a8bf-68f4-439c-bb22-bd5ef40d1d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5662a8bf-68f4-439c-bb22-bd5ef40d1d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_01966013-9798-418b-955e-03b587455a1f" xlink:href="bmy-20220930.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_01966013-9798-418b-955e-03b587455a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_eb670dfc-fd53-464c-9bfe-5b428cdac232" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_eb670dfc-fd53-464c-9bfe-5b428cdac232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_d4fc2fe7-8a33-4063-b335-cba94cf0aae6" xlink:href="bmy-20220930.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_db7aa2a1-5dc7-400b-b553-2664957f437e" xlink:to="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_d4fc2fe7-8a33-4063-b335-cba94cf0aae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eb4c42cb-9526-46f4-a56e-8599b1816e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_InterestExpense_eb4c42cb-9526-46f4-a56e-8599b1816e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_e0d508b5-883e-4ef9-9925-29d2c82aa8be" xlink:href="bmy-20220930.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_e0d508b5-883e-4ef9-9925-29d2c82aa8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f9015bcc-a4e4-49a8-9919-608866e209f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_GainLossOnInvestments_f9015bcc-a4e4-49a8-9919-608866e209f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_05496faf-c67a-4148-807d-2bc3a3eae50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_05496faf-c67a-4148-807d-2bc3a3eae50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cb302fd2-d72e-40c4-b493-962c00543711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cb302fd2-d72e-40c4-b493-962c00543711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_61240cd5-e483-4660-93a5-c0d318c02cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_61240cd5-e483-4660-93a5-c0d318c02cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4cbf342c-2825-4a85-b397-4b13dac0dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_RestructuringCharges_4cbf342c-2825-4a85-b397-4b13dac0dae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d25818e4-0a05-4fd3-9f3a-48edda4e3ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d25818e4-0a05-4fd3-9f3a-48edda4e3ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_43e066f9-e8f4-4be0-bba3-6de9ff6c51e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_43e066f9-e8f4-4be0-bba3-6de9ff6c51e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_b1059a54-8bbe-4793-9cbd-099ad465a89f" xlink:href="bmy-20220930.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_bmy_OtherOtherIncomeExpense_b1059a54-8bbe-4793-9cbd-099ad465a89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6081bc55-9c15-411e-abad-98a7f59f2b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3a1b29ab-d55a-414c-9ce5-d9e839a87e5c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6081bc55-9c15-411e-abad-98a7f59f2b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_3c131d8e-aab7-4bcf-83c6-64600c9622be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_3c131d8e-aab7-4bcf-83c6-64600c9622be" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:to="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_372348df-5355-4223-99f8-75125da6fbf7" xlink:to="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_0c26a367-3f9a-43a3-a934-78b89f436d94" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:to="loc_bmy_CelgeneIntegrationMember_0c26a367-3f9a-43a3-a934-78b89f436d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_e45e2d70-5687-411b-9b75-8d8f9385701b" xlink:href="bmy-20220930.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_841d89af-d734-41cd-bbdf-32c5934e5e1e" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_e45e2d70-5687-411b-9b75-8d8f9385701b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9501fb49-d3a1-48ce-8cbc-e0fa86d6179e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_df4a3186-ad44-4f66-b1af-8155264208ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_CostOfSalesMember_df4a3186-ad44-4f66-b1af-8155264208ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_faaff991-284a-4f01-a182-b26377060203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_faaff991-284a-4f01-a182-b26377060203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_440d157a-c166-494b-a905-d244886d67fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_375f293c-0b59-4b39-b553-107fb171f092" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_440d157a-c166-494b-a905-d244886d67fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_19b26414-643c-4647-b884-3ce11f4686dc" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_863fb29f-ac5d-46a1-85a2-6ae7a2532e71" xlink:href="bmy-20220930.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_863fb29f-ac5d-46a1-85a2-6ae7a2532e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage_32e85b29-ef37-44a0-97df-e79ec09a26f7" xlink:href="bmy-20220930.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_ExpectedSynergiesPercentage_32e85b29-ef37-44a0-97df-e79ec09a26f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_75aba32e-2535-4d9d-b295-f99203acb5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_75aba32e-2535-4d9d-b295-f99203acb5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_971fed1d-1c80-43a8-b26b-7b44dfa559c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_971fed1d-1c80-43a8-b26b-7b44dfa559c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_e7c07669-12c0-4d44-a260-35a321076676" xlink:href="bmy-20220930.xsd#bmy_Cashoutlays"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_bmy_Cashoutlays_e7c07669-12c0-4d44-a260-35a321076676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5064475a-128f-4560-8194-2d39412a04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5064475a-128f-4560-8194-2d39412a04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_b8bee88e-87b9-45ca-8311-5525607a59e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_72287696-47a5-49da-8ab7-949e3f625bbc" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_b8bee88e-87b9-45ca-8311-5525607a59e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a8b13f37-102a-4ae7-ab62-89b9848d1716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a8b13f37-102a-4ae7-ab62-89b9848d1716" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:to="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_55559193-b3cc-4b62-ade5-921ff06d7c1b" xlink:to="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_3d0ea46e-1d42-4ec9-96fa-3687414eff54" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:to="loc_bmy_CelgeneIntegrationMember_3d0ea46e-1d42-4ec9-96fa-3687414eff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_cb3e187c-fb53-4ed5-89a5-617aa7594649" xlink:href="bmy-20220930.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_22072193-1e4e-4c75-8156-e2e083d3296f" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_cb3e187c-fb53-4ed5-89a5-617aa7594649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc345ebb-107d-4082-aaa5-7dd4d6beb694" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_19d6c211-3fe6-4822-a2bc-9f0ff93b9d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_CostOfSalesMember_19d6c211-3fe6-4822-a2bc-9f0ff93b9d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_678fcd71-3b6d-4926-903a-84bdb56741fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_678fcd71-3b6d-4926-903a-84bdb56741fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6c317599-accb-4865-9ff5-137f72ee62e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_850fe0c6-0ccb-461f-9b38-67c3968b4912" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6c317599-accb-4865-9ff5-137f72ee62e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b964b663-700e-4f21-8216-ae44e8cb499e" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_a586859e-ae92-4aad-8ade-18b7cdbe539d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_a586859e-ae92-4aad-8ade-18b7cdbe539d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e5686056-a583-49dd-9285-b5392ae6c7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_SeveranceCosts1_e5686056-a583-49dd-9285-b5392ae6c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_3b6b2480-d50e-47d1-85d5-34184d688dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_OtherRestructuringCosts_3b6b2480-d50e-47d1-85d5-34184d688dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b7619458-7aca-494f-bd22-7492cca633c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringCharges_b7619458-7aca-494f-bd22-7492cca633c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_257843d5-4e59-4045-80fe-8f4603e42df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_257843d5-4e59-4045-80fe-8f4603e42df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_0fb6661f-37f7-4a78-9d2b-f9dd4a7dd835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_0fb6661f-37f7-4a78-9d2b-f9dd4a7dd835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_a9182293-b524-43fc-817d-155f462c6d8c" xlink:href="bmy-20220930.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_a9182293-b524-43fc-817d-155f462c6d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_c94ee74e-d558-4b9f-9f3a-226f8325ddc6" xlink:href="bmy-20220930.xsd#bmy_OtherShutdownCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_602ab6ae-1263-4b41-ae81-aad585e36e0a" xlink:to="loc_bmy_OtherShutdownCosts_c94ee74e-d558-4b9f-9f3a-226f8325ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_28049a6a-df36-4bf8-97c5-5962589652d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_28049a6a-df36-4bf8-97c5-5962589652d8" xlink:to="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:to="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_314c86e2-c95c-4eea-837e-2ca7fbc76420" xlink:to="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_4c883afd-ba07-4cc8-adee-9b0c9dc75e5d" xlink:href="bmy-20220930.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_7291d1a2-a745-497b-bafd-e1ab7c621b68" xlink:to="loc_bmy_CelgeneIntegrationMember_4c883afd-ba07-4cc8-adee-9b0c9dc75e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_24aea9ef-739a-4dbd-aeac-29a7a30d9c94" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_a59c6262-41bb-4ec0-a4b1-41bdff7d592c" xlink:href="bmy-20220930.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_335b5e57-0c3c-4fff-9e89-1f7c8cef7e0d" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_a59c6262-41bb-4ec0-a4b1-41bdff7d592c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8111516f-5ef1-4535-86c3-d04034b5456e" xlink:to="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b48e563e-6754-46f2-9608-a6b5d5df5851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_RestructuringReserve_b48e563e-6754-46f2-9608-a6b5d5df5851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_33d7b257-5b0e-47c1-8733-d6d436638484" xlink:href="bmy-20220930.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_33d7b257-5b0e-47c1-8733-d6d436638484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_7e4b100e-a1f7-45f3-b7fd-10b8f572e164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_7e4b100e-a1f7-45f3-b7fd-10b8f572e164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8192ab26-ba16-494d-997c-af22032b65c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_PaymentsForRestructuring_8192ab26-ba16-494d-997c-af22032b65c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_bd181e68-809c-4b21-a63d-77b0b52a0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_122a978d-a3e3-4931-b8eb-f81944648ea2" xlink:to="loc_us-gaap_RestructuringReserve_bd181e68-809c-4b21-a63d-77b0b52a0245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_13b7d6a9-3a78-4c74-af18-79a85e70a655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_13b7d6a9-3a78-4c74-af18-79a85e70a655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_acb5c207-fe8f-4ea4-93d4-b2b2aa90396e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_280f02da-da27-4fc6-8d97-87fbc9055c59" xlink:to="loc_us-gaap_RestructuringCharges_acb5c207-fe8f-4ea4-93d4-b2b2aa90396e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fddd7103-cfe5-45fd-bc4a-f79966df689f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1bdbaa2-5970-49f9-ad4c-d151c56f6d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fddd7103-cfe5-45fd-bc4a-f79966df689f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1bdbaa2-5970-49f9-ad4c-d151c56f6d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb69d2-26d1-45fe-991e-70708ed8e146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fddd7103-cfe5-45fd-bc4a-f79966df689f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb69d2-26d1-45fe-991e-70708ed8e146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d999ab7c-d085-4da2-9e27-645f508666eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fddd7103-cfe5-45fd-bc4a-f79966df689f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d999ab7c-d085-4da2-9e27-645f508666eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97a0a0d6-c235-4bb8-b4e5-385bcfbfda8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97a0a0d6-c235-4bb8-b4e5-385bcfbfda8a" xlink:to="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:to="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1f21c051-ecf0-47df-a9f7-3358a5d7e838" xlink:to="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_da825759-0f8a-4a73-8f4c-bd3def4cf592" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:to="loc_srt_MinimumMember_da825759-0f8a-4a73-8f4c-bd3def4cf592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_92152204-66d8-4cf4-8bef-c198ffc04bad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d7f85ebc-5f1a-4d02-afa2-238245d42039" xlink:to="loc_srt_MaximumMember_92152204-66d8-4cf4-8bef-c198ffc04bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d7c3b677-dd20-429c-84d9-31fddb361af4" xlink:to="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d7b8008f-ee9d-4fe8-826e-afa0867d0d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_61494733-b0e0-4855-acf6-a338e3196b99" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d7b8008f-ee9d-4fe8-826e-afa0867d0d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bab384af-d821-4537-b60c-fe656a392a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:to="loc_us-gaap_NetIncomeLoss_bab384af-d821-4537-b60c-fe656a392a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3b8a115-8d65-498f-9c1c-c41e543e69f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3b8a115-8d65-498f-9c1c-c41e543e69f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_934230ab-b703-4a37-b3fc-a9ce3cf01ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_934230ab-b703-4a37-b3fc-a9ce3cf01ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e850ea6c-a590-438b-8ac0-ab28028343e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e850ea6c-a590-438b-8ac0-ab28028343e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_b3a7b22e-2bd0-4988-8bd4-a84427987733" xlink:href="bmy-20220930.xsd#bmy_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22aed4ad-8e39-43d0-9227-576ab321922d" xlink:to="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_b3a7b22e-2bd0-4988-8bd4-a84427987733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5f670a22-f5a5-482f-b033-0d4427f76244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_b3a7b22e-2bd0-4988-8bd4-a84427987733" xlink:to="loc_us-gaap_EarningsPerShareBasic_5f670a22-f5a5-482f-b033-0d4427f76244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0fb6c971-569e-464b-9979-3378e4098f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_b3a7b22e-2bd0-4988-8bd4-a84427987733" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0fb6c971-569e-464b-9979-3378e4098f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c5886048-0850-4c92-bd92-4bf905185b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c5886048-0850-4c92-bd92-4bf905185b9f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561c363f-ef5c-4266-822c-e17a265afc8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8a95182d-e87d-4410-b705-7ed15e64a495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8a95182d-e87d-4410-b705-7ed15e64a495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_77d086a1-0077-4d48-91a6-a7b7b654be15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_77d086a1-0077-4d48-91a6-a7b7b654be15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_491146f4-a6b3-456f-aebb-86bcf73be9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cae546f1-188e-4c4c-8487-7b096c888bbe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_491146f4-a6b3-456f-aebb-86bcf73be9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_116c395e-1e60-466b-beaf-0e0287ee199d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_21ee644f-dd41-4b85-ba4e-f00e37928dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CertificatesOfDepositMember_21ee644f-dd41-4b85-ba4e-f00e37928dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_576c3af3-9ad0-48f0-b5f7-c4df71f3f506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CommercialPaperMember_576c3af3-9ad0-48f0-b5f7-c4df71f3f506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b8fef6f0-40e3-458a-a893-69ab9257db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef118b0-ab81-40d9-8583-7a77508d8659" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b8fef6f0-40e3-458a-a893-69ab9257db4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f56114f0-4ff0-4bfc-9eba-cd1183e7ab71" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_1374aa1a-d92c-45b7-beca-d90a15b5598a" xlink:href="bmy-20220930.xsd#bmy_ContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a26d5ded-298b-4f92-a38a-e6c499588e68" xlink:to="loc_bmy_ContingentValueRightsMember_1374aa1a-d92c-45b7-beca-d90a15b5598a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b7e39fd-6ca5-46d0-98df-3fa99c1ba9c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_3ab60455-d74d-4d32-b0c4-81d788a2fdca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fe4056c-7710-472c-952b-b7da67cb52fe" xlink:to="loc_us-gaap_OtherAssetsMember_3ab60455-d74d-4d32-b0c4-81d788a2fdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c095513f-5823-4f7b-8969-e4bae93e1982" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_acedf9c5-9ae5-4484-86f2-beeb390c4a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_acedf9c5-9ae5-4484-86f2-beeb390c4a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70b7a537-842b-43c2-a99c-13fc7f8e9010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70b7a537-842b-43c2-a99c-13fc7f8e9010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e285594b-c33a-4585-aba8-a7a4ca79207f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_DerivativeAssets_e285594b-c33a-4585-aba8-a7a4ca79207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1da814d2-e9c7-4332-b7d4-7a7e5b0df393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1da814d2-e9c7-4332-b7d4-7a7e5b0df393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7fd28875-4431-4c11-8eee-b6d6df809aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_DerivativeLiabilities_7fd28875-4431-4c11-8eee-b6d6df809aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_814dad63-0127-459e-b346-3d35b5c412cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e85c071e-c83d-4a2d-9602-e0f59b6ecef0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_814dad63-0127-459e-b346-3d35b5c412cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_189c81c6-a3c8-41a8-917e-55c13aab1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_189c81c6-a3c8-41a8-917e-55c13aab1d3b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1cc3ce61-5742-44d5-9be5-b83a85c163ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_46d7cf42-a4d8-4357-a3b6-240fdff1afcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CertificatesOfDepositMember_46d7cf42-a4d8-4357-a3b6-240fdff1afcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d25c7d2b-8635-41e4-8c5f-0652a417e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CommercialPaperMember_d25c7d2b-8635-41e4-8c5f-0652a417e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a8b176ee-13c0-4722-a189-6b288f189570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bacbafc7-ae2b-4ccc-aa91-5eb1e0e572fe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a8b176ee-13c0-4722-a189-6b288f189570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb0c9cd8-5c5f-42c8-8fde-49d3dc11222f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a2032545-1572-47f3-a1d8-d46682d5924d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a2032545-1572-47f3-a1d8-d46682d5924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e56ca3a5-0353-4249-bad4-f1a22ed9d23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e56ca3a5-0353-4249-bad4-f1a22ed9d23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_06201a90-2b5f-42b8-94c4-b7c12419f187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_06201a90-2b5f-42b8-94c4-b7c12419f187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_198d244d-87e0-44a1-921f-da37eddfb1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62ff8589-6444-4a1b-a3b5-aed8e1b05729" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_198d244d-87e0-44a1-921f-da37eddfb1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_29ae1e3e-4fdf-431b-b30c-bab138c4c841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_95c0bd51-ffd2-4f90-93c8-1bd9a307f69d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29ae1e3e-4fdf-431b-b30c-bab138c4c841" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_95c0bd51-ffd2-4f90-93c8-1bd9a307f69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_54eef3ed-92b3-4d25-9c71-47842f36d4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29ae1e3e-4fdf-431b-b30c-bab138c4c841" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_54eef3ed-92b3-4d25-9c71-47842f36d4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9a7cde36-4856-47ee-ab9c-292eb9bedd03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29ae1e3e-4fdf-431b-b30c-bab138c4c841" xlink:to="loc_us-gaap_EquityMethodInvestments_9a7cde36-4856-47ee-ab9c-292eb9bedd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_3c29b7cf-5aa4-4ed9-81fb-65cfed7fbb1a" xlink:href="bmy-20220930.xsd#bmy_EquityInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29ae1e3e-4fdf-431b-b30c-bab138c4c841" xlink:to="loc_bmy_EquityInvestments_3c29b7cf-5aa4-4ed9-81fb-65cfed7fbb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3d2efd28-7f2a-41b4-9c36-b7f0e49f8701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract_73b36199-0832-44b8-94a8-ad585d4f62fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d2efd28-7f2a-41b4-9c36-b7f0e49f8701" xlink:to="loc_us-gaap_EquitySecuritiesFVNIAbstract_73b36199-0832-44b8-94a8-ad585d4f62fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c2954ed7-f4b6-4ac0-88f2-c1390c7d5af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_73b36199-0832-44b8-94a8-ad585d4f62fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c2954ed7-f4b6-4ac0-88f2-c1390c7d5af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_f79d755a-a0bd-4953-856e-dc0e445b9f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_73b36199-0832-44b8-94a8-ad585d4f62fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_f79d755a-a0bd-4953-856e-dc0e445b9f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_942dd641-46df-488a-9741-17a3a424ebc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_73b36199-0832-44b8-94a8-ad585d4f62fe" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_942dd641-46df-488a-9741-17a3a424ebc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d2efd28-7f2a-41b4-9c36-b7f0e49f8701" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_e32e578d-48a3-4c35-99a0-3068d7b0f6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_e32e578d-48a3-4c35-99a0-3068d7b0f6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_ecbb8512-fecc-414e-a045-6879a9ab3724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_ecbb8512-fecc-414e-a045-6879a9ab3724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_c803452b-b77e-4e24-8bf7-6ba0f8ef81b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_c803452b-b77e-4e24-8bf7-6ba0f8ef81b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_4648acf0-6b9b-44b9-8c84-f0d77250d012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_4c1311d9-8a35-4d44-b3ab-7f6b293ff4cf" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_4648acf0-6b9b-44b9-8c84-f0d77250d012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6fea62a3-cebb-4ebb-92b6-23afec74167d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d2efd28-7f2a-41b4-9c36-b7f0e49f8701" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6fea62a3-cebb-4ebb-92b6-23afec74167d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e543b2f5-224a-40d4-a384-addd1d75a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e543b2f5-224a-40d4-a384-addd1d75a96e" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_f618d980-587b-4508-a306-d66fda953c1f" xlink:to="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_4e146aec-8c10-4ab1-a43f-6ee20a0994a2" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:to="loc_currency_EUR_4e146aec-8c10-4ab1-a43f-6ee20a0994a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_c66ff7e3-36d0-4fab-a93f-17a4bd6028ad" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_d662e08c-aa2f-4c32-9067-0f9bd9a4caaa" xlink:to="loc_currency_JPY_c66ff7e3-36d0-4fab-a93f-17a4bd6028ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_626dbd81-2a96-4395-b47d-0e49acc79a11" xlink:to="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_16dc674c-016f-4a9f-8087-7f8d0f06b605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9de0375d-5670-4ed7-80d8-fdfc1c4859f2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_16dc674c-016f-4a9f-8087-7f8d0f06b605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f65f8dd1-aed1-44e4-8cb9-a6e0cd8ca3d2" xlink:to="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c754b084-9b54-46c6-b2eb-12489931a888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0096b0c2-ff29-4e56-ae69-d91836e4e688" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c754b084-9b54-46c6-b2eb-12489931a888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b6cf7f6-f2db-4587-87a4-b27012d6d37d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.600Notesdue2022Member_eb117e08-f3b0-4ca7-9ba7-2487778ddd6a" xlink:href="bmy-20220930.xsd#bmy_A2.600Notesdue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2.600Notesdue2022Member_eb117e08-f3b0-4ca7-9ba7-2487778ddd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FloatingRateNotesdue2022Member_5fcde9f2-bda8-40e4-8ebf-bc02fcfb1a1c" xlink:href="bmy-20220930.xsd#bmy_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_FloatingRateNotesdue2022Member_5fcde9f2-bda8-40e4-8ebf-bc02fcfb1a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_6941c4e4-f954-4c77-b825-1c0b78374b99" xlink:href="bmy-20220930.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_6941c4e4-f954-4c77-b825-1c0b78374b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_e93ceb64-3dbe-4557-abaf-46eec1a03380" xlink:href="bmy-20220930.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_e93ceb64-3dbe-4557-abaf-46eec1a03380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2000NotesDue2022Member_7d002269-950c-4df2-88e7-324ae132437e" xlink:href="bmy-20220930.xsd#bmy_A2000NotesDue2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A2000NotesDue2022Member_7d002269-950c-4df2-88e7-324ae132437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250BondsDue2022Member_f31d348f-2e64-4a78-8a64-3e6d90741230" xlink:href="bmy-20220930.xsd#bmy_A3250BondsDue2022Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A3250BondsDue2022Member_f31d348f-2e64-4a78-8a64-3e6d90741230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3550BondsDue2022Member_ed4b8374-dc44-4561-b302-a160532c89b9" xlink:href="bmy-20220930.xsd#bmy_A3550BondsDue2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd9cc68c-b344-40ad-970c-debd9a3a77a9" xlink:to="loc_bmy_A3550BondsDue2022Member_ed4b8374-dc44-4561-b302-a160532c89b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5be6cb44-ca8e-4beb-8c2c-fad112e207a2" xlink:to="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_09f1dcc5-b2bf-4d35-a1f9-9e4abb001d23" xlink:href="bmy-20220930.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_09f1dcc5-b2bf-4d35-a1f9-9e4abb001d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_639c4b1b-c41b-4516-bb8e-716d57f4615e" xlink:href="bmy-20220930.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_639c4b1b-c41b-4516-bb8e-716d57f4615e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_cd8ed1e7-85dc-4afe-be0b-b622f59463b7" xlink:href="bmy-20220930.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_cd8ed1e7-85dc-4afe-be0b-b622f59463b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_ef381441-7da9-418f-96d2-45b39356628c" xlink:href="bmy-20220930.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3d795b0e-5440-4835-b542-60bf32149b7c" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_ef381441-7da9-418f-96d2-45b39356628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da211356-812f-46ef-a19d-9aafb5d6505f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b333b752-c6e9-48ba-b77d-de228aeff7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b333b752-c6e9-48ba-b77d-de228aeff7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ceaf8a5f-6315-4dcc-9a75-cc3969df90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e541a35-f51b-4034-92e8-e1251bf0bf46" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ceaf8a5f-6315-4dcc-9a75-cc3969df90ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a204ed4c-31b8-4e3d-bf9b-2ba08469c1ad" xlink:to="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_43efab40-3a76-4ff9-8d45-5219b6a3dc85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_43efab40-3a76-4ff9-8d45-5219b6a3dc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1008e637-7ef9-4153-a74a-e9cc64e1ac66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1008e637-7ef9-4153-a74a-e9cc64e1ac66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_bbbca5e7-dc8f-4d51-8641-39a7946d4477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_bbbca5e7-dc8f-4d51-8641-39a7946d4477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_378fc537-f88d-429f-8200-912c2af29aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_378fc537-f88d-429f-8200-912c2af29aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d5855f9f-e2b9-4810-b587-9f623ddb3d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d5855f9f-e2b9-4810-b587-9f623ddb3d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_60c07306-4dcd-4887-9aa0-4bb71f8da87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_60c07306-4dcd-4887-9aa0-4bb71f8da87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b2a4373-416c-4056-99c8-930ab978ec42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b2a4373-416c-4056-99c8-930ab978ec42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37673b93-d010-4155-a62a-a48b8331d98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_37673b93-d010-4155-a62a-a48b8331d98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_6240085b-45ee-4391-977b-c02223a093fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_RepaymentsOfDebt_6240085b-45ee-4391-977b-c02223a093fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251e00a8-ef28-4c7f-b382-65b9251288ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251e00a8-ef28-4c7f-b382-65b9251288ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7b9a44b4-2896-431b-b7c3-775c88fd3317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7b9a44b4-2896-431b-b7c3-775c88fd3317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e7bdf030-879e-4aa7-826c-49a42099a219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_InterestPaidNet_e7bdf030-879e-4aa7-826c-49a42099a219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_69404a63-1e72-425c-abbc-7bd7f329dba1" xlink:href="bmy-20220930.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_69404a63-1e72-425c-abbc-7bd7f329dba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b08b9e56-e408-40ec-b2cc-50b24f54b671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b08b9e56-e408-40ec-b2cc-50b24f54b671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_8e5c0033-6157-485b-9422-878121ac2102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_us-gaap_LongTermDebtTerm_8e5c0033-6157-485b-9422-878121ac2102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_004d674a-5385-489f-bf87-33261148227d" xlink:href="bmy-20220930.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c64da712-643b-4ee4-8d48-47e0e41aaca0" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_004d674a-5385-489f-bf87-33261148227d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3933d8be-7632-46f3-948d-623349f10d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3933d8be-7632-46f3-948d-623349f10d0b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_03e06f4a-eb74-45c0-9515-f9416584ee3c" xlink:to="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4a9ffb86-1a14-42db-bd1f-f42230100ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4a9ffb86-1a14-42db-bd1f-f42230100ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_24bce09e-fde0-4ca1-a373-2113aa516a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1ea4c927-a365-4ff6-b9f1-ffd820349a83" xlink:to="loc_us-gaap_NondesignatedMember_24bce09e-fde0-4ca1-a373-2113aa516a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55375e90-dc31-47bd-85d2-beda8dc61a8c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_863fb49d-8ac8-4b6a-bb0e-688c6fd09c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_InterestRateSwapMember_863fb49d-8ac8-4b6a-bb0e-688c6fd09c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_bb297de1-17b2-4c9f-b5b3-215628b182ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_bb297de1-17b2-4c9f-b5b3-215628b182ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d9ea14b0-0b04-4921-be37-432a6670623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d9ea14b0-0b04-4921-be37-432a6670623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_7f8b2d20-0bc0-4ff8-86cb-4befa131766f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_91dff359-840e-491f-88f7-7fa82241099f" xlink:to="loc_us-gaap_OtherContractMember_7f8b2d20-0bc0-4ff8-86cb-4befa131766f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b099c7d-ac7b-4d26-b2c9-dcdca3f65c17" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_dc4c7e5f-ac08-4dcf-b765-2a394069bd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:to="loc_us-gaap_AssetsMember_dc4c7e5f-ac08-4dcf-b765-2a394069bd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_a218b12b-1c33-4de8-86d0-c074705d0ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d59bd70-f936-4da0-8122-e733cfa78113" xlink:to="loc_us-gaap_LiabilityMember_a218b12b-1c33-4de8-86d0-c074705d0ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8ed0ce4-c011-4e38-a6ee-9da94a8c7a23" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_73e17a20-13ec-4739-9eda-653bb8eabbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeNotionalAmount_73e17a20-13ec-4739-9eda-653bb8eabbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_31ab31ca-ea07-4b1d-b6b5-c589faedfd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeAssets_31ab31ca-ea07-4b1d-b6b5-c589faedfd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f18ca417-2986-4fcd-a4f7-e18b13dc9f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1985013a-fdb9-4151-b84b-a2a4ffd8c8ff" xlink:to="loc_us-gaap_DerivativeLiabilities_f18ca417-2986-4fcd-a4f7-e18b13dc9f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_59de90b0-786a-4887-986c-edf6cf26a619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_59de90b0-786a-4887-986c-edf6cf26a619" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dbdd27c5-d86c-44a1-9f7e-8087e9be4d07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f02d86fe-94a6-42d0-a3fd-150e8a6c5bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_InterestRateSwapMember_f02d86fe-94a6-42d0-a3fd-150e8a6c5bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ab8c95d7-6f30-4371-a122-62169d8a33c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ab8c95d7-6f30-4371-a122-62169d8a33c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b837731b-4d45-4b55-9790-129da5574777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6494d6dd-ffa8-4443-86cc-6b43db8c3bed" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b837731b-4d45-4b55-9790-129da5574777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1919e7d7-ab21-4957-92fd-e88f92da329c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9c68fa8d-e166-4fd5-b147-f989873127a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:to="loc_us-gaap_CostOfSalesMember_9c68fa8d-e166-4fd5-b147-f989873127a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_87c11f0e-31c9-4ca6-a7c8-5314556e6480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_26bb15c0-e651-491e-8f54-7853a2c56dd5" xlink:to="loc_us-gaap_OtherIncomeMember_87c11f0e-31c9-4ca6-a7c8-5314556e6480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f53e206-9bbf-4d32-994f-e1bd00091634" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b56a9ff5-8da1-47d8-bb3d-36f101381aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3cceb2ef-f4bf-4267-9f41-cd037603d144" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b56a9ff5-8da1-47d8-bb3d-36f101381aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fd4ed605-602c-4cc5-b7d7-22d7f18523db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fd4ed605-602c-4cc5-b7d7-22d7f18523db" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67befe9b-34c9-469d-80fe-307fdef61d6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3e69b7b2-d16e-4e10-afc8-f8f19d69289f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3e69b7b2-d16e-4e10-afc8-f8f19d69289f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_818b5b3e-0548-453d-a5cc-21a4669d406c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_InterestRateSwapMember_818b5b3e-0548-453d-a5cc-21a4669d406c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_683bd32f-3e90-4a61-816f-f59b73138064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c76af32-8b43-449d-9243-10bfc425ade6" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_683bd32f-3e90-4a61-816f-f59b73138064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_178ac7d7-9504-4f19-8d3e-d6f64aaababf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bea4aaa9-f89f-467f-bd6b-8fcdaf5859bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_CostOfSalesMember_bea4aaa9-f89f-467f-bd6b-8fcdaf5859bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_5a505bd6-794e-41d3-8280-2547dc726bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_5a505bd6-794e-41d3-8280-2547dc726bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_4bb52610-b21f-4930-b173-33d6f5e1ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d403b282-20aa-4f33-a591-212652bb135c" xlink:to="loc_us-gaap_OtherIncomeMember_4bb52610-b21f-4930-b173-33d6f5e1ccc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_12b95b8e-8102-408e-b39a-57c930fddffc" xlink:to="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc97219d-e069-4ebd-9f36-5a14cdcee750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_da3e6e04-d164-4d5a-8387-bf9b0e4fec02" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc97219d-e069-4ebd-9f36-5a14cdcee750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_7c1726cd-6725-4298-b840-9a6f81e518e4" xlink:to="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_91098b33-e4f8-435d-bff7-ec526fcc0321" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1557ed11-c37e-4961-b70f-6c0f3fd69b59" xlink:to="loc_currency_EUR_91098b33-e4f8-435d-bff7-ec526fcc0321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7907be2-72c9-42e5-b35a-f97ad0e8adc5" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_1b9831cb-6ca1-46a3-ad9c-6b70e42feda8" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6ba844d3-a252-4f42-ab39-404022c0bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6ba844d3-a252-4f42-ab39-404022c0bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_94b7f4b2-62f3-4f5f-893a-f3d1195f1e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_c979bc50-e3a8-4f4d-b15e-322487738256" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_94b7f4b2-62f3-4f5f-893a-f3d1195f1e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0b916ca7-1169-447d-a00c-09de792da7ce" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_39d6079b-64b3-4f55-9100-008cefc4b80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_8e62fc55-4f2e-436d-b6c6-0bb5bd8fc4ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_39d6079b-64b3-4f55-9100-008cefc4b80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_d288dc71-8259-478a-995c-8bbfdb241467" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_abcec817-5d28-4df9-929b-09cd976a0307" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_fc18a3b5-431f-490b-9980-10c77fb72d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_12ea00ee-739f-4496-95c1-45581671cfc6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_fc18a3b5-431f-490b-9980-10c77fb72d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dd27a64c-7694-4699-9ab9-c7b101eaecc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_4090c77c-a5b3-464a-8e70-bb2146ad6703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dd27a64c-7694-4699-9ab9-c7b101eaecc9" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_4090c77c-a5b3-464a-8e70-bb2146ad6703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eb28d892-9ccc-448b-a200-fc6d91db1e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dd27a64c-7694-4699-9ab9-c7b101eaecc9" xlink:to="loc_us-gaap_LongTermDebtCurrent_eb28d892-9ccc-448b-a200-fc6d91db1e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_ed6f4d51-854d-41ea-ad6d-bef7f6338e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dd27a64c-7694-4699-9ab9-c7b101eaecc9" xlink:to="loc_us-gaap_OtherShortTermBorrowings_ed6f4d51-854d-41ea-ad6d-bef7f6338e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_99163a4c-6a98-4c85-a9f2-9ce66040e6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dd27a64c-7694-4699-9ab9-c7b101eaecc9" xlink:to="loc_us-gaap_ShortTermBorrowings_99163a4c-6a98-4c85-a9f2-9ce66040e6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0aa249c4-10de-4c0f-beeb-461bcb516dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0aa249c4-10de-4c0f-beeb-461bcb516dba" xlink:to="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f268db7-4076-48f1-92e6-ed1d7b1364e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_15282ba9-726e-4aa1-809d-03a61a0a6b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5004b45f-d18f-42f1-8068-fded777fca20" xlink:to="loc_us-gaap_InterestRateSwapMember_15282ba9-726e-4aa1-809d-03a61a0a6b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_488b943b-3534-4752-ac25-7fa374d19950" xlink:to="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d848e9c-dee2-4924-a40a-74cc15fb12fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d848e9c-dee2-4924-a40a-74cc15fb12fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e256d73e-5a68-4f7e-99dc-238ac339e299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DerivativeLiabilities_e256d73e-5a68-4f7e-99dc-238ac339e299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_693688cc-a6b9-429b-88c9-f9671bccee60" xlink:href="bmy-20220930.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_693688cc-a6b9-429b-88c9-f9671bccee60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_df6f5aa0-136e-46e0-86a4-cf0a25870fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_df6f5aa0-136e-46e0-86a4-cf0a25870fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_13fef5d5-83f2-480a-838f-bd2f1630ef46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_13fef5d5-83f2-480a-838f-bd2f1630ef46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5762de1c-ec6b-4933-a699-5da01bb6a9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebt_5762de1c-ec6b-4933-a699-5da01bb6a9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_92604bb7-7d74-4048-9974-dc941c67fb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebtCurrent_92604bb7-7d74-4048-9974-dc941c67fb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_73ff0f9a-4cd9-4bb9-96a7-9bfa8389a62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03bfeda7-6379-4ed0-b67c-af479193a010" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_73ff0f9a-4cd9-4bb9-96a7-9bfa8389a62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_df38a4d2-46a8-4251-abb1-a1b6f29d39c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_df38a4d2-46a8-4251-abb1-a1b6f29d39c5" xlink:to="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a37f65b-94e4-4031-9943-efcb76b57430" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2032Member_aa38f43f-bd48-4e75-b62e-1cc13bf6b2a5" xlink:href="bmy-20220930.xsd#bmy_NoteDue2032Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2032Member_aa38f43f-bd48-4e75-b62e-1cc13bf6b2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2042Member_28ad2427-fe55-4808-82ef-46be9bc3b762" xlink:href="bmy-20220930.xsd#bmy_NoteDue2042Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2042Member_28ad2427-fe55-4808-82ef-46be9bc3b762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2052Member_6e4f6db4-ef0b-4d0c-af54-59158759825e" xlink:href="bmy-20220930.xsd#bmy_NoteDue2052Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2052Member_6e4f6db4-ef0b-4d0c-af54-59158759825e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NoteDue2062Member_aeab961f-c13c-4c29-8898-7d9e6efaf710" xlink:href="bmy-20220930.xsd#bmy_NoteDue2062Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_NoteDue2062Member_aeab961f-c13c-4c29-8898-7d9e6efaf710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_4ecbf247-3ec7-4e3d-9c29-28b719ab5e66" xlink:href="bmy-20220930.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_4ecbf247-3ec7-4e3d-9c29-28b719ab5e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_093c9353-ade4-4e49-b0df-ab9e1f26fd6a" xlink:href="bmy-20220930.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_093c9353-ade4-4e49-b0df-ab9e1f26fd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2250SeniorNotesDue2021Member_ad510812-ce9e-4786-a888-2e14faa781b5" xlink:href="bmy-20220930.xsd#bmy_A2250SeniorNotesDue2021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58648b66-6100-4417-91c0-ee81863d79b1" xlink:to="loc_bmy_A2250SeniorNotesDue2021Member_ad510812-ce9e-4786-a888-2e14faa781b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0669c8d-cca8-45e4-a813-53a5be255c0d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_70e8469d-22de-4354-8cf3-5caba888c683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_70e8469d-22de-4354-8cf3-5caba888c683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_94ffbc76-e9af-4884-9bd2-6fc2baa892ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_94ffbc76-e9af-4884-9bd2-6fc2baa892ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e18db6de-82ee-4829-ba81-e1e863ffce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70d2744a-3b05-43d2-a7da-bcdf9cc6a8bd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e18db6de-82ee-4829-ba81-e1e863ffce8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_c86be204-a3e1-45c2-bc1a-e63d6383af9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_c86be204-a3e1-45c2-bc1a-e63d6383af9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_779a2ca6-8b1c-4544-8ed7-c47f82d2bdce" xlink:href="bmy-20220930.xsd#bmy_CashDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_bmy_CashDiscounts_779a2ca6-8b1c-4544-8ed7-c47f82d2bdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a57dc1cc-ed3d-4962-a36f-c96e800a5287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a57dc1cc-ed3d-4962-a36f-c96e800a5287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b18666f2-275e-4233-861c-0b1a302e5571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b18666f2-275e-4233-861c-0b1a302e5571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_b36aec50-9079-4165-bbbd-c6897203e725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_us-gaap_OtherReceivables_b36aec50-9079-4165-bbbd-c6897203e725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_3768ff1c-219c-421c-b8e3-bb410fb3ea39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_3d43430b-a6cf-4486-8d73-356ae12247fd" xlink:to="loc_us-gaap_ReceivablesNetCurrent_3768ff1c-219c-421c-b8e3-bb410fb3ea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#RECEIVABLESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_e903ca63-ad1e-443c-93ae-74ee1ee5eb86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_e903ca63-ad1e-443c-93ae-74ee1ee5eb86" xlink:to="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e89cef00-c341-488c-b05e-dbba10262ce5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8d509a43-b386-4c76-ac4b-db192d8b0be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_52c93349-33e5-4066-8f39-ce624347f952" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8d509a43-b386-4c76-ac4b-db192d8b0be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8fbbe6f5-f7dd-4c44-9540-a2c6cba91de9" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_5df11382-1589-48d2-9d42-8b72201b0844" xlink:href="bmy-20220930.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_5df11382-1589-48d2-9d42-8b72201b0844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_266b4feb-2afd-4655-a169-ea934f4c3443" xlink:href="bmy-20220930.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_266b4feb-2afd-4655-a169-ea934f4c3443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_72c0b382-dbac-4187-b5c6-687dca547d98" xlink:href="bmy-20220930.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4d37a8b1-61e4-4ba4-bae8-98904193ccea" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_72c0b382-dbac-4187-b5c6-687dca547d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_a3eb5089-4427-43ff-af35-b14e79bb7980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_a3eb5089-4427-43ff-af35-b14e79bb7980" xlink:to="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8e8b1b7-ad4e-4216-9b0e-625b616c709c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_9b2ffd8d-8ec9-4383-837c-1c0a3eb86785" xlink:href="bmy-20220930.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be541741-97a2-4a86-9d9f-4da230e260e7" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_9b2ffd8d-8ec9-4383-837c-1c0a3eb86785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_66ccb398-b865-4589-bb36-c46cbd9bee20" xlink:to="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bde15c46-7c06-45b0-94ab-3b91cd871a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bde15c46-7c06-45b0-94ab-3b91cd871a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_33642e68-b74e-4212-89bf-74d7302ebd28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_33642e68-b74e-4212-89bf-74d7302ebd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_38d3cc3b-c48d-4790-8d8a-0b7c9b578647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_38d3cc3b-c48d-4790-8d8a-0b7c9b578647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_1e11f8e9-58d8-43ab-bf43-18eb6e76fcde" xlink:href="bmy-20220930.xsd#bmy_Totalinventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_bmy_Totalinventories_1e11f8e9-58d8-43ab-bf43-18eb6e76fcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_75ed4737-db01-4860-a427-5feccb6945da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryNet_75ed4737-db01-4860-a427-5feccb6945da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_3b399eb1-5a5b-46a8-b904-a9ebe0456fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_InventoryNoncurrent_3b399eb1-5a5b-46a8-b904-a9ebe0456fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3a46dbca-0f85-4916-b9de-5933d405e4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3a46dbca-0f85-4916-b9de-5933d405e4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dc80f3d9-9684-454f-9488-d48517db610c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dc80f3d9-9684-454f-9488-d48517db610c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a41b78e8-0c75-4474-b27c-3e3e39440ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519ac2b4-5099-478b-b614-6b0baf2e1f0a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a41b78e8-0c75-4474-b27c-3e3e39440ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_cb13342e-9561-482b-b292-c2cbec55a52d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_Land_cb13342e-9561-482b-b292-c2cbec55a52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_a1bb85b1-abc1-48fd-a67e-34167cc1304e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_a1bb85b1-abc1-48fd-a67e-34167cc1304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_47895aab-913b-4074-93cd-f7d6fbc204ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_47895aab-913b-4074-93cd-f7d6fbc204ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_d3fe0d4d-adf2-45b3-ae11-12771571ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_ConstructionInProgressGross_d3fe0d4d-adf2-45b3-ae11-12771571ea6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4e072ba9-fb99-4550-922d-9ae17ebdbc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4e072ba9-fb99-4550-922d-9ae17ebdbc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_03a9aa2b-e0ad-4c10-8353-1caa0aa41293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_03a9aa2b-e0ad-4c10-8353-1caa0aa41293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2f4f2444-16c9-4584-8c24-5e5e9e862b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2f4f2444-16c9-4584-8c24-5e5e9e862b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1aa24aff-d4c6-4834-a852-31b11b90b233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40ec431a-46de-4f8e-bf63-0e98d3afb45a" xlink:to="loc_us-gaap_Depreciation_1aa24aff-d4c6-4834-a852-31b11b90b233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d80f573-4ca9-48bd-ae29-bee6b8a2a47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d80f573-4ca9-48bd-ae29-bee6b8a2a47f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bd5774e1-3e65-479b-a800-e3cfda5c35f4" xlink:to="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fc51d866-7520-489b-a698-3552df5f91d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:to="loc_srt_MinimumMember_fc51d866-7520-489b-a698-3552df5f91d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_223ef572-2eaa-44fc-ac05-ac458b5243aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38ea3e6a-bea8-4901-98a2-067862ac80b7" xlink:to="loc_srt_MaximumMember_223ef572-2eaa-44fc-ac05-ac458b5243aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bff5582-ea29-41e7-8fb1-891f75bac1eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_9cca5e0f-3d1c-42d7-beb2-cbb5d1218abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_LicensingAgreementsMember_9cca5e0f-3d1c-42d7-beb2-cbb5d1218abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ec6ce2c6-ab1c-4a4a-b1a7-0e85a993bf37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ec6ce2c6-ab1c-4a4a-b1a7-0e85a993bf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_52188cf3-e341-4918-b984-00c4d44725e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68a90dec-ff74-4973-8f97-e01b8060deef" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_52188cf3-e341-4918-b984-00c4d44725e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_05441606-beab-4471-bb10-182cdbab49de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6769b974-dc3f-444b-8214-0eb6105c4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ba53084e-6c3a-4589-838e-07d1bb3d284f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6769b974-dc3f-444b-8214-0eb6105c4f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce9c86f6-7800-4991-b93b-dc8717cf6f00" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d2486729-948b-4a78-83e1-cdb2a80d9927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_Goodwill_d2486729-948b-4a78-83e1-cdb2a80d9927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_93d04f86-442c-4e49-94e7-06c97c77880c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_93d04f86-442c-4e49-94e7-06c97c77880c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18ca6acb-1b95-4811-b0c1-fdf45ecce610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18ca6acb-1b95-4811-b0c1-fdf45ecce610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ec077b-a3c8-4eb8-a568-657d06d62acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ec077b-a3c8-4eb8-a568-657d06d62acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1fead4bf-b875-43ee-8b38-5245a4b24e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1fead4bf-b875-43ee-8b38-5245a4b24e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1079d3d-6e65-4cbf-9f51-4e68ebaea005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1079d3d-6e65-4cbf-9f51-4e68ebaea005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d572a891-627d-4bc1-9db4-f096d2f321ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cdce545b-5977-4549-a2bb-2fd2e1227d98" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d572a891-627d-4bc1-9db4-f096d2f321ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6511f35f-8646-48db-a166-507ad3352952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6511f35f-8646-48db-a166-507ad3352952" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:to="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:href="bmy-20220930.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameAxis_2e7894a3-9f00-414e-b337-b0d6a5343d07" xlink:to="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_e3dec3a2-62b7-4aee-84bd-15cf83d79dc9" xlink:href="bmy-20220930.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameDomain_8aefc2af-ac0f-4722-b3a8-6ce04e5b406d" xlink:to="loc_bmy_InrebicMember_e3dec3a2-62b7-4aee-84bd-15cf83d79dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2671096b-bf8d-4e96-8f6a-a1053b03499d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3128f1ec-18da-4c50-b436-6b59220679d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3128f1ec-18da-4c50-b436-6b59220679d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ad3ee2b5-0fe5-403a-996a-e875589b291b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ad3ee2b5-0fe5-403a-996a-e875589b291b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_9e826d03-3ea0-4197-8598-f782df3a2732" xlink:href="bmy-20220930.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_9e826d03-3ea0-4197-8598-f782df3a2732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5da9c37d-a657-4500-8705-85501ba70489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad603df4-56b1-4257-a6c9-ad61a42c0eaa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_5da9c37d-a657-4500-8705-85501ba70489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_38e01811-1c15-4915-b2cf-72c280aa81d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_us-gaap_PrepaidTaxes_38e01811-1c15-4915-b2cf-72c280aa81d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_89f76f37-09cb-479f-b9b3-2889ecddd25f" xlink:href="bmy-20220930.xsd#bmy_ResearchandDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_bmy_ResearchandDevelopment_89f76f37-09cb-479f-b9b3-2889ecddd25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_40b4a037-a0df-46a8-8f0a-97f982c96fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_40b4a037-a0df-46a8-8f0a-97f982c96fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent_f8ed7fc2-61cb-4b68-8d8b-2b683b53385e" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_bmy_EquityInvestmentsCurrent_f8ed7fc2-61cb-4b68-8d8b-2b683b53385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_f5d895a6-883a-4424-ba0b-3206bd991b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_us-gaap_RestrictedCash_f5d895a6-883a-4424-ba0b-3206bd991b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_d44d4cf2-0548-43a7-bd77-3dc5e597e8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_d44d4cf2-0548-43a7-bd77-3dc5e597e8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d5154145-bb47-4eb4-af41-a24a5dbc3889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_2fe83645-ddc3-453a-9cdc-04654d192d0a" xlink:to="loc_us-gaap_OtherAssetsCurrent_d5154145-bb47-4eb4-af41-a24a5dbc3889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_1b85ffb8-cc51-4fe0-9f54-bea9772a4d93" xlink:href="bmy-20220930.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_1b85ffb8-cc51-4fe0-9f54-bea9772a4d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_3e24b2f5-9451-487e-9fca-1bb4fc67414e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_InventoryNoncurrent_3e24b2f5-9451-487e-9fca-1bb4fc67414e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_94b5a038-628c-4f7b-abe7-1bffbe6c533c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_94b5a038-628c-4f7b-abe7-1bffbe6c533c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_420d9aa6-2e99-4c34-a030-097106d85808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_420d9aa6-2e99-4c34-a030-097106d85808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_0784fb68-f9c3-4da5-bb41-3df683598ad5" xlink:href="bmy-20220930.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_0784fb68-f9c3-4da5-bb41-3df683598ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_855ae6e6-12d0-41a2-a3b9-f276cc19ade8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_855ae6e6-12d0-41a2-a3b9-f276cc19ade8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_a318480c-83c0-4533-9b2a-d041f549482f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_a318480c-83c0-4533-9b2a-d041f549482f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3a8747fb-add0-4f06-82ee-55b774e0d8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3a8747fb-add0-4f06-82ee-55b774e0d8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_648557d5-5b87-48a2-889e-15e3e66f5991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_156baf82-c205-40b1-b8ef-37b863734da6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_648557d5-5b87-48a2-889e-15e3e66f5991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_ce093735-5886-4c25-898a-2b613ab200f5" xlink:href="bmy-20220930.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_bmy_AccruedRebatesAndReturns_ce093735-5886-4c25-898a-2b613ab200f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6fa461e7-2982-409c-b6f1-7b2f3a10ee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6fa461e7-2982-409c-b6f1-7b2f3a10ee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d43aab94-9c7d-40be-ac48-dc091098788c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d43aab94-9c7d-40be-ac48-dc091098788c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_ead0ae7a-d0e7-4915-9268-0f9bfc1c4618" xlink:href="bmy-20220930.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_bmy_AccruedResearchAndDevelopment_ead0ae7a-d0e7-4915-9268-0f9bfc1c4618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_d6df9f3d-d7d2-41e7-9d0f-40b59e37f161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_DividendsPayableCurrent_d6df9f3d-d7d2-41e7-9d0f-40b59e37f161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_5ec28ca5-f2d8-42e6-b0f8-db3549b4f9c2" xlink:href="bmy-20220930.xsd#bmy_AccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_bmy_AccruedInterest_5ec28ca5-f2d8-42e6-b0f8-db3549b4f9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_9e340fc9-a735-4066-8ed7-7176cd39bcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_9e340fc9-a735-4066-8ed7-7176cd39bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b8028ed0-e4e3-44b3-ab00-af4dbcfc531b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b8028ed0-e4e3-44b3-ab00-af4dbcfc531b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a1bfea6b-0cd1-49bc-89f0-171c0b120ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a1bfea6b-0cd1-49bc-89f0-171c0b120ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5bf2a500-7acb-4182-b191-668e37197e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_cf635d15-dc23-43c5-ba56-9708444682bc" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5bf2a500-7acb-4182-b191-668e37197e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:href="bmy-20220930.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0ee09b8d-1d28-4925-877b-cb324e898235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0ee09b8d-1d28-4925-877b-cb324e898235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_186c2207-5303-41ae-8b33-6dce7718fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_186c2207-5303-41ae-8b33-6dce7718fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2770dd70-4fd4-4cb0-ab17-3cc0bcb8b3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2770dd70-4fd4-4cb0-ab17-3cc0bcb8b3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_4945259c-fa8e-4f0a-9aee-3ebe1ba0e2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_4945259c-fa8e-4f0a-9aee-3ebe1ba0e2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a1377490-2854-40fa-971a-67bf12d9089c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a1377490-2854-40fa-971a-67bf12d9089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_6e823186-4533-4930-80a6-22c1d6aec140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_6e823186-4533-4930-80a6-22c1d6aec140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ae3b1c5e-709f-4650-938d-d59d9a1b0395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e22d6256-b99f-4271-94c0-eb1b13956794" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ae3b1c5e-709f-4650-938d-d59d9a1b0395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e302b526-89cc-4715-855c-051ee69fa597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:href="bmy-20220930.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e302b526-89cc-4715-855c-051ee69fa597" xlink:to="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cacb8292-0ff2-47c0-b790-363f742c4b29" xlink:to="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7971dd02-4f73-4774-934c-9701b52796bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_CommonStockMember_7971dd02-4f73-4774-934c-9701b52796bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_44de0086-502a-4c5c-99bf-5e15ee80d093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_44de0086-502a-4c5c-99bf-5e15ee80d093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a693dc5b-0a0a-45fe-9546-0b7d0ed4a54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a693dc5b-0a0a-45fe-9546-0b7d0ed4a54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4d94e7ae-91b5-4559-8476-f3ad7139a3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_RetainedEarningsMember_4d94e7ae-91b5-4559-8476-f3ad7139a3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_07491aa9-31b4-4926-9154-462e9c4077f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_TreasuryStockMember_07491aa9-31b4-4926-9154-462e9c4077f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_35fe1be2-22a9-472d-8d5b-81b3652d3236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_948a5817-eca9-4f50-8b97-97d11402db37" xlink:to="loc_us-gaap_NoncontrollingInterestMember_35fe1be2-22a9-472d-8d5b-81b3652d3236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:href="bmy-20220930.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_f8432162-c4e0-4f77-890c-9563385a5238" xlink:to="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7fb066d-2518-4c13-b619-572e1584e083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7fb066d-2518-4c13-b619-572e1584e083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_78f9229c-f18a-4891-86b8-d0330269484c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2fe8b624-b4d0-4f2f-bc95-520c7f106a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_SharesIssued_2fe8b624-b4d0-4f2f-bc95-520c7f106a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c00cacd-87ca-4f8a-9610-84787243b267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_StockholdersEquity_1c00cacd-87ca-4f8a-9610-84787243b267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_436aeca8-98b6-4dbd-bdb6-6b4c30908d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_ProfitLoss_436aeca8-98b6-4dbd-bdb6-6b4c30908d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b35b567c-e199-44da-8d84-466a40d01c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b35b567c-e199-44da-8d84-466a40d01c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7d22c1dc-92a9-4bed-baf2-0361d4706156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_DividendsCommonStockCash_7d22c1dc-92a9-4bed-baf2-0361d4706156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0ec19e55-8e57-49b0-bf0a-cc4f4ca1bcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0ec19e55-8e57-49b0-bf0a-cc4f4ca1bcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c6920e29-c756-451c-9cd2-a416e1d4e5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c6920e29-c756-451c-9cd2-a416e1d4e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b76ee1ce-18e2-4269-9065-e63cabf2d928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b76ee1ce-18e2-4269-9065-e63cabf2d928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a817a6bf-42f0-4901-8757-71a1529f754d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a817a6bf-42f0-4901-8757-71a1529f754d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_6c7d64b7-cc36-4bfb-982f-ca7b706106b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_Dividends_6c7d64b7-cc36-4bfb-982f-ca7b706106b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_135d2401-6386-4b50-926f-aa02cc717ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_SharesIssued_135d2401-6386-4b50-926f-aa02cc717ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d661f78e-419e-46f4-a558-6f384f79e1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1e77cad7-1259-4962-be4b-773f65029300" xlink:to="loc_us-gaap_StockholdersEquity_d661f78e-419e-46f4-a558-6f384f79e1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_87c693ef-68f9-40ca-92fb-1b02d38a1129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:href="bmy-20220930.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_87c693ef-68f9-40ca-92fb-1b02d38a1129" xlink:to="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eb088818-5c53-4af0-8f57-68b7a76d5cb0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_c625c8b6-4a91-4a5b-b849-ded00039814c" xlink:href="bmy-20220930.xsd#bmy_A2022ASRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:to="loc_bmy_A2022ASRMember_c625c8b6-4a91-4a5b-b849-ded00039814c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2019ASRMember_eed000da-d93d-4537-a798-f95f95803f70" xlink:href="bmy-20220930.xsd#bmy_A2019ASRMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_20a365ac-1dd0-438d-b0ce-1ba4607baa0a" xlink:to="loc_bmy_A2019ASRMember_eed000da-d93d-4537-a798-f95f95803f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:href="bmy-20220930.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_505e8414-cbfd-4e14-b1b0-3eeab2f74aff" xlink:to="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4ca8e092-4af4-4f9a-b33e-bceea11d3534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4ca8e092-4af4-4f9a-b33e-bceea11d3534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2770bab-1651-4859-94cd-c010c19fee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2770bab-1651-4859-94cd-c010c19fee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_72fb2dd4-303b-42ff-8856-94d298ed67be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_72fb2dd4-303b-42ff-8856-94d298ed67be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7599506d-8b8e-419a-ae6e-98e86c60b04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_bd791859-19d8-47cc-af02-631e1dc9c2cd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7599506d-8b8e-419a-ae6e-98e86c60b04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6f93c97e-fdb4-459f-8e53-6d67e9309699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6f93c97e-fdb4-459f-8e53-6d67e9309699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_23caaffb-8f57-41e5-a702-7811cf656d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_23caaffb-8f57-41e5-a702-7811cf656d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_51b0fbe0-d917-4586-aaa1-0b6874e09db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_51b0fbe0-d917-4586-aaa1-0b6874e09db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_e5ba6253-e0b6-4528-9e66-43df60a67d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_e5ba6253-e0b6-4528-9e66-43df60a67d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c6d62acb-1869-4687-a619-744df3bee810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c6d62acb-1869-4687-a619-744df3bee810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fe1340f7-892f-43f6-b7e7-529d10c05040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fe1340f7-892f-43f6-b7e7-529d10c05040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_0bc6baff-489d-4b5e-999c-753607d88d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_0bc6baff-489d-4b5e-999c-753607d88d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3d81f33e-8d9c-4ef2-9482-82337e3f0601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3d81f33e-8d9c-4ef2-9482-82337e3f0601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_465844da-1188-4197-9ca8-25db2f172c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_465844da-1188-4197-9ca8-25db2f172c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d58efd86-c300-43f5-898f-f67af0f55045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d58efd86-c300-43f5-898f-f67af0f55045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_90afcf2d-3c6e-43e5-94be-95559d0807de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_90afcf2d-3c6e-43e5-94be-95559d0807de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_6a5bac4d-7200-46f7-9da7-d5f977f45464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_6a5bac4d-7200-46f7-9da7-d5f977f45464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_744e6486-6dc1-4515-9077-9189f3411047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_744e6486-6dc1-4515-9077-9189f3411047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9c6717d9-99b5-4ac9-beaa-f26db7a0964b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9c6717d9-99b5-4ac9-beaa-f26db7a0964b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_01ae6d48-808f-4a14-9920-faa8fbf15dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_01ae6d48-808f-4a14-9920-faa8fbf15dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_98d0749f-24b9-46a9-9e99-5ce4d34307e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_98d0749f-24b9-46a9-9e99-5ce4d34307e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_e08b55c2-6786-435c-bc0b-6c08a216bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_e08b55c2-6786-435c-bc0b-6c08a216bc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_a85b4b62-602b-4a2b-bea8-4e1828123c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_a85b4b62-602b-4a2b-bea8-4e1828123c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a642dc93-3172-48c4-87e9-3746ab41ae26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a642dc93-3172-48c4-87e9-3746ab41ae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_130587cd-95a3-4f53-afde-c592cdf0dee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_130587cd-95a3-4f53-afde-c592cdf0dee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_760cbd67-68fd-4b54-b164-0b4f17149234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_760cbd67-68fd-4b54-b164-0b4f17149234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_968a914f-2f61-40cd-8685-cc7fb1d98f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_968a914f-2f61-40cd-8685-cc7fb1d98f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_56761a99-baf4-410d-85c1-918318e0ec75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_56761a99-baf4-410d-85c1-918318e0ec75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bbd695c0-a3d7-4401-8568-cfb17971a19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bbd695c0-a3d7-4401-8568-cfb17971a19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_cac9d8d4-582e-4384-adc7-9849f1605227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_cac9d8d4-582e-4384-adc7-9849f1605227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3ed2d221-f033-4558-8d85-ecac13930159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3ed2d221-f033-4558-8d85-ecac13930159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_75599ab8-996d-43c1-a0f4-e89dff27639c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_75599ab8-996d-43c1-a0f4-e89dff27639c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e62dca2b-194f-41a6-9d9a-539519664417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e62dca2b-194f-41a6-9d9a-539519664417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_e6365766-d99b-4f1c-b57f-2d62158dc447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_e6365766-d99b-4f1c-b57f-2d62158dc447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8204d904-0aff-4b51-bf02-a498cc720035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b61f67f-270f-4798-a34c-c47503f6b395" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8204d904-0aff-4b51-bf02-a498cc720035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_4cc04059-56dd-4549-bd35-c19a10639cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_4cc04059-56dd-4549-bd35-c19a10639cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_13e45c60-ed8f-4a17-b845-84d24eae2d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_13e45c60-ed8f-4a17-b845-84d24eae2d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f1dadbb2-0a7c-4856-92cb-9bb90909e295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f1dadbb2-0a7c-4856-92cb-9bb90909e295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_491d4ad3-07e1-46ca-95e1-fbe5f7c4664c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_491d4ad3-07e1-46ca-95e1-fbe5f7c4664c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_253bd0c5-a7d7-4324-b459-a85d8f067de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cf2f034-d3fc-4bd4-ad97-3b0887d94d1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_253bd0c5-a7d7-4324-b459-a85d8f067de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f8188254-94ab-4f12-8dac-c6733394357d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f8188254-94ab-4f12-8dac-c6733394357d" xlink:to="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c30cf6b2-bc03-4d05-9fcc-e35b5150c261" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_205a28c3-ca92-4b9c-b2b4-cb2b81635785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_CostOfSalesMember_205a28c3-ca92-4b9c-b2b4-cb2b81635785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5621cddc-8cea-41c1-8814-5f3a647aa576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5621cddc-8cea-41c1-8814-5f3a647aa576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1d41ff21-540b-4840-b49a-7973907f4647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1d41ff21-540b-4840-b49a-7973907f4647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_8e9c88d0-f587-45c1-aa6d-d9fc8bd8f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_028f0702-c017-4d0d-8678-304d551f4330" xlink:to="loc_us-gaap_OtherIncomeMember_8e9c88d0-f587-45c1-aa6d-d9fc8bd8f82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc1848ee-ac64-41d6-92c0-3a1eca856507" xlink:to="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_44600e11-db46-4e91-b660-92dd9b1a44ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_44600e11-db46-4e91-b660-92dd9b1a44ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e3fff710-5b9f-4d53-9437-fef5bfed044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e3fff710-5b9f-4d53-9437-fef5bfed044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_317ac7d9-d1e4-49cf-bc54-84e5b4e21dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9fe64755-9822-4d99-8f27-db9dfefe34f6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_317ac7d9-d1e4-49cf-bc54-84e5b4e21dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86431701-d7dd-4212-9c1b-6bd6ae5367fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86431701-d7dd-4212-9c1b-6bd6ae5367fb" xlink:to="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:to="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ca663d6-382f-4738-8a28-97e85408a0aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d785ff57-85ab-4947-b82c-7884672257b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d785ff57-85ab-4947-b82c-7884672257b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_7eb9f451-6e37-4d89-9714-8b485fa49ef9" xlink:href="bmy-20220930.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_bmy_MarketShareUnitsMember_7eb9f451-6e37-4d89-9714-8b485fa49ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6d22420d-6d1b-4b69-9cf6-f49551897823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ea0f2c5-aada-44fd-9c86-07c05c448a8d" xlink:to="loc_us-gaap_PerformanceSharesMember_6d22420d-6d1b-4b69-9cf6-f49551897823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c994223f-611b-4471-805f-d1e55744d02b" xlink:to="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_96ec0195-db64-4b91-9714-d8287085ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_96ec0195-db64-4b91-9714-d8287085ce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02ba549f-9353-47d4-bb68-43e091c626cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed4a0d85-618f-453f-b56e-504c5537d15e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_02ba549f-9353-47d4-bb68-43e091c626cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98d79b52-de4b-4ccb-8266-a26ba66bc09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98d79b52-de4b-4ccb-8266-a26ba66bc09b" xlink:to="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:to="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2ffed4c7-a1c5-4ce6-a1e4-880a5b442ede" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f8b3316b-5c8b-4b1c-991d-f1183da97d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f8b3316b-5c8b-4b1c-991d-f1183da97d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_7dbec63d-7b0a-4068-92ca-85a3945eae10" xlink:href="bmy-20220930.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_bmy_MarketShareUnitsMember_7dbec63d-7b0a-4068-92ca-85a3945eae10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d20cb7c8-c947-42a2-b1b0-a648873ae12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e75acdc1-854d-45d8-8bda-48e3e0cbcc83" xlink:to="loc_us-gaap_PerformanceSharesMember_d20cb7c8-c947-42a2-b1b0-a648873ae12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0dfbe7e3-e1f5-4d1c-872f-802f24de3bb6" xlink:to="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b9f5e91e-a679-4a98-8932-2d11615c40f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b9f5e91e-a679-4a98-8932-2d11615c40f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_571fa65e-8e03-45af-aa32-fa2aac19c069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_887a6d83-368c-42fb-9930-c1f279a32332" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_571fa65e-8e03-45af-aa32-fa2aac19c069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20220930.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_406e7c9e-4691-4b5e-a7c3-ed2e3a31c64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:href="bmy-20220930.xsd#bmy_LitigationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_406e7c9e-4691-4b5e-a7c3-ed2e3a31c64e" xlink:to="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cec806b2-37cf-46d3-9b66-26cdb20d4a2b" xlink:to="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_0de7394c-d0c4-43ad-8905-047ce1123c70" xlink:href="bmy-20220930.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_0de7394c-d0c4-43ad-8905-047ce1123c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_a92aadda-fd0d-4937-9356-32ced5e3645b" xlink:href="bmy-20220930.xsd#bmy_CARTKiteLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_CARTKiteLitigationMember_a92aadda-fd0d-4937-9356-32ced5e3645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_a3617627-bfd6-4524-a093-bb2096e7e7ff" xlink:href="bmy-20220930.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_a3617627-bfd6-4524-a093-bb2096e7e7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_d6b62b49-df3a-4a3f-8136-41e80b7e9e41" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AbilifyProductLiabilityMember_d6b62b49-df3a-4a3f-8136-41e80b7e9e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_9d2572a2-dac3-43c4-ac37-0c5668abcd64" xlink:href="bmy-20220930.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_9d2572a2-dac3-43c4-ac37-0c5668abcd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_52432d16-9d5b-4795-861b-67829198ed59" xlink:href="bmy-20220930.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b8beee14-2884-43b4-b813-7892559aef1b" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_52432d16-9d5b-4795-861b-67829198ed59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_9f918b49-9f2b-4eba-ab67-097352fa3826" xlink:to="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_aa1fb59c-5c77-4895-84e3-b45a4633b2d9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:to="loc_currency_AUD_aa1fb59c-5c77-4895-84e3-b45a4633b2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_1679102c-8489-4790-8991-5a4f3a47ee90" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_d11161f3-5fbe-432c-b0a5-d9e4c4071cf6" xlink:to="loc_currency_USD_1679102c-8489-4790-8991-5a4f3a47ee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7dde6182-8d89-4b50-b0cb-b3caad7dde89" xlink:to="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_f3a3f2bf-5256-40b6-857e-7ac6cb74d97a" xlink:href="bmy-20220930.xsd#bmy_BristolMyersSquibbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f5e979a4-462f-447c-b639-fef931fa9600" xlink:to="loc_bmy_BristolMyersSquibbMember_f3a3f2bf-5256-40b6-857e-7ac6cb74d97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1303b958-3422-481a-ae0d-61bf023a251c" xlink:to="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_da4bedcc-b371-4755-9c35-cece1c9b8063" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ffffe885-8934-4fef-9bb5-d48ff69ccb24" xlink:to="loc_country_CA_da4bedcc-b371-4755-9c35-cece1c9b8063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:href="bmy-20220930.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_79d74610-df49-48f2-9142-7ddd9bd8c519" xlink:to="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c655af57-1845-47bd-9d63-40058464ae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c655af57-1845-47bd-9d63-40058464ae3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_c58129d5-4664-45be-8aef-3cd3845a28d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_PaymentsForRoyalties_c58129d5-4664-45be-8aef-3cd3845a28d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_690cc03f-ed98-4bcf-b40a-ef491b526f2d" xlink:href="bmy-20220930.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_690cc03f-ed98-4bcf-b40a-ef491b526f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_2cd9f1a4-d510-4cf7-ab13-b557239dab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_2cd9f1a4-d510-4cf7-ab13-b557239dab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_81ac4260-12e8-41d5-9c57-f390d756e003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_81ac4260-12e8-41d5-9c57-f390d756e003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0a54e38e-b96e-4aea-be03-61a79047ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0a54e38e-b96e-4aea-be03-61a79047ea83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_7ab8e1ed-f3e3-4278-b876-b1643477095e" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_7ab8e1ed-f3e3-4278-b876-b1643477095e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_70112130-7064-49da-99ab-ce0d51508b45" xlink:href="bmy-20220930.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_70112130-7064-49da-99ab-ce0d51508b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_53e18226-9be3-4f12-97e7-016351f48bc2" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_53e18226-9be3-4f12-97e7-016351f48bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_9ce275e0-3660-45fb-a01a-54f91aae3caa" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_9ce275e0-3660-45fb-a01a-54f91aae3caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_1ad5daf2-fedd-4d20-9763-58a7cfde9072" xlink:href="bmy-20220930.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_1ad5daf2-fedd-4d20-9763-58a7cfde9072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_6eca77a4-ce6c-4d98-9a64-f60e71424d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_ContractualObligation_6eca77a4-ce6c-4d98-9a64-f60e71424d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_239f42b0-8770-4692-80e2-902950842b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_f5730edb-853c-46ed-b6d2-d8626f842018" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_239f42b0-8770-4692-80e2-902950842b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300046997168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRISTOL-MYERS SQUIBB COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0790350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">430 E. 29th Street, 14FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">546-4200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,126,160,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000014272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember', window );">Common Stock $0.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member', window );">1.000% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member', window );">1.750% Notes due 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.750% Notes due 2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember', window );">Celgene Contingent Value Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Celgene Contingent Value Rights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CELG RT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048744880">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="nump">$ 11,624<span></span>
</td>
<td class="nump">$ 34,753<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">7,544<span></span>
</td>
<td class="nump">7,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,930<span></span>
</td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">5,548<span></span>
</td>
<td class="nump">5,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">7,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AmortizationofAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">2,546<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
<td class="nump">7,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="num">(1,113)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,009<span></span>
</td>
<td class="nump">9,467<span></span>
</td>
<td class="nump">28,899<span></span>
</td>
<td class="nump">28,160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings Before Income Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,209<span></span>
</td>
<td class="nump">2,157<span></span>
</td>
<td class="nump">5,854<span></span>
</td>
<td class="nump">6,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">601<span></span>
</td>
<td class="nump">605<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
<td class="nump">4,320<span></span>
</td>
<td class="nump">4,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Noncontrolling Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings Attributable to BMS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,606<span></span>
</td>
<td class="nump">$ 1,546<span></span>
</td>
<td class="nump">$ 4,305<span></span>
</td>
<td class="nump">$ 4,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share attributable to BMS, basic (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 2.01<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share attributable to BMS, diluted (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,813<span></span>
</td>
<td class="nump">$ 11,243<span></span>
</td>
<td class="nump">$ 33,606<span></span>
</td>
<td class="nump">$ 33,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember', window );">Alliance and other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 381<span></span>
</td>
<td class="nump">$ 1,147<span></span>
</td>
<td class="nump">$ 954<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationofAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationofAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047645392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">$ 1,608<span></span>
</td>
<td class="nump">$ 1,552<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income, net of taxes and reclassifications to earnings:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total Other Comprehensive Income</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive Income</a></td>
<td class="nump">1,759<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">4,747<span></span>
</td>
<td class="nump">5,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive Income Attributable to Noncontrolling Interest</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income Attributable to BMS</a></td>
<td class="nump">$ 1,757<span></span>
</td>
<td class="nump">$ 1,640<span></span>
</td>
<td class="nump">$ 4,732<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048818176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,734<span></span>
</td>
<td class="nump">$ 13,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable debt securities</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">9,613<span></span>
</td>
<td class="nump">9,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,074<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">6,082<span></span>
</td>
<td class="nump">4,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">26,796<span></span>
</td>
<td class="nump">33,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,035<span></span>
</td>
<td class="nump">6,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">21,112<span></span>
</td>
<td class="nump">20,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">38,179<span></span>
</td>
<td class="nump">42,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,745<span></span>
</td>
<td class="nump">5,535<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">98,196<span></span>
</td>
<td class="nump">109,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt obligations</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">4,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,595<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">14,203<span></span>
</td>
<td class="nump">13,971<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">18,930<span></span>
</td>
<td class="nump">21,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">2,881<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">36,966<span></span>
</td>
<td class="nump">39,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">6,685<span></span>
</td>
<td class="nump">7,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">65,462<span></span>
</td>
<td class="nump">73,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Bristol-Myers Squibb Company Shareholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value of stock</a></td>
<td class="nump">44,956<span></span>
</td>
<td class="nump">44,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(841)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">24,675<span></span>
</td>
<td class="nump">23,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less cost of treasury stock</a></td>
<td class="num">(36,411)<span></span>
</td>
<td class="num">(31,259)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</a></td>
<td class="nump">32,671<span></span>
</td>
<td class="nump">35,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">32,734<span></span>
</td>
<td class="nump">36,006<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 98,196<span></span>
</td>
<td class="nump">$ 109,314<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047918176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization, net</a></td>
<td class="nump">7,755<span></span>
</td>
<td class="nump">8,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(2,114)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment charges</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Divestituregainsandroyalties', window );">Divestiture gains and royalties</a></td>
<td class="num">(820)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses/(income)</a></td>
<td class="nump">966<span></span>
</td>
<td class="num">(1,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration fair value adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(557)<span></span>
</td>
<td class="num">(886)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(296)<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Rebates and discounts</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(1,310)<span></span>
</td>
<td class="num">(537)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">9,760<span></span>
</td>
<td class="nump">12,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sale and maturities of marketable debt securities</a></td>
<td class="nump">5,205<span></span>
</td>
<td class="nump">2,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable debt securities</a></td>
<td class="num">(3,566)<span></span>
</td>
<td class="num">(3,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi', window );">Proceeds from sales of equity investment securities</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(772)<span></span>
</td>
<td class="num">(653)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Divestitureandotherproceeds', window );">Divestiture and other proceeds</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition and other payments, net of cash acquired</a></td>
<td class="num">(4,170)<span></span>
</td>
<td class="num">(1,458)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(2,275)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Short-term debt obligations, net</a></td>
<td class="nump">58<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(11,431)<span></span>
</td>
<td class="num">(6,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(5,585)<span></span>
</td>
<td class="num">(3,536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends</a></td>
<td class="num">(3,489)<span></span>
</td>
<td class="num">(3,297)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(13,716)<span></span>
</td>
<td class="num">(12,257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="num">(6,359)<span></span>
</td>
<td class="num">(1,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</a></td>
<td class="nump">14,316<span></span>
</td>
<td class="nump">14,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at End of Period</a></td>
<td class="nump">$ 7,957<span></span>
</td>
<td class="nump">$ 13,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestitureandotherproceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestitureandotherproceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestituregainsandroyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of gains and royalties as a result of business divestitures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestituregainsandroyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054343056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Recently Issued Accounting Standards</a></td>
<td class="text">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;, "we" or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position as of September&#160;30, 2022 and December&#160;31, 2021, the results of operations for the three and nine months ended September&#160;30, 2022 and 2021, and cash flows for the nine months ended September&#160;30, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Upfront and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statements of earnings. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows are now presented separately in Rebates and discounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective basis. Early adoption is permitted.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300056407952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,793)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,092)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,230)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $10 million and $207 million for the three and nine months ended September&#160;30, 2022, and $10&#160;million and $282&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In-Line Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $119 million and $450 million for the three and nine months ended September&#160;30, 2022 and $73&#160;million and $463&#160;million for the three and nine months ended September&#160;30, 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300158823488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Alliances</a></td>
<td class="text">ALLIANCESBMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the nine months ended September&#160;30, 2022, and 2021 are set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BridgeBio</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, BMS and BridgeBio commenced an exclusive global collaboration to develop and commercialize BBP-398, a SHP2 inhibitor, in oncology. The transaction included an upfront payment of $90&#160;million, which was expensed to Acquired IPRD during the second quarter of 2022. BridgeBio is eligible to receive contingent development, regulatory and sales-based milestones up to $815 million, as well as royalties on global net sales, excluding certain markets. BridgeBio is responsible for funding and completing ongoing BBP-398 Phase I monotherapy and combination therapy trials. BMS will lead and fund all other development and commercial activities. BridgeBio has an option to co-develop BBP-398 and receive higher royalties in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nektar</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program are being discontinued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eisai</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Japan, China and certain other countries in the Asia-Pacific region (the &#8220;collaboration territory&#8221;). Eisai is responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS is responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.</span></div>A $650&#160;million up-front collaboration fee was expensed to Acquired IPRD during the second quarter of 2021. BMS is also obligated to pay up to $2.5&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054413552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</a></td>
<td class="text">ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Turning Point </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2022, BMS acquired Turning Point for $4.1&#160;billion of cash (or $3.3&#160;billion net of cash acquired). Turning Point is a clinical-stage precision oncology company with a pipeline of investigational medicines designed to target the common mutations and alterations that drive cancer growth. The acquisition provides BMS rights to Turning Point's lead asset, repotrectinib, and other clinical and pre-clinical stage assets. The transaction was accounted for as a business combination requiring all assets acquired and liabilities assumed to be recognized at their fair value as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration for the acquisition consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for outstanding shares </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for equity awards </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Consideration paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unvested stock awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration to be allocated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unvested equity awards of $73&#160;million expensed in Marketing, selling, and administrative and $80&#160;million expensed in Research and development during the three months ended September 30, 2022.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed as of the acquisition date based upon their respective fair values summarized below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable net assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration allocated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Intangible assets primarily consist of IPRD allocated to repotrectinib ($2.8&#160;billion), a potential best-in-class tyrosine kinase inhibitor targeting the ROS1 and NTRK oncogenic drivers in NSCLC and other advanced solid tumors. Repotrectinib is currently in registrational Phase II study in adults and a Phase I/II study in pediatric patients. The estimated fair value of IPRD assets was determined using an income approach valuation method. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Goodwill resulted primarily from the recognition of deferred tax liabilities and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of Turning Point's operations were included in the consolidated financial statements commencing August 18, 2022, and were not material. Historical financial results of the acquired entity were not significant. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Divestitures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mature Products and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, BMS agreed to sell its manufacturing facility in Syracuse, New York to LOTTE Corporation for approximately $170&#160;million. The transaction is expected to close during the first quarter of 2023, subject to certain regulatory approvals and other closing conditions and will be accounted for as a sale of a business. The business was accounted for as held-for-sale and its assets were reduced to the estimated relative fair value resulting in a $43&#160;million impairment charge recorded to Cost of products sold during the second quarter of 2022. Assets and liabilities reclassified to held-for-sale and included within Other current assets and Other current liabilities were $155&#160;million and $6&#160;million, respectively, as of September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $221&#160;million and a divestiture gain of $211&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(611)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biohaven sublicense income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-license Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS obtained a global exclusive license to Immatics&#8217; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $150&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, a Phase I development milestone for interlukin-12 (&#8220;IL-12&#8221;) was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Agenus</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, BMS obtained a global exclusive license to Agenus&#8217; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and a Phase I clinical trial was initiated in October 2021. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. The transaction included an upfront payment of $200&#160;million expensed to Acquired IPRD for the third quarter of 2021. Agenus is eligible to receive contingent development, regulatory and sales-based milestones up to $1.4&#160;billion as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Extinguishment</span></div>In April 2022, BMS amended the terms of a license arrangement and paid a third party $295&#160;million to extinguish a future royalty obligation related to mavacamten, prior to its FDA approval in April 2022, resulting in an Acquired IPRD charge during the second quarter of 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054250896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other (Income)/Expense, Net</a></td>
<td class="text">OTHER (INCOME)/EXPENSE, NET<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI https://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI https://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054268784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">RESTRUCTURING<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (5%), Marketing, selling and administrative expenses (65%) and Research and development expenses (30%). Charges of approximately $3.5&#160;billion are expected to be incurred including cash outlays of approximately $3.1&#160;billion. Cumulative charges of approximately $3.0&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. Employee workforce reductions were approximately 150 and 320 for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition on August 17, 2022, and the MyoKardia acquisition in 2020. Charges of approximately $250&#160;million are expected to be incurred through the end of 2023, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of $151 million have been recognized for these actions to date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $6 million and $17 million for the nine months ended September 30, 2022 and 2021, respectively. Excludes $12 million for the nine months ended September 30, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054232496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments, intangible asset amortization, and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits as of September&#160;30, 2022 could decrease in the range of approximately $480 million to $530 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054155776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054215552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2021 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of September&#160;30, 2022 and December 31, 2021. The restrictions will expire by April 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of September&#160;30, 2022, and December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain)/loss recognized on investments sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss/(income) of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $5.1 billion and Japanese yen of $1.4 billion as of September&#160;30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, BMS entered into cross-currency interest rate swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in Accumulated other comprehensive loss and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency interest rate swap contracts was &#8364;575&#160;million ($584&#160;million) as of September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. dollar borrowings of &#8364;375 million ($368 million) as of September&#160;30, 2022, are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $1.4 billion as of September&#160;30, 2022, are designated to hedge certain currency exposures of BMS&#8217;s net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other current and Other non-current assets or Other current and Other non-current liabilities. The notional amount of outstanding cross-currency interest rate swaps was primarily attributed to the Japanese yen of $686&#160;million and euro of $584&#160;million as of September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (3.14% as of September&#160;30, 2022) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 24 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,869&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $34.3 billion as of September&#160;30, 2022 and $49.1 billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30 2022, BMS purchased an aggregate principal amount of $6.0&#160;billion of certain of its debt securities for $6.6&#160;billion of cash in tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $266&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, $4.75&#160;billion of debt matured and was repaid including $1.5&#160;billion 2.600% Notes, $500&#160;million Floating Rate Notes, $750&#160;million 2.000% Notes, $1.0&#160;billion 3.250% Notes and $1.0&#160;billion 3.550% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, we issued an aggregate principal amount of $6.0&#160;billion of debt with net proceeds of $5.9&#160;billion. The table below summarizes the issuances:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2032</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.550% Notes due 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.700% Notes due 2052</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.900% Notes due 2062</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September 30, 2021, BMS purchased an aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September 30, 2021, $2.0&#160;billion of debt matured and was repaid including $500&#160;million 2.875% Notes, $1.0&#160;billion 2.550% Notes and $500&#160;million 2.250% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $1.1 billion and $1.2 billion for the nine months ended September 30, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, BMS had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility which expired in January 2022, a three-year $1.0&#160;billion facility which expired in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. </span></div>In January 2022, BMS entered into a five-year $5.0&#160;billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5&#160;billion facilities were terminated and the three-year $1.0&#160;billion facility and 364-day $2.0&#160;billion facility expired in accordance with their terms in January 2022. No borrowings were outstanding under any revolving credit facility as of September&#160;30, 2022 or December&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054250896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Receivables</a></td>
<td class="text">RECEIVABLES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $809 million and $1.1 billion for the nine months ended September 30, 2022 and 2021, respectively. Receivables from the three largest customers in the U.S. represented approximately 67% and 59% of total trade receivables as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054170256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value adjustments related to the Celgene acquisition were $137 million as of September&#160;30, 2022 and $508 million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054413552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $148 million and $434 million for the three and nine months ended September&#160;30, 2022 and $144 million and $422 million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054275984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes goodwill and other intangible assets recognized as part of the Turning Point acquisition in 2022. Refer to &#8220;&#8212;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#8221; for further information related to the Turning Point acquisition.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of other intangible assets was $2.5 billion and $7.4 billion for the three and nine months ended September&#160;30, 2022 and $2.6 billion and $7.7 billion for the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, a $58 million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Turning Point and was being studied as a potential treatment of advanced or metastatic solid tumors in adults. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, a $40&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, a $610&#160;million IPRD impairment charge for an investigational compound was recorded in Research and development expense primarily resulting from changes in clinical timelines, expected launch dates and competitive landscape. The compound was being studied as a potential treatment for hematologic diseases and was acquired in the acquisition of Celgene. The charge represented a partial write-down of its carrying value based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, a $230&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first of quarter of 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054317744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. Restricted cash of $339 million as of September 30, 2021, was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054268784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2022: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(992)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,292)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,956&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(841)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,411)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022, June&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,198)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,625&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,572)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021, June&#160;30, 2021 and September&#160;30, 2021, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method. The outstanding share repurchase authorization under the program was approximately $15.2 billion as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $5.0&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand. In the first quarter of 2022 approximately 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The remaining amounts in the ASR agreements were settled in two tranches during the second and third quarters and 4&#160;million shares of common stock were received by BMS and transferred to treasury stock. The total number of shares repurchased under the ASR agreements was based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. In addition, as part of its share repurchase program, BMS repurchased approximately 10&#160;million shares of its common stock for $701&#160;million during the three months ended September 30, 2022. The outstanding share repurchase authorization under the program was approximately $9.5&#160;billion as of September 30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:-9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054229072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Employee Stock Benefit Plans</a></td>
<td class="text">EMPLOYEE STOCK BENEFIT PLANS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:50.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $4 million and $63 million for the three and nine months ended September&#160;30, 2022 and $7&#160;million and $36&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the nine months ended September 30, 2022 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054195920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings and Contingencies</a></td>
<td class="text">LEGAL PROCEEDINGS AND CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 Antibody Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#8217;s claims for damages before May 17, 2019&#8212;the date of the District Court&#8217;s ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. A trial has been scheduled for May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million upfront payment and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#8217;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#8220;SPC&#8221;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. The Company is seeking permission to appeal from the Court of Appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and trials have been scheduled in certain of those cases. In May 2022, a Dutch court issued a decision denying a request by the Company for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In September 2022, a trial was held in Sweden regarding Teva&#8217;s challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision is expected on November 2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($292 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, Celgene received a Notice Letter from Qilu Pharmaceutical Co. Ltd. (&#8220;Qilu&#8221;) notifying Celgene that Qilu has filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against Qilu in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. In October 2022, Celgene entered into a confidential settlement agreement with Qilu, settling all outstanding claims in the litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. Subsequently, the Company also received paragraph IV certification letters from Accord, Biocon, and Nanocopoeia challenging the same patents, and the Company filed patent infringement actions against all three companies. In July and September 2022, BMS entered into settlement agreements with Accord and Biocon, respectively. No trial dates have been scheduled in the two remaining actions against Xspray and Nanocopoeia. Both Xspray and Nanocopoeia have filed motions for a judgment based on the pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#8220;Actelion&#8221;) filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#8220;&#8217;867 Patent&#8221;). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the &#8217;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. An oral argument before the Hawaii Supreme Court is scheduled to occur in December 2022. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. In September 2022, the parties settled the New Mexico matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases were pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The MDL decision is final as to Amylin and Lilly and all MDL claims have been dismissed. As of September 2022, all of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly have dismissed their claims with prejudice. In October 2022, all thyroid cancer claims that were pending in federal court were dismissed as well. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#8220;JCCP&#8221;). On September 24, 2021, the JCCP court granted defendants&#8217; motion to exclude plaintiffs&#8217; only general causation expert and on January 5, 2022, the MDL court likewise granted defendants&#8217; motion to exclude plaintiffs&#8217; expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. Plaintiffs have filed an appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL have moved to alter or amend the MDL court&#8217;s order, and defendants have opposed. As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene</span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Securities Litigations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#8220;Schwab Action&#8221;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 (the &#8220;CalPERS Action&#8221;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#8220;DFA Action&#8221; and the &#8220;American Century Action&#8221;), and GIC Private Limited in September 2021 (the &#8220;GIC Action&#8221;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the court denied BMS&#8217;s motion to dismiss.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 19, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#8217;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 22, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS was sued with three other manufacturers of HIV medications in related lawsuits in the Northern District of California. The initial lawsuits, filed on behalf of indirect purchasers, alleged that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remained. In October 2021, BMS entered a settlement agreement with the indirect purchasers. On May 6, 2022, the Court granted final approval of that settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. In March 2022, BMS entered into a settlement agreement with the direct purchasers (excluding the retailers discussed below). In June 2022, the Court granted preliminary approval of that settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. Those complaints made allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In January 2022, BMS entered into an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains, and those cases were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. Those complaints made allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and that case was dismissed. In April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In July 2022, BMS entered into a settlement agreement resolving these seven remaining indirect purchaser cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana Inc. (&#8220;Humana&#8221;), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint. In April 2022, the Court issued an order denying Celgene&#8217;s motion to dismiss. That order addressed only Celgene&#8217;s argument that certain of Humana&#8217;s claims were barred by the statute of limitations. The Court&#8217;s order did not address Celgene&#8217;s other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have served a renewed motion to dismiss. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United HealthCare Services, Inc. (&#8220;UHS&#8221;), Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;), BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation (&#8220;Cigna&#8221;), Molina Healthcare, Inc. (&#8220;Molina&#8221;) and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#8220;MSP&#8221;)) filed lawsuits making largely the same claims and allegations as were made in the class action litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> opt-out action. Certain of the matters have made additional claims related to copay assistance for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These cases are now pending in the U.S. District Court for the District of New Jersey and will proceed as described above with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opt-out action filed in March 2019. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#8217;s motion to remand to San Francisco Superior Court. In June 2022, the San Francisco Superior Court dismissed 63 of Molina&#8217;s claims and stayed the remaining 4 claims. No activity is expected in this case until disposition of the New Jersey actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. A trial has been scheduled for January 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017,Celgene Logistics S&#224;rl (&#8220;Celgene Logistics&#8221;) and BeiGene, Ltd. (together with its assignees, &#8220;BeiGene&#8221;), entered into a License and Supply Agreement (the &#8220;LSA&#8221;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#8220;Plaintiffs&#8221;) filed a complaint against BMS, Celgene and Juno (collectively, &#8220;Defendants&#8221;). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA and Other Remediation Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $87 million as of September&#160;30, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300046838912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;, "we" or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position as of September&#160;30, 2022 and December&#160;31, 2021, the results of operations for the three and nine months ended September&#160;30, 2022 and 2021, and cash flows for the nine months ended September&#160;30, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Business Segment Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates and Judgements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Upfront and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statements of earnings. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows are now presented separately in Rebates and discounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective basis. Early adoption is permitted.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Arrangements</a></td>
<td class="text">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055413232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock', window );">Revenue Recognition Gross-To-Net Adjustments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,793)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,092)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,230)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $10 million and $207 million for the three and nine months ended September&#160;30, 2022, and $10&#160;million and $282&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In-Line Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054170256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Collaborative Arrangement and Arrangement Other than Collaborative</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055437504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration for the acquisition consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for outstanding shares </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration for equity awards </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Consideration paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unvested stock awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration to be allocated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unvested equity awards of $73&#160;million expensed in Marketing, selling, and administrative and $80&#160;million expensed in Research and development during the three months ended September 30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock', window );">Purchase Commitment, Excluding Long-Term Commitment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed as of the acquisition date based upon their respective fair values summarized below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable net assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration allocated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Intangible assets primarily consist of IPRD allocated to repotrectinib ($2.8&#160;billion), a potential best-in-class tyrosine kinase inhibitor targeting the ROS1 and NTRK oncogenic drivers in NSCLC and other advanced solid tumors. Repotrectinib is currently in registrational Phase II study in adults and a Phase I/II study in pediatric patients. The estimated fair value of IPRD assets was determined using an income approach valuation method. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Goodwill resulted primarily from the recognition of deferred tax liabilities and is not deductible for tax purposes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsTableTextBlock', window );">Licensing and Other Arrangements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(611)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biohaven sublicense income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of arrangements in which the entity has agreed to procure goods or services from one or more suppliers. May include identification of the goods or services to be purchased, identity of the seller, pricing, effects on pricing for failing to reach minimum quantities required to be purchased (such as penalties), cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054255376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock', window );">Schedule Of Other Income Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfOtherIncomeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047758688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $6 million and $17 million for the nine months ended September 30, 2022 and 2021, respectively. Excludes $12 million for the nine months ended September 30, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054255376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054229072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043240752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of September&#160;30, 2022, and December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock', window );">Schedule of Equity Investments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Debt Securities, Trading, and Equity Securities, FV-NI</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain)/loss recognized on investments sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss/(income) of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivatives and Fair Value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 24 months.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Fair Value and Other Adjustments to Long Term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,869&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The table below summarizes the issuances:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2032</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.550% Notes due 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.700% Notes due 2052</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.900% Notes due 2062</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfEquityInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054250896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule Of Receivables</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054222912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054275984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054234928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule Of Intangible Assets By Major Class</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes goodwill and other intangible assets recognized as part of the Turning Point acquisition in 2022. Refer to &#8220;&#8212;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#8221; for further information related to the Turning Point acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047681712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent</a></td>
<td class="text"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. Restricted cash of $339 million as of September 30, 2021, was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,203&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047368816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stock by Class</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2022: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(992)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,292)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,956&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(841)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,411)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022, June&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the nine months ended September 30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,198)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,625&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,572)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021, June&#160;30, 2021 and September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:-9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to &#8220;&#8212;Note 9.Financial Instruments and Fair Value Measurements&#8220; for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300054153920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Payment Arrangement, Cost by Plan</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:50.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $4 million and $63 million for the three and nine months ended September&#160;30, 2022 and $7&#160;million and $36&#160;million for the three and nine months ended September&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock', window );">Schedule Of Share Based Compensation Additional Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the nine months ended September 30, 2022 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Share-based Payment Arrangement, Nonvested Award, Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047998720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="nump">$ 11,624<span></span>
</td>
<td class="nump">$ 34,753<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">10,813<span></span>
</td>
<td class="nump">11,243<span></span>
</td>
<td class="nump">33,606<span></span>
</td>
<td class="nump">33,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,895<span></span>
</td>
<td class="nump">2,646<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
<td class="nump">8,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">2,452<span></span>
</td>
<td class="nump">9,234<span></span>
</td>
<td class="nump">8,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Alliance revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043982032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="nump">$ 11,624<span></span>
</td>
<td class="nump">$ 34,753<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(6,793)<span></span>
</td>
<td class="num">(6,092)<span></span>
</td>
<td class="num">(17,949)<span></span>
</td>
<td class="num">(16,230)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods', window );">Adjustments for provisions for product sales made in prior periods</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember', window );">Gross product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">17,606<span></span>
</td>
<td class="nump">17,335<span></span>
</td>
<td class="nump">51,555<span></span>
</td>
<td class="nump">49,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">10,813<span></span>
</td>
<td class="nump">11,243<span></span>
</td>
<td class="nump">33,606<span></span>
</td>
<td class="nump">33,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember', window );">Charge-backs and cash discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(1,907)<span></span>
</td>
<td class="num">(1,908)<span></span>
</td>
<td class="num">(5,420)<span></span>
</td>
<td class="num">(5,214)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember', window );">Medicaid and Medicare rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(3,295)<span></span>
</td>
<td class="num">(2,625)<span></span>
</td>
<td class="num">(8,003)<span></span>
</td>
<td class="num">(6,482)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember', window );">Other rebates, returns, discounts and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">$ (1,591)<span></span>
</td>
<td class="num">$ (1,559)<span></span>
</td>
<td class="num">$ (4,526)<span></span>
</td>
<td class="num">$ (4,534)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for Provisions for Product Sales made in Prior Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross to Net Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Gross to Net Adjustments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043580752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disaggregation of Revenue by Product and Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="nump">$ 11,624<span></span>
</td>
<td class="nump">$ 34,753<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Performance obligation satisfied in previous period</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">7,941<span></span>
</td>
<td class="nump">7,296<span></span>
</td>
<td class="nump">23,903<span></span>
</td>
<td class="nump">21,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,062<span></span>
</td>
<td class="nump">4,052<span></span>
</td>
<td class="nump">10,216<span></span>
</td>
<td class="nump">12,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember', window );">Other Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember', window );">Total In-Line Products and New Product Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">8,621<span></span>
</td>
<td class="nump">8,011<span></span>
</td>
<td class="nump">26,403<span></span>
</td>
<td class="nump">24,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InLineProductsMember', window );">Total In-Line Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">8,068<span></span>
</td>
<td class="nump">7,667<span></span>
</td>
<td class="nump">25,018<span></span>
</td>
<td class="nump">23,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EliquisMember', window );">Eliquis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="nump">2,413<span></span>
</td>
<td class="nump">9,101<span></span>
</td>
<td class="nump">8,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdivoMember', window );">Opdivo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
<td class="nump">6,033<span></span>
</td>
<td class="nump">5,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember', window );">Pomalyst/Imnovid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">2,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OrenciaMember', window );">Orencia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">2,551<span></span>
</td>
<td class="nump">2,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SprycelMember', window );">Sprycel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_YervoyMember', window );">Yervoy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
<td class="nump">1,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember', window );">Empliciti</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember', window );">Mature and other products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember', window );">Total New Product Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ReblozylMember', window );">Reblozyl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbecmaMember', window );">Abecma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember', window );">Zeposia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_BreyanziMember', window );">Breyanzi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InrebicMember', window );">Inrebic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OnuregMember', window );">Onureg</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdualagMember', window );">Opdualag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_CamzyosMember', window );">Camzyos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SotyktuMember', window );">Sotyktu</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_LOEProductsMember', window );">Total Recent LOE Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,597<span></span>
</td>
<td class="nump">3,613<span></span>
</td>
<td class="nump">8,350<span></span>
</td>
<td class="nump">10,369<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_RevlimidMember', window );">Revlimid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,420<span></span>
</td>
<td class="nump">3,347<span></span>
</td>
<td class="nump">7,718<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember', window );">Abraxane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 266<span></span>
</td>
<td class="nump">$ 632<span></span>
</td>
<td class="nump">$ 876<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_OtherRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InLineProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InLineProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EliquisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EliquisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdivoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdivoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_PomalystImnovidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OrenciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OrenciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SprycelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SprycelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_YervoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_YervoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EmplicitiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ReblozylMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ReblozylMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbecmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbecmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ZeposiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_BreyanziMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_BreyanziMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OnuregMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OnuregMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdualagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdualagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_CamzyosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_CamzyosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SotyktuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SotyktuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_LOEProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_LOEProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_RevlimidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_RevlimidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbraxaneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044396368">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,753<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,544<span></span>
</td>
<td class="nump">7,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">7,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="num">(1,113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AlliancesAndCollaborationCompaniesAxis=bmy_BridgeBioMember', window );">BridgeBio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_UpfrontPaymentsMadeToCollaborativePartner', window );">Upfront payments made to collaborative partner</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval', window );">Consideration for contingent development and regulatory approval</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
<td class="nump">8,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,456<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncome', window );">Deferred income from alliances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Eisai</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_UpfrontPaymentsMadeToCollaborativePartner', window );">Upfront payments made to collaborative partner</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval', window );">Consideration for contingent development and regulatory approval</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,606<span></span>
</td>
<td class="nump">33,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales | Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,234<span></span>
</td>
<td class="nump">8,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UpfrontPaymentsMadeToCollaborativePartner">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payments made to partner as part of collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UpfrontPaymentsMadeToCollaborativePartner</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AlliancesAndCollaborationCompaniesAxis=bmy_BridgeBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AlliancesAndCollaborationCompaniesAxis=bmy_BridgeBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AlliancesAndCollaborationCompaniesAxis=bmy_EisaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AlliancesAndCollaborationCompaniesAxis=bmy_EisaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300049360496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 17, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLineItems', window );"><strong>Asset Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,170<span></span>
</td>
<td class="nump">$ 1,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Turning Point</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLineItems', window );"><strong>Asset Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">$ 4,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055338608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details) - Turning Point - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 17, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">$ 4,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Unvested Stock Awards</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration to be allocated</a></td>
<td class="nump">3,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Unvested Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Unvested Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">$ 3,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044172768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 17, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">$ 763<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember', window );">Turning Point</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">2,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax assets</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income tax liabilities</a></td>
<td class="num">(643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="num">(111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Identifiable net assets acquired</a></td>
<td class="nump">3,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total consideration allocated</a></td>
<td class="nump">3,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_TurningPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300042038016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 791<span></span>
</td>
<td class="nump">$ 570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="num">(597)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember', window );">Diabetes Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="num">(595)<span></span>
</td>
<td class="num">(445)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (211)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300046945600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (205)<span></span>
</td>
<td class="num">$ (160)<span></span>
</td>
<td class="num">$ (597)<span></span>
</td>
<td class="num">$ (447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentRegulatoryMilestoneIncome', window );">Contingent milestone income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsIncome', window );">Total</a></td>
<td class="num">(374)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
<td class="num">(967)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember', window );">Keytruda Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(732)<span></span>
</td>
<td class="num">(611)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember', window );">Tecentriq royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_BiohavenMember', window );">Biohaven</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Biohaven sublicense income</a></td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember', window );">Other Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationOfDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationOfDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentRegulatoryMilestoneIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Regulatory Milestone Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentRegulatoryMilestoneIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_BiohavenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_BiohavenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047041552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 791<span></span>
</td>
<td class="nump">$ 570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_PaymentToExtinguishFutureRoyaltyObligation', window );">Payment to extinguish future royalty obligation</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember', window );">Immatics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestonePayments', window );">Contingent and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_DragonflyMember', window );">Dragonfly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_AgenusMember', window );">Agenus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestonePayments', window );">Contingent and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other | Discontinued Operations, Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other | LOTTE Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other | Cheplapharm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicenseAndOtherArrangementsUpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and Other Arrangements Upfront Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicenseAndOtherArrangementsUpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PaymentToExtinguishFutureRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment To Extinguish Future Royalty Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PaymentToExtinguishFutureRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_ImmaticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_DragonflyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_DragonflyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_AgenusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_AgenusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_LOTTECorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_LOTTECorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_CheplapharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_CheplapharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048845648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="nump">$ 328<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_OtherIncomeReceivedFromAlliancePartners', window );">Royalties and licensing income</a></td>
<td class="num">(579)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(1,197)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses/(income)</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(465)<span></span>
</td>
<td class="nump">966<span></span>
</td>
<td class="num">(1,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation and other settlements</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_OtherOtherIncomeExpense', window );">Other</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">$ (140)<span></span>
</td>
<td class="num">$ (409)<span></span>
</td>
<td class="nump">$ 793<span></span>
</td>
<td class="num">$ (1,113)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherIncomeReceivedFromAlliancePartners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherIncomeReceivedFromAlliancePartners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300046943744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Change in estimates</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance', window );">Expected cost savings and avoidance</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Cashoutlays', window );">Cash outlays</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Workforce reduction of manufacturing, selling, administrative, and research and development personnel | employee</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Cashoutlays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outlays</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Cashoutlays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ExpectedSynergiesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Synergies, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ExpectedSynergiesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044012320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 409<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other termination costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAcceleratedDepreciation', window );">Accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RestructuringRelatedCostsAssetImpairments', window );">Asset impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_OtherShutdownCosts', window );">Other shutdown costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherShutdownCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other shutdown costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherShutdownCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringRelatedCostsAssetImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs, Asset Impairments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringRelatedCostsAssetImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044351600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency translation and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, end of period</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Change in estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan | Accelerated Stock Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Excluding Accelerated Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055444816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings Before Income Taxes</a></td>
<td class="nump">$ 2,209<span></span>
</td>
<td class="nump">$ 2,157<span></span>
</td>
<td class="nump">$ 5,854<span></span>
</td>
<td class="nump">$ 6,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">$ 601<span></span>
</td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="nump">$ 1,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Tax Rate</a></td>
<td class="nump">27.20%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">26.20%<span></span>
</td>
<td class="nump">25.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055994464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">$ 480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">$ 530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300050991520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</a></td>
<td class="nump">$ 1,606<span></span>
</td>
<td class="nump">$ 1,546<span></span>
</td>
<td class="nump">$ 4,305<span></span>
</td>
<td class="nump">$ 4,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-Average Common Shares Outstanding - Basic (in shares)</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
<td class="nump">2,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Incremental Shares Attributable to Share-Based Compensation Plans (in shares)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-Average Common Shares Outstanding - Diluted (in shares)</a></td>
<td class="nump">2,148<span></span>
</td>
<td class="nump">2,243<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Earnings per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share attributable to BMS, basic (in usd per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 2.01<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share attributable to BMS, diluted (in usd per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048956160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 1,293<span></span>
</td>
<td class="nump">$ 2,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">919<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">4,667<span></span>
</td>
<td class="nump">12,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047229952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,293<span></span>
</td>
<td class="nump">$ 2,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047578352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable fair values</a></td>
<td class="nump">$ 919<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable fair values</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Limited partnerships and other equity method investments</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityInvestments', window );">Total equity investments</a></td>
<td class="nump">$ 1,959<span></span>
</td>
<td class="nump">$ 2,968<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044235920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFVNIAbstract', window );"><strong>Equity investments with readily determined fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Net loss/(gain) recognized</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 927<span></span>
</td>
<td class="num">$ (93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Net (gain)/loss recognized on investments sold</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized loss/(gain) recognized on investments still held</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract', window );"><strong>Equity investments without readily determinable fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Upward adjustments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Impairments and downward adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Cumulative upward adjustments</a></td>
<td class="num">(173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Cumulative impairments and downward adjustments</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss/(income) of affiliates</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="num">$ (214)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFVNIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFVNIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300041733584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)<br> &#8364; in Millions, $ in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>creditFacility</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 38,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Variable rate debt, lower range of basis point spread</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 34,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payment for debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,750<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Net proceeds of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_NumberofRevolvingCreditFacilities', window );">Number of revolving credit facilities | creditFacility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember', window );">$2 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember', window );">$1 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember', window );">$1.5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember', window );">$5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LongTermDebtRenewalPeriod', window );">Renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2.600Notesdue2022Member', window );">2.600% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member', window );">2.875% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member', window );">2.550% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2000NotesDue2022Member', window );">2.000% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A3250BondsDue2022Member', window );">3.250% Bonds due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A3550BondsDue2022Member', window );">3.550% Bonds due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">LIBOR</a></td>
<td class="nump">3.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.14%<span></span>
</td>
<td class="nump">3.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LongTermDebtRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LongTermDebtRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberofRevolvingCreditFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberofRevolvingCreditFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2.600Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2.600Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2000NotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2000NotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A3250BondsDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A3250BondsDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A3550BondsDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A3550BondsDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048917184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,411<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">882<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">7,978<span></span>
</td>
<td class="nump">3,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">1,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,628<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">561<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055359168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(195)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (136)<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048880624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in other comprehensive income</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 1,106<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="num">(391)<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Non-U.S. dollar borrowings gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Non-U.S. dollar borrowings gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in other comprehensive income</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(195)<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Reclassified to Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in other comprehensive income</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionAbstract', window );"><strong>Cross-currency interest rate swap contracts gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055695056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Non-U.S. short-term borrowings</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, total</a></td>
<td class="nump">$ 2,132<span></span>
</td>
<td class="nump">$ 4,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048858880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="nump">$ 38,137<span></span>
</td>
<td class="nump">$ 43,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations', window );">Unamortized basis adjustment from swap terminations</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized bond discounts and issuance costs</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized purchase price adjustments of Celgene debt</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">38,869<span></span>
</td>
<td class="nump">44,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">36,966<span></span>
</td>
<td class="nump">39,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of interest rate swap contracts</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UnamortizedBasisAdjustmentFromSwapTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044405744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="nump">$ 38,137<span></span>
</td>
<td class="nump">$ 43,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2032Member', window );">Note Due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2042Member', window );">Note Due 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2052Member', window );">Note Due 2052</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2062Member', window );">Note Due 2062</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member', window );">2.875% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member', window );">2.550% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2250SeniorNotesDue2021Member', window );">2.250% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_NoteDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_NoteDue2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2052Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_NoteDue2052Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_NoteDue2062Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_NoteDue2062Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2250SeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2250SeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044132864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RECEIVABLES - Schedule of Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,644<span></span>
</td>
<td class="nump">$ 8,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_CashDiscounts', window );">Less: Charge-backs and cash discounts</a></td>
<td class="num">(599)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: Allowance for expected credit loss</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Net trade receivables</a></td>
<td class="nump">8,021<span></span>
</td>
<td class="nump">7,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Alliance, Royalties, VAT and other</a></td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 9,613<span></span>
</td>
<td class="nump">$ 9,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_CashDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_CashDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300042130064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ReceivablesSoldOnNonrecourseBasis', window );">Non-U.S. receivables sold on a nonrecourse basis | $</a></td>
<td class="nump">$ 809<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_NumberOfLargestPharmaceuticalWholesalers', window );">Number of largest pharmaceutical wholesalers | customer</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue', window );">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberOfLargestPharmaceuticalWholesalers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the largest pharmaceutical wholesalers used by the company in the territory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberOfLargestPharmaceuticalWholesalers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PercentageOfAggregateTotalTradeReceivablesDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReceivablesSoldOnNonrecourseBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables sold on a nonrecourse basis during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReceivablesSoldOnNonrecourseBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043284272">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw and packaging materials</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Totalinventories', window );">Total inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">$ 2,291<span></span>
</td>
<td class="nump">7,544<span></span>
</td>
<td class="nump">$ 7,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">$ 2,980<span></span>
</td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">$ 7,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember', window );">Inventory Purchase Price Fair Value Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, fair value adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Totalinventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the total inventory, current and non-current, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Totalinventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055319088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">5,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery, equipment and fixtures</a></td>
<td class="nump">3,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">10,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(4,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,033)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048017408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 21,112<span></span>
</td>
<td class="nump">$ 20,502<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">69,020<span></span>
</td>
<td class="nump">66,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(30,841)<span></span>
</td>
<td class="num">(23,483)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">38,179<span></span>
</td>
<td class="nump">42,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPRD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">IPRD</a></td>
<td class="nump">6,560<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">60,477<span></span>
</td>
<td class="nump">60,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="nump">$ 1,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055174864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of other intangible assets</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember', window );">Inrebic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestoneNonCash', window );">Contingent and regulatory milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestoneNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestoneNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_IntangibleAssetNameAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300048863296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Income taxes</a></td>
<td class="nump">$ 3,181<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ResearchandDevelopment', window );">Research and development</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityInvestmentsCurrent', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">1,664<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 6,082<span></span>
</td>
<td class="nump">$ 4,832<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investments - current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchandDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchandDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044592944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityInvestmentsNonCurrent', window );">Equity investments</a></td>
<td class="nump">$ 1,959<span></span>
</td>
<td class="nump">$ 2,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ResearchAndDevelopmentNonCurrent', window );">Research and development</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">$ 4,745<span></span>
</td>
<td class="nump">$ 5,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash for contributions and settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investments - non-current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchAndDevelopmentNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development - Non-Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchAndDevelopmentNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300042116064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedRebatesAndReturns', window );">Rebates and discounts</a></td>
<td class="nump">$ 6,839<span></span>
</td>
<td class="nump">$ 6,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedInterest', window );">Interest</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,762<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 14,203<span></span>
</td>
<td class="nump">$ 13,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedRebatesAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedRebatesAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044132704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes</a></td>
<td class="nump">$ 4,398<span></span>
</td>
<td class="nump">$ 4,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">$ 6,685<span></span>
</td>
<td class="nump">$ 7,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043718880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Stockholders Equity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in usd per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">$ 1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,320<span></span>
</td>
<td class="nump">$ 4,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 32,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital&#160;in Excess of Par Value of&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">44,375<span></span>
</td>
<td class="nump">43,756<span></span>
</td>
<td class="nump">44,361<span></span>
</td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">43,852<span></span>
</td>
<td class="nump">44,325<span></span>
</td>
<td class="nump">44,361<span></span>
</td>
<td class="nump">44,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">44,956<span></span>
</td>
<td class="nump">44,375<span></span>
</td>
<td class="nump">43,756<span></span>
</td>
<td class="nump">44,292<span></span>
</td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">43,852<span></span>
</td>
<td class="nump">44,956<span></span>
</td>
<td class="nump">44,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(1,229)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(1,544)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(841)<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="num">(1,229)<span></span>
</td>
<td class="num">(1,424)<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(1,544)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="num">(1,424)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">24,217<span></span>
</td>
<td class="nump">23,948<span></span>
</td>
<td class="nump">23,820<span></span>
</td>
<td class="nump">22,168<span></span>
</td>
<td class="nump">22,204<span></span>
</td>
<td class="nump">21,281<span></span>
</td>
<td class="nump">23,820<span></span>
</td>
<td class="nump">21,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">2,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(1,148)<span></span>
</td>
<td class="num">(1,152)<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
<td class="num">(1,089)<span></span>
</td>
<td class="num">(1,091)<span></span>
</td>
<td class="num">(1,098)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 24,675<span></span>
</td>
<td class="nump">$ 24,217<span></span>
</td>
<td class="nump">$ 23,948<span></span>
</td>
<td class="nump">$ 22,625<span></span>
</td>
<td class="nump">$ 22,168<span></span>
</td>
<td class="nump">$ 22,204<span></span>
</td>
<td class="nump">$ 24,675<span></span>
</td>
<td class="nump">$ 22,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">788<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (35,292)<span></span>
</td>
<td class="num">$ (35,187)<span></span>
</td>
<td class="num">$ (31,259)<span></span>
</td>
<td class="num">$ (28,198)<span></span>
</td>
<td class="num">$ (27,199)<span></span>
</td>
<td class="num">$ (26,237)<span></span>
</td>
<td class="num">$ (31,259)<span></span>
</td>
<td class="num">$ (26,237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="num">$ (1,151)<span></span>
</td>
<td class="num">$ (300)<span></span>
</td>
<td class="num">$ (4,250)<span></span>
</td>
<td class="num">$ (487)<span></span>
</td>
<td class="num">$ (1,235)<span></span>
</td>
<td class="num">$ (1,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share repurchase program (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Stock compensation (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (36,411)<span></span>
</td>
<td class="num">$ (35,292)<span></span>
</td>
<td class="num">$ (35,187)<span></span>
</td>
<td class="num">$ (28,572)<span></span>
</td>
<td class="num">$ (28,198)<span></span>
</td>
<td class="num">$ (27,199)<span></span>
</td>
<td class="num">$ (36,411)<span></span>
</td>
<td class="num">$ (28,572)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300044269568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Additional Information (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchase program, value</a></td>
<td class="nump">$ 701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,585<span></span>
</td>
<td class="nump">$ 3,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember', window );">2022 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2019ASRMember', window );">2019 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2019ASRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bmy_A2019ASRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300043166720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized (losses)/gains, pretax</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 1,106<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized (losses)/gains, tax</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized (losses)/gains, after tax</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="num">(391)<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Reclassified to net earnings, tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassified to net earnings, after tax</a></td>
<td class="num">(153)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(341)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Derivatives qualifying as cash flow hedges, pretax</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Derivatives qualifying as cash flow hedges, tax</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges, after tax</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Actuarial gains/(losses), pretax</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Actuarial gains/(losses), tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gains/(losses), after tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization, pretax</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Amortization, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Amortization, after tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlements, pretax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax', window );">Settlements, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Settlements, after tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Pension and postretirement benefits, pre-tax</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and postretirement benefits, tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits, after tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized (losses)/gains, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Unrealized (losses)/gains, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized (losses)/gains, after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation, pretax</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, tax</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation, after tax</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income, pre-tax</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive income, tax</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, after tax</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300046926512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="num">(704)<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(933)<span></span>
</td>
<td class="num">(680)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (841)<span></span>
</td>
<td class="num">$ (1,268)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300047334800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 338<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Excess tax benefits from share-based compensation awards</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300042106224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 60.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 66.76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300055242736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300041646144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)<br> $ in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>patent</div>
</th>
<th class="th">
<div>Mar. 31, 2010 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Obligation to holders of the contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities for CERCLA matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember', window );">Bristol-Myers Squibb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember', window );">Anti-PD-1 Antibody Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember', window );">CAR T Kite Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | Australia, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember', window );">Abilify Product Liability | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberClassAction', window );">Class action claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims', window );">Individual injury claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberActive', window );">Pending claims, active | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember', window );">Abilify Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberDismissed', window );">Dismissed cases | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyNumberOfPlaintiffsDismissed', window );">Number of plaintiffs, dismissed cases | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember', window );">Onglyza Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LegalProceedingsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LegalProceedingsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyNumberOfPlaintiffsDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Plaintiffs, Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyNumberOfPlaintiffsDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberActive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Active</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberActive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberClassAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Class Action</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberClassAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Individual Injury Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RoyaltyGuaranteesCommitmentsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Guarantees Commitments, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RoyaltyGuaranteesCommitmentsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=bmy_BristolMyersSquibbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>bmy-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmy="http://www.bms.com/20220930"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmy-20220930.xsd" xlink:type="simple"/>
    <context id="i80ec74c427f849589681e2b3cded2642_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68e3823dddb74db2958072c745a03097_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibffe096d269f4247ba0455fffac494c2_I20221014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6c52b7c17b524a44903fa0bff0845939_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3909832868c44962a2e1a7cf39c79c87_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9dd8e6d78fde49408a97b0e2d733b6f0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib0a72bb56bec4e89876d1ea244b49e22_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39ec064d64084de8b739eb44e9285120_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6d46fefd70244503bf70ff1057422f86_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iae305004534c4cae8e7485e4dc74784a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if781377a20f34a65860112e032558c03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4db84d4e37a04e54af5c55bf28598232_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i29266ae9af704e83ac646ebb6641fdb3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ica0e3fbf1cf94fffa908248b335d98b8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02073132d0574931b33a0f63b07ca3c0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i01cb0332a64c4a85999046b2d17073fe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i044c0c7286a4460da3d4eeeba42cb69c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bc4b8be12534b2b9d7fa10bb00ae5c7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i62bd0e6d660744a88a4153646993b3ad_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i28a5899d8d1b4d3e8ecbde0564615570_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id23693b7b08249d3aa12050a006f0001_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5e2e1abbc7064f37a17916a3c0555574_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6434d519a5ea436c9fdf8a130125e12f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i04800f144c48480496199f7f1dcbef22_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0af3648fd4884c20a605f122dfd20cc2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i43278271a0ff474380032a771a7b1743_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ec69e1d136440a8a76da2507fd0f758_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2c166558cb7b467fb2cb4a39347b1703_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9a53451866344aabc76f70abaf649a0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i697262196a73456d97438e0a8c0db01c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ied4473234acb4698a92ec39a59dd736a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6b29234dfee8455eae5c6cd393e05ad6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2aebfbe0d44248bca085ae268561e653_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia4003ca03f1e4e1983eef1fd2275159e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i93af657bc36642fab0a352efe9e508d2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iff59a735468f412282be47f01fe403fe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48c3e2d54ddb4d6685984ee660b83ae5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9df57b8597af420d9c5ec3c15387bc01_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if8fe060f6be2495faa414c6e6ad65686_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i62fda2db6b3941ccb2dc3fc8da4450e7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7599d4a3420d4aadbcf02d4eaba7532a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i625e125bc434431ca1c8a772fea91d5e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i80724b9311fc44598901283b8226c7c7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i09afd557e9f3433cbf4edac16c1bd239_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4989d5918ce944d29e07c0809ff1d187_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7180b016692e484193376ecc09ef7603_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iafe4ffb2515d4f8b87bb7994bbe700c1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia300585bbecb4074986dc776703743c2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46c1d84a792b475cbfa2c9a371ed8496_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f72bbf8c4304428b0ed80a8686b9248_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic9d82f3486fe4d61884d139292c0a019_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic93e43e0d5e449c9a5ac169c78f5729e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91564a174e264c93b41b7a67a1aba557_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i52549b4b725c4beaa7e2e97bdb382deb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f173022564246479bb42891e0caadeb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic7621f5141c74afea188b4fd300e0324_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id2b2771b60834bc88d400a6969621023_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic33b8b166dcc47a19e7e82c8d64e0d0e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i375ecb41f5d34164b135dfb0419a036e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1e88c910ffae4f9a9d5adc44c364d44c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c86bc8fc17947e8b991889d64c5e053_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie3689d0fcaf24638a873a35863370488_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iddd8ef9dd4b34e74b6c7d422826a5a2a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib53644119d8a45f1863f5c215a118b2a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4e0cefbc0671402cb26abf2ad1c6e8e1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iddd31c065d2b4f2eac12a4313ca0b4e7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a2977ed64024e9b82c97255c6614303_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i523864ecfe934c0a8c2a8ba3767f4efc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d028b025fa34a23934845203ff86eca_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib532e1cdc30944c5b30a57aeb3373c5a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ac2713db21647efa1e4c85b8371102c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6b3a202c6cd54c6b93f8c26bfb454aab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7edc171ac604a028ae6ba6d774d1184_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc68379ebba8498fbde398dcdfa0bbb9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief4fc5728521489486f5f10510221b0c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if27953d1748346de8d241948e99fdfce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9253e2d1c9f14694a47e4b8ba936cd82_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2935cf5db0984e48a7311562d8957e88_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i312e646a32594a92819e204cbcf9d30f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5077d69051d2407dac910cb1d4b5af89_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36674f96d1ba40588e290d02748a12d3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i44bc11db15de490da4c09d2d876a005b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i00488d76ec644f9f92320a9c1dcc6355_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d096e1112a84f968934e98a7d7e8897_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia19f17c6b9684d4dae43eca5b8566729_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3c063ffd131546f19b8bc98eaa3ea8c0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i992d193b56344cfaa5ba4098f9efd6f2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icaae1d1308ff4f129502456c6536ad64_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97b7e4ca6dec410ca3364c9088373428_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c7db61f43aa43929a92deb8ac563b89_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i67b4ea4259ca469ca93f408a519be850_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i24cc65b60058474db7537ab2b6b0a254_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a140f37738545fd8986a487a0effcd0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic1539779a5914689aa5abc809e040af0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i08528bb25e714575a7f5c80c04663b81_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9ebc52b59af749918bb43f2480530ab9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib4bb28437e7b4609b9fa0648528f45d4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee7c15e9e75e4205a132cc94956026e4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c7cedbf6e5649418120798f7a9f2b6c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30592356ada44f519b3f806c7e67a991_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1276014500404e2e82de7171d6cb2c46_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2c90420b4f6d468387df80ced89cde88_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i639586984bcf4c9bb2800764224a0d97_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f8a8da7674641108fe5cccec2da9f32_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if91a0cc6973147dbb665862c990ff09c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i515f50d74f9f403dbded026f016eecea_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c92b01540e8405eb5f3908c858d4523_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i957ae0dd10d742d585460837252b996f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0651d3b0cf44b9f9157cee57ba36939_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if2a88fbea78348eaa1d5f346ce2efeef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i743233575df84038808b743f27ef5643_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if1aaa93de272430e8ff046eb7df5c78e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2cfec8659679486082b93be2576c6ee7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c20938af5ea4f559a05d063bca23a37_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6d3d417b45d149649f2fab7b9c39c309_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i62b88401122a44aaae11d63f988564e3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia85644c821814dddb2f2fe08c06ecfea_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd2c28076da74353b7a9b4be05493211_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i55b94424ed3440cdab12f30e34eef0e8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic7cfc8d0143547ffb85e8991435779d0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i718ffa0ce4264649a30d8e60f6d21e21_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5034bd9d5ac4d709b2d8bae0eda22ab_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i79c3c3b3adf74d829fdcffc4e2fd017b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i33b8d2d6534740bd9a6f4cd980bb5662_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib12e924a4a13410b84c6b424992cfa22_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2f02d98cc4647e6a09a6e50ca3b081d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i69bf82dfff6346418613dbfd38767fc2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2360c71c4d7c4f60aff7afb5bd5adb43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic2a2726ed8d946878e0409ab1bc8e479_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i097fc6808da74bd2a448a5abc583ff06_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i82055957ab0c488786f886e6b6babb70_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2b7e84f20fa4c0e8c203592f5fdc962_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb5ca12fa8cf4f118404d35732aaa0e2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id3fbc288f17842e0a75422793fa1f2d2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a091ee30a0546f2b3cf7109a52349aa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6e8a169883d84598b45391f2436b331d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i714ecd92180a4da09cfb9e1b711d8e13_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1682d31f29ab4c5c8e318685f109e06d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0e11c81e870446bea062ed2f9a4dd75a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd51bc766ca44e85bd81070b4c92220b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68864aa7457c44f0a8c064e00afcf547_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i55b2fbe9642b4229bab1c013a4539695_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie29f5777421440b5a7303c74ab686169_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:BridgeBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icc7d12df57f64215af002ee413e6d5dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8e366068274246db8687bd2bf3a8caec_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-17</startDate>
            <endDate>2022-08-17</endDate>
        </period>
    </context>
    <context id="ie54f1b4636db42e6988c8772120ddcb6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i781907222fbe4667b1cd73c65ef72721_D20220817-20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-17</startDate>
            <endDate>2022-08-17</endDate>
        </period>
    </context>
    <context id="i793cb981ce5049e8b04829bfd1aebc05_D20220817-20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-17</startDate>
            <endDate>2022-08-17</endDate>
        </period>
    </context>
    <context id="i3b224fccd35141c6ab6c59ed52eab7c5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2142a064165c42acb01e69c102b6b950_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i094ac81d52ae4652a6b2c34240a43940_I20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:TurningPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-17</instant>
        </period>
    </context>
    <context id="i740d420ab04f43438529806760d35e0c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92913744fe924bd7afa2171de108004f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79552959d6b94618905e3c748636e2ac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a6dc427b52c490eaca902fe4c834622_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:LOTTECorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i1b18f99151344cda858f618b0c9b75e5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i81f79692d5f94137b6d2126460bcc45e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8e0fb3f550cb46e7866c0f224cacb82b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb74491d80864f3eaa177e2b8be81ec4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic75f9bbfc5724ef3836a765059109689_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6bac004294b34c42a5a7dbf2057b0487_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id61db944e47a4581aaf245bb80e3db88_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id2e8f993a1cb4f79a93af4ee934de0b8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife53d46685aa4a87a864327520e67683_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i93fcbb36dbf1444a8d0f08a84b035f69_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i992ba6626a224684911867fdc13bae74_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9b7f0dbcd1d24ef9a20304ac3ce6c2f5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9bad0f88cbc4be39604292bbbed7af6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id17ef668ac624a2f9ff552599af5c465_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ea20ff7bff341c7a20fcd4a22892b01_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaadbb07e45d241d7a53c1917dfe4e639_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:BiohavenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iccec0e6e65dc4d6eb8d442778567cca1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d0c115f0d654a1aad8188931e7d60e0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5689275b495b4b2f9cf12f272a88fefc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icda18d044f594a2ea664a02127e577a6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie82664611f3e4121968092cf4cd0861d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida5d1dc816114f0ca32419717d7722db_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib44f04ed35d04422a86bc2725b539aee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:AgenusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i06dd7c1aa48f4cd691db5ffb92ff9be9_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i15769c9092334b38abe2ab74542152e2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i835e2f7f63d7466da1773c331a6cf84d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idcab3a9d790d43a4aaa580b8ce49e8db_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1410968e21274826afdf23dc9434f736_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iead756ca21984013a7bd69516352fb13_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia870ef2304084b55ab48e0eae6731bb0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8b86689f804f49e4ad0215f4c9f4f9c4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b6962ac7520419e9e5528c42e86a43e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f20b9403da74f8ebf7c5eae9ba72e8c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id1052bb4a0b64c1aac26a10e810aafe7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i02826b699eda4a97ba070709457b65f1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic4634dede34e4e588b48071be679100a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6947273e102141838832d4c25bb46991_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab45139100524f8f85cebfc6cbfa75ca_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i04e5de495c7546bfa0bb84d26e067aa1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18f652f6a9e84b1091a70c260f8d4511_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife4473abbbdf4a9eb56ed31379f62651_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibcbea72907fd45ed8c844cd0e81ebc36_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib73eeb74828048d393d64170a29ce8f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b1ef508785f46e8951a4b5d8734fe0e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7ab4f089b9af40638285fff5aa6c4a64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida7cf5a352a54110bd759e160ab71b37_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idbcbcc18ebf94d8b84927842d8b4f534_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i750af98d076240de881b7ff2bf09cd4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i664e35471e3b431f80b8059482063353_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i032be76858324a3ea8ca82c8437b0d13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf1750b8def3481db064bae547758030_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i599407fe2aa64479abc2cb9f8943ddf2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iddf109f29964447db19dbc4a67325a91_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i86460ffdc92343a1b34f3701d5ba3f73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i023d3dd7e5e2466fa118f0a377f5a86e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i023203ca7e2c44c6aef398e5ac1f362c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55f21b31cd934d95bec8c47f5cca9d7d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i751bb8a9c76a4066b66cc023f2f6e8ae_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3bfb1a2171374f4680084a5e82d83fa3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibb6cfdd1ed78472f99fc8e5e7c606f21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6520e68dbf54cdc8ec17823e10b0646_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89986bb97ecb4e97aff1b91cce777c15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e9b662730384bb7b4ead3470de0d515_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9c861dc4c60414088ec212834a771e4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifac1ef197e014b5dae4b0dcbf87a2891_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7100bf3c38b24a52bf40ec5e7f24933a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b888a0a457640ff861a14782a04bdbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib63b4fc1b0444bdfa216b46c39f99f6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaaad04a4dfb54e4baa98287704d915e1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id32df06df7ee4312b8d69963af72d16c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i001cf1d2900445718093f0ed5b320c01_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iab1b2dc24bcf49ce861f999cd524d75f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e0bd321f5bb47f88e5f9bcc836bb474_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a8881178a9a4ffd950fe4ca131ae180_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie94029425ffb44b89b3a798ad9c779fa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia027865f0ea44b3a80cf5792949a8621_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia6ee716584d44f0e92394dc97ec2e3e4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3291dcc3ae81483cb7fa13dfc3ad4b9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icecb65891a224cfeac69f536b96a8bae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i951812de5a98402d9dea34b638a13c0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i869c2864826e42ecb543c18a3ee8cad7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i007f47041a3e4a0b8f534e32f84ef88f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2ee3aac3606489e8746d195b398a934_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf0158c1228242f594f5547c1ecdf6af_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2ddfcd48ce404bf187e46620663765f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i886da8a6a90b461c9af99d1fdcba4377_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i668b51b58a0942a9aedf0c485aca6851_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5eb686bfb0e04c65a42bb3210170dda7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i24f777b58fc44c61994b5a303994de56_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic1fcfb5eba384919a6f3979d6d9e15be_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia29ecc9950894eb59b5cb3e5b2517a3c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ef79162dd034be895a4bcba78334e1c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i339caa7c1e6a43eb90fd07efce417b64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iac0fb0b0b75c45ee8d18d3d8d0b6d4c3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9113bb62f5fc4e84b6e97c82d3e2911b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bfad7762f964e1ca74853b28c6b82a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i387ddd833f71435ba85ff38a446a1ad4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5649feba80774237abf36efd972c7da1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i64ca08b52a6742409695aac6c23554f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7de81def66b94b54849c6be2071f8a4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i671a3558463349758ba20e3666722cc5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i434b45cb2aa04afc908af8ac2c0b29e3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i239d9003938740c39216c644b9c80fbb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icfa5e345526d4cb184e2c617cd44dde2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie9b5e6864bac4cc4a4d6c73ae31d6a8b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i356d70d9be5b40d3ae48415c984f8747_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae55e5eabed94fa8801cae43dc8309ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d2f488420464613bdeee86193ef4eee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ide37ecb83af748fb901addbb7d586542_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibed40edcdca04be1ac7f40fedd1fbf28_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i341c5e7c579a49489d32d9cdb3032597_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52bc3e57749345ea918765039e97891b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbf70c949b4444abb6425eec36d8fdd7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia0d78e80b73040089346da240187c709_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iff8febe75ec14be68b29d9e554cbb15a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf1cae60d9924382bb960c3201397998_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i623000336f474ce0a7c985a7099f9f33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98a2f300fd224cf69ad83417e63b0645_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia507ce7f836d4c8f9300d3ffdffc8f80_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id9681d173c7946ea819e81222ecfe950_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4fe3e81f2f1b4a57a73467c81f0b6af2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7fb1e679272541e9b87cbfb82b0c1cb7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6f2dd852e2564293b0c25120a2fea24e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id232f272e34d446b97e88ece5cdad405_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i51db28aa096b432189a3788e6aa7123f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86fff4fcd97244e8a2031133dc96e519_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i67fdac5f25c142198444d8440aeb1e36_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09ce9df741f740bb89856a5bf20958f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2e98552285044c26ba232ed5924465b9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia35153af17cf4e51a7a041e312ab160e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf7a73a7127b44f3ae2722fff64309a6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9f9f5be85464567b1c04db5316afee7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7982584c67704aeb87a3bc5199ecf7b8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac23d9ba09ef4f6f9bb57d9dc257b587_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib632c605afc443a9a1e66024aaf25726_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0daeb22196f04a9c979d9bea65d5029e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i92872acbdf1845709dc97146229773d3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44851decbabe44c2aa827ce35420cd14_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i61f45381d84d492c9d4620e158db0048_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cb0c279ee9246b5a0b911c7c61e2557_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i13e28e98ba32447bb7448a8051ebaf80_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1c7d5843d7de40ddbe92cb7c600b33f3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4cacbe74c36b42af8f2449ab4f4558d6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1cdf266395024196809286a2ed6e58ab_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic52749ea5b0c4ce2b65ccf38c233521a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a41df960fa54741b1d2968b3effa442_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i150c8a06bb804437a2510c0f68d2e14c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b217acaaa49469aad78b589be10377b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.600Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic78054c42bcb4ee9846b78e126b01988_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic24f31e173564ef08923e7298471a389_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2000NotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250BondsDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i58b5d7f1faad4e848093aeb065829a46_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3550BondsDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id6404ab102144f6ba73c22e80f018486_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idc346e3c2eca41249ffeaa6cda84f7db_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9789a0514bca4a1f9a657955e08feb99_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2052Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i203a9a6396554765b8fa0659e4a3d831_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:NoteDue2062Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i645d2dcb8c254458b2bba8716a3d4871_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i18778c0e80e94ff1bbb25132a78a2670_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2550SeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2250SeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib9a6a86876fc43d388aac8adf3fea7c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7a1031a2d014325bddb2d8b3e07d8d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5810116290c741c4ad8f11aed5bf0245_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2461c577cc2e466494498e4484b6c258_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i7a2ea2f6823b483bac68344cc193c509_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ie48edd2512e6470bab3e50e5a0158fed_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i24c74d0c904c4e3c93154b14e664eeb0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27025e532fa946c5a66af008af75071f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i886174f12723459392de618ff498cab2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0ee682ed54c547b3b7f983bfdc4c3c2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6ada0a913014cb4a8b2d1fad754e062_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib2f5ae04b7ca428da1a08620ad962073_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib58caf9412c34780974fe127d4a49141_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iba770528fa914f1e8e9ac8e274342513_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49772d239f2c4ae3ad2bb802c2f564a9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib6f0573b5eeb4100bf220e6512047183_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic605e8764c2d4fcfbfd94ae6c74b3e65_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0dc3701c2cc449cfb23ae43990a4a971_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id566a793fce34008bfef682147c19536_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i07d325d61d7f4391ae952172cc449249_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i653130003b5e4bc7b7676e60c391071f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3e8639f3418a48268cee6497be9986b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i219c2189e62b4365b40543aca350a443_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id243edc1992c42548f6d5cfeb9cb4676_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i951972d8afae4eaabb5d09508787712e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iccb38ad8451f4f6497c394f35b06eb08_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if704e1173f28402383a6c57f2e3df140_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fe41494b00144aeb5eef7881099386c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2168a62d5517410387e38e8ee41bdb64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20651cc5726a493da9cdd353ebddce96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia3d0354da6a042df94a411a0fc948ddd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide2fe15f76824880a795877832feb862_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c0282842cd245059208dde198cff004_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib08f80cfa602443b95ad13171165dfa8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib6ea8a669ebd49d098c897a367c09915_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81843f4922a440dcba130d3844c32c51_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1959f27617924dd58c01a80cf6b58c30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4a04a6cc493441c896b686ccf7d9db6c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i10004cd63b014f3f8682ee02de56861b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id062426fbfc04f8c9b4ae0975bc9b322_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i96fde31e46e241998655851bda819407_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i424fa464af494f00a96d5d2ecde941c1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i70bb84b635a14384813aff1611be542e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie36c386d500b49e9b15964e0e07d8e99_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0c5af4d6da0c46abafd596c61cea80e0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if9f675d87d624de7959d9b23d44a06ad_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if90cad36c797440684daad86d7b7980c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib3a762be7d3142c79bcc98621c63a1b4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i261fe8c2d46d4b2bbdcb71ceee0a2956_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i708233e593ac416d8961d311b12dd0d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9f6b897df93a45b0931e170cfe06cd39_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i58393e2f2a5a48d6a80d43186ff0f68a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic389bf69a1b047ae8a8ca1032a58c315_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie839b830453247969319cb4087f8432e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i66f1af0105054a9d94aaf408f96a944e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i639f28b14fcb4c98a3e7676735c73daa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i45849baa6e0c4606bd93975a061f7213_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie798c0b144ab4feaac7932ccbec3c84f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1e7be709431d46ecab3d337838ec40ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic1bb411461174751860a090a735e24e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69dbdf8184bb44cb9a23af5df39a7e17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaab6129cd90e47629f61a8c46beb198c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifbf10e85fa704140bd6819ab1c54a619_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16b6a9e7477b44bf812f52b13f664d43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdb86ddecf754f1b9ed10ee592a8c467_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9ea49ce882bf4f63af2987bb1e15d6b6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib89084d224e14efdb9d09b06d9c54c39_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id73e463a04364161a685d3c4430b5550_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2a7555f794ba413894219c16f451682c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i82d62d70afcd42918ea9a2bfec538e66_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i28b2d4d8d91d4b278caf43bb6f13b862_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic367a2ecd9d0433e86bbfb9640e1163c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i66f58e8de911437f80231a5c3f56f8a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic00793ef22204a91b9d9819706370521_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c911796bb404970a0c3702c1385d332_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i63981ccb8d3246b7aa697743bf82119c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i872f940e3394429d83f38b9f6d926087_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia128e4642cfa484ebf43540577cd5f09_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20e0a56327ff4170819c77cd3052bfc6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5304c82d5b4048f985873fbbdfca9327_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5e16a4a57b3c403e9a92285a51739e1a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie7a7b2e0f79541e592a3eb7ca30e07b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5a80b405b4bf48fba866761f2581c0ca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i57dbfe3fc0b04540a9062b9da8ae1cfe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1451fd8e009248678887b28feb0d817a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia6fd46ccee88439e82d67fa529a9ff35_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2133f6965b7a48aa889670197491b115_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5a1d2ccd1fdf457c81335d661d935b52_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe1775a56a28418cad0acff1223adbff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id8be942a9fc84e4f9d8dd09313b7c6de_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7e6a2417ce314f85af97421da8e0d628_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i10a6b956076b456c914890389667aed8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib02a3afd2d6d4dbab20a028d5348db71_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i182f6377eff94cb4b6ac7e5d4a6b565f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a95cd7d7ed541189aceda668d7d654c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1ba0cfd360d4403caf7866291f6dead2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7e212023ac5f4762aaca5b3d89139de6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6d86b71f50834432b48b0b5ae6624d4c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i457c2ed3cca24d1090b72bce50a58a8f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2019ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39ef053676a74ed99cf89ae337acf080_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i816eb507d5a445f2b307f4498312546d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7a53e0c411d4dd6a1b3906051c59f59_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7eac47f0f662452bab570a31fb550c4d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i61e87163d7174e1794368f54fd79d68d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id311a3410b814d8098ed2e0909160625_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7bcf421c5b3484f9aaf9c80235ca4cc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i137caf5a65bd4e80a938b17ee3cb93f8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bc4aed180144198bb9d2155f7e854fe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1bc5c8ecc7b1431b9d38a50d36e09fed_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic46a8d26897645bcbf98e6b68bcaa6ab_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6b708b44785543eba9d88603d0d9fe17_D20150901-20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-01</startDate>
            <endDate>2015-09-30</endDate>
        </period>
    </context>
    <context id="i239659e8afed4074998fed4287d1015c_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2f40e9186eb64a12b2819fd50ddd4855_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d729505bb21466aa4b2151156e86b6c_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i68e8486eb69e4b6e9cc08fa79cc5e099_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ide99966f8de84c51b7647698c4934494_D20100301-20100331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-03-01</startDate>
            <endDate>2010-03-31</endDate>
        </period>
    </context>
    <context id="i16e78aa141ae465bafe3f1d21cf16785_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3e26862e568b4ada9e48b0f17370e14e_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i9b6c532a43a946b58847610daa31145e_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i8cd813fc670a4450aabfafc92190f440_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i698b2027f9de4d4a949b7a23b6119c7c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i975e062f55604508986037025ddd0a99_I20220330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="i342915fb33cf4e95b5ea927f1cf7228c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18f9080b9c994fa291b5e12c3b4813d0_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="employee">
        <measure>bmy:employee</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="creditfacility">
        <measure>bmy:creditFacility</measure>
    </unit>
    <unit id="customer">
        <measure>bmy:customer</measure>
    </unit>
    <unit id="patent">
        <measure>bmy:patent</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bmy:lawsuit</measure>
    </unit>
    <unit id="plaintiff">
        <measure>bmy:plaintiff</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF80LTEtMS0xLTExNzc1Ng_08dfb6f2-613e-44a6-8906-c95395618b89">0000014272</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF82LTEtMS0xLTExNzc1Ng_be868385-ec15-469b-b2cc-ae5e5e40c812">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF83LTEtMS0xLTExNzc1Ng_55f5dcb5-2f6a-4ca7-97c4-3a4910ae2f15">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF84LTEtMS0xLTExNzc1Ng_556a1632-1f2a-4b82-8e43-8f808019a85f">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF85LTEtMS0xLTExNzc1Ng_c10ed4ef-3d4c-45e8-9121-5b48ea8a70ec">false</dei:AmendmentFlag>
    <dei:EntitySmallBusiness
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180L2ZyYWc6YTQzMjY3ZGEwZGQ1NDgwNDk0Y2Y2ZjBjNjE3MGU1NmUvdGFibGU6N2MxMjAzODlhMTVkNGYyYzg2ZmVkNzg4Yzk4N2ExZDQvdGFibGVyYW5nZTo3YzEyMDM4OWExNWQ0ZjJjODZmZWQ3ODhjOTg3YTFkNF8xMC0xLTEtMS0xMTc3NTY_491f8fe4-dcd8-4a8c-b352-fe379efcb0cb">false</dei:EntitySmallBusiness>
    <dei:DocumentType
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU4_8d12313b-c2f8-445d-882c-27b338496af0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY3_25418c5e-08cc-4191-8974-f81dc1f06822">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNjc_1c44a388-6429-478d-a7fe-59b3469c8616">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU5_1ce52918-b767-46f8-bd7d-5f1dbeffe212">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYw_33a4e1b7-4735-4383-be6c-94aac08fe20f">001-01136</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYz_e32f53b7-15c2-40e0-a43a-2dddd8e743b4">BRISTOL-MYERS SQUIBB COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6MmM4ZDMxYWEzZDU2NDJkYjk0YzJlZmZhNWQxNTYzM2YvdGFibGVyYW5nZToyYzhkMzFhYTNkNTY0MmRiOTRjMmVmZmE1ZDE1NjMzZl8wLTAtMS0xLTExNzc1Ng_61549987-0237-4339-81b9-a5e268e3edae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6MmM4ZDMxYWEzZDU2NDJkYjk0YzJlZmZhNWQxNTYzM2YvdGFibGVyYW5nZToyYzhkMzFhYTNkNTY0MmRiOTRjMmVmZmE1ZDE1NjMzZl8wLTItMS0xLTExNzc1Ng_34d9ffc6-57f6-4b93-bd32-89df15118d05">22-0790350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY4_a331558a-ee3b-4ff8-b45a-ccf37e0419a4">430 E. 29th Street, 14FL</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcw_0eb5023c-7dde-48cd-bce1-a1fdb482c603">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDYy_999553f1-271f-475c-bf35-babb298173cf">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY5_8f028af5-c91d-4878-a817-83bdd04a88b1">10016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcx_2ee9bc84-2c4c-4be2-8574-754454be8cb7">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY0_c0dc3a34-caf6-49e5-94f5-6a554b3f92b2">546-4200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTAtMS0xLTExNzc1Ng_7e80b50b-5d9c-438f-990e-d6c247d1d725">Common Stock, $0.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTEtMS0xLTExNzc1Ng_74132e47-1ba8-40d9-9e3a-ccbd1b23b790">BMY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i341d840682bc4ba58890ec2076f87ca5_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8xLTItMS0xLTExNzc1Ng_c5816628-5e65-4033-a4d6-513d64545208">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTAtMS0xLTExNzc1Ng_b7b6c446-b1f0-463b-8e33-14778456fda6">1.000% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTEtMS0xLTExNzc1Ng_1300c661-5c02-4f66-b241-26168f98b92a">BMY25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i68e3823dddb74db2958072c745a03097_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8yLTItMS0xLTExNzc1Ng_c3b66435-2093-40b1-8acb-7102034709a2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTAtMS0xLTExNzc1Ng_3bdd5b88-ca9d-4a03-8971-e8aa2769e07b">1.750% Notes due 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTEtMS0xLTExNzc1Ng_40a3590c-7e52-408f-bd54-f5b984db7079">BMY35</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib3c5c47a115641de8c1770f011ba4cb3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl8zLTItMS0xLTExNzc1Ng_605880e4-2e7c-4979-b73a-6a1634246879">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTAtMS0xLTExNzc1Ng_7eecdf4e-8655-42d3-81ba-c67d0a50b965">Celgene Contingent Value Rights</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTEtMS0xLTExNzc1Ng_217078ee-5463-4e08-bfd8-d3497144d95b">CELG RT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ieb55395155d14d7299fde4387b827dc4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGFibGU6NzM5NmIzMTNjNmI1NDAxMmFlNzgzZWIzZDA5ODAyZGIvdGFibGVyYW5nZTo3Mzk2YjMxM2M2YjU0MDEyYWU3ODNlYjNkMDk4MDJkYl80LTItMS0xLTExNzc1Ng_c6526179-224f-44c5-8340-5fc770efa1d8">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcy_08406a02-1b2b-4123-a75a-e2d23777b1ac">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDcz_044f3eee-6d33-4610-b91e-e9ece7a6b2a2">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY1_0422c029-1257-4215-84c4-f9e5ec0a9705">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDU3_ef152d29-f155-447b-9775-365ea600c4b4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yNDY2_41f553ec-fac7-46ad-9a93-28574248f529">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ibffe096d269f4247ba0455fffac494c2_I20221014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xL2ZyYWc6NmJkMzI3ODhkMWM4NGIxOWIzNmQzMmI3MDcyMDk4Y2YvdGV4dHJlZ2lvbjo2YmQzMjc4OGQxYzg0YjE5YjM2ZDMyYjcwNzIwOThjZl8yMzg1_13fa147c-1b44-400e-990b-f4ec90cadd43"
      unitRef="shares">2126160347</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi0xLTEtMS0xMTc3NTY_511f73f5-73b9-4867-92be-e7483e255b3b"
      unitRef="usd">10813000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi0zLTEtMS0xMTc3NTY_2f04681e-f420-4c88-bc7a-1e8bea3dec06"
      unitRef="usd">11243000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi01LTEtMS0xMTc3NTY_77b48c80-5ba8-4f2b-95b9-864d0a440423"
      unitRef="usd">33606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMi03LTEtMS0xMTc3NTY_fc89a1cd-6452-4ea7-bdcd-c389e97e1c21"
      unitRef="usd">33446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c52b7c17b524a44903fa0bff0845939_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy0xLTEtMS0xMTc3NTY_983f59af-a27f-452d-b056-c0e31929a2c8"
      unitRef="usd">405000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3909832868c44962a2e1a7cf39c79c87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy0zLTEtMS0xMTc3NTY_4eacf81d-5339-4f50-9a4f-d6c7812426e4"
      unitRef="usd">381000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9dd8e6d78fde49408a97b0e2d733b6f0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy01LTEtMS0xMTc3NTY_cd21235f-1d8d-46be-919c-00ed37709e15"
      unitRef="usd">1147000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0a72bb56bec4e89876d1ea244b49e22_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMy03LTEtMS0xMTc3NTY_7bc1a095-2fdd-4064-a5f8-b321f96a171c"
      unitRef="usd">954000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC0xLTEtMS0xMTc3NTY_37482043-0afb-434a-b77f-2f15a9c00db9"
      unitRef="usd">11218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC0zLTEtMS0xMTc3NTY_db5b8744-8a88-4acc-beef-d937df09afd9"
      unitRef="usd">11624000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC01LTEtMS0xMTc3NTY_c90d8ce5-507a-41b3-a97b-340953b940d1"
      unitRef="usd">34753000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNC03LTEtMS0xMTc3NTY_cd609d04-3d41-410a-8693-21bfa6dce735"
      unitRef="usd">34400000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67"
      unitRef="usd">2353000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b"
      unitRef="usd">2291000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0"
      unitRef="usd">7544000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc"
      unitRef="usd">7584000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy0xLTEtMS0xMTc3NTY_a936db7b-9730-414b-8e60-56bcc38994dc"
      unitRef="usd">1930000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy0zLTEtMS0xMTc3NTY_ea9bd535-91e6-4d6d-b11e-7c93be014b3d"
      unitRef="usd">1788000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy01LTEtMS0xMTc3NTY_8238a064-d6da-4d8a-9ac6-393fd841825e"
      unitRef="usd">5548000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNy03LTEtMS0xMTc3NTY_d64b746e-6cfe-4aa7-ac4b-66ea8c80af4a"
      unitRef="usd">5336000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC0xLTEtMS0xMTc3NTY_439e1685-2ada-4a16-a6ca-badf504dd898"
      unitRef="usd">2418000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC0zLTEtMS0xMTc3NTY_182bf2f1-d857-473c-97ee-0dd17ef982b0"
      unitRef="usd">2980000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC01LTEtMS0xMTc3NTY_595be055-bf12-4b4d-b18f-846ab243d0bc"
      unitRef="usd">6999000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOC03LTEtMS0xMTc3NTY_4cc58bb5-d75f-4ed1-8857-a9a8135db9c1"
      unitRef="usd">7677000000</us-gaap:ResearchAndDevelopmentExpense>
    <bmy:AcquiredIPRD
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS0xLTEtMS0xMTc3NTY_8ddc1c85-b5ef-43d3-b1d8-187ff7567b04"
      unitRef="usd">30000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS0zLTEtMS0xMTc3NTY_325ee1a3-758b-4fc9-9589-74cfe9311c09"
      unitRef="usd">271000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS01LTEtMS0xMTc3NTY_25133c44-46ce-4ca1-95cf-475b46327dbc"
      unitRef="usd">763000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfOS03LTEtMS0xMTc3NTY_244990b6-4059-42b5-854d-8e65a26c48c8"
      unitRef="usd">1070000000</bmy:AcquiredIPRD>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtMS0xLTEtMTE3NzU2_fc8f967f-b05a-4927-a8ae-0f4419d29cdb"
      unitRef="usd">2418000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtMy0xLTEtMTE3NzU2_b935de85-3f12-48c2-a87a-3be9348d654e"
      unitRef="usd">2546000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtNS0xLTEtMTE3NzU2_0910914a-1bc0-4aad-b421-b06b0210df9b"
      unitRef="usd">7252000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTAtNy0xLTEtMTE3NzU2_0d1e43cb-4a8b-4a40-99fb-1311c4416eca"
      unitRef="usd">7606000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtMS0xLTEtMTE3NzU2_b62f6884-1baf-4d12-b38c-d2c200023c6f"
      unitRef="usd">140000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtMy0xLTEtMTE3NzU2_52bf4823-6413-40ab-b131-36e984d5a593"
      unitRef="usd">409000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtNS0xLTEtMTE3NzU2_a5196b9f-1072-406d-9a46-883c9ab1470e"
      unitRef="usd">-793000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTEtNy0xLTEtMTE3NzU2_7316c7b0-f9e9-434e-aa87-8e1b66366a85"
      unitRef="usd">1113000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItMS0xLTEtMTE3NzU2_5a037692-6756-4231-93b9-018b61a7d78c"
      unitRef="usd">9009000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItMy0xLTEtMTE3NzU2_5f026a2d-a9f3-4b6c-a56d-09ac0fa49a88"
      unitRef="usd">9467000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItNS0xLTEtMTE3NzU2_aeccf14a-f42c-478e-af1c-ef21e4250f21"
      unitRef="usd">28899000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTItNy0xLTEtMTE3NzU2_3247625e-c384-49b7-aa41-dfa4026d2e4f"
      unitRef="usd">28160000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtMS0xLTEtMTE3NzU2_a2adcfe5-18a6-4237-87fd-364228f77ae4"
      unitRef="usd">2209000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtMy0xLTEtMTE3NzU2_48b283a3-6af8-4ef4-9866-6ab952a3a7d7"
      unitRef="usd">2157000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtNS0xLTEtMTE3NzU2_a31baa79-0071-40bb-9ade-a096b2f6469c"
      unitRef="usd">5854000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTQtNy0xLTEtMTE3NzU2_142eb004-d081-4318-b914-ffd9111948dd"
      unitRef="usd">6240000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtMS0xLTEtMTE3NzU2_30d210fc-9104-4189-9fea-a72101d537e8"
      unitRef="usd">601000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtMy0xLTEtMTE3NzU2_9144edee-ee25-48d5-a0d7-ce952e790831"
      unitRef="usd">605000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtNS0xLTEtMTE3NzU2_9e9219a7-a48b-4b7f-bc7a-33dcbfb0580b"
      unitRef="usd">1534000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTUtNy0xLTEtMTE3NzU2_0728805e-4b52-4c59-a512-6d4c5eadd2d9"
      unitRef="usd">1598000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtMS0xLTEtMTE3NzU2_bf5d1320-86f2-47b7-bc88-3fe004b214db"
      unitRef="usd">1608000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtMy0xLTEtMTE3NzU2_a4eb7728-62d1-4eca-8d12-5e5ddfd9d157"
      unitRef="usd">1552000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtNS0xLTEtMTE3NzU2_a57c105c-c78f-48be-998d-5b15ae66a59d"
      unitRef="usd">4320000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTYtNy0xLTEtMTE3NzU2_1ab96859-98b0-4bd6-837f-d44234009610"
      unitRef="usd">4642000000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctMS0xLTEtMTE3NzU2_bb42b00c-504b-4506-9bf3-97a5cf3e698f"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctMy0xLTEtMTE3NzU2_41737f4b-474b-4284-a72d-7c52ffa9f0f3"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctNS0xLTEtMTE3NzU2_9396eb5f-76b5-4bc7-a65a-2973a756f51c"
      unitRef="usd">15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTctNy0xLTEtMTE3NzU2_9a2dea80-1ab5-462a-9f07-6d704f2092ec"
      unitRef="usd">20000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtMS0xLTEtMTE3NzU2_e2f341f1-e7a2-4275-9694-917ab79788d9"
      unitRef="usd">1606000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtMy0xLTEtMTE3NzU2_60cf0243-18f6-49a3-aa43-53538ceaa0bd"
      unitRef="usd">1546000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtNS0xLTEtMTE3NzU2_3d314cd2-2e6a-4a27-9970-5aefdeec0349"
      unitRef="usd">4305000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMTgtNy0xLTEtMTE3NzU2_51a702b9-cbbc-43e5-915f-2f8135392479"
      unitRef="usd">4622000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtMS0xLTEtMTE3NzU2_07821a8f-8da9-4757-a1fd-3c09287a779b"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtMy0xLTEtMTE3NzU2_5fa61ff7-3055-4fe8-ae7d-7edc577fca98"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtNS0xLTEtMTE3NzU2_474b2c88-be1e-4cc3-8ce9-6d7cb40e433f"
      unitRef="usdPerShare">2.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjEtNy0xLTEtMTE3NzU2_202b307e-332b-4588-9738-9b7f8b4f4d54"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItMS0xLTEtMTE3NzU2_b5d974d4-0ad6-4204-96f7-8cafa2a2ce1d"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItMy0xLTEtMTE3NzU2_eed7092b-bc64-478f-8f46-114d56d3a5c9"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItNS0xLTEtMTE3NzU2_522a0004-7fcd-49bb-811b-430979267bb0"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfMjItNy0xLTEtMTE3NzU2_30122e23-d91c-462b-b8e2-3f8dd38e03a2"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi0xLTEtMS0xMTc3NTY_2ea8ff28-8dce-4ed3-9402-65d00dc3155e"
      unitRef="usd">1608000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi0zLTEtMS0xMTc3NTY_3514385c-8720-4044-a134-066692404331"
      unitRef="usd">1552000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi01LTEtMS0xMTc3NTY_69956704-590c-4736-ad76-6192cc7f0a16"
      unitRef="usd">4320000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMi03LTEtMS0xMTc3NTY_883f9ba3-ccba-46f3-bdf4-10d3143ee6fd"
      unitRef="usd">4642000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC0xLTEtMS0xMTc3NTY_8a8efcf0-aa00-496e-ad84-29b3e92c95f8"
      unitRef="usd">286000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC0zLTEtMS0xMTc3NTY_97811a5a-63f0-4894-bb5a-c6dc77eebf6b"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC01LTEtMS0xMTc3NTY_4648852e-d2a7-49eb-9643-9b1d776bb9d0"
      unitRef="usd">618000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC01LTEtMS0xMTc3NTY_6b2fee47-7732-49bb-88b3-3572350d7157"
      unitRef="usd">618000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNC03LTEtMS0xMTc3NTY_2f6cefe9-7680-4958-86d6-ffaa92002d81"
      unitRef="usd">399000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS0xLTEtMS0xMTc3NTY_b3d178d4-c55e-47a1-a5ef-97cf3e239fd8"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS0zLTEtMS0xMTc3NTY_44999901-f53e-4196-b564-8352f2bc96f8"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS01LTEtMS0xMTc3NTY_bad60823-84fa-44c2-917a-b7a16d6e93c1"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS01LTEtMS0xMTc3NTY_f39a7c2f-8023-41ea-b94f-583480806dae"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNS03LTEtMS0xMTc3NTY_9491cd64-0e31-4d02-a098-f0e57d66fe12"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi0xLTEtMS0xMTc3NTY_603f47ae-199a-4afd-b916-e4e2b622d45c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi0zLTEtMS0xMTc3NTY_05fd7662-6569-4b49-9c18-0573818c3cac"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi01LTEtMS0xMTc3NTY_ac6348f0-8681-4970-b70f-a2ee8f620895"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNi03LTEtMS0xMTc3NTY_b2e9b68c-c8b9-4eb8-9493-b4f919895436"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy0xLTEtMS0xMTc3NTY_de2bcaec-c17a-4ed1-986a-0745e298aa25"
      unitRef="usd">-153000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy0zLTEtMS0xMTc3NTY_d88e152f-7e8e-4935-a449-d2a953e5037c"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy01LTEtMS0xMTc3NTY_3620d4ec-a2b3-4043-9942-0d7acb32da34"
      unitRef="usd">-253000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy01LTEtMS0xMTc3NTY_8ec9885c-d7d0-4f28-a30a-f4da743baa25"
      unitRef="usd">-253000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfNy03LTEtMS0xMTc3NTY_3834cd16-8648-4348-aa4a-1b089180e46b"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC0xLTEtMS0xMTc3NTY_2cd18e53-b8c9-4841-9d82-2b5a7b7278ff"
      unitRef="usd">151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC0zLTEtMS0xMTc3NTY_bea9892d-5dc5-4177-835b-47cb2b984abb"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC01LTEtMS0xMTc3NTY_03cf6446-0337-498f-96e9-9e08f356b918"
      unitRef="usd">427000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfOC03LTEtMS0xMTc3NTY_c3810eea-2b2d-4202-8b32-b9d1bdde870c"
      unitRef="usd">415000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtMS0xLTEtMTE3NzU2_8cc78c45-41a2-4d29-a903-6dc07c51409e"
      unitRef="usd">1759000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtMy0xLTEtMTE3NzU2_28280a9b-0709-4333-b5f2-48f3adf69047"
      unitRef="usd">1646000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtNS0xLTEtMTE3NzU2_173e9b61-aef8-4840-976b-deee690a3a59"
      unitRef="usd">4747000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTAtNy0xLTEtMTE3NzU2_13fdfd99-52fc-45ca-a3e3-104f06170c98"
      unitRef="usd">5057000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtMS0xLTEtMTE3NzU2_bb42b00c-504b-4506-9bf3-97a5cf3e698f"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtMy0xLTEtMTE3NzU2_41737f4b-474b-4284-a72d-7c52ffa9f0f3"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtNS0xLTEtMTE3NzU2_9396eb5f-76b5-4bc7-a65a-2973a756f51c"
      unitRef="usd">15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTEtNy0xLTEtMTE3NzU2_9a2dea80-1ab5-462a-9f07-6d704f2092ec"
      unitRef="usd">20000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItMS0xLTEtMTE3NzU2_67cecd26-bf1f-4ae6-98a0-21d8109b64df"
      unitRef="usd">1757000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItMy0xLTEtMTE3NzU2_51f96c87-ed01-43c8-8d36-164530833549"
      unitRef="usd">1640000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItNS0xLTEtMTE3NzU2_ff9f3ff1-a1d9-4604-b291-44692add9744"
      unitRef="usd">4732000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjRkOWVjNjEzOTY4YTQyOWI4M2JkMGI5MGVmOTg2ODM4L3RhYmxlcmFuZ2U6NGQ5ZWM2MTM5NjhhNDI5YjgzYmQwYjkwZWY5ODY4MzhfMTItNy0xLTEtMTE3NzU2_2683433f-88cc-4ae5-a266-dde7dabd7bd6"
      unitRef="usd">5037000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMi0xLTEtMS0xMTc3NTY_8f47ee27-6b84-4c4e-abb4-e081faad48d7"
      unitRef="usd">7734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMi0zLTEtMS0xMTc3NTY_fc4a41a3-4df9-4ac6-bbcb-1988ca15a5ee"
      unitRef="usd">13979000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMy0xLTEtMS0xMTc3NTY_022250e2-e74d-4a27-ba51-591c4fbe5684"
      unitRef="usd">1293000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMy0zLTEtMS0xMTc3NTY_e2b4d8d1-3af7-446e-9d0c-b73bd3b0e67d"
      unitRef="usd">2987000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNC0xLTEtMS0xMTc3NTY_ec04a636-7426-4429-b898-498279bcc678"
      unitRef="usd">9613000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNC0zLTEtMS0xMTc3NTY_53ed4554-1735-46e8-bdab-61822d00ffb5"
      unitRef="usd">9369000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNS0xLTEtMS0xMTc3NTY_0fdc5c4d-3d07-4d3e-8497-2a30268fc3e1"
      unitRef="usd">2074000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNS0zLTEtMS0xMTc3NTY_450b17b0-512f-4802-8253-38f5e2a23b8c"
      unitRef="usd">2095000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNi0xLTEtMS0xMTc3NTY_fb3b5152-bec5-490d-8eb2-e2e317aecc81"
      unitRef="usd">6082000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNi0zLTEtMS0xMTc3NTY_bfe7f9d0-9214-44ca-bb90-7277e12ff077"
      unitRef="usd">4832000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNy0xLTEtMS0xMTc3NTY_5e0f4de8-3702-4dc0-b41f-019345144766"
      unitRef="usd">26796000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNy0zLTEtMS0xMTc3NTY_1352d0e6-e704-4def-8b2d-bd9c7ef34f18"
      unitRef="usd">33262000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOC0xLTEtMS0xMTc3NTY_8cd6b169-6d5c-44b0-b7e3-d1397b9aecc1"
      unitRef="usd">6035000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOC0zLTEtMS0xMTc3NTY_709736e8-08b1-4b88-885e-6d2a5d7db7dd"
      unitRef="usd">6049000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOS0xLTEtMS0xMTc3NTY_b9d35f14-fcce-482c-9079-955de159804a"
      unitRef="usd">21112000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfOS0zLTEtMS0xMTc3NTY_73ebfc34-4ad2-4eea-b04d-3cbbb19c732c"
      unitRef="usd">20502000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTAtMS0xLTEtMTE3NzU2_dc026477-6d75-4855-95fd-f4912e3cf818"
      unitRef="usd">38179000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTAtMy0xLTEtMTE3NzU2_991b688c-5023-46be-a83b-ecaa78fcca17"
      unitRef="usd">42527000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTEtMS0xLTEtMTE3NzU2_2de19ce2-1213-4aef-bdf8-e042b55801b6"
      unitRef="usd">1329000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTEtMy0xLTEtMTE3NzU2_862793c6-cb94-4db7-8a6d-bb339ec9d439"
      unitRef="usd">1439000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTMtMS0xLTEtMTE3NzU2_c000ec0e-4ea1-4597-a2d5-2f146bb3eb59"
      unitRef="usd">4745000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTMtMy0xLTEtMTE3NzU2_f1eef5e1-7040-4d94-b205-c57152e38be1"
      unitRef="usd">5535000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTQtMS0xLTEtMTE3NzU2_44853d22-58f3-4364-a859-99cdb7b42b41"
      unitRef="usd">98196000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTQtMy0xLTEtMTE3NzU2_8a68fcde-daa3-41a3-af59-457feefa3ae3"
      unitRef="usd">109314000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTgtMS0xLTEtMTE3NzU2_16e8a356-9f45-462c-8220-992d372ffd67"
      unitRef="usd">2132000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTgtMy0xLTEtMTE3NzU2_81f98954-c61f-41a1-a935-8049008d481a"
      unitRef="usd">4948000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTktMS0xLTEtMTE3NzU2_dd93d10e-a1ed-49ed-9762-3b4bc22d3cf3"
      unitRef="usd">2595000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMTktMy0xLTEtMTE3NzU2_bb106c91-5075-4757-a6cf-d3494bd6355b"
      unitRef="usd">2949000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjAtMS0xLTEtMTE3NzU2_20de9d00-f033-4a8e-88e6-4f2438ec6f0f"
      unitRef="usd">14203000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjAtMy0xLTEtMTE3NzU2_d49f9ccf-69b7-47cb-8684-fe06f0bb9cd4"
      unitRef="usd">13971000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjEtMS0xLTEtMTE3NzU2_09398544-bd92-48e1-8e74-88c2cee44a39"
      unitRef="usd">18930000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjEtMy0xLTEtMTE3NzU2_cf3eb837-3992-4fbd-a91e-c8507cb57948"
      unitRef="usd">21868000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjItMS0xLTEtMTE3NzU2_7e24b178-04e2-46a1-8cb8-4b4e89d0f139"
      unitRef="usd">2881000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjItMy0xLTEtMTE3NzU2_af42afe2-ad92-4021-a036-1c2c35078643"
      unitRef="usd">4501000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjMtMS0xLTEtMTE3NzU2_d2e3499a-6fd4-4fd4-943d-646d2a8e7e94"
      unitRef="usd">36966000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjMtMy0xLTEtMTE3NzU2_7b15e0c1-21f7-40a9-96a0-3a4a493e2ded"
      unitRef="usd">39605000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjQtMS0xLTEtMTE3NzU2_abdbae19-d929-47f7-835f-8eecee9a76ef"
      unitRef="usd">6685000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjQtMy0xLTEtMTE3NzU2_a243fd73-efb3-4d3f-aa66-ab1d2d344c93"
      unitRef="usd">7334000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjUtMS0xLTEtMTE3NzU2_9bb5697e-d786-4b04-a6d0-172beb8b4618"
      unitRef="usd">65462000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjUtMy0xLTEtMTE3NzU2_0b13ced1-c0a2-4caf-90f5-0498b0a6897b"
      unitRef="usd">73308000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjctMS0xLTEtMTMwNDYw_eb11afd6-08e4-4aec-96b2-124a042933f6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMjctMy0xLTEtMTMwNDYx_1e6fa3cd-4658-4bb2-942e-a4ea03e04cb4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzEtMS0xLTEtMTE3NzU2_ce76107b-1d84-495c-be4b-304d906fc5f1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzEtMy0xLTEtMTE3NzU2_95867fab-93a9-41de-8280-dd22159f8f85"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzItMS0xLTEtMTE3NzU2_705be61f-0109-4ac6-994b-06cce03f1d24"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzItMy0xLTEtMTE3NzU2_bcf4333f-e0bb-4853-8660-fdacd58417e1"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzMtMS0xLTEtMTE3NzU2_37a452d2-2cce-435a-9f8c-5e3938458fe2"
      unitRef="usd">44956000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzMtMy0xLTEtMTE3NzU2_386c9895-bc7f-4759-81cf-69fc9afc8633"
      unitRef="usd">44361000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzQtMS0xLTEtMTE3NzU2_b31c9c7c-e8c5-4012-a94c-9a9b104b7c5f"
      unitRef="usd">-841000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzQtMy0xLTEtMTE3NzU2_7965820e-1f75-4b13-84e9-12d164e0b9e3"
      unitRef="usd">-1268000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzUtMS0xLTEtMTE3NzU2_8c9f1116-d5de-46e6-a5d2-6adf4a96bfe9"
      unitRef="usd">24675000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzUtMy0xLTEtMTE3NzU2_f7f8d8b9-0e52-44a4-95d9-a74e5d20f7f0"
      unitRef="usd">23820000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzYtMS0xLTEtMTE3NzU2_489acc98-8a25-471b-afeb-b69b9f0979fa"
      unitRef="usd">36411000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzYtMy0xLTEtMTE3NzU2_e1a2d0b2-08cd-47e7-b22d-110060d33393"
      unitRef="usd">31259000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzctMS0xLTEtMTE3NzU2_a879177b-d605-4665-af8d-08b8ee6266b8"
      unitRef="usd">32671000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzctMy0xLTEtMTE3NzU2_77f85c34-ac33-4d23-bfe4-775610857acb"
      unitRef="usd">35946000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzgtMS0xLTEtMTE3NzU2_6617ed0f-d02e-45a1-90db-98ffe2919cbf"
      unitRef="usd">63000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzgtMy0xLTEtMTE3NzU2_e7c05397-b22d-46cd-9afc-1de3d65d7787"
      unitRef="usd">60000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzktMS0xLTEtMTE3NzU2_c199cfd9-b266-467e-883a-43104ae9f1e1"
      unitRef="usd">32734000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfMzktMy0xLTEtMTE3NzU2_a973ae15-a331-4103-b3db-8821e2190e66"
      unitRef="usd">36006000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNDAtMS0xLTEtMTE3NzU2_58bc12ed-92e7-4e15-8795-58aadb00909d"
      unitRef="usd">98196000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xOS9mcmFnOmJhZmQ5OWQxMGYzNDQwMmM4YjI2MTc0Mjg5YjNiMDZkL3RhYmxlOjE4NmY4ZWYzNjI3NDQxMWM4OGU5Y2UwMDYxZDA3ZGRiL3RhYmxlcmFuZ2U6MTg2ZjhlZjM2Mjc0NDExYzg4ZTljZTAwNjFkMDdkZGJfNDAtMy0xLTEtMTE3NzU2_5ac47c98-fcb8-46a5-b312-29c46e20952c"
      unitRef="usd">109314000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMy0xLTEtMS0xMTc3NTY_c6547e7b-6a48-4648-bad1-1e39eb86f1c2"
      unitRef="usd">4320000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMy0zLTEtMS0xMTc3NTY_d473a20c-9450-449f-a7f8-8c2bb1d9d754"
      unitRef="usd">4642000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNS0xLTEtMS0xMTc3NTY_6fdde5d8-81c3-42b9-be70-03ce56df0823"
      unitRef="usd">7755000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNS0zLTEtMS0xMTc3NTY_5da3b854-3793-403c-8e13-de55702ab57e"
      unitRef="usd">8107000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNi0xLTEtMS0xMTc3NTY_d7e35267-1c6e-4918-b074-9a1de5c498fc"
      unitRef="usd">-2114000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNi0zLTEtMS0xMTc3NTY_11cf6787-77df-4e9d-b458-e56f5e31b8fa"
      unitRef="usd">-127000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNy0xLTEtMS0xMTc3NTY_3a9b6f93-4c2a-497b-84b1-393435b26ba1"
      unitRef="usd">338000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNy0zLTEtMS0xMTc3NTY_314ed7c6-f764-47e9-814c-786b7b76c49a"
      unitRef="usd">450000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfOC0xLTEtMS0xMTc3NTY_da9455d0-2085-4b9f-9a49-36d091ddd2d0"
      unitRef="usd">144000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfOC0zLTEtMS0xMTc3NTY_c03a103d-7467-461d-98c3-5263c41e4702"
      unitRef="usd">1192000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <bmy:Divestituregainsandroyalties
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTAtMS0xLTEtMTE3NzU2_ed75c6e3-f48c-47b3-b832-8c7bee55474b"
      unitRef="usd">820000000</bmy:Divestituregainsandroyalties>
    <bmy:Divestituregainsandroyalties
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTAtMy0xLTEtMTE3NzU2_7d2ae9a0-f622-4e1f-acdb-446f3aae9185"
      unitRef="usd">462000000</bmy:Divestituregainsandroyalties>
    <bmy:AcquiredIPRD
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTEtMS0xLTEtMTE3NzU2_0dc065bd-86e9-44d9-b584-f4f4285179f9"
      unitRef="usd">763000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTEtMy0xLTEtMTE3NzU2_39a68296-1b68-4c9d-becb-4349c85215d8"
      unitRef="usd">1070000000</bmy:AcquiredIPRD>
    <us-gaap:GainLossOnInvestments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTItMS0xLTEtMTE3NzU2_1614e33e-947f-4801-9d48-42398b0df6ce"
      unitRef="usd">-966000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTItMy0xLTEtMTE3NzU2_00e08e87-0617-4635-9a64-940fb4356dab"
      unitRef="usd">1214000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTMtMS0xLTEtMTE3NzU2_4a3b7e63-b87b-43fa-b30d-cd809c8d9d9e"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTMtMy0xLTEtMTE3NzU2_dc41df63-b1e4-4b60-803e-b70da86d80c3"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTQtMS0xLTEtMTE3NzU2_3da6de44-d4ec-4f71-b5f4-49297c5e533b"
      unitRef="usd">-178000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTQtMy0xLTEtMTE3NzU2_acba2974-5b0b-4f09-827c-aad6f60ee8dc"
      unitRef="usd">-204000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTYtMS0xLTEtMTE3NzU2_0638aed5-23e1-471e-9a6f-2c160cc3edd3"
      unitRef="usd">557000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTYtMy0xLTEtMTE3NzU2_ed7a1bd3-b581-4021-88e4-0a566434ef8a"
      unitRef="usd">886000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTctMS0xLTEtMTE3NzU2_36f45690-c733-4d49-8093-e656157315e8"
      unitRef="usd">28000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTctMy0xLTEtMTE3NzU2_3e72b17f-6d40-4c0b-a061-1ae340ce09f9"
      unitRef="usd">-141000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTgtMS0xLTEtMTE3NzU2_cd446442-e003-4ec8-9361-3335b19d6381"
      unitRef="usd">-296000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTgtMy0xLTEtMTE3NzU2_8249031e-f3c0-4fc2-b036-3b80c6c348f5"
      unitRef="usd">19000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTktMS0xLTEtMTE3NzU2_7f6ef0f9-ad7b-41e5-8e4b-24d55f1932c8"
      unitRef="usd">730000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMTktMy0xLTEtMTE3NzU2_4b450893-2c7b-4461-bff4-953257925f81"
      unitRef="usd">902000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjAtMS0xLTEtMTE3NzU2_514dc2cd-52c1-482f-a663-ae2ba441dbd2"
      unitRef="usd">-310000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjAtMy0xLTEtMTE3NzU2_181a2684-089e-40ff-9aa9-706d8f14ad8c"
      unitRef="usd">-841000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjEtMS0xLTEtMTE3NzU2_f7478169-961f-42ec-8704-e333f00d6941"
      unitRef="usd">1310000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjEtMy0xLTEtMTE3NzU2_c0d5d911-f716-4b3f-a9e9-c420862e2b4e"
      unitRef="usd">537000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjItMS0xLTEtMTE3NzU2_a1681b97-a43a-4c98-b150-1951472e8aef"
      unitRef="usd">9760000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjItMy0xLTEtMTE3NzU2_138ee17e-aa4a-44c8-be82-6ee37ff6ff9b"
      unitRef="usd">12150000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjQtMS0xLTEtMTE3NzU2_7c538f68-0309-47f7-b1c1-47dd74b492f6"
      unitRef="usd">5205000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjQtMy0xLTEtMTE3NzU2_121ece48-93d9-4f24-b5f0-5c2f1eaa447f"
      unitRef="usd">2952000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjUtMS0xLTEtMTE3NzU2_389ced07-a278-427c-856b-e93237e12ec1"
      unitRef="usd">3566000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjUtMy0xLTEtMTE3NzU2_1bc19abf-60a3-4414-94fb-b17a55493274"
      unitRef="usd">3408000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjYtMS0xLTEtMTE3NzU2_3ffbc294-380d-4026-8071-8c4c1fb601ee"
      unitRef="usd">213000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjYtMy0xLTEtMTE3NzU2_b90090ed-8006-42ce-b6c8-db48ce956121"
      unitRef="usd">1058000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjctMS0xLTEtMTE3NzU2_db3df891-e33e-4cdb-b0e6-36c64d616603"
      unitRef="usd">772000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjctMy0xLTEtMTE3NzU2_49e696fb-7f6a-4ee2-bbcd-373a6b3b5e65"
      unitRef="usd">653000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <bmy:Divestitureandotherproceeds
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjgtMS0xLTEtMTE3NzU2_78a31e1c-1524-4df8-b40f-2a350c9ea444"
      unitRef="usd">815000000</bmy:Divestitureandotherproceeds>
    <bmy:Divestitureandotherproceeds
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjgtMy0xLTEtMTE3NzU2_c72de2ca-81e0-4c97-b417-ab98e3165b50"
      unitRef="usd">570000000</bmy:Divestitureandotherproceeds>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjktMS0xLTEtMTE3NzU2_e363ee45-0be7-46e3-9010-ad7eb597c143"
      unitRef="usd">4170000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMjktMy0xLTEtMTE3NzU2_8b4cd82a-1085-4deb-8dc8-34a321116fef"
      unitRef="usd">1458000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzAtMS0xLTEtMTE3NzU2_62f879bd-7c9b-4b14-8de2-cf8da6e33fb9"
      unitRef="usd">-2275000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzAtMy0xLTEtMTE3NzU2_42fba857-4b79-45ac-8407-8abd819c0f26"
      unitRef="usd">-939000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzItMS0xLTEtMTE3NzU2_1ae48b32-7fcd-4f8d-b751-6d3bd03e907d"
      unitRef="usd">58000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzItMy0xLTEtMTE3NzU2_a32a3cd3-2836-4a8b-86b3-fe5d96930850"
      unitRef="usd">-46000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzMtMS0xLTEtMTE3NzU2_acc7870d-7cef-4d10-97b2-4723fa703c39"
      unitRef="usd">5926000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzMtMy0xLTEtMTE3NzU2_8d7be933-f84d-44e5-b08d-479af7af5d73"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzQtMS0xLTEtMTE3NzU2_6696a30f-fcfd-40fa-bd7d-0ddfcbb9ecf7"
      unitRef="usd">11431000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzQtMy0xLTEtMTE3NzU2_f9dd4f0f-084e-49b8-a007-4b3ca66cdc6a"
      unitRef="usd">6022000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzUtMS0xLTEtMTE3NzU2_426c9a81-0232-4f84-a6b3-60349357e69c"
      unitRef="usd">5585000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzUtMy0xLTEtMTE3NzU2_93128c34-772e-4dc0-a02e-cf8100aedb87"
      unitRef="usd">3536000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzYtMS0xLTEtMTE3NzU2_e83e69da-81fc-4f7d-a887-384aabccf98f"
      unitRef="usd">3489000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzYtMy0xLTEtMTE3NzU2_af48cdf4-7738-410c-be19-34d9b286cec2"
      unitRef="usd">3297000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzctMS0xLTEtMTE3NzU2_d2dde167-6786-4856-bb07-b8dfa6891857"
      unitRef="usd">805000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzctMy0xLTEtMTE3NzU2_b78542f1-8688-4667-b979-4af30c5141cb"
      unitRef="usd">644000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzgtMS0xLTEtMTE3NzU2_94ff8ac5-d59d-4e69-90e1-457b91112765"
      unitRef="usd">-13716000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzgtMy0xLTEtMTE3NzU2_45d78364-e205-4ee1-b97c-09db7b431cd7"
      unitRef="usd">-12257000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzktMS0xLTEtMTE3NzU2_8074ac8b-189d-425b-bc50-bdecac28f228"
      unitRef="usd">-128000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfMzktMy0xLTEtMTE3NzU2_8f91e10b-5513-4425-ac72-cc61c45c71bf"
      unitRef="usd">-48000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDAtMS0xLTEtMTE3NzU2_c519048e-22ab-413a-9736-5bbd80edfa1c"
      unitRef="usd">-6359000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDAtMy0xLTEtMTE3NzU2_f71da576-ba71-46a3-8c27-be5ebc6f984d"
      unitRef="usd">-1094000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDEtMS0xLTEtMTE3NzU2_88e221b3-5db9-4913-ad3d-ce8f522b2ae6"
      unitRef="usd">14316000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if781377a20f34a65860112e032558c03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDEtMy0xLTEtMTE3NzU2_733d402f-7914-4f2e-a9ca-f7b4b7b360ed"
      unitRef="usd">14973000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDItMS0xLTEtMTE3NzU2_79f17507-6488-4395-bdea-ca0325f9ee18"
      unitRef="usd">7957000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yNS9mcmFnOjY2ZGY1NGZmNmIzNTQzMjNhMTE2YWUzNzhiOWUyMGY1L3RhYmxlOmM4NDg4ZjVmNDIxMzQ1ZTE5MGRhOGM3Yzc1NzRkOGQwL3RhYmxlcmFuZ2U6Yzg0ODhmNWY0MjEzNDVlMTkwZGE4YzdjNzU3NGQ4ZDBfNDItMy0xLTEtMTE3NzU2_706d38b5-92d2-426b-a553-572c896dcdd2"
      unitRef="usd">13879000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18yOC9mcmFnOmYwYjE0ZjM2ODcwNTRlY2Q4MGY2N2RkYmUzYjIyYzcyL3RleHRyZWdpb246ZjBiMTRmMzY4NzA1NGVjZDgwZjY3ZGRiZTNiMjJjNzJfNzY_fcc3abdb-df7d-4492-ad1d-55ade3c79482">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;, "we" or &#x201c;the Company&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position as of September&#160;30, 2022 and December&#160;31, 2021, the results of operations for the three and nine months ended September&#160;30, 2022 and 2021, and cash flows for the nine months ended September&#160;30, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Upfront and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statements of earnings. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows are now presented separately in Rebates and discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective basis. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY0NQ_2ea5e393-ef3d-4764-bb2f-1988e46221ce">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;, "we" or &#x201c;the Company&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position as of September&#160;30, 2022 and December&#160;31, 2021, the results of operations for the three and nine months ended September&#160;30, 2022 and 2021, and cash flows for the nine months ended September&#160;30, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTYzNw_17bb9cdd-9053-45e1-9c20-97a0c4780b5e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue&#x201d;.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY1OQ_ad238467-3a49-4461-9ddf-a9232898cca0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTYzMw_187945ae-1c47-49a6-bfbb-968ec2630a0d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Upfront and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statements of earnings. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows are now presented separately in Rebates and discounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zMS9mcmFnOjUxOGIyN2NiMmUyNjRmMzQ4OWUyMTYwOGM0MDI1MjMzL3RleHRyZWdpb246NTE4YjI3Y2IyZTI2NGYzNDg5ZTIxNjA4YzQwMjUyMzNfNTY1Mw_4784874a-4420-4a77-9630-a71b577ae706">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective basis. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTk1_859a378a-8626-4922-8be9-f4baacb530af">REVENUE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $10 million and $207 million for the three and nine months ended September&#160;30, 2022, and $10&#160;million and $282&#160;million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Camzyos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sotyktu&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products and New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Recent LOE Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from performance obligations satisfied in prior periods was $119 million and $450 million for the three and nine months ended September&#160;30, 2022 and $73&#160;million and $463&#160;million for the three and nine months ended September&#160;30, 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTg5_ce3b7486-f61a-4d01-b9bd-cb0be5f89113">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi0xLTEtMS0xMTc3NTY_511f73f5-73b9-4867-92be-e7483e255b3b"
      unitRef="usd">10813000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi0zLTEtMS0xMTc3NTY_2f04681e-f420-4c88-bc7a-1e8bea3dec06"
      unitRef="usd">11243000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi01LTEtMS0xMTc3NTY_77b48c80-5ba8-4f2b-95b9-864d0a440423"
      unitRef="usd">33606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMi03LTEtMS0xMTc3NTY_fc89a1cd-6452-4ea7-bdcd-c389e97e1c21"
      unitRef="usd">33446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy0xLTEtMS0xMTc3NTY_128474f1-9515-4aa4-8d49-b612aefff71a"
      unitRef="usd">173000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy0zLTEtMS0xMTc3NTY_15d61c0c-4a23-4550-9686-918a27881263"
      unitRef="usd">194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy01LTEtMS0xMTc3NTY_f64f0c2c-43e9-4425-874a-3addd2680d72"
      unitRef="usd">560000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfMy03LTEtMS0xMTc3NTY_dfbc80f1-62fd-4037-b70c-e23c647daa79"
      unitRef="usd">495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i29266ae9af704e83ac646ebb6641fdb3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC0xLTEtMS0xMTc3NTY_1beb61ab-a6a4-4300-a980-f4faaee38afd"
      unitRef="usd">232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica0e3fbf1cf94fffa908248b335d98b8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC0zLTEtMS0xMTc3NTY_5ace8fd3-5d30-47ab-acab-74de67ea57a2"
      unitRef="usd">187000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02073132d0574931b33a0f63b07ca3c0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC01LTEtMS0xMTc3NTY_1b1b9fb0-4274-4d52-ad54-9669f894629b"
      unitRef="usd">587000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01cb0332a64c4a85999046b2d17073fe_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNC03LTEtMS0xMTc3NTY_ea7b5626-8294-48ef-985d-4918e3e9010f"
      unitRef="usd">459000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS0xLTEtMS0xMTc3NTY_b98df12d-17cd-45b9-a554-e11f7a7a10ef"
      unitRef="usd">11218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS0zLTEtMS0xMTc3NTY_2414dc8e-7c55-4c9b-9459-70c663dfb337"
      unitRef="usd">11624000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS01LTEtMS0xMTc3NTY_9c169704-5356-4cab-b8e0-3613b6121f74"
      unitRef="usd">34753000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjQ3MjNmOGNlNzg2YjRmMThiMzcwN2U3N2ZiNmQ5MDU2L3RhYmxlcmFuZ2U6NDcyM2Y4Y2U3ODZiNGYxOGIzNzA3ZTc3ZmI2ZDkwNTZfNS03LTEtMS0xMTc3NTY_dc43ae96-aeca-48b7-ab02-5a59e40c4a95"
      unitRef="usd">34400000000</us-gaap:Revenues>
    <bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfOTk0_d165dac7-763c-427c-aa3c-6320dff0d5af">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $10 million and $207 million for the three and nine months ended September&#160;30, 2022, and $10&#160;million and $282&#160;million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock>
    <us-gaap:Revenues
      contextRef="i044c0c7286a4460da3d4eeeba42cb69c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi0xLTEtMS0xMTc3NTY_403e36ab-aea0-4b19-b4fc-d8db3ed182fb"
      unitRef="usd">17606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2bc4b8be12534b2b9d7fa10bb00ae5c7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi0zLTEtMS0xMTc3NTY_d02e9d2b-c8cf-48c7-891f-09b92559b6d1"
      unitRef="usd">17335000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62bd0e6d660744a88a4153646993b3ad_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi01LTEtMS0xMTc3NTY_13fb0800-ce67-4f34-b015-39dd3e2cf1b7"
      unitRef="usd">51555000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28a5899d8d1b4d3e8ecbde0564615570_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfMi03LTEtMS0xMTc3NTY_10250209-258d-4146-b250-0a5ffe433b37"
      unitRef="usd">49676000000</us-gaap:Revenues>
    <bmy:GrosstoNetAdjustments
      contextRef="id23693b7b08249d3aa12050a006f0001_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC0xLTEtMS0xMTc3NTY_1065e1d8-f2dd-4991-9b5d-c5ca27674784"
      unitRef="usd">1907000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i5e2e1abbc7064f37a17916a3c0555574_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC0zLTEtMS0xMTc3NTY_0477176f-7768-43c9-945e-7ae55bbb6dcc"
      unitRef="usd">1908000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i6434d519a5ea436c9fdf8a130125e12f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC01LTEtMS0xMTc3NTY_63c14e99-03e0-4bcf-8f59-1921e5d4a446"
      unitRef="usd">5420000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i04800f144c48480496199f7f1dcbef22_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNC03LTEtMS0xMTc3NTY_05b1ac3b-67f7-45ec-ae08-f54827384f72"
      unitRef="usd">5214000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i0af3648fd4884c20a605f122dfd20cc2_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS0xLTEtMS0xMTc3NTY_6c18d9da-09af-44ea-87bc-23669e3c74f4"
      unitRef="usd">3295000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i43278271a0ff474380032a771a7b1743_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS0zLTEtMS0xMTc3NTY_bf34f394-d134-4bea-84aa-31d6385f09ae"
      unitRef="usd">2625000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i2ec69e1d136440a8a76da2507fd0f758_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS01LTEtMS0xMTc3NTY_dd54dbaf-e707-4fc2-b73e-a71d33966224"
      unitRef="usd">8003000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i2c166558cb7b467fb2cb4a39347b1703_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNS03LTEtMS0xMTc3NTY_bcd4c3e0-3d1c-4954-b3a9-a73e9fdccd87"
      unitRef="usd">6482000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ib9a53451866344aabc76f70abaf649a0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi0xLTEtMS0xMTc3NTY_b98ccf3d-5430-4033-b9f2-5005afc260f8"
      unitRef="usd">1591000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i697262196a73456d97438e0a8c0db01c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi0zLTEtMS0xMTc3NTY_3e1a9435-ae3c-4238-9546-45cdfd8403bb"
      unitRef="usd">1559000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ied4473234acb4698a92ec39a59dd736a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi01LTEtMS0xMTc3NTY_872d448e-49dd-4e25-86a5-bfa2ffdafc72"
      unitRef="usd">4526000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i6b29234dfee8455eae5c6cd393e05ad6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNi03LTEtMS0xMTc3NTY_8b191159-b32c-4258-9c4b-90e2d94d019e"
      unitRef="usd">4534000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy0xLTEtMS0xMTc3NTY_2cf1a76f-22d8-4ead-b39d-ccfdd98d0ba3"
      unitRef="usd">6793000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy0zLTEtMS0xMTc3NTY_cc2ddff8-851c-4060-8248-1269102c52a3"
      unitRef="usd">6092000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy01LTEtMS0xMTc3NTY_bf7fddb9-a1c1-43e8-81af-003144a12b44"
      unitRef="usd">17949000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfNy03LTEtMS0xMTc3NTY_2e2856a3-9710-442a-a752-55bfefa61af4"
      unitRef="usd">16230000000</bmy:GrosstoNetAdjustments>
    <us-gaap:Revenues
      contextRef="i2566c4f0427948968e0a28e5b0365e71_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC0xLTEtMS0xMTc3NTY_27270e44-36f6-4fc3-ac16-f151423cc70e"
      unitRef="usd">10813000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a8a567a11684cafa275d8ec24beb370_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC0zLTEtMS0xMTc3NTY_0b698841-399d-469c-b3e6-0c320ca671b1"
      unitRef="usd">11243000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i593d0120db6f46f9ac739e631f897c64_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC01LTEtMS0xMTc3NTY_905581ee-1a88-4a80-9105-65fbe14396a2"
      unitRef="usd">33606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8168e24cebdc468ab29ddd2fd84948ce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjcxMzlhMDAxMWIxMDQ2MTA5YWM1NGU5ZGFmYmRlZWU2L3RhYmxlcmFuZ2U6NzEzOWEwMDExYjEwNDYxMDlhYzU0ZTlkYWZiZGVlZTZfOC03LTEtMS0xMTc3NTY_3b883520-2a91-4b20-9d34-19a9bc142aa9"
      unitRef="usd">33446000000</us-gaap:Revenues>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjY3_f6db2427-49ee-410e-8f05-6790ccd475b5"
      unitRef="usd">10000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjc0_203d9e3f-d72a-4a90-a6c4-6456203fe273"
      unitRef="usd">207000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMjk2_b39f331e-0607-4b5a-b72e-96aee4dec720"
      unitRef="usd">10000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMzAz_00b72b50-279e-46e5-a7ce-d656983b01c4"
      unitRef="usd">282000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfMTAxMA_1168e518-5fd9-4819-81ed-071cfd7f4737">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Camzyos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sotyktu&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products and New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Recent LOE Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i2aebfbe0d44248bca085ae268561e653_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy0xLTEtMS0xMTc3NTY_0d56e24f-682f-4e16-a9fc-0d160c2a2ff4"
      unitRef="usd">2655000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4003ca03f1e4e1983eef1fd2275159e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy0zLTEtMS0xMTc3NTY_2d41ab1b-c179-4535-9a1b-c58252068501"
      unitRef="usd">2413000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93af657bc36642fab0a352efe9e508d2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy01LTEtMS0xMTc3NTY_8985abfe-1cd9-485e-81fd-8de85da7bb06"
      unitRef="usd">9101000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff59a735468f412282be47f01fe403fe_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMy03LTEtMS0xMTc3NTY_3b064903-4d11-468f-89f9-70c43d942025"
      unitRef="usd">8091000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48c3e2d54ddb4d6685984ee660b83ae5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC0xLTEtMS0xMTc3NTY_2ff3eba0-8fe4-4975-b875-45d2c86b2164"
      unitRef="usd">2047000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9df57b8597af420d9c5ec3c15387bc01_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC0zLTEtMS0xMTc3NTY_5968c44d-f19d-4d24-83c5-1f51998e3693"
      unitRef="usd">1905000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8fe060f6be2495faa414c6e6ad65686_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC01LTEtMS0xMTc3NTY_412106b4-b3b4-4020-9837-53ddd149f14f"
      unitRef="usd">6033000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62fda2db6b3941ccb2dc3fc8da4450e7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNC03LTEtMS0xMTc3NTY_d30c8591-a573-4bd0-977c-c8849180a84e"
      unitRef="usd">5535000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7599d4a3420d4aadbcf02d4eaba7532a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS0xLTEtMS0xMTc3NTY_2b375c80-4bc5-43f6-a3a8-c954f5680987"
      unitRef="usd">886000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i625e125bc434431ca1c8a772fea91d5e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS0zLTEtMS0xMTc3NTY_406f2918-2e6a-4adc-b804-a19f911d3492"
      unitRef="usd">851000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80724b9311fc44598901283b8226c7c7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS01LTEtMS0xMTc3NTY_37927e9e-075d-4fe5-910e-78a108275116"
      unitRef="usd">2620000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09afd557e9f3433cbf4edac16c1bd239_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNS03LTEtMS0xMTc3NTY_a8e15bd9-af6f-450c-99bb-f43962fb33e6"
      unitRef="usd">2478000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4989d5918ce944d29e07c0809ff1d187_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi0xLTEtMS0xMTc3NTY_7bb83cd6-bf70-4069-ae13-33d05f9f8271"
      unitRef="usd">883000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7180b016692e484193376ecc09ef7603_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi0zLTEtMS0xMTc3NTY_fc727148-72d8-4291-abb3-ae61458e36aa"
      unitRef="usd">870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iafe4ffb2515d4f8b87bb7994bbe700c1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi01LTEtMS0xMTc3NTY_b408ed23-ed76-4bd1-9a42-0bc9f768fe71"
      unitRef="usd">2551000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia300585bbecb4074986dc776703743c2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNi03LTEtMS0xMTc3NTY_041c987b-7baa-4fa0-b4ea-c19bcbccaa85"
      unitRef="usd">2442000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46c1d84a792b475cbfa2c9a371ed8496_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy0xLTEtMS0xMTc3NTY_c9453257-671f-4444-b736-13d29b092fe3"
      unitRef="usd">560000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f72bbf8c4304428b0ed80a8686b9248_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy0zLTEtMS0xMTc3NTY_e2f6a9a7-155f-49ee-acee-0780c93fcce4"
      unitRef="usd">551000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic9d82f3486fe4d61884d139292c0a019_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy01LTEtMS0xMTc3NTY_47e86bc8-ce4f-4293-8cf1-a741d1063d7e"
      unitRef="usd">1587000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic93e43e0d5e449c9a5ac169c78f5729e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfNy03LTEtMS0xMTc3NTY_4e0cd856-aa70-4911-a6a3-b59003a5b400"
      unitRef="usd">1562000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91564a174e264c93b41b7a67a1aba557_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC0xLTEtMS0xMTc3NTY_ccca5b45-07f8-4915-aeae-0d604c062e3a"
      unitRef="usd">523000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52549b4b725c4beaa7e2e97bdb382deb_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC0zLTEtMS0xMTc3NTY_0c7aaaf4-f09b-471e-b9c8-e9574e11596b"
      unitRef="usd">515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f173022564246479bb42891e0caadeb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC01LTEtMS0xMTc3NTY_ce0fe7e6-ee2c-4478-993c-aa03aad6c7a4"
      unitRef="usd">1563000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7621f5141c74afea188b4fd300e0324_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOC03LTEtMS0xMTc3NTY_7c92d2c4-28e0-49d1-9907-0de97f15ded3"
      unitRef="usd">1481000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2b2771b60834bc88d400a6969621023_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS0xLTEtMS0xMTc3NTY_0002554b-5402-47b9-8b3f-a6df3935fa68"
      unitRef="usd">73000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic33b8b166dcc47a19e7e82c8d64e0d0e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS0zLTEtMS0xMTc3NTY_12f28295-7e40-44c4-a789-204298feb494"
      unitRef="usd">82000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i375ecb41f5d34164b135dfb0419a036e_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS01LTEtMS0xMTc3NTY_5f36a80e-fceb-423e-83e6-b256bf08b692"
      unitRef="usd">225000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e88c910ffae4f9a9d5adc44c364d44c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfOS03LTEtMS0xMTc3NTY_9d17a1fb-eb7f-4e2c-ba38-5b07546b650a"
      unitRef="usd">253000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c86bc8fc17947e8b991889d64c5e053_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtMS0xLTEtMTE3NzU2_854c4e18-73a1-445d-9004-4d32f7487e2d"
      unitRef="usd">441000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie3689d0fcaf24638a873a35863370488_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtMy0xLTEtMTE3NzU2_4dbba166-daba-4b0e-b020-08edf14d1849"
      unitRef="usd">480000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddd8ef9dd4b34e74b6c7d422826a5a2a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtNS0xLTEtMTE3NzU2_d2be2c1e-1703-429b-800b-3dfb66964022"
      unitRef="usd">1338000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib53644119d8a45f1863f5c215a118b2a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTAtNy0xLTEtMTE3NzU2_ba4d346a-cb26-4b30-9199-7ffd5af8a06d"
      unitRef="usd">1459000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e0cefbc0671402cb26abf2ad1c6e8e1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtMS0xLTEtMTI4OTkz_73231367-6812-462a-8b3a-01d913f72bcf"
      unitRef="usd">8068000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddd31c065d2b4f2eac12a4313ca0b4e7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtMy0xLTEtMTI4OTk1_5e47a4c6-fcd8-44db-b5f1-1863474ff297"
      unitRef="usd">7667000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a2977ed64024e9b82c97255c6614303_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtNS0xLTEtMTI4OTk2_8c875bf3-3c14-40c9-9174-f8635e597b23"
      unitRef="usd">25018000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i523864ecfe934c0a8c2a8ba3767f4efc_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTEtNy0xLTEtMTI4OTk4_f5d31b73-b696-4039-bc66-7b417c1f6e33"
      unitRef="usd">23301000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d028b025fa34a23934845203ff86eca_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItMS0xLTEtMTE3NzU2_7000b1cf-5b54-4e83-a2e3-389bb6879867"
      unitRef="usd">190000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib532e1cdc30944c5b30a57aeb3373c5a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItMy0xLTEtMTE3NzU2_7975faa6-3919-49b9-aad6-0988fc5764e4"
      unitRef="usd">160000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ac2713db21647efa1e4c85b8371102c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItNS0xLTEtMTE3NzU2_a0056f27-39f7-49a0-af91-601230c2e2bb"
      unitRef="usd">518000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b3a202c6cd54c6b93f8c26bfb454aab_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTItNy0xLTEtMTE3NzU2_0565e6dd-9c8d-438c-9302-1ff0dba95e1d"
      unitRef="usd">400000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia7edc171ac604a028ae6ba6d774d1184_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtMS0xLTEtMTE3NzU2_ed989542-4f00-461f-9a6f-e2c0619999c9"
      unitRef="usd">107000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc68379ebba8498fbde398dcdfa0bbb9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtMy0xLTEtMTE3NzU2_b18bfcde-4e49-488b-9192-7c3eaacabae7"
      unitRef="usd">71000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief4fc5728521489486f5f10510221b0c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtNS0xLTEtMTE3NzU2_a6d2ee20-1560-4b86-ba3a-d6aa00e416b4"
      unitRef="usd">263000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if27953d1748346de8d241948e99fdfce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTMtNy0xLTEtMTE3NzU2_b8edcc81-3691-4585-b702-8b650f69551e"
      unitRef="usd">95000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9253e2d1c9f14694a47e4b8ba936cd82_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtMS0xLTEtMTE3NzU2_cdf8dfa4-24b7-4688-b508-ec1826dfa5c2"
      unitRef="usd">69000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2935cf5db0984e48a7311562d8957e88_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtMy0xLTEtMTE3NzU2_1c0673e2-b40d-40a0-abe1-d2487e78d0c7"
      unitRef="usd">40000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i312e646a32594a92819e204cbcf9d30f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtNS0xLTEtMTE3NzU2_5d1614a0-3ea4-47eb-80cc-eb212dc125f5"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5077d69051d2407dac910cb1d4b5af89_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTQtNy0xLTEtMTE3NzU2_90e7cfc3-d5d7-4471-9253-15c7fac613b4"
      unitRef="usd">86000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36674f96d1ba40588e290d02748a12d3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtMS0xLTEtMTE3NzU2_e2b8d426-7f09-44ab-8b05-77719d27d2e8"
      unitRef="usd">44000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i44bc11db15de490da4c09d2d876a005b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtMy0xLTEtMTE3NzU2_d133e385-6db7-451a-a0b8-f68fec8d0e14"
      unitRef="usd">30000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00488d76ec644f9f92320a9c1dcc6355_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtNS0xLTEtMTE3NzU2_b921f2c3-243c-4773-8fbf-02f7ffbc7972"
      unitRef="usd">127000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d096e1112a84f968934e98a7d7e8897_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTUtNy0xLTEtMTE3NzU2_863b058e-2bd5-4ef9-87fa-bd2cc2209089"
      unitRef="usd">47000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia19f17c6b9684d4dae43eca5b8566729_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtMS0xLTEtMTE3NzU2_b1185d7c-b30e-49ab-90f7-03eab991e80f"
      unitRef="usd">21000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c063ffd131546f19b8bc98eaa3ea8c0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtMy0xLTEtMTE3NzU2_c4aba662-0c5d-453c-be6b-7ed836ada947"
      unitRef="usd">22000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i992d193b56344cfaa5ba4098f9efd6f2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtNS0xLTEtMTE3NzU2_711253de-2a51-4bbb-bef9-7629c2f28969"
      unitRef="usd">62000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icaae1d1308ff4f129502456c6536ad64_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTYtNy0xLTEtMTE3NzU2_2381215e-4814-428e-8c67-1705fbc4ae0b"
      unitRef="usd">54000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97b7e4ca6dec410ca3364c9088373428_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctMS0xLTEtMTE3NzU2_a1d44c5e-5714-444b-8221-3feaaf550ae1"
      unitRef="usd">32000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c7db61f43aa43929a92deb8ac563b89_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctMy0xLTEtMTE3NzU2_3cdb81fe-3a00-4e4b-a2c3-780755439436"
      unitRef="usd">21000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67b4ea4259ca469ca93f408a519be850_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctNS0xLTEtMTE3NzU2_0ec1c555-f2ea-4c82-809a-1ba583895d11"
      unitRef="usd">87000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24cc65b60058474db7537ab2b6b0a254_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTctNy0xLTEtMTE3NzU2_e7c700b4-f93c-44e6-aea8-d6ad1257c38c"
      unitRef="usd">48000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a140f37738545fd8986a487a0effcd0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtMS0xLTEtMTE3NzU2_7c9a2bc2-4ae7-4380-bfcc-057ffcd53932"
      unitRef="usd">84000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1539779a5914689aa5abc809e040af0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtMy0xLTEtMTE3NzU2_21792eba-e0d9-4336-87cb-8a2919eeb773"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08528bb25e714575a7f5c80c04663b81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtNS0xLTEtMTE3NzU2_fb75be4b-074e-488e-91d7-3d2cf629d4bc"
      unitRef="usd">148000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ebc52b59af749918bb43f2480530ab9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTgtNy0xLTEtMTE3NzU2_483b4217-c77c-44fa-86aa-2b69f31887ee"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4bb28437e7b4609b9fa0648528f45d4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktMS0xLTEtMTE3NzU2_f0f37fef-86a0-4409-9cd3-75dc0e52b2de"
      unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee7c15e9e75e4205a132cc94956026e4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktMy0xLTEtMTE3NzU2_a34c1eca-a291-44dc-9f5e-adb643bc1e29"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c7cedbf6e5649418120798f7a9f2b6c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktNS0xLTEtMTE3NzU2_a4acac1e-ac5a-407f-90ed-9cdcaecbb136"
      unitRef="usd">8000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30592356ada44f519b3f806c7e67a991_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMTktNy0xLTEtMTE3NzU2_125e86e9-5e2e-46cf-a29c-351adfdeb9b9"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1276014500404e2e82de7171d6cb2c46_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtMS0xLTEtMTI2NTM1_0af79f7b-b762-4876-95ec-5bea4d6b6c98"
      unitRef="usd">1000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c90420b4f6d468387df80ced89cde88_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtMy0xLTEtMTI2NTIx_5d86c9a9-4e49-4af0-961f-c14945e92753"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i639586984bcf4c9bb2800764224a0d97_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtNS0xLTEtMTI2NTQy_063ec3eb-b113-4d15-b28f-6df72b584baf"
      unitRef="usd">1000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f8a8da7674641108fe5cccec2da9f32_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjAtNy0xLTEtMTI2NTI4_b34a6372-3928-48e7-9470-6f997462c874"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if91a0cc6973147dbb665862c990ff09c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMS0xLTEtMTI5MDE3_40ad69c6-cdf4-4270-a0df-0d35438ceb2c"
      unitRef="usd">553000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i515f50d74f9f403dbded026f016eecea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMy0xLTEtMTI5MDE4_1b310a65-c35a-49bd-9309-bfb2b8165a1d"
      unitRef="usd">344000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c92b01540e8405eb5f3908c858d4523_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNS0xLTEtMTI5MDE5_c6e7e46e-6b28-44cf-897f-fc4e232a4fed"
      unitRef="usd">1385000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i957ae0dd10d742d585460837252b996f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNy0xLTEtMTI5MDIx_3c53efd6-3b21-4904-a07d-e6a0fbc34ae3"
      unitRef="usd">730000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0651d3b0cf44b9f9157cee57ba36939_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMS0xLTEtMTI5MDU2_71818265-f654-421d-9a5a-f7af13c6055b"
      unitRef="usd">8621000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2a88fbea78348eaa1d5f346ce2efeef_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMy0xLTEtMTI5MDU3_0cba1831-28f1-41c7-9264-48726cebe1ec"
      unitRef="usd">8011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i743233575df84038808b743f27ef5643_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNS0xLTEtMTI5MDU4_7a5bf226-b177-4f4a-9cf0-33fde238665e"
      unitRef="usd">26403000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1aaa93de272430e8ff046eb7df5c78e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNy0xLTEtMTI5MDYw_8d5d46b4-15ad-45a9-a078-b0fd4cdc0c3f"
      unitRef="usd">24031000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2cfec8659679486082b93be2576c6ee7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtMS0xLTEtMTE3NzU2_89ae7d6c-a6e1-4ebb-8c08-b3d19e9354d5"
      unitRef="usd">2420000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c20938af5ea4f559a05d063bca23a37_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtMy0xLTEtMTE3NzU2_f9489711-5ba9-4acc-9905-0c6bc5bb125a"
      unitRef="usd">3347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d3d417b45d149649f2fab7b9c39c309_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtNS0xLTEtMTE3NzU2_83cc46b8-b210-4e75-be46-d6623b80fbdb"
      unitRef="usd">7718000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62b88401122a44aaae11d63f988564e3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjEtNy0xLTEtMTE3NzU2_b3d072fc-35ba-487e-a9bc-d94fce0c37c8"
      unitRef="usd">9493000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia85644c821814dddb2f2fe08c06ecfea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMS0xLTEtMTE3NzU2_de369210-b94a-4ca8-8d57-265d2a9412e3"
      unitRef="usd">177000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd2c28076da74353b7a9b4be05493211_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItMy0xLTEtMTE3NzU2_9b7fba27-6584-4650-af4f-99ef7b4feba2"
      unitRef="usd">266000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55b94424ed3440cdab12f30e34eef0e8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNS0xLTEtMTE3NzU2_622fa59b-c6b0-40a8-8ec9-1fcaa040b5b8"
      unitRef="usd">632000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7cfc8d0143547ffb85e8991435779d0_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjItNy0xLTEtMTE3NzU2_c7a4c334-7d07-4eba-819e-2cd229a23c25"
      unitRef="usd">876000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i718ffa0ce4264649a30d8e60f6d21e21_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMS0xLTEtMTI5MDM3_70876b2b-cc7a-4bc4-9406-933291055128"
      unitRef="usd">2597000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia5034bd9d5ac4d709b2d8bae0eda22ab_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMy0xLTEtMTI5MDM4_cd79145d-14af-49dd-95e3-40cdc5f44504"
      unitRef="usd">3613000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79c3c3b3adf74d829fdcffc4e2fd017b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNS0xLTEtMTI5MDM5_6e55d71a-ef22-4113-9f08-fc8a1caa108f"
      unitRef="usd">8350000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33b8d2d6534740bd9a6f4cd980bb5662_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNy0xLTEtMTI5MDQw_5ae0ea5c-7a20-4929-b597-90541db173ff"
      unitRef="usd">10369000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMS0xLTEtMTE3NzU2_0dc61fd8-b2be-45e7-ab63-6800ad565660"
      unitRef="usd">11218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtMy0xLTEtMTE3NzU2_7e999284-0512-4d95-bbe2-2495f087ceb3"
      unitRef="usd">11624000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNS0xLTEtMTE3NzU2_58a80cee-c3be-433b-82f0-37305058e0ef"
      unitRef="usd">34753000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjMtNy0xLTEtMTE3NzU2_67765c79-392d-4ee8-8e40-3885712aeffd"
      unitRef="usd">34400000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib12e924a4a13410b84c6b424992cfa22_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtMS0xLTEtMTE3NzU2_4dccad67-6e5a-4544-8586-9069de492ed9"
      unitRef="usd">7941000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2f02d98cc4647e6a09a6e50ca3b081d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtMy0xLTEtMTE3NzU2_9aa5ae23-a1e2-4423-8d3f-f5f4e3f3cad0"
      unitRef="usd">7296000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i69bf82dfff6346418613dbfd38767fc2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtNS0xLTEtMTE3NzU2_bfae8d1d-49b7-4151-bfc9-2a9aeeda40c1"
      unitRef="usd">23903000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2360c71c4d7c4f60aff7afb5bd5adb43_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjUtNy0xLTEtMTE3NzU2_263f68a3-7846-47dd-a39e-38410c15a261"
      unitRef="usd">21694000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2a2726ed8d946878e0409ab1bc8e479_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMS0xLTEtMTE3NzU2_a2aa46a6-ced7-48f0-bd69-4158f03583ea"
      unitRef="usd">3062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i097fc6808da74bd2a448a5abc583ff06_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtMy0xLTEtMTE3NzU2_47e2c940-0fd0-4752-9bb5-31dfebc09e10"
      unitRef="usd">4052000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i82055957ab0c488786f886e6b6babb70_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNS0xLTEtMTE3NzU2_0afe0cbe-29de-4b53-b64a-84164d6e5697"
      unitRef="usd">10216000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2b7e84f20fa4c0e8c203592f5fdc962_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjYtNy0xLTEtMTE3NzU2_e9147c56-4937-485b-a788-8685d536b423"
      unitRef="usd">12075000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb5ca12fa8cf4f118404d35732aaa0e2_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtMS0xLTEtMTE3NzU2_d29d89ba-90bb-4f1f-bbdb-02d4e0bfd499"
      unitRef="usd">215000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3fbc288f17842e0a75422793fa1f2d2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtMy0xLTEtMTE3NzU2_b0f6baa9-da05-4e45-bf7b-9417c3c64908"
      unitRef="usd">276000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a091ee30a0546f2b3cf7109a52349aa_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtNS0xLTEtMTE3NzU2_9b615e9d-2661-4203-b443-336dc9e1ad6a"
      unitRef="usd">634000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e8a169883d84598b45391f2436b331d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjgtNy0xLTEtMTE3NzU2_8839e570-70a5-49cf-a0fd-e3046afe14dd"
      unitRef="usd">631000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktMS0xLTEtMTE3NzU2_7d4472cd-ca6d-4f02-ba3b-019da8fb1c4f"
      unitRef="usd">11218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktMy0xLTEtMTE3NzU2_7d091443-dd05-444b-9711-19086b68ad14"
      unitRef="usd">11624000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktNS0xLTEtMTE3NzU2_6e9fa6ea-5179-4355-a146-db43c5564217"
      unitRef="usd">34753000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RhYmxlOjg4OGRhMGUyMzA4NzRhYjliN2Y5ODE4OGE2ZmViZjI3L3RhYmxlcmFuZ2U6ODg4ZGEwZTIzMDg3NGFiOWI3Zjk4MTg4YTZmZWJmMjdfMjktNy0xLTEtMTE3NzU2_f26ce800-badf-49e0-89d1-e580165eb0b6"
      unitRef="usd">34400000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfNzgz_15e4fbb0-78ba-4114-aac5-1f7ba83a8cc7"
      unitRef="usd">119000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfNzkw_9ec9fdf1-ff4c-4612-879d-012558ee3ba6"
      unitRef="usd">450000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfODEx_94e8baca-3bdb-48a2-869a-e24dc78e6e9d"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18zNy9mcmFnOmYxZjkzMjEzYjI5NTRiYWQ4NGRlZTRkOWYxMGJlOGMwL3RleHRyZWdpb246ZjFmOTMyMTNiMjk1NGJhZDg0ZGVlNGQ5ZjEwYmU4YzBfODE4_c592a536-00f5-4310-8260-6e80681dd395"
      unitRef="usd">463000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk5Nw_cc4e28d5-fff3-49bc-a720-2f906c38880a">ALLIANCESBMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPRD &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income &#x2013; from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the nine months ended September&#160;30, 2022, and 2021 are set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;BridgeBio&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, BMS and BridgeBio commenced an exclusive global collaboration to develop and commercialize BBP-398, a SHP2 inhibitor, in oncology. The transaction included an upfront payment of $90&#160;million, which was expensed to Acquired IPRD during the second quarter of 2022. BridgeBio is eligible to receive contingent development, regulatory and sales-based milestones up to $815 million, as well as royalties on global net sales, excluding certain markets. BridgeBio is responsible for funding and completing ongoing BBP-398 Phase I monotherapy and combination therapy trials. BMS will lead and fund all other development and commercial activities. BridgeBio has an option to co-develop BBP-398 and receive higher royalties in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nektar&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Opdivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program are being discontinued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eisai&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Japan, China and certain other countries in the Asia-Pacific region (the &#x201c;collaboration territory&#x201d;). Eisai is responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS is responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.&lt;/span&gt;&lt;/div&gt;A $650&#160;million up-front collaboration fee was expensed to Acquired IPRD during the second quarter of 2021. BMS is also obligated to pay up to $2.5&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementAccountingPolicy
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk5Mg_dd47336f-9f5d-4104-9f77-514a572adfd9">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzk3OQ_e7d7bac9-53e0-4068-a6a6-a49f25058c36">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPRD &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income &#x2013; from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:Revenues
      contextRef="i714ecd92180a4da09cfb9e1b711d8e13_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy0xLTEtMS0xMTc3NTY_be8ed0f5-b4a6-48d3-8828-5f140453cebb"
      unitRef="usd">2722000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1682d31f29ab4c5c8e318685f109e06d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy0zLTEtMS0xMTc3NTY_e5848bee-2d30-4a98-a2e8-18f3339f6fc2"
      unitRef="usd">2452000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e11c81e870446bea062ed2f9a4dd75a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy01LTEtMS0xMTc3NTY_d8778f1a-7c59-4358-b139-cb6e1b30defa"
      unitRef="usd">9234000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd51bc766ca44e85bd81070b4c92220b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMy03LTEtMS0xMTc3NTY_86e241b2-20ed-42b6-899c-49feb1f5c70b"
      unitRef="usd">8139000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia90fd6afc7bf448488c65a2cb7755a4c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC0xLTEtMS0xMTc3NTY_128474f1-9515-4aa4-8d49-b612aefff71a"
      unitRef="usd">173000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f464bd814614f7f931a3357b822c20c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC0zLTEtMS0xMTc3NTY_15d61c0c-4a23-4550-9686-918a27881263"
      unitRef="usd">194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb98ddb2854649338bebe0bc6a2e9922_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC01LTEtMS0xMTc3NTY_f64f0c2c-43e9-4425-874a-3addd2680d72"
      unitRef="usd">560000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0bbfb614e3ee44ebb8de2ff93740dff5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNC03LTEtMS0xMTc3NTY_dfbc80f1-62fd-4037-b70c-e23c647daa79"
      unitRef="usd">495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS0xLTEtMS0xMTc3NTY_925b4a05-376b-4467-850a-538339992c55"
      unitRef="usd">2895000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS0zLTEtMS0xMTc3NTY_65401f85-c0f4-4455-bfec-be95f7eecbdc"
      unitRef="usd">2646000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS01LTEtMS0xMTc3NTY_b1cc98bb-6b08-40e3-9941-0aa9dd32d7e3"
      unitRef="usd">9794000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfNS03LTEtMS0xMTc3NTY_b42141dc-6d03-4a32-ba89-40e9264972d7"
      unitRef="usd">8634000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC0xLTEtMS0xMTc3NTY_fede7bdc-67cb-4be1-9d62-fe89c8388311"
      unitRef="usd">1328000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC0zLTEtMS0xMTc3NTY_5f4dfaa3-499e-4872-b46f-133f31502bda"
      unitRef="usd">1181000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC01LTEtMS0xMTc3NTY_b6a89288-b97d-4862-af6c-0aeb9dd96de9"
      unitRef="usd">4456000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOC03LTEtMS0xMTc3NTY_c03b56f2-143d-4b32-a806-83f4e8eff83e"
      unitRef="usd">3924000000</us-gaap:CostOfGoodsAndServicesSold>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS0xLTEtMS0xMTc3NTY_e3bd790e-4899-4ca4-aab1-51087c6ba5c6"
      unitRef="usd">-53000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS0zLTEtMS0xMTc3NTY_57f62a9e-bab7-4cb6-80ef-2c4340611ca9"
      unitRef="usd">-43000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS01LTEtMS0xMTc3NTY_8a6fda36-84a6-46e6-a2e4-6ce1f80eedb7"
      unitRef="usd">-160000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfOS03LTEtMS0xMTc3NTY_460f3919-be30-42e0-b5ce-2924d018b42e"
      unitRef="usd">-140000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtMS0xLTEtMTE3NzU2_2717ea9b-6ce7-4329-8093-57fb590fc9f3"
      unitRef="usd">6000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtMy0xLTEtMTE3NzU2_53ccb30f-2e95-4754-91ea-2191478c6339"
      unitRef="usd">10000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtNS0xLTEtMTE3NzU2_78b5f829-0e4b-40a0-b40d-a001320fe986"
      unitRef="usd">40000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTAtNy0xLTEtMTE3NzU2_befd76ae-ff08-4957-9b67-e9777111392e"
      unitRef="usd">17000000</us-gaap:ResearchAndDevelopmentExpense>
    <bmy:AcquiredIPRD
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtMS0xLTEtMTE3NzU2_075bb1c4-7723-4662-85c9-b01c9606eee0"
      unitRef="usd">0</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtMy0xLTEtMTE3NzU2_986de19a-b498-4fe8-aecc-139461645a15"
      unitRef="usd">0</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtNS0xLTEtMTE3NzU2_1d8af823-b779-4bb7-996d-b0473c12673f"
      unitRef="usd">100000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTEtNy0xLTEtMTE3NzU2_7402e00d-2872-45ad-a22c-47d14252caad"
      unitRef="usd">736000000</bmy:AcquiredIPRD>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i14fa09244cfa4ecaa3932203dc641a37_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItMS0xLTEtMTE3NzU2_54a3ac89-317a-4f16-bb0d-29dd4382324a"
      unitRef="usd">18000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic04460f3b573404092fc5ebb4ebd5f57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItMy0xLTEtMTE3NzU2_bec65ca4-ca5e-4886-85df-f518b569f3da"
      unitRef="usd">-1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0998c6108e6b4aff9a86cc39b6eae751_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItNS0xLTEtMTE3NzU2_797e5ca1-8c8b-451e-8f97-8f1c0a1a4866"
      unitRef="usd">41000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i32e8a64c9ba84276a31ba19cb55c1b54_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjFmMWZmNTY1MDliMjRlMDE4Y2IzMGE3N2M4ZGE2NDZkL3RhYmxlcmFuZ2U6MWYxZmY1NjUwOWIyNGUwMThjYjMwYTc3YzhkYTY0NmRfMTItNy0xLTEtMTE3NzU2_ab9d95bf-38f1-4a17-9d1b-cba71055e352"
      unitRef="usd">18000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMi0xLTEtMS0xMTc3NTY_88ce3dc6-75eb-48b8-9476-53f607016632"
      unitRef="usd">281000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMi0zLTEtMS0xMTc3NTY_d08037c2-1136-44c8-a4b1-839a47a32800"
      unitRef="usd">320000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMy0xLTEtMS0xMTc3NTY_58207a28-e346-4b20-a3af-85bd714f881d"
      unitRef="usd">1242000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfMy0zLTEtMS0xMTc3NTY_5f4af321-8a3b-47cb-bcbb-4225cefa3e65"
      unitRef="usd">1229000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncome
      contextRef="i68864aa7457c44f0a8c064e00afcf547_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfNC0xLTEtMS0xMTc3NTY_ed1e7dd5-15cb-4529-b77b-7d85dd938c6d"
      unitRef="usd">304000000</us-gaap:DeferredIncome>
    <us-gaap:DeferredIncome
      contextRef="i55b2fbe9642b4229bab1c013a4539695_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RhYmxlOjQxYmY5ZDlmOTNkMzRjMzI4MmJlZDYyZDEzYmUzZTIxL3RhYmxlcmFuZ2U6NDFiZjlkOWY5M2QzNGMzMjgyYmVkNjJkMTNiZTNlMjFfNC0zLTEtMS0xMTc3NTY_bd2fe215-9eba-43e0-b3ad-f3998f213d25"
      unitRef="usd">330000000</us-gaap:DeferredIncome>
    <bmy:UpfrontPaymentsMadeToCollaborativePartner
      contextRef="ie29f5777421440b5a7303c74ab686169_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMTk1MQ_c65e9adc-c3b1-43aa-a725-33eb74ff9afd"
      unitRef="usd">90000000</bmy:UpfrontPaymentsMadeToCollaborativePartner>
    <bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval
      contextRef="ie29f5777421440b5a7303c74ab686169_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMjEzNw_ef2af7be-89c0-4429-b751-7ffea0e491bd"
      unitRef="usd">815000000</bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval>
    <bmy:UpfrontPaymentsMadeToCollaborativePartner
      contextRef="icc7d12df57f64215af002ee413e6d5dd_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzcyMw_d3a99f3d-95f5-49b0-aa1a-400d472402fc"
      unitRef="usd">650000000</bmy:UpfrontPaymentsMadeToCollaborativePartner>
    <bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval
      contextRef="i8e366068274246db8687bd2bf3a8caec_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180MC9mcmFnOjU0YzAzNmZlYjY5YjQxZWRhYjdmYmJlMmVmYzMxMjU1L3RleHRyZWdpb246NTRjMDM2ZmViNjliNDFlZGFiN2ZiYmUyZWZjMzEyNTVfMzg4Nw_b75696c2-d32c-48c6-bafd-6c7bd3b7cdbf"
      unitRef="usd">2500000000</bmy:ConsiderationForContingentDevelopmentAndRegulatoryApproval>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkyNw_d5b81aa8-1bee-457d-8a62-6b1b25bcb587">ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Turning Point &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 17, 2022, BMS acquired Turning Point for $4.1&#160;billion of cash (or $3.3&#160;billion net of cash acquired). Turning Point is a clinical-stage precision oncology company with a pipeline of investigational medicines designed to target the common mutations and alterations that drive cancer growth. The acquisition provides BMS rights to Turning Point's lead asset, repotrectinib, and other clinical and pre-clinical stage assets. The transaction was accounted for as a business combination requiring all assets acquired and liabilities assumed to be recognized at their fair value as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total consideration for the acquisition consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for outstanding shares &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for equity awards &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unvested stock awards &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration to be allocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes unvested equity awards of $73&#160;million expensed in Marketing, selling, and administrative and $80&#160;million expensed in Research and development during the three months ended September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed as of the acquisition date based upon their respective fair values summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration allocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Intangible assets primarily consist of IPRD allocated to repotrectinib ($2.8&#160;billion), a potential best-in-class tyrosine kinase inhibitor targeting the ROS1 and NTRK oncogenic drivers in NSCLC and other advanced solid tumors. Repotrectinib is currently in registrational Phase II study in adults and a Phase I/II study in pediatric patients. The estimated fair value of IPRD assets was determined using an income approach valuation method. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Goodwill resulted primarily from the recognition of deferred tax liabilities and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of Turning Point's operations were included in the consolidated financial statements commencing August 18, 2022, and were not material. Historical financial results of the acquired entity were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Mature Products and Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Manufacturing Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, BMS agreed to sell its manufacturing facility in Syracuse, New York to LOTTE Corporation for approximately $170&#160;million. The transaction is expected to close during the first quarter of 2023, subject to certain regulatory approvals and other closing conditions and will be accounted for as a sale of a business. The business was accounted for as held-for-sale and its assets were reduced to the estimated relative fair value resulting in a $43&#160;million impairment charge recorded to Cost of products sold during the second quarter of 2022. Assets and liabilities reclassified to held-for-sale and included within Other current assets and Other current liabilities were $155&#160;million and $6&#160;million, respectively, as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $221&#160;million and a divestiture gain of $211&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Licensing and Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biohaven sublicense income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties and licensing income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;In-license Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Immatics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS obtained a global exclusive license to Immatics&#x2019; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $150&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dragonfly&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, a Phase I development milestone for interlukin-12 (&#x201c;IL-12&#x201d;) was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Agenus&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, BMS obtained a global exclusive license to Agenus&#x2019; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and a Phase I clinical trial was initiated in October 2021. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. The transaction included an upfront payment of $200&#160;million expensed to Acquired IPRD for the third quarter of 2021. Agenus is eligible to receive contingent development, regulatory and sales-based milestones up to $1.4&#160;billion as well as royalties on global net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalty Extinguishment&lt;/span&gt;&lt;/div&gt;In April 2022, BMS amended the terms of a license arrangement and paid a third party $295&#160;million to extinguish a future royalty obligation related to mavacamten, prior to its FDA approval in April 2022, resulting in an Acquired IPRD charge during the second quarter of 2022.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzI5MDk_8307cc6f-3fb7-46a0-9f94-e7c485702925"
      unitRef="usd">4100000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie54f1b4636db42e6988c8772120ddcb6_D20220101-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzI5NTg_eef202db-3973-4e8c-9e7b-ee69a1b55f79"
      unitRef="usd">3300000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNjU5NzA2OTc5ODc0NA_94725eb8-ffae-4f55-9f56-b1c245bb9451">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total consideration for the acquisition consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for outstanding shares &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration for equity awards &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unvested stock awards &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration to be allocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes unvested equity awards of $73&#160;million expensed in Marketing, selling, and administrative and $80&#160;million expensed in Research and development during the three months ended September 30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i781907222fbe4667b1cd73c65ef72721_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMS0xLTEtMS0xMjU2OTM_ce2063ae-6087-46a7-883b-817dea6d23fb"
      unitRef="usd">3811000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i793cb981ce5049e8b04829bfd1aebc05_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMi0xLTEtMS0xMjU2OTM_73b7a216-3a73-405d-9631-e80f200dc166"
      unitRef="usd">302000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfMy0xLTEtMS0xMjU2OTM_c40b7a5d-b85b-4aa7-9240-c3889ade8b96"
      unitRef="usd">4113000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfNC0xLTEtMS0xMjU2OTM_689f096e-b3a0-4369-b904-76cc20f2ba95"
      unitRef="usd">153000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjk5M2FlZmU0ZDNkYTRiNzk5ZjcxZTIwZTIxNzliZjRjL3RhYmxlcmFuZ2U6OTkzYWVmZTRkM2RhNGI3OTlmNzFlMjBlMjE3OWJmNGNfNS0xLTEtMS0xMjU2OTM_2c5c8e52-2efb-46d2-8732-36a06499488b"
      unitRef="usd">3960000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i3b224fccd35141c6ab6c59ed52eab7c5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2MTA0OA_5b2f7885-00ec-4af7-9069-d39c08d97bba"
      unitRef="usd">73000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i2142a064165c42acb01e69c102b6b950_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2MTA1Ng_5035c4e1-02b2-4941-bd8d-7bd930a78770"
      unitRef="usd">80000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNjU5NzA2OTc5ODc0NQ_b1a9b4bf-0f89-4af3-8cd2-f1c512481fc5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed as of the acquisition date based upon their respective fair values summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration allocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Intangible assets primarily consist of IPRD allocated to repotrectinib ($2.8&#160;billion), a potential best-in-class tyrosine kinase inhibitor targeting the ROS1 and NTRK oncogenic drivers in NSCLC and other advanced solid tumors. Repotrectinib is currently in registrational Phase II study in adults and a Phase I/II study in pediatric patients. The estimated fair value of IPRD assets was determined using an income approach valuation method. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Goodwill resulted primarily from the recognition of deferred tax liabilities and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMS0xLTEtMS0xMjU2OTU_6df0c250-d9b9-463e-8de0-bc9cf0c73c22"
      unitRef="usd">795000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMi0xLTEtMS0xMjk4MTc_27e8f304-42e0-4933-9de5-770e66280ad5"
      unitRef="usd">14000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMi0xLTEtMS0xMjU2OTU_a07007c1-0650-4819-92fb-2e97271452f6"
      unitRef="usd">2971000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfMy0xLTEtMS0xMjU2OTU_16800f86-83da-464e-ac5d-281fad31fd36"
      unitRef="usd">229000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNC0xLTEtMS0xMjU2OTU_25fffec6-489a-477f-a5e9-3bd56d1e2ae5"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNi0xLTEtMS0xMjU2OTU_c6c0f3f9-7b92-4fee-b905-12708e3d510c"
      unitRef="usd">643000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNy0xLTEtMS0xMjk0ODA_c8ced5e5-65bf-401f-b9c0-f19ee543d75a"
      unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfNy0xLTEtMS0xMjU2OTU_fa1a17da-dc33-4c44-8ba6-59e27b38496f"
      unitRef="usd">3265000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfOC0xLTEtMS0xMjU2OTU_495cc84b-55da-4314-8288-ffa50665af45"
      unitRef="usd">695000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i094ac81d52ae4652a6b2c34240a43940_I20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmQwYWExNzIwYzc2YTRkMGU4YjJlZDY5NGM3MDM5NDU5L3RhYmxlcmFuZ2U6ZDBhYTE3MjBjNzZhNGQwZThiMmVkNjk0YzcwMzk0NTlfOS0xLTEtMS0xMjU2OTU_6e867cc5-2a13-4e93-8ba1-25d148a75950"
      unitRef="usd">3960000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <bmy:AcquiredIPRD
      contextRef="if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMTA5OTUxMTY2NjU0OQ_4fe32242-dc21-41e3-a5b5-31c500b42cb6"
      unitRef="usd">2800000000</bmy:AcquiredIPRD>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkxOQ_9024193b-6bce-45bb-9315-0a59afcd9e15">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0xLTEtMS0xMTc3NTY_162016de-9923-4f68-ac20-8f1df6e8239f"
      unitRef="usd">205000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0zLTEtMS0xMTc3NTY_01f9ec7c-0048-4d4f-b2af-83b0a7094cae"
      unitRef="usd">153000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy01LTEtMS0xMTc3NTY_29a67fa5-757b-4bb4-853e-14977c963a26"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy03LTEtMS0xMTc3NTY_d060fb60-5fb0-4211-b86d-ace138470396"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i740d420ab04f43438529806760d35e0c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy05LTEtMS0xMTc3NTY_421465c7-40f9-41a4-9f8f-aab4ddafe3c3"
      unitRef="usd">205000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i1f42aaf5c4c048df8414e78eefe2dc8e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfMy0xMS0xLTEtMTE3NzU2_fcd52bae-aa77-4041-95e2-05de9eca90fe"
      unitRef="usd">159000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0xLTEtMS0xMTc3NTY_a508ecd5-f494-4e0a-843d-49b0fbbfe2e3"
      unitRef="usd">1000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0zLTEtMS0xMTc3NTY_46d604bf-8f5b-44c5-ae35-2fb2fc8f4c86"
      unitRef="usd">35000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy01LTEtMS0xMTc3NTY_9dce1fd2-d565-49b9-9426-5628a667b792"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy03LTEtMS0xMTc3NTY_23ba3fc4-fdd5-4e91-bcd8-cc6a45d2248f"
      unitRef="usd">-2000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i92913744fe924bd7afa2171de108004f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy05LTEtMS0xMTc3NTY_704be661-ceed-4f70-9a4f-96128a19724f"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i79552959d6b94618905e3c748636e2ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfNy0xMS0xLTEtMTE3NzU2_5234a704-2cb6-4626-8a28-42c31dfa5892"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0xLTEtMS0xMTc3NTY_08f269b0-2f89-4291-a32d-23901e7d9e2d"
      unitRef="usd">206000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0zLTEtMS0xMTc3NTY_abf3a9a1-f40a-4f7b-9cfa-b10e0cfaf8a6"
      unitRef="usd">188000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC01LTEtMS0xMTc3NTY_21a6a9cd-2d54-4cbb-ad97-7e1c6335a11d"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC03LTEtMS0xMTc3NTY_31e96dc3-ea77-4625-86af-9f97f9908038"
      unitRef="usd">-2000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC05LTEtMS0xMTc3NTY_060033d9-27aa-4c20-bad9-d591da3108ec"
      unitRef="usd">205000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOjc2NTkyODcyYzI4NjRmODNiZmU0MDMwMzVhOTgxYjIyL3RhYmxlcmFuZ2U6NzY1OTI4NzJjMjg2NGY4M2JmZTQwMzAzNWE5ODFiMjJfOC0xMS0xLTEtMTE3NzU2_f2ed557e-0c48-4205-a311-2c73dc91dce8"
      unitRef="usd">160000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0xLTEtMS0xMTc3NTY_728d662f-f9d7-4c2c-ba59-9ab4190c4e07"
      unitRef="usd">562000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0zLTEtMS0xMTc3NTY_7587bd82-9b8c-4dbd-babe-e63204c60221"
      unitRef="usd">449000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy01LTEtMS0xMTc3NTY_69d160e5-701d-4217-959d-3152c8eb52f2"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy03LTEtMS0xMTc3NTY_38d2b308-3f53-46ab-a089-299db49259b9"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic713025c5f254ce39dff89786cb046f1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy05LTEtMS0xMTc3NTY_5184813f-943c-4965-b9c5-de4572e0d8a7"
      unitRef="usd">595000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i8d503d15cc034919b06269f08eeb1a18_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfMy0xMS0xLTEtMTE3NzU2_12b637dd-8515-4126-86eb-51cdbcd31483"
      unitRef="usd">445000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0xLTEtMS0xMTc3NTY_981153bc-d821-4d6c-beb4-4e8653d8f971"
      unitRef="usd">229000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0zLTEtMS0xMTc3NTY_dfee708b-9bcc-4b2e-b584-43e4e54c7758"
      unitRef="usd">121000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy01LTEtMS0xMTc3NTY_41cfa599-058f-4664-86ce-be4d221631c8"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy03LTEtMS0xMTc3NTY_d539631a-60a1-4aa3-a60f-e46d7f279759"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ib83dff2e5f544faba3a65407e44edbd2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy05LTEtMS0xMTc3NTY_e6851b39-5ae6-4953-b914-3a7e5bce8e49"
      unitRef="usd">2000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i6c52f0467a924ffc97424436a5085a77_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfNy0xMS0xLTEtMTE3NzU2_3a31ffd3-1242-4623-b7eb-00b0e85286f0"
      unitRef="usd">2000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0xLTEtMS0xMTc3NTY_3376266e-2295-4c3b-8677-bce92d9c0cbb"
      unitRef="usd">791000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0zLTEtMS0xMTc3NTY_de078667-979d-452d-9ad6-6ffe3a996d57"
      unitRef="usd">570000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC01LTEtMS0xMTc3NTY_35e48dd5-1372-4b14-9cf1-ff74df718852"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC03LTEtMS0xMTc3NTY_e7f64b44-99fa-4e6a-8d8d-5c9c9dbfa1c7"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC05LTEtMS0xMTc3NTY_4877e5f1-2db0-446f-b46c-ca174114064b"
      unitRef="usd">597000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmI2YmQ4ZDBjZjhkYjQ2ZjFhOWQyNWUwM2M1YjExNjEzL3RhYmxlcmFuZ2U6YjZiZDhkMGNmOGRiNDZmMWE5ZDI1ZTAzYzViMTE2MTNfOC0xMS0xLTEtMTE3NzU2_54f935fe-c58e-4bf2-a8ee-bd24fe79901b"
      unitRef="usd">447000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i8a6dc427b52c490eaca902fe4c834622_I20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjAzMQ_b472486c-96ee-4008-9dd9-03dc31e792f4"
      unitRef="usd">170000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1b18f99151344cda858f618b0c9b75e5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjMzOA_7ac952af-197e-42aa-8d52-5fda3cd21547"
      unitRef="usd">43000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i81f79692d5f94137b6d2126460bcc45e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjQ2NA_cf669fb8-202d-4ac0-8853-9510bba6dda1"
      unitRef="usd">155000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i81f79692d5f94137b6d2126460bcc45e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjQ3MQ_5ace8aab-2b35-46f7-9cd0-a42d3c72e94c"
      unitRef="usd">6000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i8e0fb3f550cb46e7866c0f224cacb82b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjc1Nw_d7573f48-91f4-4444-8e66-96ada6a2c7f7"
      unitRef="usd">221000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibb74491d80864f3eaa177e2b8be81ec4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMjc4Ng_50469f2b-2644-4acd-b844-339cfbc8c6bb"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <bmy:LicensingAndOtherArrangementsTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDkyNg_fab721d0-1440-4cda-8243-c25845c283b4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biohaven sublicense income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties and licensing income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:LicensingAndOtherArrangementsTableTextBlock>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic75f9bbfc5724ef3836a765059109689_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi0xLTEtMS0xMTc3NTY_dde17393-1a09-4416-b696-797794da1611"
      unitRef="usd">268000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i6bac004294b34c42a5a7dbf2057b0487_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi0zLTEtMS0xMTc3NTY_90515fc3-4fa7-4289-a4cb-9d1a0373997b"
      unitRef="usd">215000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="id61db944e47a4581aaf245bb80e3db88_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi01LTEtMS0xMTc3NTY_04d44572-6c86-4283-bc9d-745512802eac"
      unitRef="usd">732000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="id2e8f993a1cb4f79a93af4ee934de0b8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMi03LTEtMS0xMTc3NTY_b4919b8e-3708-4563-afa3-001df029e0cf"
      unitRef="usd">611000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ife53d46685aa4a87a864327520e67683_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy0xLTEtMS0xMTc3NTY_1fb48f64-d5e3-4cc6-ab34-3aa3209c6e23"
      unitRef="usd">24000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i93fcbb36dbf1444a8d0f08a84b035f69_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy0zLTEtMS0xMTc3NTY_d233326e-e6aa-45a4-9ddb-69645e859736"
      unitRef="usd">22000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i992ba6626a224684911867fdc13bae74_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy01LTEtMS0xMTc3NTY_48ca23dd-cf41-402c-87b0-c1c69773f142"
      unitRef="usd">68000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i9b7f0dbcd1d24ef9a20304ac3ce6c2f5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfMy03LTEtMS0xMTc3NTY_f8bd31f0-1bd1-48f8-9f04-88a80e3a3295"
      unitRef="usd">67000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS0xLTEtMS0xMTc3NTY_af69e5b3-f420-4008-aca6-79d720c04a44"
      unitRef="usd">0</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS0zLTEtMS0xMTc3NTY_25a11127-24f8-4e5f-ba1e-cf3980e466b7"
      unitRef="usd">10000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS01LTEtMS0xMTc3NTY_2c27206a-ebfd-4f33-bd49-16002ea694f3"
      unitRef="usd">46000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNS03LTEtMS0xMTc3NTY_5a55b440-3562-4167-be00-8e65f805371a"
      unitRef="usd">12000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi0xLTEtMS0xMTc3NTY_8ec4affc-6331-4afb-97d2-55c95c0e1a8e"
      unitRef="usd">18000000</bmy:AmortizationOfDeferredIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi0zLTEtMS0xMTc3NTY_aac65284-5bd6-4b32-840e-8a7e6ed12a00"
      unitRef="usd">-3000000</bmy:AmortizationOfDeferredIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi01LTEtMS0xMTc3NTY_4d2ff527-58e5-4da2-afed-8544471c3e7f"
      unitRef="usd">41000000</bmy:AmortizationOfDeferredIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNi03LTEtMS0xMTc3NTY_bb2f9f4d-ee73-4f85-86e0-9d3ec2e6b9a9"
      unitRef="usd">27000000</bmy:AmortizationOfDeferredIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="id9bad0f88cbc4be39604292bbbed7af6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0xLTEtMS0xMzY4Njg_86ba2f6b-5e66-4799-87cb-825c88e970a8"
      unitRef="usd">55000000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="id17ef668ac624a2f9ff552599af5c465_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0zLTEtMS0xMzY4Njg_ca8bfc71-4f78-43f2-8353-c51ca59807fc"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="i4ea20ff7bff341c7a20fcd4a22892b01_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy01LTEtMS0xMzY4NzY_37154f60-0429-4a3d-865a-bfb7dd36d76b"
      unitRef="usd">55000000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="iaadbb07e45d241d7a53c1917dfe4e639_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy03LTEtMS0xMzY4NzY_8ebf5cd6-788b-4bf4-8c1a-4608eae27fa7"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncome>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="iccec0e6e65dc4d6eb8d442778567cca1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0xLTEtMS0xMTc3NTY_d3389f2c-c22a-460a-9fa8-3ec874cd706b"
      unitRef="usd">9000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i2d0c115f0d654a1aad8188931e7d60e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy0zLTEtMS0xMTc3NTY_dec70854-887a-4b06-8bbc-f112b5ef8e0d"
      unitRef="usd">21000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i5689275b495b4b2f9cf12f272a88fefc_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy01LTEtMS0xMTc3NTY_d900acc1-abe7-43e2-927e-69c17bff45ae"
      unitRef="usd">25000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="icda18d044f594a2ea664a02127e577a6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfNy03LTEtMS0xMTc3NTY_376e501a-9d32-4fd8-a41a-7e0d57049caf"
      unitRef="usd">33000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC0xLTEtMS0xMTc3NTY_31492d21-4be7-4a40-b6b1-ecaee7e34f23"
      unitRef="usd">374000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC0zLTEtMS0xMTc3NTY_9ba801d0-b64e-4dd8-9c34-067382246381"
      unitRef="usd">265000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC01LTEtMS0xMTc3NTY_aeee88d7-d8ca-4403-ab06-06b808bc88f2"
      unitRef="usd">967000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RhYmxlOmJiMWZlYjgyNWU0YzRmNWFiYTYwZGY1MzZiOTE0YmJmL3RhYmxlcmFuZ2U6YmIxZmViODI1ZTRjNGY1YWJhNjBkZjUzNmI5MTRiYmZfOC03LTEtMS0xMTc3NTY_9bcc4175-cb50-4454-9990-cc9cc7709951"
      unitRef="usd">750000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="ie82664611f3e4121968092cf4cd0861d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzgxMQ_0dbd55df-b600-4fbf-b6b7-5578456435d9"
      unitRef="usd">150000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:ContingentAndRegulatoryMilestonePayments
      contextRef="ie82664611f3e4121968092cf4cd0861d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzk4Mw_7b71c883-184b-4462-91e8-97eb4c02974f"
      unitRef="usd">770000000</bmy:ContingentAndRegulatoryMilestonePayments>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="ida5d1dc816114f0ca32419717d7722db_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDE2Mg_bb2efb61-983f-42c2-ada2-97fd021f8b21"
      unitRef="usd">175000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="ib44f04ed35d04422a86bc2725b539aee_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzg0ODI5MDcyNzg3Nw_b2b5b65c-1623-44f2-a91c-99c9dc412d59"
      unitRef="usd">200000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:ContingentAndRegulatoryMilestonePayments
      contextRef="ib44f04ed35d04422a86bc2725b539aee_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfMzg0ODI5MDcyNzg5MQ_79119eeb-19ac-421c-8cb2-786b3f9c76b2"
      unitRef="usd">1400000000</bmy:ContingentAndRegulatoryMilestonePayments>
    <bmy:PaymentToExtinguishFutureRoyaltyObligation
      contextRef="i06dd7c1aa48f4cd691db5ffb92ff9be9_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180My9mcmFnOjI0ZTBhZDBiZmZiMTQ3ZGZiZGExZjczZGNmNzVjM2ZjL3RleHRyZWdpb246MjRlMGFkMGJmZmIxNDdkZmJkYTFmNzNkY2Y3NWMzZmNfNDcxOQ_07b62979-4e9d-4b4c-a42e-f1d8d5e49097"
      unitRef="usd">295000000</bmy:PaymentToExtinguishFutureRoyaltyObligation>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RleHRyZWdpb246MzIzMjExNTM4ZjdhNGYxNDlmODdmYWRjMWQyNTg0NjlfNDk_a8fa3036-85d2-47bc-9251-05eed527bb55">OTHER (INCOME)/EXPENSE, NET&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses/(income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture losses/(gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <bmy:ScheduleOfOtherIncomeExpenseTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RleHRyZWdpb246MzIzMjExNTM4ZjdhNGYxNDlmODdmYWRjMWQyNTg0NjlfNTU_936e9bb6-5a16-42d3-88bf-1f0364f190aa">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses/(income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture losses/(gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfOtherIncomeExpenseTextBlock>
    <us-gaap:InterestExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi0xLTEtMS0xMTc3NTY_1e27f141-8ed9-463c-8aca-e0578ae0321c"
      unitRef="usd">299000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi0zLTEtMS0xMTc3NTY_bc44154e-1e47-4605-ac15-dd013266b87e"
      unitRef="usd">328000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi01LTEtMS0xMTc3NTY_ab27d08d-bc55-4a2d-b087-49475b13d33c"
      unitRef="usd">938000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMi03LTEtMS0xMTc3NTY_495fad33-746f-46fe-8c14-332aaadd42e4"
      unitRef="usd">1011000000</us-gaap:InterestExpense>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy0xLTEtMS0xMTc3NTY_bb3fee8e-002e-44ab-b939-e076b74eb96a"
      unitRef="usd">579000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy0zLTEtMS0xMTc3NTY_ff63ade3-674e-4fcc-9ef8-42c50e5ea475"
      unitRef="usd">425000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy01LTEtMS0xMTc3NTY_23ed518a-f96a-43ce-a93c-881425a8d90f"
      unitRef="usd">1564000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMy03LTEtMS0xMTc3NTY_b770f5c2-1570-4eed-bac9-6d033c18b640"
      unitRef="usd">1197000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <us-gaap:GainLossOnInvestments
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC0xLTEtMS0xMTc3NTY_9b5915e9-e5ea-495f-8685-fc0a080e5557"
      unitRef="usd">-14000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC0zLTEtMS0xMTc3NTY_8caf944a-3c5a-4448-adcc-f7e1d942eb83"
      unitRef="usd">465000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC01LTEtMS0xMTc3NTY_21f5414b-23b1-43a0-91d8-62e89cf55cfe"
      unitRef="usd">-966000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNC03LTEtMS0xMTc3NTY_3ee5df5a-e260-4cce-9ae7-fe4148d02722"
      unitRef="usd">1214000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS0xLTEtMS0xMTc3NTY_24a2f4c2-befb-4b71-bd26-b9c9b8825d87"
      unitRef="usd">114000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS0zLTEtMS0xMTc3NTY_7a17759d-3223-43f4-b9d6-9a0541a20387"
      unitRef="usd">141000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS01LTEtMS0xMTc3NTY_cad6b0cd-ecb3-47f7-9e66-c79221490054"
      unitRef="usd">343000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNS03LTEtMS0xMTc3NTY_6328d45c-e5a2-4560-8215-78e8d6b4f5be"
      unitRef="usd">434000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi0xLTEtMS0xMTc3NTY_bf142e86-6670-49c4-bdef-df3b3e158d47"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi0zLTEtMS0xMTc3NTY_f82bfa50-f422-4b9b-9377-9ab9d045ecea"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi01LTEtMS0xMTc3NTY_0225a6d1-bdd5-4f8a-a435-2bd01da7bdcd"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNi03LTEtMS0xMTc3NTY_253a662b-51d5-495c-a2af-a6e2aced3704"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy0xLTEtMS0xMTc3NTY_adff0ca2-b098-434a-8bea-1090821c0b3c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy0zLTEtMS0xMTc3NTY_096b1f5f-9ab3-4ba4-b55a-e7cf2e5bca31"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy01LTEtMS0xMTc3NTY_aa2915c0-68bd-4f2a-93b6-c4d81ba5c9bd"
      unitRef="usd">-266000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfNy03LTEtMS0xMTc3NTY_aa3f8208-c963-4c62-95aa-04489e2845ed"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RestructuringCharges
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC0xLTEtMS0xMTc3NTY_184d2cfc-9755-413f-8284-920be0f086f4"
      unitRef="usd">17000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC0zLTEtMS0xMTc3NTY_d262382c-f5a2-43bd-b7c6-56ca1e8691b3"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC01LTEtMS0xMTc3NTY_d0e63a45-8599-43fe-93e1-a7507f321bfc"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOC03LTEtMS0xMTc3NTY_544aee25-9eb8-4433-9d93-48ec86ed2708"
      unitRef="usd">150000000</us-gaap:RestructuringCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS0xLTEtMS0xMTc3NTY_68a3d3ac-12bc-4175-8877-e535b8bcbbcf"
      unitRef="usd">-44000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS0zLTEtMS0xMTc3NTY_dd42f6cf-6e0f-4ebc-8e6e-956ff9b0c732"
      unitRef="usd">-13000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS01LTEtMS0xMTc3NTY_26178a61-1191-4850-802f-02200ee310ab"
      unitRef="usd">-32000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfOS03LTEtMS0xMTc3NTY_33f15d12-1cce-47e9-837f-aa404d6cb8d2"
      unitRef="usd">-49000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtMS0xLTEtMTE3NzU2_c6dead9a-96c7-4c5c-b7ed-d56fd98f90ab"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtMy0xLTEtMTE3NzU2_1b01ba2f-e168-4b63-a840-35d6654dc620"
      unitRef="usd">-2000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtNS0xLTEtMTE3NzU2_3895a123-95b6-4511-9f8c-31c01dc3e332"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTMtNy0xLTEtMTE3NzU2_20416f53-3dfe-45e9-bc2c-e7a843b57def"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <bmy:OtherOtherIncomeExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtMS0xLTEtMTE3NzU2_b1e8a674-8432-44ef-b565-af173a0ae153"
      unitRef="usd">49000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtMy0xLTEtMTE3NzU2_0f6ad0d3-beb4-483e-a47f-712b787c35ff"
      unitRef="usd">30000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtNS0xLTEtMTE3NzU2_81e9d07a-1572-46e7-a831-1ae50156598e"
      unitRef="usd">38000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTgtNy0xLTEtMTE3NzU2_d25661fb-0f55-4fba-8105-96395de0a0dc"
      unitRef="usd">108000000</bmy:OtherOtherIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktMS0xLTEtMTE3NzU2_368703fa-0826-433c-95e4-bb61b2ea63ec"
      unitRef="usd">140000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktMy0xLTEtMTE3NzU2_3d2a6c0d-aaa5-47e9-9443-325216398829"
      unitRef="usd">409000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktNS0xLTEtMTE3NzU2_b7e20c97-bca5-4876-8fab-ed0f80b216d5"
      unitRef="usd">-793000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN180OS9mcmFnOjMyMzIxMTUzOGY3YTRmMTQ5Zjg3ZmFkYzFkMjU4NDY5L3RhYmxlOjA2NDljMWQwMjE4NTQwNGJiZTNkM2ZiZGEzNGMxMWIwL3RhYmxlcmFuZ2U6MDY0OWMxZDAyMTg1NDA0YmJlM2QzZmJkYTM0YzExYjBfMTktNy0xLTEtMTE3NzU2_a595ce23-ba33-406f-991f-d7098e6160fb"
      unitRef="usd">1113000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkwNg_bb1a5b68-72aa-417d-9b37-5ac5ae2bf9e0">RESTRUCTURING&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (5%), Marketing, selling and administrative expenses (65%) and Research and development expenses (30%). Charges of approximately $3.5&#160;billion are expected to be incurred including cash outlays of approximately $3.1&#160;billion. Cumulative charges of approximately $3.0&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. Employee workforce reductions were approximately 150 and 320 for the nine months ended September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition on August 17, 2022, and the MyoKardia acquisition in 2020. Charges of approximately $250&#160;million are expected to be incurred through the end of 2023, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of $151 million have been recognized for these actions to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other shutdown costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $6 million and $17 million for the nine months ended September 30, 2022 and 2021, respectively. Excludes $12 million for the nine months ended September 30, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance
      contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMjk1_35b1c82e-1292-4c6c-a852-a49b90779266"
      unitRef="usd">3000000000</bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance>
    <bmy:ExpectedSynergiesPercentage
      contextRef="i15769c9092334b38abe2ab74542152e2_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMzY3_6161df6f-efa9-4f8a-bf98-d4e636c1795e"
      unitRef="number">0.05</bmy:ExpectedSynergiesPercentage>
    <bmy:ExpectedSynergiesPercentage
      contextRef="i835e2f7f63d7466da1773c331a6cf84d_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDIw_416358bb-574d-477a-bd10-fbf7235982ce"
      unitRef="number">0.65</bmy:ExpectedSynergiesPercentage>
    <bmy:ExpectedSynergiesPercentage
      contextRef="idcab3a9d790d43a4aaa580b8ce49e8db_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDYz_4b6c8853-9f31-4afe-8af8-7f30a81ed478"
      unitRef="number">0.30</bmy:ExpectedSynergiesPercentage>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNDkz_df53db17-cf11-4a93-80a7-4629c3f48ea9"
      unitRef="usd">3500000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bmy:Cashoutlays
      contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNTQ5NzU1ODI5NzUz_46946aa2-7b36-44c1-985f-506f167930d3"
      unitRef="usd">3100000000</bmy:Cashoutlays>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i59dc6e2eaf6747698f5844e44fa3e63c_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNjMx_fabecbeb-b0c2-4541-9e0f-419011ff4498"
      unitRef="usd">3000000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTAwNw_a233d830-7e3e-4e47-a397-207ef8efb2f6"
      unitRef="employee">150</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTAxNA_84a46bb5-878e-4095-8d4a-040926196a8a"
      unitRef="employee">320</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i1410968e21274826afdf23dc9434f736_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTA5OTUxMTYzMzAzOA_efcc8239-8ccf-4d7e-95d5-3d8b88e3cc43"
      unitRef="usd">250000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i1410968e21274826afdf23dc9434f736_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTA5OTUxMTYzMzkxMQ_4d6f8399-6d5e-42bb-9ecf-cec1f09eaacf"
      unitRef="usd">151000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkxMg_0a839eaa-7d24-4ec1-84e1-2b144435cdb1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other shutdown costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iead756ca21984013a7bd69516352fb13_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi0xLTEtMS0xMTc3NTY_d752b5af-b743-46ed-b281-89991dbaa8c5"
      unitRef="usd">102000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ia870ef2304084b55ab48e0eae6731bb0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi0zLTEtMS0xMTc3NTY_a68d477c-600a-478a-ab6a-75b55268e6f1"
      unitRef="usd">153000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i86d48d0d06604c1580140fbf4064177a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi01LTEtMS0xMTc3NTY_23e3599c-d28c-4458-9c5a-db7c51ae0171"
      unitRef="usd">375000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i111a0264cc204997aefd5192fd6857ca_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMi03LTEtMS0xMTc3NTY_1c4f2d1a-655d-40f7-b4d3-6e48ae8f1cd0"
      unitRef="usd">526000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8b86689f804f49e4ad0215f4c9f4f9c4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy0xLTEtMS0xMTc3NTY_c8c3454e-e2d6-4a26-8b50-08892d54a2d4"
      unitRef="usd">29000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8b6962ac7520419e9e5528c42e86a43e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy0zLTEtMS0xMTc3NTY_f99e844d-8789-4780-be1d-60594f83f338"
      unitRef="usd">18000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i6f20b9403da74f8ebf7c5eae9ba72e8c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy01LTEtMS0xMTc3NTY_31ca18d4-1ced-4c6d-a3db-27a9f594d895"
      unitRef="usd">34000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="id1052bb4a0b64c1aac26a10e810aafe7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMy03LTEtMS0xMTc3NTY_5290e8c0-7b69-4e27-a327-4b4a2492b15f"
      unitRef="usd">74000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS0xLTEtMS0xMTc3NTY_7cce985e-baf4-46cf-99a2-67a67988ef5d"
      unitRef="usd">131000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS0zLTEtMS0xMTc3NTY_bfd00d7a-097c-4a72-9e7f-2c547a391afc"
      unitRef="usd">171000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS01LTEtMS0xMTc3NTY_43e617f0-d2c3-462e-a7b1-64e69fb24b61"
      unitRef="usd">409000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNS03LTEtMS0xMTc3NTY_633c786c-7cf3-45db-b3ff-7a0c48e8482f"
      unitRef="usd">600000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:SeveranceCosts1
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy0xLTEtMS0xMTc3NTY_a25d8f2a-827a-4078-8eac-5117631efbb7"
      unitRef="usd">16000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy0zLTEtMS0xMTc3NTY_ad05ae8c-3594-48a8-8c75-0f6b6349ad6d"
      unitRef="usd">24000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy01LTEtMS0xMTc3NTY_d3a9c86c-7366-4317-83ae-dd3fc53fd350"
      unitRef="usd">57000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfNy03LTEtMS0xMTc3NTY_9e990adc-c3bb-402f-b5cb-67c3ed16c82c"
      unitRef="usd">143000000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC0xLTEtMS0xMTc3NTY_fb38f64c-524c-4902-a58f-17181de105fa"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC0zLTEtMS0xMTc3NTY_a0e73092-371c-402c-a8e2-c61fb558f917"
      unitRef="usd">3000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC01LTEtMS0xMTc3NTY_450748ea-bb7d-4762-a18c-b10706b34d64"
      unitRef="usd">3000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOC03LTEtMS0xMTc3NTY_69f803d5-cfd0-4cc1-85f9-e0bea38a88eb"
      unitRef="usd">7000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS0xLTEtMS0xMTc3NTY_054d7587-0e83-441f-9e79-a09bf55e0081"
      unitRef="usd">17000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS0zLTEtMS0xMTc3NTY_6bd2fdc4-0ce2-47d9-8ee6-dce8963b7fcd"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS01LTEtMS0xMTc3NTY_094d6b75-7b0d-4215-ae9a-c4f0dd424276"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfOS03LTEtMS0xMTc3NTY_2b128dd6-bfc3-4bb0-b290-68620c7ee634"
      unitRef="usd">150000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtMS0xLTEtMTE3NzU2_89abf384-7a2d-4789-a180-8f556e4b753c"
      unitRef="usd">114000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtMy0xLTEtMTE3NzU2_398955ba-6d2c-40de-b8d8-b6ab78a36c7c"
      unitRef="usd">141000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtNS0xLTEtMTE3NzU2_8986feef-bb26-4bc6-a7d6-195df03317eb"
      unitRef="usd">343000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTAtNy0xLTEtMTE3NzU2_603e1250-0c4b-4d52-97d7-d5bc80f7ad7a"
      unitRef="usd">434000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtMS0xLTEtMTE3NzU2_aca10127-d905-420d-b700-bbcab2fd7ffd"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtMy0xLTEtMTE3NzU2_73fd9b99-da43-4b0b-978c-f94cfb462d20"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtNS0xLTEtMTE3NzU2_b3f38ead-13a8-4951-bd6b-273bad898de7"
      unitRef="usd">6000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTEtNy0xLTEtMTE3NzU2_6dcf5d0d-361c-4126-a2cc-dbb9852c5992"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItMS0xLTEtMTE3NzU2_59ae5c73-3b48-44b1-b6a7-18ccc2e13dec"
      unitRef="usd">0</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItMy0xLTEtMTE3NzU2_97e64d22-913f-4ec8-9e25-f1a57552bbed"
      unitRef="usd">0</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItNS0xLTEtMTE3NzU2_8634d8e2-7445-4369-be90-de8112d3c7f8"
      unitRef="usd">0</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTItNy0xLTEtMTE3NzU2_fe628396-d6ae-4cc0-bf5c-151b88b7476a"
      unitRef="usd">24000000</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:OtherShutdownCosts
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtMS0xLTEtMTE3NzU2_92583073-0517-4f18-a325-892ebc3e7ba4"
      unitRef="usd">0</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtMy0xLTEtMTE3NzU2_1287d4a8-8cd9-4243-80a4-ebfcb5b0da77"
      unitRef="usd">3000000</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtNS0xLTEtMTE3NzU2_c359d200-3802-4d5f-8d9e-b08fc92fbdb3"
      unitRef="usd">0</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTMtNy0xLTEtMTE3NzU2_c22767a2-5929-4124-9558-fc4d19554d1d"
      unitRef="usd">-8000000</bmy:OtherShutdownCosts>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtMS0xLTEtMTE3NzU2_6d66cf72-ebc9-48c6-a10c-e2dc39036957"
      unitRef="usd">131000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtMy0xLTEtMTE3NzU2_889b0010-8b06-4c8a-9f52-537f8245cdfb"
      unitRef="usd">171000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtNS0xLTEtMTE3NzU2_db4cd73a-cf6b-4a0a-a6c3-6d5b5d3e7596"
      unitRef="usd">409000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTQtNy0xLTEtMTE3NzU2_fde6fb55-aa81-4a2d-b3f1-1b40ccb12e53"
      unitRef="usd">600000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtMS0xLTEtMTE3NzU2_5b14857c-2b7c-4f86-9ba1-978083fbf747"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtMy0xLTEtMTE3NzU2_208f4c05-d2ba-4029-bacf-6288ede989e4"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtNS0xLTEtMTE3NzU2_0715e923-1996-4a71-99f9-8135738524a4"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTYtNy0xLTEtMTE3NzU2_6863beaa-0870-4d6b-9cb0-861005d21ea0"
      unitRef="usd">24000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctMS0xLTEtMTE3NzU2_cd63415f-5b41-4a07-983d-922aad490d5e"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i02826b699eda4a97ba070709457b65f1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctMy0xLTEtMTE3NzU2_a510122d-2b35-4fed-983f-3d6fe264d7a8"
      unitRef="usd">1000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ic4634dede34e4e588b48071be679100a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctNS0xLTEtMTE3NzU2_c17737db-3aab-4f79-8ec3-7c895b2ad3fa"
      unitRef="usd">6000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i6947273e102141838832d4c25bb46991_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTctNy0xLTEtMTE3NzU2_d278dceb-0990-41bf-bc29-e327fd6f0624"
      unitRef="usd">1000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iab45139100524f8f85cebfc6cbfa75ca_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktMS0xLTEtMTE3NzU2_7f6a3748-4bf8-430f-a35c-66d129716683"
      unitRef="usd">131000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i04e5de495c7546bfa0bb84d26e067aa1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktMy0xLTEtMTE3NzU2_3353160a-1abe-495c-84d9-11c3651ba756"
      unitRef="usd">170000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i18f652f6a9e84b1091a70c260f8d4511_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktNS0xLTEtMTE3NzU2_20eee69a-de2f-4f1a-89ff-858239c9c01b"
      unitRef="usd">403000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ife4473abbbdf4a9eb56ed31379f62651_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMTktNy0xLTEtMTE3NzU2_3a7c0606-88c0-40df-9aa5-5c0aada1251d"
      unitRef="usd">575000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtMS0xLTEtMTE3NzU2_72462b6e-f0c9-49e8-907c-fb2e2b15bb49"
      unitRef="usd">131000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtMy0xLTEtMTE3NzU2_a6c8aa1a-e765-477d-a36d-147c762cf272"
      unitRef="usd">171000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtNS0xLTEtMTE3NzU2_37b73dbb-c782-4c3f-a93b-4e2942ec8a4b"
      unitRef="usd">409000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOjRiMTE3Zjg5M2RmMjRlNGM4ODU0ODlhNzM1M2UzYTFjL3RhYmxlcmFuZ2U6NGIxMTdmODkzZGYyNGU0Yzg4NTQ4OWE3MzUzZTNhMWNfMjAtNy0xLTEtMTE3NzU2_825bfc16-2e04-4454-ad5a-0f19e00d8f71"
      unitRef="usd">600000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTkwNw_908d0a6a-5430-4e55-a2de-0ca383fe5f37">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $6 million and $17 million for the nine months ended September 30, 2022 and 2021, respectively. Excludes $12 million for the nine months ended September 30, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMi0xLTEtMS0xMTc3NTY_a8a7fc89-1372-4739-ab8e-63b9ffadcf20"
      unitRef="usd">101000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if781377a20f34a65860112e032558c03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMi0zLTEtMS0xMTc3NTY_cef082e0-5b7e-4b3e-ae19-e0cc30e0c721"
      unitRef="usd">148000000</us-gaap:RestructuringReserve>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMy0xLTEtMS0xMTc3NTY_81308fa5-b725-492b-a5c9-00b1da29d5c8"
      unitRef="usd">60000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfMy0zLTEtMS0xMTc3NTY_f2c8a030-9543-4614-b7e2-9d9120ca743b"
      unitRef="usd">138000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNC0xLTEtMS0xMTc3NTY_cdbca460-683e-434e-ad84-fc3ad226c800"
      unitRef="usd">-10000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNC0zLTEtMS0xMTc3NTY_f58a4176-9da2-4df8-aab8-c072602aa91d"
      unitRef="usd">-4000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:PaymentsForRestructuring
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNS0xLTEtMS0xMTc3NTY_fb314251-9ab4-46a5-bc6a-8e95731fb992"
      unitRef="usd">106000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNS0zLTEtMS0xMTc3NTY_97ce4bec-2177-41ca-8ee6-b676c0bd98df"
      unitRef="usd">170000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNi0xLTEtMS0xMTc3NTY_34582610-9523-43f2-bcd3-874e45e518f4"
      unitRef="usd">45000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RhYmxlOmYxMDdmN2UzMzExNzQ1ZDdiMTM3YTA0MWIyZTI0ZDkxL3RhYmxlcmFuZ2U6ZjEwN2Y3ZTMzMTE3NDVkN2IxMzdhMDQxYjJlMjRkOTFfNi0zLTEtMS0xMTc3NTY_aae36567-55cc-42ee-9bd4-fcb62b2d5f4f"
      unitRef="usd">112000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTc3NA_b9f9dbaf-df58-4e31-a34e-3c02845357bc"
      unitRef="usd">6000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfNTQ5NzU1ODE1ODA2_9a490abe-a2cc-432c-8754-e9e2ac93e23a"
      unitRef="usd">17000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="ibcbea72907fd45ed8c844cd0e81ebc36_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181Mi9mcmFnOjk2YWY1NjViNjNjYzQxYjhhZmNkYzY5ZTBjMmQ1YzM3L3RleHRyZWdpb246OTZhZjU2NWI2M2NjNDFiOGFmY2RjNjllMGMyZDVjMzdfMTgxMA_dafef802-1d7a-4912-81db-05402d6371d7"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfMTk3NA_82cac1af-b862-4b24-89d8-78c2c66cc2d9">INCOME TAXES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments, intangible asset amortization, and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that the amount of unrecognized tax benefits as of September&#160;30, 2022 could decrease in the range of approximately $480 million to $530 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#x2019;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfMTk3Mg_14725ec6-f7c9-4520-adfa-b1d0633d6f1e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi0xLTEtMS0xMTc3NTY_a2adcfe5-18a6-4237-87fd-364228f77ae4"
      unitRef="usd">2209000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi0zLTEtMS0xMTc3NTY_48b283a3-6af8-4ef4-9866-6ab952a3a7d7"
      unitRef="usd">2157000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi01LTEtMS0xMTc3NTY_a31baa79-0071-40bb-9ade-a096b2f6469c"
      unitRef="usd">5854000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMi03LTEtMS0xMTc3NTY_142eb004-d081-4318-b914-ffd9111948dd"
      unitRef="usd">6240000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy0xLTEtMS0xMTc3NTY_30d210fc-9104-4189-9fea-a72101d537e8"
      unitRef="usd">601000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy0zLTEtMS0xMTc3NTY_9144edee-ee25-48d5-a0d7-ce952e790831"
      unitRef="usd">605000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy01LTEtMS0xMTc3NTY_9e9219a7-a48b-4b7f-bc7a-33dcbfb0580b"
      unitRef="usd">1534000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfMy03LTEtMS0xMTc3NTY_0728805e-4b52-4c59-a512-6d4c5eadd2d9"
      unitRef="usd">1598000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC0xLTEtMS0xMTc3NTY_40ea24bb-b30d-4c42-a87f-37fdf766583e"
      unitRef="number">0.272</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC0zLTEtMS0xMTc3NTY_9b92a532-56d3-456a-ba04-15588bb022d8"
      unitRef="number">0.280</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC01LTEtMS0xMTc3NTY_fd815b89-4244-4852-ac5f-186557352391"
      unitRef="number">0.262</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RhYmxlOjhkOTdmMzE4ZjA5YTQxMDBhNDdjMWQ0MjY4NDRjODQ2L3RhYmxlcmFuZ2U6OGQ5N2YzMThmMDlhNDEwMGE0N2MxZDQyNjg0NGM4NDZfNC03LTEtMS0xMTc3NTY_0becdcea-eb0b-424a-bdaa-324cb30dafe2"
      unitRef="number">0.256</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ib73eeb74828048d393d64170a29ce8f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfODUx_1ab130b6-afe9-41d5-833e-f5fea31edb40"
      unitRef="usd">480000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i5b1ef508785f46e8951a4b5d8734fe0e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181NS9mcmFnOjJjMjJkODZmYjA5ZDQxZDQ4MjQ5YmUxMDdiZmVjZjgwL3RleHRyZWdpb246MmMyMmQ4NmZiMDlkNDFkNDgyNDliZTEwN2JmZWNmODBfODU3_9450bb25-9608-4e3a-8fd7-599b91fdd6b6"
      unitRef="usd">530000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RleHRyZWdpb246NDk5MTgzZGE1YmQ3NGIyMGJkZGE1MDY4ZmRmNTVmNjVfMjM2_8289e86a-051b-4cd9-83d8-9f7ec9d87459">EARNINGS PER SHARE&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RleHRyZWdpb246NDk5MTgzZGE1YmQ3NGIyMGJkZGE1MDY4ZmRmNTVmNjVfMjMw_dbe60351-3712-49f1-b326-3775023fd65f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi0xLTEtMS0xMTc3NTY_408c9e80-d4b6-4fb1-99bb-f456eced84a2"
      unitRef="usd">1606000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi0zLTEtMS0xMTc3NTY_f8e2c187-97e8-4ae4-b887-bcccebcf7cfa"
      unitRef="usd">1546000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi01LTEtMS0xMTc3NTY_8874f060-a82d-4549-bd28-60792b17c434"
      unitRef="usd">4305000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMi03LTEtMS0xMTc3NTY_692022a9-e354-4e9d-9a0f-1649a1087557"
      unitRef="usd">4622000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC0xLTEtMS0xMTc3NTY_6497e19e-4882-48a0-9256-0017d77d61c3"
      unitRef="shares">2133000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC0zLTEtMS0xMTc3NTY_97382047-12fd-4b0f-a45a-32412cf2a792"
      unitRef="shares">2219000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC01LTEtMS0xMTc3NTY_931880c9-fdfe-440d-a897-e08a239cecf4"
      unitRef="shares">2137000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNC03LTEtMS0xMTc3NTY_53b529ae-db36-43df-9153-c1186b6ee635"
      unitRef="shares">2227000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS0xLTEtMS0xMTc3NTY_ec6840b2-8ddb-4567-954e-ca9331258574"
      unitRef="shares">15000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS0zLTEtMS0xMTc3NTY_60ff42c5-2b7c-49fa-8053-b0b66a5c4f46"
      unitRef="shares">24000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS01LTEtMS0xMTc3NTY_ca30f2ff-c818-4fdf-947e-4b8ff8df06ea"
      unitRef="shares">17000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNS03LTEtMS0xMTc3NTY_72c6c0e8-bffb-4faa-9ae5-cece8dfb6c41"
      unitRef="shares">26000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi0xLTEtMS0xMTc3NTY_8e760dd3-a05d-4006-8c54-08599d36e966"
      unitRef="shares">2148000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi0zLTEtMS0xMTc3NTY_db15483e-7878-42fb-805d-fc06d999ad7d"
      unitRef="shares">2243000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi01LTEtMS0xMTc3NTY_24f6b3ad-f189-4e65-a57d-315d9b948be3"
      unitRef="shares">2154000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfNi03LTEtMS0xMTc3NTY_ee0ad695-27ae-4d69-9217-12b413885869"
      unitRef="shares">2253000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS0xLTEtMS0xMTc3NTY_07821a8f-8da9-4757-a1fd-3c09287a779b"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS0zLTEtMS0xMTc3NTY_5fa61ff7-3055-4fe8-ae7d-7edc577fca98"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS01LTEtMS0xMTc3NTY_474b2c88-be1e-4cc3-8ce9-6d7cb40e433f"
      unitRef="usdPerShare">2.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfOS03LTEtMS0xMTc3NTY_202b307e-332b-4588-9738-9b7f8b4f4d54"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtMS0xLTEtMTE3NzU2_b5d974d4-0ad6-4204-96f7-8cafa2a2ce1d"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtMy0xLTEtMTE3NzU2_eed7092b-bc64-478f-8f46-114d56d3a5c9"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtNS0xLTEtMTE3NzU2_522a0004-7fcd-49bb-811b-430979267bb0"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN181OC9mcmFnOjQ5OTE4M2RhNWJkNzRiMjBiZGRhNTA2OGZkZjU1ZjY1L3RhYmxlOjAxODU5ZDg1YmE5OTQzNThiOGMwN2JmZmRlYTc3Y2E5L3RhYmxlcmFuZ2U6MDE4NTlkODViYTk5NDM1OGI4YzA3YmZmZGVhNzdjYTlfMTAtNy0xLTEtMTE3NzU2_30122e23-d91c-462b-b8e2-3f8dd38e03a2"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMjc_b51e938f-f8c3-4299-ad21-86c80ca0853f">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As further described in &#x201c;Item 8. Financial Statements and Supplementary Data&#x2014;Note 9. Financial Instruments and Fair Value Measurements&#x201d; in the Company&#x2019;s 2021 Form 10-K, the Company&#x2019;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of September&#160;30, 2022 and December 31, 2021. The restrictions will expire by April 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Marketable Debt Securities and Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of September&#160;30, 2022, and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limited partnerships and other equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determined fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss/(gain) recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (gain)/loss recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss/(gain) recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss/(income) of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Qualifying Hedges and Non-Qualifying Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $5.1 billion and Japanese yen of $1.4 billion as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2022, BMS entered into cross-currency interest rate swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in Accumulated other comprehensive loss and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency interest rate swap contracts was &#x20ac;575&#160;million ($584&#160;million) as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Non-U.S. dollar borrowings of &#x20ac;375 million ($368 million) as of September&#160;30, 2022, are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency interest rate swap contracts of $1.4 billion as of September&#160;30, 2022, are designated to hedge certain currency exposures of BMS&#x2019;s net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other current and Other non-current assets or Other current and Other non-current liabilities. The notional amount of outstanding cross-currency interest rate swaps was primarily attributed to the Japanese yen of $686&#160;million and euro of $584&#160;million as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (3.14% as of September&#160;30, 2022) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 24 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of long-term debt was $34.3 billion as of September&#160;30, 2022 and $49.1 billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30 2022, BMS purchased an aggregate principal amount of $6.0&#160;billion of certain of its debt securities for $6.6&#160;billion of cash in tender offers and &#x201c;make whole&#x201d; redemptions. In connection with these transactions, a $266&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2022, $4.75&#160;billion of debt matured and was repaid including $1.5&#160;billion 2.600% Notes, $500&#160;million Floating Rate Notes, $750&#160;million 2.000% Notes, $1.0&#160;billion 3.250% Notes and $1.0&#160;billion 3.550% Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2022, we issued an aggregate principal amount of $6.0&#160;billion of debt with net proceeds of $5.9&#160;billion. The table below summarizes the issuances:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.550% Notes due 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.700% Notes due 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.900% Notes due 2062&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the nine months ended September 30, 2021, BMS purchased an aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#x201c;make whole&#x201d; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the nine months ended September 30, 2021, $2.0&#160;billion of debt matured and was repaid including $500&#160;million 2.875% Notes, $1.0&#160;billion 2.550% Notes and $500&#160;million 2.250% Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments were $1.1 billion and $1.2 billion for the nine months ended September 30, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, BMS had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility which expired in January 2022, a three-year $1.0&#160;billion facility which expired in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. &lt;/span&gt;&lt;/div&gt;In January 2022, BMS entered into a five-year $5.0&#160;billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5&#160;billion facilities were terminated and the three-year $1.0&#160;billion facility and 364-day $2.0&#160;billion facility expired in accordance with their terms in January 2022. No borrowings were outstanding under any revolving credit facility as of September&#160;30, 2022 or December&#160;31, 2021.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAxMDE_4a0427fe-5011-4196-97ef-bb1aeb3ab1a3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0xLTEtMS0xMTc3NTY_51b59b36-a502-4848-8371-19e3d56dd5b0"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0zLTEtMS0xMTc3NTY_308029a2-098b-45f2-94ac-4b90f1589c5c"
      unitRef="usd">4667000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi01LTEtMS0xMTc3NTY_76619b9a-4c23-4641-9874-cfb9114a09ae"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi03LTEtMS0xMTc3NTY_b8aa07b3-e545-4fd9-9289-e9f5f4a5ddff"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i664e35471e3b431f80b8059482063353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi05LTEtMS0xMTc3NTY_e1f01a7f-3fdc-46c4-81f2-5031f88266b3"
      unitRef="usd">12225000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMi0xMS0xLTEtMTE3NzU2_f9924cf8-4769-4fa9-979e-8c4c8b378b9a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf1750b8def3481db064bae547758030_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0xLTEtMS0xMTc3NTY_c4acb7f4-ae22-4a14-a96c-7b84fdb5a524"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i599407fe2aa64479abc2cb9f8943ddf2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0zLTEtMS0xMTc3NTY_5a9a7fcf-13d6-430b-865f-15b92679668f"
      unitRef="usd">1080000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iddf109f29964447db19dbc4a67325a91_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC01LTEtMS0xMTc3NTY_1bd772e4-2065-4f4c-ad85-ed78652525d8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86460ffdc92343a1b34f3701d5ba3f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC03LTEtMS0xMTc3NTY_e96d51b7-18f8-4a6e-b165-525052c46f22"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i023d3dd7e5e2466fa118f0a377f5a86e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC05LTEtMS0xMTc3NTY_c4a56fb4-165d-45b2-8cf3-c6bf2c108b03"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i023203ca7e2c44c6aef398e5ac1f362c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNC0xMS0xLTEtMTE3NzU2_d180e090-4ef6-4fa9-a4b9-7399dfe5e523"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55f21b31cd934d95bec8c47f5cca9d7d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0xLTEtMS0xMTc3NTY_e480e1d9-ad16-416d-9c92-da1a7f00e96b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i751bb8a9c76a4066b66cc023f2f6e8ae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0zLTEtMS0xMTc3NTY_1249424d-70f9-44eb-9b43-3e4f7e957a4e"
      unitRef="usd">168000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3bfb1a2171374f4680084a5e82d83fa3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS01LTEtMS0xMTc3NTY_3c790985-0cf8-4f34-9214-58b828738407"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb6cfdd1ed78472f99fc8e5e7c606f21_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS03LTEtMS0xMTc3NTY_55a072ee-498b-496d-9b64-2b555551bb21"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie6520e68dbf54cdc8ec17823e10b0646_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS05LTEtMS0xMTc3NTY_0b516224-61f6-497b-b9b5-2f5b809be326"
      unitRef="usd">320000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89986bb97ecb4e97aff1b91cce777c15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNS0xMS0xLTEtMTE3NzU2_2863a682-3f38-4d67-8ece-08d71f7539ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e9b662730384bb7b4ead3470de0d515_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0xLTEtMS0xMTc3NTY_e9a74820-8dc9-4131-9277-5b7dbda0e04d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic9c861dc4c60414088ec212834a771e4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0zLTEtMS0xMTc3NTY_88c0c609-8f1f-4554-a156-75169a4f8a67"
      unitRef="usd">45000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifac1ef197e014b5dae4b0dcbf87a2891_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi01LTEtMS0xMTc3NTY_70a43859-971b-4b17-99b5-d584067e8a26"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7100bf3c38b24a52bf40ec5e7f24933a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi03LTEtMS0xMTc3NTY_52863a86-a0ba-4282-8322-f2149817e18e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b888a0a457640ff861a14782a04bdbd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi05LTEtMS0xMTc3NTY_3614c78e-caa2-4b65-9918-b01b34c850cd"
      unitRef="usd">403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib63b4fc1b0444bdfa216b46c39f99f6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNi0xMS0xLTEtMTE3NzU2_e7228c50-72b7-4a87-8350-1f7dd5db2647"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0xLTEtMS0xMTc3NTY_656b07ff-dbfe-4aa6-a750-34b42fec19a4"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0zLTEtMS0xMTc3NTY_db8a2098-d486-4197-8c33-f0708ca1aa6e"
      unitRef="usd">1058000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy01LTEtMS0xMTc3NTY_91d62223-0a7e-477b-825e-d79a2e3c4a23"
      unitRef="usd">8000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy03LTEtMS0xMTc3NTY_a6e8b25c-827f-4916-a6f3-78f2e66dac4e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i664e35471e3b431f80b8059482063353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy05LTEtMS0xMTc3NTY_4825fddd-68ae-44db-b2b3-4112db148f07"
      unitRef="usd">206000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfNy0xMS0xLTEtMTE3NzU2_082d1eef-e491-4802-bc43-4b72dcfb4d14"
      unitRef="usd">12000000</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iaaad04a4dfb54e4baa98287704d915e1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0xLTEtMS0xMTc3NTY_badc6f08-c7fa-4c82-bbf0-9120a08e1841"
      unitRef="usd">426000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id32df06df7ee4312b8d69963af72d16c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0zLTEtMS0xMTc3NTY_2c293108-891b-4204-922e-6a75d0cd7bef"
      unitRef="usd">493000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i001cf1d2900445718093f0ed5b320c01_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC01LTEtMS0xMTc3NTY_d3e70862-ce72-47d3-b546-aa72446a7989"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iab1b2dc24bcf49ce861f999cd524d75f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC03LTEtMS0xMTc3NTY_7ded1a20-dcb4-4087-8485-a67c23a8b4a4"
      unitRef="usd">1910000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4e0bd321f5bb47f88e5f9bcc836bb474_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC05LTEtMS0xMTc3NTY_7b26f157-287e-489c-9d35-6a3b7f4fffd4"
      unitRef="usd">109000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1a8881178a9a4ffd950fe4ca131ae180_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOC0xMS0xLTEtMTE3NzU2_63d488dd-ddc4-4b67-946f-95bf78c81e7e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeLiabilities
      contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0xLTEtMS0xMTc3NTY_cb196429-4853-46f1-9b89-e2997b39b68e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0zLTEtMS0xMTc3NTY_3732ed0b-05c0-46de-b320-3cbe5ece5c7c"
      unitRef="usd">81000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS01LTEtMS0xMTc3NTY_bca365b0-9f44-4db6-abae-438fab2f5a5a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS03LTEtMS0xMTc3NTY_6e4e2102-90d3-4df6-9088-412fb790ac0c"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i664e35471e3b431f80b8059482063353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS05LTEtMS0xMTc3NTY_87efda02-739c-4591-9c1b-ce3b8e162582"
      unitRef="usd">25000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfOS0xMS0xLTEtMTE3NzU2_80250347-d107-4f09-a04a-bcd07755c7e0"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie94029425ffb44b89b3a798ad9c779fa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMS0xLTEtMTE3NzU2_bf47dab0-f45c-4ab3-be64-4b68354729c0"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia027865f0ea44b3a80cf5792949a8621_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMy0xLTEtMTE3NzU2_88deb6ee-1e62-4acf-9563-5b01d30a24de"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia6ee716584d44f0e92394dc97ec2e3e4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtNS0xLTEtMTE3NzU2_2597cef1-6faa-458c-8fd6-3b2c6adc5c45"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3291dcc3ae81483cb7fa13dfc3ad4b9b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtNy0xLTEtMTE3NzU2_6e0363a1-a1ca-457c-a45e-ec204b6d134c"
      unitRef="usd">8000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icecb65891a224cfeac69f536b96a8bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtOS0xLTEtMTE3NzU2_5dc90456-f42d-4023-8aad-9fede6d8f9a3"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i951812de5a98402d9dea34b638a13c0d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTEtMTEtMS0xLTExNzc1Ng_d2c4b359-9b36-46e1-9de4-8c2c0d0be542"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7ab4f089b9af40638285fff5aa6c4a64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMS0xLTEtMTE3NzU2_63328f8d-52df-495c-bf59-4fb9d46d0142"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ida7cf5a352a54110bd759e160ab71b37_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMy0xLTEtMTE3NzU2_fd1b9b0a-a6a3-4644-b74f-4ddde9dd5d4c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idbcbcc18ebf94d8b84927842d8b4f534_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItNS0xLTEtMTE3NzU2_3d74cbef-7ec7-4262-b933-65faa1473274"
      unitRef="usd">32000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i750af98d076240de881b7ff2bf09cd4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItNy0xLTEtMTE3NzU2_84365b05-7bdf-4185-beb5-465bec69515b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i664e35471e3b431f80b8059482063353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItOS0xLTEtMTE3NzU2_f33b5174-3c21-4e17-be47-324f387296be"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i032be76858324a3ea8ca82c8437b0d13_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjMxZDMyNTg0NzEwZDQxYjk5NDYzMmEwODA3ZjNhNTM1L3RhYmxlcmFuZ2U6MzFkMzI1ODQ3MTBkNDFiOTk0NjMyYTA4MDdmM2E1MzVfMTItMTEtMS0xLTExNzc1Ng_d123ac43-188a-413e-a3cf-aef4c5d50282"
      unitRef="usd">35000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNTc_c23ff281-767e-4293-a694-f0b64c5d9918">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of September&#160;30, 2022, and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xLTEtMS0xMTc3NTY_bdec9dfa-5e4a-4368-abc9-1a7fd607f99e"
      unitRef="usd">1080000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0zLTEtMS0xMTc3NTY_cc294e3e-fc8c-4360-9a2c-21bdf095b2a6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy01LTEtMS0xMTc3NTY_9b194358-973b-41fd-be32-f18aa76f3feb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i869c2864826e42ecb543c18a3ee8cad7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy03LTEtMS0xMTc3NTY_548ffa28-4dc1-48cc-ad4e-a7f601df1606"
      unitRef="usd">1080000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy05LTEtMS0xMTc3NTY_3ff4bff1-3517-47a3-9ddd-0b64ac659d5f"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xMS0xLTEtMTE3NzU2_97831790-57ad-4575-b745-2bd903dc77ee"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xMy0xLTEtMTE3NzU2_7ed8e99a-1087-402a-9096-fda2ac02b46d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i007f47041a3e4a0b8f534e32f84ef88f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfMy0xNS0xLTEtMTE3NzU2_37222c0c-295b-4303-8f4d-c3e55bc06df4"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xLTEtMS0xMTc3NTY_3a9f0aaa-c4e8-4f62-8156-f72310ce3d2a"
      unitRef="usd">168000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0zLTEtMS0xMTc3NTY_ff551a09-403c-4fe1-9b43-0f964ba5cb25"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC01LTEtMS0xMTc3NTY_4cec93ea-db40-459b-bbfe-28731945fa63"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2ee3aac3606489e8746d195b398a934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC03LTEtMS0xMTc3NTY_6888b89b-0f96-4228-824b-d997446fffa7"
      unitRef="usd">168000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC05LTEtMS0xMTc3NTY_587a877a-9644-4e90-b48c-67ddd14b2c02"
      unitRef="usd">320000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xMS0xLTEtMTE3NzU2_5b9cb2e2-6186-46c9-ac43-fc7aa78c2ba5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xMy0xLTEtMTE3NzU2_994e9163-1dae-4dfb-9604-a21b39111171"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc020ab058f34bcb90c4d1525ab27fc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNC0xNS0xLTEtMTE3NzU2_f33c6c30-c504-4f7e-9705-1605406743e5"
      unitRef="usd">320000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xLTEtMS0xMTc3NTY_0c447082-20a5-4598-800a-3ff9cc24489a"
      unitRef="usd">45000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0zLTEtMS0xMTc3NTY_2ba25d61-e7ec-4881-85d1-6767bf550a10"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS01LTEtMS0xMTc3NTY_55a7ffb0-ec78-4c6b-84b6-4a5b30de8c1e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idf0158c1228242f594f5547c1ecdf6af_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS03LTEtMS0xMTc3NTY_20d359f7-739a-4345-bea4-198d5b332ab2"
      unitRef="usd">45000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS05LTEtMS0xMTc3NTY_d8852cc3-38e8-4712-81f8-d8b1e7791095"
      unitRef="usd">401000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xMS0xLTEtMTE3NzU2_a5cc42a2-25fd-47a6-9df6-27c459ddb4ac"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xMy0xLTEtMTE3NzU2_4379a3f4-d1e2-404d-a768-d5a43213c9c4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ddfcd48ce404bf187e46620663765f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNS0xNS0xLTEtMTE3NzU2_1fc6a46f-0cf7-4027-83be-fb7f6566e9a0"
      unitRef="usd">403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xLTEtMS0xMTc3NTY_fe594653-094c-4648-ac60-2004884b1466"
      unitRef="usd">1293000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0zLTEtMS0xMTc3NTY_c332c992-80e6-4f67-b58f-6fe903a9de9d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi01LTEtMS0xMTc3NTY_8f5893fc-7a22-4dd7-a2a3-f1893108ff25"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi03LTEtMS0xMTc3NTY_bc791d2d-f64d-4cb0-a606-558b28ebeae8"
      unitRef="usd">1293000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi05LTEtMS0xMTc3NTY_da5c60b9-d651-4d34-9eb6-78e484535e12"
      unitRef="usd">2985000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xMS0xLTEtMTE3NzU2_0448f673-c1ba-48f8-a044-46ed35089fb1"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xMy0xLTEtMTE3NzU2_672b9946-2397-4fdd-96bb-82bd2ae547b9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjI1YjBkMDM0ZTk5MjRiYzJiNjQ4OWZmMTI4NDg3ZTEwL3RhYmxlcmFuZ2U6MjViMGQwMzRlOTkyNGJjMmI2NDg5ZmYxMjg0ODdlMTBfNi0xNS0xLTEtMTE3NzU2_f133c0e7-b133-489b-806e-d57d8dd2f99b"
      unitRef="usd">2987000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <bmy:ScheduleOfEquityInvestmentsTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMzA_1d0fbeec-8611-41f9-b3f7-4146d4ddf4e5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limited partnerships and other equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfEquityInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMS0xLTEtMS0xMTc3NTY_84898160-96fd-4139-b86f-253a0d2d3e36"
      unitRef="usd">919000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMS0zLTEtMS0xMTc3NTY_d32130c1-6cd3-4d4f-830b-4102dfc72ec5"
      unitRef="usd">2019000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMi0xLTEtMS0xMTc3NTY_56b0dc96-d17a-413e-ad8c-420f4accf0b7"
      unitRef="usd">505000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMi0zLTEtMS0xMTc3NTY_64f8bee6-82ee-41e3-9000-35a948196fce"
      unitRef="usd">283000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMy0xLTEtMS0xMTc3NTY_59d70c7b-2573-4a4f-9c89-4764c18daf20"
      unitRef="usd">535000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfMy0zLTEtMS0xMTc3NTY_b8f29bec-fc0c-4cbe-bf82-47932817de64"
      unitRef="usd">666000000</us-gaap:EquityMethodInvestments>
    <bmy:EquityInvestments
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfNC0xLTEtMS0xMTc3NTY_7065d90f-500c-4d35-9bb2-016190712a61"
      unitRef="usd">1959000000</bmy:EquityInvestments>
    <bmy:EquityInvestments
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjAxZGZjOTI5ZDYzYzQ0NTk5MjYwM2U2Y2Y0MjVjMjk5L3RhYmxlcmFuZ2U6MDFkZmM5MjlkNjNjNDQ1OTkyNjAzZTZjZjQyNWMyOTlfNC0zLTEtMS0xMTc3NTY_71b9dd64-0f11-4149-8abb-8545341b33b5"
      unitRef="usd">2968000000</bmy:EquityInvestments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwMzk_832adc6c-8f0b-4c74-936f-86c1159e4f5b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determined fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss/(gain) recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (gain)/loss recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss/(gain) recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss/(income) of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy0xLTEtMS0xMTc3NTY_34d8d1b7-a124-4da7-a569-5a50e6f0faaa"
      unitRef="usd">-75000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy0zLTEtMS0xMTc3NTY_8220f9e7-6c4e-4b1c-baf3-9e851def7500"
      unitRef="usd">-22000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy01LTEtMS0xMTc3NTY_52f165f7-428c-45a5-b409-7703e1f20e7a"
      unitRef="usd">-927000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMy03LTEtMS0xMTc3NTY_736a137d-a076-4a09-991e-9f44e2b01655"
      unitRef="usd">93000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC0xLTEtMS0xMTc3NTY_361d057b-98fb-41b2-9e29-aa9a1087a446"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC0zLTEtMS0xMTc3NTY_3172f2cb-3b6a-4145-8693-3bc5dfa2a885"
      unitRef="usd">-3000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC01LTEtMS0xMTc3NTY_8c6495f0-f77c-4402-b207-2050066f6990"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNC03LTEtMS0xMTc3NTY_46e21691-b13f-4649-8011-8dcb7c378a3f"
      unitRef="usd">-5000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS0xLTEtMS0xMTc3NTY_b67460c7-7dc8-48e8-b528-160d8a687a70"
      unitRef="usd">-76000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS0zLTEtMS0xMTc3NTY_ca2377cf-10d3-447c-9df2-fbb72a0d9dc6"
      unitRef="usd">-19000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS01LTEtMS0xMTc3NTY_93b7974f-1e04-4f0c-832d-5695f180ad46"
      unitRef="usd">-944000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfNS03LTEtMS0xMTc3NTY_84f36360-d2b0-4e09-8e00-fd9dc027ed30"
      unitRef="usd">98000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC0xLTEtMS0xMTc3NTY_6c63ada7-670d-4a71-8fd9-81722c28c76b"
      unitRef="usd">64000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC0zLTEtMS0xMTc3NTY_e656a515-c947-4e2a-8419-1cf265ef5c51"
      unitRef="usd">447000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC01LTEtMS0xMTc3NTY_c27c3ab8-a7f0-4e9b-ba18-5fb43c0a9f1b"
      unitRef="usd">70000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOC03LTEtMS0xMTc3NTY_76482d3f-b01c-424d-9b51-327c61ad4ec3"
      unitRef="usd">908000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS0xLTEtMS0xMTc3NTY_30ef889e-b49e-46d5-862b-0f30a4f67a9d"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS0zLTEtMS0xMTc3NTY_96de8905-33b4-4729-b676-05dd41e7240d"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS01LTEtMS0xMTc3NTY_50aa4fdd-241e-43f6-a32a-f2c6ff2c4177"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfOS03LTEtMS0xMTc3NTY_156312e4-a9e2-4053-9564-072b4605b0e5"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTAtNS0xLTEtMTE3NzU2_aa742f1c-9678-4f83-826b-a204539e2847"
      unitRef="usd">173000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTEtNS0xLTEtMTE3NzU2_f4682fb2-b66b-4cae-8fa7-51b56f09fa96"
      unitRef="usd">52000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtMS0xLTEtMTE3NzU2_a9d04aa1-e037-45b7-bccb-f559a685e657"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtMy0xLTEtMTE3NzU2_c96eeeb9-d2e0-48fe-bcad-e1bfc5984a45"
      unitRef="usd">40000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtNS0xLTEtMTE3NzU2_8f768efe-c2f1-4c35-ac46-2c855476fe3d"
      unitRef="usd">-107000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmQ1MWRmNWMxMmMxMDRhZGI5N2YzYjZlMDc0YmIxZjg4L3RhYmxlcmFuZ2U6ZDUxZGY1YzEyYzEwNGFkYjk3ZjNiNmUwNzRiYjFmODhfMTMtNy0xLTEtMTE3NzU2_01979537-2040-4e83-b6ed-218570de25cb"
      unitRef="usd">214000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i886da8a6a90b461c9af99d1fdcba4377_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzQwMA_c545ccb0-703a-49b8-abbc-71b2d8e77301"
      unitRef="eur">5100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i668b51b58a0942a9aedf0c485aca6851_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzQyMw_42057a15-fefe-4660-a124-f19b13e69eb9"
      unitRef="jpy">1400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTMzNTc_f1a450ef-666f-449d-9d71-9560ebcce9c7"
      unitRef="eur">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTMzNjE_ed6b47c4-ea68-4621-a0e1-9af778abcb63"
      unitRef="usd">584000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i24f777b58fc44c61994b5a303994de56_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDI5OQ_237de885-2cca-4418-b251-ae8c51455589"
      unitRef="eur">375000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i24f777b58fc44c61994b5a303994de56_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDMwMw_91f1e6d4-9a95-404e-964d-3d94874e7694"
      unitRef="usd">368000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDc0Nw_eb5a9d25-350f-492a-a571-fd9a88120fe2"
      unitRef="usd">1400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic1fcfb5eba384919a6f3979d6d9e15be_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNjA0NzMxMzk2NTY0NQ_93952c16-9058-4aac-a9fa-c76af68befb0"
      unitRef="usd">686000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5eb686bfb0e04c65a42bb3210170dda7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNjA0NzMxMzk2NTY1OQ_6b0221db-ea3f-4917-8267-ea2700f89601"
      unitRef="usd">584000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ia29ecc9950894eb59b5cb3e5b2517a3c_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ1NQ_987501b8-ee30-43da-a48c-b2af486112b7"
      unitRef="number">0.0314</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTUwMA_febebf35-6613-468e-85f1-d456cf5f3ae1"
      unitRef="number">0.046</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNTM_8d31ff80-a807-4261-85ad-aeb60fd72ccd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ef79162dd034be895a4bcba78334e1c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xLTEtMS0xMTc3NTY_6f5f0f79-b344-4721-a71c-75a85a1fba09"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i339caa7c1e6a43eb90fd07efce417b64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0zLTEtMS0xMTc3NTY_027dfb38-a1c1-4dff-92ae-a7e82670ccd9"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iac0fb0b0b75c45ee8d18d3d8d0b6d4c3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC01LTEtMS0xMTc3NTY_d818dcc3-2927-4e13-b094-9adc78a61c48"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i339caa7c1e6a43eb90fd07efce417b64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC03LTEtMS0xMTc3NTY_842ad3d0-1973-4cdf-af66-1517f0f2c414"
      unitRef="usd">-19000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9113bb62f5fc4e84b6e97c82d3e2911b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC05LTEtMS0xMTc3NTY_103d6374-685f-4cb3-baba-42d35d0be4f8"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xMS0xLTEtMTE3NzU2_be9877ae-d9ea-4246-ad6a-34e3847bd525"
      unitRef="usd">10000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3bfad7762f964e1ca74853b28c6b82a0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xMy0xLTEtMTE3NzU2_e0c3b69c-99d4-40b3-a78e-872759ce9b69"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i9961c2a1f4c0463a99defdbf0e9c2b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNC0xNS0xLTEtMTE3NzU2_3ce638bd-31d6-4419-a1a3-b620c7482ee9"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i387ddd833f71435ba85ff38a446a1ad4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xLTEtMS0xMTc3NTY_6f05adef-8abe-4957-aab2-3fbc2814a54e"
      unitRef="usd">1411000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0zLTEtMS0xMTc3NTY_919f1100-cdd7-4268-8e42-1b9823c437c2"
      unitRef="usd">136000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5649feba80774237abf36efd972c7da1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS01LTEtMS0xMTc3NTY_08ebf8bc-0e59-454f-ab93-9ed9b845b4e0"
      unitRef="usd">584000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ib06fb7e66bfe467a85f580dc72fc27c8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS03LTEtMS0xMTc3NTY_7c9aefae-9fe8-4618-b7ad-2fa749417156"
      unitRef="usd">-43000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i64ca08b52a6742409695aac6c23554f3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS05LTEtMS0xMTc3NTY_7ccf5c4c-80b3-40cc-bce5-cf7fa4e01c05"
      unitRef="usd">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i7de81def66b94b54849c6be2071f8a4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xMS0xLTEtMTE3NzU2_2b28e637-d138-4341-9b04-b33a70a53cf5"
      unitRef="usd">26000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i671a3558463349758ba20e3666722cc5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xMy0xLTEtMTE3NzU2_bd472847-e7dc-4447-b949-2e77f15865dd"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i7de81def66b94b54849c6be2071f8a4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNS0xNS0xLTEtMTE3NzU2_2ee0a197-a797-4975-bd07-89b856827c6c"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i434b45cb2aa04afc908af8ac2c0b29e3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xLTEtMS0xMTc3NTY_d5650fe4-ee09-4e1f-9012-ceb7eda02500"
      unitRef="usd">7978000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i239d9003938740c39216c644b9c80fbb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0zLTEtMS0xMTc3NTY_694b417d-8f16-401c-9183-d9efbf11165b"
      unitRef="usd">882000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icfa5e345526d4cb184e2c617cd44dde2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi01LTEtMS0xMTc3NTY_91afefdc-45e9-4678-ad3d-cd447f9ed9f0"
      unitRef="usd">145000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i239d9003938740c39216c644b9c80fbb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi03LTEtMS0xMTc3NTY_193ecb33-456d-435f-bf4b-49f435d1093b"
      unitRef="usd">-8000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie9b5e6864bac4cc4a4d6c73ae31d6a8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi05LTEtMS0xMTc3NTY_40767439-4a71-4b42-ac8d-f73878354cb7"
      unitRef="usd">3587000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i356d70d9be5b40d3ae48415c984f8747_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xMS0xLTEtMTE3NzU2_7a6a479b-29b3-4d30-bd04-0c5a600d1a36"
      unitRef="usd">161000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iae55e5eabed94fa8801cae43dc8309ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xMy0xLTEtMTE3NzU2_ca677513-7225-4155-91e6-f4309e408a4e"
      unitRef="usd">1814000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i356d70d9be5b40d3ae48415c984f8747_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfNi0xNS0xLTEtMTE3NzU2_d54ce1ae-0bee-4bd9-a5a3-7d511f835237"
      unitRef="usd">-20000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7d2f488420464613bdeee86193ef4eee_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xLTEtMS0xMTc3NTY_2f70e3c0-14e3-4e34-bdb4-fc03533543ca"
      unitRef="usd">1628000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ide37ecb83af748fb901addbb7d586542_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0zLTEtMS0xMTc3NTY_6ac90b29-7ba4-4fb1-b23b-3701c54b65e7"
      unitRef="usd">40000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibed40edcdca04be1ac7f40fedd1fbf28_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS01LTEtMS0xMTc3NTY_9b064238-85ec-45e4-bc12-679b8aebcb7b"
      unitRef="usd">561000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ide37ecb83af748fb901addbb7d586542_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS03LTEtMS0xMTc3NTY_0d59118a-e826-4207-b1d8-8d43d9eff687"
      unitRef="usd">-11000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i341c5e7c579a49489d32d9cdb3032597_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS05LTEtMS0xMTc3NTY_f2e48b06-75a8-4a7e-8025-5b06409a667d"
      unitRef="usd">883000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xMS0xLTEtMTE3NzU2_ddf51bda-1946-49d0-84a8-c5d475f20759"
      unitRef="usd">9000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i52bc3e57749345ea918765039e97891b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xMy0xLTEtMTE3NzU2_a44f0ce4-09e1-4232-859a-e5bf89ac1012"
      unitRef="usd">568000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i6b8c3075c1d0414fa0bdf8b8282c093f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfOS0xNS0xLTEtMTE3NzU2_91d509ee-defa-419c-a4d3-dcf042cb3b01"
      unitRef="usd">-5000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icbf70c949b4444abb6425eec36d8fdd7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMS0xLTEtMTE3NzU2_4a78303a-4365-4efe-8e6e-0acaf925c64f"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMy0xLTEtMTE3NzU2_c9829c79-934e-455e-b883-da7dd0e632a5"
      unitRef="usd">8000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia0d78e80b73040089346da240187c709_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtNS0xLTEtMTE3NzU2_cd1f4589-298e-4544-9640-5b01d6be2451"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i9c479e0f6e994146ac5fcb8cc3d15ec7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtNy0xLTEtMTE3NzU2_85b18a68-21a2-4cc5-8f4e-6a17753b65fe"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iff8febe75ec14be68b29d9e554cbb15a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtOS0xLTEtMTE3NzU2_58d45f09-ec7e-4679-976e-4583df1083a6"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="iaf1cae60d9924382bb960c3201397998_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTEtMS0xLTExNzc1Ng_bf65313c-a8f6-4046-9e22-204016ea8a4b"
      unitRef="usd">12000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i623000336f474ce0a7c985a7099f9f33_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTMtMS0xLTExNzc1Ng_fd60aa01-5063-4cc2-9f00-e04cc636068f"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="iaf1cae60d9924382bb960c3201397998_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmM4OGQ5M2E0ZWM4ZDQ5NzNiYjMyM2RlY2ZiYzRkZTQ3L3RhYmxlcmFuZ2U6Yzg4ZDkzYTRlYzhkNDk3M2JiMzIzZGVjZmJjNGRlNDdfMTEtMTUtMS0xLTExNzc1Ng_1e280dae-c769-4ad8-9866-bb1e1a7bb193"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNzg_b6e56f8b-5d58-4aa1-9835-ae118b12aca1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 24 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi0xLTEtMS0xMTc3NTY_312f423f-0cbd-44bf-9c7a-8697ae1fcd65"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i98a2f300fd224cf69ad83417e63b0645_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi0zLTEtMS0xMTc3NTY_510ba274-2d21-46d5-a274-f5726dd644fe"
      unitRef="usd">-5000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia507ce7f836d4c8f9300d3ffdffc8f80_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi01LTEtMS0xMTc3NTY_12d8ffc3-6f6c-4740-93a5-af74a1970094"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id9681d173c7946ea819e81222ecfe950_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfMi03LTEtMS0xMTc3NTY_8779b113-4263-4cbd-ab3d-abcbb1fd21e5"
      unitRef="usd">-23000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4fe3e81f2f1b4a57a73467c81f0b6af2_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC0xLTEtMS0xMTc3NTY_ffedb77d-9cbf-418c-b266-eedc4521f2ae"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC0zLTEtMS0xMTc3NTY_5417ea38-d83b-4867-a647-9bc4a9f03133"
      unitRef="usd">13000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7fb1e679272541e9b87cbfb82b0c1cb7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC01LTEtMS0xMTc3NTY_b2dad089-2e4f-44d0-929d-42ecc4393edb"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNC03LTEtMS0xMTc3NTY_a1c09ccf-ec5b-43ef-816f-80bb0582bc76"
      unitRef="usd">5000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS0xLTEtMS0xMTc3NTY_9e8a77f5-4dd6-4794-a04a-d20fbc8d6458"
      unitRef="usd">-195000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i6f2dd852e2564293b0c25120a2fea24e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS0zLTEtMS0xMTc3NTY_6cd795d3-4f50-44fc-a742-660527c65664"
      unitRef="usd">-61000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS01LTEtMS0xMTc3NTY_836fd8f4-4b22-411f-8e9d-440fa69c23ac"
      unitRef="usd">-408000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id232f272e34d446b97e88ece5cdad405_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjdlMGUxMGRhYmRhYjQwNjBhYTJlMjlhNjliZWQxY2ZkL3RhYmxlcmFuZ2U6N2UwZTEwZGFiZGFiNDA2MGFhMmUyOWE2OWJlZDFjZmRfNS03LTEtMS0xMTc3NTY_55e4c85f-7c8c-4a43-baeb-35b97d45602a"
      unitRef="usd">-136000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i51db28aa096b432189a3788e6aa7123f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi0xLTEtMS0xMTc3NTY_8e9f8299-cb2f-4f28-bc70-fb257c393e6b"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i86fff4fcd97244e8a2031133dc96e519_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi0zLTEtMS0xMTc3NTY_2cece273-bd12-43e9-8f1c-969f1fe57d5e"
      unitRef="usd">-7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i67fdac5f25c142198444d8440aeb1e36_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi01LTEtMS0xMTc3NTY_23dcf898-9d70-4745-a0c9-0b533e217b36"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i09ce9df741f740bb89856a5bf20958f7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMi03LTEtMS0xMTc3NTY_f6db9397-273f-4c2c-910e-987a432ac58a"
      unitRef="usd">-22000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2e98552285044c26ba232ed5924465b9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy0xLTEtMS0xMTc3NTY_ede5582c-5702-4887-bb7d-5f9bac30f304"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy0zLTEtMS0xMTc3NTY_c5456c47-54a1-4eaa-9edd-98617762b22b"
      unitRef="usd">-2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia35153af17cf4e51a7a041e312ab160e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy01LTEtMS0xMTc3NTY_22fab096-0922-44ae-a51a-147a2064ed96"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfMy03LTEtMS0xMTc3NTY_9a5d9c7b-4bab-4711-b6df-242a618e8c82"
      unitRef="usd">-8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC0xLTEtMS0xMTc3NTY_5573fe1c-a3df-46dd-8303-c7ed68482ed5"
      unitRef="usd">19000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icf7a73a7127b44f3ae2722fff64309a6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC0zLTEtMS0xMTc3NTY_bf1a2d9d-31a9-4bf9-ba28-73d811427865"
      unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC01LTEtMS0xMTc3NTY_b4c2302e-aba3-41da-a7f5-50bcb0d167d7"
      unitRef="usd">145000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib9f9f5be85464567b1c04db5316afee7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjEwOTAzYTIxOTdmMDQzNDM4NDJhOTNiZGM3ZWE1YjY5L3RhYmxlcmFuZ2U6MTA5MDNhMjE5N2YwNDM0Mzg0MmE5M2JkYzdlYTViNjlfNC03LTEtMS0xMTc3NTY_79491a7e-4dec-47e3-bcc1-d0786be5c06b"
      unitRef="usd">-14000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7982584c67704aeb87a3bc5199ecf7b8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC0xLTEtMS0xMTc3NTY_63447126-6fbb-48ec-8ca8-9f21101e006b"
      unitRef="usd">548000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iac23d9ba09ef4f6f9bb57d9dc257b587_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC0zLTEtMS0xMTc3NTY_07ca2757-9316-46ca-ba51-cd8f959a0f1b"
      unitRef="usd">93000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib632c605afc443a9a1e66024aaf25726_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC01LTEtMS0xMTc3NTY_1db38627-3974-4bb4-bcb4-0cea8e4026f3"
      unitRef="usd">1149000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0daeb22196f04a9c979d9bea65d5029e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNC03LTEtMS0xMTc3NTY_f398f264-d0af-4b36-b874-c3ee377f887d"
      unitRef="usd">314000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i65b81720682948e5b4ab54bfd6c21118_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS0xLTEtMS0xMTc3NTY_35b5559f-269f-44a1-be59-6c2ebad230c6"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i90b59acfd3d14c07b994035705a56ae2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS0zLTEtMS0xMTc3NTY_d3d9a4f5-b69f-4deb-a10d-3b353b5d7383"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i59df8215bf014150a70d0b2b8efdd33f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS01LTEtMS0xMTc3NTY_f38ea4ec-b436-4980-a992-6a7910d1d0c2"
      unitRef="usd">408000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic65f0eace314448a881abada7d6c2af5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNS03LTEtMS0xMTc3NTY_ae5f69bc-4f46-4d33-a30a-59028b87588b"
      unitRef="usd">-126000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0xLTEtMS0xMjU5NDE_3b1d00af-a274-4e6c-b525-222653da4042"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i92872acbdf1845709dc97146229773d3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0zLTEtMS0xMjU5NDE_05db3ca6-4754-4134-8bf9-8540e0615e80"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy01LTEtMS0xMjU5NDE_60038867-8da2-4ce3-ab5c-e1bbff56695f"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy03LTEtMS0xMjU5NDE_f9119534-308f-4326-bcd7-450b0e0750da"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i55ee32fafbfe458e9ff98e4dd54ef04e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC0xLTEtMS0xMjU5NDQ_197b12d2-632e-4c58-8f5c-67ab96c090c0"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i17411e73fe3d4ddf8f77be6f443990d3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC0zLTEtMS0xMjU5NDQ_80a567c8-7b19-41c6-b40b-0ce92d336a79"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9e656a3d77874a8ab7f20fb5aca05279_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC01LTEtMS0xMjU5NDQ_ff7b8c88-0208-4b59-912a-496bf6dc3ec1"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie516dbc9224a4d0b80008058cfa71230_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfOC03LTEtMS0xMjU5NDQ_63aab9bf-d07d-4cd6-a554-a8c96827770a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i44851decbabe44c2aa827ce35420cd14_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0xLTEtMS0xMTc3NTY_e56b8368-f55b-44bd-b563-23449c2a6b32"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i61f45381d84d492c9d4620e158db0048_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy0zLTEtMS0xMTc3NTY_5944aaa2-1d40-47b4-8e78-7619680a0fa9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8cb0c279ee9246b5a0b911c7c61e2557_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy01LTEtMS0xMTc3NTY_99f7da14-9621-447a-891e-543934f2a050"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i13e28e98ba32447bb7448a8051ebaf80_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfNy03LTEtMS0xMTc3NTY_70531f77-e319-491f-a83e-93915d9f8b7e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i80d0b2cddd14403c806d35f951f7d723_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtMS0xLTEtMTE3NzU2_47206694-8c74-4f37-b224-4e17d5bc8ccb"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i92872acbdf1845709dc97146229773d3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtMy0xLTEtMTE3NzU2_6461aa38-5938-496e-98ee-683578ba4884"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f34327ec8564e7ba40f9a41ce5b7180_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtNS0xLTEtMTE3NzU2_fa1327c0-e043-48d0-8107-33ac006c4772"
      unitRef="usd">135000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9b5d8d12fe5f49efa1ddd5d102f0c470_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTQtNy0xLTEtMTE3NzU2_cab31895-f783-4780-8ce3-a0fd3f1556fc"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i1c7d5843d7de40ddbe92cb7c600b33f3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtMS0xLTEtMTE3NzU2_61151d5e-4e97-44b6-896a-6bc5bb1769bf"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i4cacbe74c36b42af8f2449ab4f4558d6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtMy0xLTEtMTE3NzU2_ac4e9c14-055c-4ccf-b023-f67414d65855"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i1cdf266395024196809286a2ed6e58ab_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtNS0xLTEtMTE3NzU2_1882623c-c243-4f15-8797-c64bc6092b6b"
      unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ic52749ea5b0c4ce2b65ccf38c233521a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOmVmMzIxNmRjNWRiMTQyODE4Y2Y4MjNlZTFhYjJiYTUxL3RhYmxlcmFuZ2U6ZWYzMjE2ZGM1ZGIxNDI4MThjZjgyM2VlMWFiMmJhNTFfMTgtNy0xLTEtMTE3NzU2_312376da-f08a-4a15-bfea-cc8ed0722d4f"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTg_932a01fc-e031-4cec-aed4-588a59c5b438">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMS0xLTEtMS0xMTc3NTY_01fb854b-5d3a-4b02-b1f2-321f0b3a3cb1"
      unitRef="usd">107000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMS0zLTEtMS0xMTc3NTY_e5d1ed55-47a3-4723-8f3a-6f2398976979"
      unitRef="usd">105000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMi0xLTEtMS0xMTc3NTY_54b27970-7b65-4962-bbb0-44366d06934f"
      unitRef="usd">1903000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMi0zLTEtMS0xMTc3NTY_528a8255-6c88-4375-b220-f6de7119b6e9"
      unitRef="usd">4764000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMy0xLTEtMS0xMTc3NTY_a0653957-4d31-4bc9-b191-a25d5e6490c9"
      unitRef="usd">122000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfMy0zLTEtMS0xMTc3NTY_f7c3e826-6298-4849-941a-81f6a1671507"
      unitRef="usd">79000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfNC0xLTEtMS0xMTc3NTY_6301b9c0-259d-40a7-8f83-99bfa5c1e211"
      unitRef="usd">2132000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjQyMDVjMzQ2ODNmYjQ0NWRhNGQ5YTVhOWUyYjE5NWZhL3RhYmxlcmFuZ2U6NDIwNWMzNDY4M2ZiNDQ1ZGE0ZDlhNWE5ZTJiMTk1ZmFfNC0zLTEtMS0xMTc3NTY_23c22c92-2304-47b7-9c2c-7cfe38627df0"
      unitRef="usd">4948000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNjI_5ef1dad1-3481-4a9f-8649-240fc278d1ba">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The table below summarizes the issuances:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.550% Notes due 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.700% Notes due 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.900% Notes due 2062&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMS0xLTEtMS0xMTc3NTY_b3eb7565-e4ff-49e6-92cc-2244ce5c21cf"
      unitRef="usd">38137000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMS0zLTEtMS0xMTc3NTY_b15912ed-e993-4954-b553-c1cae2c11076"
      unitRef="usd">43095000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i1a41df960fa54741b1d2968b3effa442_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNC0xLTEtMS0xMTc3NTY_e5475cfd-51df-4277-ba7a-102cde057c4b"
      unitRef="usd">-19000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i150c8a06bb804437a2510c0f68d2e14c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNC0zLTEtMS0xMTc3NTY_bd5d4130-eb49-4049-b6bc-cb7501f8c543"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilities>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNS0xLTEtMS0xMTc3NTY_841e7b06-c4cb-4c7f-ac4b-e8fdb17c71fd"
      unitRef="usd">101000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNS0zLTEtMS0xMTc3NTY_394cd614-0878-4cce-bf0b-d4dd1fa337ea"
      unitRef="usd">119000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNi0xLTEtMS0xMTc3NTY_99d46fb9-9845-4963-abe9-b78a7cd88d91"
      unitRef="usd">290000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNi0zLTEtMS0xMTc3NTY_4715c89c-dcec-44ad-a715-9a45e4682ab9"
      unitRef="usd">263000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNy0xLTEtMS0xMTc3NTY_3a54f768-d244-4ab4-935a-387a27bf563e"
      unitRef="usd">940000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfNy0zLTEtMS0xMTc3NTY_c1d923df-f7e4-4957-8e6d-1f760391ee47"
      unitRef="usd">1408000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfOC0xLTEtMS0xMTc3NTY_5d96a980-bf60-46c4-82ed-ca32c03d162c"
      unitRef="usd">38869000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfOC0zLTEtMS0xMTc3NTY_d5070d04-8876-4004-8fbb-dfe0c26834a2"
      unitRef="usd">44369000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTAtMS0xLTEtMTE3NzU2_dc4ec536-6062-4c11-8fce-a75b36444489"
      unitRef="usd">1903000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTAtMy0xLTEtMTE3NzU2_3139ca47-7389-4726-8014-4f121039e9b0"
      unitRef="usd">4764000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTEtMS0xLTEtMTE3NzU2_763df134-d065-4221-bf23-813767c68e0d"
      unitRef="usd">36966000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTEtMy0xLTEtMTE3NzU2_0b5a4a7f-e6e7-4694-864c-a14e37ff6020"
      unitRef="usd">39605000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTItMS0xLTEtMTE3NzU2_5dbb3c77-aada-4417-b0ba-e9d0daa953e3"
      unitRef="usd">38869000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA3MDFhYTRiNjZiMjQ1NGViYzQ5ZWFmOGRhZmI3MDA0L3RhYmxlcmFuZ2U6MDcwMWFhNGI2NmIyNDU0ZWJjNDllYWY4ZGFmYjcwMDRfMTItMy0xLTEtMTE3NzU2_1bbfa608-40f7-4409-beb9-c141141d2d20"
      unitRef="usd">44369000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzQxMQ_e43fa75b-4c39-4c61-a70c-dcd4e9d906cd"
      unitRef="usd">34300000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzQyNA_25502e4e-7938-4058-b763-cc2e26747404"
      unitRef="usd">49100000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzc2Ng_ef828d51-6868-4403-8bcf-c752bb363926"
      unitRef="usd">6000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzgwNw_b2ff6cb1-d092-4e77-bb76-17986552df4a"
      unitRef="usd">6600000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNzkxMw_40c23fad-856d-4d43-81e5-f310eee5b7a1"
      unitRef="usd">-266000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0NDg0NQ_04d9e23c-dadf-4b41-9bd1-c71e36864816"
      unitRef="usd">4750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1b217acaaa49469aad78b589be10377b_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA1Mw_9a2366ac-b8e9-4f18-b9fd-df6b543b7d06"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1b217acaaa49469aad78b589be10377b_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA1Ng_f778d659-30f3-4fb8-8546-4d31df100a7e"
      unitRef="number">0.02600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic78054c42bcb4ee9846b78e126b01988_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODA2OQ_44bc16c5-b2d1-4dc1-8c76-caed03485bea"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic24f31e173564ef08923e7298471a389_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDcz_244bdae7-16ae-4345-8a0e-256af4f142d0"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic24f31e173564ef08923e7298471a389_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDg3_44e81e04-607e-45a3-8611-0d8f07357a38"
      unitRef="number">0.02000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NDk0_0a2a2181-9ec6-4be6-892b-74dde47e1319"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i697d2ad2a0c2467daff8d63c6edfa29b_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTA4_98fa9cf6-638a-4b1c-8922-7286d30beb98"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i58b5d7f1faad4e848093aeb065829a46_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTE2_1e9ff1a6-8b78-4c1c-b497-17e5aafdf1ee"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i58b5d7f1faad4e848093aeb065829a46_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNTQ5NzU1ODI0NTMw_bba83e56-9bd3-4722-946e-5407d0df0492"
      unitRef="number">0.03550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODE3Ng_d721797e-f8fd-4231-9c4a-eef4ea2f5bfe"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODIwOA_d515e473-1b4e-42dd-90af-a29f6a1912ca"
      unitRef="usd">5900000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6404ab102144f6ba73c22e80f018486_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMi0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo3NDA1NDhlODM5N2I0YjZlYTkyOWFlYzY0NTg5ZTQ5NV80_f70f278c-b20a-4a8c-858a-3a15b73dfe3e"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id6404ab102144f6ba73c22e80f018486_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMi0xLTEtMS0xMTc3NTY_6018ac39-8210-4f85-9953-b4eb05d1c06d"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc346e3c2eca41249ffeaa6cda84f7db_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMy0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjowNWY5ZTc0NTRiMWE0YWRhOGU2OTRjNjkwMDMwNzEwY180_25bdf5cf-f101-48e4-b2c0-e346cd472554"
      unitRef="number">0.03550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idc346e3c2eca41249ffeaa6cda84f7db_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfMy0xLTEtMS0xMTc3NTY_82169cba-21ca-4b27-a25e-22e94b20c38f"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9789a0514bca4a1f9a657955e08feb99_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNC0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2ZiYzY5YjNkMjM0YzkzOTZhYzU2MWJjNzZlMDEzMl80_3ac7967c-f3c1-4c51-95c9-d3585f241188"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9789a0514bca4a1f9a657955e08feb99_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNC0xLTEtMS0xMTc3NTY_0e41daf3-efd9-4f30-8fcc-d2e10f89cb64"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i203a9a6396554765b8fa0659e4a3d831_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNS0wLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjphZTg3OTg2OTlhZDg0OWI5YjBmYWJhY2RkZDY3MGFlMl80_1a91ab26-e60f-44f1-b0d2-2883b4b3bbdf"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i203a9a6396554765b8fa0659e4a3d831_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNS0xLTEtMS0xMTc3NTY_24f27b1c-5835-48b0-a230-17ed8c7adff0"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RhYmxlOjA5YWJhY2Q2ZjJkMDRiZmRhYmQ2OTJlMjYyZDBlNDI3L3RhYmxlcmFuZ2U6MDlhYmFjZDZmMmQwNGJmZGFiZDY5MmUyNjJkMGU0MjdfNi0xLTEtMS0xMTc3NTY_90cacc5b-00ee-4e4d-904e-d9b5f9c04d70"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODU4Nw_ac0fe003-aadd-491a-9568-22777c3df79f"
      unitRef="usd">3500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODY0Mg_1d56be8e-66e8-425a-889f-d84f34fa35b5"
      unitRef="usd">4000000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODc1Mw_1056190a-35b2-4524-81c1-3730b1118f01"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0NDg2MA_b28435c1-5304-4e76-92d1-c47410a03f93"
      unitRef="usd">2000000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i645d2dcb8c254458b2bba8716a3d4871_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODg5Nw_6dd97e02-7221-413c-a264-2e2e9aeadeb8"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i645d2dcb8c254458b2bba8716a3d4871_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkwMA_9abc059f-1a68-4a57-b91f-b3d5f56393d2"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i18778c0e80e94ff1bbb25132a78a2670_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkxNA_9d14142a-9bc5-42d1-9e49-bf633e01555b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i18778c0e80e94ff1bbb25132a78a2670_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfODkxNw_41e362f8-709f-49a6-ba66-a86ef8800c69"
      unitRef="number">0.02550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfNDk0NzgwMjM0MjEzMA_8fd7ff17-a00e-4bec-8b80-ed0bbdf34b77"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i25a6eb7f974045e0bc20b2727bd60ddd_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMzg0ODI5MDcwOTA4Ng_22f5303e-e41c-4cd0-b7e8-8de0750f413a"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestPaidNet
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0MTk5NQ_799598f5-652f-4c6e-aac3-98ff73311bf2"
      unitRef="usd">1100000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTA5OTUxMTY0MjAwNA_34fdab36-be60-4c82-805b-7832ed0f84ec"
      unitRef="usd">1200000000</us-gaap:InterestPaidNet>
    <bmy:NumberofRevolvingCreditFacilities
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTk_361696a5-abb9-4e33-b670-0e9cd448203e"
      unitRef="creditfacility">4</bmy:NumberofRevolvingCreditFacilities>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTE1Ng_d8d5ad81-f91d-428d-abc3-4ca16911cfb6"
      unitRef="usd">6000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib9a6a86876fc43d388aac8adf3fea7c7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTE4OQ_cad2f374-925a-45bd-a275-7b78dc61ab30"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic7a1031a2d014325bddb2d8b3e07d8d2_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTI0NQ_c61035a2-d1a2-4541-9aca-1198711c7a05"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5810116290c741c4ad8f11aed5bf0245_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTMwNQ_c2596852-e1d8-4765-8aa3-8fd9b1b5d3e6"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebtTerm
      contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwOTI_195e9cfa-3c3b-45ed-b955-f917527d8336">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTQzMw_4bb6ed1a-13d1-412d-b02f-c1c0e3d28d0e"
      unitRef="usd">5000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bmy:LongTermDebtRenewalPeriod
      contextRef="i5e7a918716d5477a8dd0f5bb4e7149c5_I20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwNjk_64b92e66-de7c-4446-b8b2-a71a57eee10b">P1Y</bmy:LongTermDebtRenewalPeriod>
    <us-gaap:LongTermDebtTerm
      contextRef="i2461c577cc2e466494498e4484b6c258_I20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfMTAwODI_2a60d216-5d0b-40c6-af9b-9e77196a37aa">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2461c577cc2e466494498e4484b6c258_I20220131"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTgwNQ_e2e36fff-b22d-431f-95fc-eaace1329d84"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7a2ea2f6823b483bac68344cc193c509_I20220131"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTg1NA_f13343ba-53ec-4bfa-b329-c647ad46c20f"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie48edd2512e6470bab3e50e5a0158fed_I20220131"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182MS9mcmFnOjcxYWUxYTcxYzg2NTQwYjI5ZjRlZjFmMDRlNDI1YmU4L3RleHRyZWdpb246NzFhZTFhNzFjODY1NDBiMjlmNGVmMWYwNGU0MjViZThfOTg3OA_e31228ef-8e26-4cf5-bf20-caaf0b96d8d9"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjc2_d469b655-6f2a-42f6-b873-e1466827cbb7">RECEIVABLES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, Royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. receivables sold on a nonrecourse basis were $809 million and $1.1 billion for the nine months ended September 30, 2022 and 2021, respectively. Receivables from the three largest customers in the U.S. represented approximately 67% and 59% of total trade receivables as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjc4_f2bd6437-4e69-426d-b4a8-14cc1b490926">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, Royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMS0xLTEtMS0xMTc3NTY_8a2b7cc0-a854-416f-9d5e-b05521835c94"
      unitRef="usd">8644000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMS0zLTEtMS0xMTc3NTY_f9441005-1c42-41b1-aae8-6be200c63d48"
      unitRef="usd">8723000000</us-gaap:AccountsReceivableGrossCurrent>
    <bmy:CashDiscounts
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMi0xLTEtMS0xMTc3NTY_a00ef4ae-2525-484e-9eb6-d08e02022793"
      unitRef="usd">599000000</bmy:CashDiscounts>
    <bmy:CashDiscounts
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMi0zLTEtMS0xMTc3NTY_edc15ff5-a921-4f13-b393-059adebc1255"
      unitRef="usd">723000000</bmy:CashDiscounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMy0xLTEtMS0xMTc3NTY_c56a8b4e-9fc0-47ea-b288-7211498b640b"
      unitRef="usd">24000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfMy0zLTEtMS0xMTc3NTY_df60e733-9cf6-4765-ad29-68e47313934f"
      unitRef="usd">21000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNC0xLTEtMS0xMTc3NTY_30dec437-90dc-43aa-804a-a4e5506f318f"
      unitRef="usd">8021000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNC0zLTEtMS0xMTc3NTY_97635d82-58a2-425b-b714-741dbd11a938"
      unitRef="usd">7979000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivables
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNS0xLTEtMS0xMTc3NTY_f7544a65-510b-4e45-9255-4f060ff88046"
      unitRef="usd">1592000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNS0zLTEtMS0xMTc3NTY_c33e47b3-32df-4652-bca2-6c96092cb921"
      unitRef="usd">1390000000</us-gaap:OtherReceivables>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNi0xLTEtMS0xMTc3NTY_35bcb290-6f01-4a50-8302-6a861c10eaf9"
      unitRef="usd">9613000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RhYmxlOmQ2MzMwMGQzMjIwMTQ2OGVhM2M4OGViZDczZmJlMjI2L3RhYmxlcmFuZ2U6ZDYzMzAwZDMyMjAxNDY4ZWEzYzg4ZWJkNzNmYmUyMjZfNi0zLTEtMS0xMTc3NTY_3519a799-4e7e-4a57-bdbc-56f9468f1075"
      unitRef="usd">9369000000</us-gaap:ReceivablesNetCurrent>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfODM_cf28577d-be59-412f-87fd-f8fa45a81b22"
      unitRef="usd">809000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfOTA_c7ac4849-5c14-4ed0-836f-409fde92348a"
      unitRef="usd">1100000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:NumberOfLargestPharmaceuticalWholesalers
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMTQ3_fc2a9e28-53d5-4bac-83e5-50afb87a9572"
      unitRef="customer">3</bmy:NumberOfLargestPharmaceuticalWholesalers>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i24c74d0c904c4e3c93154b14e664eeb0_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjA2_24e29791-76c5-4224-8907-5aa664d1bc7d"
      unitRef="number">0.67</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i27025e532fa946c5a66af008af75071f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN182Ny9mcmFnOjAwYzc5NGJiYjNmMjRmYzhiMzk2NTEzZTAyZGRjNmM1L3RleHRyZWdpb246MDBjNzk0YmJiM2YyNGZjOGIzOTY1MTNlMDJkZGM2YzVfMjEz_4a14fec7-46df-422c-9344-1f6551af35ec"
      unitRef="number">0.59</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfNjA3_c77bd051-174e-4088-b4cc-24c39a8707e7">INVENTORIES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value adjustments related to the Celgene acquisition were $137 million as of September&#160;30, 2022 and $508 million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfNjE2_84293041-0034-4ef0-ac1e-a2a4cc9f7275">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMS0xLTEtMS0xMTc3NTY_080b54e5-bc8d-41b1-b9ae-ea0571adf901"
      unitRef="usd">357000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMS0zLTEtMS0xMTc3NTY_707fef4f-ad7c-46ea-ab8a-b7ac238dfea3"
      unitRef="usd">543000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMi0xLTEtMS0xMTc3NTY_ca2a91a5-2923-4ba3-a788-1862ac71a882"
      unitRef="usd">1870000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMi0zLTEtMS0xMTc3NTY_c6f535ea-2afc-4b44-9552-863c53373215"
      unitRef="usd">2111000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMy0xLTEtMS0xMTc3NTY_e69ffea4-812d-45e6-a86f-d2cdb1da8c7a"
      unitRef="usd">446000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfMy0zLTEtMS0xMTc3NTY_6c30cf94-6562-4a35-ad33-59cd21b54752"
      unitRef="usd">350000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <bmy:Totalinventories
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNC0xLTEtMS0xMTc3NTY_1e7617b0-1f2d-40f4-95da-48d16d229d08"
      unitRef="usd">2673000000</bmy:Totalinventories>
    <bmy:Totalinventories
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNC0zLTEtMS0xMTc3NTY_608eb07e-5c26-4f7d-8a1d-3fa1de1558e2"
      unitRef="usd">3004000000</bmy:Totalinventories>
    <us-gaap:InventoryNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNi0xLTEtMS0xMTc3NTY_0fdc5c4d-3d07-4d3e-8497-2a30268fc3e1"
      unitRef="usd">2074000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNi0zLTEtMS0xMTc3NTY_450b17b0-512f-4802-8253-38f5e2a23b8c"
      unitRef="usd">2095000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNy0xLTEtMS0xMTc3NTY_846ef203-6b8d-4869-8989-818b7c664440"
      unitRef="usd">599000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RhYmxlOjdmM2FkZDE3MzEzODRmYTE4MjM0MzIyNThhODQ2MDgyL3RhYmxlcmFuZ2U6N2YzYWRkMTczMTM4NGZhMTgyMzQzMjI1OGE4NDYwODJfNy0zLTEtMS0xMTc3NTY_7d4c23f9-9d43-448b-8c03-6ab384b5b274"
      unitRef="usd">909000000</us-gaap:InventoryNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i886174f12723459392de618ff498cab2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfOTY_fb5fdc02-8e7e-45c0-bf18-628a484a1d2b"
      unitRef="usd">137000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0ee682ed54c547b3b7f983bfdc4c3c2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183MC9mcmFnOmNkMjk5YTJkMmQyNTQwODdhYmQ2N2RlYzEyMzViNzU4L3RleHRyZWdpb246Y2QyOTlhMmQyZDI1NDA4N2FiZDY3ZGVjMTIzNWI3NThfMTA5_2081b55c-c6d4-4865-ba17-66a226c9ae88"
      unitRef="usd">508000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTQ0_af31534f-6f49-4bb2-bf7d-fbf2dfe071fe">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $148 million and $434 million for the three and nine months ended September&#160;30, 2022 and $144 million and $422 million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTQy_03cbf4e6-9125-4a62-994c-974fc4fb1a39">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMS0xLTEtMS0xMTc3NTY_805b0346-1099-48e3-a4bc-7e8a025bc77d"
      unitRef="usd">162000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMS0zLTEtMS0xMTc3NTY_001be6b2-1a9d-43ae-9512-53f1068d24bf"
      unitRef="usd">169000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMi0xLTEtMS0xMTc3NTY_ff942afc-1d58-4946-ad9e-d2c61c2f538d"
      unitRef="usd">5749000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMi0zLTEtMS0xMTc3NTY_1c7deed1-d9fd-40bc-88ca-46e83d8fc1dc"
      unitRef="usd">5897000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMy0xLTEtMS0xMTc3NTY_9f856083-6583-4108-ac7e-0044f4abdbfd"
      unitRef="usd">3290000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfMy0zLTEtMS0xMTc3NTY_164df336-485a-4a2a-8f0b-f69025b3650a"
      unitRef="usd">3252000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNC0xLTEtMS0xMTc3NTY_a6beedca-a792-4dfd-8dd7-c048bdaca002"
      unitRef="usd">973000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNC0zLTEtMS0xMTc3NTY_a2c22359-7dbb-4c9f-b378-ccd1ae8f1d4c"
      unitRef="usd">764000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNS0xLTEtMS0xMTc3NTY_7ca343ba-d278-46df-b038-ceaa193aa9ec"
      unitRef="usd">10174000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNS0zLTEtMS0xMTc3NTY_c2cb86c4-0b06-4ec9-ac19-1f4066dd7fe2"
      unitRef="usd">10082000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNi0xLTEtMS0xMTc3NTY_cf3ece56-1a10-4625-beb6-5a05f63638b2"
      unitRef="usd">4139000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNi0zLTEtMS0xMTc3NTY_31ca32ef-e2b2-480e-914e-c174a4e87acc"
      unitRef="usd">4033000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNy0xLTEtMS0xMTc3NTY_2670cfaa-a3c9-41b9-a143-8a1ef30ec53f"
      unitRef="usd">6035000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RhYmxlOjg1ZDczMDM2NjVkYTQxZjk4MmE4YmU0ZTRkNjAwYzA3L3RhYmxlcmFuZ2U6ODVkNzMwMzY2NWRhNDFmOTgyYThiZTRlNGQ2MDBjMDdfNy0zLTEtMS0xMTc3NTY_bf9bd41a-0e3c-43e6-b674-20d7a66c8e7c"
      unitRef="usd">6049000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfNzM_78a16e98-e30b-4145-9d4a-6a42ac4e8400"
      unitRef="usd">148000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfODA_e631109c-18fb-41cc-9c80-174106fb67cf"
      unitRef="usd">434000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTAx_5b657b89-8ffb-43cf-bc73-35f8453a78a9"
      unitRef="usd">144000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183My9mcmFnOmJkYTMzNDRhNDljMDQ4ZGJhZDUyNDFlYmNkOWYwNjNmL3RleHRyZWdpb246YmRhMzM0NGE0OWMwNDhkYmFkNTI0MWViY2Q5ZjA2M2ZfMTA4_59387425-f7a7-439c-a3e2-37ce04edd6d5"
      unitRef="usd">422000000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTY2Nw_f75d7bc0-df84-4f4f-bacf-b34fb8b6ac19">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes goodwill and other intangible assets recognized as part of the Turning Point acquisition in 2022. Refer to &#x201c;&#x2014;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#x201d; for further information related to the Turning Point acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of other intangible assets was $2.5 billion and $7.4 billion for the three and nine months ended September&#160;30, 2022 and $2.6 billion and $7.7 billion for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2022, a $58 million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Turning Point and was being studied as a potential treatment of advanced or metastatic solid tumors in adults. The charge represented a full write-down.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, a $40&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2021, a $610&#160;million IPRD impairment charge for an investigational compound was recorded in Research and development expense primarily resulting from changes in clinical timelines, expected launch dates and competitive landscape. The compound was being studied as a potential treatment for hematologic diseases and was acquired in the acquisition of Celgene. The charge represented a partial write-down of its carrying value based on the estimated fair value determined using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, a $230&#160;million IPRD impairment charge was recorded in Research and development expense resulting from a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first of quarter of 2021, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inrebic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTY2OQ_d618b5d2-a1d1-40b8-8b98-fb70d51e7857">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes goodwill and other intangible assets recognized as part of the Turning Point acquisition in 2022. Refer to &#x201c;&#x2014;Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements&#x201d; for further information related to the Turning Point acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMS0zLTEtMS0xMTc3NTY_ca25590d-a232-488b-9262-979eed510d5d"
      unitRef="usd">21112000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMS01LTEtMS0xMTc3NTY_f4dc906e-f099-4334-9534-88d7527a7e74"
      unitRef="usd">20502000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic6ada0a913014cb4a8b2d1fad754e062_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo5MWJmNzc1MWI1YmU0ZWExOWJkZGUzYTI1YmNmYjZkYl80_9127a37b-88fc-46e8-a2b4-40cb88a7d389">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib2f5ae04b7ca428da1a08620ad962073_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjo5MWJmNzc1MWI1YmU0ZWExOWJkZGUzYTI1YmNmYjZkYl85_5b7f9f19-aef5-4b0a-94b8-e2ef1b9bc962">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib58caf9412c34780974fe127d4a49141_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC0zLTEtMS0xMTc3NTY_9596441e-281c-48c0-b93f-ae2cc8678421"
      unitRef="usd">370000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iba770528fa914f1e8e9ac8e274342513_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNC01LTEtMS0xMTc3NTY_11ad6150-729c-45c1-a705-e24f86cde096"
      unitRef="usd">307000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i49772d239f2c4ae3ad2bb802c2f564a9_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjplYmIxZmVlMjQwNDk0YWFmOTk2ZjJmZTY1NzJhMjU1MF80_908ef851-eedf-4ebf-9e99-9115cc5f5cf8">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib6f0573b5eeb4100bf220e6512047183_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjplYmIxZmVlMjQwNDk0YWFmOTk2ZjJmZTY1NzJhMjU1MF85_614dc565-8092-44b9-b5be-c8056a1dac04">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic605e8764c2d4fcfbfd94ae6c74b3e65_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS0zLTEtMS0xMTc3NTY_cf6ddbe0-d65d-475c-beed-739295fcfc94"
      unitRef="usd">60477000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0dc3701c2cc449cfb23ae43990a4a971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNS01LTEtMS0xMTc3NTY_9eae3091-3bd9-4da1-94eb-0b0c23493bdf"
      unitRef="usd">60454000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id566a793fce34008bfef682147c19536_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2M1N2Q2OGUzNjU0MDlkYTIxZDMzYWUxYjYxY2JlYl80_0ba0d194-e458-4a77-be93-9732c3b4b284">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i07d325d61d7f4391ae952172cc449249_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0xLTEtMS0xMTc3NTYvdGV4dHJlZ2lvbjpmM2M1N2Q2OGUzNjU0MDlkYTIxZDMzYWUxYjYxY2JlYl85_b65d8faa-013b-449a-b7bd-15569dbc4ca0">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i653130003b5e4bc7b7676e60c391071f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi0zLTEtMS0xMTc3NTY_e2ed3e98-ed02-4a90-a148-1aa2019d024c"
      unitRef="usd">1613000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3e8639f3418a48268cee6497be9986b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNi01LTEtMS0xMTc3NTY_ddf0e13c-140a-4a86-a472-d3dccdc15f8d"
      unitRef="usd">1499000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i219c2189e62b4365b40543aca350a443_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNy0zLTEtMS0xMTc3NTY_d5b41295-fb67-4c8f-9dbb-8e6ad5679d27"
      unitRef="usd">6560000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id243edc1992c42548f6d5cfeb9cb4676_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfNy01LTEtMS0xMTc3NTY_05738eca-c648-4598-ac20-f406e0f71fa0"
      unitRef="usd">3750000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOC0zLTEtMS0xMTc3NTY_a4b6eb21-aa03-4424-90bc-b226cc8964ea"
      unitRef="usd">69020000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOC01LTEtMS0xMTc3NTY_e86547ef-99d7-4917-9048-72866ca88acd"
      unitRef="usd">66010000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOS0zLTEtMS0xMTc3NTY_8b13415b-3240-4074-8f0d-af5ef339c4ad"
      unitRef="usd">30841000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfOS01LTEtMS0xMTc3NTY_6192b867-2174-4a8c-a831-c450450fd989"
      unitRef="usd">23483000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMTAtMy0xLTEtMTE3NzU2_5ae2380d-2f46-4131-afcc-4bd496c52193"
      unitRef="usd">38179000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RhYmxlOjY1MTFiZDQyNGQyNjRjOWE5NDEzNTBhNzQxNGZlNTdjL3RhYmxlcmFuZ2U6NjUxMWJkNDI0ZDI2NGM5YTk0MTM1MGE3NDE0ZmU1N2NfMTAtNS0xLTEtMTE3NzU2_1a5e2f85-1b80-421d-b76c-18e727313d5d"
      unitRef="usd">42527000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTA2_5bf76685-6d48-4b6f-90f4-494025012139"
      unitRef="usd">2500000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTEz_7ebcc3b9-ca44-40ea-a6b5-3aeee5a5e674"
      unitRef="usd">7400000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTM0_3f27c116-8688-4c69-9f18-3108b4a4bc83"
      unitRef="usd">2600000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTQx_d38bf339-cbb7-4eef-ba9c-5540cd7b985e"
      unitRef="usd">7700000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTA5OTUxMTYzMjY4OA_1b02bfe6-f6b9-420f-b5de-48e80d5fa93b"
      unitRef="usd">58000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMjA2_52f652ac-9398-4868-a422-88a9c1931980"
      unitRef="usd">40000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfNTQ5NzU1ODE2NjM1_2e6e5159-97a4-4c24-b65a-b040b82bfe48"
      unitRef="usd">610000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfNjM3_23b5335f-a3df-4172-8fd4-db05e02074a5"
      unitRef="usd">230000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <bmy:ContingentAndRegulatoryMilestoneNonCash
      contextRef="iccb38ad8451f4f6497c394f35b06eb08_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTE5NQ_e77611b7-55d2-4337-b6bc-15669bd075f7"
      unitRef="usd">300000000</bmy:ContingentAndRegulatoryMilestoneNonCash>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTIyNw_03c42614-1b8e-4b3d-9028-df8943d99251"
      unitRef="usd">385000000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i19e2b2202c864de79bead64a09d13a1a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN183OS9mcmFnOjFkODE3NTFjNzczMjQwY2U5MDk5NmY4ZjE0NzM5YTk0L3RleHRyZWdpb246MWQ4MTc1MWM3NzMyNDBjZTkwOTk2ZjhmMTQ3MzlhOTRfMTM3OQ_523d8934-d69c-4c57-b1d0-c5b8e088db17"
      unitRef="usd">315000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDYw_2d8d55fc-31fd-4e96-b6e7-d49320b1dfef">SUPPLEMENTAL FINANCIAL INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. Restricted cash of $339 million as of September 30, 2021, was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDcy_654aede5-3ca1-403f-bd74-d52f489fbbed">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMS0xLTEtMS0xMTc3NTY_ad8def6b-4325-4d8d-8e93-729695e7ff16"
      unitRef="usd">3181000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMS0zLTEtMS0xMTc3NTY_61e07a36-f0e8-45ff-985a-4540147116ee"
      unitRef="usd">2786000000</us-gaap:PrepaidTaxes>
    <bmy:ResearchandDevelopment
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMi0xLTEtMS0xMTc3NTY_029068f0-4765-40ac-9f2e-ef630903b768"
      unitRef="usd">627000000</bmy:ResearchandDevelopment>
    <bmy:ResearchandDevelopment
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMi0zLTEtMS0xMTc3NTY_cf655a73-9dc0-46a4-abb2-428dc0b69b75"
      unitRef="usd">514000000</bmy:ResearchandDevelopment>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMy0xLTEtMS0xMTc3NTY_331bc016-0069-4e74-a011-89892424e534"
      unitRef="usd">446000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfMy0zLTEtMS0xMTc3NTY_b2eb0a1f-8acf-4d0c-9678-80c1b3d1c059"
      unitRef="usd">361000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <bmy:EquityInvestmentsCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNC0xLTEtMS0xMTc3NTY_f95bc77b-69a3-41af-b47b-c22fe7be11cb"
      unitRef="usd">0</bmy:EquityInvestmentsCurrent>
    <bmy:EquityInvestmentsCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNC0zLTEtMS0xMTc3NTY_2469bd2a-eee3-4f41-8a7e-3ce095c00966"
      unitRef="usd">255000000</bmy:EquityInvestmentsCurrent>
    <us-gaap:RestrictedCash
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNS0xLTEtMS0xMTc3NTY_ba3122c2-679c-4ca5-a258-28b47ca3928d"
      unitRef="usd">164000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNS0zLTEtMS0xMTc3NTY_0a00cfd4-ec9c-4feb-867d-82d3d0f25381"
      unitRef="usd">140000000</us-gaap:RestrictedCash>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNi0xLTEtMS0xMTc3NTY_be405ab5-0d45-44dc-a633-53119feb8223"
      unitRef="usd">1664000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNi0zLTEtMS0xMTc3NTY_f270c4e8-d83d-46fa-95ee-d7372a8881fb"
      unitRef="usd">776000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNy0xLTEtMS0xMTc3NTY_3f02ee46-bf68-45a6-9b20-05158e5907c7"
      unitRef="usd">6082000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVkMDg3ZWJlOGJiYjRmNWViZjNhYjkwOThiNWE1MjJjL3RhYmxlcmFuZ2U6NWQwODdlYmU4YmJiNGY1ZWJmM2FiOTA5OGI1YTUyMmNfNy0zLTEtMS0xMTc3NTY_1a6c4a59-8027-4d59-8ac2-52ff6e44803d"
      unitRef="usd">4832000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDcx_492416e9-6dc6-4046-91f9-871b920223e9">&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. Restricted cash of $339 million as of September 30, 2021, was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMS0xLTEtMS0xMTc3NTY_4805ed97-34c7-48fc-a009-9b6adc74d122"
      unitRef="usd">1959000000</bmy:EquityInvestmentsNonCurrent>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMS0zLTEtMS0xMTc3NTY_b88df4d7-88f9-40f0-a2ef-460ce3103837"
      unitRef="usd">2713000000</bmy:EquityInvestmentsNonCurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMi0xLTEtMS0xMTc3NTY_bf0a8c63-5d65-4809-b4de-77120dd58a2b"
      unitRef="usd">599000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMi0zLTEtMS0xMTc3NTY_2a92aa21-ac5c-4e67-867d-bfa14d761e94"
      unitRef="usd">909000000</us-gaap:InventoryNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMy0xLTEtMS0xMTc3NTY_d4f49be5-96e8-4591-8ea5-59499a8765c0"
      unitRef="usd">883000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfMy0zLTEtMS0xMTc3NTY_958a79c8-f85e-46be-bd6a-1c8fb9cb479c"
      unitRef="usd">919000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNC0xLTEtMS0xMTc3NTY_e49e4d97-30d4-469d-93ee-bec1a41c6569"
      unitRef="usd">301000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNC0zLTEtMS0xMTc3NTY_0261cb6b-58d9-4075-8ecb-b807851b2a97"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNS0xLTEtMS0xMTc3NTY_8e8ce3d9-3668-42aa-8efa-fbf46a2c45d3"
      unitRef="usd">547000000</bmy:ResearchAndDevelopmentNonCurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNS0zLTEtMS0xMTc3NTY_08bb6684-a565-47fa-be86-493e16f1a9e4"
      unitRef="usd">248000000</bmy:ResearchAndDevelopmentNonCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNi0xLTEtMS0xMTc3NTY_09d22889-e167-4905-b853-420879347637"
      unitRef="usd">59000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNi0zLTEtMS0xMTc3NTY_1eccc0a4-14fa-4bb3-9f99-9b81c5bf42bc"
      unitRef="usd">197000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNy0xLTEtMS0xMTc3NTY_1801fa96-b65e-4024-8b80-4cd81fe4de9e"
      unitRef="usd">397000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfNy0zLTEtMS0xMTc3NTY_ae5ec749-29a8-4184-818b-3929335f70fd"
      unitRef="usd">232000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfOC0xLTEtMS0xMTc3NTY_eb0ae488-f9ce-4396-985a-007e5abcda03"
      unitRef="usd">4745000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOmRjM2E2NWZlZmRmZjRmODFhZGVhZTkwZmRhZDcwOWIyL3RhYmxlcmFuZ2U6ZGMzYTY1ZmVmZGZmNGY4MWFkZWFlOTBmZGFkNzA5YjJfOC0zLTEtMS0xMTc3NTY_c1e474f4-496a-45d6-a95c-9c73671ae02a"
      unitRef="usd">5535000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i4db84d4e37a04e54af5c55bf28598232_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfMzI5_bff842cb-e317-4672-9fa1-7fc060ac6b24"
      unitRef="usd">339000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDY2_70aa16d8-5528-41d7-847b-cff969d7288d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <bmy:AccruedRebatesAndReturns
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMS0xLTEtMS0xMTc3NTY_33dd5102-2520-4305-9cfb-1646f95a963c"
      unitRef="usd">6839000000</bmy:AccruedRebatesAndReturns>
    <bmy:AccruedRebatesAndReturns
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMS0zLTEtMS0xMTc3NTY_90fdbd00-830f-4214-b2e9-1a29ca871ca8"
      unitRef="usd">6399000000</bmy:AccruedRebatesAndReturns>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMi0xLTEtMS0xMTc3NTY_9937edc3-e5a5-4d0d-90da-37194cf01527"
      unitRef="usd">1287000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMi0zLTEtMS0xMTc3NTY_a04115d2-e830-4c88-ad31-db7d8630b10b"
      unitRef="usd">754000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMy0xLTEtMS0xMTc3NTY_36794825-848d-483d-96a3-25b87a5c8986"
      unitRef="usd">1008000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMy0zLTEtMS0xMTc3NTY_25ed40c9-f6cf-4e5e-8673-9358ccc081f1"
      unitRef="usd">1375000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNC0xLTEtMS0xMTc3NTY_1df879b7-664a-4502-ac85-9e9d9ca2b9cb"
      unitRef="usd">1296000000</bmy:AccruedResearchAndDevelopment>
    <bmy:AccruedResearchAndDevelopment
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNC0zLTEtMS0xMTc3NTY_c720f082-7ed7-4ff1-aa61-85920e41d743"
      unitRef="usd">1373000000</bmy:AccruedResearchAndDevelopment>
    <us-gaap:DividendsPayableCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNS0xLTEtMS0xMTc3NTY_e4551c1a-8e37-421c-b4c1-48ec23758a8f"
      unitRef="usd">1148000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNS0zLTEtMS0xMTc3NTY_9121f2e3-085a-43d5-9d5b-a5155ec4c985"
      unitRef="usd">1186000000</us-gaap:DividendsPayableCurrent>
    <bmy:AccruedInterest
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNi0xLTEtMS0xMTc3NTY_0c516a2d-4766-41f4-b6fd-4b46a8b5448a"
      unitRef="usd">311000000</bmy:AccruedInterest>
    <bmy:AccruedInterest
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNi0zLTEtMS0xMTc3NTY_bcf3df2c-a2af-4bd8-936a-af0bc71b0a5a"
      unitRef="usd">378000000</bmy:AccruedInterest>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNy0xLTEtMS0xMTc3NTY_3b83f2a8-88a4-4302-851c-5214caa52ee7"
      unitRef="usd">385000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfNy0zLTEtMS0xMTc3NTY_1a4d6a43-9cc5-43c5-a8b8-9b65773f18e7"
      unitRef="usd">410000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfOC0xLTEtMS0xMTc3NTY_04d9df2b-6df3-43b2-9219-6c83d1eda0a4"
      unitRef="usd">167000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfOC0zLTEtMS0xMTc3NTY_3cc25810-5c19-44cc-981b-5d9875fd05c7"
      unitRef="usd">169000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTAtMS0xLTEtMTE3NzU2_87483185-be4b-4724-8193-ba0518a7bc1a"
      unitRef="usd">1762000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTAtMy0xLTEtMTE3NzU2_1483b686-de96-47ab-8fd3-a86f7e62101d"
      unitRef="usd">1927000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTEtMS0xLTEtMTE3NzU2_76962423-8af3-40d8-8d8b-afb4c5ccaed7"
      unitRef="usd">14203000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjFjMWRmOTRhNzY3ZTRlNGRhZjJiOWFkM2U4MTE2MmJkL3RhYmxlcmFuZ2U6MWMxZGY5NGE3NjdlNGU0ZGFmMmI5YWQzZTgxMTYyYmRfMTEtMy0xLTEtMTE3NzU2_9f131a2d-0d69-4f2d-8127-4f1fd1c17336"
      unitRef="usd">13971000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RleHRyZWdpb246MDNkOTE0ZmYyOGY5NDM1MDhjODgxYmJmMmZiODMzZWRfNDY3_8c872188-2793-4288-92b1-ba46c83d064a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMS0xLTEtMS0xMTc3NTY_e916953e-ed58-41af-adef-b3ef1a4dca4c"
      unitRef="usd">4398000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMS0zLTEtMS0xMTc3NTY_c0238a33-b103-44de-87ab-8fa39b2eb7cf"
      unitRef="usd">4835000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMi0xLTEtMS0xMTc3NTY_f356f3dd-5e9a-46a5-89ea-075a8a15f3d1"
      unitRef="usd">553000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMi0zLTEtMS0xMTc3NTY_e71fda5e-591f-4b68-821a-449aaa817b8e"
      unitRef="usd">654000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMy0xLTEtMS0xMTc3NTY_01b85f8d-cd9e-490a-a10f-4e10fc3c3b1b"
      unitRef="usd">845000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfMy0zLTEtMS0xMTc3NTY_16c0706b-e395-428d-97ac-ea4345b4dc98"
      unitRef="usd">874000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNC0xLTEtMS0xMTc3NTY_f8cf845c-d2ad-4043-afd1-5a231a80a8fd"
      unitRef="usd">296000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNC0zLTEtMS0xMTc3NTY_87308870-8eb3-48fb-bb18-89031d6841f8"
      unitRef="usd">326000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNS0xLTEtMS0xMTc3NTY_0490b2b0-c03c-4853-b322-435899ad849a"
      unitRef="usd">337000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNS0zLTEtMS0xMTc3NTY_46725e09-9d0f-4a39-8a17-da9f026f36ba"
      unitRef="usd">427000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNi0xLTEtMS0xMTc3NTY_b385dd63-e48a-4160-bb92-2a704146f939"
      unitRef="usd">256000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNi0zLTEtMS0xMTc3NTY_be7c1355-7eba-436a-8ff3-94fad1e74070"
      unitRef="usd">218000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNy0xLTEtMS0xMTc3NTY_468b79a2-aaa3-4148-89a2-d9d6581fc592"
      unitRef="usd">6685000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184Mi9mcmFnOjAzZDkxNGZmMjhmOTQzNTA4Yzg4MWJiZjJmYjgzM2VkL3RhYmxlOjVjMWJjNjA4NTFiMzQxZTM5MDYwM2Y5NDRiYmJiYjgzL3RhYmxlcmFuZ2U6NWMxYmM2MDg1MWIzNDFlMzkwNjAzZjk0NGJiYmJiODNfNy0zLTEtMS0xMTc3NTY_de2699ec-ea36-412d-9c30-eaa900fe42c9"
      unitRef="usd">7334000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjMxNw_ceb5588b-2247-4e77-bb55-b2acd754080c">EQUITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the nine months ended September 30, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022, June&#160;30, 2022 and September&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021, June&#160;30, 2021 and September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method. The outstanding share repurchase authorization under the program was approximately $15.2 billion as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $5.0&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand. In the first quarter of 2022 approximately 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The remaining amounts in the ASR agreements were settled in two tranches during the second and third quarters and 4&#160;million shares of common stock were received by BMS and transferred to treasury stock. The total number of shares repurchased under the ASR agreements was based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. In addition, as part of its share repurchase program, BMS repurchased approximately 10&#160;million shares of its common stock for $701&#160;million during the three months ended September 30, 2022. The outstanding share repurchase authorization under the program was approximately $9.5&#160;billion as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to &#x201c;&#x2014;Note 9.Financial Instruments and Fair Value Measurements&#x201c; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:-9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to &#x201c;&#x2014;Note 9.Financial Instruments and Fair Value Measurements&#x201c; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjM1MA_5e503b46-076e-4590-9f73-e06e08c83966">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the nine months ended September 30, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022, June&#160;30, 2022 and September&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021, June&#160;30, 2021 and September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesIssued
      contextRef="if704e1173f28402383a6c57f2e3df140_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xLTEtMS0xMTc3NTY_09e44ab5-05ce-4db4-bf3f-019cd5ca73af"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if704e1173f28402383a6c57f2e3df140_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0zLTEtMS0xMTc3NTY_18594bb9-87a9-4143-8f9c-0dd6b76c2755"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1fe41494b00144aeb5eef7881099386c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi01LTEtMS0xMTc3NTY_28c22004-2da1-4cbe-9da3-25876b348aa3"
      unitRef="usd">44361000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2168a62d5517410387e38e8ee41bdb64_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi03LTEtMS0xMTc3NTY_7ad24096-3df8-4f68-ace0-1029bcd19b2a"
      unitRef="usd">-1268000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20651cc5726a493da9cdd353ebddce96_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi05LTEtMS0xMTc3NTY_5289cda6-6463-4d26-9fe6-73fa9641eb4d"
      unitRef="usd">23820000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ia3d0354da6a042df94a411a0fc948ddd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xMS0xLTEtMTE3NzU2_95de805f-06be-4367-af5f-b82fae2fd50d"
      unitRef="shares">747000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia3d0354da6a042df94a411a0fc948ddd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xMy0xLTEtMTE3NzU2_8716e660-6ae7-4e37-bc1c-5bd7239050a7"
      unitRef="usd">-31259000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide2fe15f76824880a795877832feb862_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMi0xNS0xLTEtMTE3NzU2_774b3bac-5ff7-414c-971a-ae6dd842adbc"
      unitRef="usd">60000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i3c0282842cd245059208dde198cff004_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMy05LTEtMS0xMTc3NTY_87909b43-d04b-4170-a1c5-512c27950517"
      unitRef="usd">1278000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib08f80cfa602443b95ad13171165dfa8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMy0xNS0xLTEtMTE3NzU2_bc997721-630f-43a7-90d1-22b016d9aff2"
      unitRef="usd">-5000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6ea8a669ebd49d098c897a367c09915_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNC03LTEtMS0xMTc3NTY_5337e248-63dd-431a-afca-638af250e6c2"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3c0282842cd245059208dde198cff004_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNS05LTEtMS0xMTc3NTY_2f3664aa-aeb5-43fa-b716-45b4c8c324d7"
      unitRef="usd">1150000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi01LTEtMS0xMTc3NTY_8141bf58-f5aa-4aec-8e19-c687f7e761bb"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi0xMS0xLTEtMTE3NzU2_7b1be789-92ec-48b9-8b28-1d848e0e666e"
      unitRef="shares">65000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNi0xMy0xLTEtMTE3NzU2_df08ec62-e909-40f8-981a-efb461443f9a"
      unitRef="usd">4250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5639f150b47645e7a4cbad4be1e93c68_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy01LTEtMS0xMTc3NTY_5fcea34f-c6da-45df-b95e-f70aae3c739f"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy0xMS0xLTEtMTE3NzU2_e565fbf4-ec7b-47d7-877b-7cba0e35b188"
      unitRef="shares">18000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i81843f4922a440dcba130d3844c32c51_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfNy0xMy0xLTEtMTE3NzU2_477853c0-2a77-441c-afcf-937d5a26286b"
      unitRef="usd">322000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i1959f27617924dd58c01a80cf6b58c30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xLTEtMS0xMTc3NTY_5246cd8b-9f6d-419e-ad0c-446d793e68eb"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1959f27617924dd58c01a80cf6b58c30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0zLTEtMS0xMTc3NTY_638c6fa6-0ef4-499e-afbc-a01434f1c8d6"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a04a6cc493441c896b686ccf7d9db6c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS01LTEtMS0xMTc3NTY_e1e7f439-8a71-407e-817e-e4e4168a0036"
      unitRef="usd">43756000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10004cd63b014f3f8682ee02de56861b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS03LTEtMS0xMTc3NTY_1c6f325c-3b32-4c37-bea1-5de0b1bff794"
      unitRef="usd">-1229000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id062426fbfc04f8c9b4ae0975bc9b322_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS05LTEtMS0xMTc3NTY_0dc72223-84d6-4b5d-beb4-399ba1e5217c"
      unitRef="usd">23948000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i96fde31e46e241998655851bda819407_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xMS0xLTEtMTE3NzU2_e8189236-ee33-4150-b7a2-479060722541"
      unitRef="shares">794000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i96fde31e46e241998655851bda819407_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xMy0xLTEtMTE3NzU2_5d62be37-b330-4a34-877c-29c13a756dcc"
      unitRef="usd">-35187000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i424fa464af494f00a96d5d2ecde941c1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfOS0xNS0xLTEtMTE3NzU2_427e987c-2c12-47eb-81ad-cf689bdb1bcc"
      unitRef="usd">65000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i70bb84b635a14384813aff1611be542e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTAtOS0xLTEtMTE3NzU2_56f9ce36-d61f-4e0d-b0f7-68b8b823801c"
      unitRef="usd">1421000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie36c386d500b49e9b15964e0e07d8e99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTAtMTUtMS0xLTExNzc1Ng_b3aaee63-04a8-42b9-ba61-01241b811b31"
      unitRef="usd">-8000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0c5af4d6da0c46abafd596c61cea80e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTEtNy0xLTEtMTE3NzU2_9c8a3e2c-f779-4e4f-95db-e8c9491799f7"
      unitRef="usd">237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i70bb84b635a14384813aff1611be542e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTItOS0xLTEtMTE3NzU2_6062b1f1-3875-4571-985a-b561d9ab9d6a"
      unitRef="usd">1152000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtNS0xLTEtMTE3NzU2_deef722d-98be-437a-b4e2-0831f0bca284"
      unitRef="usd">-300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtMTEtMS0xLTExNzc1Ng_70f890f6-ab25-41ab-8507-d1a677dfa771"
      unitRef="shares">2000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTMtMTMtMS0xLTExNzc1Ng_7e2488e1-a4b2-4e97-87cb-e615ed3f8726"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i12d21c2b856047e1a96b405321b9dd75_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtNS0xLTEtMTE3NzU2_66574c52-7ebc-4a3d-8780-7ab84c2ef5f8"
      unitRef="usd">319000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtMTEtMS0xLTExNzc1Ng_a6db9c00-4844-44ad-95cd-9bc9d911438c"
      unitRef="shares">8000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i968227348bbd4ed79075870a7629fa4c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTQtMTMtMS0xLTExNzc1Ng_8ed93805-4ad8-4b48-bc9d-e7c7bd8c546f"
      unitRef="usd">195000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:Dividends
      contextRef="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTUtMTUtMS0xLTExNzc1Ng_e6ef80f9-633b-46a4-9180-e0c535765c40"
      unitRef="usd">12000000</us-gaap:Dividends>
    <us-gaap:SharesIssued
      contextRef="if9f675d87d624de7959d9b23d44a06ad_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMS0xLTEtMTE3NzU2_9281b169-1460-4517-a404-c19584dfe89f"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if9f675d87d624de7959d9b23d44a06ad_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMy0xLTEtMTE3NzU2_64439d46-c979-4812-a045-bd55534552fd"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if90cad36c797440684daad86d7b7980c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtNS0xLTEtMTE3NzU2_1b451d18-9cdf-4e49-ad68-4310f91c430b"
      unitRef="usd">44375000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3a762be7d3142c79bcc98621c63a1b4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtNy0xLTEtMTE3NzU2_820db78f-20eb-4ac3-a874-0d1e5b5d8dc8"
      unitRef="usd">-992000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i261fe8c2d46d4b2bbdcb71ceee0a2956_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtOS0xLTEtMTE3NzU2_c7abaac1-2abe-4d5e-a579-f354df89e3b7"
      unitRef="usd">24217000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i708233e593ac416d8961d311b12dd0d9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTEtMS0xLTExNzc1Ng_77ea01c5-1585-439b-9c29-b71f8f10d772"
      unitRef="shares">788000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i708233e593ac416d8961d311b12dd0d9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTMtMS0xLTExNzc1Ng_6634700f-aed7-49e6-a7a6-d03e1123f4e4"
      unitRef="usd">-35292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f6b897df93a45b0931e170cfe06cd39_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTYtMTUtMS0xLTExNzc1Ng_2bed277b-6fbc-450e-afc2-ae5edb2bdaf3"
      unitRef="usd">61000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTctOS0xLTEtMTE3NzU2_6ef9ae09-2940-47ce-8567-3e650e23df91"
      unitRef="usd">1606000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i58393e2f2a5a48d6a80d43186ff0f68a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTctMTUtMS0xLTExNzc1Ng_051b7742-947d-4299-9db5-d0dc30263eda"
      unitRef="usd">-2000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic389bf69a1b047ae8a8ca1032a58c315_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTgtNy0xLTEtMTE3NzU2_eac8a3a5-5ca4-4dbc-98cf-333d6318aca5"
      unitRef="usd">151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="iaca8cff3683045fb8a13705a0de12004_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMTktOS0xLTEtMTE3NzU2_dbb397e8-22b1-482f-b7fe-99ca5d4fce60"
      unitRef="usd">1148000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtNS0xLTEtMTE3NzU2_49345030-e367-43b2-ad0b-588b3f6e2647"
      unitRef="usd">-450000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtMTEtMS0xLTExNzc1Ng_0a24d1f6-8588-4009-81c2-6d8650edd191"
      unitRef="shares">12000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjAtMTMtMS0xLTExNzc1Ng_1210139e-54ef-43dd-9989-0b5cf470f5ee"
      unitRef="usd">1151000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i93a6f71081124d41af158ac88a105a8c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtNS0xLTEtMTE3NzU2_936f4afb-ce0b-4cb2-8c45-fdf52885f2e0"
      unitRef="usd">131000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtMTEtMS0xLTExNzc1Ng_2c829c4a-0e18-4b6a-bc8a-5b8571a99264"
      unitRef="shares">1000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if713dbf10d5c4a55bcab49113e8e7b99_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjEtMTMtMS0xLTExNzc1Ng_dec0d133-e4f3-46a2-9701-3e4a99165e2a"
      unitRef="usd">32000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ie839b830453247969319cb4087f8432e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMS0xLTEtMTI1OTAw_81186cc6-5945-4113-b2e3-1506945a670d"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie839b830453247969319cb4087f8432e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMy0xLTEtMTI1OTAy_5e4bec81-bad0-46ab-8b9d-b40fc7d61383"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66f1af0105054a9d94aaf408f96a944e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtNS0xLTEtMTI1OTA0_da4d2c5d-e525-4324-9bcd-e07c82ead947"
      unitRef="usd">44956000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i639f28b14fcb4c98a3e7676735c73daa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtNy0xLTEtMTI1OTA2_0a69df44-4a9b-4125-9df5-24788d737cd8"
      unitRef="usd">-841000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45849baa6e0c4606bd93975a061f7213_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtOS0xLTEtMTI1OTA4_05bea900-fd3f-46eb-9805-47bbeba612a1"
      unitRef="usd">24675000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ie798c0b144ab4feaac7932ccbec3c84f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTEtMS0xLTEyNTkxMA_5b05867d-2150-4866-a6fc-f7d0f6cfccb0"
      unitRef="shares">799000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie798c0b144ab4feaac7932ccbec3c84f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTMtMS0xLTEyNTkxMg_b24811c7-4d18-4601-8618-3f43f8f1eae8"
      unitRef="usd">-36411000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e7be709431d46ecab3d337838ec40ca_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjZkNzljNmE5MTQyZDRkMzVhZjBmMjYxOGFhYWY4MmIwL3RhYmxlcmFuZ2U6NmQ3OWM2YTkxNDJkNGQzNWFmMGYyNjE4YWFhZjgyYjBfMjQtMTUtMS0xLTEyNTkxNA_299d3bff-c805-49b3-aa62-a4cc681a34ed"
      unitRef="usd">63000000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8ad07205896d48dda170efc39ce2642e_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_03eb350c-6da9-4615-a295-c8a7aa1a9336"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5fd33eee90d24e7ca7c2bc2c69033d20_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_be6ca4cb-6245-4e48-aa9b-5d5187d45a98"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTM2_fb44fb3f-f1ac-4e75-9b21-beb1d41036f8"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesIssued
      contextRef="ic1bb411461174751860a090a735e24e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xLTEtMS0xMTc3NTY_8a3a3ed1-7bf3-4b2c-af4b-bf7841833792"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic1bb411461174751860a090a735e24e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0zLTEtMS0xMTc3NTY_1f93914f-4c66-409c-8c84-3857f97d9b86"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69dbdf8184bb44cb9a23af5df39a7e17_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi01LTEtMS0xMTc3NTY_67f70d0f-ff4a-476b-a3c3-2aa42e652bd9"
      unitRef="usd">44325000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaab6129cd90e47629f61a8c46beb198c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi03LTEtMS0xMTc3NTY_c9822110-8ffb-43ef-9b3f-3cc7c29ce754"
      unitRef="usd">-1839000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbf10e85fa704140bd6819ab1c54a619_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi05LTEtMS0xMTc3NTY_e2cbdf62-0b2c-415f-a3d7-13c1a866ca67"
      unitRef="usd">21281000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i16b6a9e7477b44bf812f52b13f664d43_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xMS0xLTEtMTE3NzU2_04a42c16-1ae1-4e7a-a01a-01803fc87879"
      unitRef="shares">679000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i16b6a9e7477b44bf812f52b13f664d43_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xMy0xLTEtMTE3NzU2_6728c1da-924b-41aa-96ab-f891c20ec63c"
      unitRef="usd">-26237000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibdb86ddecf754f1b9ed10ee592a8c467_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMi0xNS0xLTEtMTE3NzU2_1002fe0c-00ae-4c8c-8b8c-418f3f4122cb"
      unitRef="usd">60000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMy05LTEtMS0xMTc3NTY_019f174f-6461-4ec7-8589-6e0d481aad94"
      unitRef="usd">2021000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9ea49ce882bf4f63af2987bb1e15d6b6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMy0xNS0xLTEtMTE3NzU2_0370195c-e52c-49f0-94af-f3ac06667b36"
      unitRef="usd">-8000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib89084d224e14efdb9d09b06d9c54c39_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNC03LTEtMS0xMTc3NTY_cd7ae8c4-22ac-48b5-95e7-942199e6381c"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i36568420f59e45f0a135ae3b97a75049_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNS05LTEtMS0xMTc3NTY_b69a16cb-a5e6-4f15-918f-502c46d709d9"
      unitRef="usd">1098000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNi0xMS0xLTEtMTE3NzU2_835763e0-3f7e-49d1-b739-c9cdd4350586"
      unitRef="shares">28000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNi0xMy0xLTEtMTE3NzU2_a5321fa3-d610-42c5-8e38-12c3bcca5518"
      unitRef="usd">1768000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id73e463a04364161a685d3c4430b5550_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy01LTEtMS0xMTc3NTY_4b0f9fa4-d79b-4851-93b1-19fd8e88d6f1"
      unitRef="usd">-473000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy0xMS0xLTEtMTE3NzU2_3f3a6492-0db5-4175-93b2-16a68ef6adb1"
      unitRef="shares">15000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib37580ef21574d7ea78bf9b10a94064a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfNy0xMy0xLTEtMTE3NzU2_329e8d14-c655-4b2c-b87f-6bfde7557736"
      unitRef="usd">806000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i2a7555f794ba413894219c16f451682c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xLTEtMS0xMTc3NTY_6ee6e5fd-c8c2-4dab-98ce-0e97925407fb"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2a7555f794ba413894219c16f451682c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0zLTEtMS0xMTc3NTY_4bec8e88-50bd-41bd-b270-b40fc763c884"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82d62d70afcd42918ea9a2bfec538e66_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS01LTEtMS0xMTc3NTY_f9eb5b5e-f8fc-40a1-abc5-9ad01b2d4d89"
      unitRef="usd">43852000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28b2d4d8d91d4b278caf43bb6f13b862_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS03LTEtMS0xMTc3NTY_dbb1f936-4ba0-4814-9f9a-a53517aa709f"
      unitRef="usd">-1544000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic367a2ecd9d0433e86bbfb9640e1163c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS05LTEtMS0xMTc3NTY_a23b40fc-0743-49ce-ad4c-b311141b3b2e"
      unitRef="usd">22204000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xMS0xLTEtMTE3NzU2_423159b0-a5b8-4b7b-be38-d0b1b55b7e28"
      unitRef="shares">692000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i753ded94ccfc47fd85f30e65ffa36a5f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xMy0xLTEtMTE3NzU2_b536fddb-ac71-4ac2-bfdf-94d0a04e0855"
      unitRef="usd">-27199000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66f58e8de911437f80231a5c3f56f8a1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfOS0xNS0xLTEtMTE3NzU2_7cae14e2-9a46-4863-91eb-a3d734c198b9"
      unitRef="usd">68000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ic00793ef22204a91b9d9819706370521_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTAtOS0xLTEtMTE3NzU2_c4825bca-a7f0-4085-abda-e28a37b1424d"
      unitRef="usd">1055000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c911796bb404970a0c3702c1385d332_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTAtMTUtMS0xLTExNzc1Ng_4d65f605-976d-4c4c-bd16-590fbb5627f1"
      unitRef="usd">-6000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i63981ccb8d3246b7aa697743bf82119c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTEtNy0xLTEtMTE3NzU2_1564d612-718a-4e4f-ac26-def03eab5fd0"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic00793ef22204a91b9d9819706370521_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTItOS0xLTEtMTE3NzU2_64afdf17-84d0-41a9-a49e-af5fc0a62925"
      unitRef="usd">1091000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTMtMTEtMS0xLTExNzc1Ng_f0a30c2d-0a08-467e-9989-f9b31420ad90"
      unitRef="shares">19000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTMtMTMtMS0xLTExNzc1Ng_13e07e2a-a387-4208-81ad-4ce047b78826"
      unitRef="usd">1235000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia128e4642cfa484ebf43540577cd5f09_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtNS0xLTEtMTE3NzU2_41ab571c-8f2d-4ab7-86d6-8c7b4404420d"
      unitRef="usd">212000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtMTEtMS0xLTExNzc1Ng_02747bc9-c554-466f-aec7-5ec6a0becae4"
      unitRef="shares">10000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i872f940e3394429d83f38b9f6d926087_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTQtMTMtMS0xLTExNzc1Ng_e7b494d5-4ee5-4dac-8dc7-8d8ffdbaf8f2"
      unitRef="usd">236000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:Dividends
      contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTUtMTUtMS0xLTExNzc1Ng_247ac4e7-0d87-4ea1-a1fb-6bdae86389ae"
      unitRef="usd">8000000</us-gaap:Dividends>
    <us-gaap:SharesIssued
      contextRef="i20e0a56327ff4170819c77cd3052bfc6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMS0xLTEtMTE3NzU2_640180cc-00d8-4a26-8c06-22b2b0d8b5d1"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i20e0a56327ff4170819c77cd3052bfc6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMy0xLTEtMTE3NzU2_fd2085df-7dcb-4fd2-93a7-40d8cf19a031"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5304c82d5b4048f985873fbbdfca9327_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtNS0xLTEtMTE3NzU2_218d88da-48b7-475d-bf9e-72928a651435"
      unitRef="usd">44064000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e16a4a57b3c403e9a92285a51739e1a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtNy0xLTEtMTE3NzU2_13f71e0a-2a78-4d89-ab70-fd9a8a1378ba"
      unitRef="usd">-1518000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7a7b2e0f79541e592a3eb7ca30e07b8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtOS0xLTEtMTE3NzU2_8eb6f916-c4b2-40c7-ab9d-7c981b3a098d"
      unitRef="usd">22168000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i5a80b405b4bf48fba866761f2581c0ca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTEtMS0xLTExNzc1Ng_2ee903b8-2c2c-4000-b51f-4bc29954c30e"
      unitRef="shares">701000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5a80b405b4bf48fba866761f2581c0ca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTMtMS0xLTExNzc1Ng_185511a1-e2e1-404d-b369-927ca72a8729"
      unitRef="usd">-28198000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57dbfe3fc0b04540a9062b9da8ae1cfe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTYtMTUtMS0xLTExNzc1Ng_393dd21a-97b8-4605-86b4-c3c541030535"
      unitRef="usd">66000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTctOS0xLTEtMTE3NzU2_1a3da7e1-3022-4adc-8914-71219213ecec"
      unitRef="usd">1546000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1451fd8e009248678887b28feb0d817a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTctMTUtMS0xLTExNzc1Ng_60d410b3-e4da-4d9d-b56d-344af85306fd"
      unitRef="usd">-5000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia6fd46ccee88439e82d67fa529a9ff35_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTgtNy0xLTEtMTE3NzU2_9f6959b9-e974-430e-995c-02f1c7dd085e"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia28cd1621284487e81b8ebaa99b615ef_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMTktOS0xLTEtMTE3NzU2_f21dea49-45fc-47e7-b817-80b1c30bbf8a"
      unitRef="usd">1089000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjAtMTEtMS0xLTExNzc1Ng_b96a99ff-a59b-4639-95af-25caac41e4fa"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjAtMTMtMS0xLTExNzc1Ng_b21930d2-029b-4fee-8d0a-335d31a873e5"
      unitRef="usd">487000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5a1d2ccd1fdf457c81335d661d935b52_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtNS0xLTEtMTE3NzU2_4991e027-6296-4433-bc92-2cf446eb6974"
      unitRef="usd">228000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtMTEtMS0xLTExNzc1Ng_e9090e55-e59d-4f86-a34b-e54bda19a471"
      unitRef="shares">5000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2133f6965b7a48aa889670197491b115_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjEtMTMtMS0xLTExNzc1Ng_7d73b023-6518-452d-b265-bb3dc09df116"
      unitRef="usd">113000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ibe1775a56a28418cad0acff1223adbff_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMS0xLTEtMTI1OTIx_41686410-f86c-45f5-9a34-7833ffa104eb"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibe1775a56a28418cad0acff1223adbff_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMy0xLTEtMTI1OTIx_63f38c01-afbf-4b13-95e6-79fb4c409278"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8be942a9fc84e4f9d8dd09313b7c6de_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtNS0xLTEtMTI1OTIx_c1d22686-1e0f-4ea2-bb5d-bf1c30166271"
      unitRef="usd">44292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e6a2417ce314f85af97421da8e0d628_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtNy0xLTEtMTI1OTIx_90a90cc4-f7dc-43cd-8378-1c65f9387820"
      unitRef="usd">-1424000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10a6b956076b456c914890389667aed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtOS0xLTEtMTI1OTIx_86e8497d-2a99-4bb6-8455-4b8f380e77c3"
      unitRef="usd">22625000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ib02a3afd2d6d4dbab20a028d5348db71_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTEtMS0xLTEyNTkyMQ_20e9c5aa-dfb5-4e45-a955-de554974b393"
      unitRef="shares">703000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib02a3afd2d6d4dbab20a028d5348db71_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTMtMS0xLTEyNTkyMQ_51d00873-283f-4e92-9d6c-c0086168a900"
      unitRef="usd">-28572000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i182f6377eff94cb4b6ac7e5d4a6b565f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjE5MDJiNmJlMzQyNTRhYzVhYjk5MGM5NjJkNjkxZmVhL3RhYmxlcmFuZ2U6MTkwMmI2YmUzNDI1NGFjNWFiOTkwYzk2MmQ2OTFmZWFfMjQtMTUtMS0xLTEyNTkyMQ_df7cd58f-08ce-4fe4-8265-3c9d0368b38f"
      unitRef="usd">71000000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2a95cd7d7ed541189aceda668d7d654c_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_9bce01ef-1d0c-4acf-8faa-b6b09745db6c"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i951972d8afae4eaabb5d09508787712e_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_b1100fdd-88d0-4c6f-9409-4a8ea699774b"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzA1_f92922cb-06a2-428e-8c63-dcf1ccdcf0db"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNTkzMg_5374022d-65d9-4e3c-a8cd-f80f32c2b7de"
      unitRef="usd">15200000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1ba0cfd360d4403caf7866291f6dead2_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTAzNQ_5e30f5d4-75b9-49c9-aaf8-9c50eba3ce88"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7e212023ac5f4762aaca5b3d89139de6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTIyMw_ea6bbed4-fea8-4874-a3eb-a3c9cd578b56"
      unitRef="shares">65000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i6d86b71f50834432b48b0b5ae6624d4c_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTI2MQ_36d93e34-a109-4553-85e7-268a0cd9c346"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i457c2ed3cca24d1090b72bce50a58a8f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMTQ0OQ_4d71e2a6-51fc-4265-9302-fef2c85c138e"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNDk0NzgwMjMzMTg4NQ_defa140d-efda-4c02-aa48-c92a34eb2435"
      unitRef="shares">10000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMzg0ODI5MDcwNDA5MQ_d4654f74-41d8-4b36-a9fa-b10f776cc860"
      unitRef="usd">701000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfNTQ5NzU1ODE5NTIz_adc67ae7-3f94-45fb-acbe-45fb1eeda88f"
      unitRef="usd">9500000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjMzOA_5f2a4d85-ebc6-46e1-9047-ba3d373f5de3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to &#x201c;&#x2014;Note 9.Financial Instruments and Fair Value Measurements&#x201c; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:-9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to &#x201c;&#x2014;Note 9.Financial Instruments and Fair Value Measurements&#x201c; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0xLTEtMS0xMTc3NTY_92d8f8f2-6d1e-4072-a9c5-885c6da366e3"
      unitRef="usd">505000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0zLTEtMS0xMTc3NTY_96fc183b-9e16-4f78-b665-7ec806b5b447"
      unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC01LTEtMS0xMTc3NTY_64f6c8f3-acad-4066-83ee-5504cf72ca83"
      unitRef="usd">439000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC03LTEtMS0xMTc3NTY_a4e9b8c4-bd3a-48cc-be29-d7009a89cd02"
      unitRef="usd">93000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC05LTEtMS0xMTc3NTY_c016a9cf-919d-4330-9d6d-46d725d32edc"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNC0xMS0xLTEtMTE3NzU2_4db21f01-00d5-4e97-b785-949d1f6bdc52"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0xLTEtMS0xMTc3NTY_41daa82a-e7ef-4ab2-95f6-79535df9c1bd"
      unitRef="usd">175000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0zLTEtMS0xMTc3NTY_a236659c-9a36-4ed5-a668-2919eed7555d"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS01LTEtMS0xMTc3NTY_1562cf6f-1a1c-471d-a998-a13468ee185f"
      unitRef="usd">153000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS03LTEtMS0xMTc3NTY_84bd78ac-c9e2-4057-9235-cfae1d108889"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS05LTEtMS0xMTc3NTY_c7471884-66d1-4215-9875-bf8b5b782177"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNS0xMS0xLTEtMTE3NzU2_549de4fe-1f50-4813-8834-dd183f16ac23"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0xLTEtMS0xMTc3NTY_2a44a95f-6fb6-4cf1-9735-79554bd81fc6"
      unitRef="usd">330000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0zLTEtMS0xMTc3NTY_c1ec56b4-e555-43b3-a516-74a1fba33457"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi01LTEtMS0xMTc3NTY_e5686083-4ef2-4602-8c6e-40e1daffc75c"
      unitRef="usd">286000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi03LTEtMS0xMTc3NTY_177a0535-815c-47a4-936b-9e8b2d9a83e7"
      unitRef="usd">130000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi05LTEtMS0xMTc3NTY_60508bb9-b92a-4f43-8252-237204d76627"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfNi0xMS0xLTEtMTE3NzU2_30ff8105-4bd7-448c-81b5-44b7e8a03456"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0xLTEtMS0xMTc3NTY_9fa9928d-e597-4ed1-997a-8fa013bdd0f0"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0zLTEtMS0xMTc3NTY_87e5b60d-2da0-4ce8-9705-34497f626558"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS01LTEtMS0xMTc3NTY_ab0ea94f-05c1-4327-9841-baaa9495bc83"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS03LTEtMS0xMTc3NTY_1e46faee-41c8-40ec-84a4-ebe2f84690a7"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS05LTEtMS0xMTc3NTY_8dab5af7-c16a-47d7-84dc-a8a9166b9261"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfOS0xMS0xLTEtMTE3NzU2_ba234b5b-9861-4a8d-ab7c-e696f8ee3531"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMS0xLTEtMTE3NzU2_a0ce9824-05b6-4c73-9241-918983e21e7e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMy0xLTEtMTE3NzU2_4cb2e716-5389-454f-847b-1bf63425fa32"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtNS0xLTEtMTE3NzU2_c5c6f2d4-d126-4787-85d0-f6906f6080aa"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtNy0xLTEtMTE3NzU2_40a4e8c5-3cbd-414f-af3d-a95f3e5c3552"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtOS0xLTEtMTE3NzU2_e2321a20-6a45-46d5-ac68-2d979452d47a"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTAtMTEtMS0xLTExNzc1Ng_2512ef59-d364-4b64-9c01-3159e39c5602"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMS0xLTEtMTE3NzU2_4bd9f3d5-ca61-4db2-9e57-c4590dd33bd8"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMy0xLTEtMTE3NzU2_7a811021-9518-4140-92bb-6521a9a6e3ad"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtNS0xLTEtMTE3NzU2_ada6e4b6-acbc-4396-b563-667889666235"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtNy0xLTEtMTE3NzU2_8d52f99c-a12f-4743-b098-9d1df5e10ed1"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtOS0xLTEtMTE3NzU2_9952cd5d-cf8a-4570-85c3-495b8979c66d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTEtMTEtMS0xLTExNzc1Ng_539c2365-e2c0-4d9e-bee6-73e5a16d0825"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMS0xLTEtMTE3NzU2_79761037-9844-4e9c-85ea-d7726c3fc58b"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMy0xLTEtMTE3NzU2_381d0c18-00df-46a6-b706-cdf8f1164062"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItNS0xLTEtMTE3NzU2_8142e076-8c88-4a85-995b-cb73a0314905"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItNy0xLTEtMTE3NzU2_71dbf30d-393b-4aee-bd10-6bec41fb6e76"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItOS0xLTEtMTE3NzU2_314a7604-8363-4cff-8c8b-a8687181a6d9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTItMTEtMS0xLTExNzc1Ng_70ce9640-e02e-463e-a2fb-0ebdd949c506"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMS0xLTEtMTE3NzU2_804ed2b0-e688-4747-b3ff-47b69a7f1b5c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMy0xLTEtMTE3NzU2_183c3ae6-7c67-4aa0-a45c-e235e87a0a48"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtNS0xLTEtMTE3NzU2_79bcc8ff-5801-4917-81b1-0fffce3dac6e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtNy0xLTEtMTE3NzU2_77d6cd34-4e73-4013-8451-0d96ffea0fb7"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtOS0xLTEtMTE3NzU2_c07e2008-582e-4b1b-83cc-5874ea63d475"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTUtMTEtMS0xLTExNzc1Ng_c60d0dd3-1490-4999-8bf9-a2c8a505bec8"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMS0xLTEtMTE3NzU2_7bb97903-c801-40e2-bd87-76bd19887819"
      unitRef="usd">-131000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMy0xLTEtMTE3NzU2_018826ab-8f3b-443d-9bcf-bb20ffcb4570"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctNS0xLTEtMTE3NzU2_1add4ec9-3e4b-4ed1-b5c7-003dc3525943"
      unitRef="usd">-153000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctNy0xLTEtMTE3NzU2_05d3d230-478b-425f-860a-d7b6b8ffed09"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctOS0xLTEtMTE3NzU2_2798543e-1879-45d1-9287-ba4a05d92559"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTctMTEtMS0xLTExNzc1Ng_e2fa8436-b71b-4dee-9f7a-6cfac07c4a86"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMS0xLTEtMTE3NzU2_f11565eb-2d2b-43bb-a6d2-14e44bba02d7"
      unitRef="usd">222000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMy0xLTEtMTE3NzU2_47facead-b936-4492-82eb-d84bc3d446b1"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktNS0xLTEtMTE3NzU2_6331e086-077c-4770-ac92-c372bac6c005"
      unitRef="usd">151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktNy0xLTEtMTE3NzU2_227032a8-32f5-4b7f-8b23-eca1bd82f7d4"
      unitRef="usd">117000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktOS0xLTEtMTE3NzU2_f15671b6-2e2d-4e0f-a0a9-5867c1c6594a"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmI0ODdkOGI3ODJkNjQxNTliNjM1MWFmZmY4MjBiMGFlL3RhYmxlcmFuZ2U6YjQ4N2Q4Yjc4MmQ2NDE1OWI2MzUxYWZmZjgyMGIwYWVfMTktMTEtMS0xLTExNzc1Ng_62f2e215-c103-4de9-88bd-36f77ba9277d"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0xLTEtMS0xMzA0NzQ_aa90ace8-0634-4ab4-b905-206eb468aa89"
      unitRef="usd">1106000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0zLTEtMS0xMzA0ODA_e5d7cff8-eb96-49ab-8634-3d302f17ddd4"
      unitRef="usd">147000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC01LTEtMS0xMzA0ODI_166ea8ef-2b70-401e-8ecf-81d7f2bd13c3"
      unitRef="usd">959000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC03LTEtMS0xMzA0ODQ_77cac9e2-1418-484e-9c9f-beb5bbfc9e6f"
      unitRef="usd">314000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC05LTEtMS0xMzA0ODY_b74a8634-3594-4428-8f81-d6bf31f70a35"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNC0xMS0xLTEtMTMwNDg4_38e6ecbf-6303-4249-be40-7ef5d7e76495"
      unitRef="usd">287000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0xLTEtMS0xMzA0NzQ_1f6eb134-a2a4-4d9f-a39e-9921dd221950"
      unitRef="usd">391000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0zLTEtMS0xMzA0ODA_4d2e3cd8-1b80-4d26-87ed-270d790e189c"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS01LTEtMS0xMzA0ODI_73754d7e-a8ff-403f-9faa-64d3da65dddf"
      unitRef="usd">341000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS03LTEtMS0xMzA0ODQ_4abd009c-2827-4c63-9edc-d747df224e80"
      unitRef="usd">-126000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS05LTEtMS0xMzA0ODY_3f906036-4fa2-4b93-a79c-2a5aadb35faa"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNS0xMS0xLTEtMTMwNDg4_1f26475f-c506-4479-8a58-d14af877d634"
      unitRef="usd">-112000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0xLTEtMS0xMzA0NzQ_4f737e1b-6b48-4c77-94bf-0307cd73ec71"
      unitRef="usd">715000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0zLTEtMS0xMzA0ODA_2252b0ea-72fc-4096-ae27-7e48eeac6f72"
      unitRef="usd">97000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi01LTEtMS0xMzA0ODI_4648852e-d2a7-49eb-9643-9b1d776bb9d0"
      unitRef="usd">618000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi01LTEtMS0xMzA0ODI_6b2fee47-7732-49bb-88b3-3572350d7157"
      unitRef="usd">618000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi03LTEtMS0xMzA0ODQ_8a499f9a-3314-479e-87a3-fbe1508ddbc9"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi05LTEtMS0xMzA0ODY_6688559d-39e3-4f72-b888-18949ba90711"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfNi0xMS0xLTEtMTMwNDg4_36397acc-0190-43a7-880f-3d44108c375b"
      unitRef="usd">399000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0xLTEtMS0xMzA0NzY_88871122-74b1-4c45-909b-346cd0d84b81"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0zLTEtMS0xMzA0ODA_04cc407a-1177-40eb-8a66-23493a82a0b2"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS01LTEtMS0xMzA0ODI_6129d172-31c3-4a17-bc78-f66525b36c54"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS03LTEtMS0xMzA0ODQ_d4fa22e6-78db-4cb8-932f-b79b76626996"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS05LTEtMS0xMzA0ODY_c7d89bef-d468-4a35-b00b-f476091a27ad"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfOS0xMS0xLTEtMTMwNDg4_8492bd9c-6a6f-46a5-b9d4-92714c2f1334"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMS0xLTEtMTMwNDc2_d05c7d14-81ac-41c1-9d88-4b6a1661eb6c"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMy0xLTEtMTMwNDgw_bc44747d-bee5-488a-916a-2e0fef0918b2"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtNS0xLTEtMTMwNDgy_55666333-de04-4dec-a463-951416f29db8"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtNy0xLTEtMTMwNDg0_2756f3cf-f12d-4a89-8adc-1c7c73859835"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtOS0xLTEtMTMwNDg2_e844fe0b-0248-4e7c-8109-70c2e11c8cb7"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTAtMTEtMS0xLTEzMDQ4OA_7b82f81c-656c-437b-9424-4b544647eb05"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMS0xLTEtMTMwNDc2_f3a91e51-ddf4-4044-be31-55fdad1769a8"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMy0xLTEtMTMwNDgw_68c352bb-d471-4d87-a00a-394c3884ca50"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtNS0xLTEtMTMwNDgy_87bcc4c4-f215-4104-8416-ea15956121a0"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtNy0xLTEtMTMwNDg0_efbb8677-95e3-4f6f-88d2-bbf7d3795db5"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtOS0xLTEtMTMwNDg2_a3175532-04ba-4339-9d7f-967817e294a1"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTEtMTEtMS0xLTEzMDQ4OA_6c661a54-4ed6-4411-ac5e-03b1e96a90e3"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMS0xLTEtMTMwNDc2_379967a1-e042-464e-a5be-2a6f8e2a4903"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMy0xLTEtMTMwNDgw_6307795d-4b5f-4fb1-becf-2126ac4dc4c5"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNS0xLTEtMTMwNDgy_bad60823-84fa-44c2-917a-b7a16d6e93c1"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNS0xLTEtMTMwNDgy_f39a7c2f-8023-41ea-b94f-583480806dae"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItNy0xLTEtMTMwNDg0_27f58ab9-1fa0-41b0-94d0-29e175a1e6dd"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItOS0xLTEtMTMwNDg2_5728611e-ddfa-4b18-9a94-aafb81047e53"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTItMTEtMS0xLTEzMDQ4OA_cc7891ff-be58-464a-951c-7e17c62b4477"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMS0xLTEtMTMwNDc4_b232922f-6ef8-461f-9baa-aa7fd79005db"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMy0xLTEtMTMwNDgw_c3f7a999-3ac2-4327-97a5-2a84e1d9b839"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtNS0xLTEtMTMwNDgy_96496fe4-a6ba-43dc-913a-5e0cb428f113"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtNy0xLTEtMTMwNDg0_3bea6211-a819-4a64-ab0b-80f836b53282"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtOS0xLTEtMTMwNDg2_c53cde37-022c-4e94-b06b-235bca6336d2"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTUtMTEtMS0xLTEzMDQ4OA_16fa128c-18fe-464b-8a7f-a745e73916bb"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMS0xLTEtMTMwNDc4_fea87bc1-f09b-4243-b96c-f875d4d0c42b"
      unitRef="usd">-201000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMy0xLTEtMTMwNDgw_87d610be-a73d-4507-8234-faa809e8685e"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNS0xLTEtMTMwNDgy_3620d4ec-a2b3-4043-9942-0d7acb32da34"
      unitRef="usd">-253000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNS0xLTEtMTMwNDgy_8ec9885c-d7d0-4f28-a30a-f4da743baa25"
      unitRef="usd">-253000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktNy0xLTEtMTMwNDg0_2cafae57-dd13-45a7-8500-28d7d1bf0b26"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktOS0xLTEtMTMwNDg2_20af45a2-c27b-4ab8-91b5-6eba13a134c6"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMTktMTEtMS0xLTEzMDQ4OA_c221bad4-8f39-44c3-b2c7-a15fd27a2033"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMS0xLTEtMTMwNDc4_2de7f4ab-f428-4ff9-848f-76ac78ac15df"
      unitRef="usd">592000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMy0xLTEtMTMwNDgw_b5bcddeb-79fb-4622-b9f4-4e2660489e30"
      unitRef="usd">165000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtNS0xLTEtMTMwNDgy_1041d1c0-ba83-4bb1-835c-d5429166f2d2"
      unitRef="usd">427000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtNy0xLTEtMTMwNDg0_cb2cff27-7d60-4e14-9629-f8d2619ffa9c"
      unitRef="usd">480000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtOS0xLTEtMTMwNDg2_eed4206d-eea6-492f-8fc3-6a3d2d4423f6"
      unitRef="usd">65000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOjhkZDk2NmUzMWY4MDQwMWVhMjZmZjI1YzM5YWJjM2MzL3RhYmxlcmFuZ2U6OGRkOTY2ZTMxZjgwNDAxZWEyNmZmMjVjMzlhYmMzYzNfMjEtMTEtMS0xLTEzMDQ4OA_e1c2cca1-644b-44f8-ac6e-75c43faffb71"
      unitRef="usd">415000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RleHRyZWdpb246M2VmNTUyZjI0OGQyNDU0ZDlhZTAyYjUxZWQxZTc3ZDdfMjM0NA_b95dcd86-98b3-4102-949e-645fb4c4b0b1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMS0xLTEtMS0xMTc3NTY_c1fdcd24-e0ea-42e7-8235-c36b431e2031"
      unitRef="usd">796000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMS0zLTEtMS0xMTc3NTY_a1f06638-1c5d-4c2b-9c57-ac9cf90656e8"
      unitRef="usd">178000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMi0xLTEtMS0xMTc3NTY_e6ad3ef6-f92f-469c-bdce-9861e955a893"
      unitRef="usd">704000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMi0zLTEtMS0xMTc3NTY_7c8f18b4-308c-4a4c-85c4-b0232b167066"
      unitRef="usd">768000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMy0xLTEtMS0xMTc3NTY_7f89ed34-5b0f-4d70-901c-6feb31fda8c1"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfMy0zLTEtMS0xMTc3NTY_d328e903-984e-4ccd-b1a5-4212af038d3c"
      unitRef="usd">2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNC0xLTEtMS0xMTc3NTY_8fee7e9f-898d-4342-b5f7-6fc532eb3932"
      unitRef="usd">-933000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNC0zLTEtMS0xMTc3NTY_d62653de-7ef3-4262-ad8c-661b8a141b87"
      unitRef="usd">-680000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNS0xLTEtMS0xMTc3NTY_dd8d20c9-0d44-4153-8d16-add8ee68435b"
      unitRef="usd">-841000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae305004534c4cae8e7485e4dc74784a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN184NS9mcmFnOjNlZjU1MmYyNDhkMjQ1NGQ5YWUwMmI1MWVkMWU3N2Q3L3RhYmxlOmE1NTVjZDA4ZDhkYTQ2YjY5NmU0Y2Y0NDBiNjNhYzA4L3RhYmxlcmFuZ2U6YTU1NWNkMDhkOGRhNDZiNjk2ZTRjZjQ0MGI2M2FjMDhfNS0zLTEtMS0xMTc3NTY_4ccd6991-56a4-4c72-bb0b-2ca0b4e09bee"
      unitRef="usd">-1268000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDI1_5776505a-0e69-4bd5-a7e4-de5c2a377c5b">EMPLOYEE STOCK BENEFIT PLANS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $4 million and $63 million for the three and nine months ended September&#160;30, 2022 and $7&#160;million and $36&#160;million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the nine months ended September 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMx_c1f0d871-404c-4995-910e-e68f78a84bfc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $4 million and $63 million for the three and nine months ended September&#160;30, 2022 and $7&#160;million and $36&#160;million for the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia5c6fb0d180a4d078a5f3f752a9d04b5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi0xLTEtMS0xMTc3NTY_eafecf93-5546-45f6-9809-4858cd6a7fa4"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i79b26b864c774975afc6e0d3e715458f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi0zLTEtMS0xMTc3NTY_52d99a77-7bcc-46ea-923d-94714c8c838e"
      unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8ed3fefe80d945f9b3a5d7a3a1daf82a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi01LTEtMS0xMTc3NTY_1ff9eb84-68ef-4d48-9ddf-281680f6c9cb"
      unitRef="usd">30000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibaca6465528d4ed09625549aae63c60a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMi03LTEtMS0xMTc3NTY_29b1587b-6858-4798-b7ec-d5227068f2f9"
      unitRef="usd">44000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6ee8411e374b459c9514cb9c2ad72674_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy0xLTEtMS0xMTc3NTY_52ce4c43-f5be-42d4-aedf-3417e0e6f9c9"
      unitRef="usd">48000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i02826b699eda4a97ba070709457b65f1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy0zLTEtMS0xMTc3NTY_63c6bad2-a80b-4f99-9e9c-d8927b1c00f4"
      unitRef="usd">59000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4634dede34e4e588b48071be679100a_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy01LTEtMS0xMTc3NTY_08f46ba6-f996-4b34-8b6e-1767603c0bae"
      unitRef="usd">144000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6947273e102141838832d4c25bb46991_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfMy03LTEtMS0xMTc3NTY_76b09898-40f1-403b-83ec-a1efd44cb4a6"
      unitRef="usd">184000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39ef053676a74ed99cf89ae337acf080_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC0xLTEtMS0xMTc3NTY_0df4286f-bf83-4f9b-ae38-874d055edc90"
      unitRef="usd">56000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i816eb507d5a445f2b307f4498312546d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC0zLTEtMS0xMTc3NTY_d9798763-0b29-48a4-a09c-0d443b228bf2"
      unitRef="usd">66000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if7a53e0c411d4dd6a1b3906051c59f59_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC01LTEtMS0xMTc3NTY_7c96e224-bb24-4589-b71d-29cddc9cb64a"
      unitRef="usd">164000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7eac47f0f662452bab570a31fb550c4d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNC03LTEtMS0xMTc3NTY_97859f98-2453-4fc8-a1ec-13bb9409a5d4"
      unitRef="usd">210000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61e87163d7174e1794368f54fd79d68d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS0xLTEtMS0xMTc3NTY_3a43a4cb-9664-4d93-88b4-58353e37096c"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id311a3410b814d8098ed2e0909160625_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS0zLTEtMS0xMTc3NTY_d4a0b906-03cc-48d9-8c78-8912739a2fe0"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if7bcf421c5b3484f9aaf9c80235ca4cc_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS01LTEtMS0xMTc3NTY_b67ca243-c3b3-48f5-895a-ce99e1b77e3c"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i137caf5a65bd4e80a938b17ee3cb93f8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNS03LTEtMS0xMTc3NTY_25b43284-4813-4db4-9929-219510778810"
      unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi0xLTEtMS0xMTc3NTY_8bd12278-1d46-49b2-8713-d314d43add36"
      unitRef="usd">115000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi0zLTEtMS0xMTc3NTY_3f2cc81a-3464-45c7-a235-3022dcebfa8a"
      unitRef="usd">142000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi01LTEtMS0xMTc3NTY_3d770ce8-991c-4867-8d96-d7a5eef411f2"
      unitRef="usd">338000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfNi03LTEtMS0xMTc3NTY_2467ac39-ea74-429c-8c60-007c8f97ca3b"
      unitRef="usd">450000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC0xLTEtMS0xMTc3NTY_41f7d7f2-de46-4085-b7f5-266036e05a0a"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC0zLTEtMS0xMTc3NTY_80284df2-2967-477f-98d0-26c5d182ea90"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC01LTEtMS0xMTc3NTY_152f0263-9411-426c-808d-e34bbe60a512"
      unitRef="usd">67000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjljOGJjNGE1YTVmYzQ2NTA5OWEzNjliOTE1NzZiOTgyL3RhYmxlcmFuZ2U6OWM4YmM0YTVhNWZjNDY1MDk5YTM2OWI5MTU3NmI5ODJfOC03LTEtMS0xMTc3NTY_69f44306-dd2a-4d85-9096-24726c237c02"
      unitRef="usd">93000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjE3_563a9670-535c-46ec-a431-f60e66263051"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjI0_93f14684-1f81-471c-8ad6-7d66ae37b641"
      unitRef="usd">63000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i39ec064d64084de8b739eb44e9285120_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjQ1_07770261-e5d8-40a1-bc6e-d714bc4b8d1e"
      unitRef="usd">7000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i62f7e021202b49c7a1c413f3af901207_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfMjUy_2600fbf0-1ed1-4a69-8357-cec24c58978c"
      unitRef="usd">36000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMw_ba89825d-8e6c-4e22-87b3-f8d65f74f0c5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the nine months ended September 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMi0xLTEtMS0xMTc3NTY_1e60d7bd-70fb-447f-a85d-99ce2e585ddb"
      unitRef="shares">8100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMi0zLTEtMS0xMTc3NTY_252e7dd6-3d6b-4a8f-a83c-9f3ab0a9212e"
      unitRef="usdPerShare">63.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMy0xLTEtMS0xMTc3NTY_2bdd152f-8ab6-440a-a0a6-21bff77b5fef"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfMy0zLTEtMS0xMTc3NTY_f44f6976-568c-41e0-9be7-a6bcb8aac28a"
      unitRef="usdPerShare">60.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfNC0xLTEtMS0xMTc3NTY_f28c3f1e-3f9a-4020-8692-7d40f665a601"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjJkMmNmZTVhZDI1YjRhOGQ4MmY0ZGE2MDQ2Mjc1MTdlL3RhYmxlcmFuZ2U6MmQyY2ZlNWFkMjViNGE4ZDgyZjRkYTYwNDYyNzUxN2VfNC0zLTEtMS0xMTc3NTY_edf5604b-bf18-46eb-97a7-10b67b7d993a"
      unitRef="usdPerShare">66.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RleHRyZWdpb246ZTA2NDIxZjY5MGU1NDBjZTliYTdmZDU1NzA1ZjZlMmFfNDMz_71fe3197-39d9-4b7b-9b97-427c7176397f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i0bc4aed180144198bb9d2155f7e854fe_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS0zLTEtMS0xMTc3NTY_72b94477-b06e-43d0-a82c-44a4de549180"
      unitRef="usd">810000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i1bc5c8ecc7b1431b9d38a50d36e09fed_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS01LTEtMS0xMTc3NTY_8beccd06-c8cd-4f16-ba6d-3a8115fced8c"
      unitRef="usd">62000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ic46a8d26897645bcbf98e6b68bcaa6ab_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMS03LTEtMS0xMTc3NTY_24daf54f-0a43-49a2-9083-528ccbdf241e"
      unitRef="usd">111000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi0zLTEtMS0xMTc3NTY_c634daaf-89d6-46b0-90db-d006592e8b3f">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i476f07f68b6647aea6a0c9a8ff0255b5_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi01LTEtMS0xMTc3NTY_78ee305e-04c5-400b-bb07-a190bfc530a3">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i93b0fa40ab2f44a49d136f7a6301ee12_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185MS9mcmFnOmUwNjQyMWY2OTBlNTQwY2U5YmE3ZmQ1NTcwNWY2ZTJhL3RhYmxlOjFjY2JhZGIxMGVkMTQ4MDZhMDQ2OTkyNjg4MjZiMDY5L3RhYmxlcmFuZ2U6MWNjYmFkYjEwZWQxNDgwNmEwNDY5OTI2ODgyNmIwNjlfMi03LTEtMS0xMTc3NTY_9f8df021-fcef-409f-b596-e15326245668">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i80ec74c427f849589681e2b3cded2642_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NzM_2dced8b2-2d32-4edf-b379-c8453b8dccda">LEGAL PROCEEDINGS AND CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#x2019;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#x2019;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#x2019;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#x2019;s tax contingencies, see &#x201c;&#x2014;Note&#160;7. Income Taxes&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-PD-1 and Anti-PD-L1 Antibody Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, Dana-Farber Cancer Institute (&#x201c;Dana-Farber&#x201d;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#x2019;s claims for damages before May 17, 2019&#x2014;the date of the District Court&#x2019;s ruling that Dana-Farber was a co-inventor of the patents&#x2014;are preempted by federal patent law. A trial has been scheduled for May 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CAR T&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#x201c;SKI&#x201d;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#x201c;Kite&#x201d;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product infringes certain claims of U.S. Patent No. 7,446,190 (the &#x201c;&#x2019;190 Patent&#x201d;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#x2019;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#x2019;s defenses, finding that Kite willfully infringed the &#x2019;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million upfront payment and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; through the expiration of the &#x2019;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#x2019;s motions in their entirety. In April 2020, the Court granted in part Juno&#x2019;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* from December 13, 2019 through the expiration of the &#x2019;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#x2019;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020 and January 2021, Sandoz Limited (&#x201c;Sandoz&#x201d;) and Teva Pharmaceutical Industries Ltd. (&#x201c;Teva Limited&#x201d;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#x201c;SPC&#x201d;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. The Company is seeking permission to appeal from the Court of Appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and trials have been scheduled in certain of those cases. In May 2022, a Dutch court issued a decision denying a request by the Company for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In September 2022, a trial was held in Sweden regarding Teva&#x2019;s challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision is expected on November 2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the UK and the Netherlands, and may seek to market generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patents being filed in various countries in Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Australia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#x201c;GenRx&#x201d;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#x201c;GenRx-Apotex&#x201d;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#x2019;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#x2019;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#x201c;Full Court&#x201d;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($292 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#x2019;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#x2019;s decision and an appeal hearing concluded in February 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, Celgene received a Notice Letter from Qilu Pharmaceutical Co. Ltd. (&#x201c;Qilu&#x201d;) notifying Celgene that Qilu has filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene initiated a patent infringement action against Qilu in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. In October 2022, Celgene entered into a confidential settlement agreement with Qilu, settling all outstanding claims in the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. Subsequently, the Company also received paragraph IV certification letters from Accord, Biocon, and Nanocopoeia challenging the same patents, and the Company filed patent infringement actions against all three companies. In July and September 2022, BMS entered into settlement agreements with Accord and Biocon, respectively. No trial dates have been scheduled in the two remaining actions against Xspray and Nanocopoeia. Both Xspray and Nanocopoeia have filed motions for a judgment based on the pleadings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#x201c;Actelion&#x201d;) filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#x201c;&#x2019;867 Patent&#x201d;). The Complaint alleges that the sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infringes certain claims of the &#x2019;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; State Attorneys General Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. An oral argument before the Hawaii Supreme Court is scheduled to occur in December 2022. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. In September 2022, the parties settled the New Mexico matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRODUCT LIABILITY LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and Otsuka are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs allege &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Byetta*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta*.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases were pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#x201c;JCCP&#x201d;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The MDL decision is final as to Amylin and Lilly and all MDL claims have been dismissed. As of September 2022, all of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly have dismissed their claims with prejudice. In October 2022, all thyroid cancer claims that were pending in federal court were dismissed as well. BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* to AstraZeneca in February 2014 as part of BMS&#x2019;s global diabetes business divestiture and any additional liability to Amylin with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and AstraZeneca are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza* &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#x201c;JCCP&#x201d;). On September 24, 2021, the JCCP court granted defendants&#x2019; motion to exclude plaintiffs&#x2019; only general causation expert and on January 5, 2022, the MDL court likewise granted defendants&#x2019; motion to exclude plaintiffs&#x2019; expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. Plaintiffs have filed an appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL have moved to alter or amend the MDL court&#x2019;s order, and defendants have opposed. As part of BMS&#x2019;s global diabetes business divestiture, BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to AstraZeneca in February 2014 and any potential liability with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SECURITIES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Celgene&lt;/span&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Securities Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2018, &lt;/span&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;two&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#x201c;Celgene Securities Class Action&#x201d;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#x2019;s 2020 outlook and projected sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Otezla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and (3) the new drug application for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#x2019;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#x201c;Schwab Action&#x201d;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#x2019; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#x2019; motion to dismiss consistent with its decision in the Celgene Securities Class Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The California Public Employees&#x2019; Retirement System in April 2021 (the &#x201c;CalPERS Action&#x201d;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#x201c;DFA Action&#x201d; and the &#x201c;American Century Action&#x201d;), and GIC Private Limited in September 2021 (the &#x201c;GIC Action&#x201d;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above Celgene Securities Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Value Rights Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#x201c;CVR Agreement&#x201d;) entered into in connection with the closing of BMS&#x2019;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#x201c;diligent efforts&#x201d; to obtain FDA approval of liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#x2019; fees. BMS disputes the successor trustee&#x2019;s allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the court denied BMS&#x2019;s motion to dismiss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 19, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#x2019;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the court granted on September 22, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above CVR Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OTHER LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;HIV Medication Antitrust Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS was sued with three other manufacturers of HIV medications in related lawsuits in the Northern District of California. The initial lawsuits, filed on behalf of indirect purchasers, alleged that the defendants&#x2019; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evotaz&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, violate antitrust laws. In July 2020, the Court granted in part defendants&#x2019; motion to dismiss, including dismissing with prejudice plaintiffs&#x2019; claims as to an overarching conspiracy and plaintiffs&#x2019; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remained. In October 2021, BMS entered a settlement agreement with the indirect purchasers. On May 6, 2022, the Court granted final approval of that settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. In March 2022, BMS entered into a settlement agreement with the direct purchasers (excluding the retailers discussed below). In June 2022, the Court granted preliminary approval of that settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. Those complaints made allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In January 2022, BMS entered into an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains, and those cases were dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#x2019; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. Those complaints made allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and that case was dismissed. In April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In July 2022, BMS entered into a settlement agreement resolving these seven remaining indirect purchaser cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, Humana Inc. (&#x201c;Humana&#x201d;), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#x2019;s complaint makes largely the same claims and allegations as were made in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#x2019;s complaint. In April 2022, the Court issued an order denying Celgene&#x2019;s motion to dismiss. That order addressed only Celgene&#x2019;s argument that certain of Humana&#x2019;s claims were barred by the statute of limitations. The Court&#x2019;s order did not address Celgene&#x2019;s other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have served a renewed motion to dismiss. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United HealthCare Services, Inc. (&#x201c;UHS&#x201d;), Blue Cross Blue Shield Association (&#x201c;BCBSA&#x201d;), BCBSM Inc., Health Care Service Corporation (&#x201c;HCSC&#x201d;), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation (&#x201c;Cigna&#x201d;), Molina Healthcare, Inc. (&#x201c;Molina&#x201d;) and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#x201c;MSP&#x201d;)) filed lawsuits making largely the same claims and allegations as were made in the class action litigation and in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Humana&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; opt-out action. Certain of the matters have made additional claims related to copay assistance for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These cases are now pending in the U.S. District Court for the District of New Jersey and will proceed as described above with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Humana &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;opt-out action filed in March 2019. No trial dates have been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#x2019;s motion to remand to San Francisco Superior Court. In June 2022, the San Francisco Superior Court dismissed 63 of Molina&#x2019;s claims and stayed the remaining 4 claims. No activity is expected in this case until disposition of the New Jersey actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#x2019;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#x2019;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. A trial has been scheduled for January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#x201c;HPI&#x201d;), a Humana subsidiary, in Delaware Superior Court. Celgene&#x2019;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#x2019;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BeiGene Arbitration Matter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2017,Celgene Logistics S&#xe0;rl (&#x201c;Celgene Logistics&#x201d;) and BeiGene, Ltd. (together with its assignees, &#x201c;BeiGene&#x201d;), entered into a License and Supply Agreement (the &#x201c;LSA&#x201d;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vidaza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in China. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MSK Contract Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#x201c;Plaintiffs&#x201d;) filed a complaint against BMS, Celgene and Juno (collectively, &#x201c;Defendants&#x201d;). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abecma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GOVERNMENT INVESTIGATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ENVIRONMENTAL PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#x2019;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CERCLA and Other Remediation Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#x201c;potentially responsible parties,&#x201d; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $87 million as of September&#160;30, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i6b708b44785543eba9d88603d0d9fe17_D20150901-20150930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMjcxMg_6655294b-319e-4123-a4fe-df35c1e6b776"
      unitRef="patent">6</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:PaymentsForRoyalties
      contextRef="i239659e8afed4074998fed4287d1015c_D20191201-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDg4NQ_743495ce-8bcb-463a-884f-db445892a272"
      unitRef="usd">585000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i2f40e9186eb64a12b2819fd50ddd4855_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDkxMA_d111b7c8-0362-4fee-8ae6-2c2c5a1b6327"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:PaymentsForRoyalties
      contextRef="i3d729505bb21466aa4b2151156e86b6c_D20200401-20200430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNTQ0NA_034d07f0-1627-4f6a-a6c1-f887dfdc0402"
      unitRef="usd">1200000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i68e8486eb69e4b6e9cc08fa79cc5e099_I20200430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNTQ5Nw_5ddbe7cb-6f01-47f9-9c6b-d0cf2cac0a0d"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ide99966f8de84c51b7647698c4934494_D20100301-20100331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTAxNTU_46c7009e-0bd8-40e9-b319-8a1b5354405a"
      unitRef="aud">449000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i16e78aa141ae465bafe3f1d21cf16785_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTAxNjM_38464f33-716e-4cd1-b86d-e0eeded97296"
      unitRef="usd">292000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i3e26862e568b4ada9e48b0f17370e14e_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTQ3ODk_2dfd3d60-9ab6-418d-8857-31eabd1098a4"
      unitRef="usd">834000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i9b6c532a43a946b58847610daa31145e_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTQ3OTg_6ba403b6-6a16-4aa2-8c3d-1b5ba8ce3262"
      unitRef="usd">417000000</us-gaap:LossContingencyDamagesSoughtValue>
    <bmy:LossContingencyPendingClaimsNumberDismissed
      contextRef="i8cd813fc670a4450aabfafc92190f440_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTYyMTE_5e61d58d-5018-43b6-8b7b-9963ef59734c"
      unitRef="lawsuit">2700</bmy:LossContingencyPendingClaimsNumberDismissed>
    <bmy:LossContingencyNumberOfPlaintiffsDismissed
      contextRef="i8cd813fc670a4450aabfafc92190f440_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTYyNDY_c1cad716-9d7b-4c02-82ff-b90d0e992582"
      unitRef="plaintiff">3900</bmy:LossContingencyNumberOfPlaintiffsDismissed>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTY1MzA_70d87689-ddde-4d4b-bd94-96efbcb9f704"
      unitRef="lawsuit">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberClassAction
      contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NjU_2f99ef14-6efe-4aec-99e5-6d3f888c3dbf"
      unitRef="lawsuit">4</bmy:LossContingencyPendingClaimsNumberClassAction>
    <bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims
      contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NjY_0ec151f0-9082-4465-8fcc-8293a5056ade"
      unitRef="lawsuit">7</bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMTY2MjI_70d87689-ddde-4d4b-bd94-96efbcb9f704"
      unitRef="lawsuit">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberActive
      contextRef="i698b2027f9de4d4a949b7a23b6119c7c_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA4NzI_fd7831a6-819c-441c-8e7c-69c7f099b189"
      unitRef="lawsuit">2</bmy:LossContingencyPendingClaimsNumberActive>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i975e062f55604508986037025ddd0a99_I20220330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDk0NzgwMjYyMDQ0OQ_88c1ab02-07cc-40dd-a086-c44dd2ae8d93"
      unitRef="lawsuit">18</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:ContractualObligation
      contextRef="i342915fb33cf4e95b5ea927f1cf7228c_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMjQ2MDk_1ddb4488-e00b-4551-bfc9-6ef5a1bc2ce7"
      unitRef="usd">6400000000</us-gaap:ContractualObligation>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i18f9080b9c994fa291b5e12c3b4813d0_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfMzg2NDE_b285c33f-6732-4790-8b2d-55c8772719f8"
      unitRef="number">0.015</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i6d46fefd70244503bf70ff1057422f86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN185NC9mcmFnOmEwNDM4ZjFkNjNmNTQwYWRiOGQzZjcyMDJiYjA2NGZjL3RleHRyZWdpb246YTA0MzhmMWQ2M2Y1NDBhZGI4ZDNmNzIwMmJiMDY0ZmNfNDA0NDg_8ed96fb2-be61-4a39-9dcc-b2daff0b5850"
      unitRef="usd">87000000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes amortization of acquired intangible assets</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0zLTEtMS0xMTc3NTY_ab35a946-f781-4537-9d59-cc4b49adf36b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi0xLTEtMS0xMTc3NTY_90896c37-8569-48b5-88c8-3b3ec7cb0a67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi01LTEtMS0xMTc3NTY_62543b71-15ff-4d6c-abfd-9401118b05c0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RhYmxlOjEzMWRkZDNlZGUzODQ2NWFiYjI5OGE4MDE5NDIyOWRlL3RhYmxlcmFuZ2U6MTMxZGRkM2VkZTM4NDY1YWJiMjk4YTgwMTk0MjI5ZGVfNi03LTEtMS0xMTc3NTY_ea026665-5c3c-408b-85db-fd63eeecd3bc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYWVmYWQyNGJhYTQxOWJhZmE5MDgzYzMwNDllMDA3L3NlYzo0MmFlZmFkMjRiYWE0MTliYWZhOTA4M2MzMDQ5ZTAwN18xNi9mcmFnOmU3MDA3ZWRkMDI4ODQ1ZjhhNWNhMWMxN2ZjNTEyY2QzL3RleHRyZWdpb246ZTcwMDdlZGQwMjg4NDVmOGE1Y2ExYzE3ZmM1MTJjZDNfMzU1_c9f7b155-b0a2-49a1-ae7c-228df83e50c3"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M58E<%PK&S2R"]K4Z_B":6=7#4LTOU?12YJ,>F_;A<<\_.!H\VEP:\J&-R">
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M;RS-B6#+^C/%A G!BOIP08FL5F4@K\\8$R\GZLO'_DO7\!]02P,$%     @
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M$)*?0NKG+?0NK0E<1AA)DV\U_I2'FKXV:]E5.N-)FPQC6(+ZVS;[/%)BM,3
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ME02.T OX?*[!I.4-;5!]7>7-?P%02P,$%     @ J5Q:56<7PQ9J P  -0<
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MEM8NJ5VE3X OJ:RX@+9&%^ ((FM<X"G-HXVG29N2DNDSML%45!89EXT%.?,
MU+XA+^CA.3@("TH[ZH0.#5/APF%EY\N<BT=Q/1=U/>.9>O:ER8I<GMUS#S<\
M::L%FIW_/"Q1K92K.VPK;?^G6=V6?ZK7G]N#,+N<RD#BEDPYTP&8^L.H-TZ7
MODEOM*.6[Y=[^F/1L *=;S5EO=FP@_;7GOX#4$L#!!0    ( *E<6E4GXZ>
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M+H%*(QJN?>3])=F_-18W2BS*G'N/I KS>(X^8]W:'[RZ@\N(:=_QSX<"P]9
M\E!N-@E?(U0+"BVF\_L,"SYS6YZ(03RR]XJ$@%AD=IL@W7*O5Z^4=E,*M%B\
MBW_KM;[C  0,(%ZSV9=*HL]-B=&+%5"$4$+&//..UQ5_E!FI<Y/'(5X&BQ%0
M)50;UIB$>ZYEQ!57,/ZL1*>"!#U.]Y7H^%V1S0D6V3&=WE6\C@$U)_>-%YI"
MG=)'U=A..,V*JN-.A5M66+3O#+NB3!V)C<8Z%;B9E_OB5^C=!>(%(]V.UQ$8
M1[^#G4"S)'VX"BA0PM.P+*$2:B-#PB519+R0!ANV;!]HS.(V.H"U4P\E%*"
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MVK]#<:/__$+]NOXC%I^#?$D;DHE<H.D G.!,HWIU460;_F,,\ZPHLC7_7,D
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M!?A];M"NS0T':%]&'?\)4$L#!!0    ( *E<6E54G/(4QP0   P+   9
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MZU%KG=^0^5>XN\T**":_8\_<8,S9U.(D)HP)>Z<A8W;9U/?X8U\;46MK#@M
MR;ND06,S("^H1:2IS&5M\%Z/T>'@_..'P0D3"[AZ@75]T^,9'AK'$$75E)KV
M>A:,G0VWN">&*!7"<G]5F\ BFUEM89?N'B;8YHVQ_TVFERRE,*W*YP#$T.]5
M>5C"';VA_R]:-JS%:5YW?U2.X"]K%N^QO97K7E1DJ3RQ#,(U)&+6A""IE=PW
M*].\F1G=;OVH(V@MZ;2=;&259>"O/J !);7.6UHW%>@A$2XAPFQK907WQ+:T
MM5YFR "M.BS"]K\E_$$Y:"\UES6YB:[VBJ(K:B=VP[VCK%G'LW?%@P=/S12P
M<EWE32&?WYA3>(K;:[CCHM6UX1E<[;A-5P<0MU!K$])&AGF16D214ZLC; XA
M[R3I5#/]'4F2)!.SWQNE+5=@7#6B-.-;PK2 E)Q9>IU]M@(9GQ0S.V=$\;F"
M&>[EV;UYG-3=5=A]YW6=/?8C@O<T0<G]&4&8]=RN:OHEJM^5_IB$E8R#G7QU
M:&>""%5I+(!91_HHXZV@95MF==J>"E!I7?>5W6;R?8TN]99]PM_YG%($7>T=
M_&34U'TKLL/LI:RS:T$56E&$Y=G\SL2PLIEI#G;84L[0K)^RSR6")3<58X%8
M5Y-A#M@G%:&.P#%-:1B>F,:%6M'$ !/7HY'806<-!*(4ZJ.-O!)85*ZQ*"&6
MH1L%A%RI8<(BCV 7?KQ'\(C9#E9A&8]#YM*-&UG4];Y]9T=.OT+AA+90,<G'
M495+.8?WG;+S5"/+9(C^'0%=WS#C.O:'#<'@>5'5>NTYP^D)X42T*J&9!2@6
M0]64YFP(TH1MT\#O73^ -W06%D#&+#;;1 3)ODA[M#*34TT9$_&ALQU3K668
M&)$.H^A.YTK7;ZH:::MDH%G+,KVSN2=OI74]L##D_*0UECGQ)OZ&''='/)UP
MJ\&QD3G!HL-"_'?-.PQN7 7= GG#5:?>F$,21!#"<-:DE'>JW)8&N],P,\1/
M)L!=V$Z.R+G&\+@Y17-EY.+.+ZUX[RI4OF3\)BM1=<C65R54WE@S$=$W(EN?
MTKPUU<&:L*5BTM*\J<W.66E?04,I8V/B+MM'F7NJ"']'!V9/'^ [7@,;C5S'
MOIGPS>E2$E",>ZYO#R),1Q)'#XARC_KY "'BT>&FRT,B23'*'Q/HD4O'WQ&=
M=,?HCB@NZ< U2?[/0 ^HAP8EWZ-0HS!VPWZDTZD!\1R@/8,KFZRU&^SK;+ .
MUX<$>4P)"RD4G7P0V!,%/_C.0!]VWJ#0]3"A!$3,'@]M[E!HT_N7(3>A'9Y8
MIDRX'PWMH&U1P\!4 4Y1[4,F*@QVB*SV)PAN*OZB<]P\M:T^84@[ +[1M"VW
M".$X0#!D#4 3M]1X]O#"OARRFP<Z/=4C NT9BQ**>S>*'^3"P\A!9 S-T>EA
MQ^T4O^/>F'C&!6-$0O?\OC*J2N^IBMR_\]*D?5.^[Z.(2>?3E$+6"_,!#H%/
MP&C[E<IF=/.-S[G]M&4[W7X@!!$7F0'C<RQUQE$P8+7]Z,;>Z&IE/G295EI7
MA;E<2@&821/P?%[!8]L;VF#SY=/9_P!02P,$%     @ J5Q:54-KH\5"!
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MG8"J@"++%AZ956:9 +W +E.G'.!<A\F7$N1MR#3$)P.BZ;P&&B$J:H@<\,&
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M![<^V)SP:9:C4EY'V\8EQ/ZDWQAOJ"E0G*%]1P0/"KCB!V1K65OQFL2?P 6
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MR:7Z T11$W3:IAW9'!B=G@Q@0PMC%4572]9M+4E8-6M<9Q,#*OF9RA26L"N
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M <FF4Q2V'W@@VS,;7]QE2U@WXADTC';&34C(1$7#UVDH6#R+YW:RF+B4C=U
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M;;NMH_$>/20".*L7*(H'0.XA#1PM]_E5E/;47"BR&[(V^HWQR,%.. /5#4<
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M#?L!Z.80T$RLJOV/=ZDL=3#_6-*Y";4SH.\KI>QNX@+L3V*S?P%02P,$%
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M 0]4VWC;B9&U:W8;::AU.K6@OPJ5-:#]K93F.+$!NM]O]A-02P,$%     @
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MFJ#!R6C@@6X\WP165;7/5LJ2:^MI0<\D:I= ^VNE["YP!;J'-_D#4$L#!!0
M   ( *E<6E5OU: IP@(   $&   9    >&PO=V]R:W-H965T<R]S:&5E=#,T
M+GAM;'U4;6_:,!#^*Z>LFEH)-6^\=H $A6V52I?1=M,T[8-)#F+-B5/;*>V_
MWSF!E$F4+[;/ON>YYVS?#;=2_=4IHH&73.1ZY*3&%%>NJ^,4,Z8O98$YG:RE
MRI@A4VU<72AD207*A!MX7M?-&,^=\;#:B]1X*$LC>(Z1 EUF&5.O4Q1R.W)\
M9[^QY)O4V UW/"S8!N_1/!:1(LMM6!*>8:ZYS$'A>N1,_*MIV_I7#C\X;O7!
M&FPF*RG_6N,F&3F>%80"8V,9&$W/>(U"6"*2\;3C=)J0%GBXWK-_KG*G7%9,
MX[44/WEBTI'3=R#!-2N%6<KM5]SET[%\L12Z&F%;^[8I8EQJ([,=F.R,Y_7,
M7G;W< #H>^\ @AT@J'37@2J5,V;8>*CD%I3U)C:[J%*MT"2.Y_91[HVB4TXX
M,XZ6WZ+Y\N%7"Z+;R=T#3.YF,/_^>!,MYF2=/["50'TQ= W%L@@WWO%.:][@
M'=X!+&1N4@WS/,'D?[Q+&ANAP5[H-#A)>(_%)81>"P(O"$[PA4WB8<77>R]Q
M11];F5=*7+#< ,L3F#^5O* ?9^#W9*6-HB_SYUCJ-7-XG-F6T94N6(PCA^I$
MHWI&9_SQ@]_U/IW0W6YTMT^QG]9]3.Q)NN-B9U((IC3P'!9<"*H>#73_!K,5
MJNH19ACO#+\%MU;#&?C=H!H',"VY2'B^T=!I]=H#&ON#'BQ8G%)T1=*QN6@+
M7?,74U)P"%O!P+-C)X!K"FI46=<N"2F4W)"/AD$OA%ZW#5^4)*MHKJ-HKN.-
MW?=:?J]M)Z\?P*V%LS@NLU(P@PE5+^4<<U;%.&^W_'!P86<O#"\@.LE\!EUR
MZ]0SI7CL9=V#LLQ0;:KFHR&696[J"FUVF_XVJ<OZS;UNC@NF-IQ>0>":H-YE
MK^. JAM.;1A95$6^DH9:1K5,J4>CL@YTOI;2[ T;H.GZXW]02P,$%     @
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M=(N_/[@F ?R^5LK>+^B \1?-\F]02P,$%     @ J5Q:5?9O?+!K"   <A\
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MSN(-XNQ[WKKR<*)W6(A]OI[7#B+,TZ?0?\@![_F@,;;L7[)PN^4P>RE9_M(
M%N?XU^4*90K!08QT35/,%TA:'K,X26Q^"!H#5AR8'9$7;?#5*[*#A^MI]M;9
M$20[LL,&=(_L",+U[."BS3Y^& ;XZR8[G"!@$P*L=[9UL$];%$@";C$@<".$
M.TY3BP&1&W ['OG68]N\.<,KLK9E:ELR]^A9[%?O. P6C==,:K72>9\CE+N2
MA+;1K5G@PN%ZIBS'+1Z/V<\D OS_B0AX&XB "-L.D?AMAT"O2#B+8IL=(G*!
MSZ\A L+UWJQ#I.M-\8TQP$MW8<"^'6*K 0F](XZ2@W# "6)_72F'AT<L68+7
M;6Q@C?2!X86BC748!#;6PA5>P"+[W!&QR].6]"6'XKT7KH<HVEX76QVUWC7>
M/-#\#<!^JR-2R[7\\*! X]\&5<$JA/_DCS>B!,E61L"?,P(O"FRF$/E$GG#D
M1.QQ9$F"+,%8%!V:(V&P'MW-&X.=.0+J^K-S)$E_8H[$*&PBW8<DB%C?4CG(
M,<[]O2C!AOU?>^$0CY]#081.$'N^A8+$#6-!XS%_'2D(TKU) 7=7\G C*> K
MI&#'646X.*L(]SZKV-B0* \W'5OL%DMLA<)9E:HTEC[LZ'G67U)W]$:?= R.
MW##G ,N-_[H&HWA@M_B[&($KV*N-@[?6Z\O'62L^_:#J_$Z2-S7[T<@B'ST2
M!8$N&05[!'48_ -B=<*^E: M!<C6D(U!:'3?*> :I2E#0L\2B"@ZLDV&:$-J
MDXC[-))X8$$9'0#EHQSK3<5*X(::XP9EE\/CD%"&FAL6^50B^/$/T!&S/:S"
M,I%$H- >"6TKY+H[=:6TFH$@P5MYK:8(#ANH4HUR PLO,M. 3H+XK1C( ZL,
M]]H?$.8C=C&M:I/_V1:K,SBBFD9;B>PLE$T"5QM3V'=H.^$)X,6SZSUT0Q=H
MBSUAB7U-3.7S7;4T>*@&AFF5-75N\I50S6WH6Y.V(]X2RZ#K3U6M\G')(+-6
M9?;(3"U+77368G>"@ EQU 7+GDZ0?H[ W8Y,)XRQF!/;W09M[/"?V_,F85,%
MR$[9@/E%0_F*Q+>$%A4$D!TV&9RAJV)HO=6^R<FM\*.^>B#X5"XEUS$R;H2'
M2#6R2WCO.O.^5$:Q]/A37@(J*=97)5S>M&$BH9]D/F?4GRU/;T/82;&(-FIJ
M^^:\;#\BP"G'-L3+:N]4[JTJ_ MM;MZ^P%>R!C%RN=>>(@5V)Y"&5.,^#UK2
M:+M'$N]1Y3YQ+VR3'9\VHAQD#R*I1L4AA1YS.JJ(Z50B02>CNJ3-,7:S_UVA
MA\1W("GPJ=2HC'FT7NG$\$CG$*T4J6Q1:[78YV@P+]=]BCPAP *$@G6!2EOV
M%X2O+'1GZ;2+KIV4 (B4W5W:PJ/2IK,R1]C2CHY:I6RY[RSML*,346B[@*"J
M#F 3-89VB*+VOU_<.UA)M& ET=ZLY*5#AA=XRNX7$4^12R\8M Q2@V>U W"Q
MDN!I"S*SF\M8#] 40)72[CJUV01WJY"U=%YQ ": IZ8$43Q.]JHV)_90Q([=
MD6^OL:4^O;MP4M]62X*B78Y895V5/7,55>K265SW 693VO27OH-.53VV7WMA
M>]64IOTDNAA=?%"^:+^C/DUOOT;#Q#$!0Z%&6.H=QR"P=?N%M[TQU<Q^51U4
MQE13>SE1<JAJFH#GHPK%U=W0"Q:?V<__ U!+ P04    " "I7%I5$^:A!XD$
M   K"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6RE5FUOVS80_BL'
M-2A2(+5>K3BI;<!)'2Q8DQB)TV(8]H&6SI80B=1(^B7[]3M2BJ:TCCN@@$%3
MY-W#YU[)X5;()Y4A:MB5!5<C)].Z.G==E618,M43%7+:60I9,DV?<N6J2B)+
MK5)9N('GQ6[)<NZ,AW9M)L=#L=9%SG$F0:W+DLGG"RS$=N3XSLO"?;[*M%EP
MQ\.*K? !]6,UD_3EMBAI7B)7N> @<3ER)O[Y16SDK<#7'+>J,P=CR4*()_-Q
MG8X<SQ#" A-M$!C];? 2B\( $8V_&TRG/=(H=N<OZ%?6=K)EP11>BN);GNIL
MY P<2'')UH6^%]O?L+&G;_ 242@[PK:6C3T'DK72HFR4B4&9\_J?[1H_=!0&
M;RD$C4)@>=<'69:?F6;CH11;D$::T,S$FFJUB5S.35 >M*3=G/3T>'HS^W+W
MQW0*#_.[R]_A8GH[O;J>P^S+Y/8!CN=L4:#Z,'0U'644W*2!O:AA@S=@S^!&
M<)TIF/(4T]?Z+E%L>08O/"^"@X /6/4@]$X@\(+@ %[8VAU:O-.W\#(F\>,%
MQ3.%&7NF--,PD9+Q%=KYGY.%TI)RYJ]]QM?8X7YL4T?GJF()CAPJ%(5R@\[X
M_3L_]CX=8!ZUS*-#Z WSQ5O,3^!2* V+9Y@5C.\C_Q-X+9*G!CX1)16_8K9^
M<&?F"%NF@'Y+45!!JW.89Q+Q5;B!@J6Q7*"T$;NE$P[M?R8D)A7D'&[RHJ"S
ME(VR&?S.S-HEEE!)D:X3K4")(H4C\'TS1#2$'@U1!#=,/J'.^>H$J/[)PA4P
MG@)+J8!R$U;3"2 :0/^,%"/P!Q'<4Z"83#(KF>*&VE5E?=N/(8[!CR,(? _N
M=$:TCW-.OL$/;N.4$^#4/]^_&P1^\ G"=N8',!>:%:!^YE5C1M_:$1A#PH&Q
MI._!M3T(--O! CDN<PW'[ -M!J$9SFB(3VDX"^WZ'G'<)<4Z164FJ%1WCZ(H
M10FJDU&OR+$MDREI9$S#%B7"!I4F(2$)#&62&PV*R%%$K<E&SGKO* [;;[HV
M2)\8V2PQN]RD0UFG ^Y)!QMP"W/Z&C6,?PW5/Z%;1%5H[X'BN7>@%OMM+?8/
M%PO=D>FZ0+A;@JU+J#O*9=>+DS3-S832X)K7URA][:O,@X?M;RMS\@)?6S,I
M$&MN@KJB9F#"9/QBO+2U5Q.F']D&)=VTL&2YA TKU@C$SXA8%4B9QM:W_RM.
M-BNZW>#1,NB6<KWR[87#I.%P93A\M1RH]+3,$T/9UDECQJ!G"CL.>X.XJ>@Z
M4YMMO^=![/5.(YBAM&[E"7XG$5'I]DYC.!#JN UU_&MM]U;PICPFIFSJ/KPO
MRH?/V=<-.PZR[;GQ:>.4.O'JI:XKNNN/7&(B5CS_Y_L:3TQ7/8*!;WIG'-A&
MY,-T9^J$9'_(G0IE+E)#[QD-3\JZ'_&TH!8#G2.#WAF$%#"_-]@7"[?S@"E1
MKNPS31'6FNOZ+=.NMB_!2?T ^D^\?D:24U8Y^:S ):E2?E!1R?II5G]H4=GG
MT$)H>ES9:4:O691&@/:70NB7#W- ^SX>_PM02P,$%     @ J5Q:5482TW)?
M!   9!P  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULM9E=;]LV%(;_
M"J$50PMTD:A/*[,-)*:&%5BZ(%FZBV$7C$W;0B71(VF[ _KC1WU8LB1:L!?Z
M)I'D]SS4X:%>ZYCC/65?^9H0 ;ZE2<8GQEJ(S:UI\OF:I)C?T W)Y"=+RE(L
MY"E;F7S#"%X406EBVI;EFRF.,V,Z+JX]LNF8;D429^21 ;Y-4\S^O2<)W4\,
M:!PN/,6KM<@OF-/Q!J_(,Q$OFT<FS\R:LHA3DO&89H"1Y<2X@[<1#/. 0O$E
M)GM^= SR5%XI_9J??%I,#"N_(Y*0N<@16/[;D1E)DIPD[^.?"FK48^:!Q\<'
M^B]%\C*95\S)C"9_Q@NQGA@C RS($F\3\43WOY(J(2_GS6G"B[]@7VH#RP#S
M+1<TK8+E':1Q5O['WZJ). J0''6 7078W0#W1(!3!3CGCN!6 >ZY(WA50)&Z
M6>9>3!S" D_'C.X!R]62EA\4LU]$R_F*LWRA/ LF/XUEG)@^15^BSR\1^ F@
MF./5BI$5+BI(E^")[$BV)> ](@+'"?\@52_/"+Q_]P&\ W$&'N(DD5H^-H6\
ME1QHSJMA[\MA[1/#.N"!9F+-090MR$(1CX;CPX%X4TY!/0_V81[N[4'@,]G<
M ,?Z"&S+MA7W,SL_'*K2>=OHT?\>O3493KTHG((7G."=7@I__2:EX),@*?];
M5?62ZZBYN>G=\@V>DXDA78T3MB/&],<?H&_]K)IRG3"D$Q9I@K6*X];%<8?H
MTS^HP,FA(,I'KXSWBOC\BV(WA="&H[&Y.YY=E<JWW;8*]56.&WA.6Q6I5*YE
MU:I6HEZ=J#>8Z&?Y-;EA=+&="\!QHLYU$''I@M,)0SIAD298JPY^70?_2F[@
MZRR.3AC2"8LTP5K%">KB!&]T@S+>/7[.K1'L/,$SA0K:;D>%^BK'\2V_XP8J
ME>OZ:C<8U8F.!A/]7:P)DZ^FIQ,=C+]TM>F$(9VP2!.L582P+D)X)2L(=19'
M)PSIA$6:8*WB0*MYE[?>: 85X/C9M!V[XP4*$1P%'2M0B+RN*%*(7"]4&P$\
M:EG@8)IWLNO V9P,NL$PX](5IY6&M-(B7;1V->RF&O:5/*$"ZRJ13AK22HMT
MT=HE:MHY.-B0G.,+3M\71J'7-0:%RG?]KC/T56$0NEUKZ*M&ON.>\(:F.8+#
MW5'/&\!W<%8C,<R]>#'JI"&MM$@7K5VAIJN#WK7\0FNSIY6&M-(B7;1VB9J&
M#PZV+.?XA=]W@L#NO4@H5*YG=_VBKPIMI^<7?97L8DZ]2S3M$QSNGU1^<=[[
MQ2#WXL6HDX:TTB)=M':%FKX/CJ[E%UH[0JTTI)46Z:*U2]1TA7"PKSG'+\+^
MKXU!]S<(E:C[WH 4(L^WNF;1%[E';S-EFN;1KDE*V*K8KN)@3K>9*'\KKZ_6
M6V)WQ490Y_H]O)U!Q764;Z$5NS0-OMQ_>\!L%6<<)&0IA[)N GFGK-S2*D\$
MW11[-J]4")H6AVN"%X3E OGYDE)Q.,D'J#<6I_\!4$L#!!0    ( *E<6E5_
MFQGX @4  . >   9    >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;+5977.C
M-A3]*QJZT]F=V00DODQJ>R8QM-V99IM)FNU#IP\*R#%=0%Y)MK?_ON(C8+!,
MXD9YL9$X]TCW7G'01=,=95_YBA !ON=9P6?&2HCUA6GR>$5RS,_IFA3RSI*R
M' O99(\F7S."D\HHSTQD69Z9X[0PYM.J[X;-IW0CLK0@-PSP39YC]N\5R>AN
M9D#CJ>,V?5R)LL.<3]?XD=P1<;^^8;)EMBQ)FI."I[0 C"QGQB6\B%!E4"&^
MI&3']ZY!Z<H#I5_+QJ=D9ECEC$A&8E%28/FW)0N29263G,>WAM1HQRP-]Z^?
MV'^NG)?./&!.%C3[,TW$:F9,#)"0)=YDXI;N?B6-0V[)%].,5[]@UV M \0;
M+FC>&,L9Y&E1_^/O32#V#"2/V@ U!FAHX!PQL!L#^Z4C.(V!\](1W,:@<MVL
M?:\"%V*!YU-&=X"5:,E67E31KZQEO-*B7"AW@LF[J;03\]OH2_3Y/@)GX);$
MM(C3+,55!ND2_,(HY^"&T603"W"',\*!H."S7+[]SO<A$3C-^ =)<W\7@O?O
M/H!W("W =9IEDHQ/32'G6HYHQLV\KNIYH2/SLL$U+<2*@ZA(2**P#\?M@Q%[
M4\:H#11Z"M05&B6\(^MS8%L? ;(04LQG\7)SJ'+G=:-'_WOT7C#L=M78%9]_
MA*]>&<U:N$S^D>M4BH?@X*_?)!)\$B3G?ZN27M/::MI2%"_X&L=D9DC5XX1M
MB3'_\0?H63^I(JZ3+-1)%FDBZ^7&:7/CC+'/_Z "9_)IWI)B0Y1/7FWO5O;E
MBV0[AQ#!R=3<[D=7A?*0TT>%ARC;\5V[CXI4*,>R6E3/4;=UU!UU]-@B5+E<
M,SE[$SCS_& PS84*905HX+("!?W "08^JV >LH\X[;5.>Z-.[S]L<IL UHQN
MT_*MW38K7>:5+N<X(:4,KUE:WB/R+U&&QSN8*[0&L7D>$AY"D.4/HJ+ 3) Z
M)'X;$O\%ZZ#GN<K'49)3I4<G6:B3+-)$ULO$I,W$Y&U>"Q.=N=%)%NHDBS21
M]7(3M+D)7OE:" Z?<-^SO($.J%"V[0ZDX!#E0M<=H*)#E!-XOJ>6 VAU6UIK
MU-5R]3TK!^,<IZXYK6RA5K9(%UL_&WL%!GP;46AX=65()UNHE2W2Q=;/$.HR
MA%XI#0U!_^T_@</]DPH&D3. A0J8;1\H3:2$.<XQ>>AJ%SBZ_9XO5I@]DK,'
M''_E !<)B#%?@23E,=T<V3Z.,YZ\%+46+EK9(EUL_=QTM0MTWD@L1HNBDS.D
MDRW4RA;I8NMGJ"NZH+ZJ"ZIJH&!8$RR.P"9#V5# 7 =90]E0P1!TCLA&5WC!
M\<KKFB1IC-.DDHRZP0A@Y &+(Z(YRG?RDM3)%FIEBW2Q]3/3U7_0?R/1T%H3
M:F4+M;)%NMCZ&>KJ0CA:VIPF&I/#Y]=&@3L4#04,>6A8B*A@$\L:?J!2P3SG
MV)<)V!5=<+SJ^EVL"'L2B8_R0FQ8(2_:W4:E)OB9B(R.<?(RU<D6:F6+=+'U
MO_!WA2.RWD9(D-9B4BM;J)4MTL76SU!73*+14N@D(6FHW-ZVP@W@0$C4,'?P
M.3=4P1P7#8L6-<P>[C[,O1.[G,ARI#PJY:#2A/H8INUMCV,OJT/(0?\5O%A
M17\(+Z+ZL+6CK\]^KV7UDQ8<9&0IA[+.?3E75A^GU@U!U]5YX0,5@N;5Y8K@
MA+ 2(.\O*15/C7* ]E![_A]02P,$%     @ J5Q:5=5LE2M."P  97,  !D
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M(3 5-K0Q[OS1C%ZG=S4I1"GKK#]"17V%J&G:AKS4K&QFR3L<0E3?Q,0>/?%
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MVR^DS*>C^2*>R/P7;4M;RT!1)A5/2S!$D%)6?/%3J<,>P&Z? #@EP'D)Z)P
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MSZ<A5Y_@D+]K&<#?<4&C/%C.(")Q]HU^YHDX"H"M"P%V'F"?!K0O!#AY@*-
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MOR[D)YRLL[?A3X1S$F>'*XP"3%. N+X@A+^>I [*;SSC_P!02P,$%     @
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M"1#7EX3PEQ,Y0;W;.?P74$L#!!0    ( *E<6E507<<%;P@  #)<   9
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M_]<ZUH93??B-7W3>.!CN'-]YH^V[^+%]]WXL.WMKWU\.[+JB VO[H[-*W/
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M/"B-H6BJ=&L#R!B\2Q4 =86@-!M*HU": Z6Y4)H'I3$43=5U;6,9>A_KJ"H
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M252^7'%_SD710'Z^2)+\]4V18+M,^/A_4$L#!!0    ( *E<6E6KGQWHC@0
M #\1   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;*V8;6_B.!#'OXJ5
M6YU:J31Q$A[2 Z06LMI*UP>5W;V33O<B)0:L36+6-M!^^QLG(:6V2:N]OH$D
M_&?&/\_$'C/<,?Y#K B1Z"G/"C%R5E*N+UQ7S%<D3\0Y6Y,"?EDPGB<2;OG2
M%6M.DK0TRC/7][R>FR>T<,;#\MD]'P_91F:T(/<<B4V>)_SYBF1L-W*PLW_P
M0)<KJ1ZXX^$Z69(9D=_6]QSNW,9+2G-2",H*Q,EBY%SBBQB'RJ!4?*=D)PZN
MD4)Y9.R'NKE.1XZG1D0R,I?*10)?6S(A6:8\P3A^UDZ=)J8R/+S>>_]<P@/,
M8R+(A&5_T52N1L[ 02E9))M,/K#=%U(#=96_.<M$^8EVM=9ST'PC),MK8QA!
M3HOJ.WFJ)^+  /S8#?S:P-<-PB,&06T0O#="6!N$[XW0K0U*=+=B+R=NFLAD
M/.1LA[A2@S=U4<Y^:0WS10M5*#/)X5<*=G)\]_5+_(!.KF\G=S?QJ1O_?1_?
MSN(S=!M_11TT@[I,-QE!=PMT)U>$H^MBSG*"XB>H5$'0R93(A&;B%,3?9E-T
M\ND4?4*T0#<TRZ 0Q-"5,$H5RYW7([JJ1N0?&5& ;E@A5P+%14I2B_VTW3YJ
ML7=A=IHI\O=3=.6W.IR1]3D*O#/D>[YO&<_D_>;8AO/_HL>_'/W59 1-O02E
MO_ZQ>BFKX)85L%3Q1-)BN2^)D[HF3M$_EX]"<E@"_K5EO_(?V/VK=?%"K),Y
M&3FP\ G"M\09__X;[GE_V*;^(YU-/])9_$'.7B4I;)(4MGD?7Q>2@%>)2)42
M6QHJ#]W2@]I-MF,_BH;N]G!V34W@#UYKIJ8F"C1-;&JPAW$C>L78;1B[K8P/
M[#G))"4")46*,CI7FQ=4(RVKT49<^0L/1M'I]G5DBRCTNQJS182[O5"CMJEP
MU+=C]QKL7BMV_'-#Y3-0;B&_L&%+E#$AB'!/*O!3&WG/& G6!CLQ)9VPIW.;
MHJC7TZ@MCK!_$.X5=;^A[K]9T$NUW$!K4=>T=6?IFZ &J4438@W4U 1AH(&:
MFC X@CEH, >MF!/8N*"&55;GL'?2E%3,-M2!$=[30-]43$V%-A&QJ>ATL6>G
MC!K*J)7R3RA8!(E,R:.$7C,E^?H89/0FY)N*J:GPC:*U: 9'UB?LO7167BOG
M/6=;6C;4T,\CM1[SS5QN.&38VA5Y9C;Z&JU%XVN:J473T^8DML7J'DDK/F@E
M<7MBJ:3+ZB55:S(K6P5!I,R(6JGLO2 V7R/]C;5H<*!3FYK UZDML:(CT/X+
MM-\*/:5J)::05](LQ4LXH GK2EP[:ZMHB\3784U)Q\?ZNVM3'<-]:?]P:^-2
M]7]6LL"R@^B[JTT4Z"^L5:2W%#81]@9'\%X:)]S>.57M[7XO=>N]Y@P51%JA
MS<ZF@T,CHQ95Z$4ZMJGJ1_JF8PV(#]Z&BML].!#FA"_+D[B 3653R*K7;YXV
MI_W+\HRK/;_"%Q-L>3Y5_PZ4!] 7]]5?"S<)7T+UHXPL()1WWH>Q\NJT7MU(
MMBZ/HX],PN&VO%R1!+8Z)8#?%XS)_8T*T/QG,OX/4$L#!!0    ( *E<6E4>
M21+^L 0  )T8   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;+5976^C
M.!3]*Q8[6LU(V8)-DWYL$JE-.[N5MKM5.MUY6.V#"S<!U=B,[22MM#]^;: 0
M$DH_!"\--O;Q/>=>\,$=;X1\4!& 1H\)XVKB1%JGIZZK@@@2J@Y$"MS<60B9
M4&V:<NFJ5 (-LTD)<XGGC=R$QMR9CK.^&SD=BY5F,8<;B=0J2:A\.@<F-A,'
M.\\=\W@9:=OA3L<I7<(MZ+OT1IJ66Z*$<0)<Q8(C"8N)<X9/9^303LA&_!W#
M1FU=(TOE7H@'V[@*)XYG(P(&@;80U/RL80:,6203QX\"U"G7M!.WKY_1OV;D
M#9E[JF FV/<XU-'$.790" NZ8GHN-K]#06AH\0+!5/87;8JQGH."E=(B*2:;
M")*8Y[_TL1!B:X*/7YA B@GDK1/\8H*?$<TCRVA=4$VG8RDV2-K1!LU>9-ID
MLPV;F-LTWFII[L9FGI[.+V^_S>]FW^[F5W_^AGY!9V$86WTI0U<\KQ*K]N<+
MT#1FZ@OZA&*.KF/&3+<:N]K$8)'<H%CO/%^/O+#>";H67$<*7?(0POI\U\1>
M$B#/!,Y)*^ MI ?(]P:(>(2@N]L+]/G3%P1)RL030$. L[?CX5?P:@'[I>)^
MML#12XJ#TG(5Z)6,^1+-A-*(\A"9;I!K0/_\8<:C*PV)^K=)WAS<;P:W#_VI
M2FD $\<\U1FB,_WY)SSR?FV2HB.PF@Z'I0Z';>C3643Y$FPU&4%B4V?06$XY
MR# #L>^D]70T=M?;)/9'X*-R2"VT81G:L#TTFQ2Q0*D4H<F40DJPL"FX5ICW
M)J,CL!KC4<EXU&=1CKK4H2.PF@Y'I0Y'K9F_?$S-_@(A4D\<Y#(&-4 IR "X
M-IM:$_4<[WBK^KP#;[A3HJV+?I#2<4GIN)72-94/H$U:!\CLGLSFUZ:6AF8W
MB4W6J=U'FYBUPKXWJ1V!U10X*14XZ;.X3[K4H2.PF@[8JS9[K^/R+@#K]3W:
MK>_V93]*:\O#X%9:-I-4!E&6UA#6QIRFQFKJ1D*M4.]-9U=H=>*D(D[ZK.P"
MO2LM.D*K:U'9*MSJ5CY2VWY#;?N[I=V'1\*52<*ON"1@2S!)/ M^K&*567-T
MPRAOY-,*]>YT=H16)UY9,#SLM;0[M69=H=6UJ,P9;O4\56D'5@9%UT82E>_B
M:Q&'E ?-]3W:<\:^YWF[!=Z'W\*5X<)O=%RREG!+3@*C&>N(RF7SUT$!?KA-
M<;A/L0__A2L#AML=V/PU9N8C*%A):3JT0*&YTTCU>)]J0S;[,%JX<EJXU<!,
M9U1%R)X6T:?F?)WLER3>)]&'2R*52R+M+NF[D \+878.DR?[_6??N>9K,*%\
MM:!%&DLS/=AQTH,BP<V.Q.Y(2G .#/W7=DAQ7H2XG6T\W-6I89!/O.9O7U*Y
M*=+NIO[2$4A4*]K&"#LU4EVAU3E71HKT:J1(IT:J*[2Z%I61(F\T4A]Z(Q?@
MVT\XV2_</DP5J4P5:3=5W;R02</!TQ#O,NW41;E;![V),;G9^;<RMF#%=7YD
M6O:69^QGV<GR3O\Y/IWE)^453'YP?VT$B+E"#!8&TCLX,OQD?A:>-[1(L^/D
M>Z&U2+++"&@(T@XP]Q="Z.>&7:#\C\3T?U!+ P04    " "I7%I5^8H#:9P%
M  #<(@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6RU6EU3XS84_2N:
M=*?#SK#8EIV$4,@,Q-Z6F=(R =J'3A^$+1(/MI65%,+^^\H?V+&D**0K7B!V
MSCW2T95OSK5]OB'TF2TQYN USPIV,5AROCIS'!8O<8[8"5GA0GSS1&B.N#BD
M"X>M*$9)%91G#G3=D9.CM!A,SZMSMW1Z3M8\2PM\2P%;YSFBWZ]P1C87 V_P
M=F*>+I:\/.%,SU=H@>\P?UC=4G'DM"Q)FN."I:0 %#]=#"Z]LPB.RH *\5>*
M-VSK,RBE/!+R7!Y<)Q<#MYP1SG#,2PHD_KW@&<ZRDDG,XUM#.FC'+ .W/[^Q
M?ZW$"S&/B.$9R?Y.$[Z\&)P.0(*?T#KC<[+Y#3>"AB5?3#)6_06;!NL.0+QF
MG.1-L)A!GA;U?_3:+,16@.#1!\ F ,H!P8X OPGPWSM"T 0$[QUAV 14TIU:
M>[5P(>)H>D[)!M 2+=C*#]7J5]%BO=*BW"AWG(IO4Q''I_/H[G[^,+M_F%__
M\2OX N[$3DS6&0;D"<PQXW0=\S5-BP5 12+.9(CC!,P(XPP<A9BC-&.?1=S#
M70B./GT&GT!:@)LTR\0N8.<.%U,L!W+B9CI7]73@CNGXX(84?,E 5"0XT<2'
MYOB)(=X12].N#WQ;GRMH)+S#JQ/@N\< NA!JYC-[?[BGD_-CHT?_>_3>8OCM
M9O$KOO&NS=+;$.4F:'8%P_0%@W]^%WAPS7'._M6EOB;W]>1E13QC*Q3CBX$H
M>17C8/KS3][(_46W[C;)0IMDD26R7H:"-D.!B7UZ3SC*0+Q$=(&UEU\=/JS"
MRQ^1EZGGBZWQLKVT&LQ8PH0J)G G?4RD8D:NVV)Z^H:MOJ%17Y2O,O(=8\ Q
M%=4053\V<5F-=&)KKF!;R$C2JD)@($E5(<.QI%0S4.#KE8Y:I2.CTC_Y$M/W
MR1RIHTLJ580OB=R+B%3$6*]PW"H<&Q7>4O*25H9#^!UA.K9JBT[E6%4II6&F
M0J $"57(R)6$:@8:[MBVIZW44Z/4ZX+C!:W3B%^%R6/ZJ_-4'=J3MN-,@PGD
MJU/%^(&<3Q43^(%>YJ25.3'*O(QCX0!I91$2+,I;G%::=5(GRO!2'F9[$:&*
MD"[OR,31D^BYG6%RS2(9$_X]S5<HI<(QZR_)AL,D;S\DW ^)-!"X(XO>EB?T
MWE%[V'+-$[)I"L\Q*##72O7V2U4A<OW9SQ)I(%].=TB%G51HE%J9&.%U5Y0D
MHOHPP$BF\YU79IY#W8M5MM J6V2+K9^1SF-Z'VHR/:LNTRI;:)4MLL76SU/G
M-+T?M)I-O+$P[(6$^R&1!K*S!G9&TS,[S1M$GS$76_ 8,"S:V:8#1HGP8ZG8
MH:B\P:&5;>0]> /:9 NMLD6VV/H9Z@RR-_K00F'TWP?GR29;:)4MLL76SU-G
M\SVSS]]?*%3'K10*C2F7"X7&VLN%PL325]<Y>\]L[6NO=)06,<GQ9Z=Q][O=
MDI'MX%UGDRVTRA;98NOGI6M%O,F'5@=CIW-PGFRRA5;9(EML_=NK73L%S>W4
MWNH U0Y'O66E XUE*Z$!!:[<%FM P_%07R5@UU%!<T<UP]D"BPUW&7];IRRM
M;@3<9DC;&9NI#MUZ5ME"JVR1+;9^4KK>#\*/+!'0:D=HE2VTRA;98NOGJ>L(
MH;&3>4>)\-6KWX5RB=" AO)M" W(W[KZF^5004,XVE$BNGX*FONIVDC,]]T&
M-;,<O.MLLH56V2);;/U\= T@''YH=;#:!EIE"ZVR1;;8^GGJVD!H?E"ROSJ,
ME.=0<"(7!Q7CG<JU0<7X@5P:5,Q8OA7A;#VMS[&8=?F:! ,Q61>\?A;;GFU?
MQ;BL7D"0SE]Y9S-/<S[TSJ+Z18N.OG[OXT8L4EHPD.$G,91[,A83I?6K%/4!
M)ZOJ78%'PCG)JX]+C!),2X#X_HD0_G90#M"^T#+]#U!+ P04    " "I7%I5
M\I,A#R@$  #O$P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6RU6&UO
MVS80_BN$5@PMT$8O?DUF&X@M=^N'%(:==!^&?:"ELR5$(EV2MFM@/WXDI<B6
MQ AQIWVQ1>KNX=W#X^EXHR-ESSP"$.A'FA ^MB(A=G>VS8,(4LQOZ Z(?+.A
M+,5"#MG6YCL&.-1*:6)[CM.W4QP3:S+2<PLV&=&]2&(""X;X/DTQ.TTAH<>Q
MY5HO$\MX&PDU84]&.[R%%8BGW8+)D5V@A'$*A,>4( :;L77OWLW=CE+0$M]B
M./*+9Z1<65/ZK 9?PK'E*(L@@4 H""S_#C"#)%%(TH[O.:A5K*D4+Y]?T#]K
MYZ4S:\QA1I,_XU!$8VMHH1 V>)^()3W^ ;E#/847T(3K7W3,91T+!7LN:)HK
M2PO2F&3_^$=.Q(6"Q#$K>+F"5U7HOJ+0R14Z;UVAFRMTW[I"+U?0KMN9[YHX
M'PL\&3%Z1$Q)2S3UH-G7VI*OF*A 60DFW\923TR6\]7C\FGV^+3\\O5W] FM
M9"2&^P00W: E<,'V@=BSF&S5"-@!T/J$'D\[+3"C7*#W/@@<)_R#U'Y:^>C]
MNP_H'8H)>HB31,8"']E"&JJ6LX/<J&EFE/>*41WT0(F(.)J3$$*#OM^L?]N@
M;TN""I:\%Y:F7B/@"G8WJ.-\1)[C>09[9F]7=TWN_+?5YS^]>HF,3A$R'8TW
M>"UDC&'QUY(F"9*']XA9^+=ISS/4CAE5)<0[OL,!C"V9\32F-?GU%[?O_&8B
MO$TPOTVP>4M@I:WI%EO3;4*O;$V._Q&M81L3HJ;DH=T!BZGI4$T;L:_=H#;!
M_ RLI\'4I^\P<1T9RH=+W@TRW6$A4Z*S5]#9NX+.(,)L"\9TU@AS+7-M@OD9
M6/>"E;Y3(:XNXG9>(:Y?$-=O)$ZF ?F%)O(#QAB0X(0$PX0G.*L-2(BHB("9
MF&S$O9;)-L'\?HVF3VZ52H-,U\SDH&!RT,CD I]D62:,4=>H>2U7;8+Y Q-7
M_0I9)J&!8Z9K6- U_)D$""KDFE+?L)8\NKVRN;.ZB.MZ91E_6'.I"C.OBUS"
ME)R^+9R^;71Z%F&R!55R2>]C63R;DU0CR+7ATB:8?UM/4A76ZA+NP$R:ZYPK
M7Z?Y:#%ZB/6%1]ZW5*R<(\=8LCKU !A48L0@XU5D?(-,+27G,B5_>Z\<#?>B
MU'>;XP22+1! ]\'WO71<)^-%@@GZ1TX%\N[&9.B$:"5H\(RF\O85R@H_E5=2
MKA.WD93&%:\-JE;1_%;1YFVAE??..^^=][\4W3EL6QO4)IK?*MJ\+;3R!ITO
M16YC87]U-FGU-M0JFM\JVCQ'*^7-Z@?/OFA@I""K;-4YXBB@>R*RBVDQ6W2G
M[G5/IC(_=>]FKF'>5]TLW3 YPV>ML =9U,>$HP0V<BGG9B -95EW*1L(NM/M
MDS45@J;Z,0(< E,"\OV&4O$R4 L4/;[)OU!+ P04    " "I7%I5S?;!+ 8#
M  #&"0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RM5FMOVC 4_2M6
M5DVMM)$7X36(5"#3^H$-E7:;-.V#"1>PFL29;:#[][.=D$$PJ-KZ!6SGG'/O
MN7[V=Y0]\36 0,]IDO&!M18B[]DVC]>08MZ@.63RRY*R% O992N;YPSP0I/2
MQ/8<IV6GF&16V-=C4Q;VZ48D)(,I0WR3IIC]'D)"=P/+M?8#]V2U%FK #OLY
M7L$,Q&,^9;)G5RH+DD+&"<T0@^7 NG5[44OA-> K@1T_:"/E9$[ID^K<+0:6
MHQ*"!&*A%+#\V\((DD0)R31^E9I6%5(1#]M[]8_:N_0RQQQ&-/E&%F(]L#H6
M6L 2;Q)Q3W>?H/03*+V8)ES_HEV)=2P4;[B@:4F6&:0D*_[Q<UF' X+4,1.\
MDN#5"<TS!+\D^"^-T"P)S9=&"$J"MFX7WG7AQEC@L,_H#C&%EFJJH:NOV;)>
M)%/K9":8_$HD3X1WGT=?)A%ZN/T>S=![-)/K<+%) -$EFC*Z)7H]R.6([K*8
MIH >\#-P=#T&@4G";R3E<39&UU<WZ J1#$U(DD@&[]M")J="V'&9R+!(Q#N3
MB(\F-!-KCJ)L 0L#?WR9W[W MV51JLIX^\H,O8N",\@;R'?>(<_Q/$,^HY?3
M79.=_XL>_7/THV+XU3+QM5[[W#*I9A^-"8\3RC<,T(_;.1=,[O6?IODN%'VS
MHCK_>CS',0PL><!Q8%NPPK=OW);SP53LUQ0;OZ98]$IB1]/2K*:E>4D]C##+
M2+;B: ARC\+1)C5-2:$6:#5U@VQ#SW.Z?7M[6&H#R W:QZ#Q*2CH!,UC4'0*
M:GE-IP(=60XJR\%%R^=/)9/AX#0#QZWY-6&"FMU3C!OX=;LF4+=CMMNJ[+8N
MS_!R"?HNU7OO'@LPV2PTN@>1G8;7]FI&"Y3K',,Z-:M&K59-*S*B@E;-K'UP
M,:7 5OI%P%%,-YDH#I]JM'ITW.J[MC8^='LCUS ^EH^4XDWQ5[YXX4PP6Y&,
MHP26,I33:,MY8<6KH>@(FNMK<4Z%O&1U<RT?6L 40'Y?4BKV'16@>KJ%?P!0
M2P,$%     @ J5Q:5<$\>(8[ @  < 4  !D   !X;"]W;W)K<VAE971S+W-H
M965T-30N>&ULO51-C],P$/TK5EBA70F:-&W*:DDB]6,1/12JE@6N3C)IK'7L
M8#M-EU^/[:11@;8'#EQBC^WWYLV+QV'#Q;,L !0ZE)3)R"F4JAY<5Z8%E%@.
M> 5,[^1<E%CI4.Q<60G F065U/4];^*6F# G#NW:6L0AKQ4E#-8"R;HLL7B9
M >5-Y R=X\*&[ IE%MPXK/ .MJ">JK70D=NS9*0$)@EG2$ >.=/APRPPY^V!
MKP0:>3)'II*$\V<3++/(\8P@H) JPX#UL(<Y4&J(M(P?':?3IS3 T_F1_8.M
M7=>28 ES3K^13!61<^^@#')<4[7AS4?HZK$"4TZE_:*F/3OQ'9364O&R VL%
M)6'MB ^=#R< _Q+ [P"^U=TFLBH76.$X%+Q!PIS6;&9B2[5H+8XP\U.V2NA=
MHG$J7GZ:?UX]HB_3[X];]!9-LXP8MS!%2];^<N/=[0(4)E3>H1M$&%H12O6R
M#%VE)1@B-^W2S=IT_H5T6Z@&:.2]0;[G^^AINT"W-W>_T[BZ@KX,OR_#M[RC
M"[PKPDA9E^<$706:._\@*YQ"Y.A++4'LP8E?OQI.O/=79(UZ6:.KLC: I38S
MH2^HXE*2A(*^,JGN'@G&R)H)2/F.D9^0(84/* $&.5%GG6U3!3:5Z;5]/+[W
M0G=_1M^XUS>^;AL^7++M*O ?;0MZ6<'_LRWXR[9@]*=M[DD#F;=HA<6.,(DH
MY!KE#=YIN&C[NPT4KVQ/)5SI#K730C^)(,P!O9]SKHZ!:=/^D8U_ 5!+ P04
M    " "I7%I5W*#J<0($  !##P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6RMEUUSZC80AO^*QLUTDIDD_C:0 C. W9Y<)&7PI.>BTPMA"_ <V::2
M@--_WY5L?(Q12*8E%\&6=]^5GEU+WN&A9-_XAA"!ON>TX"-C(\3VR31YLB$Y
MYH_EEA3P9%6R' NX96N3;QG!J7+*J>E85F#F."N,\5"-S=EX6.X$S0HR9XCO
M\ARS?Z:$EH>181O'@46VW@@Y8(Z'6[PF,1%OVSF#.[-12;.<%#PK"\3(:F1,
M[*?(MJ2#LO@C(P?>ND9R*<NR_"9OGM.18<D9$4H2(24P_.S)C% JE6 >?]>B
M1A-3.K:OC^J_JL7#8I:8DUE)OV:IV(R,OH%2LL([*A;EX0NI%^1+O:2D7/U'
MA]K6,E"RXZ+,:V>809X5U2_^7H-H.8".WL&I'9RN@_>.@UL[N)^-X-4.WF<C
M^+6#6KI9K5V!"[' XR$K#XA):U"3%XJ^\@9>62$+)18,GF;@)\;19/'Z_/I;
MC.;1 L5?)HL(W89$X(SR._2 WN(0W=[<H1MD(K[!C'"4%>BMR 2_;PV\9)1"
MVF'LIGT[- 5,408RDWHZTVHZSCO3<=%+68@-1U&1DE3C'U[V'USP-P%-P\<Y
M\IDZ%P5CLGU$KG6/',MQ-/.9?=[=UBWG_T6/_G/T$QAN4RRNTNN]5RR8%5FQ
MYFA.&(IE]M&?DR47#%[WOW3)KN1<O9S< Y_X%B=D9, FQPG;$V/\\T]V8/VB
M(WU-L?":8M&5Q$YRXC4Y\2ZICU_A,&GR,A&"9<N=P$M*D"C1]"5&;YRD"$X4
M-,4\2Q N4A1F="=@-)K':(9ILJ-8[MJZ#%;!?15<'CK[,<P[&)K[=F8T1K[7
M,0K/C3S7\D^-(HU1("M_KR'D-X3\BX2^JL."I ^3/6%P^*%9F>=P1L75]O7[
M3G !5  @;'@5I%O8Q*K=[4X'I8KGM6;IV*[;@:(Q<NQ!!XI6J=>!HE-R>GHH
M00,EN CEN4@8@0-?8'H$T2T>-?P 0*!2 !E\FG!5)FA.<<$_8A2<3=KN)'MV
M;N)X'3X:E2X=C4J@9]-KV/2N5S#'=^D#'#U-HKU^!XC&R/$Z=17JE/P.MTBG
MY+MZ+/T&2_]SN_\6=O\V$MUZ^]?<^:\I%EY3++J2V$D^!DT^!A?+]"0?294/
M58$(GQ\#]_)SNM[9=CQ5/LI86ZU5X*!5/M9CK_OZ:HTZQ7INXSQ:=J=8M49]
M?;':UH\/6^N:>-+6>_PQH#KV!X2T5D%_</+7(5;[M(] I\-+(PO _ XPL]44
MY(2M53?&@<2N$-4G7S/:='P3U>=TQJ?VT\S6C(>R0U1-R _YJKU\P6R=P1%!
MR0I"23 &8E7'5MV(<JM:DF4IH,%1EQOH<@F3!O!\59;B>",#-'WS^%]02P,$
M%     @ J5Q:50!G\BQ,"   VT@  !D   !X;"]W;W)K<VAE971S+W-H965T
M-38N>&ULS5Q=;]LV%/TKA%<,'=#5$B51=I<8</.!!4BR(FZZAV$/BLW$0F7)
ME6BG ?;C1\F**5K4E1C0@%Y:?UR>7%X>TT?G4CYY3M+OV9)2AGZNHC@['2P9
M6W\:#K/YDJZ"[&.RIC%_YS%)5P'C3].G8;9.:; H!JVB(;8L,EP%83R8G!2O
M?4DG)\F&16%,OZ0HVZQ60?KRF4;)\^G 'KR^<!<^+5G^PG!RL@Z>Z(RR^_67
ME#\;[E$6X8K&69C$**6/IX.I_>G,)_F (N);2)^SRF.43^4A2;[G3ZX6IP,K
MSXA&=,YRB(#_MZ5G-(IR))['CQ)TL/^;^<#JXU?TRV+R?#(/04;/DNCO<,&6
MIX/1 "WH8[")V%WR_"<M)^3E>/,DRHI_T7,9:PW0?).Q9%4.YAFLPGCW?_"S
M+$1E@.TV#,#E -QU@%,.<(J)[C(KIG4>L&!RDB;/*,VC.5K^H*A-,9K/)HSS
M99RQE+\;\G%L<GEU.[T]NYI>HZO;V=>[^YN+VZ\S-+T]1Y?3JSOT;7I]?X%N
M+J:S^[N+W7N_HQGGTF(3490\HLLP#N)Y&$1HFF6492B(%^@Z#!["*&0AS= -
M#;)-2A<H8.@R"%/T+8@V%+T_IRP(H^PWCG<_.T?OW_V&WJ$P1C=A%/'US4Z&
MC$\O3W(X+Z?R>3<5W#"5&5U_1([U 6$+8\7P,WCX.9WSX78QW):'#WE1]Y7%
M^\KB L]OJNQ^LA]::\/Y?$?GFS0-XZ<BZC:)T_T+GX,LS- _U_P/H"M&5]F_
MJN+LLG'4V>2[P:=L'<SIZ8!_W#.:;NE@\NLO-K'^4)7*$)A4.&=?. ="G]P$
MZ7=.C@=.L 5]8"C+"U$43#7M'9978.5[UG9BX[%S,MQ6IU,/PN.1OP^2TG3W
M:;I@FA<_-B%[X93=THSQC8TIT]MAN)6_/+;'!]G58[!5"9*R\_;9>6!V9S1E
MX6,X#QCG&?^<+N@ZR4*F2A$$TB6.(3!ISF0_9]*K3QPQ63A#8%+A_'WA?(.?
M.+]&5]L:60><K@=A3%PUIT?[-$<PIY/5BJ;%E\TZ6--4E1R(H+LFAL"DR8[W
MDQWWBLQCDX4S!"85SK:$I+$,TKD$D_A,1@=T5@0YV%+3V:YH+[N%T.DZ2?D6
MW2E/$$MWA4RAR3,7VLCNESBRC:HC4VAR\80^LDT*I!*L2EW7.Z2W(L9R&N@M
M!)(-*Z1KNJ71;MZV,C-PN/:B&$*3)ROTENWUB]%&99LI-+EX0KC9H+R9G 79
MLBC$/'] N;+>!E$NJ?G5X2J)Z0N_Y,TY7\0D;$G3-M*3&J$/%0H8(L]#Z"@;
M%E+G-.69Y\8$"@H.*'.K:Z-:;E"(G)L03S:LGBJY18*4R@1'[0E"(7*"0O#8
MH"S@WX8QX_SGRX[F29R%"\J_&G.KYS7=%V6RX_9DH1#YVEYH# QKC.K>AOY#
M?Q6<G#:N.8RF?75N"$V>NY MV.[55H>-*A]3:'+Q*JX0* XZV@8EB/2%C,D!
MKQ5!]MANHK:0%QB6%P?4KGPLMX5UE^;.J#IK$%A[H0RAR640Z@6[_6*Y435D
M"DTNGE!#N,5^>M->7H)6"5WC?#UDU$!XH3XPK#X."=_=.H.!M=?L&!X0%N(%
M^_TB/*BEM(MG"$TNGE!7&%97>M=DN%UA@2%RDD)A85AAU7;V=C\-1M1>I&,8
M0XX0;8[5*X8[1E6?*32Y>$+U.;!9I=F6L5L9#H;(20IUY<#JJL9P#8,-AM9>
MK:.TT"H]-*=?5#<J_4RAR<43TL^!C2M-JM?[=S6J0R%RDD)B.;#$*JB.5(WN
MS_!([<4XAC?D"'7F]*NKYQC5=*;0Y.()3>? AI1Q8\VI.U,N(?XAWQ4]0HRQ
MU\!YH;*<SAY6L[_FU)63;7F''1U%%+9(0X)"83FPPNINLCEU4VID'^98CVFJ
MH2M$D L[5V^[-'/K#;##30X,D9,5HL.%14>YR75PV& @W8^M*31YVD+&N/UJ
MC[E&I8\I-+EX0OJXL'_5\6".HN55.S>D"+*MAI,Y;N7@4(>^6$%J#6\-QM1>
MHF/80Z[0+FZ_FF6N44%D"DTNGA!$;DNS[&T;>'M'# R1DQ4"Q(4%2(7KW6TU
M&%-[N8[A#+E"L[BC?G'=Z!$H4VAR\82><F$]I7<EYM;UDN)HFB*J^6R:)W25
MUZ$C6.[J[;X:#*9]ZO(8UI G5)K7KX:@9U3KF4*3BR>TG@=;5GH4]Q0]O]II
M-450XVDU3^@JKT-?L"2XAJT&HVHOUC&<(4](-Z]?34'/J.HSA287KW(D'7:L
M-)E>[_35SJVI8IK.K7E"8'F=^X&.,C.C#I$I-'FR0J!Y_>KZ>4:UG2DTN7A"
MVWDM)])-VVM>>V,0#)'G(626U]FV:O;5/(5C=9B;0H!A=7)$""L""ZONGAII
M-ZG $#E!(7](VS'NMUR0D7K[R\&'V2IB&@Q (@0'Z=PC<SH8:S":]FTNQ_"&
MB- PI%]M,6)4_)A"DXLGQ \Q<<<;:6^'@2%R<D)<D [M,,%J#6<-!M9>HZ/<
M 5>Y!:Y?W3)B]B:X8V@A(K00:>F6O6TC;S_/#8;(R0KM06#M<4CX[O8:#*R]
M9L=PB(B0+J1?]\D1HP>B3*')MWT*:>6;O%/.;Y=78(B<I)!7?H<>8'5G;W?7
M8$3=13*%)L]?Z#6_7\U WZC@,X4F%T\(/A\VK3097N_WU1@.A<A)"F'E=[Y1
MSM&UUV!H[=4ZAD/D"Q'G]ZLOZ!N5?J;0Y.()Z>?#MI4FU7=@'D1U*&27Y+#R
MRS/YS_[P')[".$,1?>1CK(]Y2=+=+^GLGK!D7?P8S4/"6+(J'BYIP(56'L#?
M?TP2]OHD_WV;_>\93?X'4$L#!!0    ( *E<6E6:48FI7P0  +(5   9
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M@A=$& ']?,FY>EN88[ODF+;['U!+ P04    " "I7%I5R8\G?.D"  "@!P
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M:W-H965T<R]S:&5E=#4Y+GAM;*U8:V_B.!3]*U9VM&JEI7D0'ND"$B6I%FE
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M!9#O-Y2*UX9R4'Q &?T/4$L#!!0    ( *E<6E6#/3VJ$P\  &G.   9
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M+/>/PNP/5+1)GR9YC)2*UNG+E> +(9, _?DRBM3+0?* 2OY TO@_4$L#!!0
M   ( *E<6E71&3]CL00  'P?   9    >&PO=V]R:W-H965T<R]S:&5E=#8R
M+GAM;+69;4_C.!#'OXJ56YU HB1.TI9R;:52F[M*P"&Z[+TXW8O0NFVT2=RS
MW9:5[L.?\T#2A#10=G@#>9CYC<?C_/'@_HZ+[W+%F$+/81#)@;%2:GUIFG*V
M8J$GS_F:1?K-@HO04_I6+$VY%LR;)TYA8-J6U3%#SX^,83]Y=B^&?;Y1@1^Q
M>X'D)@P]\>.*!7PW,+#Q\N#!7ZY4_, <]M?>DDV9>ES?"WUGYI2Y'[)(^CQ"
M@BT&Q@A?4MN*'1*+;S[;R;UK%*?RQ/GW^&8R'QA6/"(6L)F*$9[^M65C%@0Q
M28_CWPQJY#%CQ_WK%_IUDKQ.YLF3;,R#O_RY6@V,"P/-V<+;!.J![_Y@64+M
MF#?C@4Q^HEUF:QEHMI&*AYFS'D'H1^EO[SF;B#T'S:EWL#,'N^K@'G!P,@?G
MO1'<S,%];X1VYI"D;J:Y)Q-'/.4-^X+OD(BM-2V^2&8_\=;SY4?Q0IDJH=_Z
MVD\-KR=WH[OQ9'2#)G?3KP^/M_3NZQ2-[@BZ'DT>T+?1S2-%MW0T?7R@Z;L6
M(DSX6R\N,)I$4HF-7CA*GJ'?];I$)S=<RE-T0ICR_$!?M=#CE*"3+Z?H"]+O
M;_T@T"M$]DVEAQ\/PIQE0[U*AVH?&*J#;GFD5A+1:,[F-?ZDV;_7X&_J:<OG
MSGZ9NRN[$3AEZW/D6&?(MFR[9CSC][OCNG1^+CK]</329#CY0G(2GG. -XD4
M$TPJ)#S%D-QY:S33TRVT$DCT'QIS_8HOT%KP^29^)'E05\.KQBBQ;%[*M3=C
M T/KHF1BRXSAK[_@CO5;70$@80021H%@I5*Y>:G<A-X]4*KW?+]_WV@G-%$L
ME/_4E<F%+!,DC$#"*!"L5*9V7J9VXQ>5EB-(RJ'_I,[SJIVAB*FZHJ2\=L*+
M=PC;H=4WM_LS_:8%>=."-EF4$NWDB79^1CK^5"LFT(D?S7C(3DWVK#=)\O D
M-,8Z=F5"P@@DC +!2@7KY@7K?KJ ="'+! DCD# *!"N5Z2(OTP6P@*0\=^_3
M;K4K"E)CTJU(2(V)[51$I,[&KI>17IYNKS'=L="9MF8;(5@T^Z'WFC ;DL:@
MQRY42!B!A%$@6*ERV"JZ$.O3%24+ 50I4!H!I5$H6KE8>RTC!M:5#.@V[$S>
M-B%OF]!&DW*Z=I&N#:@K1^Y6FF,?O6@A:0241J%HY2H6[2EV/E]A0)M34!H!
MI5$H6KE818.*&QNKCRB,^^K#QTY58E[;M.RJQKRV:5<UI@9S<4!DBEX/-S=[
MUUPP?QFA7&867.P\,?_8GJ4YV-$+%9)&0&D4BE8N6]&YXL[GJPIHQPI*(Z T
M"D4K%ZOH6G%CM_415>F^_M1QK]H2U5CA7E57:DBN=5&5EAJ2VSZ@+44;B)O[
MP'=IR['[EL:01R]:2!H!I5$H6KEX15.+>Y^O,* ]+"B-@-(H%*U\'E2TL79C
MY_4!A<F ^_]-;75P16!JC*K[ECH.=CH5?:FU<BOZ8NZ=)H9,+)-C7*G%8A.I
M]#PH?YH?%8^2 ]+*\RM\.<8USPF^I.E!<(%/SZ5O/;'T(XD"MM"AK/.N'JE(
MCWK3&\77R5GF$U>*A\GEBGEZGF,#_7[!N7JYB0/D!^[#_P%02P,$%     @
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M8;:)8_7.'(N<W_SIAVDMRGLD<%Q$<*S/X"7'ZM4[%F2XGH'2*!1-U:X(ZW@
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MD)(%T(QK^FE%;Q^A=\ MS<6*@WF>X$2!G^OQ@09ORE";>.W7>*>VEO !KR^
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M>! EE1HV@NM:T+@@:((MSMB1 C^+4"3 >W+\5()7^>1;!XQG!]:&E/ .Y3?
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M/F]27X;4#8;SZO#^@!G#:?5X1#!"I!S W^\Q9L^-4J"]DEK^#U!+ P04
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M1S(\OFU &^5WYH[;UP_H[XK@33"W3/&1B+]$,[TX;?0::,;G+(OUC5A]X)N
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M_O>S'1I1$N@>]@)V<M_SY\X^7[I;QI]$"B#12YY1T;-2*8M+VQ9)"CD6%ZP
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M?4-W,@6.!FO.@4K4%P*D0.?7(#')Q!=E\#"_1N=G7] 9(A2-29:I'1)=6RI
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MQM; (FO8T'VB[OCQ;RB!0NTOYHDTO^18VCH6B?=2\;048P0IRXI_^KU,Q(G
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MN^#[/VNO2)M]TDOK+Y\;*K8,V1/8H,JYZ*-<%!\3Q43QW+37*ZZP63?#'7Z
M@= &>'_#N7J<Z(Z]^J2;_ ]02P,$%     @ J5Q:53/V%BY[ P  Q H  !D
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M#$][SC^ZA^PWP U56R8T=OL&9;V+!/6JOE?KB9%E=36MI,&+KAKN\%,$E#7
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M,D_+P[_&0ZN=C(SEOJSR;9NX+L%VDQW_C[^V%7&6H.;@"5B;@,$$_)$$5IO
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M90=Q?4T(?SN1 9K_42S_ 5!+ P04    " "I7%I5^]-S@Z,&  #2(P  &0
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MZ.]7>:Z>+JH*VM=XIO\#4$L#!!0    ( *E<6E4YB>X<^0(  . '   9
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MY *!Y9U=9%E>$44Z+<'7(,QIC68&5E4KK<E19KPR5D+O4BVG.H/AZ/;^]V
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M\!53.06J99":!=4H5&-0C4,U&ZHY4,U%:6K+5&FRH0WA!@^K<"R2_)W5S>$
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MKV)K4YOQ':QO/I5?LOI.W4-C:JAF034*U1A4XZ6V7_=OWB^"9L]0S45IZI=
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M&V1_G\6QW%[()]B=76_P/U!+ P04    " "I7%I5.7J&)'4#  ".%@  #0
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M;V]K+GAM;,6;6V^;6!1&_\J1GU(I'<=<W:JI1&R<H'&  9*9/D7$/HY1,5B
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MU+F@F)?I\O"SKL-/TC[_"U!+ P04    " "I7%I5DS&\_8 "  "3,0  &@
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M^4Z]A_'S4(=;S]<:K_^=5(^7<^OM\M?EU\[)W7O%.=Q7#,]_ 5!+ P04
M" "I7%I5]S F!B<"   R,   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VTUN
MVS 0!>"K&-H&%LU_M8BS:;MML^@%6&D<"Y9$@F12Y_:EY"1 B]1(X )]&PLV
MR7DC#O#M?/W],5!:'<=A2MMJGW/XR%AJ]S2Z5/M 4UG9^3BZ7+[&.Q9<>W!W
MQ,1F8UCKITQ37N>Y1G5S_9EV[G[(JR_'\G/J_;2M(@VI6GTZ;9RSMI4+8>A;
ME\LZ>YBZ/U+63PEU.;GL2?L^I*NRH6*O)LPK?P]X.O?M@6+L.UK=NIB_NK'L
M8L>!I?PX4*K/EWBE1[_;]2UUOKT?RY$ZA4BN2WNB/ [UJ>C5^>1<;IA.G_SB
M_*7,N<"R\S;ZD,K$(KT_[GDD\^EU*(4HYO[\*[XDEM(7OQ_-T^ZH>V-VN=Z?
M/AZ6>22V/"Z_X]]G_%+_G7T(D#XD2!\*I \-TH<!Z<."]-& ]/$!I ^^06D$
M152.0BI',96CH,I15.4HK'(45SD*K!Q%5H$BJT"15:#(*E!D%2BR"A19!8JL
M D56@2*K0)%5HL@J4625*+)*%%DEBJP215:)(JM$D56BR"I19%4HLBH4616*
MK I%5H4BJT*15:'(JE!D52BR*A19-8JL&D56C2*K1I%5H\BJ4635*+)J%%DU
MBJP:15:#(JM!D=6@R&I09#4HLAH460V*K 9%5H,BJT&1U:+(:E%DM2BR6A19
M+8JL%D56BR*K19'5HLAJ461M4&1M4&1M4&1M4&1M_J>L/[P__./XY5F/KI^>
M\]GR5X&;7U!+ 0(4 Q0    ( *E<6E4'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ J5Q:5792.D#N
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ J5Q:59E<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "I7%I5]TV6:L,&  #3*0
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ J5Q:5;,B5J_R!0  ^QD  !@              ("!!@\  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *E<6E7\RX:'>@0
M %T1   8              " @2X5  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " "I7%I5*/\$FCH&  #U&@  &               @('>
M&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ J5Q:5>]R
M_T.1!P  /"$  !@              ("!3B   'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( *E<6E7,<4FMN@H  )T;   8
M  " @14H  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "I
M7%I5V6E*Z>,&  "Y$   &               @($%,P  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ J5Q:57+ 9-!@"0  -!8  !@
M         ("!'CH  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( *E<6E7M<;++!@T  +HB   8              " @;1#  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "I7%I59Q?#%FH#   U!P
M&0              @('P4   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( *E<6E65?;VN4 8  ,<0   9              " @9%4  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ J5Q:55>QS977
M!0  , T  !D              ("!&%L  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " "I7%I5'Z%EF7<#  #!!P  &0
M@($F80  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *E<
M6E4GXZ> )!0  *E#   9              " @=1D  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ J5Q:5>.G=QQ- P  (@<  !D
M         ("!+WD  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " "I7%I5O+>]P@4#  !I!@  &0              @(&S?   >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( *E<6E6A=FL\!P,  -8&
M   9              " @>]_  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ J5Q:58?;Y$Q[!@  F!(  !D              ("!+8,
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "I7%I55)SR
M%,<$   ,"P  &0              @('?B0  >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( *E<6E6K+UC"I0H   4E   9
M  " @=V.  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
MJ5Q:54-KH\5"!   OPD  !D              ("!N9D  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " "I7%I5J-:FIY(I  "<AP  &0
M            @($RG@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( *E<6E7DQ>Z"6@P  *TA   9              " @?O'  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ J5Q:58$G2R;%!@
MF1   !D              ("!C-0  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " "I7%I52H_Y?ED$  "5"0  &0              @(&(
MVP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( *E<6E60
M;3$NRP<  +03   9              " @1C@  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ J5Q:53E"N;!R P  )P<  !D
M     ("!&N@  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *E<6E7H:/LDRP(  / %   9              "
M@7P! 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ J5Q:
M5>BPJFR7 @  A 4  !D              ("!?@0! 'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6Q02P$"% ,4    " "I7%I5;]6@*<("   !!@  &0
M        @(%,!P$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0
M   ( *E<6E7(<DTHK0,  *('   9              " @44* 0!X;"]W;W)K
M<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ J5Q:5<OX%5;Z!   W0P
M !D              ("!*0X! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q0
M2P$"% ,4    " "I7%I5]F]\L&L(  !R'P  &0              @(%:$P$
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( *E<6E43YJ$'
MB00  "L+   9              " @?P; 0!X;"]W;W)K<VAE971S+W-H965T
M,S@N>&UL4$L! A0#%     @ J5Q:5482TW)?!   9!P  !D
M ("!O" ! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "I
M7%I5?YL9^ (%  #@'@  &0              @(%2)0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( *E<6E75;)4K3@L  &5S   9
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M970T-2YX;6Q02P$"% ,4    " "I7%I55CAHEHT$  #O&0  &0
M    @('?3 $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    (
M *E<6E7RYK.;^P0  /D<   9              " @:-1 0!X;"]W;W)K<VAE
M971S+W-H965T-#<N>&UL4$L! A0#%     @ J5Q:55!=QP5O"   ,EP  !D
M             ("!U58! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"
M% ,4    " "I7%I5JY\=Z(X$   _$0  &0              @(%[7P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( *E<6E4>21+^L 0
M )T8   9              " @4!D 0!X;"]W;W)K<VAE971S+W-H965T-3 N
M>&UL4$L! A0#%     @ J5Q:5?F* VF<!0  W"(  !D              ("!
M)VD! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " "I7%I5
M\I,A#R@$  #O$P  &0              @('Z;@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4R+GAM;%!+ 0(4 Q0    ( *E<6E7-]L$L!@,  ,8)   9
M      " @5ES 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%
M  @ J5Q:5<$\>(8[ @  < 4  !D              ("!EG8! 'AL+W=O<FMS
M:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " "I7%I5W*#J<0($  !##P
M&0              @($(>0$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+
M 0(4 Q0    ( *E<6E4 9_(L3 @  -M(   9              " @4%] 0!X
M;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ J5Q:59I1B:E?
M!   LA4  !D              ("!Q(4! 'AL+W=O<FMS:&5E=',O<VAE970U
M-RYX;6Q02P$"% ,4    " "I7%I5R8\G?.D"  "@!P  &0
M@(%:B@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( *E<
M6E6/#4.T- 0  $P1   9              " @7J- 0!X;"]W;W)K<VAE971S
M+W-H965T-3DN>&UL4$L! A0#%     @ J5Q:58,]/:H3#P  :<X  !D
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M=#8T+GAM;%!+ 0(4 Q0    ( *E<6E6Q\_L\L0,  "<,   9
M  " @=*U 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @
MJ5Q:5:YJ][@D!0  /R@  !D              ("!NKD! 'AL+W=O<FMS:&5E
M=',O<VAE970V-BYX;6Q02P$"% ,4    " "I7%I5"XE/C04#  !\"   &0
M            @($5OP$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4
M Q0    ( *E<6E4,._RY30,  ,L+   9              " @5'" 0!X;"]W
M;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ J5Q:591FK+N$!
MX!0  !D              ("!U<4! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX
M;6Q02P$"% ,4    " "I7%I5&H:QHP8$  ">$@  &0              @(&0
MR@$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( *E<6E5K
MG$$$= 4  'HD   9              " @<W. 0!X;"]W;W)K<VAE971S+W-H
M965T-S$N>&UL4$L! A0#%     @ J5Q:54EXDELF!   _Q@  !D
M     ("!>-0! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *E<6E55_:YJD0L   MH   9              "
M@??F 0!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ J5Q:
M5>NU>-,#!   KQ@  !D              ("!O_(! 'AL+W=O<FMS:&5E=',O
M<VAE970W."YX;6Q02P$"% ,4    " "I7%I5^]-S@Z,&  #2(P  &0
M        @('Y]@$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0
M   ( *E<6E4YB>X<^0(  . '   9              " @=/] 0!X;"]W;W)K
M<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ J5Q:50^3.%L9!   @!(
M !D              ("! P$" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q0
M2P$"% ,4    " "I7%I5NM);B T#  !Y"0  &0              @(%3!0(
M>&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( *E<6E43]Y29
M$@,  ,4)   9              " @9<( @!X;"]W;W)K<VAE971S+W-H965T
M.#,N>&UL4$L! A0#%     @ J5Q:50+271A+"0  :6\  !D
M ("!X L" 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    " "I
M7%I5.7J&)'4#  ".%@  #0              @ %B%0( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( *E<6E67BKL<P    !,"   +              "  0(9
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *E<6E6YMN4_, 8  !8W   /
M          "  >L9 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "I7%I5
MDS&\_8 "  "3,0  &@              @ %(( ( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "I7%I5]S F!B<"   R,   $P
M        @ $ (P( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     7 !< #L9
(  !8)0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>503</ContextCount>
  <ElementCount>398</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>130</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EARNINGS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCES</Role>
      <ShortName>ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS</Role>
      <ShortName>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - OTHER (INCOME)/EXPENSE, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENET</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2122106 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLES</Role>
      <ShortName>RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2151111 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2154112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2157113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2161114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2167115 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITY</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2173116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2178117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/REVENUE</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - ALLIANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESTables</Role>
      <ShortName>ALLIANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENET</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RESTRUCTURING</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INCOMETAXES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2332307 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2335308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESTables</Role>
      <ShortName>RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2355311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2358312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2362313 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2368314 - Disclosure - EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYTables</Role>
      <ShortName>EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITY</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2374315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails</Role>
      <ShortName>REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails</Role>
      <ShortName>REVENUE - Disaggregation of Revenue by Product and Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - ALLIANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESDetails</Role>
      <ShortName>ALLIANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails</Role>
      <ShortName>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails</Role>
      <ShortName>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails</Role>
      <ShortName>ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - RESTRUCTURING - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails</Role>
      <ShortName>RESTRUCTURING - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails</Role>
      <ShortName>RECEIVABLES - Schedule of Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - RECEIVABLES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESDetails</Role>
      <ShortName>RECEIVABLES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLESTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2453431 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIESTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2459433 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2460434 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463435 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2464436 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465437 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466438 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2469439 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails</Role>
      <ShortName>EQUITY - Schedule of Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2470440 - Disclosure - EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYAdditionalInformationDetails</Role>
      <ShortName>EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2471441 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2472442 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2475443 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2476444 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2477445 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="bmy-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2479446 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</ParentRole>
      <Position>84</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntitySmallBusiness -  bmy-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="bmy-20220930.htm">bmy-20220930.htm</File>
    <File>bmy-20220930.xsd</File>
    <File>bmy-20220930_cal.xml</File>
    <File>bmy-20220930_def.xml</File>
    <File>bmy-20220930_lab.xml</File>
    <File>bmy-20220930_pre.xml</File>
    <File>bmyex31a_20220930.htm</File>
    <File>bmyex31b_20220930.htm</File>
    <File>bmyex32a_20220930.htm</File>
    <File>bmyex32b_20220930.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1405">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmy-20220930.htm": {
   "axisCustom": 4,
   "axisStandard": 31,
   "contextCount": 503,
   "dts": {
    "calculationLink": {
     "local": [
      "bmy-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmy-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmy-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmy-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmy-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmy-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 680,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 6
   },
   "keyCustom": 52,
   "keyStandard": 346,
   "memberCustom": 81,
   "memberStandard": 46,
   "nsprefix": "bmy",
   "nsuri": "http://www.bms.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.bms.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - OTHER (INCOME)/EXPENSE, NET",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENET",
     "shortName": "OTHER (INCOME)/EXPENSE, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - RESTRUCTURING",
     "role": "http://www.bms.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - INCOME TAXES",
     "role": "http://www.bms.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.bms.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - RECEIVABLES",
     "role": "http://www.bms.com/role/RECEIVABLES",
     "shortName": "RECEIVABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151111 - Disclosure - INVENTORIES",
     "role": "http://www.bms.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
     "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2167115 - Disclosure - EQUITY",
     "role": "http://www.bms.com/role/EQUITY",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2178117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - REVENUE (Tables)",
     "role": "http://www.bms.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - ALLIANCES (Tables)",
     "role": "http://www.bms.com/role/ALLIANCESTables",
     "shortName": "ALLIANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables",
     "shortName": "OTHER (INCOME)/EXPENSE, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - RESTRUCTURING (Tables)",
     "role": "http://www.bms.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.bms.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332307 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.bms.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - RECEIVABLES (Tables)",
     "role": "http://www.bms.com/role/RECEIVABLESTables",
     "shortName": "RECEIVABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.bms.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2355311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2362313 - Disclosure - Supplemental Financial Information (Tables)",
     "role": "http://www.bms.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2368314 - Disclosure - EQUITY (Tables)",
     "role": "http://www.bms.com/role/EQUITYTables",
     "shortName": "EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2374315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - REVENUE - Disaggregation of Revenue (Details)",
     "role": "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
     "shortName": "REVENUE - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i29266ae9af704e83ac646ebb6641fdb3_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "role": "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails",
     "shortName": "REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:GrosstoNetAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)",
     "role": "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
     "shortName": "REVENUE - Disaggregation of Revenue by Product and Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - ALLIANCES (Details)",
     "role": "http://www.bms.com/role/ALLIANCESDetails",
     "shortName": "ALLIANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ie29f5777421440b5a7303c74ab686169_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:UpfrontPaymentsMadeToCollaborativePartner",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details)",
     "role": "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
     "shortName": "ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Acquisitions Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ie54f1b4636db42e6988c8772120ddcb6_D20220101-20220930",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details)",
     "role": "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
     "shortName": "ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Consideration for the Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "if3c379cf04aa4053babe3d97509a23e4_D20220817-20220817",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details)",
     "role": "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
     "shortName": "ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i094ac81d52ae4652a6b2c34240a43940_I20220817",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i740d420ab04f43438529806760d35e0c_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyIncomeNonoperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:LicensingAndOtherArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:ContingentRegulatoryMilestoneIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "role": "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
     "shortName": "DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i06dd7c1aa48f4cd691db5ffb92ff9be9_D20220401-20220430",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:PaymentToExtinguishFutureRoyaltyObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
     "shortName": "OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveAccrualAdjustment1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - RESTRUCTURING - Additional Information (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
     "shortName": "RESTRUCTURING - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i15769c9092334b38abe2ab74542152e2_I20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "bmy:ExpectedSynergiesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "role": "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ib73eeb74828048d393d64170a29ce8f3_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "role": "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ib73eeb74828048d393d64170a29ce8f3_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://www.bms.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i7ab4f089b9af40638285fff5aa6c4a64_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i1a41df960fa54741b1d2968b3effa442_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i339caa7c1e6a43eb90fd07efce417b64_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i527216e7e793494faa0253f4f8dbad0b_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i1c7d5843d7de40ddbe92cb7c600b33f3_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:UnamortizedBasisAdjustmentFromSwapTerminations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Issuance of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)",
     "role": "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails",
     "shortName": "RECEIVABLES - Schedule of Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - RECEIVABLES (Details)",
     "role": "http://www.bms.com/role/RECEIVABLESDetails",
     "shortName": "RECEIVABLES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453431 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.bms.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - REVENUE",
     "role": "http://www.bms.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459433 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460434 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463435 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464436 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465437 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466438 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469439 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails",
     "shortName": "EQUITY - Schedule of Stockholders Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470440 - Disclosure - EQUITY - Additional Information (Details)",
     "role": "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
     "shortName": "EQUITY - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iae305004534c4cae8e7485e4dc74784a_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471441 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - ALLIANCES",
     "role": "http://www.bms.com/role/ALLIANCES",
     "shortName": "ALLIANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472442 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i6d46fefd70244503bf70ff1057422f86_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475443 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "iac24c3928a0f4e23b4320f17b889c321_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476444 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "ib14db07cad634bdeab72fe1703bc1d56_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i0bc4aed180144198bb9d2155f7e854fe_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477445 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i0bc4aed180144198bb9d2155f7e854fe_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i18f9080b9c994fa291b5e12c3b4813d0_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479446 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i18f9080b9c994fa291b5e12c3b4813d0_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS",
     "role": "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS",
     "shortName": "ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220930.htm",
      "contextRef": "i80ec74c427f849589681e2b3cded2642_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 130,
   "tag": {
    "bmy_A1.000Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One000NotesDue2025Member",
        "label": "1.000% Notes due 2025 [Member]",
        "terseLabel": "1.000% Notes due 2025"
       }
      }
     },
     "localname": "A1.000Notesdue2025Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1.5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1.5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.750Notesdue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One750NotesDue2035Member",
        "label": "1.750% Notes due 2035 [Member]",
        "terseLabel": "1.750% Notes due 2035"
       }
      }
     },
     "localname": "A1.750Notesdue2035Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2.600Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.600% Notes due 2022 [Member]",
        "label": "2.600% Notes due 2022 [Member]",
        "terseLabel": "2.600% Notes due 2022"
       }
      }
     },
     "localname": "A2.600Notesdue2022Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2.875SeniorNotesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% Senior Notes due 2021 [Member]",
        "label": "2.875% Senior Notes due 2021 [Member]",
        "terseLabel": "2.875% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2.875SeniorNotesdue2021Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2000NotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.000% Notes due 2022",
        "label": "2.000% Notes due 2022 [Member]",
        "terseLabel": "2.000% Notes due 2022"
       }
      }
     },
     "localname": "A2000NotesDue2022Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2019ASRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 ASR [Member]",
        "label": "2019 ASR [Member]",
        "terseLabel": "2019 ASR"
       }
      }
     },
     "localname": "A2019ASRMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2022ASRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 ASR",
        "label": "2022 ASR [Member]",
        "terseLabel": "2022 ASR"
       }
      }
     },
     "localname": "A2022ASRMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2250SeniorNotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.250% Senior Notes due 2021",
        "label": "2.250% Senior Notes due 2021 [Member]",
        "terseLabel": "2.250% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2250SeniorNotesDue2021Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2550SeniorNotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.550% Senior Notes due 2021",
        "label": "2.550% Senior Notes due 2021 [Member]",
        "terseLabel": "2.550% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2550SeniorNotesDue2021Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2 Billion Maximum Borrowing Capacity [Member]",
        "label": "$2 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$2 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A2BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A3250BondsDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.250% Bonds due 2022",
        "label": "3.250% Bonds due 2022 [Member]",
        "terseLabel": "3.250% Bonds due 2022"
       }
      }
     },
     "localname": "A3250BondsDue2022Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A3550BondsDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.550% Bonds due 2022",
        "label": "3.550% Bonds due 2022 [Member]",
        "terseLabel": "3.550% Bonds due 2022"
       }
      }
     },
     "localname": "A3550BondsDue2022Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$5 Billion Maximum Borrowing Capacity",
        "label": "$5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ALLIANCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALLIANCES [Abstract]",
        "label": "ALLIANCES [Abstract]",
        "terseLabel": "ALLIANCES [Abstract]"
       }
      }
     },
     "localname": "ALLIANCESAbstract",
     "nsuri": "http://www.bms.com/20220930",
     "xbrltype": "stringItemType"
    },
    "bmy_AbecmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abecma",
        "label": "Abecma [Member]",
        "terseLabel": "Abecma"
       }
      }
     },
     "localname": "AbecmaMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability Litigation",
        "label": "Abilify Product Liability Litigation [Member]",
        "terseLabel": "Abilify Product Liability Litigation"
       }
      }
     },
     "localname": "AbilifyProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability [Member]",
        "label": "Abilify Product Liability [Member]",
        "terseLabel": "Abilify Product Liability"
       }
      }
     },
     "localname": "AbilifyProductLiabilityMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbraxaneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abraxane [Member]",
        "label": "Abraxane [Member]",
        "terseLabel": "Abraxane"
       }
      }
     },
     "localname": "AbraxaneMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AcceleratedStockBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Stock Based Compensation [Member]",
        "label": "Accelerated Stock Based Compensation [Member]",
        "terseLabel": "Accelerated Stock Based Compensation"
       }
      }
     },
     "localname": "AcceleratedStockBasedCompensationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest",
        "label": "Accrued Interest",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedRebatesAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.",
        "label": "Accrued rebates and returns",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "AccruedRebatesAndReturns",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.",
        "label": "Accrued Research And Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquiredIPRD": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired IPRD",
        "label": "Acquired IPRD",
        "terseLabel": "Acquired IPRD"
       }
      }
     },
     "localname": "AcquiredIPRD",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquisitionsDivestituresandOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "label": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "terseLabel": "Acquisitions, Divestitures and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "AcquisitionsDivestituresandOtherArrangementsAbstract",
     "nsuri": "http://www.bms.com/20220930",
     "xbrltype": "stringItemType"
    },
    "bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "label": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "terseLabel": "Adjustments for provisions for product sales made in prior periods"
       }
      }
     },
     "localname": "AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AgenusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agenus",
        "label": "Agenus [Member]",
        "terseLabel": "Agenus"
       }
      }
     },
     "localname": "AgenusMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AllianceandotherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliance and other revenues [Member]",
        "label": "Alliance and other revenues [Member]",
        "terseLabel": "Alliance and other revenues"
       }
      }
     },
     "localname": "AllianceandotherrevenuesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AlliancesAndCollaborationCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliances And Collaboration Companies",
        "label": "Alliances And Collaboration Companies [Axis]",
        "terseLabel": "Alliances And Collaboration Companies [Axis]"
       }
      }
     },
     "localname": "AlliancesAndCollaborationCompaniesAxis",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_AlliancesAndCollaborationCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliances and Collaboration Companies",
        "label": "Alliances and Collaboration Companies [Domain]",
        "terseLabel": "Alliances and Collaboration Companies [Domain]"
       }
      }
     },
     "localname": "AlliancesAndCollaborationCompaniesDomain",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AmortizationOfDeferredIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 3.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of deferred income",
        "label": "Amortization of deferred income",
        "negatedTerseLabel": "Amortization of deferred income"
       }
      }
     },
     "localname": "AmortizationOfDeferredIncome",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AmortizationofAcquiredIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Acquired Intangible Assets",
        "label": "Amortization of Acquired Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationofAcquiredIntangibleAssets",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AntiPD1AntibodyLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti-PD-1 Antibody Litigation [Member]",
        "label": "Anti-PD-1 Antibody Litigation [Member]",
        "terseLabel": "Anti-PD-1 Antibody Litigation"
       }
      }
     },
     "localname": "AntiPD1AntibodyLitigationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BiohavenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biohaven",
        "label": "Biohaven [Member]",
        "terseLabel": "Biohaven"
       }
      }
     },
     "localname": "BiohavenMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BreyanziMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breyanzi",
        "label": "Breyanzi [Member]",
        "terseLabel": "Breyanzi"
       }
      }
     },
     "localname": "BreyanziMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BridgeBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BridgeBio",
        "label": "BridgeBio [Member]",
        "terseLabel": "BridgeBio"
       }
      }
     },
     "localname": "BridgeBioMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BristolMyersSquibbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bristol-Myers Squibb",
        "label": "Bristol-Myers Squibb [Member]",
        "terseLabel": "Bristol-Myers Squibb"
       }
      }
     },
     "localname": "BristolMyersSquibbMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CARTKiteLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAR T Kite Litigation [Member]",
        "label": "CAR T Kite Litigation [Member]",
        "terseLabel": "CAR T Kite Litigation"
       }
      }
     },
     "localname": "CARTKiteLitigationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CamzyosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Camzyos",
        "label": "Camzyos [Member]",
        "terseLabel": "Camzyos"
       }
      }
     },
     "localname": "CamzyosMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CashDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reductions to trade receivables incurred during the period attributable to cash discounts.",
        "label": "Cash Discounts",
        "negatedTerseLabel": "Less: Charge-backs and cash discounts"
       }
      }
     },
     "localname": "CashDiscounts",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Cashoutlays": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outlays",
        "label": "Cash outlays",
        "terseLabel": "Cash outlays"
       }
      }
     },
     "localname": "Cashoutlays",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CelgeneContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Contingent Value Rights [Member]",
        "label": "Celgene Contingent Value Rights [Member]",
        "terseLabel": "Celgene Contingent Value Rights"
       }
      }
     },
     "localname": "CelgeneContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CelgeneIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Integration [Member]",
        "label": "Celgene Integration [Member]",
        "terseLabel": "Celgene Acquisition Plan"
       }
      }
     },
     "localname": "CelgeneIntegrationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ChargebacksandcashdiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charge-backs and cash discounts [Member]",
        "label": "Charge-backs and cash discounts [Member]",
        "terseLabel": "Charge-backs and cash discounts"
       }
      }
     },
     "localname": "ChargebacksandcashdiscountsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CheplapharmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cheplapharm",
        "label": "Cheplapharm [Member]",
        "terseLabel": "Cheplapharm"
       }
      }
     },
     "localname": "CheplapharmMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CommonStock0.10ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CommonStock010ParValueMember",
        "label": "Common Stock $0.10 Par Value [Member]",
        "terseLabel": "Common Stock $0.10 Par Value"
       }
      }
     },
     "localname": "CommonStock0.10ParValueMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ConsiderationForContingentDevelopmentAndRegulatoryApproval": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.",
        "label": "Consideration for Contingent Development and Regulatory Approval",
        "terseLabel": "Consideration for contingent development and regulatory approval"
       }
      }
     },
     "localname": "ConsiderationForContingentDevelopmentAndRegulatoryApproval",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentAndRegulatoryMilestoneNonCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone, Non-Cash",
        "label": "Contingent and Regulatory Milestone, Non-Cash",
        "terseLabel": "Contingent and regulatory milestone"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestoneNonCash",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentAndRegulatoryMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone Payments",
        "label": "Contingent and Regulatory Milestone Payments",
        "terseLabel": "Contingent and regulatory milestone payments"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestonePayments",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentRegulatoryMilestoneIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 2.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Regulatory Milestone Income",
        "label": "Contingent Regulatory Milestone Income",
        "negatedTerseLabel": "Contingent milestone income"
       }
      }
     },
     "localname": "ContingentRegulatoryMilestoneIncome",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BMY Contingent Value Rights [Member]",
        "label": "Contingent Value Rights [Member]",
        "terseLabel": "Contingent value rights"
       }
      }
     },
     "localname": "ContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DiabetesbusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes business [Member]",
        "label": "Diabetes business [Member]",
        "terseLabel": "Diabetes Business"
       }
      }
     },
     "localname": "DiabetesbusinessMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Divestitureandotherproceeds": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.",
        "label": "Divestiture and other proceeds",
        "terseLabel": "Divestiture and other proceeds"
       }
      }
     },
     "localname": "Divestitureandotherproceeds",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Divestituregainsandroyalties": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the amount of gains and royalties as a result of business divestitures.",
        "label": "Divestiture gains and royalties",
        "negatedTerseLabel": "Divestiture gains and royalties"
       }
      }
     },
     "localname": "Divestituregainsandroyalties",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_DragonflyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dragonfly",
        "label": "Dragonfly [Member]",
        "terseLabel": "Dragonfly"
       }
      }
     },
     "localname": "DragonflyMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "terseLabel": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_EisaiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eisai",
        "label": "Eisai [Member]",
        "terseLabel": "Eisai"
       }
      }
     },
     "localname": "EisaiMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EliquisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliquis [Member]",
        "terseLabel": "Eliquis"
       }
      }
     },
     "localname": "EliquisMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EmplicitiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Empliciti [Member]",
        "label": "Empliciti [Member]",
        "terseLabel": "Empliciti"
       }
      }
     },
     "localname": "EmplicitiMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments",
        "label": "Equity investments",
        "totalLabel": "Total equity investments"
       }
      }
     },
     "localname": "EquityInvestments",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - current",
        "label": "Equity investments - current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsCurrent",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - non-current",
        "label": "Equity investments - non-current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsNonCurrent",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity [Line Items]",
        "label": "Equity [Line Items]",
        "terseLabel": "Equity [Line Items]",
        "verboseLabel": "Equity [Line Items]"
       }
      }
     },
     "localname": "EquityLineItems",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_EquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity",
        "label": "Equity [Table]",
        "terseLabel": "Equity [Table]"
       }
      }
     },
     "localname": "EquityTable",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_ExpectedSynergiesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Synergies, Percentage",
        "label": "Expected Synergies, Percentage",
        "terseLabel": "Expected synergies, percentage"
       }
      }
     },
     "localname": "ExpectedSynergiesPercentage",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bmy_FloatingRateNotesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes due 2022 [Member]",
        "label": "Floating Rate Notes due 2022 [Member]",
        "terseLabel": "Floating Rate Notes due 2022"
       }
      }
     },
     "localname": "FloatingRateNotesdue2022Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_GrosstoNetAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments",
        "label": "Gross to Net Adjustments",
        "negatedTerseLabel": "Gross to Net Adjustments"
       }
      }
     },
     "localname": "GrosstoNetAdjustments",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_GrosstoNetAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Axis]",
        "terseLabel": "Gross to Net Adjustments [Axis]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsAxis",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Domain]",
        "terseLabel": "Gross to Net Adjustments [Domain]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsDomain",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_GrosstoNetAdjustmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Gross to Net Adjustments [Table]",
        "label": "Gross to Net Adjustments [Line Items]",
        "terseLabel": "Gross to Net Adjustments [Line Items]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsLineItems",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_ImmaticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immatics",
        "label": "Immatics [Member]",
        "terseLabel": "Immatics"
       }
      }
     },
     "localname": "ImmaticsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InLineProductsAndNewProductPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-line products and new product portfolio",
        "label": "In-line products and new product portfolio [Member]",
        "terseLabel": "Total In-Line Products and New Product Portfolio"
       }
      }
     },
     "localname": "InLineProductsAndNewProductPortfolioMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InLineProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-line products",
        "label": "In-line products [Member]",
        "terseLabel": "Total In-Line Products"
       }
      }
     },
     "localname": "InLineProductsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InrebicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inrebic [Member]",
        "label": "Inrebic [Member]",
        "terseLabel": "Inrebic"
       }
      }
     },
     "localname": "InrebicMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_IntangibleAssetNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Axis]",
        "terseLabel": "Intangible Asset Name [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetNameAxis",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_IntangibleAssetNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Domain]",
        "terseLabel": "Intangible Asset Name [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetNameDomain",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InventoryPurchasePriceFairValueAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Purchase Price Fair Value Adjustment",
        "label": "Inventory Purchase Price Fair Value Adjustment [Member]",
        "terseLabel": "Inventory Purchase Price Fair Value Adjustment"
       }
      }
     },
     "localname": "InventoryPurchasePriceFairValueAdjustmentMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_KeytrudaRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Keytruda Royalties",
        "label": "Keytruda Royalties [Member]",
        "terseLabel": "Keytruda Royalties"
       }
      }
     },
     "localname": "KeytrudaRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LOEProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOE products",
        "label": "LOE products [Member]",
        "terseLabel": "Total Recent LOE Products"
       }
      }
     },
     "localname": "LOEProductsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LOTTECorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOTTE Corporation",
        "label": "LOTTE Corporation [Member]",
        "terseLabel": "LOTTE Corporation"
       }
      }
     },
     "localname": "LOTTECorporationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LegalProceedingsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Proceedings And Contingencies [Line Items]",
        "terseLabel": "Legal Proceedings And Contingencies [Line Items]"
       }
      }
     },
     "localname": "LegalProceedingsAndContingenciesLineItems",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicenseAndOtherArrangementsUpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and Other Arrangements Upfront Payments",
        "label": "License and Other Arrangements Upfront Payments",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "localname": "LicenseAndOtherArrangementsUpfrontPayments",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Axis]",
        "terseLabel": "Licensing and Other Arrangements [Axis]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsAxis",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingAndOtherArrangementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Domain]",
        "terseLabel": "Licensing and Other Arrangements [Domain]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsDomain",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LicensingAndOtherArrangementsIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements Income",
        "label": "Licensing and Other Arrangements Income",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsIncome",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Table Text Block]",
        "terseLabel": "Licensing and Other Arrangements"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsTableTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_LicensingArrangementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements",
        "label": "Licensing Arrangements [Line Items]",
        "terseLabel": "Licensing Arrangements [Line Items]"
       }
      }
     },
     "localname": "LicensingArrangementsLineItems",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingArrangementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements [Table]",
        "label": "Licensing Arrangements [Table]",
        "terseLabel": "Licensing Arrangements [Table]"
       }
      }
     },
     "localname": "LicensingArrangementsTable",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LitigationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation [Table]",
        "terseLabel": "Litigation [Table]"
       }
      }
     },
     "localname": "LitigationTable",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LongTermDebtRenewalPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Renewal Period",
        "label": "Long-term Debt, Renewal Period",
        "terseLabel": "Renewal period"
       }
      }
     },
     "localname": "LongTermDebtRenewalPeriod",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bmy_LossContingencyNumberOfPlaintiffsDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Plaintiffs, Dismissed",
        "label": "Loss Contingency, Number of Plaintiffs, Dismissed",
        "terseLabel": "Number of plaintiffs, dismissed cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffsDismissed",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberActive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Active",
        "label": "Loss Contingency, Pending Claims, Number, Active",
        "terseLabel": "Pending claims, active"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberActive",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberClassAction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Class Action",
        "label": "Loss Contingency, Pending Claims, Number, Class Action",
        "terseLabel": "Class action claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberClassAction",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Dismissed",
        "label": "Loss Contingency, Pending Claims, Number, Dismissed",
        "terseLabel": "Dismissed cases"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberDismissed",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "label": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "terseLabel": "Individual injury claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberIndividualInjuryClaims",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_MarketShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market share units [Member]",
        "terseLabel": "Market share units"
       }
      }
     },
     "localname": "MarketShareUnitsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureAndOtherBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature and Other Brands",
        "label": "Mature and Other Brands [Member]",
        "terseLabel": "Mature and other products"
       }
      }
     },
     "localname": "MatureAndOtherBrandsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureBrandsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature Brands and Other",
        "label": "Mature Brands and Other [Member]",
        "terseLabel": "Mature Products and Other"
       }
      }
     },
     "localname": "MatureBrandsAndOtherMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MedicaidandMedicarerebatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Medicare rebates [Member]",
        "label": "Medicaid and Medicare rebates [Member]",
        "terseLabel": "Medicaid and Medicare rebates"
       }
      }
     },
     "localname": "MedicaidandMedicarerebatesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MyoKardiaAcquisitionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MyoKardia Acquisition Plan",
        "label": "MyoKardia Acquisition Plan [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "MyoKardiaAcquisitionPlanMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NetproductsalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net product sales [Member]",
        "label": "Net product sales [Member]",
        "terseLabel": "Net product sales"
       }
      }
     },
     "localname": "NetproductsalesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NewProductPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New product portfolio",
        "label": "New product portfolio [Member]",
        "terseLabel": "Total New Product Portfolio"
       }
      }
     },
     "localname": "NewProductPortfolioMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NoteDue2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Due 2032",
        "label": "Note Due 2032 [Member]",
        "terseLabel": "Note Due 2032"
       }
      }
     },
     "localname": "NoteDue2032Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NoteDue2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Due 2042",
        "label": "Note Due 2042 [Member]",
        "terseLabel": "Note Due 2042"
       }
      }
     },
     "localname": "NoteDue2042Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NoteDue2052Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Due 2052",
        "label": "Note Due 2052 [Member]",
        "terseLabel": "Note Due 2052"
       }
      }
     },
     "localname": "NoteDue2052Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NoteDue2062Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Due 2062",
        "label": "Note Due 2062 [Member]",
        "terseLabel": "Note Due 2062"
       }
      }
     },
     "localname": "NoteDue2062Member",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NumberOfLargestPharmaceuticalWholesalers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of the largest pharmaceutical wholesalers used by the company in the territory.",
        "label": "Number Of Largest Pharmaceutical Wholesalers",
        "terseLabel": "Number of largest pharmaceutical wholesalers"
       }
      }
     },
     "localname": "NumberOfLargestPharmaceuticalWholesalers",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_NumberofRevolvingCreditFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Number of Revolving Credit Facilities",
        "terseLabel": "Number of revolving credit facilities"
       }
      }
     },
     "localname": "NumberofRevolvingCreditFacilities",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_OnglyzaProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onglyza Product Liability Litigation",
        "label": "Onglyza Product Liability Litigation [Member]",
        "terseLabel": "Onglyza Product Liability Litigation"
       }
      }
     },
     "localname": "OnglyzaProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OnuregMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onureg",
        "label": "Onureg [Member]",
        "terseLabel": "Onureg"
       }
      }
     },
     "localname": "OnuregMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdivoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Opdivo [Member]",
        "terseLabel": "Opdivo"
       }
      }
     },
     "localname": "OpdivoMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdualagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opdualag",
        "label": "Opdualag [Member]",
        "terseLabel": "Opdualag"
       }
      }
     },
     "localname": "OpdualagMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OrenciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Orencia [Member]",
        "terseLabel": "Orencia"
       }
      }
     },
     "localname": "OrenciaMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherIncomeReceivedFromAlliancePartners": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.",
        "label": "Other Income Received From Alliance Partners",
        "negatedTerseLabel": "Royalties and licensing income"
       }
      }
     },
     "localname": "OtherIncomeReceivedFromAlliancePartners",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.",
        "label": "Other Other Income Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherOtherIncomeExpense",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Region [Member]",
        "terseLabel": "Other Region"
       }
      }
     },
     "localname": "OtherRegionMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Royalties",
        "label": "Other Royalties [Member]",
        "terseLabel": "Other Royalties"
       }
      }
     },
     "localname": "OtherRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherShutdownCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other shutdown costs",
        "label": "Other shutdown costs",
        "terseLabel": "Other shutdown costs, net"
       }
      }
     },
     "localname": "OtherShutdownCosts",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherrebatesreturnsdiscountsandadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other rebates, returns, discounts and adjustments [Member]",
        "label": "Other rebates, returns, discounts and adjustments [Member]",
        "terseLabel": "Other rebates, returns, discounts and adjustments"
       }
      }
     },
     "localname": "OtherrebatesreturnsdiscountsandadjustmentsMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues [Member]",
        "label": "Other revenues [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherrevenuesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PaymentToExtinguishFutureRoyaltyObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment To Extinguish Future Royalty Obligation",
        "label": "Payment To Extinguish Future Royalty Obligation",
        "terseLabel": "Payment to extinguish future royalty obligation"
       }
      }
     },
     "localname": "PaymentToExtinguishFutureRoyaltyObligation",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_PercentageOfAggregateTotalTradeReceivablesDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.",
        "label": "Percentage Of Aggregate Total Trade Receivables Due",
        "terseLabel": "Percent of aggregate total trade receivables due from three pharmaceutical wholesalers"
       }
      }
     },
     "localname": "PercentageOfAggregateTotalTradeReceivablesDue",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_PlavixAustraliaIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Australia Intellectual Property [Member]",
        "label": "Plavix Australia Intellectual Property [Member]",
        "terseLabel": "Plavix Australia Intellectual Property"
       }
      }
     },
     "localname": "PlavixAustraliaIntellectualPropertyMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PomalystImnovidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pomalyst/Imnovid [Member]",
        "label": "Pomalyst/Imnovid [Member]",
        "terseLabel": "Pomalyst/Imnovid"
       }
      }
     },
     "localname": "PomalystImnovidMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReblozylMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reblozyl [Member]",
        "label": "Reblozyl [Member]",
        "terseLabel": "Reblozyl"
       }
      }
     },
     "localname": "ReblozylMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReceivablesSoldOnNonrecourseBasis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables sold on a nonrecourse basis during the year.",
        "label": "Receivables Sold On Nonrecourse Basis",
        "terseLabel": "Non-U.S. receivables sold on a nonrecourse basis"
       }
      }
     },
     "localname": "ReceivablesSoldOnNonrecourseBasis",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "label": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "terseLabel": "Revenue Recognition Gross-To-Net Adjustments"
       }
      }
     },
     "localname": "ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ResearchAndDevelopmentNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development - Non-Current",
        "label": "Research and development - Non-Current",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentNonCurrent",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ResearchandDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development",
        "label": "Research and Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchandDevelopment",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance",
        "label": "Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance",
        "terseLabel": "Expected cost savings and avoidance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "label": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesExcludingAcceleratedStockbasedCompensation",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringRelatedCostsAssetImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related Costs, Asset Impairments",
        "label": "Restructuring Related Costs, Asset Impairments",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "RestructuringRelatedCostsAssetImpairments",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RevlimidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revlimid [Member]",
        "label": "Revlimid [Member]",
        "terseLabel": "Revlimid"
       }
      }
     },
     "localname": "RevlimidMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_RoyaltyGuaranteesCommitmentsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Guarantees Commitments, Percent",
        "label": "Royalty Guarantees Commitments, Percent",
        "terseLabel": "Running royalty"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercent",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bmy_SalesRevenueGrossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross [Member]",
        "label": "Sales Revenue, Gross [Member]",
        "terseLabel": "Gross product sales"
       }
      }
     },
     "localname": "SalesRevenueGrossMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ScheduleOfEquityInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Equity Investments",
        "label": "Schedule of Equity Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfEquityInvestmentsTableTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfOtherIncomeExpenseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Income Expense [Text Block]",
        "terseLabel": "Schedule Of Other Income Expense"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeExpenseTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Schedule of Provision for Income Taxes [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfProvisionForIncomeTaxesTableTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Schedule Of Share Based Compensation Additional Information [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation Additional Information"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.",
        "label": "Selling, General and Administrative Expense - Collaborative Arrangement",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralandAdministrativeExpenseCollaborativeArrangement",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_SotyktuMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sotyktu",
        "label": "Sotyktu [Member]",
        "terseLabel": "Sotyktu"
       }
      }
     },
     "localname": "SotyktuMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SprycelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sprycel [Member]",
        "terseLabel": "Sprycel"
       }
      }
     },
     "localname": "SprycelMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SupplementalFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Financial Information [Abstract]",
        "label": "Supplemental Financial Information [Abstract]",
        "terseLabel": "Supplemental Financial Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalFinancialInformationAbstract",
     "nsuri": "http://www.bms.com/20220930",
     "xbrltype": "stringItemType"
    },
    "bmy_TecentriqRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tecentriq royalties",
        "label": "Tecentriq royalties [Member]",
        "terseLabel": "Tecentriq royalties"
       }
      }
     },
     "localname": "TecentriqRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Totalinventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the total inventory, current and non-current, as of the balance sheet date.",
        "label": "Total inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "Totalinventories",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_TurningPointMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Turning Point",
        "label": "Turning Point [Member]",
        "terseLabel": "Turning Point"
       }
      }
     },
     "localname": "TurningPointMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_UnamortizedBasisAdjustmentFromSwapTerminations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.",
        "label": "Unamortized Basis Adjustment From Swap Terminations",
        "terseLabel": "Unamortized basis adjustment from swap terminations"
       }
      }
     },
     "localname": "UnamortizedBasisAdjustmentFromSwapTerminations",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UpfrontPaymentsMadeToCollaborativePartner": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payments made to partner as part of collaborative arrangement.",
        "label": "Upfront Payments Made To Collaborative Partner",
        "terseLabel": "Upfront payments made to collaborative partner"
       }
      }
     },
     "localname": "UpfrontPaymentsMadeToCollaborativePartner",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_YervoyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yervoy [Member]",
        "terseLabel": "Yervoy"
       }
      }
     },
     "localname": "YervoyMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ZeposiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zeposia",
        "label": "Zeposia [Member]",
        "terseLabel": "Zeposia"
       }
      }
     },
     "localname": "ZeposiaMember",
     "nsuri": "http://www.bms.com/20220930",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "terseLabel": "Australia, Dollars"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "Currency [Domain]",
        "verboseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r85",
      "r87",
      "r163",
      "r164",
      "r357",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r334",
      "r336",
      "r337",
      "r338",
      "r356",
      "r381",
      "r442",
      "r444",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r643",
      "r705",
      "r708",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r334",
      "r336",
      "r337",
      "r338",
      "r356",
      "r381",
      "r442",
      "r444",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r643",
      "r705",
      "r708",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r240",
      "r336",
      "r337",
      "r415",
      "r418",
      "r645",
      "r704",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r240",
      "r336",
      "r337",
      "r415",
      "r418",
      "r645",
      "r704",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r314",
      "r334",
      "r336",
      "r337",
      "r338",
      "r356",
      "r381",
      "r430",
      "r442",
      "r444",
      "r469",
      "r470",
      "r471",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r643",
      "r705",
      "r708",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r314",
      "r334",
      "r336",
      "r337",
      "r338",
      "r356",
      "r381",
      "r430",
      "r442",
      "r444",
      "r469",
      "r470",
      "r471",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r643",
      "r705",
      "r708",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r86",
      "r87",
      "r163",
      "r164",
      "r357",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r241",
      "r242",
      "r415",
      "r419",
      "r707",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r241",
      "r242",
      "r415",
      "r419",
      "r707",
      "r718",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Account Receivables [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r68",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts payable \u2013 to alliance partners"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r22",
      "r48",
      "r244",
      "r245"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Net trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r40",
      "r655",
      "r680"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r43",
      "r655",
      "r680"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r661",
      "r692"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued Liabilities",
        "terseLabel": "Accrued liabilities for CERCLA matters"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r27",
      "r73"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r32",
      "r306"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r95",
      "r100",
      "r439"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r89",
      "r97",
      "r99",
      "r100",
      "r582"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r52",
      "r97",
      "r99",
      "r100",
      "r685",
      "r713",
      "r714"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r96",
      "r100",
      "r109",
      "r110",
      "r111",
      "r167",
      "r168",
      "r169",
      "r542",
      "r609",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Supplemental Financial Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r50",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value of stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r480",
      "r481",
      "r482",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital\u00a0in Excess of Par Value of\u00a0Stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r56",
      "r246",
      "r267"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Less: Allowance for expected credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r150",
      "r288",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Asset Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Asset Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about contingent consideration in asset acquisition.",
        "label": "Asset Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Asset Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r150",
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r36",
      "r159",
      "r222",
      "r232",
      "r238",
      "r265",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r537",
      "r543",
      "r587",
      "r610",
      "r612",
      "r653",
      "r679"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r25",
      "r65",
      "r159",
      "r265",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r537",
      "r543",
      "r587",
      "r610",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r13",
      "r15",
      "r18",
      "r303",
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r252",
      "r273"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r249",
      "r253",
      "r273",
      "r660"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable debt securities, fair value",
        "verboseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r552",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r441",
      "r443",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r441",
      "r443",
      "r509",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r518",
      "r519",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration to be allocated"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Unvested Stock Awards"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r149",
      "r524"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration fair value adjustments",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r517",
      "r520",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Integration expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r511",
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r511",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r511",
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total consideration allocated"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r20",
      "r29",
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents - money market and other securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r145",
      "r152",
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Period",
        "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r145",
      "r591"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r156",
      "r159",
      "r183",
      "r187",
      "r188",
      "r190",
      "r192",
      "r200",
      "r201",
      "r202",
      "r265",
      "r342",
      "r346",
      "r347",
      "r348",
      "r351",
      "r352",
      "r379",
      "r380",
      "r384",
      "r388",
      "r395",
      "r587",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "terseLabel": "Collaboration Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r527",
      "r528",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Alliances"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Alliance revenues"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Alliance Statement [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r78",
      "r662",
      "r691"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r167",
      "r168",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r47",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r105",
      "r107",
      "r108",
      "r121",
      "r669",
      "r699"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income Attributable to BMS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r107",
      "r120",
      "r535",
      "r536",
      "r547",
      "r668",
      "r698"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling Interest",
        "verboseLabel": "Comprehensive Income Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r107",
      "r119",
      "r534",
      "r547",
      "r667",
      "r697"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r289",
      "r293",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r243",
      "r584",
      "r585",
      "r716",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r207",
      "r209",
      "r210",
      "r211",
      "r584",
      "r586",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r209",
      "r210",
      "r243",
      "r584",
      "r585",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r404",
      "r405",
      "r416"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Performance obligation satisfied in previous period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Obligation to holders of the contingent value rights"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r431",
      "r440",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r125",
      "r645"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r431",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-currency interest rate swap contracts"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r208",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "verboseLabel": "Short-term debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r38",
      "r40",
      "r42",
      "r158",
      "r165",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r373",
      "r374",
      "r375",
      "r376",
      "r605",
      "r654",
      "r656",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r42",
      "r371",
      "r656",
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r353",
      "r373",
      "r374",
      "r603",
      "r605",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal Value",
        "verboseLabel": "Principal value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r362",
      "r373",
      "r374",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r75",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rates"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r76",
      "r158",
      "r165",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r373",
      "r374",
      "r375",
      "r376",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r76",
      "r158",
      "r165",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r373",
      "r374",
      "r375",
      "r376",
      "r396",
      "r397",
      "r398",
      "r399",
      "r602",
      "r603",
      "r605",
      "r606",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSIssuanceofDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r360",
      "r602",
      "r606"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized bond discounts and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r360",
      "r602",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Unamortized purchase price adjustments of Celgene debt"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Reasonably possible decrease in unrecognized tax benefits"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncome": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Income",
        "terseLabel": "Deferred income from alliances"
       }
      }
     },
     "localname": "DeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeNoncurrent": {
     "auth_ref": [
      "r340"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Income, Noncurrent",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredIncomeNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r486",
      "r487"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r150",
      "r160",
      "r494",
      "r499",
      "r500",
      "r501"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r486",
      "r487"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r440",
      "r652",
      "r678"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r150",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r150",
      "r219"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization, net"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r83",
      "r84",
      "r87",
      "r583"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Variable rate debt, lower range of basis point spread"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain (loss) on derivative, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r87",
      "r553",
      "r556",
      "r561",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r551",
      "r553",
      "r561",
      "r565",
      "r566",
      "r568",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r83",
      "r84",
      "r87",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Fair value of interest rate swap contracts",
        "verboseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r446",
      "r447",
      "r475",
      "r476",
      "r478",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Employee Stock Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r5",
      "r6",
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sales price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r150",
      "r302",
      "r308"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedLabel": "Divestiture (Gains)/Losses",
        "negatedTerseLabel": "Divestiture losses/(gains)",
        "terseLabel": "Divestiture gain"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r400",
      "r674"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Distributions"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r122",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r181",
      "r183",
      "r190",
      "r191",
      "r192",
      "r196",
      "r197",
      "r574",
      "r575",
      "r670",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per common share attributable to BMS, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r122",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r183",
      "r190",
      "r191",
      "r192",
      "r196",
      "r197",
      "r574",
      "r575",
      "r670",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per common share attributable to BMS, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Excess tax benefits from share-based compensation awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r109",
      "r110",
      "r111",
      "r167",
      "r168",
      "r169",
      "r171",
      "r177",
      "r179",
      "r199",
      "r266",
      "r395",
      "r400",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r573",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r609",
      "r709",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r30",
      "r223",
      "r263"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 2.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Limited partnerships and other equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFVNIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI [Abstract]",
        "terseLabel": "Equity investments with readily determined fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r23",
      "r39",
      "r581"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 1.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity investments",
        "verboseLabel": "Equity investments with readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r262",
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "negatedTerseLabel": "Net (gain)/loss recognized on investments sold"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r262",
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Net loss/(gain) recognized"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r259"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 3.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "terseLabel": "Impairments and downward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "terseLabel": "Cumulative impairments and downward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "negatedTerseLabel": "Upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "negatedTerseLabel": "Cumulative upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r576",
      "r577",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r362",
      "r373",
      "r374",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r577",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r362",
      "r431",
      "r432",
      "r437",
      "r440",
      "r577",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r362",
      "r373",
      "r374",
      "r431",
      "r432",
      "r437",
      "r440",
      "r577",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r362",
      "r373",
      "r374",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r577",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r362",
      "r373",
      "r374",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r552",
      "r558",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r370",
      "r393",
      "r571",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r34",
      "r294"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r289",
      "r291",
      "r294",
      "r297",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r289",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r294",
      "r646"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Derivatives [Abstract]",
        "terseLabel": "Foreign currency forward contracts gain/(loss):"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transaction [Abstract]",
        "terseLabel": "Cross-currency interest rate swap contracts gain:"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r127",
      "r150",
      "r251"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Equity investment losses/(income)"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation and other settlements"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r150",
      "r377",
      "r378"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt redemption"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralCashFlowHedgeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Cash Flow Hedge Information [Abstract]",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "GeneralCashFlowHedgeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r33",
      "r282",
      "r283",
      "r284",
      "r286",
      "r612",
      "r651"
     ],
     "calculation": {
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r551",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r150",
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of other intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r150",
      "r300"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r115",
      "r222",
      "r231",
      "r234",
      "r237",
      "r239",
      "r648",
      "r664",
      "r672",
      "r702"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings Before Income Taxes",
        "totalLabel": "Earnings Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r116",
      "r150",
      "r220",
      "r263",
      "r663",
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net loss/(income) of affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r16",
      "r17",
      "r18",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r309",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r490",
      "r492",
      "r493",
      "r497",
      "r502",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r178",
      "r179",
      "r221",
      "r488",
      "r498",
      "r504",
      "r703"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r192",
      "r445"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Incremental Shares Attributable to Share-Based Compensation Plans (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r287",
      "r292"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r113",
      "r218",
      "r601",
      "r604",
      "r671"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r141",
      "r146",
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r57",
      "r278"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r21",
      "r62",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Other non-current assets",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r62",
      "r278"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw and packaging materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r58",
      "r278"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Non-derivatives qualifying as net investment hedges"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings and Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r72",
      "r159",
      "r233",
      "r265",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r538",
      "r543",
      "r544",
      "r587",
      "r610",
      "r611"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r55",
      "r159",
      "r265",
      "r587",
      "r612",
      "r659",
      "r688"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r26",
      "r74",
      "r159",
      "r265",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r538",
      "r543",
      "r544",
      "r587",
      "r610",
      "r611",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r13",
      "r15",
      "r18",
      "r303",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r42",
      "r361",
      "r372",
      "r373",
      "r374",
      "r656",
      "r682"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-Term Debt, Term",
        "terseLabel": "Long-term debt, term (in years)"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r332",
      "r333",
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Damages paid"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r332",
      "r333",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery, equipment and fixtures"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r19",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r82",
      "r159",
      "r265",
      "r342",
      "r346",
      "r347",
      "r348",
      "r351",
      "r352",
      "r587",
      "r658",
      "r687"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NameOfReportingCategoryDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of reporting category or type of financial instrument.",
        "label": "Name of Reporting Category [Domain]",
        "terseLabel": "Name of Reporting Category [Domain]"
       }
      }
     },
     "localname": "NameOfReportingCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used in Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r145",
      "r148",
      "r151"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r103",
      "r106",
      "r111",
      "r117",
      "r151",
      "r159",
      "r170",
      "r172",
      "r173",
      "r174",
      "r175",
      "r178",
      "r179",
      "r189",
      "r222",
      "r231",
      "r234",
      "r237",
      "r239",
      "r265",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r575",
      "r587",
      "r665",
      "r695"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net Earnings Attributable to BMS",
        "verboseLabel": "Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r400",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r608"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r608"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r607"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r166",
      "r180",
      "r215",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r64",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r552",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets",
        "totalLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r94",
      "r97",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Actuarial gains/(losses), after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Actuarial gains/(losses), tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax": {
     "auth_ref": [
      "r98",
      "r534"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax",
        "negatedTerseLabel": "Settlements, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r90",
      "r97",
      "r588",
      "r589",
      "r592"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation",
        "verboseLabel": "Foreign currency translation, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r89",
      "r97",
      "r588",
      "r589",
      "r592"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in Other Comprehensive Income",
        "verboseLabel": "Foreign currency translation, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r92",
      "r93",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Unrealized (losses)/gains, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r92",
      "r93",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Marketable debt securities",
        "verboseLabel": "Unrealized (losses)/gains, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r92",
      "r93",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "negatedTerseLabel": "Unrealized (losses)/gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r109",
      "r110",
      "r118",
      "r264",
      "r593",
      "r598",
      "r600",
      "r666",
      "r696"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive income, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r91",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges",
        "totalLabel": "Derivatives qualifying as cash flow hedges, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "auth_ref": [
      "r91",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "totalLabel": "Derivatives qualifying as cash flow hedges, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTotalLabel": "Derivatives qualifying as cash flow hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r91",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized (losses)/gains, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r91",
      "r97",
      "r555",
      "r559",
      "r569"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in other comprehensive income",
        "verboseLabel": "Unrealized (losses)/gains, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Unrealized (losses)/gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r97",
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassified to net earnings, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r560"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Reclassified to net earnings, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Reclassified to net earnings, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Settlements, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Settlements, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r89",
      "r98",
      "r590",
      "r599"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Foreign currency translation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r104",
      "r107",
      "r109",
      "r110",
      "r112",
      "r118",
      "r395",
      "r593",
      "r598",
      "r600",
      "r666",
      "r696"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, after tax",
        "totalLabel": "Total Other Comprehensive Income",
        "verboseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income, net of taxes and reclassifications to earnings:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r95",
      "r97",
      "r438",
      "r440"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTotalLabel": "Pension and postretirement benefits, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r95",
      "r97"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits",
        "negatedTotalLabel": "Pension and postretirement benefits, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r94",
      "r97",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Actuarial gains/(losses), pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r95",
      "r98",
      "r534"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "totalLabel": "Pension and postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r102",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r102",
      "r438"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Amortization, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Amortization, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r98",
      "r109",
      "r118",
      "r488",
      "r503",
      "r505",
      "r593",
      "r596",
      "r600",
      "r666",
      "r696"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTotalLabel": "Other comprehensive income, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r87",
      "r431",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r426",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other (Income)/Expense, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r73",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 1.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "negatedTerseLabel": "Biohaven sublicense income"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income)/expense, net",
        "negatedTotalLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Reclassified to Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r63",
      "r281"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Alliance, Royalties, VAT and other"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other termination costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-Term Borrowings",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchase program, value"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r142",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "terseLabel": "Payments for royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "Payment for debt extinguishment"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r133",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition and other payments, net of cash acquired",
        "terseLabel": "Payments to acquire businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSAcquisitionsNarrativeDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r250"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43",
      "r427",
      "r428",
      "r429",
      "r440"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r46",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r24",
      "r280",
      "r281"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting category or type of financial instruments related to a group of items that represent revenue.",
        "label": "Principal Transaction Revenue, Description of Reporting Category [Axis]",
        "terseLabel": "Principal Transaction Revenue, Description of Reporting Category [Axis]"
       }
      }
     },
     "localname": "PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from divestiture of businesses, net of cash divested",
        "verboseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Net proceeds of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r136",
      "r140"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Short-term debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r130",
      "r131",
      "r250"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Sale and maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": {
     "auth_ref": [
      "r143",
      "r258"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Proceeds from Sale of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sales of equity investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r18",
      "r103",
      "r106",
      "r111",
      "r144",
      "r159",
      "r170",
      "r178",
      "r179",
      "r222",
      "r231",
      "r234",
      "r237",
      "r239",
      "r265",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r534",
      "r540",
      "r541",
      "r546",
      "r547",
      "r575",
      "r587",
      "r672"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net Earnings",
        "totalLabel": "Net Earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r313",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r31",
      "r305"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r307",
      "r612",
      "r673",
      "r690"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock": {
     "auth_ref": [
      "r44",
      "r657",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of arrangements in which the entity has agreed to procure goods or services from one or more suppliers. May include identification of the goods or services to be purchased, identity of the seller, pricing, effects on pricing for failing to reach minimum quantities required to be purchased (such as penalties), cancellation rights, and termination provisions.",
        "label": "Purchase Commitment, Excluding Long-Term Commitment [Table Text Block]",
        "terseLabel": "Purchase Commitment, Excluding Long-Term Commitment"
       }
      }
     },
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r612",
      "r689",
      "r717"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables",
        "totalLabel": "Receivables",
        "verboseLabel": "Receivables \u2013 from alliance partners"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r485",
      "r644",
      "r735"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r29",
      "r154",
      "r650",
      "r684"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r152",
      "r154",
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash for contributions and settlements"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r35",
      "r154",
      "r719"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r316",
      "r318",
      "r321",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r317",
      "r320",
      "r327",
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and related charges incurred to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r317",
      "r320",
      "r327",
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Workforce reduction of manufacturing, selling, administrative, and research and development personnel"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r150",
      "r315",
      "r324",
      "r327"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Provision for restructuring",
        "totalLabel": "Provision for restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r317",
      "r318",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "totalLabel": "Total charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r318",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, end of period",
        "periodStartLabel": "Restructuring reserve, beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.",
        "label": "Restructuring and Related Cost, Accelerated Depreciation",
        "terseLabel": "Accelerated depreciation"
       }
      }
     },
     "localname": "RestructuringReserveAcceleratedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r318",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Change in estimates"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r318",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation and other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r51",
      "r400",
      "r612",
      "r686",
      "r712",
      "r714"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r167",
      "r168",
      "r169",
      "r171",
      "r177",
      "r179",
      "r266",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r573",
      "r709",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r417",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r114",
      "r159",
      "r216",
      "r217",
      "r230",
      "r235",
      "r236",
      "r240",
      "r241",
      "r243",
      "r265",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r587",
      "r672"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyIncomeNonoperating": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 4.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Income, Nonoperating",
        "negatedLabel": "Royalty Income",
        "negatedTerseLabel": "Royalty income, nonoperating"
       }
      }
     },
     "localname": "RoyaltyIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule Of Receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r100",
      "r598",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r509",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSScheduleofPurchasePriceAllocationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r76",
      "r165",
      "r373",
      "r375",
      "r396",
      "r397",
      "r398",
      "r399",
      "r602",
      "r603",
      "r606",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Fair Value and Other Adjustments to Long Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r553",
      "r561",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives and Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r16",
      "r17",
      "r18",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings/(Loss) Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r289",
      "r293",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule Of Intangible Assets By Major Class"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r28",
      "r59",
      "r60",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Gross to Net Adjustments [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r327",
      "r328",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r318",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of units granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Stock compensation (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r66",
      "r693"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-Term Bank Loans and Notes Payable",
        "terseLabel": "Non-U.S. short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r37",
      "r612",
      "r654",
      "r681"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "totalLabel": "Short-term debt, total"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r156",
      "r159",
      "r183",
      "r187",
      "r188",
      "r190",
      "r192",
      "r200",
      "r201",
      "r202",
      "r265",
      "r342",
      "r346",
      "r347",
      "r348",
      "r351",
      "r352",
      "r379",
      "r380",
      "r384",
      "r388",
      "r395",
      "r587",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails",
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r80",
      "r109",
      "r110",
      "r111",
      "r167",
      "r168",
      "r169",
      "r171",
      "r177",
      "r179",
      "r199",
      "r266",
      "r395",
      "r400",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r573",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r609",
      "r709",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/CoverPage",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r199",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/CoverPage",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Equity Awards"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDIVESTITURESLICENSINGANDOTHERARRANGEMENTSConsiderationfortheAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r46",
      "r47",
      "r400",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r46",
      "r47",
      "r395",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchase program (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r47",
      "r53",
      "r54",
      "r159",
      "r247",
      "r265",
      "r587",
      "r612"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Bristol-Myers Squibb Company Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Bristol-Myers Squibb Company Shareholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r110",
      "r159",
      "r167",
      "r168",
      "r169",
      "r171",
      "r177",
      "r265",
      "r266",
      "r400",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r532",
      "r533",
      "r545",
      "r573",
      "r587",
      "r593",
      "r594",
      "r600",
      "r609",
      "r710",
      "r711"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r394",
      "r400",
      "r403",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Net Investment Hedge Activity [Abstract]",
        "terseLabel": "Derivatives qualifying as net investment hedges"
       }
      }
     },
     "localname": "SummaryOfNetInvestmentHedgeActivityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired marketed product rights"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r370",
      "r393",
      "r571",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r79",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r47",
      "r395",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r79",
      "r401",
      "r402"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Less cost of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r395",
      "r400",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r317",
      "r318",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]",
        "terseLabel": "Non-U.S. dollar borrowings gain:"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedTerseLabel": "Net unrealized loss/(gain) recognized on investments still held"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates and Judgements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r182",
      "r192"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-Average Common Shares Outstanding - Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r181",
      "r192"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-Average Common Shares Outstanding - Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r736": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r737": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r738": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r739": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r741": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r742": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r743": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r744": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r745": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r746": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r747": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r748": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0000014272-22-000196-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000014272-22-000196-xbrl.zip
M4$L#!!0    ( *E<6E4U .3Q.6D# (3<+@ 0    8FUY+3(P,C(P.3,P+FAT
M;>R]6Y=;QZTM_+Y_A3\_GX[K@JI">20^0Q?;VWM;DB,IR;%?,@ 42J+=32ID
MMZSVK_]0?9$E6XGEA.+B8G><.,TF>Y%<$\"<J$(!?_R_KTZ./WJIZ\UBM?S3
MQ_X/[N./_N]G?_S_CH[^W]W'7W]T?R5G)[H\_>C>6NE4VT<_+DZ??_2WIIL?
M/NKKU<E'?UNM?UB\I*.CB[^YMWIQOEX\>W[Z47 A_.+)]:>UN"A:\,BW[(]
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MJ5"+4%Q3U]*5E>RW+ID9XZQ?K$8YYWWETR<J9^O%A^F4_T'TB509/>X%3(^
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M#!4+LU>?F@7-PT-UDJW/2;!EK ZA!<NZ/&AO/)J/L,NMFBJ1>( >._W6YS1
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MX,0E]&I2,\8*EM>U_Y^];^UJ(U?:_2N]V.]YS\Q9**/[);-?UF("R6:?V"1
M)@>^9.D*)L9FVR8!?OTIM2$7# F$-MA&^4 PW>Z65'H>595*59HEIIU),A@J
ML5:+)^@'=I$]O$@MH3IRR:E/EFL>'5B @F.AE \B8;-X(GTT%]G#"Y?BB*V0
MC*J4.%$8U"B?!<M CW+)7_IAYE^F#^@B:^@,K&"8>TU#+L;*=3)::,62<R%Y
M:T!@"R.:1W*1-26F2*3E5BC'/,<L&FLHU<(*HIB)Q"Z.F![?1=:0R**RRM&(
MDS*"DSH AD6GO&4YRZ'3"R.RAW:1-04IJW%.5^<XZ!HZ.:NE5)(D*L"(N Q
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M$,P((D0@/!>,-"E$SK1RFJK@>=$E&I[&^-J=CNA#XA%I*03B-+!\*M,B+U7
M5F!G9-[IB-W]V(O5"Y ?S#V89N--CFHKRWKXE,GZGK.X:!5WG<(36@4EH#?H
M&)'@$JRZB#5R*6@4&+ RX3P8 >KPB_77KZJMG3)5[TVX1:]H<#9/^BBDH)*
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MZH),@<*KT^1567CUR8%*+:VLGQYT7*<$F2V*/,5/(KWGG21_E,:P3):[' K
M2RO;)T='=G"6E:55YW)BOCH(=2<.C@HA+(B,Q0,'CQ?)-2(Y!NB$<;6CL@>\
M.!(5/XP!OS'ISL0IJI]E@$0_/FKUB^E^;Y5![O_<5-?G,C/DL'*#;*3GK%ZU
M#7\\Z(<3/QI6GP\Z_J"R@YA3RH:8$T<.ZZRS_<^]<8'%OUK;SZKMX^@[J>._
MWE7?,!@>=(ZK3F^<_RO']G:&\-%W3\(XE>0X>62M[5;0F'A:753?BM":R[)>
M;T]LKM#5/:O&M00K>,Y+>&*=Z&4R9]6MTN[,7<XD@I<NOS1+29-^.-BWN/B
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MGKQ!V3I#8*NE:!@A'ALPSU5)J+G \&S,."_PO!\\)TQM*@ACGG/$I8^(>TL
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MX))8<('A.B5?18'KO>%Z54T E8#'$".*D0H$2H$ FR$HY*,1-"J#-2,9KJ+
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M/ZCF.6(I(.4%3<F:A!-;6KEWUO5"!XM(!U/(AE+HX"'I8#*4@AD9G4A(22?
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M53X-*V)"1OG$8 :8%#08MK.40*WIVAQ/'O4-N*X*ZF<9]1/N+,X-_ -Y)L$
M]<1(Y(3D2#-!$W7>R.RQ5@7TBPOZ!KP3!?2S#/H)CX6S06)-&=(\6<2YIW6Y
M<>1@T0<K)AKF29E"90K]8 HE9JSR-"&-81YQ$F'V&)Z0T(QKK+$,%NP^R1OW
M>9659'97D@9\7H4&9ID&)OQ@AAOBP5Q .#*">, 466PT2C@*%:1,D="E%3Y+
M%9">6M16RPX^QG'BGA#=J!I&?S+HC#HE2FM&HK16/]E.-\OG97^P#6RT_45
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ML3;*^[?&G\/_QN[7M?_%?\YN_-*U0BKNW?S1R!OMO)\Z+H0V4ZIL,/8'1T5
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MYR!%=%YQ(EI#OI]ZAYU#?*DA0[1M7UVWUREWT"E//#@>E:N6K-$1TGUGKS=
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M<+)YN@Y;I_CWS[WN%M^5VZ]>XVNO^<>#_W8_?MX05_-0ME_MP<<WK[]]W-G
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M=>%Q&IYX'X<7=[F\[UIV5C6Z]JP1VY4WK-T;2^S\>*/8Z8#N< )7@#V"98]
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M)DD+Y''B@'$BCW.-'KEH1%(Q>A=\QCC)[SW0M6!<P;CGC7'8&.TEP3I*4 S
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MYVPURUH LFMCE6M8>]9J_)QVU#7#L1A-"WVT]]_60L&2&@O<1N5Y&M;6U#^
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MTT$C)ZU3VC+I51T!6")RGC&"%V[G%P3?&X+;S3U8RP2J.W*.2C 0O$16@;U
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M08>W^7K@*@LZPWCTK3]J%;/J-)II;E^/ICK==-?/S[R>[++2,GOJ;&Q'T\9
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M%6>_YR15;M*7T3=[%55.''M[O0N\$Y.DS)=47XVPD-B2B(U__1D])4 PP99
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MO(? Y.Y@['J=0S?\E";'V%\3<E]JW]2FG*-S+YH#AW"%/!\FE,G=?]*+4KN
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M>!7$IR#FPD9+J;#":*!!6,Y44 #>!D.S]S6B?#_X;$64%:I[P'0D)C-%@+)
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MO)));VQ!W?&ZQN#T*0)-,<3@*/C$7- 9:$XQLNPSOT$)IIJ2=QN0ME/R/%7
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M7]CS@U_YWIMMMO<&VWCU%K9W]P_V#CZ>;/,_>]M_O>YN'_Y[?V?W]94)+TH
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M&8SV[I?+_HK?_F96>\8C)TKPA'J,-,1DU&.4=MZJ0"T-M!1Y6*%LQUJH<LE
M7\(I3W>'[ZK)+ /W7R_CWE GE0Z&(/PM0?L4-1F@ONS-L#P*41(-EGT<;P7_
M"H+?)B65$U%KH\$9YW7F-'OI@J.2:WN/#HLJY9>$=G89[;G4,PC&$,JI(>"E
M)99Q1\ JGU4,(@56I?QZ WT)AT=5*;_:N!>7<:^$0S7>YU*V.J)V'Q5Q4@)Q
M)EAEN-::+L]?L7H;FE;:1_%Z6JAK-';8J:;P]+5Y1IV28'2S_*)Y7;JUC=5I
MH[KKJKMN8?D.8"1#>>V=3^4$=N>0X$,2$C@-D<&#;NJK\GVYV4:G)[5+Y8U0
MAF0I/0'PD7BI!.$"P.(24%[P593O5;E?,O@5RR"%8=% !,N#C: X34R:Z"D%
M4UUXCQ[\K4V T@(XYSAA$2@![8&8I W1BJ%R3QW-KKKP'BWX%THN#IX&KFU*
MEH/RTE%O&0LZ*):XE+KN!'PT*&_M!+0VZ^@8$*LX0Q&O'3&6)2)!6 &9.RKI
MQM9M\HPJM%=7KC.1N$G6>"<XSKWWNMD-2"5+WF53G7:/'_'MH^>H%"QK39(H
MH3G+,G%&)&*%93+:;+Q.JRC7IUZ+TV>=G>#60'M57"NUC=5L8[WVE2YZG$@_
MC3O=/GX^+N<.+G"FR*/</EG;N)/MI"NR]I>SI[H&.YY*&T\PV'%WFZF?A%&T
MA+W4\QM%.VG\]DPRU_U5=V$$8;N- =080KN_BIVO?_"_H=2G5!:("64C=1::
M>,[+EFJFH_3!A. WMC1;(0.H>C\>\V[JFP*]>D&60P GEPA @6+."4.DQ1]@
M52+6I$24$5(;[\ 86$4W2&6!9?M ;[^ENHK[%4/[SF5QGQW#.0Z4) J"@(F4
M&&1V(H0+E*H 6O.-+2;:98LKTM<&Z?>ZJ[HB_7Z0?EFN!^<%,U:2K TB71M$
M>E,^@>8H,I-2Y;"Q=?NBAS6R4=M8A3:>0F1C9] GL48W:AM/-+I1UO\?F^\W
M.W'0Z[EAQP^&P\%G['T-9CRM-FHPHP8S%O1N!!VE 1%U3$!C],GRX'50E'HA
M\O*"&:_1IL&!^64:@MT=XOM-NE<LF_)7K[%SJA6T="OH8SN\H1B3+,I$(%E=
M=FXH8JQR1/D@O6=:65_JQ]4=V6L,?0@N^*0A".6!NVPR![#.0P8I351+"V]4
MZ#\D]"\[0%Q S <&A$H9"(20B:=<D*PT,(A*&BEK,8;UAC[[_]G[TJ:VEF3;
MOZ+@W;ZW.X*B:QY\;A"!#>;BL(3-D4W %Z)&$&B@-1C#KW]96P(#$H- @(#=
M<1J#AKUK5V6N6EF5M=*'1*5D1F#*B^,ZAFII:0PR"FW=S/8T2M=_0=<?V^4@
M6E-)F4>>YEV.1 32"N9_+[D#QF>HDT7%E_'C'*7OOQG?]X(J;J(5#GON(XRY
M@#F :4\9$Y38F>URE+[_DKY_?=IGX-9*!HL2UA9Q"[[O4K3(>QT#5I0&GAG_
M/&UP%JL9_^Y;UXSP;VC\6OY?^'%^Z]$=4%Z4^$#T50\]'/3ZC70Z?*G1#K'=
M_X#RAV;MG_HN]Z3%:4K[KV$WCO^L'\1*RQYVNHW^::71JV2U"=\?"E&X6.E>
MUJ9HM.'%:+OM8FFOT:Z YU7:\(@5RBLM:,5!;^EBH(K^&@UF;=""=OLK_3?>
M6Z.^6?Y?U_WW\M7KW.=[S[CJ3X?G&5R_LNF@)050]*9O\:0GO=)AUQ,_HX=P
MB5.5-#<" F9- #^9#S%0R>E$UG05*__V!S$,FG$S_7W0Z?;KL=O*CU&'>WQL
M=OS1ZT2W9OR_K=/=[7#L*)>UL\\'&<G@W\/-U1U26_W8J!XV6[5U0+_MG9/:
M^@]</?S9V*T? %*MG&S6]_<,HQ:3Y%'$C&0Y>X]L#!P)K:TP7CC.]$(EPAQP
MG,>S.\@+CB]KDY,=O1A5U(=AA2D3S+/SQSS!7WUS$.*'&^VT9;O[C3;J=XX_
MB(EPEK=[,QI>H&^G&V(W(V_3'O?BA_-?_@J-WG'3GGYHM(LF%E_Z:W3Y(<86
M=[B&OL4-AV__==((_8-,+I;PD&",5I5'=QZ]O52\=6U.&+ZG^))6],:W\1*Y
M\;W;+DOPDI#R09>]_3UN^-,T5M_KLG>LW$^Y&_4T7/3.N6YXS*S8@RJFIVJC
MV;R"S#<3^EL>T,=\6N=E'G'R?O/?\;@?6RYV*PPO%G-(QOLIGO(>&S^OJD-6
MHQ_U![GH#W*E/]Y6&L(=V["]/[/ GZW8:1GT"-SS;) )=*_3;(3*^4/<&:(^
M'RK<LW/^Z^F>_\V$YC)PF6(*"E/.!68N*9P2P4)Q2I.6>QOW6XV[X)8?;?OH
M:P<:#U%TK=./O6_V-'.!MQ%.0]NJJS\/JV??Z>9JK;5S^!U#6'U06_\N=NH_
M#S:W?YSN'*Z)&MS[>C@-USJI;5?/:JL0>M/=1FWU.X35:WAWM7E0VUZ#]GV!
M\/R(P'.DB\VS2R()0%:=%MPA$1A$TPY3Y$BBB%&2L&.6>4<6E@E6,PJG[^T,
M+[S,5H):"6K70,U&A@7&7# (G;V-.BJN1>0!8FFEN2U C1#*2 EJSPIJ8XIN
M4002@Q"(*YM3HRE#.@&\R429T49)DXLRP'3T6D#M/>3^#9?7^Y5C\([LB9U4
M:7;:^W_6(-Y95>P7H%M?H;_/5_)&PW'U7&9[T$*ATT>CBY1 -0U0-<;9%Q O
MJHS"2#DI\ME,8%_.8<0YDS)@F97I *@6#7[T3N9D1"BK8,Z#_\Z*693^^[3^
M.RX=2[75%(B&S$5A.%,BBRM@E&2(BA#C9 2BP1>5Y'/DO^]A":O8RR^SI9^:
M,13=_">@N5@C+)%E&F29H$AOL13,"(5XR!N)SAODB"'(4A%$E-Q@GT.8O%@_
M-VD.98;3G/*"TDMGXZ5C\W]2GD5-)9+4P/RON4&&$XLT2=(2J8C :F%9F3ER
MTADM);R:DU7U3M\VIV59HP6=488!@\<-G4'.5SAO[[M=_IU]![T9M)[]IM<E
MH"ZCN-F@>.W3.->2#!-G/$94F( XM@KII!DRQB4K/(DPQRXLTT7"'LVV9NX^
M+[R&4P)I":1S2WM+('U:(!VCPY1Y2KVAB#+,<R4EA8RG'BF?(M.2JI!P7@XS
M7+\9()V0VW\]5SW_G0V\T1X4&;0SR5X?.1>3X'W'G5XC7_A#-S8+Y9@_6:__
MN)I?/.HH_.<KUD&?#/HW?V4L7^^%,I*)NG8BX-+/@PM-J6.['Y'K1GN$;(+&
M?K#-$WO:6_CWU03E1AM=[L![/'MA"K<,S472_>61'L((YEA9XX &\L2ETB9$
M"0 F-4Y<TZB&\ ??B6$E(Q,QR6JKG,#"<Z*M-@:^SJFRV#@LY<+S)??GG82-
M=J_?'63)H=Y[3N^O'6[LB9A(L($@QC5!W)J$M(2@GW*</%4Z$&>OCR9CTC,O
M4W)2\:"XA4[G)C$;J<3,^%=Q'.#KE9WXBFV'XLB.OVO/OCPK4)X5*,\*O(G4
M^/*L0'E68$(O?.L"Q#>.;;/RTS8'8P)591YMF4?[1.ND5[GI9^OC2@MZ^%VD
MO*RPZNIG:--6HW:X"[3U.P':VM@Y@^MO?VYMKF]!.S?@,ROX>HQ?7?4GU6V@
MO>L;M-;:.*VM_L"[VU\.\[/L;._PW?7/K9U#^,SJUL0# XY%IX04*/*4$#=1
M(D.]1T!JN8_"4^+3PC+3BX259P9*K'OG6#>KI<P2ZYX!Z\;6,QT1AM 84#2&
M =8)CIP0#'D"0TD](5C)A67.%K%Y;4<)KBTCEAKL[T!S?#*:K82\T%(L[V6I
MEFM\_F&2R^](3_O5),)\MHUNY5<>T[Q,=UOAT'=VT.:?T^@-6DY",A(G*[CB
MQ)% C=1 BE.RG-.;8Y<>/"?\-CZQGZO]?VU8UV@V^HWX5O+RGF?BGI31$6%P
MA$\!"1@MQ*E2R%EE$<'4APB1IN=9'W \+^]?Y7F:>773:;Q48*\MELYIS#E3
ME@J"/4Y2!QH)]_=GW:5S/MHYQUEU$($3AE%TW"".X8>3SB/OE, D:2\XRZ=S
MW]Z)F5?#%7Z '^0MO5R/P-E>HU>Q%RRQDKJ=UI QY&V^1ON::%V9Q3_C]4[7
M.OUP:4 ^YO'X0]H_PVC\#8-1OS06)41- U$3%CDU)U$Y+)'GWB'N54(6* .*
M.@5'E%<DA0Q19=7D-^RWCUV[*_WVJ?UVC%HPPWV0N22 5CJ7!(C()>Q0X"&0
M9!E3T8+?3B#^Y8&<%^$6G7:HA$;/Y[7L7I%6U.CU!K;M(_1%KUR*>/9MU$NC
MLSH:EQ*5ID&E"2H?QN2A<@89S0N5#X:LBQ#U*&V5#UH'D\^7F/&(IUR.>!.N
M^C2[@*6K/MI5QP@$5T1X;3P*6;J;<QN0A9>0L1S&2VIJG<E%E<?E>%[$5=_S
MNL3QH.L/;"]6CKL-H OVTC96)U4^Q>9^;,>'"X>]BQ#GR3G$MVYL-0:M$I>F
MP:4)<B#,"IZ4U"C 0"%N'4>&"8N85I8JEX1DX).FK'/XEKWUR6G$A;>6244S
M<^4QBN%),)2%A)**/"<5*:2C#(B ?V-F2(Q<9<T_CA]]2').5RFH6%+SSC0>
M(QOR_A(\IW[^-X/)3R&]6N+OK/!W<T)NB A&6J,Q<DEBQ*7G2.<<3V\9]9@%
M(JDO$MBU?/0R\;1^\3K4/$I\>S_X]A32M"6^S1#?QOAE$%CA@ '5M)((# !^
M2\ZAD"+V5&K&+5U8YGR1O1Y\FTG2^@P3BB\]\ 3-D7E)>WY *\M" Q/6"Q^]
M>_'Z9[ZW.;F5=1->P1Q7K:_TJ]<+P ?/HQ=,(HDE1=P3 I.<C\@JX9CD\#]M
MWFSAA!*/WB@>E74@7@L>C1>E9\9;KI!BVN2*4Q)I3#CBB5""F8G&X;(0Q$NX
MW]?'UY!Z%YM+3\&%:IVV+^%GUO"S-DZ'E&0A$<91P+F.%*4$N92KWA&FI/)2
M1QP6EIE<-%+.T:92N4/\"@A$Z<1/Y,37.01VPG*K$HHR*L2EX5E<TB-+>&0J
M)8DI< AF%N7,"E>6.\-E08GY".A*'?1R;_FU8?C&.!$3P3GFE4+6!HLX)PHY
M["R*)N!@K1$LLJ?97"YK29086F)HN7_]^C#T.@\FSB4KL48<)^#!'!ODHC/(
M$T[@OT!#YL%/L8$]WV4D9E T8F[TY.L'L9*N"%)=TXT_L;W*?ST]5])W"2TV
MNH4,VOU<WKQ.EW]P683:V???U>][D;.4-]X0]\S #TF053B?H0H<B(_!TN?5
M)[XTOA=7<4.U](HM3NU<:(P/W9CAQ4H>MN)@\#36\$#4+ZWAD=9P6EO9HT)@
M&GE$RK",X4(CIR1#WM-()?0_QQS@VRR-BV?\L89^Y5Q=?60)I+ $,L2+4!GT
M ' K7^.OV!Q^@%8:[>-!O[=8.3EH^(.*[<:L7),_>@P7S,4J_C/H].'OENT>
MQ?[PU%@O#V3Q9@_&O0*_]QJ =K9[7KSBHO+)4F4<LGJYOM00L]Q%A:F*/3[N
M=GZ#)?3A\D61#-OMGN;F#K\8X/_]SO"F^0+0H/Z@6TA+Y8OFU\=N/CV@OY:)
M8!4>';HF/W4;WJRTX!L'O4IL!QBJRR4'"B!8K'RL_GUQ\B\ +E3L_GXW[F<1
MP^,+Y4I;:./FWIP&-!Y4..<VSKCVNP_/-FCT#O(H#HOI3"/;^_X Q-/:_EY,
MFNH@")):ZLS_&-+.)^25H!!=2V:H7%B62S>==3L'$1A^#Y3+-HI?&_W>T*]Z
MT9^[6W;^%[60;_:T</"A;5RUET]9_Z(TE,F&LG]2.]ES-"7I'4$!&XIXS"J/
M,-4@HHR60M"0N,V&<M.6UV5#L;V#7+REGX&G"Z^DV!WJD?SW_],PDG^U[%&$
MJ:73C,4+Y*]*-X;8.BYT>Y8J&^UL*>TX-*&31O\@0UH/D+X+X#B\*\Q-]KG-
M[0;5T75PBM[73J\7>YOM23#UID/<1]C=T>_JR1['G@+C#4@+&1 //&^T1H$2
M(SC&*)RR6<_CQJW6ULCNVD!#FC (%?B]@*8_)E7$/]WH._OM<Q$^^#DB,M<(
MQ6724"CH#$MNY5\J1>7WRC_AI4XK_NO?\?=Q;/?B8K[U4J5D%:/X8O%9W5)=
M]\:M>'QE'BA!_X8:?&*S_N-WM;Z#:ZO[N/9]#_-@(F40:=HL\^LX0<8% DR!
M1 ;L@6N2]?F7U$W[I9=F@,)]"BI>\,HP\L!CVSCWJ&Q1T]@)<90HZZVUW'!I
MK U*.S 7%PEF2KF'+DE,5_OAO9G)YNH* 8PVEC(IK4=.1Y/3\" *-2F@D*03
MG#D5,)@&6;K+,FX<;^AO@)"9##F[?<0W1E+M6Q#D_-V''^%;[.9R:'8_7@PS
MHN]PG"%82$KI((5!#"<&X^PTS,I<PJS,2$@$8ZLBS,5+$H^'"_^HU#H0I$^'
M_EYI+#+Z.^]XC$9SZ92.A$J'B=&ZK%[U1*---[_O<>X\D5X@1P'F>? $:0^,
MW]L8,.-:N*SO*":,]57F];G9L9GT5K)//<@** >V%XEB0O*8L#:4147!&A2Q
M3)O2"IZ$?]>_B]K9#[*YN@$4P)_M43"(8*-"1-J(..,":8LCHD+:!*#/:< +
MRTK<90_3H?S#!K]$^4>/^#X#!(C MC%'$BL8<6$A]I*$(!QTPC @"@8@XSV>
M%=Y+HP*U\!\$?5RJ8%.""8=Y&4.RU)0L[AG&_0CO84LM)1H(?O0PN[LH$;B=
M0XJ'$+F*A)%\X.O.1<'I//UA@\]+3W_DB$-[]HQ.UO@DD63:PH@3GT><(D6U
M# SGE #P=+9$)Z#[R-.GWC<4P-:#2B0!<P>@X1J&UD:'I=#46/[@7>32V>\_
M]&MTCT23$K'@XJZ0\8:A=]S +*^BL#8!KX]Q]L[^L,$OG?W1(P[ANG-6LRAD
M7K]A^?P<11! 1R0XAD@]),P-S<XN;G;V<I/TSW+F22QTU&>]0_HT<J&?1LO9
M)43>%O^NL=K^7E"4* /$-^D4$*<,^)#G%L68>+0T"9?B/;=&AUE6>:.J761#
M='R,H??<>^9C,^>W44-R>8R-42F S31]]N7[,Y"-D\V5O2"( #K,$'$<PB,:
M C+8)@1D-4E+#*$^+Y LW90X.3*0I6+JS"/=: ^*VB3#WF1,>F"_*3D)Q%MQ
M"V/*38)IDF;M2C^T#OA.#"MY@)CE 8-Y 'F#F!ECYU1DB3H74B0VIF$B8)'U
M6'&QV3FI] :MENT"-@YS9\ZK0?0^% V^W*('X/;]\3[/T$ 0EF_HACL?ZW^'
MSW2>=SK,'H7IHFF/>_'#^2]_A4;ON&E//S3:!>@77_H+GG^_T3Y/1LW'H:YE
MCA;M'+[]UTDC] ]R6G2.>'-J].@DUNC.H[>7BK>N9<,.W]-JB3)VX]MXB=SX
MWFV7)7A)2'6OR]YQ@&S*P^9/DYBN[Y67OIK'M=O+&Z_5H2/=7,!D_ &G$6*:
MBTZY9[;^ RH*ST4QY@(>YNIXP\2P)4B.N74$4\)YDLXJYBF-&B=,((BY@92)
M=QRVG!]Q$#O0EAWZG>X>?CF"SS1V6_F][W2S_J59/=PYW5W]F+_'QH\X-.'O
MSX>[J[NM:NL[3,1?6KOKGQN[JSNBVOIQ6LO7*R;GD*H-?')-HN]76/_)P_]]
M:>[2YB]WV&&UO)>U>M#<7*V*&MW .X>[S9WZT>GF]F?HDQT(D?;AF2%D^JGQ
M7N;<5&D(B2FVB%OX30MM$;-$.,5@"F+%CI>Y95TDYZ!2S.C5J? AIX;O?93J
M1<_LWO\HU:1'O/,HQXL^VQ1L_6%0\13QVRO=N7INY!@3+Y8P4#:?LM"48,23
M%L@8P1"P?8=%(![+7)AR\>8MK^>1"+CPB!=1E7PM,[=G7$9PP>@M)SF02M%:
MZ8/5/*EPP^Y".7,_E_^=WCESG]2V=^"9/,S06XTJ///.]M;!YOH/:,?68>WP
MZ*2Z"OUTMG:R0V#FI@("1.$32GD]A.O(80[W&$4P Q^XHD+P.Q8Y1S,WOV'F
M?OJ::Z]FJGN0;Y53W8NYVG@-9DJD\<XB2GS>_Z,*62HB L)BX"_LF4YYJINT
M__><DGJ/G.K>1Y!JE#86"\(=N*,ER5@IE!$B8IVB,S>DS)13W3/Y7^W375/=
M<:M*=QL0C(J=PQH\=Q7OG!V=;=9W#W;.?M!J/M]_M@M]M'96;<)4QZQ71BJ/
M$O,PU7E!D!'>H,"$%HER0G2Q>:]N3M,9377B,5/=HT3?7LM4]S#?*J>Z%W.U
ML:D.1TZ"30S%%'*R.L-9S=JC0"/!2<,L*($8TL5)26UE5#=G4QW%S((+,B.!
MSBLIG$X62V$BMRQH1LJI[F7][^\[I[J#W?H^VZSOPWV;![NK^WAS>P.FO8^M
M8?NVCN"ZK+K^N5E,=<0:8AV5*$J<$.>)((<#151KYKAC>5<P3W7FSJE.EE'=
M'5/=PWRKG.I>S-7&ICK*$U4YEU-H)A#7#D-4!_,=43%HKVQ(">>H;@93W?Q%
M=4-_?&L2IU>K#3VG/-_KVE-Z3GF^UP+H\Y-16 +Z/0!]PHZ4P=YZ+QS".$;$
M(\\99SRB8)Q(QF,.8[NP+&<8N[R$6-^$Z>!"K&\\+^T\L>QU91GG5+QV04>[
MMGU4B?\9V&;S-"<S%5V24T-'.@7#O%%X-[_VL?KW__0J\7>C5YRHS$<NTB ?
MHZ_T8KO1Z8+[%Y([A2!%SCJ-H1U[P[,96:4KBU[$5I$N9[. Q6FE#T^UF.];
MZ*TL9EDN^./8=ON+^2._[%#]HG<,+IP:<-U+NADC6:_CY@#NX'UW,#K-/VB/
M3O(/XZBWF2Q.Z-3)XN1));4D32K"3>!&CAN@=\1SPA*SR6!X417IP>0\/9C<
MG1Y<2FI-FQ;\@]=.]JS'*6+,LBQU0!P"5F2$U(A2I91G(2E3Q*CWT,FXAZ36
M)04\P(\7M9=28.N!9K.#J_M[) CIHHY(RJ@1I\(BK4U"0?/$>+),.)'U5>ZC
MQ#82V+*5#&LCJ<-Y$MMZK.F58ELSMT&?A5P@%I#$8(O V"CB@G*DB2>(*88=
M(40GG,6V]+B:Z-4C_G,EM'4KHW@EM.%%<;V4S'J 9!:MKNPYJCD3X#^"89XU
M$R4R64O%<\4)MI@EPPK]A)=0S))<!!J\TYX*SH5V-)\+541:%CC\.Y1M+E55
M9@VT^P(XH@S!9"=%*I>/ _?TR%+)$8TT&ALM#+>^C[;.E H+#QKR][Q;]HAQ
M/CH!!##6>2R Q1&;Y76M4,@9DI!C020AF6&!9@30$U3S'J2@0K12VN.H<30\
M)>*<HX(P:I4& U/X!J\N114>.]J_:S#:@7#"*<1[SN?*D"$KJ'"#7)*,14R$
M$&[V4@H/&_+2JQ\ZSB=[/"M>TJ21PN#:W%B)G)4262UCTAIC+TWVZMMRBZ=5
M2X%X4$:GDLF2_B)BYREV5%'E@L0AA'*Z?A+MC-4CG 6P<PY>]7#M#"!=IZ#
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M_P]</5*6YG(34E/FN&: 5U(SSKTGAGF!36DRSV@RI+:REPAC',8!"19A"G1
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M:6>Y"8QJ+WFB7F)Z7:OFV];FM[6M^LYBY=O7E5J]LE);K:Q]_['QK;I6JS]
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M$%O'.<3/]X6OM>/06D\:_8/"P(^[C4ZW<1%MP$7\H-O-USMN'!?U.BJ=XV/
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M=(UB '-DKD:AK!K,%INM$2%L;-FYPA>"+;$KF8G,M*9FFJWQEJO.0!7P4B(
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M5 BF"!6<D=>S&TT-70;-=9I[IA!$\<JPJJTY R> ^>*1H59:6$3+?6FEO!J
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M2F:][UT7SJU7N4@I.: 7P2?OA+?<*,NU%*=GN.#L#)=1_/MB__P,;LI>+&A
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MXHDIKT)EC)Q92((S$W($48+)UBRNMI4(8_4)8_6/T5#X<8<,T=F,J:H!K>'
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MY(V?6P+(LE=\-OD=(G.&4T,)]X+*0D@FL",Z-Z"/$49)6:" [Z5 X17 Z!M
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MA(%717YU+XE6P#P+ ?/P$:/6;GQ,1%CH#&&45Z[@R%H,$J90H& 668:( (C
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MR4VH9"?[+'./*1,482] ?^48]%=E&>*6,>5RKAD%*F&+0J$F$]A:0!O KSA
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MH8R: @$!::0!DY'",M/>%'FF\K7-?)I2W[+@/;/@K1*[6A9\LBRX8&-(+RS
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MK8R@S[U%>9YSFP:63$C#7_YA>EC:J*JD-R7MUD59.@P5JK)H3T-V6(P5/&F
MNJ%8^.2"C_>!:O1>J%C8GVH[H1%HRD'9,F,7_6H+?;P.ME,CKXLN^/!^O;.S
M]ZI6V:L+;]'4:+8ZY_TX,ND-E;]&F[ZP[$J3:[I[9IZYI/-.Z/55X'7!^++6
M.^'/LZUWIJ4LS=Y(HZD#(U3$KI[M\*"\=J'I<'%#I$9)YW3/9VFQ43;4K#JO
M/$U?8^_*KO-SR+\DK:5- _T1::#\J::!7IG6.9<&ZD56>"X+(ET>@AO"<FDU
MUB*7EL.75[09^+N_=E[M[+U=[[S?^N-UFMKU[J_]W?V#G?V]V!Y\Z]7!SBOX
MY(^=@YVW6^'/3UHN/L$<KR@%.UN  <.^.Q^%,&MT!?]1E@4^Z?.XT8"S,CP0
MG?[5N)S8%LZJ<G1%/<SJ=%IS6ZGN>EA'MV.Q4KVAA^6&@L3YESI3W6[2W.$=
M=MVWKAG,5$!&CXT*,X)FAG?]DH:9E9UU5D[2)SI^U,87TYA,J>25>UUU;3+E
M-)-D?&?+>B)/RW\7@S*5VE?22+0 =T$Q[<:<D5A5W$]=:VH#+TQH;0Q-N5$K
M(T>88,053&BJK)*."IUYS'.>.4Q=#"7C+#7V"S\0<9M0\OM(L6TP^9)@\I_Y
M_O:7S\1ZFUN6(:DT0Q0+BX0H.,JQ4]KB3 I%US9%3A>"R2FUIXPHKR<OPDTH
M06IFBIPHFBM)F2Z$H)SAS"J58TR+EA(>DA(.#C\SK6B6 Q& K@:4H!1!PN06
M85UH)8P+(W_7-BGFEU-"$ _#KIZ4"5( )1MST!+"P-']-$V9G W'#ETCBZX[
M!OPK6^6HX>$DN7M2'_4&&,YT:HG&33/K/F)D@*]&7]70-B9Y=8.K:C2-4-0C
MZ@"OTPRT\$^:)U"FY<6I9-VC09JS6 XVFW;0G[[I_/0^-PJY>]W14561'F9K
MNK#>LSA0L:QP:"9R+:WL3JW=XV3/*IVL+%NM96_Y[>>@Y%RD@>]O?WAU  KV
MUN\[H&5_?"ZJ]I6J77<F0;JJT%R<-5KUO]CHO(ONE:[WE1"OFBFDFN:F!R U
MQ$C&?R#IZO9IV/UHQAUTZH:CLO@V-IZ*/9V D08GH1O"( RNW9H991;FDL'?
M0_)CHRXXO,5TXF%47F-VM@J9NI-^F=9>Q?ZJ$M[4VS*^\\OR]&Z%X_7G__VD
MW_E:]LO^>#3YHJ)$, ,T:[$L(?<Z'MQ,T5TM>V+^[!YC=V?@(+%RNTN+[H,X
MGC&*U9,XY+)_"!B9;.63TTEO%'RDA^I$ITR%&CF[\4.7ADP/>@'R!D.;)EE&
MQ%W2C&@4/16Q)5^9KA:[V92-0!O=$^(-XA27<HXL?/F5ZH,AE3SI_Y[8;ISE
M^B[VV MUAA.PW>HF@-.);;/%*['/8?/1Y:-BN&'HDOEY.AF"23BU R\+QNX-
M8MY\?R;8\"96GZAY"S5TN)_C^+GLD1,U2BGM2_)&YE0J@(6P2-N\&/YV.%3Q
M%.-0[:]Q,E1+\TMHOB+M@*=5T[04A(J:<)T4(<KNFR4I[&[_$:XX"W,3X-]*
M9TATG6BY.8%^.ARC]AA5T?J#08PSK,^U2[[0L"SUACGC4A@K<.X-XYFBM,B4
MTEYY(PF6F:<TB\UP%Q+5&V/K0CO<^9%UB>5>Q5U)8^JVJQ*-ZYF6+VY@W<''
M\]V#UY\+Q[ MA$5%A@6BP<@4FFLD)<N=+R3/J5G;).N@[BSFK$<@6H^4.>R.
MZO26JRGCM!)R#T ;B1SV_52PMJ1Q)6GL;7_\;+!1EF.&0K '49,1)(CW2,O,
M9DY*4@BRMIFORV6D49\PT,=4JM9U4].LD#2EO'LZ4[.[1$"$@J_IP/(8=3]/
M7HK&Q95NF>1DDNUET_Q>(_'%J'E1&4"RH:/&%0-!FW+=I6B*Y5[!.]+MJQ2(
M37=*=PXW;,3LWT\!MII>'[2#&Z(EDT(#S7,OK:.6*DFEYHH GV(L#3=7<L1%
M0SX7$;,=[+F<&?#N]ZW//+.",R&1M=8A. F-M)442>:\-EIZGM&US3!2TO4O
M ,I%Q;#STT-3P_5D)_P\&FW%%5U.%"^*%/:VM^C>\8?/Q$OI/*8(CAY(03D#
MTM(5B-G<"Q$<L]JO;7I@_"6$$':VBMZM/S@87._X=^ O7[MVHGH[T7>4/FLI
M88X2/G[.G,$%]AF2F2"(4E8@X8T!,2ES560%4]:M;8Z68T*WWN7*19>4^I\W
M.ON3NM*]%1=/BC) 7)#=XYW[$!=A"L_-K:O;$4!V,X#8BLI/"PBS@/!]Y[.W
M7.18@0T%FPV @ $+'#>(P=;[3$J-A5S;')\-%L\\AM:24OE3V;)A*BF"RO#G
MQ&EGDB<F]&#O#GY>KV<KI2+AV>]$);8_.$LJ;)DUOY 3^,1\TS?TQ_]^#L:!
M>L;N^*V3<_ACZ+.3FC$MMO))=0U_=&.+DN?CK2]/=N-1?7*QYU!CMU($K#F:
M ?ZHW9'J^7 :3:,X<6SRN[E* SAM./^G+KO2V:?/.Z/3P60T3<Y*7FWM^LX'
MU_*P'%_5; P[',\:NL$3?:*.!\-ILYLZWCBUTQMI95,U!19T-*B"$O/AQ1%P
M06H[%K-=.Y/1ZK7R323SJ ECL:'R"1P/,",\WPP=$(Z!_0]3;B.GQ@,<#4Y<
M[5T+IU]67,;([MEPT#_TDQ[(;S4^6CS2=)BQX5+#XIQK ! 3#SO;77<XB.'>
M?G2!Q!D<L:AA$#K01\Z?MM=)AFOM'GX_B;T0AM-;@N;0V0*M(>0/5H43_W[U
MZMUL%[>Z,T&97U)CT=S0PA"O&$U.3@*4+58352&1TQ!L.*UG_UWSVZFS^RAT
MQ0A;5F5+AKA2XF3W-22<I!$CM1<]3("!URDKHJIZI[C3C=F$]3!$G-+ZJ_?%
M\W5;!^5]FSWWTT0K8/K0%R]B>Q.^2T]6^%()"DM\:S&P'_K8S8\<F/:#.IW/
M.8COU?EI&@98 DBA.UW$GU^FB-.\XN=$H8UBX+IOY_R+Q%5/G8%I F3YI>C3
M2Y,FNZ&/QD(9<RJV.Q\.NK9DG.JK:2+$'.'/QL[BI],GERA;SJ@9]%:M^<D*
M0%:DQ-#+XQ.<NE%S;3<P#7L8QW$F=:/NXW'8&^A0F0):A0L53SJ(A)"+!?+$
MQ1'R0U?V^#AO!E*G:LB4!2)-E,RSJJK(XQY2<UQ'F@\W.E+#JO=AX_S:DJ ?
M41(DGFI)T)4E/G,E0<;G"BM"''>6>FOAERPOI!3&92$A^ EUAC_LG7]_SJ9A
ME;?1!.]G9 #.'^#CIVO%#BUUL\^I+M68<#>KNZ^G?KH@V":]*#]#DZMQ'>>L
M+3P3YD$-OJJ1F839:5$WZ\92W% ;G RRJ-B4>5&I&J@;K+ 5K-!=C8.;RW,J
M&_[>($DK1I>=+=71:8[6:F[VHXZ32Q9I4DL B_HC[V)95&QP%ZV9:Z2MO8Z)
M9K-9:_\!H3\Q7\YC#VM W-@6!.R\.0]';8_,6@:E75<6R$16FPG2WMH.#J;U
M&WA/,.O,X )+>'^F<H"N-\K!HBUF9D;>3P&[U*\K,S=D/WY+/J2I)59=$P,(
M2VS;T!$RU9PW)O86S;F8T<*,*PCU%&?=D;OC4M(SXVLG^SC/FL];\LH+QGOH
MZ5L_.WQM CJO]Y4]/=_"\(:!$\D+ES'BBX)EM,B$%"S+>48*:VVFRAGM),OO
M)7+V0J-C>]M?LKWOAV>[QQ_AGG]F^W]^%L)@I3.",FX,HIFU2&6"(4.IM40Y
M866^MHG%TE!ZX.E&!<-,?D7-GJ-F'DY#7#<ZU]1=)@%\%MU1"X18TOMB?F5S
M1/:4@RJ"'DPG&%2SL1=J/^+7XLI.!E]+A.S%4M)A!ZBL;%!4W[LVMJ,P2I[^
MAFX7;S0XC4FWJ=SCEG;Z^JKZ1U9!E[C:05(Z.4(3\=1E;ZIIK[9G8R6V][:N
MC:=IRUW06/#UJP]_[1SL/)^F%9>^;MG?Z!*RPQ(;['_@$D [,V!EQ3+.J=;_
M>(TI[O&%+W 7!-=]OY2?C\GP]?P)<>D0[!^^(3%-XQ%Q[W0R5BG)>":M(QKZ
MI6Y2QE>J=F#-OB)E;?3 @TD4[)K;=YYM=@NKGM1@CI@LVDG9HK.]P^K6:'4I
M6]T[K*&D@/:6/$R5 3V:WCNHZL&;<:+2O Q0[X,V=U(-<X]!\*CT#U*9.+QJ
M).&?\,_5 '-XF;>OMU$8@K'>"1T\RW>H%: 8BAQ,QKW!X$L:T3(<'"=QDUJA
MK)X'9>R^]QY7*B==\Z?\YWB<?;BI'4X.%R:+K=:^K4!ON*JK7JSCFR_S"^TY
MZZ:<06D$U;V;)MJGL<JU7;V>?@_SQ$:N5XYJ&B#0*[NC6$ 8_UYS]BR4+"OR
MNSP4'TSO9%U/EU#S3[1+G&UT0@Q1UTF(JN[,M'6HGE/-_>EWR_=>?$HW%8;$
M]ZKLI\NO;,2N@T>N]OBDNJ38';9*H)B%D:$[#.Y5N*B""8"OK=[X**3 --9[
M&(RIF>!Y.(.O+I4NHM,T]_JH&5VN7<'CCNLE1 D=)\+J!V!-33O.SG\E>JI"
MZM[T@R5A\>; U:RYM=6.)<$QVR]WWN (WVI4QJ015,]!L[RP>W1S-$;=A<L<
MG2D-<J:OZJZ=P?J-/]8]?6>SN>:^ZU,+ALJAT$CO+AU0]]'[O:>&A\'753<O
MCC1=]IA6HT0#E\OHQ0EZT^.?C0M%:5TNOJD$E"\\+_*K?L=3:KP6H,SFHU3^
MPN5@,DVM64;N3= HT:7ZTV5.RVHA 8Y#-^VJX7U0GZ:I.?WK[.TS9IPHMJ9>
MM7<3#3*W\QI.:7#N7+VM?[EQ=Y@XZ/TY;.9)G!Q:IT#-*I.J]^[U7^_G".FW
MSO:;+3CLFOVVX37Z2<-[.QQ,3LNQHDMYL=1Z(R_^EJ*?H5>0@?UZ%6(%(.]V
M)^/ E&_")>O7O5?,RJNH&]ZBF<C5:;Q26/K,Z]007_41GE_.[,LGD?!VYU7G
MW;#[-3@NJV&O<V-^YK8R?&/^3HGE1BXT3Q^[14"ZBTUPSXA4[E$)+(O0>0/(
M&HQ<]7[SN6,)-*:?ES'3IA96-E5 95>%QF3!NB'6#/I5ADX]='/F;K&)_"0F
M.J4)FO63ARKI)0!S)_!^<7YB_ "V&8R>U&\"+K[HL<\79Z[7S#[L;!G;4QK4
MH&4DUO#:/(O]NL!55H6:QIW82:_S5_AP-7Q6#Z'-_7L"IYZ86U5]4>.$M%D7
M2>S-=37<O1],%GNCA,5^' R_-&?PU/V\*Z,BY'4!A::_=2XZE:VZ-TH5%7[U
M]U_3O];=Y6>:K*0>L/VR]6N-"*%;5SG MAG/4>9_)]URHBQ\5#'&J\'P=#"L
MJ^P;M@.6"<7*7GEA)X9PJLYU0/*YM"\SJYQM!1]VMGQYN^1:766H6! 2(;.E
M[#D;4E/*+;#PQ[A5SL,Y)!4MB,[0'5#7HXZ:DU-Z8.4B P;N3ZOE8/A]Z,Y5
M_WOW,3T,/U<M&%7J<P0L$20I/ EDS  H(?5P"63NPN%\'723U7RS9K&42%QX
MG>?&4R<+73@E"??8>$Z(2'6&.&-SXT;%?+3\U72)^Z!1)L2Z7E\.^<*BY[O'
M<,WVE\_86DVI$,AEF4:T*##2WLA0CEXHK TQCJ]MLHV+^L+JLAOH-!PYJ'<^
M3FP>]&+?C"IW9@IE7R.4#1.4I:F.=;;9/$3T[86L?^J&H-,""B4=.N$4J$>A
M=#1@4S5J+4:_F].EQ\M0ZB+P"MT31W7[Q%3C4C9&3E%$Z\9A(;%F:5PJ'?-=
M%IMI?-5(UN2:JSIM5X:/=V'F3]E#-4SZ'"U?[A2GFWIRWUYB(0\JTR-/64(Q
MBR;)/=I,HC%-OUI3)"S<LDT"_Q%)X/*I)H%?F=0]EP3.J?2$.I=A2ZGA6BI,
M%2^LT9(#_NM'GPMQH;8X:PU6NEM9.ENI2B FS9<*!1?G_/P -;+I?E#S@;^&
M$C>SLE"-64]( _2M[?D 0O ^A_!*45EL3@M*T;;*U!RYTA[%]"?U<SD;+OQ4
M8G_#FGK]S1S%L7-;Z6VPS.G"$('C$*X(9O.W\T[M8@\ /74DAEC?L!IA/#65
MXT)5/V%O>6G=@[$V^R/"K9>%?C/?GQY/5&Q2$6K##+ABRZ<[#5(L:M!#V.*0
MS^52Y\C+=[;*U Z)DNN7[C-0'2:PPS^1TM>#BR6;/=WC/-7=U=_/?M+PQ9GC
M(M<]KKFH[.)$IVE,B)0]!)<>:-S7T.(MB,PHVD-337AI$"WE?#?8W)B+'D(?
M0?*GU)VJQ?#4<)CJ!V':8G\0A6R_DE;+M/^PN:WZ?ZGZ7\X"2:%8W7-SNG_M
MRUY0V.*Q5.[/1HCL1%D7;AM.#+:_NB+^VL@O2*/1NZ;S_O6KP'?!;[;><2J&
MY$.;]EYO% J@0W(A((=+]<UIM%7P]B;?VP@>67).->5^)H:8VE(V0U_)CW<%
M05;07+H/U2@X[[;G<B7KI,MF<*)FF&?A1;I0-#:WM'2F5*W$)T, DU'(0O5)
MT%PH%&=[_5>P%#-PFQ(P'$;]RZN@DY_?1BHVL?IRU*W@LL+>RS'W2J <NL,@
MV),*-<7%6F M<]?4W6]+ 1(+(4I)5Q%Z,Y$G<-?] .T49,,]%X"V?*<QT%,+
MNG<$W8L]+@LT%<E]-%\J'QNVQ$R'R(SUC L]4,,XT2(%$@:AKV7CW$IR7BJN
MUV?RPF9 .ZB0H6ZF]-PM)^MZ%D<"QZ,J?E(I?;=6A-.63-,I%BW@$.;I+WMF
M(ZF_F72_D' _#9F%Y).8=/]"07R)"7$IC#=+FF9B?^MADBEL[;5@.V0TU1'(
M601/'<XBZ4Y!O!(PJ39I\<- B67,++[(%<HV@/U-]>T6^UOL?T[8?WO<;TX:
MKEV)I:L$],'N\$3URQGU81Z-^P;\%-F[?,Q=Y,9%:0=+_:152>F3E4V$/'O9
M=-NP/JCX+R..OW_PK]=_O8CBGG_M_-W9=;9*2-T*DT]#;.1N*0N/T5TCB.@X
ML[,4]*$U?/)@PNTG(7]G4BDNX:5/ZI<NPURI[J'N%5@J7TOGLTQ3[Q(R=?O=
M5$E8S^9*"#6C?85$JIAV5%OPHZG3>TDM1A7+JB>XC%+1]5?7&YR6CL@>: 3=
M;\XB.XB3=$YTJ(^/\<1RX%<-L./0W:X:1P\;T RFK98>L07[?/K(%15Q?U=K
M6UY_'8S5]\<M,RG+@V!W*I@()+\LVWAY,O U,G^;=-EH(C";<;\L1[E4WT9E
M(XL0$ \)RBFQKS\Z[8(ZF)26Q2_#B@>QB<ML3\+*Y:;.*\89#L[+&;\IJ'&J
M8HJR^Q9NGW(0]R/F5-4&1X,SX-CA>IDD&4J_%R)? ;VJ'".U?'A3;;PL09&R
MC\-YAS7CS[,'4'8R;&3M1,29/NM9"/,++?&I=A<[-D]W/U K6,5Q8M=P6J4Q
MDY.:9BS.1:Y&75BI&BZULY><T(7I\M.:DM+"3A4HLS>HYIG!VGME!G+*.:OR
MWF;K1I9^/2G$,2&W+,.)<[ Q"V9LC -N=/Y5$>M<H4VC\61=95,W0 C-(NO:
MPO7:6;"@K?>7U"8-JFW!K,JF:.X4F>6-<LC9Y0RRL/F=GU(CE*H5R="-@WD^
M'$7C?)(&X(!,/:NJ)E(*XU(V.@V)*"? 2V&&YXMDIOTEIA).3-1H&]D?]%&3
MDY:0Y+0<M5%#&Y*4.OW8ER6E(86CZIP>*3!O2_ ^#&G@H<?Q.*35!=.W/V.T
MI]@9+.=ZNE]0X$K=J5I/#+ U$X(J7J\Y*"2,3X/AZ4'+I@)6)FECVG##'DUL
M:=W(#+NZ(L)$@]7TN M8H-\@_/&@)+P$"6D:X4RV;;=.U[KN?E:U</^7O2_M
M;ALY%OTK.+[C7#F/I EP$^UDSM'(FHEOO%W)D[R\+SE-H"DB!@$.%FDXO_Y5
M53= @)M(62) HG)./#8)-KIKK^I:@JP;=;%3ZPG3=[$8,]7.^]&4@A;Y(E@H
M0AC/VE'E:$%CY4)GKQF_Z.90ZV[J]$]4(RP:L9VV]WV\ZY!V)F<7XOF*LHLH
MT)R:A@&U]9AK\)@:V&1^%HSL+531,I:2RSB#\ GPUVD?:P;A@QF!2QF$PNZ*
MOK#['7O@="US*'IVWQQVVF.[W[:=[K"Z&82Y7!04U6,,>*\S0YI9U>\&TSIG
M@^P6^%D8NH]X7RX7;F-[-$S-1\'ZD/H144[P/\J:><B,6>Y0D-HD:9G)-HL\
MY]3L IRE#O<J!2H%6*ZG?KYPW%JQ/K<OK."^L%!5N&_9@E30R$,V%^/8PR]1
MPRJU[Q%A(OP=C;!,?;5-%'G<)M:>[9^_@N<<3%WG,.IZ0XNI,B-^Z[=T+>_0
MVRP7+,=U#Y!OFY6OJNLN[E[7=G):Q/VW='3ZC@KM@K&>KI<U6TH-\<SB:U#(
M,L'+7;#"8Y7!H%1.XH^%#KG(V,WVCLX$Y=5E*0:J<Q/6DOFJ%6R$AXZ2&<[J
M3:_'LXWGT@LQ.8(&)(4HJV)5CD:-:UV[H'Q4(Y?L/=3AZMY/7Z'"(I[K(&=G
MX]2T[RF3&+PE%-4@*1V7+L?/1OGMAW*LQA:1V0S>2B1 IU6Q =1AI=?1W%<<
M5GIM ,LHI/XC87)+_E?*:.NH.=K&"R,WD+\E[IWP: Y1C!T"@#9]B?5D:!;A
M;\6G=Q=I9^TH&4W=6'?)I'3^=Q?JH31L")]/1?A-QMEN[F 3:=Z4LA92%QR8
MP\XSQP@9#C>0^$K@NG1-$:M>.6/\5ID?^>M,:DNKFMBFZSC@O\V+V459=M2Z
M756+PICQ*LMXC;0AX)F3IUNRF'7Y9I SF(FXMM(O>1.I"E_/ODLI=I35@CEV
MJ%4S=0F?J3;ET5)24;34> 88< IZYTZ'<9?3)=4C;N@T\6(3Y\?-Z4(_4K/Z
M<"J$KS2>JEU5?9!4_:MZ<RJ+BI9'H8Y*.Q93:K:?%6*A$ %]J*73TN52NY&9
M%VO]LUS# I%O(+?2GZ5PC[NXG507B4J4*+F1WJODW1\\:WZ@&.9.T@W3U^)%
M"3RENK I-TDN76NE^$8K)';3O,]@1CE;B[',M;AXR2$9LZ?_EF![-.J8E'6O
M4)\M>@ZI=+<5<*EDK@70&ED^G2;%IS-\6\9B3Y2QN+CZFXIOU%-TJ6%1>HVO
MANOE>Q?INB(GVTZUI"XKH\HJHUPDO>CS9:[M<DZPS@=0N23Y24)%':&9D(KF
MXF@Q[==5/0XPUJ.&?<R$30(L?V-"TX96@C]$^%':L[#X94-?W<AO>$,W#;#=
M#(6IXHFJ[HM#B16&2E_Y2MMIG=/8H)+6MD[0'4RC.%4N:6/2K'AY8WN$3?R^
M&K/+E O\+%$) DJM.-*?(X"6LYU7&R<H=:*5D>-@+2,E4H! 6?XQR)E$W9?F
MRRHS'"XVK.=>HK 9"1J,D_:Z  ,@45<OE(2QN#_6!RG.?\A4F][8RHX4ZF[#
M0+6J#,+T6+KS!4I@[&*JJ"!7-()-.U1E9I;0H<ZF&FL =GUYC^4-*\@9!YX7
MW*<*6Q6%4E7'<F)&'N^(+$WH6S(YUG6_IEAJEC&S+.*S5*M<Y':L,_9SHK^U
MLB09=K#J'9'@QM.VC$*:,_PL6DIR/F%KX5>?LH3^)H473RZQ@>T- ,RUI>ZR
MF-D,O_[M9F$P_(0=92[# $B%_GHS<:6',^NBP';5!5/ZNY\N?[JYR/T2_OE1
M]V]4+S7R;RTTO,K,E<N;R[7O)D3GW@\4^C. #8QB_89+ +!8NR9]LUCT(YC2
M\*3:D2UP=DKA].K[K-&7$J]*:'^\^9(E!6?VYQE^>BUM3"Z<&Y<ZQP\.22WN
M/ER^Q9]=Z"\,LZ$_N_C<_'CS>?'#]^_IF^R77SY^>=\@._T6&R!3LW/U#1Q]
MTZ_I7<N;25?L=K<\\^7Z\S^*N\:#KWOR\N+]N_R3QED<W%(3AD;:+PQ^EL+O
ME180F4>C.\5_CY&W06%K"5E!.U")RE+-';#XFVCO"]T5\W*A[1:^6%ID3]>#
M"PFL49,;-&D',T&5A6#AXX#G"K:29]N[LK8WV4=9&EG:27UI[M\CB\_N72]K
M"ZONP=-4.N7BKNNN7BT,:;NJ3 05A<4B*V$1;%@RI-;6BYVP*;4PA,W,H""'
M9=DN79DU62S<;AD+:^/)8R$;_=I<UH+96-GRX^I!=TJ-<9?36)7C54BG7@+(
M:CEG\ !$5_.UMSV?BTGV.V1:+2%D 6]0=?.L'C?-U>BF$QF0(>@^$X?&Y2>B
M$3;<2.6L)& U>M2 ,%AT@$W3@5,Q9I].*>4#[(,3I(I^Y$/QQB_N-YEV-KAT
M0QL?+?2RN:3F _?*WRA,H-T8=DP["*2ODOZMN%682WS8#XZ##L;CIB=&TM,7
M=%I3+?<2J.@\(C:&*FL,Z>C>VGX#^;Z XU D3D,W<J:+$)VNT3!\>:O[,X,D
M"V6^15=#WP8#38-0GF0W,<6&' OADW''M;"!RJ4,09Z.P>\&(]]1_0:",$QF
ML?$YO!6^^X=>Y,*.4P:CD">VA/7CQ<Q?J:*AN4'KJP<Q[@(/^%J$ .3EX.N!
M YP7VK99C0_1WG-*K+.<:'V2<CI_A:BG5N1EM$;\%UU#LA10^=N7][GI&7DJ
MH<#XG$9WO /G\IZB0TOJ?#E$NJ'Q"[QDT>2<2"U8-/M8M$^FZ'UZDI%R86]S
M@Y7P:[U!M:SZ.ZAO=%&RP.5:\LQ:&2.)Z$/3EC6IZQG$.L@OX86A #I<S"U^
MD.ZR&]T.]P=^CNQ^\UBS^ZN;K;]G>NM/TL6*)^,B'+EIOYN/%)NJOK3\K-VJ
M'K5F'312,?,AP.8]KAT9-W_Z+\OJO@V]16QZ^9E"W%E#HV%\B)W6(LZZF'ZE
MQ)=$39?&X-5/%@)W*2']@PLL%BEU>:.2,G,C+]" U@M]6(3R\;8Q2H0J+%0)
M!"F>, =?>V[KM7,AT=33+U<7,B#J1DFLAZ*"U2Y#&V0? )RMQ#6Y4]6"R3]<
M1_Q1;D2[>N[$Q2@4OXNM4[&?'RQ8/ 2\)T[9+DVEC^JQ$^O[YYS*6,P%6_&E
M%M(XNXY6I;+O45"J,E>PP"XG(JTXOU2R2:H)<RJR!/;PXA8[S=K+IHEF^1QK
MG)S%R!Z0L&L:?ZSNTP''Y8YDN!_$>'$*XC.%@!J0(;++=%AS)<3-3+)Z 7&A
MDQ8G4E#NJ>[N@K/_,.L2M-H$;YG=0BPQ+=W'[$XWC7F3$R"I$03XCLUTP5$(
MSB9Z"D?-A7M:;Q]O_FZD\X)R14*5.,I#IIO*0S+3=CD?Y30@5^S&"V _?Y>Q
MSE*^Q/O.D*9#ZM2LJR24WP1ZA*&841%+EE !^_?2*929B?:ET&J(#*S5/J^%
MEI/Y$#W08[!AX7>%8O_<S->,@A>OWI*WT\H_EI\+GVO&/EHD$J=&G=AIHMC"
MT*-Z'NSR3AWP]62Q7$^"1CZ5N['&2A19RI8]<6EJ)R7UW5(MI2UGJET]%4ND
MTX[R,X[$O'!.(TQ4E9AJYT2U2G!F;((?&QOG;JF^)$NCM\SS\;!]WAX-[>&P
M.Q;6T!SUI&G9G5'WW.PX;1J]9;6[.+=E,7KK_:>?T]E;H^G\S;7:QB^)(/-:
M1JB&7&JU$'U!=>3'V:"MIE6W25M_W%J?WEW]>V2=]^Q.9]SL#SI6LSL8MIOG
M(\MI]GKV^6!@#<SA^/S%CV:KMS)IZR7B]SX(/><>*]$J&K>_&$E[6K*9G7%R
M<*^2/W)<LS!F5J1 878#>'OTA6[9EBWPW_G[M>T3J-<.L<^*KQ^3V%<Y;;M5
MM_[R^1]7UY\^7GWZ:KS_](^KF[0-Z<U1&QA;:>\#WO6I<,)2B6@V\'W1BF=I
M*'0A[UI0ZYW1?[1!#.?#>=5T)W";J'L0U ZI\=_0/1>HMUJ [Q-)/ ET*_)\
M?LJB*X"-5Y)IDK>.D6!#YYG$SNIXI4 Z1D:)%S>45J=*V;2Q-_ZW@7'FW#ZS
MRD0:Y(=,I=. ];8Q=NSZV'S=U=<7:DR+6\@*4!%G['V*M528BB=O<R.FZ=YD
M,489+ ;,OD9C-G)'GM;\=D@=SCSL!172Q0K"-Q9J.B'8N>K]6-QENW?83DKZ
MJB<B5BTGGJ-/KLZ\. _VF2L<)K_]XS:=MS+SU:=_O+_^3-Q\\0%S+R^OKMZ]
M__3+"3,ST#\6CR-!D^6G>BLJ_G61-U3-')4 JFQ;Z=^Y89#2?7[4]X+M=-ZB
M3B^)TLF41+E*.:5,1"S=R'J9D,()0MBAJI7/>^V75]>7'R[4Y(+,Q,2+0=6R
M-Z-1JJ,GHL>1.HZK/D)34$S3AEF*[FF^$9+^#*U)UW>22(^S3#-&U+BMQ2U7
M$H::/W1#]\C%-"NL\Z/Q7K'46214>8?P1/BHOJA@,[N>$E9:_NB"!3=T4N?U
MA)E+H4]U]20BN4ZQDUTFG/#$[7\N17]RT$CGIBZ@D:;](J4OE-:^?.06(F>*
MFW"=>#Y#;8TUO@"1*>4)+F;:*H[**CY<7XT4IIPHFG*!EYZD(E-M>U40"%^R
M)AC&!?A\>.T<:#TL0^HLK+2X8B%B=$'/I4P;Q<#NDL02/*YX!%A38B(J\AZU
MV_!0R16D W6]"W 'Z:ETVL!B@IFKC0?\1Y8'AL\THPF%AV ]S$2 +:N.2(08
M[<5G$"(QN4"#9MQ&.GP["U_:=IA@JJ K1BG;WT\D62ES,GU -(Q$FB.1^=PI
M5N +-0AB<1PRH";X4Q!XXP0=\.(1(ZGED6ILL,]<ZK[3[8_EV!FTK6ZWU^Z,
MQH/V>&RV>X.N98W/^]HY'B[-I>XOSZ6^H&,['Q:GOE0R\\)W/@6^%J"[#:KN
MU\Q]_O3NHOWIW>V_SZ4S[(]'5G,D^V:S*SK#YM"Q[2:XT&(\;H]ZY[WVBQ_/
M!RO>,XY/H1'5@G1BUOU5S:_NM-,HFI(I64I2.G%Y2NTS<%+S0C $(0WSI&3P
MXG>&+?P\V8Y4FFLC_V-=Q>#ZB-<<P:MQTNIB$LQO&KB)$X@2V):BZ#/D0$QV
MCE5ABKHGM6WU0W^>DUBAJH1!!B/!I%T3Q9>O5$Z(?J,2%U(=>)V<P)5S)1;9
MCCTJ=M+%58O!!3)O/*4#A!R5=6O\%"9^=._:WXROP;T?3=R9\3?0",:-/0D"
MKZ#^;H!K.7?D.7)'K,VY([A=DB]=2\BQ<*SN2(BN.1R)L1BVSSMVI]T=RG9[
M\._AX$7E$DZJ:.*]!W&C9(W5,CY>?+KXY0I]*6T^WQCOWM]<_GIS\_[S)^/B
MTSOX_\6'?]V\OS$^_VS\_/[3Q:?+]^!V77[^].[]U_29ZZN;7S]\I4<^?[FZ
MWA!;.2Y;\*/PA6J:DCD6NK]Y6BX'#WCSR(U49VTT=^BORFW(X@-X5^;;RFCS
ME<RB& %V^G!4G8U0+;ZR_M.4,#\AUW]$;4?2T6LJ'S,_>ZW0WF3QJMQX6V6W
MJ.HS/X@IR$+RU3&D%TFE-M(\^_]-0"#+$.3D-3F9:%S^#$: 8;:;_TOA'W]"
M-6OX;K)M,9#AZ++G( G7 Z*Q%@H4>1+1Q!A[P?T:IVH[O>PF%("'7U2#RC8$
M,_[OU>6O7]__X\JX^?7CQXOK?YVN<_53Z$9QX#4_8F,?X^:WQ!V-,#]@ANJ<
MHABW'BAR#WN#K0U9SG&R6X26BN)!-THG @8T9"'?CUO?^P-A^\&=:C1$#<4I
MVD9AN8GT9M@BR24N00L!6[GC2E0KC.X:+"U5P];/"5Z' >.X,^(NC O<SO4.
M5(]OJ8M;(N "*@LG^U@3^4P9VG,]['?#Z5*F!O]3)XR/ Q XRL-3YU@4O0"4
MP(6;I &1N=JD^@')E,U@=&G)%'#D4FG8Z;!,"CYRV6C^7.I>XO2_#([4WBR%
M( 9.<(['$NRHA0(:H-I O<=*-\^5=SHZ>B]5*@!VJYBAR$'W9ZZ:N7W#>\JI
M%'BUB'4DCCL>PQH@?][  9!N 0=G8/A,#!*"1IQ,:7X@G& B8</TQ"MP&*?3
MQ*=_-  9H>,"+$&48]=>?-:724C?9HA.X]7HQA&&57MG54KE S^HCDS4RFT\
M)\&'>Q_#+K#<*\2F5>#,@[BF>3GX/?XJO5'-GFV '7N'@E$_)$6(=])35Z$?
MI783)"P8WC-W)I&G5+1.CR-4(WV *#WR^$?8X!%;8VALJJND?Z8E5W0%G/70
M Z<]R=[KR%&L-04XK"JG6\SPJHV"BNC.JJFJP L_8U @H8JU8N#!IZ52YFA@
M8G?JEZ/-80S W%A5JN^*2O4BIU1_SI3&94%I7"]TS.=,Q]""UMNK;%#C33*=
MBG"N/[_1VTHC *[:+>8-91KN[RU8>BS#M&9/KX#ON1B-T(<@+?I5AM-L2"4.
M;5&MRQ[2GN3^TT\3U<6+J(2\)QPV (Q[^AVWM&>K>1XS#5PLES0'6<]$)560
M619RAHRM8CMJ.V]A 8B37$6.#E\ &E2Y&4VF3==R,7#W'YPT2]]%*F\70V0-
MX^I7E24"XMI_56@M1$RJ[#,DG%3VI)Q.(V4QF^6R,,6F6O?AGV=.(CQQ6VXJ
MKFJ4 V:C\>5=TP1H3MR1&P=*$'^X^*79,49>8']3FBAV1X$SST_1:!D7&25X
MJOQE/0)5%_/*H<"]"\IMX$HQ8YR)"]1,EH+"AD<63#J01'%AXF/HR8Y5.$CQ
M@$-3FF4LT,5P;>/JYO)2C_4BRL=N\O^4!8VI?YF[9$VEKXT7K#'E?LW7*%!*
M7:@L/U4@OX1JPO'%:R?*3/'R#-Q*8SH':V"JZ\@7@K9R$*W"P.O%181$3[5)
M?*'N([ YZ3*;D.OOB5FD&".48PSSXGT\&JN8M$=="(R?FD3KWGPZF\ F5Q(A
MKGYMI!=/E)>XQ$3J+@2.I1V %>99I/MIVVUQGX$=W="T_-U5/99S-YRPBW^"
M PZ?QMJT6E2S-I8R(#*.Q)!#'"9VZHR@KJ9X0S,8-^&!)EX?%?=3?.5'$47"
MGB38,3--O3 ^2->1(+0_496.!Y^JGFFYX6BI[9#=<"U(>1F<"ZZH%H7?!/'\
M6YR4VJ#DS)&)'8H[:J'HNZ-7U0+1LU?K;'V[NG0A7G.HRVO>L0,J6WB2ZV7N
MS!._ </.(DR !C<&^-C%<JXEMY/H>!0&PJ&L(GP-'N"+]@^_9*_,8@)D8E96
M%UZ*Z1_S("I5<)]-D:;%-);^JV)H0G67 -$;!U,R6H*1EF#@A/SM\B,)FM3!
M()/R(KG%PO],Y @;,\70]]/>\9? Q4:_ @-'MJO$<NH5Z#!+8X&\VT A3=%5
MZG3G8A8Y(LM^E&Y(Z9A9$&/;2F387#Y"&A6@@IKX,8DI!T=3];?XF<+8=])/
M5+ <HU<JP\%\F7&]CU"?PEJ3R%#)M1LN<@U'6<'O_>8'_,V7= K@V2QTI]2P
MH6+,?.6Y0.U1J7(82+Q:0#&4[_;<RO+ALLWU>J*RQ%2^E]2H%D",*L1A*E@
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M^*RS^.PGU0(--@H[73YX* &<6)>;#5[PA*VG$*0CA:AA+E:7WHJ90D&464C
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MY!H>JIB&S 5@45-B*MB,,A@QY78<4DKKW/"P*MWXJ4G^HC>?@@8$YU/5[ 9
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MJ_CIH]Y@8C/0:"8!0G?2F[>,KQ/LU[\!9 "8J0@!1_"(!P=W\/O4HX3/TN<
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M3S(!U/Q))H":/\D$4/,GF0!J_B030,V?9 *H^9-, #5_D@F@YD\R =3\22:
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M,2$5+5)#Y2)<!G   D53-M%@$SEJCM$DT,BP0 ($#)IO)O%3BEM&!G L!IF
MRCU@W^C-1O""- '#G,+8G6*L=P%MBC)F(545][9Q*N\LDF_2O[QUW&CFB?D;
MUR?8T8_>ZN5U&'W-4#QZH?KZK1[TW6ZWVA3Q3!/3])L?G@/>:[?,WN:O'SM>
MW&RW>OW=YHOO]]USS$+GS3[G9@>[4=>.T[<WWM4,CW- ^2&&MQ\I:,J;W?X\
M^;8\NYV'1)<_)+JNL&&B>A*BJD/#G"LW$F[FEY"U#AA5E]-CN3+7:<>\F%5J
M>%SF5*F@>;HI?GMF195ZZC_]U[EE6F^?>(C?(S-J,DB4D"'(-,PTS#1< 6PR
M#3,-,PT?(PWW>]^77OU,]%N'3CL7M])/HLRP5]<$$DUZ8Z-S^&S=!HY0D'Y7
MSX''B<O2FT*4BB:K?="NR8PBYJ0315.IG%2'F-E'<2=L,8VE;X3!7'CQW(#=
MPNX3-YJ4,WCQ".7"=Y5:/8M#PF@Z+C1]GUBI7@F?->P=9]?E>I-U'=S)=Z&X
M#?RQ-U\DJ[$;R<9O]=#48P15&T'F@%%4<125B* ZN(_OIU,!FUD;G&7/\;A=
M$D83HZD\U?K8ZS9&46TXJ0[.ZD^AZ]S*G]S@R33L\=IR[+8RFAA-3]:IF.^H
M*XZATAFI#A[LES"()](71C"+FZ[/#BR;W8PF1A.CJ1YH.B\QS% '__47Z<<N
MNZ_4OYD-[HICJ'2#F]'$C'0*&"J=D>K@N:H!U.RDLEE=/33U^XRA:F/(.N@X
M$<;0(Z[ ._LF+U7/-U60;E=<DZ[M=[FOV;)UC%)-"\"?$C359M;'^B1/ 9J2
M?1EF#&:,+7;&P*P]9QR2 :HYH/$@=%[JT0?]!PSJ@Y+SX^8KLJ!G0?]X=Z71
M'ARA$528+OE,<*,5=Y\RL(CI+;>PUX]U^K#R+%"M\]_0X"GW3BZ:RL,:^5]I
MN+87/Q$C@&(2;_[)2G/3PQ,5@:+;+<(B_^<D3'<S$[>R.0JE^-848]CL&^'=
MBWGTXG6Q_[_K-_, 7#[[YAD-1S6B8FDDY\*W78SDO*"1G$\VO^+@I&'VUAQT
M\^S1I0DUIG6^Q[BF3J^[84"-'DLCC'0,C%H+Q^+8.,L%_N*&V?;PJRF-F,+!
M,5X2N7=N/#=F</B 9LI49\8;@?<++.K-H_B9=[5U#^F0P[$;1O$2>OJK@V<J
M-V1E3]95%SIG[WT[F,I7KZ_4?*4&O/"$QTOI0[OZT#(]M"]CS5B*:ZW^4!D7
MN[.NV=(_&>TV8$J" *%I,SB,B6;7-/*C;>Z$!\_IJ3/X@H"V[L9R"B+&C>PD
M(A$CO>#^0%.1>%S-D0U5X<WRN!H>5U,IT/"X&AY7\WT'KO=DD4=*BQ.%#1,5
MCZO9M7<*8@$\C720[I,U%C^QNZ/O/W^U;XZLX?").\L?^M[HN88C,"$?%2%W
MK',F9";DXR?D88<)F0GY! C9;+3-?=.O#D7*=:A^O::6^JY4]P6+^?;JMN/P
M]:^E$N-9;S!\=9ABL&=)?SIU]'2M'J.GNN@Q&[U^EQ%49029PT$I"*I#M.QJ
M^7+>\((HDM'K-'7@\(6PY9IVW4,6ASV+%W+B&#KK]O=0J(R>0SOYAZU19A0]
M2J5:YAXVSQ,BJ [>*5Y W>H,57T'M3D)X#2--G-O-<IV]<$-G4<6$#**#G;Q
MT]VWF02CZ, HZG9*%'1U\$\O%XGB=N!'KB.59JV96UI"?R:VK!E-)XJF1][=
M,8(.=Z=EMMD_?2;@?@BBR #?U)&CV BE(Z>S1VO4X[7<2NBER08VH^E$T63M
M'?5E%!T:1><E!GSJX*I^"8,[-\*H+[8=P!*$,+'C)(3]U\Q;-0=L8%<;0Q9C
MJ.(8ZA]T@@ICZ!%2[K"S=&OHJ+JQ>ZON41=]02(9QYZD-B(U\UB[?*=:<0R9
M?%]7<0QU+,90M3'4W;=J]W!>:MKPR0_\!UH:\Y/%)QFP#-CC>K(. :MW+B;]
MNW$2RBSK_U:X?E2WI'^^MC\*-.UKNS&"#GUM;YDFEV94%SU[U D?+E15/=U_
M+$\R8!FPQ_5D':+6U'F[9J'ILRZWH*@P=CI[)%,R=@Z.G7/&3G6Q8[;+0<\3
M!:".8U+LEFD5CVRPM7[H%9Z"F[ ]&8"JSKK=_8L(G@XZQ]&+D/F$^:3;WC\P
MQ'S"?%(S/AD,]TWO85YA7JDGKV#7/K-SA%JE,+?VR:;,Z9TUD8+5E-35E=1'
MKN](/W[3-,^)\PZ,.RN]#;?ZF90[_!;>%L!E=EL]A,7VIK_X'R]Q)(X,%",9
MPU]&"7POH\@(TU\VJC,,E"#]=SF/P\01Y8'ZQ8]_KBYXODH<J1.ZOU4$/D1X
M\ H9Q0$0%I5YS<+ 2>PX,N*)B(V)N).&'\1&,(H%+(5J=SJ5H>T*SQ S>/A.
M>"WC6HYEB*,QB=7:;]_'<FJ8+>-GUQ<^/7L3BU@EN>O<E$]!+(UN2\T=5N.F
M 5^Y#![XUX>,)W"C*J9R$88X[#-;RC+?TK['2:C&;/KPKRDEV;<V#\AF^?7]
M\NO!3JL+$386;JCGH@H'P4OH([SEIJCF2"Z4PJ&)JR#XPBE0$>K,_"I8/C&"
MP]S1-[,0*$6/@5U=]MZ-)T$2/[1HA"6.B8?=>7(S7\=A,(75@$"!BF>@NUW;
M",9 [O!89,";:+!L<R9"@(7($3/.F(77N\1H]Q/7GACWTIA(SX'=&\&]+\-H
MXLYP##6-=VH9GY/0B"8BE/A3K07@!0A5M0T]>'8JX3Q.X8ANM#JF=@/010P2
M:)3@Y&EXR'.G+OX5]Z]W%#V>GX?Y1][___:^M+F1'$?[KS!J:V:KWDVK=<NJ
MFNT(E>WJ<9>OL5T]V_ME@\JD)':E,M5YV%;_^A< F8<N6Y(/I21NQ$Z7I123
M!$  !($''A:,ZI<"O[[B?'ZC^9P+'L(6G]G$0S\0$SMXU0UL=NNBW3H/Q#$G
M,^E615 JO0EZ OX&(9##D2I08D?"[0M/Y*J7<A)/DIR\0NV8"-4Y;"N7:W$#
M@V$+5!(T1#@.L2GRREPV:GH%QB\"')O'_ 4J(].+I(:PG?9D+_LHX-@05:EA
M4%Z+NF'+,(SA.53(]+M4GC(I*K%;'!X&"+@=Q:!'?-"YNFH.)8B/U006O$*K
M=I0WF-ROW(MY,,9FWQ76%3:/0T$__WK< <?:(=]&^3$"=&'H']C"91]^/>I<
MERNMC]A1_!B<-M7DM6+A.&4CKJ\IK@O ?+0, E=3$10\ -G-/0*"Y_HP'HJ
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M=!8=%A?)P)'AR.7C3YZ/>3R/<=4\.?GD/D0"K@+_3H885._Y <,<M2"VHSB
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M!YT1?>$VI#*722/:GC90?-+>J2\3HU=BUZ*GSD^8TE8M?T; *@9<^YJ>1VY
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MN<+<&N*_3%S@'\XMU54?20]A)3\=X$-OGM-*I<ZY.J,W?_LDH=JE2@VI<*K
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M -V[M<4>P"KC.1TA6PV_BCTKQ)XP,K;]LK#B!=2*VG./+K9Q_&".8-#:3ZN
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M*:#VT%TXZ[_0[E*I#VN.A42'D&97H*I&L]FN3[ +#A/;0V,;%<V&:%>?RZ1
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M45PF!:H%/D6<12>W"BLB5Z J6Y_5H(^$+^CY18^L'VP'>CT,/DG&<O$,)RU
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M)/8IW= :.1TJJ^&EC'D8CC'OANF8/.K9$M'OL0S3<#Z03OJ<R,AE8\CF2<7
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M/SZ2F[9[L'MR5?1X6!8"N356Y/G^Z;-?M:$KVH;%1B6=#W@(5S-;D'/'F8O
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MD'=A.CVO5\,7U\NVXY\^E9HM>JL;":I!VYY[KQW(7#3S%)4'"K,([!+!Z1Q
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M"E(=EZU,!7#(&E@IA8R8U:GY'8E'">II5-H*(\UTT4UF<FEKR[YD'7F$DE"
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M8LU5T@H//&@EP66OZPT/7KM)<\@N!H,^FB);![MK$;;U9;P2/3=R,MZQZ&0
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M+\-QP@&AB1*9A9(=@I*Z@+.)@\O",RZU5M&T(_G:Z$^'Z5W$NN8D9*>CKBO
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MZ=;:"36X\>77S^2FXL"K$KV)#+B0J2;9<O!!5Z?3*Q6\-TJW5H=NR!Z]:O1
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MOF 6$-!+L$X$B3$9GEK?UO4ZH1_ZW /Q/81.M)S<8JNIY;PO[S\#[J+C47O
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M*>%#X#E)Z<F$TDY8%S:[">^O->'EFI^K@YID5 Z6"S!*UC:6==6KI3&4I?=
M\1!2:+VPK('1KL[LF\F9\(Y.)J?C^4!)\F.B8B"#-35\VM?I:=""^V@">?NN
M=>F5V[#L?\G<E>_;:\;N(.4>#*VZ$%^L\;^&A$M<G#&'1EJP2) 4U[(VD ^U
M&#+) 7E(IG7*Y6U8G@+[#:3<:[WZOX?IL)[OO1K/<8JS^7O:I <QQA0T6B E
M+$#.+"<#3W&0/EA/'H)2MO4UZ=V(GH(F-)-X#]>3%^@6)[X?/D\QY+?C%=0%
M1&E=2;7%0G$NUXZ+!9Q@##P7281">WCSZ- .L)Z29K21?2\EZ:\N8\L[A4'6
M3NM"8,@CH%7,U?IQVEGPQ0A9VW!FT[I0\RU0GH(:["[C'M))7GZM*5*GP]FG
M"JN>%L7Y<@\S+#$K&1DO.9%2N@HJA)IK%RTO+@=G6Y_*W([F\2M (TGW4-G]
M7?BV. @XPW059XUOK!D2(BAI)5DR)D&-F0?ODP/R;$/TUB'Y>(U5X5Y0CU\C
MVLK]IF*8716C1@C.:IP5SMZ.U^DO;5S&RN@E9%8S*'AMT6U$@*!<=%+R[%WK
M->)>4(]?,=K*_:9BV%T5XSU^OJ*[ R,4>3R:)JH104G/P5L;(1%[0@;F96D=
M-WP=P^.G?2>IWF39M34++_LSBV;M^1U.$_TB'.- :(Z,!0=81.TX:PM$Z4@*
MNA9ZX<*Y'IR'KN@>OV;TQ,1-G?$[VQ+324+,LU]))J]FL].:>O>VO/[_V_NR
M+C=RY<SW^2^XQKZ\S#FEI=N:44L:2>U[_,2#)5"B;XF429:ZY5\_ 2ZULEB9
M))"LHF3[M&HS\T-\D4!LB)A.SC_#[.M2JTUP7LH@";<.31[!RH6[*(@Q*EJ;
M$VY?M:,/CZ-Z_CI26?);HE('!R4WBOO!C],[6(S A)2IH,0:A_N;]P;=WF+H
M($Q.G?.<U;XS=@?"\Z?]$)ENX?B@UB7O+LO:I_DC?)]>?$>KY>4,TKC$13?#
MU+235'HM"(-R28JK2'P(D2!HDP5W*?@[[2VV-C!Y]$'/E]?Z<MS"\L$!Q;+&
M]_D6K!_K&?0OIK/9]*\"VG_#WRQ^C *UP0'Z+B"I+;W@(@D\1J)HX#(K&73U
M+FM]\#U?76G.QA;5.3C8>/-$*O^.+*A(J1!$,V6(+/:NDYSC!F899SYR1FL'
M%^YB. $5.$2J6VC>.[!8]J^;8#["!/[R%VBACJ=I1*E,NB3"E+ *43FT3K,U
M1 A>VGE9SDWJL/\_^(#G2V0]N6UAL][PQ_GU>N?;.FN\^'']!Z7_ULS'1:D]
M>O'CWR&=XS[T"N;C\]7$R]7% \^IA"0C07,4100BX=)<(#QX:J5VD?GJLQR:
MK6:HFTFUMX\GPN^Q+QS-9XO1R\O9#";QQZK+H&8V.4N)LJ:$8?#$]"50G[3.
MR3LE(NMT2PX_^(9BXG?72GGWF4>_2G1D%9A6H*)B245<8QB=75RL\91;H>O&
MHATP=;@4-(?XC_/I]W_;/&NE*IOOKE5E%Y9A+_8<QLZTD6B'HATQ<*"V%,CR
M3&04G#BJ#:&HU G][.C]KFCGTZ7[@=LQ[=GN(]$6++_^\^-( I/:HSMD8\FI
M^,"(ER(3#<"II\Y)O\L/Z<TJ/G,X<[6>]._2V5=T%8L=KS#\GP__B>:/SMF
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M2*&)#LJAQFKC4NT"XMV(GI2WNI]VW-T0*U+0HE/JUV]^/"L[\WUL]ZL)?1(
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MT4G%ZL5##Z,Y=C:[%[?;:L@.EW&K:YKWD*W=\"[8&F6T=^$Z4F*[$H>=5.,
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M11.%^Y7\+2_JYKD?U;*VW]J8RIBS-(*<I\I@0D2W&8XY#%/D*>2XB%,K/W>
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MIYQWS6#VCF/3A#"7G\5SOGS6^9]U\.X=8?I$LZXQQ3"108Q"& B?-"82E:&
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MW#5#MP#4UUX9 I]));Y\(T^M7^0Q3W#DZ1KC0D(4(@2I]"5,");2%XRDR.H
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M442MVI]V338W.MG+4=P(>TW:4"?.9L3B"KV12>4<<.[-#Q,PG!4(Z)AJXEH
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M0Y!JDD(4(RZ48#IAI*_H^_DFIQ8>5A;WEW^_@*L;=X5%:V"N:@O$WX$#>^_
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M%52OZ- #HH[(T.4IHT6%'BZU(T*?V_J7<'M7E(+-_S_%5N_,OY2S-,D2BI6
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M7[AEIX@8SSC/4HPE@RQ+3&"%9 :I1)GE.)5P)!,EO1*,1K)[:H2Y-QB(ML5
MV]63[]7J"=MOC/K%:&.]"W&<X5@+!9&T)=FQ0)!3EL-(,T:)HD0+X9=B.\&W
M8:2\W OOPS0[WBVZGV!G#AT';(_9MERNMFRW?7O@PL&YHSM0.PX*\^^5ZU;W
M]-*M=^"Z$K+W/&/D_@HT41G+ZE%G.B-WQ?%4:>SF>]>+66V4_+)\87.;5;TM
M9\)CI7*52J@384(4)2CD*-60)K$R'RFF)?$Z\7^AG:F%%#O[O"O#G$71C>,#
M8#,P)S<6@IV)PQ1[Z4(A7)V7LZV,7>*ER]4SU5TZ+^\W\G='*CXH5JHOQ<.C
MH9O?R[K.PDQ%"8H3):")14U82H6&/$LH)#F.%:>$&G+P&?^=K4V-!?8'B^;6
M6D\RZ ;6C1*"P34P,>R1J@R] Y6I<*FA,;8NOA*.(9Q "<03W6V-RA9.;A]S
MAMM-/6.&[ZR8VU2;=\N5S6M]J_AZ+Z/>JJI:Y2?_OE@I-B_^I:2M$O9&Z>5*
M?6,_9HAFL33S6R@CFMNB\#'DG%3[3(H3Q9($XQ[5&H(8YS3"QJ_F4*?1;W8V
M@[GYW3M6"=)[CI'-:)TQ4JJQK9NQ=^ .[!R$QEAH7;P#[?K/=8_M'6LJY?'*
M-V"<"Q@_A<0Z5+05Q*9Q8[.0,)Y$<D$?WGO&MVVE$A&QRK\K]6B51;ZK6D5D
MNXLBTXC@7,.,:6P8&F60D#2#<9*JG"12Y)E7/3_GEJ<6#[9'=*UV<V!Z-:B]
M)XR.G> \A0P/[="3RD^_O ?WZ_6JX)NZ?,YZ"3ZS5778-GA)+F^$PDTX'=L=
M>PKJ!\>92:GG WKF*FV>GMCJY9/^J-;O%]]5O9GS'TH^J$8+X&4GB9&25$1I
MQF$L8@&Q(2_(N/DU2W*1"AQC)/P.[KNW/37*>JM6Q?<J)Z,$_]R8KXA^J3*7
M2K!0:U#LG &/UAM/]O+I$S?^&@CI@1FLL=IN,MB#K7O#067Y5I;D91!1DAZ0
MA4IK\FAYW-PF?TA.$IQZ/,(_R^G_JI?U:B/9;DFO^=@G*$[3-.%0,F0K&*H8
M,I&GD)@?2209UIFS7OJ%-J9&5%LS@>?2>Q>,W9P3")R!N>44EQYY49< <L^/
M"@#42'E2'B^25\+4%00Z$J<NW3E: M45T]N)5-<N]>>X.F_ZZZ,)Z']?%.L=
MQ:D<LSQG,#>S2XBUCB'7@L),IG$6ZQ@1[32IO-S$U!BNMA*4UDRPL7:Z#^ +
M(%XGN-NA&9C?3E$)7%6@&X&.87OAQM%&;;?A[4%[Y<H>=5V>K++WORJF_J3?
M*JU6*RN_5JD:,V0':JR@BH@9N4H+2!*!H.0BUT(1%6'NL6!_K;V)KL&W3;:!
MOVR,-G,J/R'I3JRO#_";H1MID6<4N#PJLP2";:2@IB]\?O57'##I*KK2=?MX
ME58<G#@HK^)R?;\E*UMBZY,^J,'7*%H0%(E4,PDUD99"(PR99!ED*N%Y1@1+
MF%=6Q<66IA8#64/M^WM8?;*?4LAE>-W6FH* -C!M]L3+>Q'I*A:!EHPNMS/J
M M%5=X^7@Z[?T%]H_]N*+<K"\D]=4666HTPB*QV"920@IAI!JM(<9DQ0B37%
ML4I\E?:/&YD:,>RDY/>&-J6!_*7V3P#MYH-0, U,!3T0ZB6V?PF"F]3V3QXZ
MNMS^);?.Z>U?O-9_D'\PF,\_/RX7ZN.FFK(+Q9(LTA%,.3$C'+,4FJ]]!C%3
MYM.?JI0K)\&.<P^?VJ"N[ .5@:"VT'TPGP!W?1#? L? @]<#":]!>\GE7H/U
MY&&C#=)+;K0'Y\5K>J:_V 3([3I:E&IICV)"E@D$<4H5I#HQOT84(Y+R-,IC
MKPR7UL.G-BAKVSS35-I@N477?2$8>AVB,FN(O)(S_H9*'6D_>MSLD#-.G22
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MEFNF4Y$Z?2)]&IW:.-[9714_.; <[$SO46G<N1,<%J4'@';H9>G71M5C<7H
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M1^/-A3]7,I1V-6>Y*+_9,W&SE&N<93R&@DH3)MCR&003!3-.*,M3JG*DO+8
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MA-WRD@I2A3A$"<D0$[$BL=<*UL66ID8IM:&^TY/+0+JQ1!!X!F:(G8U@;^0
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MA69&#AR[G3V-%J]<'_YDM2'X3]H>JV7_/W?OVAPWCJ4)_Q5&;.QN583038(
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M=-!C!GZ$;.^56_%?#\6F:$+3;(296FUMD)KY4M89^I7YM: 8Y8C '"AI"_%
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MZB 4KPE]4C$GW*8GBSR+ 6)2 081 SF*$TD4Y1#ZI@-<'G5N7Z[7[$>Q;<H
M;1K!O</_'<!V^]($AW#DST(K;]0*?',4D#M"64<OE,)E #B,.74*@#L,)W(
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MY+21W7I2&^@COA-_\JEQ^UR-!?C(WZ@NUHUXT:L.UDVFGI6^_?MYK+V_74-
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MH7.-%,@R:&UDA %7. $09T0G6N8H\2RZ<GG0>7X:BKTE-^3KX(1VK+26*".
M&'@!PHD"%.4(I(*(G#!!49KZ%'\/CO8$T9/3H>WV10V-X<C?Q:,-1^UH_64G
M<]0*?3ZQ>T &G3M&P1+I'(:<.)_.'83CM#J/>P?6/65K6\9K\UFMJS3@*I%<
MR05$C(LDED#Q/ 9(B0SP'.6 ",RD)%H1MZ(U%\:9&ZFW8D8_K-E?I]Q7!0\B
M=I!Q_^KWKS>1K+6HZB(\;&1U5W6Y9WF$<[/@QD4!L!V9?G:P&A'KP@0W42-E
MP-JH_3"$*HQZ9I1IJZ+VJWI4$O7"Y0/C IMR?[:P0%$%7N_(Z4.YNC/+]7[_
MI^?MU1=2*B*S7 *><@H00P10HA1@(D]2SE1"_0Y9KY!E;A34JA+M!;Z)]M]I
MJP[X9O3I_-TS%NV*>7,CI(EF8V32&C 132/3R*H35?H$/,P-@&JH4+8K))DV
MLNUZR(X"W0(\TC]W[I/9Y(N"M14%N8UCRVTQ08&-<:9CP!F&(%6"YUH*A+E3
MF^FC)\^-"QOAW-/"GN/4SU97:3\R]S1R!:Y<=U+;GL2OY]=/EO1U4LQNPM?I
M"_Q7U9O"_&JK-FVL=[N\%!62$@BP8@(@DF: ,HJ!$&F.-,%YRC/7Y75ZB+FM
MLU;*722V^XH[@^'EI7<],B.OP1THK80#:G&>0<<]5_5ZE"9*6!V EA=W]0/1
M0V)G;IR,S?H%[]+:A2L''O!4R;'[2)I_%MOOY</VBV*R6#Z]4=9@*5;63MG%
MX_[QXR^VEI_7A5"W\C\?ZJ3:V]7J@2V;SBT)UTIRR@##VA@@.6& )B0#F,D8
M&:K,)50#LKS&D-5IJ4R?#5;+';&=S)Y'V:-,J^-QTTO-TJ15"?;Z17_5"D:-
MAE%7Q:B;6=!,:J5GM%?T)JI5#=\-:,29"'5<-H:(TYZUC0CRT4'=F&,-+(:@
MM%JO;?B3*._51X-9$P#,$>,X12G($FJLY"2&((]S"5*>")823%+%O:H=G!EH
M=K9R(V=45()Z5C XAZ8;]8; :&RKN86GEO$FVDL9L 3!!1Q"U1@X-\RT100N
M*'M4)>#2]<.(X+65=K6MJPM\*3;_>O5D&\Q6;8U3E>H$\AR8'T1=^81*F@*:
M0:05B2F47GU>>\::&QT\$S6RLD96U$$]H_L@=B.(0,"-S!$#,?.F"0<T C%%
MWTB3DH6#RH=\X7++,,KHA*NU:4.0QKEFQDR0G.4 *<X %XD BF-$<$Q50I!/
M+-/Q$'.+7*KKOK41I!UY_;CA!)9NE' =0B,S04>X$?*MSJL>:-F?&&#2U7Y>
MP<-%WG/EL+5=!>3584F[C$LDLX1P"A*AS-KFBH%<Y[8F-X$X1H2@U*O^V?$0
M<_OX7Y\>< I&0X]Q@BC0G"& \IR G"8<I%API%B>,25]*/)*&"<+[@P,HQL[
M7@?.V%[ "I<V8#,X/9[7/1 ]GAA@4GH\K^ A/?9<.;!9M/BNY,-2?=*W0MAC
MF,W'<JLV'TJVLBWLWQ4KMA+%ZF[?)V$?9"-PHK!9ZK9RFB$ A2"@-(T!YCKC
M4N:"8*_H^BMDF1OAMJI$G[13UX_@<^/&*A,A/C+][, N==3J8<]SMM98JW2I
M,J9VVG1F9-1 J #HAFH+?84DT_:%OAZRH\;0 1XYC%O->.N']GSK&_NI-IV#
M5)TQE*+<6$^8QP EE .N! >Y@I3G9L,)A5?9C[[!YL:.M9#1UDKI1XF]D+IQ
M7BB@1B:U1LSF>#JJ!!WGD-H%D$ \U#O4I$3CHO0ADSC=,_#0^F&S-0]='YUQ
MM8$X(DY('D/ L-)FRPI3P!@C($N),;LRD:=^6]8+X\V-,%IQH^,36<^3ZPLX
M.YY>AT-O[!/L\\"-4$_0$9=09]D71IOV/-M-]:,S;<?;0OC$%SF"G"@E099K
M0R(09<;D2#&07#/!\SR!T"D<^_3CY\89!_[OR,Y9Q);+PIA[OF;' 9!N+#$<
MGI%)X<#U/9:[>U0G]TNZMMT<V@/7;M4HY.</);9*?GU:J?5=H6Q"G*4'=J<6
MMF\RRV ..,T10"Q+ 6>I!(P+"C,4,S/GKD'?/>/,;36WHD:;5M8;F\7:2.O1
MCZ<'VOYE'1"PD=?W#JNO>ZP^!\;*HXM1&,RFZF<T##N_WD:7$>GK<M1S]W3]
MCBZK\*SSD</EPTR<+\IVV1/;A[5M!UENMK<K:7ZGUH_JPZY0'X]1DG-. %*5
MIXI@P&&> 4(1)IH*K;53HHS/H',CT&<R1U;HZE"T$?N*4HE.,^!F,87&=62>
M#0&IMXWE@U$@R\MIR$GM,1\0#JTTKWL'.M5L\8(OZD>3@OMY7=ZMV7T5'I<0
M+3*F4Y (FMEFLC$P=EP,"(<I8CQ5 GI%(Y\?:FX$5$D:[46-&ED'12#V(.SH
M^0J"V]B.K8&0^7NJ+J(1RA%U?J!I_4P7%3YR(UV^X\HV,9LW:ET\,MO%>O.*
M+>TQQ=?O2FT_V.DS1N^KI_T%MA7VFHFM#8!\]=2T'&[[$)MK*Z_F(J:),7&R
M'# LF-DK,@H8E;:F*L4HE9!SOYJJXXDZ-[+:9TMMHHZN4:-L5&D;M>I&KYXZ
M5T6MQG6PL/E;VQ*ZHW7C>/8M2SW>N^)&F_-X T:FW3.3?W-F]F\BWC/]E^9Y
M>-.>T:8@=,^?\(*^3,N@T0 _VW%HO!&'YM:L?Y1KME5O%-_NT_\:YYE95]"8
ML!S$.F:VJ5D*N(@Y$"3/>9QH;C;;?MDU/:/-[8NQ$_:Z5B;]"#NZ)T/A-K9S
M<@>9%;2;R3R":](%DV!)-GUC39QFXZ#V<:*-RTT#W!K+PK:6;=[E%&J1"$B!
M1EP"!#4&G"<*))K&1'$I"(;.CHSND^?&#(UP'N?NSW!R\$H,U7YL/T0M5^ "
M*R>U[3LO?W;]="?DI\1\=B9^\H(PQ5/>/7XL_EBM%5O:4NV_L6+UH=QL%BD1
M4C.! <P5-OO!- 54V*^T8CF"F4Z() '*H9P>W>G%G+[ B2TOO33B_?V7.R/H
MK]%Z5^'^ND(G9Z; [0L>$-$7*D9R$[W[!_CX_B;:BQU9N:-?K.0!BW?[0352
MM9 S@[YH_8]^("Y5]+APMW^_T[>KK1G@5DKSVFV:_]CS]F21*)5E1F$@9!S;
M/+(4Y(PIP"F%".4:4^84V]@[RNR,@DK0J!'QIOTAJGQ&GU8>74_/ ]O/-<'@
M&IM:AB+EU?OT(A*#FI^>?^IDW4\O*M9M?WKYXBN2<%^7]S_6ZKM:;8I'5<=(
M64[YQGXN>*[BG.0<",0SLQ=0">!F#P!R"6F"$8JY2G>&B6=&Z?EAAU@DTV69
M=L5N8AAO;,K$@(33'N3=[)$00$Z9BOI,U#:%HK8\;FPJ1>#<U,O(A$Q4[1EM
M^JS5RZJ?3&%UN&U@L?]U*922FW=&W,_LJ:I8^*Y<5X/N4KUNQ;9XK,R<!6<9
MD3*C(,LQ 2BU/8ORF( X2[AD)$M2&7L5^/<;?VYF27_#N""(NS'.B#B.S$"M
MY'7 ^2^M\)$NU[_6#?DZF:A[#0+6WQ\&7:B:^YZC3UMG?Q@T1[7U!SYF&*4=
M;\,^K<QHJKA;U34 1,<+9'LOO5+F7;,):K=\4[F$%K'.J# B XELQ9-42)#'
M5 "HI880"D*$5]31]2+-C?@^EN:_?_OZMTB6RR5;1[Q<K\N_JEY ]ESHW_PX
M,<"4N='DM!,Q,G.>/BJ*RE74J!2U.CUWRQNU;B)>*6:-N^C/5K> _J-P0 ?B
MV0 "34J]X0 \9.. 3Q[@T[K_L2R$H?DV41?A3#-C0*HXDP#%-E$W2<P_58RP
M0HH1XI36?^+9<Z/,G7@>GJT#M!Q\6\,Q&/M<JI5L0+N%H[?&/9MF.!Y39="X
MX^+G]SNM>9_G[^".Z7Q_IT5]YOT[<TDX$_']RK!=7;)_P=)4*"2YX2+" ((D
M RRUC6,X43#)THQP-,#Q=V'8&7O\'O:FQFGGG[4ZBKTJT69;+)?1=[7T= M>
MFIGA9IXOT"]MPW7D'=<L.P',B#97=[07-ZA.J.YB+9VZS8^(-NNMW17+![']
MM/ZJUH^VS+_-QJ Y5%+ &""S!07_7W7?UMPXCJ7Y/K^"#ST151%&#4B"(+ /
M$Y'IS.IU;-XB,ZLW8NM!@:O-*5GR2')6>G_] J0H41)% 1!)<Q^Z.FV+P#D?
MA \XA^>"D$* ZIB#3,D8$J)YBIVB?,Y-,+5+T5;&,A%L*Z97@LM9(+N)H@]X
MAO>+^2+C3 >7U._:_^;9QMXW/^WW_=EA1]GHEY2J=_;%SUWO2?^JGK9NKL_Z
MV\-RM;']1&UTX$Q1GF4P50#G,@4HAQ!0AA*@TCPWMA!22GM5U'>:=6J;OA0.
MV*8G5?#ODL^+^_*:O;Z)%LJW[ZT3\/YN]%[@'-=YOA<Y6NI?HPKGLI>ME7L8
ME_E%F 9PE)^?\]7<XQ=AZ'**7WXX,/]@SM9VR,U2_/5N^6@N,+,8IAG& @*6
MB-@04&:,')5I '6N4!;G,5%>=11/IY@:VY02VEJGI8S1GY64OBT\3I%T8Y3K
M\!F8/GRA\4\C.*M]7[D#IQ.,FS!P5L&3+('SGPS;W'5/U]OE(R^JG*6O.WO\
M3AHV*71ADYBJ^M=OQ'\_%RLEWRQDHVF ^=OSHY+EJ[A]=<;JB1F$6(K<W$ZT
MBAE L;)-/50*&$14,96D<>QDC(PF\=2HIWI]O5@NP#5%\(=?:#<JF]3R#<R,
MM:Y10]F;:*]NU-1W6\H_JC4N;;:&SM%6Z9MM/,->[^V3_1'N:&O4$W\/+^^H
MQ\%H\!^?+N--/%J[XKO')_-/>RNV7K?;Y\?G>?E*LNY5S&2<$TY!G"<"()89
M2SKC.4@$A#DW)U8>.Q7V&TS"J1U&>_FB8B=X5>I?+O]>C-ZW^,+ZNIU)K[IJ
M0[\Q#>]8O-<QLDK:)C.[Q9] MV*W)7B]5L47Y)MZGV(W>'MH4NPX40^E"K<5
MQ[ZOV&(]+X^W?5?D&4%QFDG. <$X TAE!% NB?DQUW&F$@Q3+Z>J\\Q3H_@Z
M[DO4<5^;O=0ET2_]XY7=E\&-L0<!=V F/JQ<N!7ZYC3,KJ'',-F;WN -4=*P
M<][7JVOH D=G<4.G :XL6O:N6(OY<OULOIV[T-44"T8QI8"AU-"7$!(0A<QU
M%L=(*I4G"<N#RHZU3#8YQMI=6J*&M"XAJ?XXN_%37^@-3$GAP(57T.I I.\:
M6&U3O4X5JPZES]:AZGHFC$#N%F8W&K*RE:$7:S5C1&K!"068XP08WE" LIP!
M'0OS?=%40Q[[<,;1^%.CB5J\2%7R^;'",7AN1' %) /O_1T:[R^@X;W5S^C<
MT^X^'GW4#7U&M>,]?.YCH1UEZD#Z?[%5Z7^KQ__*-FJFD2(JPS'(LJRLZ00!
M(5D.)%4,LEA1G'NUJ>J>;FJ;^L/=V\]??1O+=.+IMK'[0VG@?;X7]":J18UV
MF]\*VV<O&A=0>NM-TSG9R+UJ7!0_[5WC]-15Y1^J^I1UL4B8")X8(X'HG /$
M-08$B1PH) 6&(I$Y\CKP6^:8&C\$)%>W(>=&"E?B,3 3U&4:MI5R^Z_WV*%^
MO[48#F9XC?H+;2J>J;G0^M' 2*R5DL7F=R;LJ[:7,D(9PSB#1%!S^,O<[&AS
MA><:(@"YD)D@20Y5ZA6)=3+%U#9T)6%4BQC4R: %2+<-?AT\ ^]O3V3\X[#.
M*M]7'-;I!./&89U5\"0.Z_PG0TWS'VIAX']IM%96L9(TD0@P6Z(58<$ 4\1Z
M^#B7A-)<<J_2SBUS3&US]Q/KU 8FU31E0B<@Y1(#1# $',4<X%AS(A$UII*8
M_5 KOAP)SN9<0UKYE9#>-;';,'1U>5R%R^!NCZUTP_3U[E"^-__'Z0PC^T#.
MJGCJ!SG_T>L39+ZQN7JSD!^9??.R>?FLW_Q@Q;Q\M[Q<V3_N7T//> YACI$&
M(K/%6#(2 Y) #9(LSHG$V#!M<,J,AQQ3XULK7?E.][$2WL:'++7Y:?67VI2>
M@JL*ZX>NEAO1C+ & Y/18>;-;C%J+>Q2'%7IOXEVB@&]7 '[S# I.0&(#I"D
MXR/%JZ7M!$#5E<@3,IQ_$94W\=MB/B^6BX_L9_'X_/BV+KYTR\RWU<Q;MPR(
ML>"$0-OVV%R<-%2 VMSB+">8:Q83K)W*6'G,.366_$<<;>6.MH)'.\FC6G3W
M0B2NR'>SX$!X#LQX3E &%'=QQ=2]Z,L V(Y4#*8GC+T*Q7BBU5% QG6DT0K+
M>*K6+#CC^VA@YU/QH.3S7)F#0HC5LVI&XY<-J+ZKGYNW1IV_9H*H5"">@31-
M)4!($,!CR$'"F(0J$X3%F5<G5.>II\;IM>3VCK5UC&\]#@T5//NCNJ^#VP5W
M&'0'9O@FL%NQ#]*8JMY\D14]*F7OLZ6J-V!]M5AUGWC<EJO>@)RT8/4?X4H/
MZ#[N:;]?8,9XFL8I4'%25KQ( 1,< 4CC##,8YYGPBF[LFFQJ3'6]"Z\-44]?
MWI4XC>74:X0Q&J(9@F)<$.G;T]<VU>NX_#J4/NO[ZWK&CRKJC(39']_>S91,
M<A1C!;2,S56&8@A(HA, (8-$*!SGRHD2FH-.;>O_L2@VYOC\9BR&RC'WYE&M
M"L%NHG=EQ61'0CC K7OCAZ(Q\ 8/!\)Y@[=IWM%_IOYXM9'KG_:;^&"X439K
MFP+UIFS]6X#/*'.SLF'*8&9[H&N84("D5H#B3 "2Y4ADF99FSSK[C-SFG-K6
M_4?6K\_($7D'GU'_> [M,W*!,L1GY(BIA\^H?VS'\AE=]77U<Q7Y@=3E*G(<
M:3Q7D9]J!ZXBST>O=179]TIW"YNX5B;J[PV#C*:QQIH B9,RD8P!KK$QM21)
M$$&IBM- %]&Y*:=&W4T/1B-#RKZ9JSQ%^XR^=;191A^69H]<+I 7NB"^OJ(^
M8![11V31VY<7C!J2C^0JNH17[RZBLQ.^DFOH$@#G74(7G[RFSLLNY5)#G6>$
M(* R:1@I5] P4AX#303C29[$,/.*6C\<?FKLLRW8$9J\>H2=&WF$(S(P4;B#
M$5AQ9* 4U*/!7Z'6QZ4TTS.?\K<)ORH^7_[?EWF=8I)(1;,L!@)S!)#9FX"A
M' .I%(HYCZ',G2HJG0X]M8U:2^=N<!Q!==E6"P=@X'U9"Q9@=1V!X&Y<A8,Q
MD@WE#HJ7O=2N=X=9=/3 :-9/NZ!-(^?,)T(;FW]G/^NJ=*)<VT_/Y7?*MA'E
M4"N0XS2QY8D3P"!C@.1*0J:35%(G$^;B3%.CI&W;;MN/[5#<J)+7M\'Y.8"[
MF:M7V(:^8(0B%M#H_ (:5S0[/S?RR W/+RAXVO3\T@-AYL,_U4*MV/R6K1]^
MGR___I]*WJN[A5ZN'JMZ//7=F"%.$<\0H$I;3T<: T*$!D(E/"%QBJC"/G:%
MX[Q3(XU&G[[HOY_9O- OUNG'UI$PFD3:J!(]6%T\7S^[+H.;B3( N -3RU;B
MR(H<69FC4NBH(?4@AHTG4CU9/*ZSCFH*>4)Q;"/Y/GYM>8_UKO;/AV*A[C;J
M<3W#.,6\;..4Y<K<98PI16 F06*,+*13:&Y^**RZ1\ML$Z:FFZ8K]D\K<52*
M[.D>Z0;;C8IZ@W!@ KH*O2MJ?W2@TGOIC[:Y7JGR1X?:YPM_=#W43X;<9WU<
MD_7W'Y^*68Y)HF-(0<RA!(@C!@RC8)!K3C/*,<VYU^7';=JI$<QA M;:R%U&
MEZC*[;CO1=E;!MR9U7 CGOXQ'IB!6O+;#+HG):D-._T+?+H;+H^M&ZB!TM;.
M3/JJ66K=0%Q*2KOP=(CO6"A#A-QLNV_+N?R\^+1<V':PSV;GOV5K6]]$"P0%
M20$4"0:("0YXK&.0LT1F&4DP(]+=G7QAMJFQDY$/_/';M]]LB]Q:\FAM1+>M
M79DMDU"+'W$KOX\3]A+P+L[I'N$<W%^]!] *&WU>1 UQH[=]P^?CUNX1QI$\
MW=\?5,3*\NR6SQV_G9&L*E]OS,,OBJU^Z\L][HA?I\?\TA@C.M$=U3GTJ[L^
MY,_1^[?]WQ[8R@ZGY.WRT1:VW):WEH7]?S9OF,9'Z4XLEKD0,@$I4>:RR1(-
MJ$X-J4-SS<S3V-:A=67Q'N29&L_OPF$^ZZA4*BJUBIIJ17N]FAXD=\[J8QTO
M'PHCK\[ Q\85"^,3O#3(6KF?0".OV5AG%.//<[:*Y#XCR)Q5]O#9+#=FK8K%
MQAQ'ZT)$/TJOB/GC\JEL'QRIGVHE"KO0ORQ7T;I<^.=%L5E'AL!_J-5&R5]O
MML-HZU?9C5!^=AU9L]$\?73@E1&$]H>_57'_8#X F!F,W:OH?L46&R#91AV-
MMS5$:\&,-&7SC;V!N@^6*\<XG;2G4[;'[TC'.=S'+*.=U#U"TCS+^QPV(,,C
M23+X32V*Y>K3<J/6[YZ56:6XK@5"8QQ#J0'&1 %D#W.F% =IB@2CJ5;"K?'X
MQ9FF=D(GOQEA_SVJQ(U*><U&4Y&5V"/AH!/<RX=K;Y -?&QVH162I]$)FT=V
M1E_PC72"!7WI_%(Q7!#I2L#H?'Z\M L7-0Z2+9P>"/6_FU&_*/-?:<PRVZ]Y
M%]VPSQMXI]9B592G^BQ%<99#*H 4MC1=SC&@>08-LTJ9X0S'%'K5[_<58&I<
M>RRTM\?=$W]7W_MPJ [O_#J0]Z:T7]BJJN/PTDAGB?[\LIP7M@?9$"D7H1#V
MYI_WG'YD3WT8.*<^^\!Q H,7BC6[OU^I^W*&S_JK^J$6S^K(%J5*$%NR&.2I
M+JN4,\ R:.Z-#.40R225PBNGS&G6J?':H=#6NMN*[1G!X(2X8R1#WS@.'=%P
M#L)!4\6\4.HKPL%ISG$C'7Q@.(EX\'HXP&[E*_:3+=36*$@(DY@I# B/M8UN
MX("2+#%VJT:8) ARYIR%<CCTU%BEEL[#G#J$RL'L# 9@8#JH!0NQ*0]!\# B
M@\$8R6IT!\7/5&S5N\LV/'Q@/&.P5= #ZZ_]$P&DL\\#_]U<NE;+'\7:&BS5
M#_)9;&S4Q/HCD^INT;B8K6?F-ZE"N4VREP*@1%# F;D0:8XHDURD(G-WI(5*
M,3DJ:Z35Z^4J>MJI4O]HE=E&:3T:=:)B87YKG2-/E48>^S]XZ1SX<HP%&9I:
MC];BR^%:;/4H0[KV:U'J$GT9;RT\:'N,-1F+X8=;&[\CX5I,NTZ/X+''.VBN
M5?_@3+IZL##[?7L/MQ%^=:NR_UUL'FZ-,,M'M=HEZ4B:$")A#O(L(0!!R0 1
M<0*H.;\D82+5?FD(CO-.[8BJS<TRGG772>]O(WE4BQY<N<%U*=Q,^P$ 'MQ-
MV0NVWN:])U(]&?BNLXYJXGM"<6SD^SX>V 6Q;6C;)>R3VFQK>,]$2C*5BQAD
M@B* *,3F?IUIP&+*:4YA$A.O>L$.<TZ-JG8[**2#F@O&;CS4,W(#<U [[=Q$
MI<0W$=,;6_YK/E_^S<R&*J];VZZ+'Y;K]4U=0[['GHON\/75A-%AQG&[,KI#
M<-*FT>-1?_/_]H&M[A5GXJ\U6TB;+&UCS6Q4]'KK5E(9YCJ7"<@8S@!2F00<
MJ00P%%,$H6("0U<S_^)LDR.@4F!02ER&OI7IY#NAW>W#RSA?MLE[16]H$NH&
M+L#;>1E!=TNZ5R1'LIBO1M3++G9&J,/^O3S&:':NLSI->];]H<!"IF6@[1=6
M2&,A?V<_+<,_+.>R6-S;)FFMD9.S3*>*T%P#FMID,I%+P(AF("6(F5]Q2G@Z
M6]AW5$I^]ZAP&B"+TR:AU28YD6BXC?)MLQ1_1:(9WOY+L=B&-?_J6=HT9(G<
M+I6#(3Y26H$5$%2I!%_82QEY\V:U,A]1]M\W5:[!.BK54G-9WC-MB:*&GM%G
M/B_NNW- _(NB7H%K7V520T08MW#J%2"=E%*]9BS_&^O_44_+=<&V9WX<:Y4P
ME -IK&1;JA$!QB U:X(Y0T3 %#OY]$Y&GMI-="N<^WWI$*?+M\M@[0<FFJU<
M 3?&0P3<;X?!2(QT$[ST5?"ZZ+4JVW&I._S\:!>X5C&;E[7V#X0&!/XHI%I(
M0VHO-KBG]A:E0JE$)CG %"7&%*82$*P3@!-[*Z-$,#^/W)EYID8].S%]@_S:
M472['O6 S<#$M),PVHHX@.OL @J]!>JUSS)R:%ZGJJ?!>-T?#_3+&R//_L_6
M"/G!YO95YE>UWJP*88P7^X<W"WGXB\8GJ[>9=PNQ4N:^\TY5_V]^GC_;R]#[
MG^+!7H^_&D/HO=;*5H6G*LY2E0"%! -(:PR(C:.)#<_PE$(2"S4K<S0=7?RC
MBN_%4SLE!MR06Y%MJ(#5[:8J6]A0L?2;[ $H_^[Y4F'<+XCC^XG)+OO07L;6
M5;XY7N*;MG4_?*)"(:IAB'ZI@?CU)MIA$=5@1!:-J(*CQ_<DK[*,?;UR&5?X
M<=_>O,K"G+P(>ATI D)*X]\@A&52HBR3$K.ZKT*:2073') \AP EJ;D_FZ<!
M)2GC,:%2J-0Y8O3,)%.[/)=B_OMAYFOF$5=X#LO+!GT?" W,WZW@A$3"GT/)
M([BR![1&LO\_+U0MZKNFJ#U%1%X HBO@\=RCX\4S7A#^(%SQTF>O;4]7DO&S
MV)3%3,P/:O5#O7WY;H;]K&^7Z\T^TRUG22H23$":"V7L *4!QP@!\TV0<2PP
M%'[=H0)DF!IO-MNK'2@1;;6(^$MD]; ?L)J$]JQS7R7']SK#8C_T:QU?V$=J
M<.>-9>\=[]PE>*46>-X0G>^)YS]4KUQ97F3G]GVQG:S11A)S'N?FM@@0UMR&
M1'(;O$U SB%D*E:2QEX.6,_YI\:1AQNTLG%+L<N=Z>FN]5V+J]BP#X0'9L(+
MX+X&[UU";5C..SO[%/CN$C2.7'=QF-!P[\='6XZ/S;^P)[7:&B<<*:;23-M;
MGP0H3@6@B!' ,I$@FN>V6;%?@'?++%/CK+V0T9.5TC>FNPU(1R_IM? ,[<S<
M(U,*V&-$GQ,$O<5>M\TQ<K1UAYJG\=5='PYMZW>K;-3V_&XAU<__I5YF.<E0
MDJD89#G*C(6';+)T; P^GF:*"RYH[M2JXNP,4]OGVZ9T6RFC4LS(R.G;ON\8
MR.Z]W@L\ ^]S;V0"VO2=T?Z*]GS'(X[<EN^,0J?M^,Y]\)HNWH>](LP=P8:X
M+9\W7Q63Q?SEG3(;ZK%8V/O@KA7.+M4Q0P+*6$% N2V-EZ8(&"O%F#"2DCC/
MI!)^6:?7BS0YJCCN5+,N4Y>,-M&J4B>2#7T:Y84]39P>5M/MJC'N&@W-5V=:
MW90V4;U06YVBIE('_;H&ZW[>!\J]=DR_2J!7Z++>!X#MG=E[&3F,N'\O%L5&
M?2A^*'FWV)BO<V$F*=/FUF]?/K+_6JYN;5W!-S^+]0S2#"%HR#EGRM8%P,IP
M-4P CS.94Y&F>>I5V<]C[JE1<24Z*&6/]L)7N:-KZ_LMY8]*!<RF-BIX5@CP
M61@WLAT([H%9M5>DO:DS +.>.-)GYE'), "28]8+&2+4H30W/RY79?_%1MK-
MNUVCB+VCE@M,48:M<RF# ,5( 28U 5E&,$H9@9G?!=1C[JG1VYOYO+!)[]Z5
M!-S1=O5%#8+AX!ZJAM3-;*]H+W?TYR >\0# >O-GN<\\LI?+&Y)3WY?_$&&$
M]?9Y72S4>GV[?.3FQF<#9&Z7BW5A1JB:?YBYUUJM5DK&LY@+1A*F 1)Q;AWC
M*2"<*H#S3,M<0@93IY(#(9-/C;*^EQUZ1%/<:+.,N(K8O-PV2OJ1F==*N+'9
M4/@.3&>UV%%#;EM7O@EU0_3^R"P$KY[8S&OJ4>DL!)1C/@L:X]K0!9O7NE(/
MRLSSPT;4+A^5+:1S5,P\%0S%F:: T8P!A+D$3,02<,$SE3">4NK5(<-S_JG1
M6C/.Z$"!J-*@K$44&L#@MB)NW#8@SL._3SR%]1<K\J\C!2]X(=9[\(+;[*\4
MO. %S?G@!;]A EUIM6ONHV+V2F@OB'>+I^?-NLW^T0D2:99*($E* ,H,SW'.
M.&"*R0RK'$/N5+4^:/:IL=SOYA!:E&_T[QI=#JW?O.$:;RCFR7A^*^/H31L*
M[Z']::V EE@W?ZY4L1EBXGFUB^RJ6@UO?S&, 1N$:U\^-Z^YQ_6ZA<!RXG<+
M&B2,#3_;WJ5OA%@]*_FAJ-I/%6I=)[?GC$.A4PUDG"F %&: 8IJ#))8XUED6
MH\S+=.V>;FI\5TKKQV$7\'0CK?Y0&IBE2D&CK:110]0!:@>X@=(3Q5R8;%1.
M<5/\F$0<GPIIZZ/$8UV%1N,LC5',@8IA;/@AC0%7D@",XUPQ(G/(I7M3G_W
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M2(Q(%RVQ$3R>$H)&897TL;8COCV5[7I&[YS>WK 0.W#*X](B4CKYA*R^\ /
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M-+YGU-W315%MLTC"$1=XJ9@LD5LY2Q(L3\"D]";5OMO?B+!V*\<W!*_Z(ND
MSGXI+92.)M/^-;HTDU[669E4.E>;($M?.$Z<L)QPIXU#^JVM7MWW,07M5E)O
M"#E[,+D#$#D;]T?C>37W<X@#/YGT<S_.99+^YW8RLU=7*F#V&(HXNEGZAN)$
MN@#$Q5#>"3D7K/>E%%7UA)OM:&RWFGE#,&M44!T X@G\OL*Y\6B(7\9Y(:'U
MNKAT#5 QX?8*IA3J8)$X5,^X2 ?H(E&@J7[[H.UH;+<\>4- ;%10'0#B2[7W
MGK#SKD<!-!,R$!^40O^9*A("*"(,>M#<&*5#[=ZWF]+6;D>UQCR !@33P<#&
MH@CRY>P9R YABL=_7ZDD\SIJWKDPLP1N@T6O3LZRK SU*%;)B*/).1&YD[E^
M.^!W*<S\L3_Q5U?CTBD217.:%]/.>/Z@1Y,(S(*1A$N5T<F-F@3E,TD\^:B3
M5[QZHZ6-"&N[H$Y]]*RY*ZHLGQ;/N9*DA!;D:!C[@_YL0:/\>3R:3/ L3[=Q
M>N%QHT]')S!=_>#)6AG3S)7N)HZ+$IVFCEC*./'&.QIU9LF+-]14#3K:#44T
M";UWEU('+*^+^ W2[:"XTWB<3^_^VD^PDM:VPNXC/'G&0S]8LGKRX6[!AG+?
M<0'C[_VX>M61LI=9B$C0,3=H@J+%X9/SA'L020B==:Q]=#2VF':#*.^A;KN!
M@PY:AO=%QG>V#9^.4*U\?@/VX?JRZLR6@'Z,Q+/R?E)K]"LMHP1<E-1%\%KP
M#4Z>ZD7T'T#[DI]2('F""OV%'U_B5Q,DI-0T?J+'K=*>&I8)LQ'0LO#H0?.8
M"*1@)*#=X:K?I#6XG"X5Z=\&32^KJ78EWD%%M7&I^YT5V;8S[*OH]EI16R7\
MG:5<20#"@BOU(J0EOD3>*/.&:P#0(6ZB*ULHX?^PN99MN%:I^'"W\MW*-;"*
M6C*!Z_71$<F4)CY81A2XG'@T/NO:(>%=Z/S!RO=O@Z*7=61#8NR VW)V.X[?
M_ 0>\KN._ECT0?XR&E[A1-<//WJBYXT"Q4(,A*;R](>I5+)('6',Y8P.FK!0
M.X:\![GMN-NM />]A-H!_#[LT7E;#3_X/![=WDSNNWF7[,19"N$MI--Y]7P4
MP[Q,['T/W ]^X(<1+KX!E&( #R_4UO;GH(D9A8LA7D$F4IE,G-:)9$JCXRR!
MX[4??K>PS'9<]985?3=!U'+ ]4L_PG RK\S^3 !/U$=4T<8(FH $B3Z)D\0Z
MB,185^HVVZCU6];QEE.VDS#QKCAM4@@==,#6MNC9V=EZ;;1&F@DU>-NX81L8
MP[R,(49"<WE0))@G-@5+E+".2LM<E+4?<C3;4FCV-OU>2:]TJEF,OQ)[X$9G
M)1G!I98[^E+2D 9)C A!4^4UHYM$V#::[(=H";0-%E;U37UV=U#3/&J\LT?.
MPO-1JK8$:C1_X966+D$F8XV/!%1)?C))$F=5) FT38RR1*LG<3?9&.@!TB_T
MFYF]FYPQNQ=]"MR;2*(3Q8WGZ,9; XAS39-W0DO;G(W_)GEM9RU4PLS+=GA=
M 77 3WVTH%)T[N"/_J27# ,(CI(HM"=2YHB+8/B/L!P,*!UM_:R@-82TBZ?&
MQ/Y:EZF=9-!%('T<7?O^L&<,TY*'2(0HO6VH4B24%]X@0W8V>YU]HTW<'DCI
MD'+:3<AOP68'CK?LP1_"X J&<#R<PM4\>/$5K@.,>SD%R117)*52G*6\0G/)
M*L)H9E:I0(5G&YC++XW?,2CL(KA192YV3844W3K3M!,8?P>T3^%X"M>3'@4K
ME6&&E-K+1#HP)  #PI+S1N'*4O6$S4WH:C=IKI63JH:$.H"Z#7GWX%IZ'5SF
MG@059^T=$W',F\).PV))P>>U@QA;DM@A[58%([M9XSL)K+MX7+#PP]TECE.R
M8R;3E<M=+5S&S5N24'&)T3-<K(79&9*99%E6#ZSM0&;;B<7MX+*:X#H8IUKI
MT+ISE.KY&!7[QC88H7JM4ZBV.5F9.+$LJ%(YRQ(;:.G5%V.@W >C:^_'!KK'
M/@ZWGHU'W_L3E,.GT?A^LF?9\5+KP *7Q.5RQ>.E+#TY$LG*"*VYY=[+#0SW
M+:=MNR5)'22L#W/7YWL'%<G3=JT[:Y,7!JK=3K9!O?)B,U'CF?$Y<\*#X$0:
M""0$=.Z495PD+UCRM2M---54=N4QPI,9/OA)/^+)_+$_N$53[@G**0/%DE&$
M*RT0Y>C%!#R5"4(<_QM"Z8#:W).3;4CM:$/:;3#TR@N2QH360=6T38O7G=76
M#I.\9^O:!M7=JXU(N?'.6:U)I)279*1ROHF < T1C>.HA*J=>]QD ]N''70_
MR[S_!>Z=+WT?^H/^M ^31>?4=#H\AW@[+DY$V6%/CWSMI(^9HYOB2ZU[G@VQ
MT0<2HY;.6FITJ'T>5%U AQO@;H.[E]7D>PNY \&+KW[\&TS+$B[*JF8K73%2
MO0_4V4@<*_'HG#,)/F5D*Q5<!@]&UNY'_2I![08D&D-@/2&T?#VT8G',BNR7
M5HWSFDQ/MTF@UBFI!-%)E@:0R"D/+!+P/(+.,AJY27KGQA.V^UZX.G*:8W8'
M=%)I!HS:]6$OE.J],)[Z_G#QH[E^7HG*15<NWCQ1.I:+N%*;4&I<I;4"(AJP
MN.[*>FIK(MNMQ]:8[FI66!U XTI./XS[WV?/5X^')5X\VVK'P_N\?30@EGV(
MSD;S=.Y[MJ^\OF<@?%*:" ]JW@,273M#F*/9.9V4B\V%_JLLH=V";N]@![Z_
MH+N/\\^XH;^,)B^Q <:SRA3#N-J+665N*:[8NJ2)E(82JT 2885,4;M@1>TB
MF=47T6X-N;:PWK"P.X7VBV^C\?02QM<?(:Q>])G,!2B&/(VJ=!XH]C?-Q# %
MQJ3 XM.$IHK@74_31E@T/S 6*XBB4] JRUC952M'@U:"BD!)BE#8E2P)P3JB
M@E*T7"(GTQRX7J)J(WC9'QA>5<31P8!WZ7UQ_.O!AR][7.H_'V/_AR>O4E6W
M\\;D'"+@.8;SG,!*8W?)C$BE:0P3:5Y_RY4.Q2%2R!)"-*JAYAOK":JG6I;3
ME#:&DR\C/RQ^U^*$+BDLR\E7WN-'=/0]=22D4@^V>%S..$:B8B+;3+5@M7WD
M/<CM1/>."JAZ61LU*\$.JJGCDU^/3BY/SX_WRCUZ.L;^N4>O4E4M]^@[4C8:
MWZWB*%FM<@B.))48'CM9$\N9(&"REEI$&GFHGG3TG(YZ2NE^],/;\?AY11":
MC,'#.A.6?"92YTQ<8J47O0I&(H:!QL8TT.NTM9V/M"<Z7M8R%472095R=GYZ
M=G1^^;?2.[8T^BH-JL_*!?C."N:M$?=5-UM17$GYG(W+T^[I77FY4I)HRW7!
MS:QF_+U]G0.S5*'S7LX3:=$4]K2<:")15ZI0J>K-[-\D:O^>+B],L%+>PL5,
MO0%BJ8GH6/K2?)Y'PA1//L1L0@-=7-ZBJEU55!<KS]NW5)5)!S72Y]/3CW\]
M_O)E613QN.SRS\?H!1U<7!SMD7"TX<#[ZJ==Z*^DICZ/1NGW_F" N#A&LH=7
M?9QJ?GFT+D^74^]2*'VE2I]VEP5Q62(JM;6E1HUUU5]0;$5@3:OJ\5PX_9*2
MI_52!>@8A2%!4U%R3SP)L_W)/=,9SWD?FJLUL#&9[2JXYE#VFA'6A 0[J/TN
M;F]0DQ6%[@?WUP4K1<MWUGX;#KRO]MN%_@IE;=^:]J$F1LS<):<):&Z)#*HT
M,K."&*:=B4'"LV(BZ[-F-IROG@Z;E?Y9N""+?(#'P!<Q(?F1$\9*I7P>'?'9
M1:(-^,2L]<8V%YUZB[KV2M4V@HR7%555,77J*F9>Z6ZVI%*+?.$,/]Q>2@OH
M\V;B12QZUT;B(_.$1PD*F \A-7<A\SIM[96;;0-\=434*>@=Q#B^A=54XJ>5
M<J,*/#D@.I8>E5X'='YD*2P": 70;#FKWN)X8^K:J][ZSO"K*J8. '!9UF^Q
MD5Y>5];*R>@LL0(7)TU*)#"7"0A<71 L,UK[C=:FM+57DO5=P->(B#KH%I0@
MY^7?=G\BNOKG>S\,?9&66L]!9\G8#Y>%*24=32+)E@=\,DOB7?E'NY1X3$Y5
MCS$^IJ!BIM04L?AM-,!=-YG/\=1[3<D(<(IH!GA$X](1L#D205VI:Q2I;?"U
MYUO4M?S <W=4O)(O55,@'3BR5GL)72,1WTJAZI*86![1EWS$IR<RLR'3TD(W
M&4<D>""AM/?SW&M% 1F:4F-XVXC$=A\L-0*Z^J+I%/+0#+R]OIV5)9I[PQLM
M5U";( A->$8#0&K'B4TY$:5BX)JR'&US3SMW(KG=!U&-(+-YT771MOIZ]N7T
M;T='%Y>GA__YX>CDZ-/Q9;E<WOVFZ:T1][; MJ&XDE'V$-J?*S#$Q**+YD,!
MLEEEA. GD,[\W>->"RJ ELIJDF7IF*FR(H$RA&MD&3_WP*N_W-Z/XKHG\7+N
M,NFGT7T)B?MI'_6G&,Q&GW6(?OC%IZ.4%J4#/WRZ%8T1SM%0S@M=>J86-\<K
MDF!6'%ZX')N+PKWC0MLU1=]Q+[QN17015IUY0+U^D0^]@)[>2JT$2J/+H%TF
M5*M0["]<;I$2* 8R.Z[<TUK@;SRMWIF4=JW?%G#>A@@[93W_,AQ#'%T-^_]X
MOCE/1K,'ZI .?O?C]-0,<P*R YD(0ZZCJUK:'5(CB3*0M E9<M_<L]B=R6[7
MBNZ$)G\?D7?0\CX_^O7HY)<C%(*_NAK#U6RL45XT9O\(4]\?[/849Y-Q]W^>
MLS7UU3K%W'>N/QP-9U#\:W_Z;=F]_AZ>U$K./##"12D#3*4@(29.> P!G-%4
M,UI9(VQ(VK[Z\C'33Y=,GY?[9@:$9,R0;!7NRI)\Y+6)!"B+4B=FO:BM"%^C
MI^W:U/6Q\E2559-&!T[B><GB%<-YUK3"HRUAM?;$9I\(*OM 0@9%J!+4,&F,
MJ?[P8BTAK?L]E>3\M 3*WDSO '(>.5O#A">W?_CD$K^:X#XK#2J7K2H<I38(
M() B+5<+DGC!&8E2*C1:O<;CK#*FMB2Q7;15 ,7H_234 0 >C@;XZ6@\JT6Q
MLM;%:FQ,S!LJB$FI=,$ 37"G&N(S%2EG&7+U>]37*6KYA6J38!@U)ID.X.QL
MW!_&/IKA*URZMWHG<=R_61X/-Z-Q:8=YB+[4U6A\-]O .0 -/C)B'+5$FH@^
MDPJ9>+!@7*D1'FKG:NU%<.LAF&:.W/<38@<0>^*O8<U2%DVHK(F .S 0HX(F
M4CA5BE>@*^TH<S0*'ZO7OGN5H+;?K[T;,$9-2:GE&/0)3&_&HW0;IQ,_@.4!
MXDN5%48#25PC:\!29(U(A,G@19)1&?;$+5T;55X[>+N0J2BX44TN=D#SO''R
M!X=JVI>F9(F76L<TDV"%)BQJ&B";[%3M]V85;++&3KOZ0&I #BTKEUEBQGBN
MD)>;(EFP: MD$L$K4MI[H2$@-7Y;*AW0'*3-&ZB6-4.W&YYO1K'LR\$.J)47
MS,(O]UV]+#62H2HDI6@ZGL-<X1&<D#<^*<L\50IL9<7R%DVMW_0T8TA7%44'
MH+6@?]*C/F7-I"&"EIK7%!AQZ(\2"YYRP[FCU5-VEG-W,LRYHT2?]1/=@;W=
MO;L[ASA"=V'07]Q^?1Z/)I.SN=EV4<RVZ0CMN-4/]K[6VWW*2C=^E=;\SI>!
M/" JJ.*$FTR+B6.(+4V7C=71XKF9>*K=6.:=+@,?-8XK/'^:%M+360$K-2^9
M+DY#-IH$[20IR2!@O+(T-9=<_ )1/\:UX#:H>3G#H89<6C:[9YM\MK$/TO_<
M+KI$S$(>,:2<HV8$;"[-=DN?$:<B\2P$I:0RFF[2N/W%"=H%2F4ACFISM(NP
M6/@GT@@?M-9$)%%N#(PG+F;<.UQQ-!.,TMGN"HPV(X45A?<6'';@9,N ./SF
MQU<0?/QMXH<I^LFWU)_,ZY0N7$UNG0@Q4K0>RT624))XDPT!H[+E@6LK] :P
M>'.BCH%C%U&.FN)KRR#Y"JD??3_A2N9?CJ&D&$X?HIR"Z<PY>@/)2O0P&#H7
M4 K5@C7()A>]VZ2G\%OSM%<9HPF(5.5J-Z)\,^K',+T=#R?W>,?U^0>F+=?F
M@F;1 A$\)%2[LO0XTY'0G 2+4DH5-CELMIVWO>(632"H4:YW(+:SW]V>L-I0
M90T)PFDB*>K60''9+GB9J&/&Z=J/BW[@F_MF#.?WEV0'8/O&-8#,661?[@$+
M&P,NRS-%"04118XN2%J["/@_[?7]5L#8[OI^"RFU_82LA.P6/)N=,@ME#\88
MD9A%9<]+@R80N)ARWY0IN&BME4][N:Y_%K9^^$Y?X6\CO%%=3G8REP.B 989
M(]2PDH40!'$&2LTB#R5(1N/3+MV5<SG:NH+?$0C[<[&+<9Z5&Z'DE(W($NM+
MF1BO0CG*-5&0%'JBKOQXUU!/1RY0WSD0N!MO.V"LW%_P62MDY$D0G1DMF>J4
M..8Y\=[39 ,P(VJ_&6GW_K2V+%^Z.=V&L5U4&[TL DOH.1+-F"-2J41LE+RT
ME-;!6L^CW^3T6#MXQT(Z^XF^#@NWQX";8V!84@ @75:!P@KUGT9CU*'?^Y/R
MO&#^S?U5\5>?X'B(5CQ^#/AOFO1<YLIPQXF@5!&9RN.7* 4:3]0#=49#VJ0<
MP<X$="S&LS^DWD<4W4W:>.')<KA;K-X/TSE<X8^:>H+]\DS-/LK><(7OG)D1
M0RA/B!#&E'LBG>#H;P,C.62PB0K!54.)5N^7F7$TG/:G=W_MEQUU;S:N4'&$
M+!\/_6!)0:E#LW 8#H;I L;?^W%1U+7GP0H7F"34YU+U@ 94 %P2!XQ*!5DR
MU5R1S(H+^3$R0+9!Y\L9(&W)OT7[;S*>]A9K.!TO5C!_(R,I)&85R5+Z4O!8
MD> -(^A#6V6U15]IHX>_.,$*=O&[!]R^-'=7<DE:@\.HHFRZ@:U5ABRB--Y2
M84(P))G2 2QK0WQ,DF@E&(_H-+&\441\,X ])Z =E-61Z7. [,G@ECW0XV([
MP<I23N#WQ7=GH_$TCP;]T2(<)T34U$$F !K-:5M>.)<Z(+D4%LV1 G-T S]C
M\QE;Q\F^HATUSN=.H6=!O\S!4ZL#B;GT5?4BD?)"G:0 203<4L)OXH^N&[N]
MP%53\GL1(CLPLV4P' WZ?[_MWP?OD3S#T>4VL:0^F&1)2)*CDO71"^<8IYN$
MO!\-VA7Q[R*;40U&M9UU=)/ZWY<PCTR#A7(U)VGIUL(TL4)[%"$ ESGG\+0_
MY/J,HI4QVPM.5I7OSFQJ6;QG>,0-[B;3X^OAZ'L_+1:@N39& B7*4X/XS %/
M/*<(9TQ2([3(SFP@Y[6#MQ<ZK"KP_1G7]L9&=L6^7Q#.C)3"02+6E.MW"X$X
MAR9/3,+&Z%V*3_L5K=_9JX.VUVBH[M;>F5%M)ZW<C.\B#):YT-D;DPV2.^L@
M$9 1(5%!($F*=JP&GC9Y$/YHT(TDK#HOX=T9U;*$_X:.RNAN0;>A7B<M+=%6
MH)N"!@;277+?+2B&'HP4=I-<I-4Q-Y*O[KQ\=V93V];U]<V@'_O3_H)T9Y,"
M+S11+&8B593$>30;8U(B"Y65W*A<S)-A-Q*RZ;R0]V%6VV\__+3TQQ[..ZQ\
M&/MANL\FC\D$BYZDY[P8%-Z5IU.::,.$M](:GS>QQ%Z>82/IV\Y+OQ(+6\\L
M?"G 8%R(S/E,S.Q>6WM#+'66,'#<4R55T&_=O[XZ05?<L$:B+'78VC(VSB$,
M1O^X6UHI&GRP%@PQI16=5,(2*ZDB*AAAJ,J:\[ !(!Z/VEZPI9*(1E7XU;*D
M#P+$ZZ6_8;PPJ*44"1*0;BDDL4I+7 :8J+QWQFZ2&+8Z9GM[O;Z4=^95RS+^
MOW SFMP[E8E39G4YZR@+!9P"CZB42R8;=3P[+I_V:%HKY$>#MA=GJ2_EW;G5
MLI@_C.'.#_^QM$D9]RFQR(E@LVM'0XE-#(B7*=/2U#A;MX&<'X_:7IBEOJ#W
MX%?KUV)C"/VX(%PY!B)G(%E"Z;WH//&*2D(%FBA26NW,)EK[T:#M!5OJRWEW
M;K4=-1VBFW&U+-*=9,;% Z&N-,C0)A/KT%G1%&Q**B0GXP927AVSO8A+?2'O
MS*NV97R3;OW +RD'PRP:#^B2>H$NJ=:&.$F!1)<T=XIYP3>YVWX\:GM!EP;D
MO#N_VJ[,XJ__<3=:!@JHH4&52E8V%344.9T]<B7 ,S-<A!B>OAI>7X5E==#V
MPBOUY;P[M]J^"!E-[WZ;WBY#3%& 5Y(3FHOY&"(EGD% +X$JK:4T>2.M_6C0
MC<3L?@PQ[\ZMEL7\Y?3H2301)*1@/2.4*DJD$1P=0J:(%]:"<TR8IP4.UXKZ
MV<#M>-#-9*GMQ[76@V+?!_WKA^MWU$#1:B0UEJN[4J[;"A6)\"%:2#%[MUE0
M;'74]H)B>XIF5(5/K0?#QOX//X3[]^%41+"<0.:R%/@N?22T)>@,XOH=#9F)
M#23\>-3V F+U)+P'GUI.6K] 5L\*[W^&T=78WWSK1S^896E#-,98M"X4VA-$
M,N2%MVA3 D3!8F NPT;/I=](6G^1@*Y4"^K"TX@Z4FH;:G#U= F+TY-[R_"X
M%(0'XTJORT"\P5TH.,O>I QH/]6 VDL$M)?W7DFPH]I<;A$JL^INX[O>+Q<]
M:[V-,C!BI4$]JD(DGE--LM$>K5^A6'CMW<P$XI^O1M]_7HPXA\;BFP=D/,S7
M(@SJ"&VT%P=;C^'.].B\D?PRE]<9G36N/HA264*A@1UT+%ZOL!)/YF"LW\#@
M6#-T>TY$75G7X%S;$;^2-#)__7T?DBY-RY!NI3P23W6<VT]:.S3.$E-LHVO7
M9P.W<RO7C-#WXUH'ZO)L:U=]N2\S(9)R.E!/&/7H;$-4Q$;N20S:\RR29+1V
M?\"=B>U*C:BVK=CWE7H'X'U?'2GF'".81%Q)B9 ^4=S@HI2D%8&RG+5CM3L_
M=:-MSSN)^J6J5-OPO0-X65?SX0S&,\8-(YR&07]>/.4"_YWD/J12"@>^]T>W
MDWDUG!X' ]Q105+(R#8A!;&9":*$4Y;[Q/ PJ8RT_:ENU\UO!Z/O+.L.%CXZ
M^/+E^.#D\.AB]XI&SX;8MU31ZS3M68-H%B5<3G!?R\5J:HQ,F0 M.7->HX%N
M PJ5@_8H!CQ+-ZHD]G3@>G6"7NK3N6C1'E_X\6J_]D4Q2JNRMRZ04B$, 9L3
M"4D[$CU(D7+42:;*RJG^*MJ[C=@/.R_7 6I%OATX;O<KRVUBD"ER() S)S*)
MTL\ E3%Z<IE%2#$]=5!_@,K[[U!FJ!VT52W5OXWH.X#SU\M'!Q]X$I#0B!%
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MZC532P<0^[A<)#*4J]])I'="QELYWEF0=_7WF$]CD107TE$L+-2.7^4AQN+
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M2M:B>"Z;^O-/G>;E\SC*/T!^4\\H6H:OBWDY^[$A/6@50VUP\,R[.EV%U5D
M$43T3&5KLS-#'GT>_-AIGA>/H_M#)#BQ\D^^XOSRIMK4I8S%2_ FU%T=*H!/
M5H!Q+''F2^(/)R1L3];?^9G3O.L=1^U[RZZ#9-R#9-&[^C^8;5:?1Q&2\JF
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M&=X>VNMIE-N!KW##^*L?-[_]]QG%9LOT[<<[_ //U@4EVO D#7&%I8Z7%,:
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M)[LHK ?L;>UER$(GFT7M=*W+R3@J</7B84:+H,@O$J$YZG[QAI.#\':PDKI
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MG0)P<S1-UCYFRZ!X61O> JLSP02@E3*58!WGK7/KCU,SK>/>1ML#(+2'Z#L
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M 1!J(/8.P#/TS=\X&;,4!60=IZ6"X>"XH2A=TU&1%#DSTSH+U[(88Z(1+ ?
M:PS%=("W)]_=K NIAC->U\$R9&S!93I)V12C0@@QQ-977[>OYT?STULII%]L
M;0XC65X9A1,$@A"(&2G),'M.AED8+6+D4A^I-J,'1[V9VG=Z_]Y%!QT ZN<7
MV8BA2L"3+^@+A3!U268V$5Q).13MR.BV3MN]J/?OG13\[/OW+M+N "[K%]D/
MWW$9+M;SLZN@WOSU'>>KZQ=:'333Q )8KRBRX%F"$XZ!T,KF9.MS<&LOZEFB
M>GX?/P1.;;71"[SN/?BK&+4P%)Y&P>E\>$F_XU:"E&2J-?*44NOBU?W**T9S
MOT>&S][2[@ NCZR>X")Z'1U2E, $*$:_B]('T#811R7G4CK:"S/>_+IC^=<-
MU- EF*Z/6)!HD-S$S WYBIFDXJ2S$(N/#%7!U'S'Y(O:]+*3GH=N>ME%Z!V
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MEN*R9CXH\L4D^7FJOMN%I"*)B7N17601F\/I:9(Z@]2^JG\(J89ZZ !6UW[
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MZ>"S+2,1:4F"!$:"A4R$"58+(V3RNH.IV7=(YUG;[D&8(Q:LRCE8$F,I8<]
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ML_D__3R-&!@3T>HBC*,5)AUNQ  R$&-$UNA#XOE1._N](XE#'U-UL-:G7AJ
MW6K/+"X6BQO<,F4:0]!E?(M<M1KCF83H%%&<1C36J/:J=JQY>_UAXX6]*OIQ
MWF)?J>^-F.^KT:>?EWZ^K)3I>BR;$8N41A_1.D.Y(!^XU9QFM'B(UG I M?5
MT?.$BF&#AD?%T&$:: 9)5_-9'B\O9XO%2(I2(>0M<;@AB$PAD9!"&78OHZ".
MVE3]&<G#ZL/& H^)G#TEWL!M]5)0L_#R 98?\Q?_YR@(%90VD0 K7<5E\F5V
M78D[:"]IHBSJ7F8OO4'7L"'"8^*KNI::</ON/8TM[V,U_LZD57$C>KZK^$0
MW$.^#"\3FB5IJ&:J=FSH)5J&#2L>$V-5M+$[KMP:5U.X7K7^JAZD_C]^<@-G
M$46UJNTN,;#EUUD:48C,@5+$0AE1[P(EH;PKB%%F&3T+\7%CR;I1ZQ?H&C8.
M>4R\5=?2H=C[TD^69.V9W/$VPD.84^".1*-*33>+93X?)UXR#;B?0$&ON/N9
MG&&JH >'VP$Z:<!F6[&P=G7?W\S'T^NKE0.QVD,KSGY!6?[TCF44C 9@$0BS
MP(GDVA%'M2*@1?0A\^1X[0$9NU,Y3$^?P3S-_C38 D97.ZR4Y:"\T#HM$].+
M*)%7_,$+/'K+C->AO'7(%$5*&?K=JO3,\DQQEXV2M4OL]J%SF/9 PT75>M1B
M.W?VO?D[TM$D+8-!(T/@;1!R0%^>9Q*]"<7:I3K4S@/<+SY0JZ!!_8V=!-X.
M8'Z*.#.A$I>(="W*2[U0WE1QG8GWE,=HF(G0S\FU2YS_KQ?HWT7L!X9GSZ=U
MG--G@LQ):Y9->=B.O@Z1.DOBE;)$9V%E-@Y-T-K][_8,\[._:IQ_%Q54!5+M
M=Y$/)=%;+TH/?1#YZH?6>0G9G>Y^GD!:@TZ@@$RTS8@G&CV>)'@1L4!Y$M8S
M5OTE63]/(!558"63)(:<B 3\*B 31 #XP+.1/N<WE-[R$\A=]/32$\A=1-2*
M*_4)OM_,XU<\&:_FL^NY_[9ZI@6!6FN9)2HJ09!N2FQ&4UO;8+S12<7JINK+
MU Q=";6'<I^S+0Z7=+.8V=25<NJ%5CX2MII_5][^!UHB"\%+34U ZZEV9]37
MZ!GX'60EG7>"TAX*&'J^0%'EV>=/F\KAJ+F*J\2V=PS_HP()5CJ"]S'%E9UE
MG<IO?_[4%@&PCZ9F5<0VO,*9>Z <5A0F3Y(3J;2@,<0;5P9&*_Q_2T4VM)O"
MMSYUV)*BOA2^K]@:J[ /R3AFT:EBK@S ,#$2//DXNM@,O:#H(H^ILP%YV5:%
M_3[&P:$R:L$:* [O$\1_@H+X\?3Z[&;Y=38?_ZO,5;K[F[-OLYOIDHUD]!:H
MX^7ZDT1FYTD0 DB(*#+&DE!"UK85]J9V: MT3X \%Y[H7UO-XO*!P3NVH+02
M#1Z]/*WP^BQR=3(F$BFCD;D,(&M/8N](VM#'6I^(.TP/[<'KIU3K.HP\,CP'
MGI(D@HI0$E:96%O&'LC$G86D3:@]A_UMJH;K'-PCJ Z5?@-XNO*WI6'.XM?9
M_(&OCWFK7FYDE'.*ZD1L6 >3/?&@@2 W5D=- ZV>P7Z;JN&Z!M?$4V7I-SA7
M_7%/P!<*?NNU-WQC@=H]#G?AIY\HOPJ:96TRX::,<RP>F2_=A:(T"GTR'>IW
M(*T3Y>]2"%Z*=7^=S/[Y;Y"NX3<T%LL/?X$\*]YNW#0PCNM]/TVE8EQG)Z(S
M0'(J_024RZ7.LLP!T 80-$Z[8];U[\Q 4YF)7;"U2WU_OVIMXB% )?8+[UQ$
MCTY\6$=J)0-%O,$;QEC&8M9*)U-]4&$UZEOHS]42GG=5:#O%0;4V=$9KHTA!
ML4!S $J28R@%937QWC-"@[9&HLN?0B\C$NNQT$)CL):PO9=J&W""=F;_,>-K
M<13.006O.5Y,0$MJ1'%+'&C\2J2LJ=<FT<'/ZA>I;Z$_V3!XKJ/0$SZKG[NF
M(AI7O(RY9%8[(G'K$E]ZHQ@I4Q8!P+)>1F<<2'<+7=/:0/&N2OPK',7W=U &
M5J:5EWY3'"6/LB;!@"&*N\1HI(KV,_BE!O$M=&YK \)[J?.$S^$5OR_?1C1$
M'=!U*.V)4BD.!^*<B\0HH:E)UB91.Q9;F85A7V<.">V*JJTVPF9H9!?&1;(L
MEXRN3<BNA,R)DY83RX4P(#+5M':OU6K$#_N\LSDT[ZK.@P_JQN"\"59*K>RJ
M5PECUI:<C2&NM,_A"OW>S P_;F^97>D?]BUH<Z#>0ZF-G\^O3ES>'K7\ 99_
M3/VWV7Q92B;NI30?+\;3Z^WD]\,UEI2%G*PF4=!2;)@56FPV$]2ASS0KM--Z
M&8AW?%8'?M=ZI'W2"E8:]DV?F5'>61A%#([Z'#-/1$0-* 90>&.&,FI!*9>H
M1>NO=L%.3ZP,_&;W"%OBF+INWXT]1!KW/=ZT5\%'F8CAY130Z..[Y U)*CMC
MLE12UR['[9.?@1\=-[X']M)ZPV?_LS&K]%\WBV6Y'W]%]9Q]?'?1^1+]=39'
M"?V<92O2,E*"EGA3ZA19Z>:$QP8U*#)F71:2,2IK=\T=EN-NN^C4<ZN-(:?]
M"Z=7H:WNYZ@-,\F5L6J*2!\="> ]R5RG8#QUNOH<LJ%X[;;%3CW=VPQ:_JZ7
MV/V-3YD'G:0EEJ*/)SV3*#9.2?;>YI"92M6'C0[*<+?]=>J)Z+9P<QHWV*_C
MJ9^,_[62U\?\()\/L^GFFY^%5*13^B@^RA@YF\KT-%2I#"6U[_$< N>(BB"3
MD((:.);C5(^K;KOFU'/? R"@X?OG(&FLBK2H#4I%3K0I/=.$BB1$&HB.U'K.
M=(@F'FDG',I+-_R?<H+\J-K^&UP(]Q>EMRK(H%$NE >\*/$_:(W:TA/ <LNX
M.-XNJ,94M^UPZAGVX^N_X=M@IZS3@[GY<"MZ+7F*3A#!#"?21DFL 4>$P1LR
M2#0G>>U1&WWQT@W^IYZ+/YJV3Z/>I+,X"OM,4&5-3,0I+\I 74%\3D"B<CRF
M3!/ ,6M-=J&]V].POTT"?5=M_E6*3!XV]?U-9C2-(>G2EBZO:B%+3R,M"0TR
M,\.DX]4[]/3$2C>,GW)&_)BZ/HWS^^R''T]*;ZXR3\!/X#/$F_EX.89G[R^G
MK7=,HDZR9J7[:R)66T5B-#FPY&QFQWP&N1/QW=!]RKGN?O79N!7^,N.K1Y[:
M:.:=*Y/3))&,(J,JLI)9%,P"A6B.6>GW*K'=@'KJZ>1Z^CJ-L$F7C?DP2A(O
M&:<B15$G0V29L&"5MB3BKC2N#')QQTP_[4)[-_2>>J:V-VTVW0\$F87Q]?3=
M#5(UC;=?YF@EH90W=>?EN\E*TYVZI$0?7;))$F5YJ2ZTDO@4#7%6NLPT59P?
MJTRH)E_=\'_*F=3!4-#TWEB%1I^1S.11IGGU[ @23YPSDJE S[D,.K$)S2Y
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MB]_A6X#YB%/EN8V"1%]F5 <72>"A3&/GP3*-)[.M'9EY0D23P-E'P;.:TFX
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MAD1E]8[!=2AOY+2K ]$!E'F:$#[_$^9QO #TJTLJY>/W\B>+D6#&Q]+).#'
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M,PP?Q@S85R_% .<]8M>064@"T"_V6KWF4:=9=>R,@>W_!(%M[UQ@S[C!6<?
M) MVFZJYA.@&JA@88<K(8/RTCU^DT)A485[%L;A(&4:;Y:G5.: OF&E=TE4Q
MXRS!)RVX9#$/\95F*A&66>7E'@FD$((Q7"]().&WX*"QU&GP781FX9#296P<
M@P1"H3%#HUB*W=&2"'$TGXIPRDQ./ZO^<]!0*"$'$F$DIG*J"N;"3M%!DT'H
M#"2]&9JF(G1SAMTB%BPV3\A/@LK.WP>5P&*18K0).*OH5A&(*([->JU=I$@Q
M"#.L*/'O4.;$+XB@C:&L(@X%/68(!4(QH5O*%4P+A)@'1N!*B%S16B6)7*(
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MT/)P:!/<S!-X\[L4?\2P@=8H@YZ&+UEM*SB+XA2Z ,*@AJSZY&\@\YL\ 8#
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MMW?9=DUGZTVKXM/?^W(WT$[_ U!+ P04    " "I7%I50ASU,>H$   *$
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M(0DV\-KL9MEU3=EY+VV?S2W9W=>/_P%02P,$%     @ J5Q:53)Y8R#;!
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M\[K9/.O+K[N&'_\-4$L! A0#%     @ J5Q:534 Y/$Y:0, A-PN !
M         ( !     &)M>2TR,#(R,#DS,"YH=&U02P$"% ,4    " "I7%I5
M:NNGN@0:  !,)@$ $               @ %G:0, 8FUY+3(P,C(P.3,P+GAS
M9%!+ 0(4 Q0    ( *E<6E7#9PS?VC,  .<7 @ 4              "  9F#
M P!B;7DM,C R,C Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( *E<6E59[&2<6H<
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M>#,Q85\R,#(R,#DS,"YH=&U02P$"% ,4    " "I7%I5N)#X]54(  #<)@
M%0              @ %W4 8 8FUY97@S,6)?,C R,C Y,S N:'1M4$L! A0#
M%     @ J5Q:54(<]3'J!   "A   !4              ( !_U@& &)M>65X
M,S)A7S(P,C(P.3,P+FAT;5!+ 0(4 Q0    ( *E<6E4R>6,@VP0  .$/   5
M              "  1Q>!@!B;7EE>#,R8E\R,#(R,#DS,"YH=&U02P4&
/  H "@"0 @  *F,&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
